{"_type":"map","map":[["D009101",{"mesh_id":"D009101","trials":[{"ligand":"abemaciclib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D009101","phase":"Phase 2","start_date":"2016","completion_date":"2019","nct_id":"NCT02693535;NCT03732703"},{"ligand":"acalabrutinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02211014"},{"ligand":"acalabrutinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02362035;NCT02328014"},{"ligand":"afatinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02693535;NCT04439136;NCT02465060"},{"ligand":"alpelisib","mesh_id":"D009101","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02144038"},{"ligand":"axitinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03297606"},{"ligand":"binimetinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02465060;NCT04439344;NCT02834364"},{"ligand":"bosutinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03297606"},{"ligand":"cabozantinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01582295;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01866293;NCT03201250"},{"ligand":"cetuximab","mesh_id":"D009101","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00368121;NCT01524978"},{"ligand":"cobimetinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2016","completion_date":"2019","nct_id":"NCT02693535;NCT03312530;NCT03297606;NCT03732703"},{"ligand":"copanlisib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02693535;NCT04439266;NCT03297606;NCT04439253;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D009101","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03091257;NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439292;NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04603872;NCT00560352;NCT00560391;NCT01643603;NCT01609816;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT04439305;NCT03297606;NCT00429949;NCT01116128;NCT02465060"},{"ligand":"encorafenib","mesh_id":"D009101","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02834364"},{"ligand":"erdafitinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02952573;NCT03732703;NCT02465060"},{"ligand":"erlotinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00725634;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03297606"},{"ligand":"everolimus","mesh_id":"D009101","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00729638;NCT01889420;NCT02240719;NCT00962507;NCT02407509;NCT03878524"},{"ligand":"everolimus","mesh_id":"D009101","phase":"Phase 2","start_date":"2005","completion_date":"2010","nct_id":"NCT00618345;NCT00474929;NCT00918333;NCT01234974"},{"ligand":"ibrutinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2014","completion_date":"2019","nct_id":"NCT02109224;NCT03702725"},{"ligand":"ibrutinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT02902965;NCT03015792;NCT01962792;NCT01478581;NCT02548962;NCT02943473"},{"ligand":"imatinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00167180"},{"ligand":"larotrectinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nintedanib","mesh_id":"D009101","phase":"Phase 1","start_date":"2003","completion_date":"2003","nct_id":"NCT02182141"},{"ligand":"osimertinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D009101","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT02030483;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D009101","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT02693535;NCT03297606;NCT00555906;NCT02465060"},{"ligand":"pazopanib","mesh_id":"D009101","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00256880"},{"ligand":"pemigatinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02393248"},{"ligand":"pertuzumab","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02693535;NCT03297606;NCT02465060"},{"ligand":"ponatinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D009101","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02693535"},{"ligand":"ruxolitinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03110822;NCT03017820;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT03773107;NCT00639002"},{"ligand":"selumetinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01085214"},{"ligand":"sirolimus","mesh_id":"D009101","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00602693;NCT01689987;NCT00398515;NCT01396200;NCT03963024;NCT01163357;NCT02240719;NCT00962507;NCT00973804;NCT00060632;NCT03657420;NCT03018223;NCT00317798;NCT00513474;NCT00060645;NCT01634217;NCT03878524;NCT00693433"},{"ligand":"sirolimus","mesh_id":"D009101","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT02693535;NCT00105001;NCT00691015;NCT01116232;NCT00079456;NCT01460420;NCT01177397;NCT00133367;NCT03225417;NCT00474929;NCT02356159;NCT03297606;NCT01303965;NCT01251575;NCT04176380;NCT01239368;NCT01534143;NCT03246906;NCT00918333;NCT03192397;NCT00544115;NCT00589563;NCT02991898;NCT00520130;NCT00089037;NCT00483262;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D009101","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01231412"},{"ligand":"sorafenib","mesh_id":"D009101","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00303797;NCT00687674;NCT00118170;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D009101","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00536575;NCT00474929;NCT00253578"},{"ligand":"sunitinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT02693535;NCT03297606;NCT02465060;NCT00514137"},{"ligand":"trametinib","mesh_id":"D009101","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01476137;NCT03091257;NCT03878524"},{"ligand":"trametinib","mesh_id":"D009101","phase":"Phase 2","start_date":"2013","completion_date":"2016","nct_id":"NCT04439318;NCT04439279;NCT04439292;NCT02465060;NCT01989598;NCT02140840;NCT04439357"},{"ligand":"trastuzumab","mesh_id":"D009101","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00991562;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D009101","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02693535;NCT02393248;NCT04439110;NCT03297606;NCT02465060"},{"ligand":"vemurafenib","mesh_id":"D009101","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D009101","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT02693535;NCT03297606;NCT01524978;NCT02115035"}],"predictions":[{"target":"IGF1R","probability":"0.5825326909841706"},{"target":"EPHB2","probability":"0.488502824858757"},{"target":"EPHA2","probability":"0.48374695555750885"},{"target":"MST1R","probability":"0.48029954341504494"},{"target":"AXL","probability":"0.47988999933252025"},{"target":"PTK2","probability":"0.4654773175332334"}],"source_name":"Multiple Myeloma"}],["D008228",{"mesh_id":"D008228","trials":[{"ligand":"abemaciclib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02693535"},{"ligand":"acalabrutinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03527147"},{"ligand":"acalabrutinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02180711;NCT04257578;NCT04094142"},{"ligand":"afatinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02693535"},{"ligand":"axitinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03297606"},{"ligand":"bosutinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03297606"},{"ligand":"brigatinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2018","completion_date":"2020","nct_id":"NCT03719898;NCT04260009"},{"ligand":"cabozantinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ceritinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02729961"},{"ligand":"cetuximab","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"cobimetinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02693535;NCT03297606"},{"ligand":"copanlisib","mesh_id":"D008228","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT03884998;NCT03498430;NCT02253420;NCT02155582;NCT03886649;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D008228","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02535247;NCT01660451"},{"ligand":"copanlisib","mesh_id":"D008228","phase":"Phase 3","start_date":"2015","completion_date":"2016","nct_id":"NCT02367040;NCT02626455;NCT02369016"},{"ligand":"crizotinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01606878"},{"ligand":"crizotinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT02693535;NCT03297606;NCT01979536;NCT00939770"},{"ligand":"crizotinib","mesh_id":"D008228","phase":"Phase 4","start_date":"2015","completion_date":"2015","nct_id":"NCT02487316"},{"ligand":"dabrafenib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04603872;NCT01643603;NCT00608361;NCT01609816;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT03023046;NCT03297606;NCT02043587;NCT00550615"},{"ligand":"duvelisib","mesh_id":"D008228","phase":"Phase 1","start_date":"2013","completion_date":"2016","nct_id":"NCT01871675;NCT02640833"},{"ligand":"duvelisib","mesh_id":"D008228","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT04038359;NCT01882803"},{"ligand":"duvelisib","mesh_id":"D008228","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02576275"},{"ligand":"erdafitinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03297606"},{"ligand":"everolimus","mesh_id":"D008228","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT01567475;NCT01088048;NCT00622258;NCT03878524"},{"ligand":"everolimus","mesh_id":"D008228","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT01075321;NCT04305444;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2011","completion_date":"2018","nct_id":"NCT03479268;NCT01479842;NCT01955499;NCT02954406;NCT02109224;NCT02303392;NCT01569750;NCT02950220"},{"ligand":"ibrutinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02662296;NCT02207062;NCT04419389;NCT03310619;NCT01980654;NCT04659044;NCT03198026;NCT02332980;NCT01109069"},{"ligand":"ibrutinib","mesh_id":"D008228","phase":"Phase 3","start_date":"2014","completion_date":"2019","nct_id":"NCT03570892;NCT01974440;NCT02703272"},{"ligand":"ibrutinib","mesh_id":"D008228","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03229200"},{"ligand":"imatinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2008","completion_date":"2018","nct_id":"NCT02431403;NCT03023046;NCT00684411;NCT02538926"},{"ligand":"imatinib","mesh_id":"D008228","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02881086"},{"ligand":"larotrectinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"lenvatinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155817"},{"ligand":"palbociclib","mesh_id":"D008228","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00141297;NCT03792256;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02693535;NCT03297606;NCT03526250;NCT03155620"},{"ligand":"pertuzumab","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02693535;NCT03297606"},{"ligand":"ponatinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D008228","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03013218"},{"ligand":"regorafenib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02693535"},{"ligand":"ruxolitinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02613598;NCT03017820;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01431209"},{"ligand":"selumetinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213691;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D008228","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT04473911;NCT01614197;NCT01658007;NCT02728700;NCT00068302;NCT00973804;NCT01088048;NCT03018223;NCT00622258;NCT01403415;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D008228","phase":"Phase 2","start_date":"2002","completion_date":"2017","nct_id":"NCT02693535;NCT00105001;NCT00290472;NCT01177397;NCT01281917;NCT01381692;NCT03297606;NCT01251575;NCT01075321;NCT02790515;NCT00350181;NCT00033267;NCT01181271;NCT03213678;NCT01170052;NCT01076543;NCT00918333;NCT00577278;NCT03155620;NCT01220297"},{"ligand":"sirolimus","mesh_id":"D008228","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01231412"},{"ligand":"sirolimus","mesh_id":"D008228","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01180049"},{"ligand":"sorafenib","mesh_id":"D008228","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00118170;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D008228","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00278382;NCT00131937"},{"ligand":"sunitinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT02693535;NCT03297606;NCT00392496"},{"ligand":"trametinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D008228","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03013218;NCT03432741;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02693535;NCT03297606"},{"ligand":"vemurafenib","mesh_id":"D008228","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D008228","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02693535;NCT03220035;NCT03297606;NCT03155620"},{"ligand":"zanubrutinib","mesh_id":"D008228","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02914938"},{"ligand":"zanubrutinib","mesh_id":"D008228","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03332017"},{"ligand":"zanubrutinib","mesh_id":"D008228","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT04002297"}],"predictions":[{"target":"BCR","probability":"0.6821"},{"target":"EPHB2","probability":"0.6341666666666668"},{"target":"AXL","probability":"0.6191735019366598"},{"target":"TYRO3","probability":"0.6010714285714286"},{"target":"PTK2","probability":"0.5463157894736842"},{"target":"BMPR1B","probability":"0.5445968992248063"},{"target":"MAP2K7","probability":"0.5441666666666667"},{"target":"STK11","probability":"0.5381440449737306"},{"target":"ACVR2B","probability":"0.5344"},{"target":"PTK7","probability":"0.5307204994238103"},{"target":"TGFBR1","probability":"0.5201418196607018"},{"target":"AKT2","probability":"0.5178455838935441"},{"target":"TGFBR2","probability":"0.515570706840556"},{"target":"EPHB4","probability":"0.5152505310874502"},{"target":"YES1","probability":"0.5060207701675593"},{"target":"MUSK","probability":"0.49"},{"target":"EPHA2","probability":"0.4745138303183695"},{"target":"SYK","probability":"0.4668955928040873"},{"target":"ACVR1B","probability":"0.46594138331639107"},{"target":"BMPR2","probability":"0.46548906271632284"},{"target":"ACVRL1","probability":"0.46062387357973095"},{"target":"TEC","probability":"0.46034783819194236"},{"target":"MST1R","probability":"0.4565488311113773"}],"source_name":"Lymphoma, Non-Hodgkin"}],["D008175",{"mesh_id":"D008175","trials":[{"ligand":"abemaciclib","mesh_id":"D008175","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02779751"},{"ligand":"abemaciclib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02450539;NCT02308020;NCT04010357;NCT04545710"},{"ligand":"abemaciclib","mesh_id":"D008175","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02152631"},{"ligand":"afatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT03711422;NCT03827070;NCT01288430;NCT01836341;NCT04448379;NCT01999985;NCT02364609"},{"ligand":"afatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT02716311;NCT02629523;NCT02747953;NCT02488694;NCT03157089;NCT04148898;NCT02768337;NCT02625168;NCT02470065;NCT04470076;NCT01542437;NCT02271906;NCT04497584;NCT01480141;NCT01415011;NCT02906163;NCT02465060;NCT03399669;NCT00711594;NCT01156545;NCT01466660"},{"ligand":"afatinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02438722"},{"ligand":"afatinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"alectinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02013219"},{"ligand":"alectinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04302025;NCT03944772;NCT04634110;NCT02706626;NCT04111705;NCT03202940;NCT03087448;NCT03131206;NCT03779191;NCT03737994;NCT03445000;NCT02450903;NCT01871805;NCT02521051"},{"ligand":"alectinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2014","completion_date":"2017","nct_id":"NCT03178552;NCT02838420;NCT02075840;NCT02604342"},{"ligand":"alectinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"alpelisib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02276027"},{"ligand":"apatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT03050411"},{"ligand":"apatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03190239;NCT03547804;NCT03127319;NCT04133337;NCT03129256;NCT03461185;NCT03135977;NCT02974933;NCT04201990;NCT03417895;NCT03164694;NCT02540824;NCT01270386;NCT04425135;NCT03256721;NCT02733107;NCT02945852;NCT04128800;NCT02515435;NCT04683198;NCT03811054;NCT04749394;NCT04379739;NCT02995187;NCT03652857;NCT02980809;NCT03201146;NCT03389087;NCT04659785"},{"ligand":"apatinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2011","completion_date":"2020","nct_id":"NCT02875457;NCT01287962;NCT04490421;NCT02702323;NCT04203485;NCT03651219;NCT02780778;NCT02332512"},{"ligand":"apatinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03792503"},{"ligand":"avapritinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT00094094;NCT03386929;NCT03472560;NCT00735904;NCT04459663"},{"ligand":"binimetinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT02185690;NCT04005144;NCT02451865;NCT02964689;NCT01859026"},{"ligand":"binimetinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT04735068;NCT04526782;NCT04292119;NCT03915951;NCT03170206;NCT02465060;NCT02276027"},{"ligand":"brigatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03707938;NCT04227028;NCT04005144"},{"ligand":"brigatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT04634110;NCT02706626;NCT04111705;NCT03087448;NCT03737994;NCT04223596"},{"ligand":"brigatinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02737501"},{"ligand":"cabozantinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04173338;NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2007","completion_date":"2021","nct_id":"NCT02132598;NCT04151563;NCT00596648;NCT04131543;NCT03911193;NCT01639508;NCT01866410;NCT04310007"},{"ligand":"ceritinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT02292550;NCT02299505;NCT01772797;NCT03611738"},{"ligand":"ceritinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT01964157;NCT02040870;NCT01685060;NCT02336451;NCT01685138;NCT04634110;NCT02706626;NCT04111705;NCT03087448;NCT03737994;NCT02450903;NCT02276027;NCT03399487"},{"ligand":"ceritinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01828099;NCT01828112"},{"ligand":"ceritinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"cetuximab","mesh_id":"D008175","phase":"Phase 1","start_date":"2005","completion_date":"2019","nct_id":"NCT00522886;NCT00397384;NCT03808701;NCT00288054;NCT00622674;NCT00207116;NCT01212627;NCT00569296"},{"ligand":"cetuximab","mesh_id":"D008175","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT00910676;NCT00828841;NCT02716311;NCT00112346;NCT00408499;NCT00081302;NCT00165334;NCT00124618;NCT00216203;NCT00492206;NCT00097214;NCT00034541;NCT00085501;NCT00986674;NCT01004731;NCT00315185;NCT00103207;NCT03717155;NCT00118183;NCT01102231;NCT00870870;NCT04285671;NCT00101348;NCT00998101;NCT04648189;NCT00343291;NCT00203931;NCT04464967;NCT01059188;NCT02845856;NCT00368992;NCT00193453;NCT00694603;NCT00117962;NCT00323869;NCT00330746;NCT00519831;NCT00097227;NCT01109524;NCT00673738;NCT00768131;NCT00063388;NCT00867009"},{"ligand":"cetuximab","mesh_id":"D008175","phase":"Phase 3","start_date":"2004","completion_date":"2015","nct_id":"NCT00533949;NCT00095199;NCT02438722;NCT00148798;NCT00112294;NCT00946712;NCT00820755"},{"ligand":"cobimetinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04302025;NCT03202940"},{"ligand":"cobimetinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03178552"},{"ligand":"copanlisib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2006","completion_date":"2018","nct_id":"NCT01579994;NCT00585195;NCT02277457;NCT02695550;NCT01441128;NCT01121575;NCT03607188;NCT00965731;NCT01998126;NCT02511184"},{"ligand":"crizotinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT01964157;NCT02584634;NCT04211922;NCT02040870;NCT03088930;NCT01970865;NCT01752400;NCT02183870;NCT01685060;NCT01500824;NCT02336451;NCT01685138;NCT04292119;NCT04634110;NCT04084717;NCT04641754;NCT02664935;NCT02465060;NCT04111705;NCT03087448;NCT02314364;NCT03215693;NCT01712217;NCT04621188;NCT03737994;NCT01945021;NCT01822496;NCT01871805;NCT02574078;NCT02134912;NCT03399487"},{"ligand":"crizotinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2011","completion_date":"2019","nct_id":"NCT02838420;NCT04632758;NCT02075840;NCT02201992;NCT01828112;NCT01639001;NCT02767804;NCT02604342;NCT02737501;NCT01154140"},{"ligand":"crizotinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"dabrafenib","mesh_id":"D008175","phase":"Phase 2","start_date":"2011","completion_date":"2018","nct_id":"NCT02672358;NCT02465060;NCT01336634;NCT03543306"},{"ligand":"dabrafenib","mesh_id":"D008175","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03340506"},{"ligand":"dacomitinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2010","completion_date":"2019","nct_id":"NCT03755102;NCT03810807;NCT01918761;NCT01441128;NCT01121575;NCT00971191"},{"ligand":"dacomitinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT04027647;NCT04504071;NCT04339829;NCT01858389;NCT04675008;NCT00769067;NCT01465802"},{"ligand":"dacomitinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2009","completion_date":"2011","nct_id":"NCT01000025;NCT01360554"},{"ligand":"dacomitinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04511533"},{"ligand":"dasatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2009","completion_date":"2013","nct_id":"NCT00787852;NCT01999985;NCT00779389"},{"ligand":"dasatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT00826449;NCT00787267;NCT01491633;NCT00470054;NCT00509041;NCT00564876;NCT00570401;NCT02465060;NCT00858403;NCT00459342;NCT02954523"},{"ligand":"encorafenib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02109653;NCT04526782;NCT03915951"},{"ligand":"entrectinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04302025;NCT04621188"},{"ligand":"entrectinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03178552"},{"ligand":"erdafitinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03827850;NCT02465060;NCT02699606"},{"ligand":"erlotinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2001","completion_date":"2018","nct_id":"NCT00633529;NCT00042835;NCT02013219;NCT02157883;NCT01069757;NCT02468661;NCT01594398;NCT00569114;NCT02134886;NCT00072072;NCT00738335;NCT02277457;NCT01302808;NCT00975767;NCT00088959;NCT01193881;NCT00397384;NCT00702182;NCT02507375;NCT01121575;NCT01545947;NCT01570296;NCT00738751;NCT02321293;NCT01251796;NCT00965731;NCT01288430;NCT00294736;NCT00708448;NCT00456833;NCT00581789;NCT01515969;NCT01454102;NCT01839955;NCT00536861;NCT03050411;NCT02342353;NCT02991651;NCT01998126;NCT02364609;NCT01026844;NCT00030498;NCT01967095;NCT03628521;NCT01911507;NCT00779389;NCT01859026;NCT00707252"},{"ligand":"erlotinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2002","completion_date":"2019","nct_id":"NCT00391586;NCT00910676;NCT00087412;NCT00826449;NCT01204307;NCT01728181;NCT02716311;NCT01211483;NCT00370383;NCT01248247;NCT00701558;NCT00940875;NCT00997334;NCT00367601;NCT00251589;NCT01998919;NCT00553462;NCT03126799;NCT01027598;NCT00408499;NCT00871923;NCT01104155;NCT00596648;NCT01928160;NCT02759835;NCT01294306;NCT00855894;NCT00351039;NCT00973310;NCT01556191;NCT01378962;NCT00531960;NCT02738983;NCT01350817;NCT00339586;NCT00577707;NCT01130753;NCT00281021;NCT00387322;NCT01130779;NCT01091376;NCT01116219;NCT00801385;NCT00312728;NCT03497767;NCT00840125;NCT00062101;NCT02747953;NCT00266877;NCT00750698;NCT00621049;NCT03461185;NCT00778167;NCT01131429;NCT00547105;NCT02250846;NCT00615758;NCT00147537;NCT00125359;NCT01410214;NCT04148898;NCT00518011;NCT00777309;NCT02318368;NCT00854308;NCT00888511;NCT02625168;NCT00278187;NCT00411632;NCT01259089;NCT00265317;NCT00783471;NCT00673569;NCT01250119;NCT01372384;NCT00800202;NCT02774278;NCT01857271;NCT00661193;NCT01455389;NCT03119519;NCT01174563;NCT00550537;NCT00702975;NCT00809237;NCT00816868;NCT00567359;NCT01229150;NCT00390429;NCT02353741;NCT01260181;NCT03123484;NCT01610336;NCT00503971;NCT00585533;NCT00287989;NCT02117024;NCT00466284;NCT02095782;NCT00283244;NCT00773383;NCT00499655;NCT00410059;NCT00101348;NCT00453362;NCT00473083;NCT00043823;NCT00652340;NCT00445848;NCT00570401;NCT00436332;NCT00200395;NCT03595644;NCT00950365;NCT01480141;NCT02770014;NCT00063258;NCT00391248;NCT00072631;NCT00600015;NCT03865511;NCT01471964;NCT01189435;NCT00554775;NCT00466089;NCT00087269;NCT00678964;NCT00609804;NCT01344824;NCT02424617;NCT02191059;NCT00280150;NCT00039182;NCT02906163;NCT01557959;NCT02039674;NCT00100854;NCT00462995;NCT01101334;NCT00385398;NCT01188707;NCT00908336;NCT00994123;NCT00137800;NCT02117167;NCT00760929;NCT01068587;NCT01514877;NCT00590902;NCT01221077;NCT00749567;NCT00606502;NCT03137771;NCT00063895;NCT02495233;NCT00531934;NCT00278148;NCT00452075;NCT02314364;NCT00769067;NCT00830245;NCT00416650;NCT00284141;NCT01796288;NCT02556593;NCT02352948;NCT00722969;NCT02045446;NCT03076164;NCT02034097;NCT00988169;NCT00522938;NCT03399669;NCT00711594;NCT02013206;NCT00085839;NCT01714908;NCT00343187;NCT01204697;NCT02069418;NCT01822496;NCT02705820;NCT00660816;NCT00354549;NCT01310036;NCT01504542;NCT01955421;NCT00563784;NCT01866410;NCT01487265;NCT01562028;NCT00663689;NCT01996332;NCT02954523;NCT01395758;NCT00452413;NCT02574078;NCT02507518;NCT00976677;NCT03424759;NCT02044601;NCT01306045;NCT01580735;NCT00095225;NCT00550173;NCT03399487"},{"ligand":"erlotinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2001","completion_date":"2017","nct_id":"NCT01342965;NCT01887795;NCT00883779;NCT01158170;NCT00091663;NCT00556322;NCT00989690;NCT02296125;NCT01328951;NCT02134015;NCT00312377;NCT01244191;NCT01404260;NCT01377376;NCT01360554;NCT00047736;NCT00446225;NCT01351415;NCT02152631;NCT02411448;NCT00036647;NCT02031744;NCT03074864;NCT00364351;NCT00874419;NCT02714010;NCT01456325;NCT00153803;NCT00718315;NCT02416739;NCT00300586;NCT01887886;NCT00349219;NCT01667562;NCT01183858;NCT00257608;NCT00275132;NCT00637910;NCT02588261;NCT00373425;NCT01407822;NCT00096265;NCT00130728;NCT00556712;NCT00440414;NCT00738881;NCT01802021;NCT00673049;NCT00457392;NCT00955695;NCT02633189;NCT02926638"},{"ligand":"erlotinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2004","completion_date":"2020","nct_id":"NCT01287754;NCT01320501;NCT01230710;NCT03890055;NCT01066884;NCT01196078;NCT04401059;NCT02031601;NCT03264794;NCT00949910;NCT04356118;NCT01336192"},{"ligand":"everolimus","mesh_id":"D008175","phase":"Phase 1","start_date":"2004","completion_date":"2012","nct_id":"NCT00434174;NCT01063478;NCT00655655;NCT01470209;NCT01167530;NCT00401778;NCT01079481;NCT00807755;NCT00466466;NCT00456833;NCT00892801;NCT00457119;NCT01700400"},{"ligand":"everolimus","mesh_id":"D008175","phase":"Phase 2","start_date":"2004","completion_date":"2018","nct_id":"NCT00406276;NCT00096486;NCT03670030;NCT00374140;NCT00770120;NCT01563354;NCT01427946"},{"ligand":"everolimus","mesh_id":"D008175","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01317615"},{"ligand":"gefitinib","mesh_id":"D008175","phase":"Phase 1","start_date":"1999","completion_date":"2018","nct_id":"NCT02157883;NCT00255489;NCT00328562;NCT01121575;NCT01570296;NCT00372515;NCT02321293;NCT00252798;NCT01288430;NCT03599518;NCT01147211;NCT00310154;NCT02374645;NCT03050411;NCT00005806;NCT01967095"},{"ligand":"gefitinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2001","completion_date":"2019","nct_id":"NCT03122717;NCT02716311;NCT01192243;NCT02025218;NCT01982955;NCT03292133;NCT00891579;NCT00062270;NCT01928160;NCT02759835;NCT01556191;NCT01196234;NCT00333294;NCT00096486;NCT00062062;NCT02319577;NCT03944772;NCT00411047;NCT01498562;NCT02347839;NCT02747953;NCT00266877;NCT03461185;NCT00615758;NCT04148898;NCT00319800;NCT00173875;NCT00298688;NCT00238628;NCT01783834;NCT00025207;NCT00452244;NCT02179671;NCT03119519;NCT00809237;NCT03123484;NCT01610336;NCT01192230;NCT00029003;NCT01510990;NCT02804776;NCT00570401;NCT00188617;NCT03595644;NCT00986284;NCT01480141;NCT01749072;NCT03865511;NCT01189435;NCT01312337;NCT02191059;NCT02906163;NCT01784549;NCT02039674;NCT01871480;NCT00068653;NCT02025114;NCT01514877;NCT01530334;NCT00616499;NCT01037998;NCT00238251;NCT00614809;NCT00040794;NCT01391260;NCT00234442;NCT03399669;NCT00711594;NCT01951469;NCT00231465;NCT01039948;NCT00193336;NCT01024712;NCT01997775;NCT00344773;NCT00217698;NCT01466660;NCT01955421;NCT01513174;NCT02954523;NCT00098462;NCT00588445;NCT03424759;NCT00048087;NCT01580735;NCT00409006;NCT03399487;NCT00103051"},{"ligand":"gefitinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2000","completion_date":"2020","nct_id":"NCT01158170;NCT02296125;NCT00049543;NCT02518802;NCT02350361;NCT00020709;NCT00144066;NCT01405079;NCT01544179;NCT01404260;NCT02326285;NCT02411448;NCT04239833;NCT02714010;NCT04028778;NCT04248829;NCT03787992;NCT01040780;NCT03856697;NCT02416739;NCT01066195;NCT00091156;NCT02588261;NCT02338011;NCT00357734;NCT00252707;NCT01017874;NCT00955695;NCT00006048;NCT00006049"},{"ligand":"gefitinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2008","completion_date":"2020","nct_id":"NCT01720901;NCT00770588;NCT01000740;NCT04401059;NCT02031601;NCT03264794"},{"ligand":"gilteritinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02495233"},{"ligand":"ibrutinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02950038;NCT02403271;NCT02321540"},{"ligand":"icotinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02066870"},{"ligand":"icotinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT01744925;NCT02264210;NCT02738983;NCT03396185;NCT03153358;NCT03749213;NCT02407366;NCT02027090;NCT03123484;NCT02375022;NCT03595644;NCT02062515;NCT02009605;NCT02961270;NCT01929200;NCT02191059;NCT01514877;NCT03349203;NCT01688713;NCT02215356;NCT03346811"},{"ligand":"icotinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2009","completion_date":"2019","nct_id":"NCT01724801;NCT01996098;NCT02714010;NCT01040780;NCT03008109;NCT03992885;NCT02448797"},{"ligand":"icotinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2013","completion_date":"2020","nct_id":"NCT01720901;NCT04401059;NCT02031601;NCT02194556;NCT02744664"},{"ligand":"imatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2002","completion_date":"2003","nct_id":"NCT00052494;NCT00045604"},{"ligand":"imatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2002","completion_date":"2016","nct_id":"NCT01083589;NCT00425646;NCT00408460;NCT00248482;NCT01011075;NCT00193349;NCT01019798;NCT00323362;NCT00222144;NCT02127372;NCT00156286;NCT02954523;NCT00052949"},{"ligand":"imatinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03264794"},{"ligand":"lapatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2006","completion_date":"2007","nct_id":"NCT00528281;NCT00313599"},{"ligand":"lapatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2003","completion_date":"2019","nct_id":"NCT00073008;NCT03845270;NCT01306045"},{"ligand":"larotrectinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00832819"},{"ligand":"lenvatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2011","completion_date":"2018","nct_id":"NCT01529112;NCT03516981"},{"ligand":"lenvatinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT04716933;NCT03976375;NCT03829332;NCT03829319;NCT04676412"},{"ligand":"lorlatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02584634;NCT01970865;NCT04292119;NCT04634110;NCT02927340;NCT04111705;NCT04621188;NCT03737994"},{"ligand":"lorlatinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04541706"},{"ligand":"necitumumab","mesh_id":"D008175","phase":"Phase 1","start_date":"2015","completion_date":"2016","nct_id":"NCT02789345;NCT02451930"},{"ligand":"necitumumab","mesh_id":"D008175","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03574818;NCT03944772;NCT02443337;NCT01769391;NCT04285671;NCT01788566;NCT02392507;NCT02941601;NCT01763788"},{"ligand":"necitumumab","mesh_id":"D008175","phase":"Phase 3","start_date":"2009","completion_date":"2010","nct_id":"NCT00982111;NCT00981058"},{"ligand":"neratinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00266877;NCT01827267"},{"ligand":"nintedanib","mesh_id":"D008175","phase":"Phase 1","start_date":"2013","completion_date":"2015","nct_id":"NCT02225405;NCT01683682"},{"ligand":"nintedanib","mesh_id":"D008175","phase":"Phase 2","start_date":"2011","completion_date":"2018","nct_id":"NCT03377023;NCT01948141;NCT01441297;NCT02531737;NCT02152059;NCT02299141"},{"ligand":"olaratumab","mesh_id":"D008175","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT00918203"},{"ligand":"olmutinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02485652"},{"ligand":"osimertinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT02228369;NCT03255083;NCT03755102;NCT02157883;NCT02789345;NCT02317016;NCT03567642;NCT03891615;NCT03535363;NCT03810807;NCT04676477;NCT03858491;NCT04762199;NCT04141644;NCT04479306;NCT03050411;NCT04448379;NCT04085315;NCT02163733;NCT04780568"},{"ligand":"osimertinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03392246;NCT03122717;NCT04743505;NCT03460275;NCT02917993;NCT03434418;NCT03586453;NCT03804580;NCT02759835;NCT03257124;NCT03831932;NCT03455829;NCT04563871;NCT03944772;NCT03667820;NCT03497767;NCT02504346;NCT02841579;NCT04519983;NCT04148898;NCT03769103;NCT02442349;NCT02179671;NCT03410043;NCT04410796;NCT02803203;NCT04606771;NCT04285671;NCT02664935;NCT03865511;NCT03450330;NCT04099836;NCT02465060;NCT03433469;NCT04425681;NCT03810066;NCT04233021;NCT01802632;NCT03909334;NCT03239340;NCT02954523;NCT02769286;NCT03424759;NCT04335292;NCT04517526;NCT04545710"},{"ligand":"osimertinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2014","completion_date":"2021","nct_id":"NCT04765059;NCT02151981;NCT02296125;NCT03515837;NCT02411448;NCT04035486;NCT04351555;NCT02511106;NCT02474355;NCT04181060;NCT03521154"},{"ligand":"osimertinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2019","completion_date":"2020","nct_id":"NCT03853551;NCT04356118"},{"ligand":"palbociclib","mesh_id":"D008175","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02897375"},{"ligand":"palbociclib","mesh_id":"D008175","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT02022982;NCT02349633;NCT03386929;NCT04553133;NCT02664935;NCT03170206;NCT01291017;NCT02465060"},{"ligand":"palbociclib","mesh_id":"D008175","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02785939"},{"ligand":"panitumumab","mesh_id":"D008175","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT04667975;NCT02192541;NCT00352950"},{"ligand":"panitumumab","mesh_id":"D008175","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT00979212;NCT01042288;NCT00034346;NCT00101920;NCT03582124;NCT01038037;NCT00094835"},{"ligand":"pazopanib","mesh_id":"D008175","phase":"Phase 1","start_date":"2009","completion_date":"2010","nct_id":"NCT01060514;NCT00866528"},{"ligand":"pazopanib","mesh_id":"D008175","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT01027598;NCT02193152;NCT01179269;NCT00549328;NCT00871403;NCT01253369;NCT01262820;NCT00367679;NCT00459862;NCT01049776;NCT01392352;NCT01313663"},{"ligand":"pazopanib","mesh_id":"D008175","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01208064"},{"ligand":"pertuzumab","mesh_id":"D008175","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT02507375"},{"ligand":"pertuzumab","mesh_id":"D008175","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT00855894;NCT00063154;NCT04246671;NCT02465060;NCT03845270"},{"ligand":"ponatinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01935336;NCT01813734;NCT03704688"},{"ligand":"ramucirumab","mesh_id":"D008175","phase":"Phase 1","start_date":"2015","completion_date":"2016","nct_id":"NCT02789345;NCT02443324"},{"ligand":"ramucirumab","mesh_id":"D008175","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT04151563;NCT04267913;NCT04394624;NCT04340882;NCT04040361;NCT00735696;NCT02831491;NCT04120454;NCT04332367;NCT01160744;NCT01703091;NCT03689855;NCT03909334;NCT02730247;NCT04310007;NCT03971474"},{"ligand":"ramucirumab","mesh_id":"D008175","phase":"Phase 3","start_date":"2010","completion_date":"2015","nct_id":"NCT02411448;NCT01168973"},{"ligand":"regorafenib","mesh_id":"D008175","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01187615"},{"ligand":"regorafenib","mesh_id":"D008175","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03520842"},{"ligand":"ribociclib","mesh_id":"D008175","phase":"Phase 1","start_date":"2015","completion_date":"2017","nct_id":"NCT02292550;NCT02974725"},{"ligand":"ruxolitinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02119650"},{"ligand":"selumetinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2010","completion_date":"2016","nct_id":"NCT02503358;NCT01605916;NCT01586624;NCT01809210;NCT01146756"},{"ligand":"selumetinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2006","completion_date":"2019","nct_id":"NCT03392246;NCT01248247;NCT03586453;NCT01610544;NCT03004105;NCT02179671;NCT01229150;NCT02664935;NCT02117167;NCT02025114;NCT01750281;NCT02583542;NCT03581487;NCT02337530;NCT00372788;NCT01306045"},{"ligand":"selumetinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01933932"},{"ligand":"sirolimus","mesh_id":"D008175","phase":"Phase 1","start_date":"2004","completion_date":"2019","nct_id":"NCT00655655;NCT00796796;NCT01522820;NCT01383668;NCT02145559;NCT00659568;NCT00401778;NCT01545947;NCT02372227;NCT00352950;NCT00555256;NCT01155258;NCT02126527;NCT04348292"},{"ligand":"sirolimus","mesh_id":"D008175","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT03670030;NCT01737502;NCT00079235;NCT00818675;NCT00770120;NCT02583542;NCT03664115;NCT01827267;NCT00028028;NCT00098462"},{"ligand":"sorafenib","mesh_id":"D008175","phase":"Phase 1","start_date":"2006","completion_date":"2009","nct_id":"NCT00533585;NCT00466232;NCT00870532;NCT00954278;NCT01005797;NCT01069328;NCT00543335;NCT00635791"},{"ligand":"sorafenib","mesh_id":"D008175","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00098254;NCT01248247;NCT00801801;NCT01159327;NCT00801385;NCT00647426;NCT00754923;NCT00454194;NCT00098540;NCT00101413;NCT00182689;NCT00600015;NCT00417248;NCT00547443;NCT00609804;NCT00726986;NCT00532025;NCT00411671;NCT00722969;NCT00922584;NCT00064350;NCT00107432"},{"ligand":"sorafenib","mesh_id":"D008175","phase":"Phase 3","start_date":"2006","completion_date":"2009","nct_id":"NCT00300885;NCT00863746;NCT00449033"},{"ligand":"sunitinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00581789;NCT00555256"},{"ligand":"sunitinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2005","completion_date":"2015","nct_id":"NCT01850147;NCT00620347;NCT00113516;NCT00864721;NCT00698815;NCT00748163;NCT00430261;NCT01216371;NCT00265317;NCT00953459;NCT00616109;NCT01019798;NCT01210053;NCT02465060;NCT00372775;NCT00695292;NCT00092001;NCT00434226;NCT00392444;NCT01306045"},{"ligand":"sunitinib","mesh_id":"D008175","phase":"Phase 3","start_date":"2007","completion_date":"2008","nct_id":"NCT00693992;NCT00457392"},{"ligand":"tivozanib","mesh_id":"D008175","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01728181"},{"ligand":"trametinib","mesh_id":"D008175","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT03299088;NCT02258607;NCT01938456;NCT02974725"},{"ligand":"trametinib","mesh_id":"D008175","phase":"Phase 2","start_date":"2011","completion_date":"2018","nct_id":"NCT01362296;NCT02580708;NCT03704688;NCT03225664;NCT03232892;NCT02672358;NCT02465060;NCT03087448;NCT03076164;NCT01336634;NCT03543306"},{"ligand":"trametinib","mesh_id":"D008175","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03340506"},{"ligand":"trastuzumab","mesh_id":"D008175","phase":"Phase 1","start_date":"1999","completion_date":"2021","nct_id":"NCT04686305;NCT00028535;NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D008175","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT00003881;NCT02289833;NCT04246671;NCT01679743;NCT04644237;NCT03505710;NCT02308020;NCT04285671;NCT03334617;NCT00758134;NCT04464967;NCT00016367;NCT02465060;NCT00004883;NCT03845270"},{"ligand":"vandetanib","mesh_id":"D008175","phase":"Phase 1","start_date":"2005","completion_date":"2011","nct_id":"NCT01004419;NCT00745732;NCT00807170;NCT01586624;NCT00734890;NCT00506051;NCT00937417"},{"ligand":"vandetanib","mesh_id":"D008175","phase":"Phase 2","start_date":"2003","completion_date":"2014","nct_id":"NCT00410189;NCT00777179;NCT01823068;NCT00066313;NCT02117167;NCT00459121;NCT00753714;NCT00290537;NCT00687297"},{"ligand":"vandetanib","mesh_id":"D008175","phase":"Phase 3","start_date":"2006","completion_date":"2007","nct_id":"NCT00418886;NCT00404924;NCT00312377;NCT00364351"},{"ligand":"vemurafenib","mesh_id":"D008175","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04302025"},{"ligand":"vemurafenib","mesh_id":"D008175","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03178552"},{"ligand":"vemurafenib","mesh_id":"D008175","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"}],"predictions":[{"target":"KIT","probability":"1.0"},{"target":"PDGFRA","probability":"0.965"},{"target":"EPHA2","probability":"0.89"},{"target":"BCR","probability":"0.885"},{"target":"AXL","probability":"0.88"},{"target":"RYK","probability":"0.875"},{"target":"TGFBR1","probability":"0.865"},{"target":"RPS6KB2","probability":"0.860037037037037"},{"target":"MAP2K7","probability":"0.855"},{"target":"EPHB2","probability":"0.85"},{"target":"MAP3K20","probability":"0.8464871328923526"},{"target":"ACVR2B","probability":"0.845"},{"target":"SRC","probability":"0.8150245012250613"},{"target":"BMPR1B","probability":"0.8100111507582516"},{"target":"MST1R","probability":"0.8060791349248672"},{"target":"PTK7","probability":"0.800357296403749"},{"target":"STK38","probability":"0.8001"},{"target":"ZAP70","probability":"0.8"},{"target":"MAP3K4","probability":"0.7950484050435204"},{"target":"ROR2","probability":"0.7902681982305475"},{"target":"TGFBR2","probability":"0.7850495049504951"},{"target":"HASPIN","probability":"0.7750370370370371"},{"target":"EPHB4","probability":"0.7750370370370371"},{"target":"CDK11B","probability":"0.7650684931506849"},{"target":"ACVRL1","probability":"0.7650462962962963"},{"target":"SYK","probability":"0.7605072463768116"},{"target":"YES1","probability":"0.7601947364804508"},{"target":"TEC","probability":"0.756932859665667"},{"target":"PRKG2","probability":"0.7564285714285713"},{"target":"MATK","probability":"0.7464285714285714"},{"target":"PIM2","probability":"0.7451326909841707"},{"target":"AKT1","probability":"0.745"},{"target":"DYRK4","probability":"0.745"},{"target":"LIMK2","probability":"0.7403271438878583"},{"target":"CAMK2A","probability":"0.7400128810648348"},{"target":"PTK2B","probability":"0.7371405255425654"},{"target":"GRK4","probability":"0.7352681982305476"},{"target":"PTK2","probability":"0.735193992750485"},{"target":"EPHA7","probability":"0.735126845637584"},{"target":"DDR2","probability":"0.735"},{"target":"CILK1","probability":"0.7314554170661554"},{"target":"CASK","probability":"0.7314554170661554"},{"target":"CLK1","probability":"0.731439722186823"},{"target":"BMPR2","probability":"0.7308591484135896"},{"target":"SIK1","probability":"0.7300465413996833"},{"target":"AMHR2","probability":"0.7264285714285714"},{"target":"TIE1","probability":"0.725"},{"target":"TAF1","probability":"0.7214285714285714"},{"target":"ACVR2A","probability":"0.7200872713817529"},{"target":"SRMS","probability":"0.72"},{"target":"OBSCN","probability":"0.7164285714285714"},{"target":"PTK6","probability":"0.7152023022798776"},{"target":"CDK10","probability":"0.71146829813099"},{"target":"CDK12","probability":"0.7101326909841706"},{"target":"SGK3","probability":"0.710126845637584"},{"target":"DYRK1B","probability":"0.71"},{"target":"ATP23","probability":"0.71"},{"target":"MAP3K2","probability":"0.7067023809523809"},{"target":"PIM1","probability":"0.7058912525124573"},{"target":"ACVR1","probability":"0.7050555555555555"},{"target":"NEK6","probability":"0.705037037037037"},{"target":"TTN","probability":"0.705"},{"target":"EPHB1","probability":"0.7001000000000001"},{"target":"CAMKV","probability":"0.7"},{"target":"KSR1","probability":"0.6951782572258804"},{"target":"NUAK1","probability":"0.6950128810648347"},{"target":"PKDCC","probability":"0.695"},{"target":"MYLK3","probability":"0.6903444840915849"},{"target":"ACVR1B","probability":"0.690136612021858"},{"target":"GRK7","probability":"0.6900370370370371"},{"target":"TYRO3","probability":"0.690011911852293"},{"target":"NEK1","probability":"0.69"},{"target":"EPHA5","probability":"0.6864554170661553"},{"target":"CDK2","probability":"0.685142857142857"},{"target":"TRPM6","probability":"0.685"},{"target":"PDK2","probability":"0.685"},{"target":"PRKCH","probability":"0.6838568981377278"},{"target":"GRK2","probability":"0.6810121583244618"},{"target":"ITK","probability":"0.6802820345749248"},{"target":"PRKCA","probability":"0.6755894736842106"},{"target":"NPR1","probability":"0.675272544283414"},{"target":"BMPR1A","probability":"0.675203318335665"},{"target":"PKN1","probability":"0.6751585614637813"},{"target":"EPHB3","probability":"0.6751576994434138"},{"target":"PDPK1","probability":"0.6751051547522866"},{"target":"IRAK2","probability":"0.6750484050435204"},{"target":"EPHA1","probability":"0.6750326909841706"},{"target":"EIF2AK1","probability":"0.6719361029635302"},{"target":"PRKCB","probability":"0.6717402230727094"},{"target":"AKT3","probability":"0.6706610970745344"},{"target":"MAPK13","probability":"0.6701688502016653"},{"target":"CDK14","probability":"0.6700499181018718"},{"target":"CDKL1","probability":"0.67"},{"target":"SRPK3","probability":"0.67"},{"target":"AKT2","probability":"0.6664525817985285"},{"target":"ILK","probability":"0.6659756920818124"},{"target":"NLK","probability":"0.6650326909841706"},{"target":"CAMK1G","probability":"0.6650030450669914"},{"target":"CLK2","probability":"0.665"},{"target":"ANKK1","probability":"0.665"},{"target":"CDC42BPG","probability":"0.665"},{"target":"MARK4","probability":"0.6614682981309901"},{"target":"PDIK1L","probability":"0.6614682981309901"},{"target":"FAM20C","probability":"0.6614285714285714"},{"target":"PAK1","probability":"0.6604911678917279"},{"target":"CDC42BPA","probability":"0.6600128810648347"},{"target":"DCLK2","probability":"0.66"},{"target":"CSNK1A1","probability":"0.6564414524934062"},{"target":"PRKCI","probability":"0.6553993315327414"},{"target":"SMG1","probability":"0.6551771548436308"},{"target":"MAP3K3","probability":"0.6501576994434137"},{"target":"PAK3","probability":"0.6500684931506849"},{"target":"FYN","probability":"0.6500649350649351"},{"target":"CAMK1","probability":"0.6500481877952886"},{"target":"FRK","probability":"0.65"},{"target":"AVP","probability":"0.65"},{"target":"ALPK3","probability":"0.65"},{"target":"PRKCQ","probability":"0.6450791551806841"},{"target":"PRKACB","probability":"0.645"},{"target":"STK32B","probability":"0.645"},{"target":"MOK","probability":"0.6414554170661555"},{"target":"CDK8","probability":"0.6406734351470961"},{"target":"MAPKAPK3","probability":"0.64"},{"target":"TSSK3","probability":"0.64"},{"target":"MAP4K4","probability":"0.6354176913172401"},{"target":"MAPKAPK5","probability":"0.6351"},{"target":"CDKN1A","probability":"0.635"},{"target":"PRKACA","probability":"0.6322704100175108"},{"target":"TNK2","probability":"0.6302672230725741"},{"target":"HCK","probability":"0.630182200668475"},{"target":"GRK6","probability":"0.6300684052698851"},{"target":"CCL3","probability":"0.630056032885002"},{"target":"MAP3K13","probability":"0.6300128810648347"},{"target":"DMPK","probability":"0.6253658225832138"},{"target":"MELK","probability":"0.6253291479174614"},{"target":"PAK6","probability":"0.6250455720490055"},{"target":"STK32C","probability":"0.625"},{"target":"PRKACG","probability":"0.625"},{"target":"PAN3","probability":"0.625"},{"target":"CAMK2B","probability":"0.6223490678598061"},{"target":"STK11","probability":"0.6221391124155854"},{"target":"GRK5","probability":"0.6214365260786027"},{"target":"BRD4","probability":"0.620775782632157"},{"target":"PIM3","probability":"0.6201576994434137"},{"target":"MAPK1","probability":"0.6201263157894737"},{"target":"MKNK2","probability":"0.6200446028364638"},{"target":"MAP3K12","probability":"0.6200397267024186"},{"target":"EPHA4","probability":"0.620037037037037"},{"target":"MYLK","probability":"0.6161464749294269"},{"target":"TTK","probability":"0.615911596509047"},{"target":"PKN2","probability":"0.6151397267024186"},{"target":"CCNK","probability":"0.6151397267024186"},{"target":"DCAF1","probability":"0.6150128810648348"},{"target":"CCL2","probability":"0.615"},{"target":"CIT","probability":"0.6114554170661554"},{"target":"PDK1","probability":"0.6111846008649293"},{"target":"SRPK1","probability":"0.6108338070517647"},{"target":"CDK3","probability":"0.6104892626080356"},{"target":"TRIO","probability":"0.6102845450809976"},{"target":"CCL8","probability":"0.610136612021858"},{"target":"WNK4","probability":"0.6100111507582515"},{"target":"CSNK1G1","probability":"0.61"},{"target":"NEK5","probability":"0.61"},{"target":"MUSK","probability":"0.61"},{"target":"RPS6KB1","probability":"0.6099063883298417"},{"target":"CDK19","probability":"0.606556601201011"},{"target":"MAPK3","probability":"0.6051263157894737"},{"target":"PRKCG","probability":"0.6010403920410734"},{"target":"PRKCE","probability":"0.6009118258016393"},{"target":"NME2","probability":"0.600713832560718"},{"target":"DYRK2","probability":"0.6003331885025982"},{"target":"GRK1","probability":"0.6000481877952886"},{"target":"VRK3","probability":"0.6"},{"target":"IRAK4","probability":"0.5958569745725262"},{"target":"MAP4K1","probability":"0.5952845450809976"},{"target":"TRIM24","probability":"0.5951953387882688"},{"target":"SBK1","probability":"0.595"},{"target":"CDK15","probability":"0.595"},{"target":"SGK1","probability":"0.5932844544321688"},{"target":"MARK2","probability":"0.5917666666666667"},{"target":"TBK1","probability":"0.591609406680484"},{"target":"MAP3K10","probability":"0.5915053351680271"},{"target":"EPHA8","probability":"0.5910453367053381"},{"target":"GRK3","probability":"0.5904527839837621"},{"target":"INSRR","probability":"0.590047030162167"},{"target":"PLK3","probability":"0.586267862956533"},{"target":"MAPK7","probability":"0.5855249809305874"},{"target":"MAPK12","probability":"0.5851166809459736"},{"target":"RPS6KA4","probability":"0.5850128810648347"},{"target":"MAPK10","probability":"0.5850111507582515"},{"target":"TESK2","probability":"0.585"},{"target":"HIPK3","probability":"0.5814414524934062"},{"target":"MAP2K6","probability":"0.5806678245943437"},{"target":"CSNK1A1L","probability":"0.58"},{"target":"TSSK6","probability":"0.58"},{"target":"PHKG1","probability":"0.58"},{"target":"MAPK6","probability":"0.58"},{"target":"RNASEL","probability":"0.5775429938219518"},{"target":"PRKX","probability":"0.5764554170661554"},{"target":"CDK13","probability":"0.5764414524934062"},{"target":"LIMK1","probability":"0.5756253625868333"},{"target":"DYRK1A","probability":"0.57514785823005"},{"target":"AURKB","probability":"0.575054347826087"},{"target":"TSSK4","probability":"0.575"},{"target":"ACVR1C","probability":"0.575"},{"target":"TSSK2","probability":"0.575"},{"target":"PRKD1","probability":"0.5713172942413925"},{"target":"IKBKB","probability":"0.5708927334080078"},{"target":"BUB1","probability":"0.5708316310365518"},{"target":"CSNK1E","probability":"0.5701913001682288"},{"target":"MKNK1","probability":"0.5701123348931071"},{"target":"CCL5","probability":"0.5700423106069981"},{"target":"ALPK1","probability":"0.5700326909841706"},{"target":"TAF1L","probability":"0.57"},{"target":"PRKCD","probability":"0.5686683707267496"},{"target":"PAK2","probability":"0.5655612204085323"},{"target":"CDK20","probability":"0.5650432138284252"},{"target":"ROCK2","probability":"0.5633245885603001"},{"target":"CHUK","probability":"0.5617973293482419"},{"target":"CSNK2A2","probability":"0.5613156557439595"},{"target":"PRKCZ","probability":"0.5607248161820784"},{"target":"MAP3K11","probability":"0.5602846612006794"},{"target":"STK35","probability":"0.56"},{"target":"PLK1","probability":"0.5578083773018839"},{"target":"DCLK1","probability":"0.5554432188551156"},{"target":"AURKA","probability":"0.5554104205637119"},{"target":"IRAK1","probability":"0.5553612456296156"},{"target":"IRAK3","probability":"0.5552891363884688"},{"target":"WNK2","probability":"0.5550397267024185"},{"target":"ADCK1","probability":"0.555"},{"target":"FASTKD1","probability":"0.555"},{"target":"ROCK1","probability":"0.5517511193220596"},{"target":"CDKL2","probability":"0.5514887224076054"},{"target":"CDK1","probability":"0.5506900035388393"},{"target":"CSK","probability":"0.5506580535710038"},{"target":"RPS6KA3","probability":"0.550315172634117"},{"target":"DAPK2","probability":"0.550109171146863"},{"target":"RIPK4","probability":"0.5500638826746209"},{"target":"STK40","probability":"0.55"},{"target":"CSNK2A1","probability":"0.5469228086851335"},{"target":"LRRK1","probability":"0.5464285714285715"},{"target":"PAK5","probability":"0.5452172360651683"},{"target":"MARK3","probability":"0.5416259975744038"},{"target":"MAK","probability":"0.5414285714285715"},{"target":"MAPK11","probability":"0.5412379581728571"},{"target":"LATS1","probability":"0.5408421419553663"},{"target":"MAP3K1","probability":"0.5401605993010214"},{"target":"CSNK2B","probability":"0.540110871750613"},{"target":"MAP3K8","probability":"0.540026845637584"},{"target":"CAMK2G","probability":"0.5395660423155406"},{"target":"KALRN","probability":"0.5364554170661554"},{"target":"NEK2","probability":"0.5359386951847668"},{"target":"TRIM28","probability":"0.5355950208240636"},{"target":"CAMK4","probability":"0.5355581801962047"},{"target":"PEAK1","probability":"0.535"},{"target":"MYO3A","probability":"0.535"},{"target":"WNK1","probability":"0.5325846298870583"},{"target":"EEF2K","probability":"0.5309795394305113"},{"target":"PBK","probability":"0.5303829540513625"},{"target":"TRPM7","probability":"0.5303432607512623"},{"target":"DSTYK","probability":"0.53"},{"target":"MAP3K15","probability":"0.53"},{"target":"FASTKD3","probability":"0.53"},{"target":"IKBKE","probability":"0.5273353969580782"},{"target":"CDC7","probability":"0.5254975169818095"},{"target":"MASTL","probability":"0.5250128810648347"},{"target":"CAMK1D","probability":"0.5222222222222223"},{"target":"RPS6KA6","probability":"0.5215232431859351"},{"target":"PDK4","probability":"0.5204368166577198"},{"target":"NEK7","probability":"0.5201397267024186"},{"target":"NEK9","probability":"0.5200962900820284"},{"target":"STK39","probability":"0.517517812928628"},{"target":"RPS6KA2","probability":"0.5159653741375303"},{"target":"CDKL5","probability":"0.5154190636573303"},{"target":"PDK3","probability":"0.515"},{"target":"MAP2K4","probability":"0.5113402845237291"},{"target":"PLK4","probability":"0.5107013111024308"},{"target":"POMK","probability":"0.51"},{"target":"MAST3","probability":"0.51"},{"target":"LRRK2","probability":"0.508804013232179"},{"target":"UHMK1","probability":"0.50646829813099"},{"target":"RPS6KA5","probability":"0.506295805523336"},{"target":"BUB1B","probability":"0.5059676918156487"},{"target":"EIF2AK3","probability":"0.5016719256670008"},{"target":"MOS","probability":"0.5014562634442487"},{"target":"VRK1","probability":"0.5005105359439725"},{"target":"CDK7","probability":"0.4957747942553015"},{"target":"MAPKAPK2","probability":"0.49484500053730457"},{"target":"CSNK1D","probability":"0.49145541706615536"},{"target":"STK4","probability":"0.4900767637394556"},{"target":"MAPK4","probability":"0.4900268456375839"},{"target":"GSK3A","probability":"0.48988144923793703"},{"target":"MAP3K5","probability":"0.48760355763086627"},{"target":"VRK2","probability":"0.48646829813099"},{"target":"MAP2K3","probability":"0.4861594717773103"},{"target":"CAMKK2","probability":"0.48588620510601943"},{"target":"CDK17","probability":"0.485"},{"target":"CLK3","probability":"0.485"},{"target":"LMTK2","probability":"0.485"},{"target":"WNK3","probability":"0.4814554170661554"},{"target":"RPS6KA1","probability":"0.4807552479295534"},{"target":"ULK2","probability":"0.480209171146863"},{"target":"MARK1","probability":"0.480142045860204"},{"target":"MAPK14","probability":"0.4801157382001342"},{"target":"PAK4","probability":"0.48010275045017964"},{"target":"TBRG4","probability":"0.48"},{"target":"WEE2","probability":"0.48"},{"target":"CDK9","probability":"0.47615646977431664"},{"target":"RIPK1","probability":"0.47601970491466006"},{"target":"NPR2","probability":"0.4751326909841706"},{"target":"TAOK3","probability":"0.475"},{"target":"SIK2","probability":"0.4722619489246408"},{"target":"LATS2","probability":"0.4720973844812505"},{"target":"CDK18","probability":"0.47146829813099006"},{"target":"TNNI3K","probability":"0.47146829813099006"},{"target":"STK38L","probability":"0.4714554170661554"},{"target":"PIK3C3","probability":"0.47070340628519475"},{"target":"NRBP2","probability":"0.47"},{"target":"CDK5R1","probability":"0.4664299263283997"},{"target":"TAOK2","probability":"0.4662018355408663"},{"target":"CHEK2","probability":"0.46168664608671284"},{"target":"SRPK2","probability":"0.46146829813099005"},{"target":"CAMKK1","probability":"0.46012684563758394"},{"target":"MAPK15","probability":"0.46"},{"target":"STYK1","probability":"0.45642857142857146"},{"target":"PLK2","probability":"0.4561689640910098"},{"target":"GSK3B","probability":"0.456079774820174"}],"source_name":"Lung Neoplasms"}],["D002289",{"mesh_id":"D002289","trials":[{"ligand":"abemaciclib","mesh_id":"D002289","phase":"Phase 1","start_date":"2014","completion_date":"2016","nct_id":"NCT02857270;NCT02779751;NCT02411591;NCT02079636"},{"ligand":"abemaciclib","mesh_id":"D002289","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02450539;NCT02308020;NCT04165031"},{"ligand":"acalabrutinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02448303"},{"ligand":"afatinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT03711422;NCT03827070;NCT02191891;NCT01288430;NCT01647711;NCT03054038;NCT01090011;NCT00993499;NCT04448379;NCT01999985;NCT02364609"},{"ligand":"afatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2007","completion_date":"2021","nct_id":"NCT02716311;NCT02098954;NCT02369484;NCT03810872;NCT02595840;NCT02795156;NCT03574402;NCT02747953;NCT02488694;NCT03157089;NCT04148898;NCT03623750;NCT02470065;NCT02597946;NCT04470076;NCT01932229;NCT01542437;NCT03727724;NCT04497584;NCT01415011;NCT02906163;NCT01003899;NCT02183883;NCT00730925;NCT00525148;NCT03399669;NCT00711594;NCT01156545;NCT00796549;NCT02450656;NCT01746251"},{"ligand":"afatinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2008","completion_date":"2015","nct_id":"NCT02044380;NCT02438722;NCT01853826;NCT01523587;NCT01814553;NCT01121393;NCT00656136;NCT00949650;NCT01085136;NCT01953913"},{"ligand":"afatinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2014","completion_date":"2020","nct_id":"NCT04413201;NCT02695290;NCT02208843;NCT04356118;NCT02514174"},{"ligand":"alectinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02013219"},{"ligand":"alectinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT02314481;NCT04302025;NCT03944772;NCT02706626;NCT03535740;NCT04111705;NCT03202940;NCT03087448;NCT03131206;NCT03445000;NCT02450903;NCT01801111;NCT01871805;NCT02521051;NCT03155009"},{"ligand":"alectinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2014","completion_date":"2019","nct_id":"NCT03456076;NCT03178552;NCT02838420;NCT03596866;NCT02075840;NCT02604342"},{"ligand":"alectinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"apatinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT03050411"},{"ligand":"apatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03190239;NCT03801200;NCT04670913;NCT03127319;NCT03083041;NCT04133337;NCT03129256;NCT03461185;NCT04506242;NCT02974933;NCT03267654;NCT02540824;NCT03416231;NCT01270386;NCT03256721;NCT02733107;NCT02515435;NCT03811054;NCT03758677;NCT03777124;NCT04749394;NCT04379739;NCT03652857;NCT03201146"},{"ligand":"apatinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2011","completion_date":"2020","nct_id":"NCT01287962;NCT02824458;NCT04203485;NCT02780778;NCT02332512"},{"ligand":"apatinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03792503"},{"ligand":"axitinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT00094094;NCT03386929;NCT03472560;NCT00735904;NCT00600821;NCT00768755;NCT00386555;NCT04459663"},{"ligand":"binimetinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT03991819;NCT04005144;NCT02451865;NCT02964689;NCT01859026;NCT04543188"},{"ligand":"binimetinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2019","completion_date":"2021","nct_id":"NCT04735068;NCT04526782;NCT03915951;NCT04585815"},{"ligand":"bosutinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03023319"},{"ligand":"brigatinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03707938;NCT04227028;NCT04005144"},{"ligand":"brigatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT04318938;NCT02094573;NCT01449461;NCT03410108;NCT02706626;NCT04074993;NCT03535740;NCT04111705;NCT03087448"},{"ligand":"brigatinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2016","completion_date":"2019","nct_id":"NCT03596866;NCT02737501"},{"ligand":"cabozantinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04173338;NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2007","completion_date":"2021","nct_id":"NCT02132598;NCT03468985;NCT04151563;NCT00596648;NCT02795156;NCT04131543;NCT01708954;NCT03911193;NCT01639508;NCT01866410;NCT04310007"},{"ligand":"cabozantinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04471428"},{"ligand":"ceritinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT02292550;NCT02299505;NCT01772797;NCT02393625;NCT03611738"},{"ligand":"ceritinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01964157;NCT02040870;NCT01685060;NCT02336451;NCT01685138;NCT02706626;NCT03535740;NCT04111705;NCT03087448;NCT02450903;NCT03399487"},{"ligand":"ceritinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01828099;NCT01828112"},{"ligand":"ceritinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"cetuximab","mesh_id":"D002289","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00522886;NCT03319459;NCT04449874;NCT00397384;NCT03808701;NCT02496663;NCT02857270;NCT01090011;NCT00288054;NCT01451632;NCT00207116;NCT01212627;NCT00162318;NCT00569296"},{"ligand":"cetuximab","mesh_id":"D002289","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT00910676;NCT00828841;NCT02716311;NCT00112346;NCT00408499;NCT00081302;NCT00165334;NCT00406302;NCT00124618;NCT00216203;NCT00492206;NCT00097214;NCT00034541;NCT00874848;NCT00085501;NCT00986674;NCT01004731;NCT00315185;NCT03717155;NCT00118183;NCT01102231;NCT00870870;NCT03727724;NCT04285671;NCT00101348;NCT00998101;NCT00561054;NCT00343291;NCT00203931;NCT04464967;NCT00115518;NCT01059188;NCT02845856;NCT00368992;NCT00694603;NCT00117962;NCT00323869;NCT00330746;NCT00097227;NCT01109524;NCT00985855;NCT00673738;NCT00768131;NCT00063388;NCT00867009;NCT00842712;NCT04165031"},{"ligand":"cetuximab","mesh_id":"D002289","phase":"Phase 3","start_date":"2004","completion_date":"2015","nct_id":"NCT00533949;NCT00095199;NCT02438722;NCT00148798;NCT00112294;NCT00820755"},{"ligand":"cobimetinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02457793"},{"ligand":"cobimetinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04302025;NCT03600701;NCT03337698;NCT03202940"},{"ligand":"cobimetinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03178552"},{"ligand":"crizotinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2006","completion_date":"2018","nct_id":"NCT00585195;NCT02277457;NCT02695550;NCT01441128;NCT01121575;NCT03607188;NCT01998126;NCT02511184"},{"ligand":"crizotinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02568267;NCT01964157;NCT02098954;NCT02584634;NCT04211922;NCT02040870;NCT03088930;NCT02094573;NCT01970865;NCT01752400;NCT01449461;NCT03574402;NCT03439215;NCT01685060;NCT01500824;NCT02336451;NCT01685138;NCT02499614;NCT04084717;NCT04641754;NCT02664935;NCT03909971;NCT00932451;NCT04111705;NCT03087448;NCT02314364;NCT03215693;NCT04193007;NCT01712217;NCT04621188;NCT04056572;NCT01945021;NCT01801111;NCT01822496;NCT01871805;NCT02574078;NCT03155009;NCT02134912;NCT03399487"},{"ligand":"crizotinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2009","completion_date":"2021","nct_id":"NCT03052608;NCT02838420;NCT03596866;NCT04632758;NCT02075840;NCT00932893;NCT02201992;NCT01828112;NCT01639001;NCT04603807;NCT02767804;NCT02604342;NCT02737501;NCT04009317"},{"ligand":"crizotinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2019","completion_date":"2020","nct_id":"NCT03672643;NCT04356118"},{"ligand":"dabrafenib","mesh_id":"D002289","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT02672358;NCT04452877;NCT01336634"},{"ligand":"dabrafenib","mesh_id":"D002289","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03340506"},{"ligand":"dacomitinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2010","completion_date":"2013","nct_id":"NCT01918761;NCT01441128;NCT01121575;NCT01034748;NCT00971191"},{"ligand":"dacomitinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT00548093;NCT04027647;NCT04504071;NCT04339829;NCT01858389;NCT04675008;NCT00769067;NCT01465802;NCT00553254"},{"ligand":"dacomitinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2009","completion_date":"2013","nct_id":"NCT01000025;NCT01360554;NCT01774721"},{"ligand":"dacomitinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04511533"},{"ligand":"dasatinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2007","completion_date":"2013","nct_id":"NCT00787852;NCT00444015;NCT01999985"},{"ligand":"dasatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT00826449;NCT00787267;NCT00564876;NCT02750514;NCT01514864;NCT04284202;NCT00858403;NCT00459342;NCT02954523"},{"ligand":"encorafenib","mesh_id":"D002289","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02857270"},{"ligand":"encorafenib","mesh_id":"D002289","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02109653;NCT04526782;NCT03915951;NCT04585815"},{"ligand":"entrectinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02568267;NCT04302025;NCT04621188"},{"ligand":"entrectinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2017","completion_date":"2021","nct_id":"NCT03178552;NCT04603807"},{"ligand":"erdafitinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02699606"},{"ligand":"erlotinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00692640;NCT00633529;NCT00042835;NCT02013219;NCT02157883;NCT01069757;NCT02468661;NCT04449874;NCT00254384;NCT01594398;NCT00569114;NCT02134886;NCT00072072;NCT00738335;NCT02277457;NCT00934076;NCT01302808;NCT00975767;NCT00088959;NCT01193881;NCT00397384;NCT00702182;NCT02507375;NCT01121575;NCT01545947;NCT01570296;NCT00444015;NCT01251796;NCT01288430;NCT00777699;NCT00294736;NCT00619424;NCT01090011;NCT00993499;NCT01115803;NCT00456833;NCT00581789;NCT02206763;NCT01515969;NCT01454102;NCT01839955;NCT00536861;NCT01602289;NCT03050411;NCT01199068;NCT02342353;NCT02040064;NCT02991651;NCT01998126;NCT02364609;NCT01026844;NCT00030498;NCT02080078;NCT01911507;NCT00975182;NCT01859026;NCT00729742;NCT00707252"},{"ligand":"erlotinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT00391586;NCT00910676;NCT00087412;NCT00826449;NCT01204307;NCT01728181;NCT02716311;NCT01211483;NCT02098954;NCT00370383;NCT01248247;NCT00732810;NCT00701558;NCT00940875;NCT00294762;NCT00997334;NCT00251589;NCT01998919;NCT02355431;NCT00553462;NCT03126799;NCT01027598;NCT00408499;NCT00871923;NCT01104155;NCT00596648;NCT01928160;NCT01294306;NCT00855894;NCT00351039;NCT00973310;NCT01378962;NCT01217619;NCT00531960;NCT00592007;NCT02738983;NCT01350817;NCT00642473;NCT00339586;NCT00283634;NCT00548093;NCT00281021;NCT00387322;NCT01130779;NCT02064491;NCT01091376;NCT01573702;NCT00801385;NCT00312728;NCT03497767;NCT03799094;NCT00840125;NCT00062101;NCT02747953;NCT00266877;NCT00750698;NCT00621049;NCT03461185;NCT00778167;NCT01131429;NCT02146118;NCT00547105;NCT01854034;NCT02250846;NCT00615758;NCT00147537;NCT00125359;NCT01532089;NCT01410214;NCT04148898;NCT00518011;NCT00777309;NCT02318368;NCT00854308;NCT00888511;NCT00278187;NCT00411632;NCT01259089;NCT00265317;NCT00783471;NCT00977470;NCT02036359;NCT00673569;NCT00600587;NCT00743938;NCT01250119;NCT01372384;NCT00602030;NCT01683175;NCT00800202;NCT02774278;NCT01857271;NCT03151161;NCT01186861;NCT00661193;NCT03382795;NCT03119519;NCT04455594;NCT01174563;NCT00550537;NCT00124280;NCT00702975;NCT00809237;NCT01167244;NCT00816868;NCT00567359;NCT01229150;NCT01932229;NCT02353741;NCT01260181;NCT03123484;NCT02535338;NCT01610336;NCT00503971;NCT01233687;NCT00287989;NCT02117024;NCT00620269;NCT00466284;NCT02095782;NCT00321815;NCT00773383;NCT00499655;NCT00101348;NCT01897480;NCT00453362;NCT00522145;NCT00652340;NCT01900652;NCT00200395;NCT03595644;NCT00950365;NCT02770014;NCT00391248;NCT00072631;NCT00600015;NCT01471964;NCT00466089;NCT00087269;NCT00678964;NCT00609804;NCT01470716;NCT02424617;NCT01755923;NCT02191059;NCT00536640;NCT00385996;NCT00280150;NCT02906163;NCT02006043;NCT00835471;NCT00230126;NCT01557959;NCT02655536;NCT02039674;NCT00100854;NCT00462995;NCT01101334;NCT00447057;NCT01188707;NCT00908336;NCT00994123;NCT00137800;NCT02117167;NCT00760929;NCT01514877;NCT00590902;NCT00983307;NCT01221077;NCT00749567;NCT00606502;NCT03137771;NCT00063895;NCT02495233;NCT00568841;NCT00531934;NCT00553800;NCT00278148;NCT02066038;NCT00452075;NCT02314364;NCT01708954;NCT00769067;NCT00830245;NCT01796288;NCT04193007;NCT02556593;NCT01153984;NCT00722969;NCT02045446;NCT02034097;NCT01047059;NCT00522938;NCT03399669;NCT00711594;NCT01518621;NCT02013206;NCT00085839;NCT01714908;NCT00343187;NCT01204697;NCT02069418;NCT01801111;NCT01822496;NCT02705820;NCT00660816;NCT01310036;NCT01504542;NCT01955421;NCT00563784;NCT02037997;NCT01866410;NCT01487265;NCT00663689;NCT01996332;NCT02954523;NCT01395758;NCT00452413;NCT02574078;NCT00553254;NCT04165031;NCT02507518;NCT00976677;NCT03424759;NCT01306045;NCT01580735;NCT00095225;NCT00550173;NCT03399487;NCT00654420"},{"ligand":"erlotinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2001","completion_date":"2018","nct_id":"NCT00775385;NCT01342965;NCT00298415;NCT01887795;NCT00883779;NCT01158170;NCT00091663;NCT00556322;NCT00989690;NCT00268684;NCT02296125;NCT01328951;NCT02759614;NCT02193282;NCT02134015;NCT00312377;NCT01244191;NCT01404260;NCT02186301;NCT01377376;NCT01360554;NCT02178397;NCT02775006;NCT00446225;NCT01351415;NCT02411448;NCT00036647;NCT02031744;NCT03074864;NCT00364351;NCT01523587;NCT00874419;NCT02714010;NCT01456325;NCT00153803;NCT00718315;NCT02795884;NCT01383148;NCT01487174;NCT02416739;NCT00300586;NCT01887886;NCT00349219;NCT01667562;NCT01183858;NCT00257608;NCT00637910;NCT02588261;NCT00373425;NCT02001896;NCT00656136;NCT01407822;NCT01652469;NCT03529084;NCT00096265;NCT00130728;NCT00556712;NCT00440414;NCT00738881;NCT01802021;NCT01085136;NCT00673049;NCT00457392;NCT00955695;NCT02633189"},{"ligand":"erlotinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2004","completion_date":"2020","nct_id":"NCT01287754;NCT01320501;NCT01230710;NCT01066884;NCT01196078;NCT04401059;NCT02031601;NCT03264794;NCT03460678;NCT00949910;NCT02000531;NCT04356118"},{"ligand":"everolimus","mesh_id":"D002289","phase":"Phase 1","start_date":"2004","completion_date":"2016","nct_id":"NCT00434174;NCT01063478;NCT00655655;NCT01167530;NCT02890069;NCT00933777;NCT01115803;NCT00456833;NCT00892801;NCT01061788;NCT00457119;NCT01700400"},{"ligand":"everolimus","mesh_id":"D002289","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00096486;NCT00124280;NCT01427946"},{"ligand":"fostamatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00923481"},{"ligand":"gefitinib","mesh_id":"D002289","phase":"Phase 1","start_date":"1999","completion_date":"2018","nct_id":"NCT02157883;NCT00255489;NCT00497250;NCT02088112;NCT00328562;NCT01121575;NCT01570296;NCT00372515;NCT00252798;NCT01288430;NCT03599518;NCT01090011;NCT01147211;NCT02151721;NCT00993499;NCT00310154;NCT02374645;NCT01602289;NCT03333343;NCT03050411;NCT02040064;NCT00162318;NCT00005806"},{"ligand":"gefitinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT03122717;NCT02716311;NCT01192243;NCT01982955;NCT02139579;NCT01746277;NCT00891579;NCT02856893;NCT00062270;NCT01928160;NCT01933347;NCT01196234;NCT00333294;NCT00096486;NCT00062062;NCT02319577;NCT03944772;NCT01469000;NCT00411047;NCT01498562;NCT03799094;NCT02747953;NCT00266877;NCT03461185;NCT01854034;NCT00615758;NCT04148898;NCT00319800;NCT00173875;NCT00059722;NCT03267654;NCT01783834;NCT03151161;NCT02976116;NCT02179671;NCT04358562;NCT03382795;NCT03119519;NCT03002844;NCT00124280;NCT00198393;NCT00809237;NCT01167244;NCT01932229;NCT03123484;NCT01610336;NCT01027676;NCT01192230;NCT00029003;NCT01510990;NCT01864681;NCT03758287;NCT00522145;NCT03595644;NCT00986284;NCT02930954;NCT01749072;NCT01312337;NCT01755923;NCT02191059;NCT00824746;NCT02906163;NCT01784549;NCT02039674;NCT01871480;NCT00256711;NCT02025114;NCT01514877;NCT00280787;NCT00616499;NCT02066038;NCT01037998;NCT01017679;NCT00614809;NCT04193007;NCT00040794;NCT01391260;NCT00264498;NCT00234442;NCT03399669;NCT00711594;NCT01951469;NCT00231465;NCT01039948;NCT00193336;NCT01024712;NCT03374280;NCT01997775;NCT00217698;NCT01955421;NCT01513174;NCT02954523;NCT00098462;NCT00588445;NCT00553254;NCT01833572;NCT03424759;NCT00048087;NCT01580735;NCT00409006;NCT03399487"},{"ligand":"gefitinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2000","completion_date":"2020","nct_id":"NCT01158170;NCT02296125;NCT00049543;NCT00020709;NCT03866499;NCT00259064;NCT00076388;NCT01405079;NCT01544179;NCT03849768;NCT01404260;NCT03381066;NCT02326285;NCT02411448;NCT04239833;NCT02714010;NCT04028778;NCT04248829;NCT03787992;NCT01040780;NCT03856697;NCT02387086;NCT02824458;NCT02416739;NCT00090675;NCT01774721;NCT01066195;NCT00322452;NCT02859077;NCT00091156;NCT02588261;NCT00656136;NCT03529084;NCT02338011;NCT00234468;NCT00252707;NCT01017874;NCT00807066;NCT01085136;NCT00955695;NCT00006048;NCT00006049"},{"ligand":"gefitinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2007","completion_date":"2020","nct_id":"NCT01203917;NCT00770588;NCT02299765;NCT01000740;NCT00536107;NCT04401059;NCT02778893;NCT02031601;NCT00608868;NCT03264794"},{"ligand":"gilteritinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02495233"},{"ligand":"ibrutinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02950038;NCT02403271;NCT02321540"},{"ligand":"icotinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02066870"},{"ligand":"icotinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT01744925;NCT04029350;NCT02264210;NCT02738983;NCT03396185;NCT02430974;NCT01690390;NCT03736837;NCT03749213;NCT03151161;NCT02407366;NCT01707329;NCT02027090;NCT03123484;NCT02960607;NCT03595644;NCT02062515;NCT02961270;NCT01929200;NCT02191059;NCT01514877;NCT03349203;NCT01688713;NCT02215356;NCT02272127;NCT01843647;NCT02820116"},{"ligand":"icotinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2009","completion_date":"2019","nct_id":"NCT02486354;NCT01724801;NCT02714010;NCT01040780;NCT02883543;NCT04206072;NCT03008109;NCT03992885;NCT02448797"},{"ligand":"icotinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2011","completion_date":"2020","nct_id":"NCT01926171;NCT04401059;NCT02778893;NCT02031601;NCT01465243;NCT02404675;NCT01646450;NCT02194556"},{"ligand":"imatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2004","completion_date":"2016","nct_id":"NCT01083589;NCT00425646;NCT00408460;NCT01011075;NCT01019798;NCT00323362;NCT02127372;NCT02954523"},{"ligand":"imatinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03264794"},{"ligand":"lapatinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00528281"},{"ligand":"lapatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2003","completion_date":"2019","nct_id":"NCT00073008;NCT03845270;NCT01306045"},{"ligand":"lenvatinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00832819"},{"ligand":"lenvatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT01529112;NCT03516981;NCT04777084"},{"ligand":"lenvatinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT04716933;NCT03976375;NCT03829332;NCT03829319;NCT04676412"},{"ligand":"lorlatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02584634;NCT01970865;NCT03439215;NCT04127110;NCT03909971;NCT03612154;NCT02927340;NCT04111705;NCT04621188"},{"ligand":"lorlatinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03052608"},{"ligand":"lorlatinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04541706"},{"ligand":"necitumumab","mesh_id":"D002289","phase":"Phase 1","start_date":"2015","completion_date":"2017","nct_id":"NCT02789345;NCT02496663;NCT03054038;NCT02451930;NCT02411591"},{"ligand":"necitumumab","mesh_id":"D002289","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03944772;NCT01769391;NCT04285671;NCT01788566;NCT02392507;NCT02941601;NCT01763788"},{"ligand":"necitumumab","mesh_id":"D002289","phase":"Phase 3","start_date":"2009","completion_date":"2010","nct_id":"NCT00982111;NCT00981058"},{"ligand":"neratinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00266877;NCT01827267"},{"ligand":"nintedanib","mesh_id":"D002289","phase":"Phase 1","start_date":"2005","completion_date":"2016","nct_id":"NCT00979576;NCT02182102;NCT02668393;NCT02225405;NCT01346540;NCT02751385;NCT02182232;NCT02300298;NCT01683682;NCT01684111;NCT00876460"},{"ligand":"nintedanib","mesh_id":"D002289","phase":"Phase 2","start_date":"2005","completion_date":"2018","nct_id":"NCT03377023;NCT02452463;NCT01948141;NCT02182050;NCT02299141"},{"ligand":"nintedanib","mesh_id":"D002289","phase":"Phase 3","start_date":"2008","completion_date":"2014","nct_id":"NCT02231164;NCT00806819;NCT00805194"},{"ligand":"olaratumab","mesh_id":"D002289","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT00918203"},{"ligand":"olmutinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT04510415"},{"ligand":"olmutinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT02444819;NCT03228277;NCT01588145;NCT02485652"},{"ligand":"osimertinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT02197247;NCT02228369;NCT03255083;NCT02520778;NCT02157883;NCT02529995;NCT02789345;NCT02317016;NCT03535363;NCT04772235;NCT02143466;NCT02908750;NCT03463525;NCT02197234;NCT04077463;NCT04676477;NCT03858491;NCT04762199;NCT04141644;NCT04479306;NCT02496663;NCT02503722;NCT03050411;NCT04448379;NCT02163733;NCT04780568;NCT04001777"},{"ligand":"osimertinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03392246;NCT03122717;NCT03784599;NCT04743505;NCT03460275;NCT02917993;NCT03434418;NCT03586453;NCT02856893;NCT03133546;NCT03257124;NCT04029350;NCT03831932;NCT03455829;NCT04563871;NCT03944772;NCT03667820;NCT03497767;NCT03799094;NCT03418532;NCT03940703;NCT04438902;NCT02841579;NCT04338243;NCT04148898;NCT03769103;NCT02442349;NCT02094261;NCT03446417;NCT02771314;NCT02179671;NCT03410043;NCT04316351;NCT04769388;NCT03381274;NCT04606771;NCT04285671;NCT03318939;NCT03414814;NCT02664935;NCT03450330;NCT03758677;NCT04099836;NCT02811354;NCT03433469;NCT03191149;NCT02971501;NCT04425681;NCT04233021;NCT04486833;NCT01802632;NCT03909334;NCT04764214;NCT03239340;NCT02824952;NCT02954523;NCT03424759;NCT04335292"},{"ligand":"osimertinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2014","completion_date":"2021","nct_id":"NCT04765059;NCT02151981;NCT02296125;NCT03515837;NCT02454933;NCT02411448;NCT04035486;NCT04351555;NCT02511106;NCT04695925;NCT04181060;NCT02972333;NCT03521154;NCT04487080;NCT02959749"},{"ligand":"osimertinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2019","completion_date":"2020","nct_id":"NCT03853551;NCT04413201;NCT04356118"},{"ligand":"palbociclib","mesh_id":"D002289","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02897375;NCT04606446"},{"ligand":"palbociclib","mesh_id":"D002289","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT02022982;NCT02349633;NCT03386929;NCT04553133;NCT02664935;NCT01291017"},{"ligand":"panitumumab","mesh_id":"D002289","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT04667975;NCT02192541;NCT00352950;NCT01061788"},{"ligand":"panitumumab","mesh_id":"D002289","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00979212;NCT01042288;NCT01088620;NCT00034346;NCT00101920;NCT01038037;NCT00094835"},{"ligand":"pazopanib","mesh_id":"D002289","phase":"Phase 1","start_date":"2007","completion_date":"2013","nct_id":"NCT01060514;NCT00619424;NCT00678977;NCT00866528;NCT02009449"},{"ligand":"pazopanib","mesh_id":"D002289","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT01027598;NCT02193152;NCT01179269;NCT00549328;NCT00871403;NCT00367679;NCT01049776;NCT01313663"},{"ligand":"pazopanib","mesh_id":"D002289","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00775307"},{"ligand":"pertuzumab","mesh_id":"D002289","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT02507375"},{"ligand":"pertuzumab","mesh_id":"D002289","phase":"Phase 2","start_date":"2003","completion_date":"2019","nct_id":"NCT00855894;NCT00063154;NCT03845270"},{"ligand":"ponatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01935336;NCT01813734;NCT03704688"},{"ligand":"ramucirumab","mesh_id":"D002289","phase":"Phase 1","start_date":"2014","completion_date":"2016","nct_id":"NCT02789345;NCT02443324;NCT02079636"},{"ligand":"ramucirumab","mesh_id":"D002289","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT04151563;NCT04394624;NCT03904108;NCT04040361;NCT00735696;NCT02831491;NCT04120454;NCT04332367;NCT01160744;NCT01703091;NCT03689855;NCT03527108;NCT03909334;NCT02730247;NCT04310007;NCT03971474"},{"ligand":"ramucirumab","mesh_id":"D002289","phase":"Phase 3","start_date":"2010","completion_date":"2015","nct_id":"NCT02411448;NCT01168973"},{"ligand":"regorafenib","mesh_id":"D002289","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01187615"},{"ligand":"regorafenib","mesh_id":"D002289","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02795156;NCT03475953;NCT03520842"},{"ligand":"ribociclib","mesh_id":"D002289","phase":"Phase 1","start_date":"2010","completion_date":"2019","nct_id":"NCT02292550;NCT04000529;NCT02974725;NCT03333343"},{"ligand":"ruxolitinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02119650"},{"ligand":"selumetinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2010","completion_date":"2016","nct_id":"NCT02503358;NCT02143466;NCT01783197;NCT01605916;NCT01586624;NCT01809210;NCT01146756"},{"ligand":"selumetinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2006","completion_date":"2019","nct_id":"NCT03392246;NCT01248247;NCT03586453;NCT01610544;NCT03004105;NCT02179671;NCT01229150;NCT00890825;NCT02664935;NCT02117167;NCT02025114;NCT01750281;NCT03581487;NCT02337530;NCT00372788;NCT02450656;NCT01306045"},{"ligand":"selumetinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01933932"},{"ligand":"sirolimus","mesh_id":"D002289","phase":"Phase 1","start_date":"2004","completion_date":"2019","nct_id":"NCT00655655;NCT00796796;NCT01383668;NCT01545947;NCT00993499;NCT00352950;NCT00555256;NCT01155258;NCT03217669;NCT02126527;NCT04348292"},{"ligand":"sirolimus","mesh_id":"D002289","phase":"Phase 2","start_date":"2004","completion_date":"2018","nct_id":"NCT02920450;NCT01737502;NCT00079235;NCT00124280;NCT00818675;NCT03664115;NCT00921310;NCT01827267;NCT00923273;NCT00098462"},{"ligand":"sorafenib","mesh_id":"D002289","phase":"Phase 1","start_date":"2006","completion_date":"2009","nct_id":"NCT00533585;NCT00870532;NCT00954278;NCT00933777;NCT01005797;NCT01069328;NCT00543335;NCT00635791"},{"ligand":"sorafenib","mesh_id":"D002289","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00098254;NCT01248247;NCT00801801;NCT00801385;NCT00647426;NCT00754923;NCT00454194;NCT00098540;NCT00101413;NCT00473486;NCT00600015;NCT00417248;NCT00547443;NCT00609804;NCT00532025;NCT00722969;NCT00922584;NCT00064350"},{"ligand":"sorafenib","mesh_id":"D002289","phase":"Phase 3","start_date":"2006","completion_date":"2009","nct_id":"NCT00300885;NCT00558636;NCT00863746;NCT00449033"},{"ligand":"sunitinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2004","completion_date":"2007","nct_id":"NCT00581789;NCT00555256;NCT00712504"},{"ligand":"sunitinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00113516;NCT00864721;NCT00698815;NCT00748163;NCT00265317;NCT01019798;NCT01210053;NCT00372775;NCT01803503;NCT00092001;NCT00434226;NCT01306045"},{"ligand":"sunitinib","mesh_id":"D002289","phase":"Phase 3","start_date":"2007","completion_date":"2008","nct_id":"NCT00693992;NCT00457392"},{"ligand":"tivozanib","mesh_id":"D002289","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00826878"},{"ligand":"tivozanib","mesh_id":"D002289","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01728181"},{"ligand":"trametinib","mesh_id":"D002289","phase":"Phase 1","start_date":"2010","completion_date":"2018","nct_id":"NCT03299088;NCT02258607;NCT01938456;NCT02974725;NCT03333343;NCT01912625"},{"ligand":"trametinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT01362296;NCT02580708;NCT03704688;NCT03225664;NCT02642042;NCT03232892;NCT02672358;NCT03087448;NCT04452877;NCT01336634"},{"ligand":"trametinib","mesh_id":"D002289","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03340506"},{"ligand":"trastuzumab","mesh_id":"D002289","phase":"Phase 1","start_date":"1999","completion_date":"2021","nct_id":"NCT03319459;NCT04686305;NCT00004074;NCT04042701"},{"ligand":"trastuzumab","mesh_id":"D002289","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT02226757;NCT03784599;NCT02314481;NCT04579380;NCT02289833;NCT04644237;NCT03505710;NCT02308020;NCT04285671;NCT03334617;NCT00758134;NCT04464967;NCT00016367;NCT00004883;NCT03845270"},{"ligand":"tucatinib","mesh_id":"D002289","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04579380"},{"ligand":"vandetanib","mesh_id":"D002289","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01004419;NCT00745732;NCT00807170;NCT01586624"},{"ligand":"vandetanib","mesh_id":"D002289","phase":"Phase 2","start_date":"2004","completion_date":"2014","nct_id":"NCT00777179;NCT01823068;NCT00252746;NCT02117167;NCT00459121;NCT00753714;NCT00687297"},{"ligand":"vandetanib","mesh_id":"D002289","phase":"Phase 3","start_date":"2006","completion_date":"2007","nct_id":"NCT00418886;NCT00404924;NCT00312377;NCT00364351"},{"ligand":"vemurafenib","mesh_id":"D002289","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT02314481;NCT04302025"},{"ligand":"vemurafenib","mesh_id":"D002289","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03178552"},{"ligand":"vemurafenib","mesh_id":"D002289","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"}],"predictions":[{"target":"MOK","probability":"0.925"},{"target":"AMHR2","probability":"0.915"},{"target":"TAF1","probability":"0.915"},{"target":"CILK1","probability":"0.905"},{"target":"EPHA5","probability":"0.9"},{"target":"AXL","probability":"0.8951572731788828"},{"target":"SGK3","probability":"0.875"},{"target":"CIT","probability":"0.87"},{"target":"RPS6KB2","probability":"0.8650111507582515"},{"target":"HASPIN","probability":"0.865"},{"target":"MAP3K20","probability":"0.8621612903225807"},{"target":"EPHA2","probability":"0.86"},{"target":"CLK2","probability":"0.86"},{"target":"MAP3K4","probability":"0.857"},{"target":"CAMK2A","probability":"0.85"},{"target":"BCR","probability":"0.8450109170305677"},{"target":"EPHB4","probability":"0.845"},{"target":"PRKG2","probability":"0.845"},{"target":"EPHA7","probability":"0.845"},{"target":"RYK","probability":"0.84"},{"target":"TYRO3","probability":"0.83"},{"target":"MST1R","probability":"0.83"},{"target":"CAMK2B","probability":"0.825"},{"target":"TEC","probability":"0.8170000000000001"},{"target":"EPHB2","probability":"0.8153333333333334"},{"target":"EPHB1","probability":"0.815"},{"target":"TGFBR2","probability":"0.815"},{"target":"CASK","probability":"0.815"},{"target":"SIK1","probability":"0.8100235577061423"},{"target":"CSNK1A1","probability":"0.81"},{"target":"TRPM6","probability":"0.81"},{"target":"TIE1","probability":"0.805"},{"target":"TGFBR1","probability":"0.8"},{"target":"OBSCN","probability":"0.8"},{"target":"ACVR2B","probability":"0.795"},{"target":"ACVR1C","probability":"0.795"},{"target":"MATK","probability":"0.795"},{"target":"PDIK1L","probability":"0.795"},{"target":"PTK7","probability":"0.7925326909841707"},{"target":"MARK4","probability":"0.7900555555555556"},{"target":"AKT2","probability":"0.7900239675516224"},{"target":"RPS6KA6","probability":"0.7900124069478908"},{"target":"MAP3K10","probability":"0.79"},{"target":"GRK7","probability":"0.7850111507582516"},{"target":"EPHB3","probability":"0.785"},{"target":"CDK10","probability":"0.785"},{"target":"FAM20C","probability":"0.78"},{"target":"PRKCQ","probability":"0.777"},{"target":"PRKCI","probability":"0.7758387257991468"},{"target":"ACVRL1","probability":"0.775"},{"target":"NUAK1","probability":"0.7700124069478907"},{"target":"PKN2","probability":"0.77"},{"target":"SRMS","probability":"0.77"},{"target":"CDK11B","probability":"0.7652098804950919"},{"target":"SRPK1","probability":"0.7650432138284251"},{"target":"STYK1","probability":"0.76"},{"target":"MAP3K9","probability":"0.76"},{"target":"CCL8","probability":"0.76"},{"target":"PIM2","probability":"0.7567857142857142"},{"target":"CCNK","probability":"0.75"},{"target":"NEK1","probability":"0.75"},{"target":"CDK12","probability":"0.7466666666666666"},{"target":"PIK3CB","probability":"0.7452988734693307"},{"target":"TRIM24","probability":"0.7452098804950918"},{"target":"DDR2","probability":"0.7450789473684211"},{"target":"PIK3CD","probability":"0.740048514379417"},{"target":"DYRK1B","probability":"0.7400111507582515"},{"target":"BMPR1B","probability":"0.74"},{"target":"PIK3CG","probability":"0.74"},{"target":"MAK","probability":"0.74"},{"target":"STK4","probability":"0.74"},{"target":"ACVR2A","probability":"0.74"},{"target":"MAP3K13","probability":"0.74"},{"target":"CDK19","probability":"0.7352783736457766"},{"target":"PRKACB","probability":"0.735"},{"target":"IRAK2","probability":"0.735"},{"target":"MAPK6","probability":"0.735"},{"target":"KSR1","probability":"0.7320111507582516"},{"target":"STK11","probability":"0.730194979117417"},{"target":"ACVR1","probability":"0.73"},{"target":"CDC42BPA","probability":"0.73"},{"target":"NEK6","probability":"0.73"},{"target":"MAP3K12","probability":"0.7250667063138071"},{"target":"DAPK2","probability":"0.7250111507582515"},{"target":"BMPR2","probability":"0.725"},{"target":"FRK","probability":"0.725"},{"target":"HIPK3","probability":"0.725"},{"target":"PKN1","probability":"0.725"},{"target":"NPR1","probability":"0.7216666666666666"},{"target":"CSNK1E","probability":"0.72"},{"target":"KALRN","probability":"0.72"},{"target":"EPHA4","probability":"0.72"},{"target":"RIPK4","probability":"0.72"},{"target":"PIM1","probability":"0.7150245468277946"},{"target":"SRPK2","probability":"0.715"},{"target":"PKDCC","probability":"0.715"},{"target":"DCAF1","probability":"0.7100111507582515"},{"target":"CDK16","probability":"0.71"},{"target":"WNK2","probability":"0.7070000000000001"},{"target":"PAK1","probability":"0.7057349468713104"},{"target":"CDKL1","probability":"0.7050111507582515"},{"target":"NUAK2","probability":"0.705"},{"target":"PRKX","probability":"0.705"},{"target":"SIK2","probability":"0.705"},{"target":"RPS6KA4","probability":"0.705"},{"target":"STK38","probability":"0.705"},{"target":"DYRK2","probability":"0.7019742288705285"},{"target":"BRD4","probability":"0.700179825850283"},{"target":"PEAK1","probability":"0.7000111507582516"},{"target":"ULK2","probability":"0.7"},{"target":"PDK3","probability":"0.7"},{"target":"GRK2","probability":"0.6986666666666668"},{"target":"AKT3","probability":"0.6951221611968461"},{"target":"CDK8","probability":"0.695043213828425"},{"target":"LIMK2","probability":"0.6950111507582516"},{"target":"PDK1","probability":"0.695"},{"target":"MAP2K7","probability":"0.695"},{"target":"TNIK","probability":"0.695"},{"target":"PAK6","probability":"0.6916790736145575"},{"target":"PTK2B","probability":"0.6902144202455162"},{"target":"MKNK2","probability":"0.6901612903225807"},{"target":"PRKCB","probability":"0.6901029149200434"},{"target":"DCLK2","probability":"0.69"},{"target":"CCL3","probability":"0.69"},{"target":"MAPKAPK5","probability":"0.69"},{"target":"PKMYT1","probability":"0.69"},{"target":"MAPK4","probability":"0.69"},{"target":"CAMKV","probability":"0.69"},{"target":"CDK14","probability":"0.6866666666666665"},{"target":"RPS6KB1","probability":"0.6851195219123505"},{"target":"ITK","probability":"0.6850685943271954"},{"target":"PTK6","probability":"0.6850326909841706"},{"target":"VRK2","probability":"0.6850124069478909"},{"target":"MAP3K2","probability":"0.6850111507582516"},{"target":"STK32B","probability":"0.685"},{"target":"ALPK1","probability":"0.6801612903225807"},{"target":"HIPK1","probability":"0.68"},{"target":"MAPKAPK3","probability":"0.68"},{"target":"MARK3","probability":"0.6751612903225807"},{"target":"CSNK1D","probability":"0.675"},{"target":"PRKACA","probability":"0.675"},{"target":"NEK8","probability":"0.675"},{"target":"BMPR1A","probability":"0.675"},{"target":"LMTK2","probability":"0.675"},{"target":"MUSK","probability":"0.6719021739130434"},{"target":"PRKCZ","probability":"0.670078947368421"},{"target":"TTK","probability":"0.67006387498545"},{"target":"PAK5","probability":"0.6700124069478909"},{"target":"INSRR","probability":"0.67"},{"target":"PIM3","probability":"0.6671943785578748"},{"target":"ROR2","probability":"0.6670618795422558"},{"target":"CDK20","probability":"0.665078947368421"},{"target":"CDK13","probability":"0.665"},{"target":"TNK2","probability":"0.665"},{"target":"LRRK1","probability":"0.665"},{"target":"ALPK3","probability":"0.665"},{"target":"NEK7","probability":"0.665"},{"target":"PRKCH","probability":"0.6600913543163119"},{"target":"ILK","probability":"0.6579439618306315"},{"target":"NLK","probability":"0.6571612903225806"},{"target":"ATP23","probability":"0.655"},{"target":"MAP4K1","probability":"0.655"},{"target":"NPRL2","probability":"0.655"},{"target":"PDPK1","probability":"0.6517210312533434"},{"target":"PTK2","probability":"0.6506350657452731"},{"target":"PRKCA","probability":"0.6503026030231112"},{"target":"NEK9","probability":"0.65"},{"target":"MAPK15","probability":"0.65"},{"target":"BRSK2","probability":"0.65"},{"target":"TNNI3K","probability":"0.65"},{"target":"CDKL2","probability":"0.6472098804950918"},{"target":"PRKCE","probability":"0.6459561403508772"},{"target":"YES1","probability":"0.6452756597145566"},{"target":"CCL5","probability":"0.6452355072463769"},{"target":"AURKA","probability":"0.6451955603266633"},{"target":"NME2","probability":"0.6451221611968461"},{"target":"TRIO","probability":"0.6450566459414364"},{"target":"RPS6KA3","probability":"0.6450543645866768"},{"target":"CDK3","probability":"0.6416790736145574"},{"target":"CLK1","probability":"0.6402222874429826"},{"target":"PRKCD","probability":"0.640200839487806"},{"target":"EPHA1","probability":"0.6370555555555556"},{"target":"FYN","probability":"0.635145172533984"},{"target":"CDK7","probability":"0.6351428571428571"},{"target":"CAMKK1","probability":"0.635"},{"target":"TAOK1","probability":"0.635"},{"target":"MAP4K4","probability":"0.6336666666666667"},{"target":"EIF2AK1","probability":"0.6322888278635128"},{"target":"PLK3","probability":"0.630627589114416"},{"target":"AURKB","probability":"0.6302211725205665"},{"target":"MAP3K3","probability":"0.63"},{"target":"TESK2","probability":"0.63"},{"target":"UHMK1","probability":"0.63"},{"target":"GRK3","probability":"0.6250438417424222"},{"target":"GSK3B","probability":"0.625023386342376"},{"target":"CDKN1A","probability":"0.625"},{"target":"WNK3","probability":"0.625"},{"target":"SRPK3","probability":"0.625"},{"target":"PHKG2","probability":"0.62"},{"target":"MASTL","probability":"0.62"},{"target":"MARK2","probability":"0.6187109056602123"},{"target":"MAP3K8","probability":"0.6174983420335534"},{"target":"SBK1","probability":"0.615"},{"target":"STK32C","probability":"0.615"},{"target":"STK35","probability":"0.615"},{"target":"PAK3","probability":"0.6103679411252108"},{"target":"DMPK","probability":"0.6100112866817156"},{"target":"STK25","probability":"0.61"},{"target":"PRKD2","probability":"0.61"},{"target":"LMTK3","probability":"0.61"},{"target":"AVP","probability":"0.605078947368421"},{"target":"SMG1","probability":"0.605"},{"target":"DYRK4","probability":"0.605"},{"target":"CDK1","probability":"0.600641382332414"},{"target":"TAOK2","probability":"0.6002651743865455"},{"target":"CAMK1","probability":"0.6000124069478908"},{"target":"AKT1","probability":"0.6"},{"target":"CAMK1G","probability":"0.6"},{"target":"IRAK4","probability":"0.5974983420335533"},{"target":"IRAK3","probability":"0.5957385995530106"},{"target":"GRK4","probability":"0.5950667063138071"},{"target":"ACVR1B","probability":"0.5950555555555556"},{"target":"STK38L","probability":"0.595"},{"target":"MYO3A","probability":"0.595"},{"target":"STK33","probability":"0.595"},{"target":"PIK3R4","probability":"0.595"},{"target":"MAP2K3","probability":"0.5904983420335533"},{"target":"TTN","probability":"0.5904233006736068"},{"target":"PDK2","probability":"0.5901333119550977"},{"target":"SGK1","probability":"0.5900996085254459"},{"target":"GRK1","probability":"0.59"},{"target":"PBK","probability":"0.5875229094208907"},{"target":"CAMK2G","probability":"0.5866900530090426"},{"target":"CDK2","probability":"0.5850313479623824"},{"target":"ROCK1","probability":"0.5850239675516223"},{"target":"CCL2","probability":"0.585"},{"target":"MAP4K3","probability":"0.585"},{"target":"RPS6KA5","probability":"0.5822098804950918"},{"target":"MYLK3","probability":"0.5820000000000001"},{"target":"TRPM7","probability":"0.5817333729804738"},{"target":"MAPK12","probability":"0.5808374696095077"},{"target":"IKBKB","probability":"0.5804049987718005"},{"target":"PRKCG","probability":"0.580078947368421"},{"target":"NEK5","probability":"0.58"},{"target":"EPHA8","probability":"0.5798074401327208"},{"target":"VRK1","probability":"0.5774128765697534"},{"target":"BUB1B","probability":"0.5760775681341719"},{"target":"EEF2K","probability":"0.5758705578448018"},{"target":"CDK15","probability":"0.575"},{"target":"BUB1","probability":"0.5730638749854499"},{"target":"MAPK13","probability":"0.5708374696095077"},{"target":"ROCK2","probability":"0.5701551640810014"},{"target":"PRKG1","probability":"0.57"},{"target":"EPHA6","probability":"0.57"},{"target":"CDK11A","probability":"0.57"},{"target":"PRKD1","probability":"0.5673995584988962"},{"target":"HCK","probability":"0.5670291885580853"},{"target":"TRIM28","probability":"0.5668333333333334"},{"target":"MYLK","probability":"0.5653031834193922"},{"target":"MOS","probability":"0.565078947368421"},{"target":"PAK2","probability":"0.5650403393163368"},{"target":"CAMK1D","probability":"0.565"},{"target":"SGK2","probability":"0.565"},{"target":"CHUK","probability":"0.5613691613541785"},{"target":"MELK","probability":"0.5610409613150322"},{"target":"MAPK7","probability":"0.5575762167125804"},{"target":"IKBKE","probability":"0.5574719137695429"},{"target":"WEE1","probability":"0.5574348229601261"},{"target":"RNASEL","probability":"0.5572456140350878"},{"target":"RPS6KA1","probability":"0.5567574995427108"},{"target":"CLK3","probability":"0.555"},{"target":"LIMK1","probability":"0.5520111507582516"},{"target":"CSK","probability":"0.552"},{"target":"ZAP70","probability":"0.5500432138284251"},{"target":"PLK2","probability":"0.5477211182614897"},{"target":"GSK3A","probability":"0.5453007464092098"},{"target":"LATS1","probability":"0.5450870555708474"},{"target":"ADCK1","probability":"0.54"},{"target":"CDK18","probability":"0.54"},{"target":"FASTKD3","probability":"0.54"},{"target":"CSNK2A2","probability":"0.5351663148392529"},{"target":"ANKK1","probability":"0.5351221611968462"},{"target":"TTBK2","probability":"0.535"},{"target":"CDC42BPG","probability":"0.535"},{"target":"MAP3K11","probability":"0.5328374696095077"},{"target":"PRKAA2","probability":"0.5301668246944795"},{"target":"DYRK1A","probability":"0.5300789473684211"},{"target":"FASTKD1","probability":"0.53"},{"target":"TLK1","probability":"0.5255555555555556"},{"target":"PASK","probability":"0.525"},{"target":"DCLK3","probability":"0.525"},{"target":"DAPK1","probability":"0.522658470475599"},{"target":"DCLK1","probability":"0.5222666955932462"},{"target":"MARK1","probability":"0.5222502198114286"},{"target":"CDKL5","probability":"0.5222456140350877"},{"target":"MAP2K4","probability":"0.5211450572922904"},{"target":"HIPK2","probability":"0.5179218285174979"},{"target":"PLK1","probability":"0.5175569683227857"},{"target":"CSNK2A1","probability":"0.5154468515922574"},{"target":"PLK4","probability":"0.5152070059830034"},{"target":"PRKAA1","probability":"0.515139116458434"},{"target":"NPR2","probability":"0.5128333333333334"},{"target":"TBK1","probability":"0.5105830746587958"},{"target":"PRKACG","probability":"0.51"},{"target":"CSNK1G1","probability":"0.51"},{"target":"RPS6KA2","probability":"0.5086118358510444"},{"target":"RIPK1","probability":"0.5065775790149933"},{"target":"NEK2","probability":"0.5060930635435351"},{"target":"TSSK4","probability":"0.505"},{"target":"NRBP2","probability":"0.505"},{"target":"STK17B","probability":"0.505"},{"target":"PIK3C3","probability":"0.5025275305916386"},{"target":"MAPK1","probability":"0.5"},{"target":"CAMKK2","probability":"0.4967210312533434"},{"target":"KSR2","probability":"0.495"},{"target":"MAPK3","probability":"0.495"},{"target":"PDK4","probability":"0.49387654716175844"},{"target":"MAP3K5","probability":"0.4936680950789605"},{"target":"IRAK1","probability":"0.4902884615384615"},{"target":"PAK4","probability":"0.4890274066960824"},{"target":"CSNK1A1L","probability":"0.485"},{"target":"CDK5","probability":"0.4837008512095408"},{"target":"MKNK1","probability":"0.48324221965184866"},{"target":"CSNK2B","probability":"0.4801783446663988"},{"target":"MAPK10","probability":"0.4801221611968461"},{"target":"PRKD3","probability":"0.48"},{"target":"TLK2","probability":"0.48"},{"target":"LATS2","probability":"0.4782313640051455"},{"target":"CDC7","probability":"0.4754308700593415"},{"target":"LRRK2","probability":"0.4752111797696061"},{"target":"ATM","probability":"0.47119582110311353"},{"target":"MAP2K6","probability":"0.4702456140350877"},{"target":"MAPKAPK2","probability":"0.4701552963480174"},{"target":"CHEK2","probability":"0.46966266258798944"},{"target":"MAPK11","probability":"0.4687385995530105"},{"target":"SIK3","probability":"0.465"},{"target":"EIF2AK2","probability":"0.46270419915441857"},{"target":"ERN1","probability":"0.4621790092579641"},{"target":"CAMK4","probability":"0.4620789473684211"},{"target":"MYLK2","probability":"0.46"},{"target":"EIF2AK3","probability":"0.4589623589797748"},{"target":"CHEK1","probability":"0.45781959747467105"},{"target":"CDK9","probability":"0.4576972203846063"},{"target":"MAP3K1","probability":"0.4559570297632641"},{"target":"AAK1","probability":"0.45555555555555555"},{"target":"PHKG1","probability":"0.455"}],"source_name":"Carcinoma, Non-Small-Cell Lung"}],["D001749",{"mesh_id":"D001749","trials":[{"ligand":"abemaciclib","mesh_id":"D001749","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03837821"},{"ligand":"afatinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2013","completion_date":"2015","nct_id":"NCT02122172;NCT02465060"},{"ligand":"axitinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"binimetinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT03824691;NCT01688999;NCT03866382;NCT04289779"},{"ligand":"cetuximab","mesh_id":"D001749","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT00645593;NCT04464967"},{"ligand":"copanlisib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02631590;NCT02465060"},{"ligand":"crizotinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02788201;NCT02465060;NCT02612194"},{"ligand":"dabrafenib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02788201;NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04172675;NCT02465060"},{"ligand":"erlotinib","mesh_id":"D001749","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00030498"},{"ligand":"erlotinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT02788201;NCT00380029;NCT02169284;NCT00088946;NCT00749892"},{"ligand":"everolimus","mesh_id":"D001749","phase":"Phase 2","start_date":"2009","completion_date":"2010","nct_id":"NCT01215136;NCT00933374"},{"ligand":"gefitinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2001","completion_date":"2017","nct_id":"NCT00479089;NCT00246974;NCT02788201;NCT00014144"},{"ligand":"gefitinib","mesh_id":"D001749","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00352079"},{"ligand":"imatinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"lapatinib","mesh_id":"D001749","phase":"Phase 1","start_date":"2006","completion_date":"2011","nct_id":"NCT00623064;NCT01245660;NCT00313599"},{"ligand":"lapatinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT01382706;NCT02788201;NCT01700010"},{"ligand":"lapatinib","mesh_id":"D001749","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00949455"},{"ligand":"larotrectinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"nilotinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"osimertinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"panitumumab","mesh_id":"D001749","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01374789;NCT01916109"},{"ligand":"pazopanib","mesh_id":"D001749","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT01620970;NCT01108055;NCT02788201;NCT01265940;NCT00471536;NCT01031875"},{"ligand":"pemigatinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03914794"},{"ligand":"pertuzumab","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ruxolitinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"selumetinib","mesh_id":"D001749","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02546661"},{"ligand":"sirolimus","mesh_id":"D001749","phase":"Phase 1","start_date":"2012","completion_date":"2016","nct_id":"NCT01522820;NCT02646319;NCT01827618;NCT02753309"},{"ligand":"sirolimus","mesh_id":"D001749","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT03047213;NCT02009332;NCT01938573;NCT02788201;NCT04375813;NCT01827943;NCT01090466"},{"ligand":"sirolimus","mesh_id":"D001749","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03298958"},{"ligand":"sorafenib","mesh_id":"D001749","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00544609"},{"ligand":"sorafenib","mesh_id":"D001749","phase":"Phase 2","start_date":"2005","completion_date":"2017","nct_id":"NCT01222676;NCT02788201;NCT00112905;NCT00461851;NCT01215266;NCT00112671"},{"ligand":"sunitinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT01118351;NCT00859339;NCT01089088;NCT00792025;NCT02788201;NCT00578526;NCT00847015;NCT02465060;NCT00526656;NCT01118039;NCT00397488;NCT00818350"},{"ligand":"trametinib","mesh_id":"D001749","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D001749","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D001749","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT00005831;NCT00238420;NCT04464967;NCT02465060;NCT01828736;NCT00004856"},{"ligand":"vandetanib","mesh_id":"D001749","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT02788201;NCT01191892"},{"ligand":"vemurafenib","mesh_id":"D001749","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"}],"predictions":[{"target":"IGF1R","probability":"0.6603161787746284"},{"target":"BCR","probability":"0.66"},{"target":"INSR","probability":"0.635"},{"target":"ERBB3","probability":"0.620041881443299"},{"target":"FLT4","probability":"0.5500284495021337"},{"target":"MAP2K7","probability":"0.55"},{"target":"ZAP70","probability":"0.5450649377162117"},{"target":"PTK2","probability":"0.5006411432925608"},{"target":"PLK1","probability":"0.49541314811189935"},{"target":"EPHB2","probability":"0.49505474452554743"},{"target":"SRC","probability":"0.48564114329256086"},{"target":"BTK","probability":"0.4702517626691865"},{"target":"ACVRL1","probability":"0.46685967281544455"},{"target":"TEK","probability":"0.46000847457627114"},{"target":"CDKN1A","probability":"0.45516949152542374"}],"source_name":"Urinary Bladder Neoplasms"}],["D001943",{"mesh_id":"D001943","trials":[{"ligand":"abemaciclib","mesh_id":"D001943","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT04188548;NCT04316169;NCT04481113;NCT04483505;NCT02779751;NCT03099174;NCT04585724;NCT04514159;NCT03846583;NCT03616587;NCT02057133;NCT03878524;NCT04088032"},{"ligand":"abemaciclib","mesh_id":"D001943","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT04523857;NCT04352777;NCT04305834;NCT02747004;NCT04432454;NCT04256941;NCT03979508;NCT04603183;NCT04351230;NCT02308020;NCT03939897;NCT03130439;NCT03227328;NCT02831530;NCT03280563;NCT02675231;NCT03703466;NCT04614194;NCT04293393;NCT02102490;NCT04305236;NCT02441946;NCT03913234;NCT04227327"},{"ligand":"abemaciclib","mesh_id":"D001943","phase":"Phase 3","start_date":"2014","completion_date":"2021","nct_id":"NCT02763566;NCT03155997;NCT04565054;NCT04752332;NCT03425838;NCT02246621;NCT04158362;NCT02107703"},{"ligand":"abemaciclib","mesh_id":"D001943","phase":"Phase 4","start_date":"2019","completion_date":"2021","nct_id":"NCT04707196;NCT03988114;NCT04031885"},{"ligand":"afatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00950742;NCT01649271;NCT03878524"},{"ligand":"afatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2006","completion_date":"2020","nct_id":"NCT01594177;NCT00826267;NCT02768337;NCT02511847;NCT01271725;NCT00431067;NCT01325428;NCT02465060;NCT01531764;NCT01441596;NCT02115048;NCT00425854;NCT00708214;NCT04158947"},{"ligand":"afatinib","mesh_id":"D001943","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01125566"},{"ligand":"alpelisib","mesh_id":"D001943","phase":"Phase 1","start_date":"2010","completion_date":"2019","nct_id":"NCT02734615;NCT01623349;NCT03207529;NCT02058381;NCT04188548;NCT02167854;NCT02077933;NCT02038010;NCT01219699;NCT02088684;NCT02051751;NCT01791478;NCT01300962;NCT01870505"},{"ligand":"alpelisib","mesh_id":"D001943","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT02379247;NCT02506556;NCT01923168;NCT04300790;NCT04544189;NCT04215003;NCT03056755;NCT04524000;NCT04762979;NCT04216472;NCT03284957;NCT03386162;NCT01872260"},{"ligand":"alpelisib","mesh_id":"D001943","phase":"Phase 3","start_date":"2015","completion_date":"2020","nct_id":"NCT04251533;NCT04208178;NCT02437318;NCT03439046"},{"ligand":"apatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2017","completion_date":"2019","nct_id":"NCT03075462;NCT03945604"},{"ligand":"apatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03982485;NCT03243838;NCT03394287;NCT03805399;NCT03348098;NCT03735082;NCT03932526;NCT03086785;NCT03535961;NCT03457467;NCT04303741;NCT03775928;NCT02878057;NCT03254654;NCT01653561;NCT01176669;NCT03650738;NCT02768415;NCT04722718"},{"ligand":"apatinib","mesh_id":"D001943","phase":"Phase 3","start_date":"2017","completion_date":"2020","nct_id":"NCT03580395;NCT04335006;NCT04296370"},{"ligand":"avapritinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00076024"},{"ligand":"binimetinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04494958;NCT03106415;NCT03971409;NCT02465060"},{"ligand":"bosutinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03854903"},{"ligand":"bosutinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2006","completion_date":"2009","nct_id":"NCT00319254;NCT00959946;NCT00880009;NCT00793546"},{"ligand":"cabozantinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT01441947;NCT03316586;NCT01738438;NCT02260531"},{"ligand":"cetuximab","mesh_id":"D001943","phase":"Phase 1","start_date":"2006","completion_date":"2015","nct_id":"NCT01552434;NCT00367250;NCT02391727"},{"ligand":"cetuximab","mesh_id":"D001943","phase":"Phase 2","start_date":"2005","completion_date":"2021","nct_id":"NCT03692689;NCT00463788;NCT00633464;NCT00248287;NCT00232505;NCT00353717;NCT04464967;NCT00275041;NCT01097642;NCT00600249"},{"ligand":"cobimetinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT02322814;NCT03566485;NCT03395899"},{"ligand":"copanlisib","mesh_id":"D001943","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT04042051;NCT02705859;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT03803761;NCT03939897;NCT04345913;NCT03377101;NCT04108858;NCT02465060;NCT03128619"},{"ligand":"crizotinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02074878"},{"ligand":"crizotinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03620643;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT00452673;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT00820170;NCT00566618;NCT01471106;NCT00817531;NCT01306942;NCT00767520;NCT02720185;NCT00696072;NCT00924352;NCT02465060;NCT00371345;NCT00754325;NCT00371254;NCT00780676;NCT00903006;NCT00546104;NCT00410813"},{"ligand":"entrectinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04551495"},{"ligand":"erdafitinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03238196"},{"ligand":"erdafitinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT01594398;NCT00600496;NCT01650506;NCT00574366;NCT00030498;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2001","completion_date":"2019","nct_id":"NCT00732810;NCT00597597;NCT00030537;NCT00054275;NCT04034589;NCT00611715;NCT01205685;NCT00033514;NCT01013506;NCT00109265;NCT00739063;NCT00491816;NCT00059852;NCT00733408;NCT00633750;NCT00570258;NCT00054132;NCT00834678"},{"ligand":"everolimus","mesh_id":"D001943","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT02058381;NCT04188548;NCT00473005;NCT03154281;NCT02077933;NCT02619669;NCT00426530;NCT00253318;NCT02152943;NCT00680758;NCT01482156;NCT02120469;NCT01857193;NCT00574366;NCT02616848;NCT03616587;NCT02057133;NCT03878524;NCT00426556"},{"ligand":"everolimus","mesh_id":"D001943","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT00317720;NCT01627067;NCT00855114;NCT02531932;NCT02871791;NCT00107016;NCT01163929;NCT00934895;NCT01298713;NCT01127763;NCT02273752;NCT02035813;NCT02742051;NCT04355858;NCT01520103;NCT03032406;NCT02456857;NCT02049957;NCT02387099;NCT00674414;NCT03805399;NCT02028364;NCT01272141;NCT00930475;NCT00930930;NCT03750396;NCT00255788;NCT02216786;NCT01939418;NCT00458237;NCT02520063;NCT02829008;NCT01499160;NCT00912340;NCT02069093;NCT00466102;NCT01088893;NCT01797120;NCT01783756;NCT00915603;NCT02344550;NCT01283789;NCT02015559;NCT02258451;NCT01698918;NCT01931163;NCT03312738;NCT01783444;NCT02269670;NCT04395989;NCT02236572;NCT02229136;NCT03659136;NCT02732119;NCT00570921;NCT00827567;NCT01031446;NCT02291913;NCT02313051;NCT00499603;NCT01305941"},{"ligand":"everolimus","mesh_id":"D001943","phase":"Phase 3","start_date":"2007","completion_date":"2015","nct_id":"NCT02511639;NCT01626222;NCT02376985;NCT00876395;NCT02404051;NCT01007942;NCT01773460;NCT01805271;NCT00567554;NCT03176238;NCT01674140;NCT00863655;NCT02137837"},{"ligand":"everolimus","mesh_id":"D001943","phase":"Phase 4","start_date":"2011","completion_date":"2014","nct_id":"NCT02248571;NCT01948960;NCT01743560;NCT01231659"},{"ligand":"gefitinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2001","completion_date":"2013","nct_id":"NCT00080743;NCT00206414;NCT00239343;NCT00051051;NCT00255463;NCT00024154;NCT00999804;NCT00632723;NCT00319618;NCT00234403;NCT00077025;NCT00229697;NCT00066339;NCT00252811;NCT00428896;NCT00206492;NCT00049062;NCT00086957;NCT00057941;NCT00066378;NCT00637026;NCT01732276;NCT00052169;NCT00247481"},{"ligand":"ibrutinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02403271;NCT03379428"},{"ligand":"icotinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02362230"},{"ligand":"imatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00080665;NCT03878524"},{"ligand":"imatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2002","completion_date":"2006","nct_id":"NCT00338728;NCT00193180;NCT00323063;NCT00045188;NCT00087152"},{"ligand":"imatinib","mesh_id":"D001943","phase":"Phase 4","start_date":"2006","completion_date":"2006","nct_id":"NCT00372476"},{"ligand":"lapatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2003","completion_date":"2016","nct_id":"NCT01434303;NCT01245205;NCT01471847;NCT00424164;NCT02650752;NCT01875666;NCT00849329;NCT00996762;NCT00169533;NCT00371488;NCT00821054;NCT01238029;NCT00807859;NCT00388076;NCT00790816;NCT00331630;NCT01199367;NCT00544804;NCT00367471;NCT00258050;NCT00632489;NCT00379509;NCT00359190;NCT01281163;NCT00462956;NCT00316875;NCT00470847;NCT00650910;NCT02073916;NCT00313599;NCT00148902;NCT01300962;NCT00513058;NCT00085020;NCT00634088;NCT00614978;NCT01133912;NCT02131506;NCT00251433;NCT00753207;NCT01705340"},{"ligand":"lapatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT01361945;NCT00479856;NCT01594177;NCT00826267;NCT01873833;NCT00455039;NCT02396108;NCT00356811;NCT00299286;NCT00952692;NCT00912275;NCT01273610;NCT00320411;NCT01589861;NCT00444535;NCT00477464;NCT03500380;NCT00347919;NCT01118975;NCT00657137;NCT01565200;NCT00759642;NCT00316407;NCT01137994;NCT00404066;NCT01068704;NCT01218529;NCT00706030;NCT01138046;NCT00105950;NCT00343759;NCT01262469;NCT00436566;NCT00709761;NCT00694252;NCT00999804;NCT00842998;NCT01557764;NCT00903656;NCT02238509;NCT01973660;NCT01161368;NCT00496366;NCT03273595;NCT00820924;NCT01431196;NCT00263588;NCT00754702;NCT01272141;NCT01477060;NCT00548184;NCT00756470;NCT01934894;NCT00499681;NCT01658358;NCT04334330;NCT01688609;NCT01494662;NCT00524303;NCT00118157;NCT01138384;NCT00741260;NCT00111787;NCT01499160;NCT00820872;NCT00098605;NCT00769470;NCT01044485;NCT00777101;NCT03755141;NCT01783756;NCT02362958;NCT01868503;NCT01985893;NCT01827163;NCT00721630;NCT00709618;NCT01283789;NCT00450892;NCT00225758;NCT01485926;NCT01275859;NCT01441596;NCT00437073;NCT01912963;NCT00967031;NCT00482391;NCT00089999;NCT00206427;NCT00841828;NCT01622868;NCT01172223;NCT02422199;NCT00429299;NCT00051103;NCT02213042;NCT03913234;NCT00684983;NCT02073487;NCT02768415;NCT01730677;NCT00062686;NCT01309607;NCT01205217;NCT02139358;NCT01005641;NCT00558103;NCT01534455;NCT00422903;NCT00470704;NCT01495884;NCT01479179"},{"ligand":"lapatinib","mesh_id":"D001943","phase":"Phase 3","start_date":"2003","completion_date":"2018","nct_id":"NCT00770809;NCT00508274;NCT00688194;NCT02394496;NCT00078572;NCT01426880;NCT00374322;NCT03085368;NCT01160211;NCT00667251;NCT03262935;NCT00490139;NCT00553358;NCT01419197;NCT01808573;NCT01619111;NCT01526369;NCT00073528;NCT00567554;NCT00281658;NCT00272987;NCT01104571;NCT03084939;NCT00320385;NCT03080805;NCT00075270;NCT00829166;NCT00486668;NCT00820222;NCT00390455;NCT04185649;NCT03523585"},{"ligand":"larotrectinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02915172;NCT04427293;NCT03878524"},{"ligand":"lenvatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02562118;NCT03168074"},{"ligand":"lorlatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT01423123;NCT00146172;NCT03878524"},{"ligand":"neratinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT02673398;NCT02396108;NCT00398567;NCT01008150;NCT01111825;NCT00706030;NCT03377387;NCT04366713;NCT00445458;NCT04760431;NCT03289039;NCT00915018;NCT03812393;NCT01494662;NCT00741260;NCT03101748;NCT00777101;NCT01042379;NCT00300781;NCT01670877;NCT02236000;NCT03182634;NCT02400476;NCT04460430;NCT03094052"},{"ligand":"neratinib","mesh_id":"D001943","phase":"Phase 3","start_date":"2009","completion_date":"2013","nct_id":"NCT00878709;NCT01808573"},{"ligand":"nilotinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04205903"},{"ligand":"nintedanib","mesh_id":"D001943","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02619162"},{"ligand":"nintedanib","mesh_id":"D001943","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT02389764;NCT01658462;NCT01484080"},{"ligand":"osimertinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D001943","phase":"Phase 1","start_date":"2011","completion_date":"2021","nct_id":"NCT03332797;NCT02897375;NCT01976169;NCT02599714;NCT03685331;NCT04360941;NCT03006172;NCT04498520;NCT04504331;NCT02389842;NCT04483505;NCT03284723;NCT02626507;NCT03238196;NCT03471663;NCT03854903;NCT02913430;NCT03455270;NCT02499146;NCT01320592;NCT02684032;NCT04585724;NCT03900884;NCT03959891;NCT04288089;NCT03616587;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D001943","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT03530696;NCT03560856;NCT04494958;NCT03644186;NCT01709370;NCT02917005;NCT03609047;NCT02448771;NCT04567420;NCT02871791;NCT02592083;NCT03633331;NCT04247633;NCT02491983;NCT02764541;NCT03628066;NCT04075604;NCT02603679;NCT01723774;NCT03709082;NCT04012918;NCT02530424;NCT02774681;NCT02296801;NCT03691493;NCT02760030;NCT02592746;NCT04256941;NCT04436744;NCT02549430;NCT02536742;NCT03304080;NCT03819010;NCT04334330;NCT03227328;NCT02907918;NCT04318223;NCT02605486;NCT02778685;NCT01684215;NCT03377101;NCT02668666;NCT03147287;NCT03280563;NCT04224272;NCT03065621;NCT00721409;NCT02738866;NCT02894398;NCT02008734;NCT02384239;NCT03573648;NCT04669587;NCT02465060;NCT03054363;NCT02400567;NCT03809988;NCT02690480;NCT03322215;NCT02630693;NCT03184090;NCT04563507;NCT03007979;NCT01823835;NCT03284957;NCT02632045;NCT04072952;NCT03913234;NCT03560531;NCT03128619;NCT03774472;NCT01037790;NCT02624973;NCT02448420;NCT02942355;NCT03439735;NCT02040857;NCT04220476"},{"ligand":"palbociclib","mesh_id":"D001943","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT03423199;NCT01864746;NCT02297438;NCT04478266;NCT04711252;NCT02028507;NCT02947685;NCT04047758;NCT03447132;NCT02600923;NCT03969121;NCT03079011;NCT01942135;NCT04060862;NCT03425838;NCT04191499;NCT03820830;NCT01740427;NCT02692755;NCT04546009;NCT02513394"},{"ligand":"palbociclib","mesh_id":"D001943","phase":"Phase 4","start_date":"2016","completion_date":"2019","nct_id":"NCT03220178;NCT03355157;NCT04137640;NCT02679755"},{"ligand":"panitumumab","mesh_id":"D001943","phase":"Phase 2","start_date":"2009","completion_date":"2016","nct_id":"NCT01036087;NCT02593175;NCT01009983;NCT02876107;NCT00894504;NCT00933517"},{"ligand":"pazopanib","mesh_id":"D001943","phase":"Phase 1","start_date":"2006","completion_date":"2013","nct_id":"NCT01498458;NCT00388076;NCT00722293;NCT01060514;NCT00450879;NCT01639911"},{"ligand":"pazopanib","mesh_id":"D001943","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00509587;NCT00347919;NCT00849472;NCT01394211;NCT01466972;NCT00615524;NCT00558103"},{"ligand":"pertuzumab","mesh_id":"D001943","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT02598427;NCT02390427;NCT01875666;NCT04692831;NCT03006172;NCT02060253;NCT02605915;NCT04253561;NCT03135171;NCT01805908;NCT03387553;NCT01918254;NCT02738970;NCT03716180;NCT02057133;NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D001943","phase":"Phase 2","start_date":"2003","completion_date":"2021","nct_id":"NCT04398914;NCT02910219;NCT03058939;NCT01594177;NCT03238495;NCT03988036;NCT03644186;NCT04578106;NCT04197687;NCT04001829;NCT04246502;NCT00875979;NCT04569747;NCT04721977;NCT04329065;NCT01847001;NCT01922921;NCT04249622;NCT00934856;NCT03125928;NCT03820141;NCT02326974;NCT04215003;NCT02530424;NCT04538742;NCT02491892;NCT02993198;NCT04750122;NCT00976989;NCT00999804;NCT01491737;NCT03881878;NCT03412643;NCT03272477;NCT04760431;NCT04266249;NCT02229149;NCT01796197;NCT04717531;NCT01276041;NCT04733118;NCT04301375;NCT04255056;NCT04351230;NCT00301899;NCT03304080;NCT01674062;NCT02789657;NCT01817452;NCT02252887;NCT04094896;NCT04675827;NCT01835236;NCT00943670;NCT00545688;NCT02379585;NCT00951665;NCT02682693;NCT01597414;NCT02000596;NCT03101748;NCT03742986;NCT02689921;NCT04419181;NCT02436993;NCT01959490;NCT04108858;NCT01042379;NCT01669239;NCT01730833;NCT01565083;NCT02465060;NCT03820063;NCT03144947;NCT03747120;NCT03894007;NCT01912963;NCT01937117;NCT02536339;NCT03674112;NCT01855828;NCT02132949;NCT03913234;NCT03417544;NCT02073487;NCT02339532;NCT02411344;NCT03112590;NCT04425018;NCT02624973;NCT02827877;NCT01904903;NCT03414658;NCT02139358;NCT02345772;NCT02909751;NCT03161353;NCT03329378"},{"ligand":"pertuzumab","mesh_id":"D001943","phase":"Phase 3","start_date":"2008","completion_date":"2021","nct_id":"NCT03493854;NCT03726879;NCT02003209;NCT04784715;NCT02125344;NCT04514419;NCT01358877;NCT04024462;NCT02586025;NCT04254263;NCT02344472;NCT02625441;NCT04337658;NCT01996267;NCT01583426;NCT01120184;NCT02947685;NCT01026142;NCT04665986;NCT02514681;NCT04208178;NCT04193059;NCT02213744;NCT02568839;NCT04740918;NCT00567190;NCT03199885;NCT01966471;NCT02402712;NCT03595592;NCT02896855;NCT04629846;NCT02131064;NCT02019277;NCT03811418;NCT01572038"},{"ligand":"pertuzumab","mesh_id":"D001943","phase":"Phase 4","start_date":"2011","completion_date":"2015","nct_id":"NCT02445586;NCT01501487"},{"ligand":"ponatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D001943","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01256567"},{"ligand":"ramucirumab","mesh_id":"D001943","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01234402;NCT01427933"},{"ligand":"ramucirumab","mesh_id":"D001943","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00703326"},{"ligand":"regorafenib","mesh_id":"D001943","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03251378;NCT03878524"},{"ligand":"ribociclib","mesh_id":"D001943","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT02734615;NCT02333370;NCT02599363;NCT03294694;NCT04483505;NCT02608216;NCT02586675;NCT02088684;NCT02754011;NCT01857193;NCT04315233;NCT04585724;NCT02154776"},{"ligand":"ribociclib","mesh_id":"D001943","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03090165;NCT03078751;NCT03613220;NCT03839823;NCT02035813;NCT03285412;NCT04256941;NCT03822468;NCT03477396;NCT03555877;NCT03227328;NCT03280563;NCT02712723;NCT03944434;NCT01919229;NCT02632045;NCT03913234;NCT02732119;NCT02657343;NCT03671330;NCT03283384;NCT01872260;NCT03248427"},{"ligand":"ribociclib","mesh_id":"D001943","phase":"Phase 3","start_date":"2013","completion_date":"2019","nct_id":"NCT03096847;NCT02344472;NCT01958021;NCT03701334;NCT03081234;NCT03425838;NCT03905343;NCT02278120;NCT03462251;NCT04055493;NCT02422615;NCT03439046;NCT02941926;NCT03050398"},{"ligand":"ruxolitinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03012230;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT02066532;NCT02041429;NCT01594216;NCT02120417;NCT02876302;NCT01562873"},{"ligand":"selumetinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2007","completion_date":"2017","nct_id":"NCT00600496;NCT03162627;NCT01313039"},{"ligand":"selumetinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2009","completion_date":"2016","nct_id":"NCT02685657;NCT01160718;NCT02299999;NCT00780676"},{"ligand":"sirolimus","mesh_id":"D001943","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01248494;NCT00473005;NCT01522820;NCT02646319;NCT00600496;NCT02145559;NCT01552434;NCT02619669;NCT00659568;NCT01220570;NCT02152943;NCT02684032;NCT02120469;NCT01155258;NCT02616848;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D001943","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT04720664;NCT01495247;NCT01298713;NCT01111825;NCT02273752;NCT04355858;NCT01520103;NCT02456857;NCT01658176;NCT02723877;NCT03805399;NCT01272141;NCT02642094;NCT00736970;NCT02216786;NCT01234857;NCT01797120;NCT01783756;NCT00411788;NCT00062751;NCT02269670;NCT00376688;NCT01430585;NCT02313051;NCT00499603;NCT00699491"},{"ligand":"sirolimus","mesh_id":"D001943","phase":"Phase 3","start_date":"2004","completion_date":"2021","nct_id":"NCT04736589;NCT01626222;NCT00083993;NCT01633060;NCT01805271;NCT03176238"},{"ligand":"sorafenib","mesh_id":"D001943","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT01498458;NCT01724606;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D001943","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00632541;NCT00828074;NCT01320111;NCT00548899;NCT00096434;NCT00634634;NCT00499525;NCT00954135;NCT00607438;NCT00101400;NCT00493636;NCT02624700;NCT00825734;NCT00217399;NCT00622466;NCT01194869;NCT00525161;NCT00722072;NCT00764972;NCT03318562;NCT00573755"},{"ligand":"sorafenib","mesh_id":"D001943","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01234337"},{"ligand":"sunitinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00372424;NCT01498458;NCT02074878;NCT00291577;NCT00174434;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2004","completion_date":"2016","nct_id":"NCT00824538;NCT00078000;NCT00931450;NCT00513695;NCT00243503;NCT00905021;NCT00616122;NCT01070706;NCT00471276;NCT01176799;NCT00887575;NCT00417885;NCT02465060;NCT00270413;NCT00246571;NCT00482755;NCT00434356;NCT02790580;NCT00570908;NCT00662025"},{"ligand":"sunitinib","mesh_id":"D001943","phase":"Phase 3","start_date":"2006","completion_date":"2007","nct_id":"NCT00373113;NCT00393939;NCT00435409;NCT00373256"},{"ligand":"tivozanib","mesh_id":"D001943","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00717340"},{"ligand":"tivozanib","mesh_id":"D001943","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01745367"},{"ligand":"trametinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01467310;NCT03878524"},{"ligand":"trametinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2013","completion_date":"2015","nct_id":"NCT02465060;NCT01964924"},{"ligand":"trastuzumab","mesh_id":"D001943","phase":"Phase 1","start_date":"1999","completion_date":"2021","nct_id":"NCT00009997;NCT02598427;NCT01097460;NCT04398108;NCT02390427;NCT04382352;NCT03281824;NCT01434303;NCT04042051;NCT00932373;NCT01245205;NCT00620594;NCT01471847;NCT00393783;NCT00803556;NCT01976169;NCT02025192;NCT04556773;NCT03014076;NCT01265927;NCT01875666;NCT00199212;NCT03032107;NCT04704661;NCT01730118;NCT01423123;NCT00372424;NCT04188548;NCT03429101;NCT04367090;NCT00371488;NCT00412412;NCT00960960;NCT01238029;NCT00807859;NCT02167854;NCT02705859;NCT03006172;NCT00950742;NCT00790816;NCT00301730;NCT03364348;NCT00028535;NCT01432886;NCT03432741;NCT00014430;NCT01921335;NCT01513083;NCT03153163;NCT02060253;NCT02038010;NCT00367471;NCT03944499;NCT02605915;NCT01148849;NCT04509596;NCT03062007;NCT04253561;NCT01304797;NCT02569489;NCT00426530;NCT04120246;NCT01649271;NCT00367250;NCT00674791;NCT04332588;NCT02152943;NCT02649686;NCT03135171;NCT00462956;NCT04294628;NCT04296942;NCT01816035;NCT01805908;NCT03767335;NCT01596530;NCT03387553;NCT00605397;NCT00788931;NCT04102618;NCT00004074;NCT00470847;NCT00068757;NCT01445054;NCT02073916;NCT01880385;NCT00949247;NCT02738970;NCT02562378;NCT01300962;NCT00085020;NCT03716180;NCT02135159;NCT03953833;NCT01420146;NCT01969643;NCT03013881;NCT01384253;NCT00928330;NCT00039455;NCT03846583;NCT00251433;NCT01983501;NCT01602406;NCT02063724;NCT01705340;NCT02057133;NCT03878524;NCT00426556;NCT04023110"},{"ligand":"trastuzumab","mesh_id":"D001943","phase":"Phase 2","start_date":"1998","completion_date":"2021","nct_id":"NCT01401959;NCT00317720;NCT04398914;NCT02910219;NCT00670982;NCT02066532;NCT03058939;NCT00193063;NCT01423695;NCT00479856;NCT03765983;NCT01594177;NCT03238495;NCT00532857;NCT00826267;NCT01340430;NCT01873833;NCT00193089;NCT00193076;NCT03988036;NCT03644186;NCT04578106;NCT02129556;NCT00475670;NCT04197687;NCT04001829;NCT02843126;NCT04246502;NCT00003539;NCT00875979;NCT00455039;NCT03735966;NCT04569747;NCT00574587;NCT04721977;NCT02396108;NCT00387907;NCT00118053;NCT03203616;NCT01206881;NCT00004888;NCT00429247;NCT01779050;NCT01745965;NCT04329065;NCT01254136;NCT01847001;NCT00254592;NCT00952692;NCT01922921;NCT04152057;NCT03997539;NCT00258960;NCT01273610;NCT04681911;NCT02177175;NCT00398567;NCT00320411;NCT03571633;NCT00955890;NCT02000882;NCT00250874;NCT04001621;NCT01163929;NCT04579380;NCT01589861;NCT01008150;NCT01329640;NCT01439191;NCT03095352;NCT01570036;NCT04383275;NCT03140553;NCT00934856;NCT03500380;NCT00679341;NCT00567879;NCT01009918;NCT01111825;NCT01472146;NCT01042925;NCT02654119;NCT04170595;NCT00657137;NCT00006123;NCT01565200;NCT00379015;NCT00051051;NCT01137994;NCT04508803;NCT03125928;NCT03709082;NCT00404066;NCT01363986;NCT02658084;NCT03820141;NCT00079326;NCT01928615;NCT00943410;NCT02091960;NCT02326974;NCT01262469;NCT03368729;NCT01220128;NCT02530424;NCT00024154;NCT00182793;NCT00054470;NCT04681287;NCT00509769;NCT00129896;NCT00436566;NCT00365365;NCT00006108;NCT00629499;NCT02774681;NCT04538742;NCT01306942;NCT02993198;NCT04750122;NCT00976989;NCT00444587;NCT00773344;NCT00398489;NCT03501979;NCT00191373;NCT04095390;NCT00542451;NCT00999804;NCT04034589;NCT01679743;NCT01196052;NCT01190345;NCT00842998;NCT01512199;NCT02297698;NCT01491737;NCT00093808;NCT03881878;NCT01557764;NCT00944047;NCT03412643;NCT04481932;NCT00446030;NCT00095706;NCT00903656;NCT03272477;NCT02041338;NCT00427427;NCT01271920;NCT00331552;NCT00503750;NCT00403988;NCT02238509;NCT00674414;NCT04760431;NCT00003612;NCT00243503;NCT01973660;NCT04266249;NCT02229149;NCT00216073;NCT00194779;NCT01106898;NCT02199418;NCT01796197;NCT04717531;NCT03273595;NCT01750073;NCT00043394;NCT01276041;NCT01428414;NCT04733118;NCT04301375;NCT04255056;NCT04351230;NCT02308020;NCT00428922;NCT00301899;NCT01431196;NCT03304080;NCT00263588;NCT02510781;NCT00811135;NCT00297596;NCT04469127;NCT01674062;NCT00847171;NCT00717405;NCT01367028;NCT00110695;NCT00407888;NCT00138125;NCT02789657;NCT00548184;NCT01817452;NCT04066790;NCT00033514;NCT00885755;NCT01853748;NCT04307329;NCT00006381;NCT02252887;NCT00736970;NCT00401427;NCT04334330;NCT00134680;NCT00003992;NCT00618657;NCT00915018;NCT03321981;NCT03213925;NCT01688609;NCT04094896;NCT04675827;NCT01387295;NCT02907918;NCT01835236;NCT00464646;NCT00943670;NCT00545688;NCT01084863;NCT00405938;NCT01373710;NCT03923166;NCT04759248;NCT00303108;NCT02725541;NCT00788333;NCT00726180;NCT00810017;NCT02379585;NCT01494662;NCT04088110;NCT01690325;NCT01625429;NCT00617942;NCT04034823;NCT00256243;NCT00524303;NCT01630226;NCT00458237;NCT00951665;NCT01436604;NCT02682693;NCT02154529;NCT00741260;NCT02924883;NCT04539938;NCT02748213;NCT00518583;NCT01597414;NCT03367676;NCT02000596;NCT04172259;NCT00820872;NCT00392392;NCT00912340;NCT03101748;NCT04158856;NCT04262804;NCT03742986;NCT01641406;NCT02689921;NCT01242449;NCT03907800;NCT00864175;NCT01132664;NCT04752059;NCT01142778;NCT01816594;NCT00533936;NCT00769470;NCT00216047;NCT03994107;NCT01763710;NCT04236310;NCT03931551;NCT04419181;NCT00364611;NCT00270894;NCT03755141;NCT02436993;NCT01290718;NCT00453635;NCT01959490;NCT00431067;NCT04108858;NCT00006825;NCT02675231;NCT01194908;NCT00086957;NCT00088985;NCT01783756;NCT04464967;NCT01042379;NCT01325428;NCT00337649;NCT01269346;NCT01975142;NCT02362958;NCT00490646;NCT00077376;NCT02214004;NCT01669239;NCT01985893;NCT00036868;NCT01325207;NCT00386685;NCT01730833;NCT02598310;NCT01548677;NCT01565083;NCT01827163;NCT00136539;NCT00817362;NCT00431704;NCT02465060;NCT03820063;NCT02048059;NCT03248492;NCT00411788;NCT03144947;NCT02614794;NCT00721630;NCT00232479;NCT00780000;NCT04296162;NCT00006228;NCT00242203;NCT00343109;NCT01283789;NCT00300781;NCT00093145;NCT03242551;NCT00450892;NCT00004013;NCT01480583;NCT03747120;NCT00485979;NCT03894007;NCT01670877;NCT00830544;NCT00824733;NCT01485926;NCT01185509;NCT02674204;NCT01441596;NCT04553770;NCT00550771;NCT00295893;NCT01432223;NCT01434134;NCT00522457;NCT02236000;NCT00591851;NCT00258349;NCT01912963;NCT03190967;NCT00399529;NCT00482391;NCT04512261;NCT00795899;NCT00821886;NCT00841828;NCT01937117;NCT00006110;NCT00006104;NCT03760588;NCT02536339;NCT00266110;NCT01832051;NCT01828021;NCT00429104;NCT00041067;NCT02422199;NCT02400476;NCT01388647;NCT03674112;NCT03379428;NCT01401166;NCT03879577;NCT00107393;NCT00964704;NCT00429299;NCT01855828;NCT03933319;NCT00019812;NCT01321775;NCT02015676;NCT01387373;NCT02213042;NCT02132949;NCT03913234;NCT00684983;NCT03417544;NCT00238290;NCT00687440;NCT00712881;NCT00679211;NCT00303992;NCT00284180;NCT02073487;NCT02339532;NCT00796978;NCT00068341;NCT00148668;NCT02411344;NCT00133796;NCT03742102;NCT00191451;NCT04639271;NCT02488564;NCT03112590;NCT00130507;NCT01730677;NCT03587740;NCT00434031;NCT02657343;NCT04158947;NCT00146042;NCT00005635;NCT00377780;NCT04425018;NCT04278144;NCT00493649;NCT01702558;NCT02624973;NCT02827877;NCT04298918;NCT03179904;NCT01004172;NCT04126525;NCT01904903;NCT01205217;NCT02448420;NCT00971737;NCT03910712;NCT00057993;NCT03414658;NCT01830244;NCT02059876;NCT03094052;NCT00201760;NCT02139358;NCT04605575;NCT03698383;NCT02345772;NCT02307227;NCT02260531;NCT00041470;NCT00397501;NCT00148681;NCT04420598;NCT01534455;NCT01170143;NCT02297230;NCT00768859;NCT02909751;NCT00470704;NCT00004925;NCT03161353;NCT01495884;NCT01479179;NCT03329378;NCT01305941;NCT00140140"},{"ligand":"trastuzumab","mesh_id":"D001943","phase":"Phase 3","start_date":"1998","completion_date":"2021","nct_id":"NCT03493854;NCT00513292;NCT00639366;NCT00770809;NCT03726879;NCT02003209;NCT01275677;NCT04784715;NCT02125344;NCT03588091;NCT04736589;NCT00440622;NCT04514419;NCT00512993;NCT00878709;NCT01358877;NCT01426880;NCT00288002;NCT03529110;NCT01917578;NCT01950182;NCT04024462;NCT02586025;NCT04254263;NCT02344472;NCT01964391;NCT04400695;NCT04290793;NCT02194166;NCT02625441;NCT02236806;NCT01566721;NCT00045032;NCT00593697;NCT03980054;NCT04494425;NCT04337658;NCT01996267;NCT01413828;NCT03085368;NCT01583426;NCT00294996;NCT01125566;NCT04547907;NCT03561740;NCT01772472;NCT01160211;NCT01120184;NCT00448279;NCT02947685;NCT01875367;NCT02187744;NCT00667251;NCT03949634;NCT04457596;NCT01926886;NCT03262935;NCT02973737;NCT03006614;NCT01026142;NCT00309556;NCT00712140;NCT00876395;NCT03863223;NCT04665986;NCT04109391;NCT00490139;NCT00553358;NCT00146549;NCT02514681;NCT01419197;NCT00615602;NCT03556358;NCT03734029;NCT01007942;NCT03975647;NCT00391092;NCT01901146;NCT00381901;NCT01940497;NCT04208178;NCT03418961;NCT00430001;NCT01084876;NCT00047255;NCT03433313;NCT01104935;NCT00520975;NCT04193059;NCT02213744;NCT00021255;NCT01526369;NCT00798070;NCT03705429;NCT02568839;NCT04740918;NCT03989037;NCT01989676;NCT00054587;NCT00567190;NCT03199885;NCT00103233;NCT01966471;NCT00567554;NCT02162667;NCT00625898;NCT00629278;NCT03084237;NCT04646759;NCT03168880;NCT00637325;NCT02402712;NCT00004935;NCT03595592;NCT02492711;NCT00016276;NCT01810393;NCT01764022;NCT02896855;NCT00169104;NCT01998906;NCT04629846;NCT02149524;NCT00148876;NCT00272987;NCT03425656;NCT02131064;NCT01104571;NCT03084939;NCT04622319;NCT00320385;NCT01702571;NCT03080805;NCT00038402;NCT00829166;NCT00950300;NCT00486668;NCT02019277;NCT02040935;NCT01613482;NCT00004067;NCT02144012;NCT00820222;NCT02472964;NCT03811418;NCT00003440;NCT00005970;NCT04185649;NCT00022672;NCT03523585;NCT03013504;NCT01572038;NCT01785420"},{"ligand":"trastuzumab","mesh_id":"D001943","phase":"Phase 4","start_date":"2003","completion_date":"2021","nct_id":"NCT02696707;NCT00127933;NCT02658734;NCT02445586;NCT01501487;NCT00171847;NCT02419742;NCT04739761;NCT01301729"},{"ligand":"tucatinib","mesh_id":"D001943","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT02025192;NCT03846583;NCT01983501"},{"ligand":"tucatinib","mesh_id":"D001943","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT04721977;NCT04579380;NCT04538742;NCT03501979;NCT04760431;NCT04539938;NCT01042379;NCT03054363;NCT02614794;NCT04512261"},{"ligand":"tucatinib","mesh_id":"D001943","phase":"Phase 3","start_date":"2019","completion_date":"2021","nct_id":"NCT04457596;NCT03975647"},{"ligand":"vandetanib","mesh_id":"D001943","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00496665;NCT00937417"},{"ligand":"vandetanib","mesh_id":"D001943","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT00811369;NCT00752986;NCT01934335;NCT02299999;NCT00494481;NCT00481845"},{"ligand":"vemurafenib","mesh_id":"D001943","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"KIT","probability":"1.0"},{"target":"PDGFRA","probability":"0.745"},{"target":"IGF1R","probability":"0.7308603697111888"},{"target":"BCR","probability":"0.7200537634408601"},{"target":"NTRK1","probability":"0.65743849536141"},{"target":"EPHB2","probability":"0.587230221191333"},{"target":"INSR","probability":"0.5607830477056082"},{"target":"NTRK2","probability":"0.502267572787573"},{"target":"PLK1","probability":"0.4866181371625052"},{"target":"AURKB","probability":"0.4703396896710527"},{"target":"TGFBR1","probability":"0.46721204608079075"},{"target":"MAP2K7","probability":"0.4657988344988345"},{"target":"NTRK3","probability":"0.45790030709958"}],"source_name":"Breast Neoplasms"}],["D018365",{"mesh_id":"D018365","trials":[{"ligand":"abemaciclib","mesh_id":"D018365","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04523857"},{"ligand":"dasatinib","mesh_id":"D018365","phase":"Phase 1","start_date":"2012","completion_date":"2013","nct_id":"NCT01751425;NCT01460498"},{"ligand":"dasatinib","mesh_id":"D018365","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT03516279;NCT01883219"},{"ligand":"dasatinib","mesh_id":"D018365","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03624530"},{"ligand":"ibrutinib","mesh_id":"D018365","phase":"Phase 2","start_date":"2016","completion_date":"2021","nct_id":"NCT04758975;NCT02649387"},{"ligand":"imatinib","mesh_id":"D018365","phase":"Phase 1","start_date":"2012","completion_date":"2013","nct_id":"NCT01751425;NCT01460498"},{"ligand":"imatinib","mesh_id":"D018365","phase":"Phase 2","start_date":"2005","completion_date":"2018","nct_id":"NCT03516279;NCT01883219;NCT00267085"},{"ligand":"imatinib","mesh_id":"D018365","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03624530"},{"ligand":"midostaurin","mesh_id":"D018365","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03951961"},{"ligand":"nilotinib","mesh_id":"D018365","phase":"Phase 1","start_date":"2012","completion_date":"2013","nct_id":"NCT01751425;NCT01460498"},{"ligand":"nilotinib","mesh_id":"D018365","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT03516279;NCT01883219"},{"ligand":"palbociclib","mesh_id":"D018365","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04130152"},{"ligand":"ponatinib","mesh_id":"D018365","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01883219"},{"ligand":"ponatinib","mesh_id":"D018365","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03624530"},{"ligand":"ruxolitinib","mesh_id":"D018365","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01751425"},{"ligand":"sirolimus","mesh_id":"D018365","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03192397"},{"ligand":"trastuzumab","mesh_id":"D018365","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01772472"}],"predictions":[{"target":"BRAF","probability":"0.54"}],"source_name":"Neoplasm, Residual"}],["D002277",{"mesh_id":"D002277","trials":[{"ligand":"abemaciclib","mesh_id":"D002277","phase":"Phase 1","start_date":"2019","completion_date":"2021","nct_id":"NCT04481113;NCT03905889;NCT04627064;NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D002277","phase":"Phase 2","start_date":"2019","completion_date":"2021","nct_id":"NCT04305834;NCT03781960;NCT03979508;NCT04351230;NCT03939897;NCT04616183;NCT04003896;NCT03531645;NCT03655444;NCT04469764"},{"ligand":"acalabrutinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02448303;NCT02454179;NCT02351739"},{"ligand":"afatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT02451553;NCT03652233;NCT01288430;NCT03878524"},{"ligand":"afatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT01824823;NCT03088059;NCT02795156;NCT03486509;NCT03157089;NCT02491099;NCT01608022;NCT00514943;NCT02541903;NCT03940976;NCT04183712;NCT01538381;NCT02465060;NCT02353936;NCT01415674;NCT04533321"},{"ligand":"afatinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2011","completion_date":"2012","nct_id":"NCT01427478;NCT01523587;NCT01345682"},{"ligand":"afatinib","mesh_id":"D002277","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT04132102"},{"ligand":"alectinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"alpelisib","mesh_id":"D002277","phase":"Phase 1","start_date":"2013","completion_date":"2019","nct_id":"NCT03207529;NCT01822613;NCT02537223"},{"ligand":"alpelisib","mesh_id":"D002277","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT02145312;NCT02298595;NCT03601507;NCT01602315;NCT04216472"},{"ligand":"apatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2016","completion_date":"2021","nct_id":"NCT04665362;NCT02645864;NCT04073784"},{"ligand":"apatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03520257;NCT03130270;NCT03511703;NCT04318730;NCT02727309;NCT04297202;NCT03193424;NCT02976896;NCT03424291;NCT04548271;NCT03092895;NCT03732105;NCT04191889;NCT02775370;NCT04014101;NCT03793725;NCT04188847;NCT01192971;NCT02942329;NCT04479527;NCT04411706;NCT04666090;NCT03267121;NCT03261791;NCT03709953;NCT03096184;NCT03046979;NCT03857763;NCT04156698;NCT02942693;NCT02874651;NCT03167385;NCT04535687;NCT04204577;NCT04586088;NCT02772029;NCT03612219;NCT04724226;NCT04547088;NCT04440917;NCT03251417;NCT03320629;NCT03913182;NCT03114085;NCT03213587;NCT03609489;NCT03427242;NCT03702491;NCT04350190;NCT03510416;NCT04701060;NCT02774200;NCT03839550"},{"ligand":"apatinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2009","completion_date":"2020","nct_id":"NCT04639180;NCT03355612;NCT00970138;NCT02329860"},{"ligand":"apatinib","mesh_id":"D002277","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03725423"},{"ligand":"axitinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01441388;NCT04522323;NCT03289533;NCT02814461"},{"ligand":"axitinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT01441414;NCT04540705;NCT02667886;NCT01798446;NCT01806064;NCT01649180;NCT03494816;NCT01334112;NCT02788201;NCT04118855;NCT01273662;NCT03092856;NCT03438708;NCT04387500;NCT04698213;NCT03172754;NCT02639182;NCT01210495;NCT01558661;NCT04385654;NCT04337970;NCT02535533;NCT03990571;NCT03595124;NCT01352728;NCT02187302;NCT00835978;NCT02489695;NCT04370509;NCT02700568;NCT01727336;NCT03736330;NCT03592199;NCT01263769;NCT01483638"},{"ligand":"axitinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2016","completion_date":"2021","nct_id":"NCT02853331;NCT04510597;NCT04394975;NCT04764487"},{"ligand":"binimetinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2015","completion_date":"2018","nct_id":"NCT02185690;NCT02105350"},{"ligand":"binimetinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03981614;NCT04390243;NCT03971409;NCT04061980;NCT02465060;NCT01828034"},{"ligand":"brigatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03707938;NCT04227028"},{"ligand":"brigatinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02737501"},{"ligand":"cabozantinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT02496208;NCT03299946;NCT03200587;NCT04514484;NCT02293980;NCT01709435;NCT03798626;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04540705;NCT03824691;NCT03468985;NCT02036476;NCT03367741;NCT03149822;NCT03534804;NCT02795156;NCT04300140;NCT04454762;NCT04472767;NCT01658878;NCT03541902;NCT04316182;NCT03967522;NCT04066595;NCT03463681;NCT03899428;NCT04644432;NCT04079712;NCT03354884;NCT04497038;NCT03170960;NCT03586973;NCT01688999;NCT02867592;NCT03914300;NCT01835158;NCT01811212;NCT04511455;NCT03635892;NCT03634540;NCT04413123;NCT04071223;NCT04442581;NCT03370718;NCT04134390;NCT03612232;NCT03945773;NCT02761057;NCT03866382;NCT03339219;NCT04022343;NCT03943602;NCT02315430;NCT03468218;NCT01716715;NCT03428217;NCT01935934;NCT04767906;NCT04204850;NCT03685448;NCT04310007"},{"ligand":"cabozantinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04586231;NCT04338269;NCT03729245;NCT03141177;NCT01865747;NCT03755791;NCT01908426;NCT03793166;NCT03937219"},{"ligand":"cabozantinib","mesh_id":"D002277","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03963206"},{"ligand":"cetuximab","mesh_id":"D002277","phase":"Phase 1","start_date":"2005","completion_date":"2021","nct_id":"NCT01380600;NCT03319459;NCT02764593;NCT00906360;NCT04361409;NCT01334177;NCT00104910;NCT03524326;NCT01552434;NCT02277197;NCT00397384;NCT04091867;NCT01198535;NCT02350712;NCT03498378;NCT02429089;NCT01360827;NCT02438995;NCT02938273;NCT02496663;NCT00903461;NCT01637194;NCT01716416;NCT01254617;NCT00207116;NCT01758731;NCT00402545;NCT04722523;NCT01935921;NCT02229656"},{"ligand":"cetuximab","mesh_id":"D002277","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT00910676;NCT03387111;NCT04106362;NCT01218048;NCT01271439;NCT01332266;NCT01133665;NCT00508664;NCT02573493;NCT00084318;NCT03422536;NCT02014831;NCT00957853;NCT01245985;NCT01836029;NCT03953976;NCT03088059;NCT04229459;NCT00971932;NCT02124707;NCT03744208;NCT01884259;NCT01614938;NCT04017650;NCT02633800;NCT01230476;NCT02822482;NCT03389477;NCT04508829;NCT00240682;NCT01181401;NCT03944941;NCT01015664;NCT00499031;NCT01221753;NCT00725400;NCT01192087;NCT00939627;NCT01326559;NCT00142428;NCT00700440;NCT04508816;NCT01009203;NCT02718820;NCT03067610;NCT02624128;NCT01540344;NCT00933387;NCT03370276;NCT02255097;NCT02298595;NCT01816984;NCT01040832;NCT02054442;NCT01256385;NCT02812641;NCT01289522;NCT01025089;NCT03254927;NCT00292955;NCT00514943;NCT03169764;NCT01154920;NCT03817567;NCT02123381;NCT03769311;NCT00353717;NCT04285671;NCT02281955;NCT04428151;NCT00671437;NCT00101348;NCT00865098;NCT04375384;NCT03082534;NCT01760811;NCT03874741;NCT02753140;NCT01640444;NCT03365882;NCT03944252;NCT01104922;NCT01696955;NCT01488318;NCT04616183;NCT00362102;NCT02270814;NCT01316757;NCT00736944;NCT01830556;NCT03646461;NCT00591149;NCT03727061;NCT01602315;NCT03001570;NCT02507154;NCT01712919;NCT00096174;NCT00766142;NCT00570674;NCT01133678;NCT01794845;NCT02128906;NCT02369458;NCT01394939;NCT00082212;NCT00545545;NCT00617734;NCT00409565;NCT01109524;NCT03563170;NCT01417936;NCT02499120;NCT00044863;NCT01301248;NCT00894569;NCT04534855;NCT01252628;NCT01427205;NCT02143622;NCT00733889;NCT00636298;NCT01592721;NCT02599324;NCT01468896;NCT03109158;NCT02707588;NCT00934518;NCT03077243"},{"ligand":"cetuximab","mesh_id":"D002277","phase":"Phase 3","start_date":"2008","completion_date":"2020","nct_id":"NCT01211938;NCT04590963;NCT03358472;NCT02347332;NCT02105636;NCT01855451;NCT03342352;NCT02236936;NCT01950689;NCT01810913;NCT00946712;NCT03717038;NCT02383966;NCT02563002;NCT03529279;NCT01012258;NCT01874171;NCT03258554;NCT01086826;NCT01177956;NCT02633176;NCT03349710"},{"ligand":"cetuximab","mesh_id":"D002277","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02015650"},{"ligand":"cobimetinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03600701;NCT03181100;NCT03202316;NCT03108131"},{"ligand":"copanlisib","mesh_id":"D002277","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03586661;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02631590;NCT02822482;NCT03939897;NCT02728258;NCT04345913;NCT04108858;NCT02465060;NCT03735628;NCT03128619"},{"ligand":"crizotinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441388;NCT01441128"},{"ligand":"crizotinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02788201;NCT04644432;NCT02761057;NCT02465060"},{"ligand":"crizotinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2014","completion_date":"2016","nct_id":"NCT02201992;NCT02737501"},{"ligand":"dabrafenib","mesh_id":"D002277","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT03975231;NCT01947023;NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT04675710;NCT04644432;NCT04739566;NCT02465060;NCT04554680"},{"ligand":"dacomitinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01441128;NCT01737008;NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01728233;NCT01449201;NCT01608022;NCT02353936"},{"ligand":"dasatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04164069;NCT01440998;NCT01660971;NCT00608361;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT02059265;NCT00859937;NCT02788201;NCT00563290;NCT01488318;NCT00671788;NCT02465060;NCT00459108;NCT00507767"},{"ligand":"encorafenib","mesh_id":"D002277","phase":"Phase 2","start_date":"2019","completion_date":"2021","nct_id":"NCT04017650;NCT04390243;NCT04061980"},{"ligand":"entrectinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04551495"},{"ligand":"erdafitinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT03999515;NCT04754425;NCT02465060;NCT02421185"},{"ligand":"erlotinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00047346;NCT00079053;NCT00254384;NCT01515137;NCT00954226;NCT00823290;NCT00049283;NCT00397384;NCT01660971;NCT01288430;NCT00113347;NCT01115803;NCT00878163;NCT01332279;NCT00049166;NCT00966472;NCT00030498;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT00391586;NCT00910676;NCT00031993;NCT00942734;NCT01294306;NCT01454180;NCT00392665;NCT04172779;NCT03486509;NCT00410826;NCT00193258;NCT00522249;NCT01009203;NCT02788201;NCT00055913;NCT04644432;NCT01192815;NCT00602030;NCT00353301;NCT00047333;NCT00369512;NCT01608022;NCT00081614;NCT00287222;NCT01927744;NCT01180959;NCT00033462;NCT01688973;NCT00101348;NCT02169284;NCT00950365;NCT00737243;NCT00476476;NCT01316757;NCT02039674;NCT00063895;NCT00830245;NCT00832637;NCT00242502;NCT01198028;NCT00749892;NCT01093222;NCT02353936;NCT00791544;NCT00532441;NCT02748707;NCT00055770;NCT01064479;NCT02273362;NCT01465815;NCT01306045"},{"ligand":"erlotinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2006","completion_date":"2016","nct_id":"NCT01149122;NCT00448240;NCT01752205;NCT02193282;NCT02775006;NCT00901901;NCT01523587;NCT00442455;NCT00673049;NCT02926638"},{"ligand":"everolimus","mesh_id":"D002277","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00384969;NCT04339062;NCT01204476;NCT00655655;NCT01677390;NCT00788060;NCT01637194;NCT00422344;NCT02152943;NCT02454478;NCT01115803;NCT01218555;NCT02577458;NCT00828594;NCT03324373;NCT01332279;NCT03878524"},{"ligand":"everolimus","mesh_id":"D002277","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT02283658;NCT02687958;NCT00688753;NCT01051791;NCT00942734;NCT01136733;NCT01442090;NCT00607113;NCT02113800;NCT01731158;NCT01152840;NCT00719264;NCT00936702;NCT02273752;NCT03173560;NCT00714025;NCT02248012;NCT01108445;NCT01215136;NCT01616186;NCT00830895;NCT02456857;NCT01715935;NCT01185366;NCT01034631;NCT01566747;NCT01239342;NCT03163667;NCT00516165;NCT00113360;NCT01545817;NCT00448149;NCT01399918;NCT00390195;NCT01217931;NCT04134390;NCT02695459;NCT03008408;NCT01491672;NCT01582009;NCT01488487;NCT01563354;NCT01797523;NCT00886691;NCT01133678;NCT02187302;NCT01379521;NCT02724020;NCT01453595;NCT00827359;NCT02315625;NCT04203901;NCT01642186;NCT00363051;NCT01510119;NCT00805129;NCT02915783;NCT02599324;NCT00903175;NCT02049047"},{"ligand":"everolimus","mesh_id":"D002277","phase":"Phase 3","start_date":"2006","completion_date":"2020","nct_id":"NCT01035229;NCT01224288;NCT04195750;NCT01865747;NCT01265810;NCT00410124;NCT01668784;NCT02811861;NCT01198158"},{"ligand":"everolimus","mesh_id":"D002277","phase":"Phase 4","start_date":"2009","completion_date":"2015","nct_id":"NCT02056587;NCT02081755;NCT01206764;NCT01514448;NCT01266837;NCT02338570"},{"ligand":"fostamatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00923481"},{"ligand":"gefitinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2002","completion_date":"2011","nct_id":"NCT00033449;NCT01288430;NCT00083057"},{"ligand":"gefitinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT00113529;NCT00181688;NCT03486509;NCT00228488;NCT00126555;NCT00233636;NCT01449201;NCT02788201;NCT01608022;NCT01027676;NCT00229723;NCT00215202;NCT02039674;NCT00519077;NCT00082667;NCT00027690;NCT02353936;NCT00212108;NCT01039948;NCT00071994;NCT00054691"},{"ligand":"gefitinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2003","completion_date":"2003","nct_id":"NCT00234429;NCT00206219"},{"ligand":"ibrutinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT02884453;NCT03646461;NCT02599324"},{"ligand":"icotinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2012","completion_date":"2014","nct_id":"NCT01855854;NCT01534585;NCT02328261;NCT01973725"},{"ligand":"imatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00314873;NCT03878524"},{"ligand":"imatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT00193258;NCT01153750;NCT02788201;NCT04644432;NCT00354523;NCT00180921;NCT00506779;NCT00068783"},{"ligand":"lapatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2011","completion_date":"2013","nct_id":"NCT01434303;NCT01245660;NCT01454479;NCT01947023"},{"ligand":"lapatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00114283;NCT00095563;NCT00096447;NCT01612351;NCT01382706;NCT02788201;NCT00371566;NCT00098631;NCT00118157;NCT00107536;NCT01044433;NCT01622868;NCT00684983;NCT01666431;NCT00239200;NCT01306045"},{"ligand":"lapatinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00390455"},{"ligand":"larotrectinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT03006926;NCT03524326;NCT02953743;NCT02454478;NCT03324373;NCT02788708;NCT03418922;NCT03878524"},{"ligand":"lenvatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT04444167;NCT04241523;NCT04267120;NCT04731740;NCT01136733;NCT04710628;NCT04605796;NCT00946153;NCT04490694;NCT04327700;NCT04170179;NCT03173560;NCT02860936;NCT04227808;NCT02780310;NCT03899428;NCT04317248;NCT04193696;NCT04042805;NCT04741165;NCT04443309;NCT03775707;NCT04209660;NCT03433703;NCT04428151;NCT03746249;NCT03919383;NCT03914300;NCT04273100;NCT04368078;NCT04511455;NCT04740307;NCT04626479;NCT04044313;NCT04626518;NCT04599790;NCT04171622;NCT04080154;NCT04704219;NCT04728321;NCT03803254;NCT04781088;NCT03499626;NCT04401800;NCT03841201;NCT04203901;NCT03506048;NCT02973997;NCT02657369;NCT02915783"},{"ligand":"lenvatinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT03713593;NCT04194775;NCT04586231;NCT04053985;NCT03898180;NCT03744247;NCT04736706;NCT04246177;NCT04044651;NCT01761266;NCT03905967;NCT04237740;NCT04229355;NCT04319484;NCT04168944;NCT03791918;NCT04687163;NCT04199104;NCT02811861;NCT04053972;NCT04039607;NCT03775395;NCT04770896"},{"ligand":"lenvatinib","mesh_id":"D002277","phase":"Phase 4","start_date":"2019","completion_date":"2021","nct_id":"NCT04127396;NCT04297254"},{"ligand":"lorlatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"necitumumab","mesh_id":"D002277","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02496663"},{"ligand":"necitumumab","mesh_id":"D002277","phase":"Phase 2","start_date":"2018","completion_date":"2021","nct_id":"NCT03387111;NCT04285671"},{"ligand":"neratinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03101748"},{"ligand":"nilotinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"nintedanib","mesh_id":"D002277","phase":"Phase 1","start_date":"2012","completion_date":"2016","nct_id":"NCT02835833;NCT02225405;NCT01594125"},{"ligand":"nintedanib","mesh_id":"D002277","phase":"Phase 2","start_date":"2009","completion_date":"2015","nct_id":"NCT02866370;NCT02278978;NCT02452463;NCT02393755;NCT01004003;NCT00987935;NCT01225887"},{"ligand":"osimertinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2016","completion_date":"2021","nct_id":"NCT02520778;NCT04762199;NCT04479306;NCT02496663;NCT02503722"},{"ligand":"osimertinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT03831932;NCT04644432;NCT03410043;NCT04285671;NCT02465060;NCT03191149"},{"ligand":"osimertinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2015","completion_date":"2020","nct_id":"NCT02511106;NCT04181060"},{"ligand":"palbociclib","mesh_id":"D002277","phase":"Phase 1","start_date":"2018","completion_date":"2021","nct_id":"NCT04498520;NCT03498378;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D002277","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT03981614;NCT03088059;NCT03389477;NCT02774681;NCT04644432;NCT03194373;NCT01356628;NCT01536743;NCT03531645;NCT02465060;NCT02499120;NCT03128619;NCT04605562"},{"ligand":"palbociclib","mesh_id":"D002277","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02785939"},{"ligand":"panitumumab","mesh_id":"D002277","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00513383;NCT04163952;NCT03733210;NCT02192541"},{"ligand":"panitumumab","mesh_id":"D002277","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT01285778;NCT00500760;NCT03992456;NCT03983993;NCT01221753;NCT00446446;NCT02876107;NCT00111774;NCT02337946;NCT00425035;NCT01581840;NCT00756444;NCT01418742;NCT01129154;NCT00547157;NCT01843452"},{"ligand":"panitumumab","mesh_id":"D002277","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT02818725"},{"ligand":"pazopanib","mesh_id":"D002277","phase":"Phase 1","start_date":"2007","completion_date":"2016","nct_id":"NCT01472081;NCT02406521;NCT02729194;NCT01716416;NCT01221506;NCT00450879;NCT02795819;NCT01202032;NCT02014636;NCT02009449;NCT00992121"},{"ligand":"pazopanib","mesh_id":"D002277","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT01513187;NCT01813136;NCT02324803;NCT02959554;NCT01731158;NCT02122003;NCT01377298;NCT01649180;NCT01157091;NCT03334409;NCT01767636;NCT01361113;NCT01684397;NCT02788201;NCT01566747;NCT00454142;NCT01465659;NCT00625846;NCT02393820;NCT02089802;NCT00731211;NCT02956798;NCT01545817;NCT04462445;NCT02279576;NCT01855724;NCT01217931;NCT01147822;NCT00454363;NCT02187302;NCT03379012;NCT00782275;NCT01236547;NCT01664182;NCT04534855;NCT03200717;NCT01392183;NCT02700568;NCT00244764;NCT01577784;NCT01468909"},{"ligand":"pazopanib","mesh_id":"D002277","phase":"Phase 3","start_date":"2006","completion_date":"2018","nct_id":"NCT01064310;NCT01613846;NCT01575548;NCT01224288;NCT03260894;NCT01235962;NCT03592472;NCT01265810;NCT00387764;NCT02535351;NCT00334282;NCT00720941"},{"ligand":"pazopanib","mesh_id":"D002277","phase":"Phase 4","start_date":"2012","completion_date":"2015","nct_id":"NCT02570789;NCT01514448;NCT01521715;NCT02338570"},{"ligand":"pemigatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT02872714;NCT04096417;NCT04586244;NCT04003610"},{"ligand":"pertuzumab","mesh_id":"D002277","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D002277","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT04351230;NCT03101748;NCT03365882;NCT04108858;NCT02465060;NCT02120911"},{"ligand":"pertuzumab","mesh_id":"D002277","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03199885"},{"ligand":"ponatinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D002277","phase":"Phase 1","start_date":"2011","completion_date":"2019","nct_id":"NCT01286818;NCT02443324;NCT02069041;NCT03652467;NCT03798626"},{"ligand":"ramucirumab","mesh_id":"D002277","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT02520141;NCT03921671;NCT03694002;NCT04267913;NCT04316182;NCT00515697;NCT04179110;NCT01282463;NCT00721162;NCT04120454;NCT01246986;NCT03650764;NCT03762564;NCT03008278;NCT04310007"},{"ligand":"ramucirumab","mesh_id":"D002277","phase":"Phase 3","start_date":"2010","completion_date":"2015","nct_id":"NCT02426125;NCT01140347;NCT02435433"},{"ligand":"regorafenib","mesh_id":"D002277","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03347292;NCT03878524"},{"ligand":"regorafenib","mesh_id":"D002277","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT03992456;NCT01003015;NCT02795156;NCT02053376;NCT04170556;NCT04718909;NCT04327700;NCT04316182;NCT03899428;NCT02098538;NCT04310709;NCT04183088;NCT03475953;NCT02584465;NCT04696055;NCT03732547"},{"ligand":"regorafenib","mesh_id":"D002277","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04777851;NCT01774344"},{"ligand":"ribociclib","mesh_id":"D002277","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT04000529;NCT04213404;NCT02429089"},{"ligand":"ribociclib","mesh_id":"D002277","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT02524119;NCT03008408;NCT02555189;NCT02657928;NCT03673124"},{"ligand":"ruxolitinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03120624;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT02788201;NCT02928978"},{"ligand":"selumetinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00551070;NCT00604721;NCT01658943;NCT01011933;NCT02151084;NCT01029418;NCT00559949;NCT02393690;NCT01306045"},{"ligand":"sirolimus","mesh_id":"D002277","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT04339062;NCT01204476;NCT01198184;NCT00655655;NCT01522820;NCT02646319;NCT01552434;NCT01008917;NCT02142803;NCT01548482;NCT02833506;NCT01637194;NCT02152943;NCT01625351;NCT01218555;NCT03324373;NCT01155258;NCT00563147;NCT03333694;NCT01332279;NCT00999882;NCT00408655;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D002277","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT02283658;NCT03047213;NCT01517243;NCT02687958;NCT02730923;NCT01764607;NCT01195922;NCT01798446;NCT03190174;NCT01374750;NCT01010126;NCT01015664;NCT02273752;NCT01737502;NCT01009203;NCT02788201;NCT01372813;NCT02456857;NCT00072176;NCT01026792;NCT00353301;NCT01566747;NCT01256385;NCT02565901;NCT01687673;NCT01239342;NCT01567930;NCT02330783;NCT00390195;NCT00112840;NCT01762033;NCT00093782;NCT03008408;NCT01582009;NCT00417677;NCT00886691;NCT00729586;NCT00782275;NCT02514824;NCT01453595;NCT00723255;NCT00378703;NCT04203901;NCT02093598;NCT00619268;NCT01392183;NCT01856101;NCT00494091;NCT03685448;NCT01510119;NCT00805129;NCT01335074;NCT01460979;NCT00923845;NCT00699491;NCT02049047"},{"ligand":"sirolimus","mesh_id":"D002277","phase":"Phase 3","start_date":"1996","completion_date":"2019","nct_id":"NCT00474786;NCT00065468;NCT01223027;NCT00328770;NCT00631371;NCT01265810;NCT04168944;NCT00355862;NCT01198158"},{"ligand":"sirolimus","mesh_id":"D002277","phase":"Phase 4","start_date":"2009","completion_date":"2012","nct_id":"NCT01206764;NCT01521715"},{"ligand":"sorafenib","mesh_id":"D002277","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00384969;NCT01337492;NCT00956436;NCT01131689;NCT02101593;NCT02143401;NCT01618253;NCT01441388;NCT00892658;NCT00844168;NCT02988440;NCT01498952;NCT00823290;NCT01383343;NCT02406521;NCT01008917;NCT02642913;NCT02035527;NCT00622479;NCT00846131;NCT01628640;NCT01801163;NCT01844947;NCT02358395;NCT00976170;NCT02989870;NCT00828594;NCT02323906;NCT03966209;NCT00478374;NCT01308723;NCT00712855;NCT01008566;NCT01042041;NCT02240433;NCT01348503;NCT00960167;NCT01666756;NCT02354898;NCT00635791;NCT01897038;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D002277","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT01900002;NCT01556815;NCT02290977;NCT01964235;NCT03211416;NCT03163992;NCT00480389;NCT01126645;NCT00752063;NCT01387555;NCT03520257;NCT01171482;NCT00768937;NCT00044512;NCT03008512;NCT01840592;NCT00703365;NCT02702414;NCT00882869;NCT02452853;NCT01798446;NCT00126594;NCT00557830;NCT02425605;NCT01100242;NCT00110344;NCT01444807;NCT03582618;NCT00496301;NCT02279719;NCT00854620;NCT02981498;NCT03511703;NCT01731158;NCT01658878;NCT04170556;NCT00609934;NCT01342627;NCT00906373;NCT00678288;NCT01217034;NCT00923130;NCT02122003;NCT01171651;NCT01649180;NCT01205828;NCT00389285;NCT04327700;NCT00939627;NCT00618384;NCT01306058;NCT03439891;NCT00448721;NCT03535259;NCT01272557;NCT04316182;NCT02311205;NCT00848640;NCT01041482;NCT03722498;NCT02788201;NCT03899428;NCT01372813;NCT01616186;NCT01170104;NCT00238212;NCT04317248;NCT01953406;NCT04193696;NCT00862082;NCT00098618;NCT00112905;NCT01502410;NCT00943449;NCT00919009;NCT04599777;NCT00712790;NCT00609401;NCT01271504;NCT02406508;NCT03316872;NCT02114658;NCT01687673;NCT01777594;NCT01752933;NCT01567930;NCT04135690;NCT00576056;NCT02942329;NCT04479527;NCT01180959;NCT03586973;NCT03645980;NCT01624285;NCT00101413;NCT01204177;NCT00461851;NCT01258608;NCT00634751;NCT02129322;NCT02330783;NCT03812783;NCT02716766;NCT01754987;NCT03914300;NCT03578874;NCT00464919;NCT02115373;NCT00687596;NCT00126659;NCT00448149;NCT00786110;NCT01264705;NCT00093626;NCT03812770;NCT03648073;NCT00494182;NCT01605734;NCT02089763;NCT01101906;NCT00445042;NCT02400788;NCT01381211;NCT00844688;NCT01480817;NCT03780634;NCT02939807;NCT01375569;NCT00619541;NCT00490685;NCT04611165;NCT01357486;NCT03009461;NCT00844883;NCT02178358;NCT01246986;NCT04518852;NCT00096200;NCT01545804;NCT00532025;NCT01736878;NCT00121251;NCT02772029;NCT01762150;NCT01911000;NCT02575339;NCT00108953;NCT04710641;NCT00855218;NCT01582009;NCT00661375;NCT00126503;NCT01032850;NCT00467025;NCT01033240;NCT01004003;NCT01507064;NCT02187302;NCT02672488;NCT00618982;NCT01988493;NCT00808145;NCT00782275;NCT01093222;NCT01935700;NCT03499626;NCT01897610;NCT01911273;NCT03606590;NCT02560779;NCT00990860;NCT03563170;NCT00378703;NCT02024087;NCT00791544;NCT01664182;NCT01915602;NCT01232296;NCT00971126;NCT01029418;NCT00586495;NCT03516071;NCT00390325;NCT00987935;NCT01934829;NCT03732547;NCT03389126;NCT00872014;NCT04000737;NCT02227914;NCT00117637;NCT00999843;NCT01335074;NCT03318562;NCT00096512;NCT04162158"},{"ligand":"sorafenib","mesh_id":"D002277","phase":"Phase 3","start_date":"2004","completion_date":"2021","nct_id":"NCT01030783;NCT00474786;NCT04709380;NCT01035229;NCT01901692;NCT01903694;NCT01223027;NCT02436902;NCT02460991;NCT03164382;NCT02867280;NCT00492986;NCT00586105;NCT04720716;NCT00494299;NCT01613846;NCT03434379;NCT01076010;NCT01906216;NCT01829035;NCT01655693;NCT01015833;NCT00901901;NCT00699374;NCT02627963;NCT03298451;NCT04465734;NCT04560894;NCT00858871;NCT00732914;NCT04344158;NCT00606866;NCT01747642;NCT01481870;NCT01761266;NCT01009593;NCT01140347;NCT01833299;NCT01932385;NCT04167293;NCT01405573;NCT00478114;NCT03794440;NCT01108705;NCT03755791;NCT01214343;NCT01387503;NCT01135056;NCT01887717;NCT00111020;NCT01908426;NCT04229355;NCT00692770;NCT01265810;NCT04387695;NCT04667351;NCT00410124;NCT00105443;NCT01774344;NCT01482442;NCT01730937;NCT00492752;NCT03468231;NCT04103398;NCT02856126;NCT00326898;NCT04723004;NCT04687163;NCT02576509;NCT04143191;NCT02435433;NCT02562755;NCT01004978;NCT03533582;NCT03412773;NCT04039607;NCT03775395;NCT03236649;NCT04770896"},{"ligand":"sorafenib","mesh_id":"D002277","phase":"Phase 4","start_date":"2006","completion_date":"2019","nct_id":"NCT02056587;NCT04127396;NCT00352859;NCT03212625;NCT01203787;NCT03963206;NCT02504983;NCT03518502;NCT01409499;NCT01098760;NCT02733809;NCT02338570"},{"ligand":"sunitinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00906360;NCT01441388;NCT01472081;NCT01243359;NCT00499135;NCT00788060;NCT01061411;NCT00372853;NCT00422344;NCT00421512;NCT01381822;NCT02386111;NCT03905889;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT00113529;NCT00486538;NCT01118351;NCT03323710;NCT00979992;NCT01517243;NCT00478426;NCT01673386;NCT01219751;NCT02324803;NCT03066427;NCT01798446;NCT02072031;NCT01391130;NCT00387335;NCT04710628;NCT00859339;NCT02959554;NCT00254540;NCT00247676;NCT01731158;NCT01089088;NCT01342627;NCT00678288;NCT00853372;NCT00923130;NCT01377298;NCT01649180;NCT02919371;NCT00453895;NCT03541902;NCT01824615;NCT01309633;NCT00448721;NCT00522249;NCT03598816;NCT01108445;NCT00381641;NCT03035630;NCT02788201;NCT01372813;NCT01216371;NCT01616186;NCT04644432;NCT01185366;NCT00480935;NCT00389974;NCT00089648;NCT01566747;NCT00077974;NCT02623127;NCT02398552;NCT00731211;NCT00709995;NCT01835158;NCT03463460;NCT00137423;NCT00663559;NCT00886132;NCT00556205;NCT01147822;NCT00787787;NCT02761057;NCT01082809;NCT02465060;NCT00891475;NCT00453154;NCT01491672;NCT01482949;NCT01042795;NCT01582009;NCT00519896;NCT00417677;NCT02432846;NCT03075423;NCT00617253;NCT01215565;NCT00678119;NCT00444314;NCT02071641;NCT02187302;NCT02626754;NCT01984242;NCT03379012;NCT00782275;NCT03109015;NCT00556049;NCT00975806;NCT00794950;NCT02315625;NCT01070186;NCT01664182;NCT00619268;NCT00715442;NCT02700568;NCT00570882;NCT03592199;NCT01158222;NCT00408252;NCT02689167;NCT03449173;NCT00361309;NCT01069770;NCT01306045;NCT02060370;NCT00903175"},{"ligand":"sunitinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2004","completion_date":"2020","nct_id":"NCT00474786;NCT01064310;NCT02231749;NCT01582672;NCT02853331;NCT00869011;NCT03091192;NCT04394975;NCT00699374;NCT03260894;NCT00732914;NCT03729245;NCT03141177;NCT01481870;NCT03013946;NCT01265810;NCT00410124;NCT02420821;NCT00326898;NCT01265901;NCT00428597;NCT02535351;NCT02811861;NCT00930033;NCT00720941;NCT00083889"},{"ligand":"sunitinib","mesh_id":"D002277","phase":"Phase 4","start_date":"2008","completion_date":"2015","nct_id":"NCT02570789;NCT02056587;NCT01514448;NCT00706706;NCT00930345;NCT02338570"},{"ligand":"tivozanib","mesh_id":"D002277","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00563147"},{"ligand":"tivozanib","mesh_id":"D002277","phase":"Phase 2","start_date":"2007","completion_date":"2019","nct_id":"NCT01673386;NCT03970616;NCT01297244;NCT00502307;NCT01835223;NCT01834183;NCT03136627"},{"ligand":"tivozanib","mesh_id":"D002277","phase":"Phase 3","start_date":"2009","completion_date":"2016","nct_id":"NCT01030783;NCT01076010;NCT02627963"},{"ligand":"trametinib","mesh_id":"D002277","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT03975231;NCT03299088;NCT01935973;NCT03825289;NCT03317119;NCT03878524"},{"ligand":"trametinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04675710;NCT02042443;NCT04644432;NCT03225664;NCT04739566;NCT02152995;NCT02465060;NCT04554680;NCT01964924;NCT02881242"},{"ligand":"trastuzumab","mesh_id":"D002277","phase":"Phase 1","start_date":"1999","completion_date":"2021","nct_id":"NCT01434303;NCT03319459;NCT04704661;NCT03364348;NCT01454479;NCT04120246;NCT02152943;NCT00004074;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D002277","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT01556815;NCT03185988;NCT00005831;NCT02774681;NCT04644432;NCT01750073;NCT04351230;NCT04285671;NCT03101748;NCT03365882;NCT01641406;NCT04430738;NCT04108858;NCT02465060;NCT02120911;NCT01828736;NCT00126607;NCT00004856;NCT00684983;NCT00006089"},{"ligand":"trastuzumab","mesh_id":"D002277","phase":"Phase 3","start_date":"2007","completion_date":"2021","nct_id":"NCT00769379;NCT02158988;NCT04457596;NCT00520975;NCT03199885"},{"ligand":"tucatinib","mesh_id":"D002277","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04430738"},{"ligand":"tucatinib","mesh_id":"D002277","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04457596"},{"ligand":"vandetanib","mesh_id":"D002277","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT02495103;NCT01661179;NCT02788201;NCT01372813;NCT00508001;NCT00753675;NCT00514046;NCT01414426"},{"ligand":"vandetanib","mesh_id":"D002277","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00404924"},{"ligand":"vemurafenib","mesh_id":"D002277","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D002277","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201;NCT03181100"}],"predictions":[{"target":"IGF1R","probability":"0.9150261173700699"},{"target":"INSR","probability":"0.8051212052388523"},{"target":"NTRK1","probability":"0.7550580746075917"},{"target":"BCR","probability":"0.7454172951231776"},{"target":"NTRK3","probability":"0.720268595481671"},{"target":"SRC","probability":"0.7149099251419778"},{"target":"NTRK2","probability":"0.7000617012974344"},{"target":"TGFBR1","probability":"0.6660568510881011"},{"target":"ACVRL1","probability":"0.665023166023166"},{"target":"STK32B","probability":"0.64"},{"target":"PTK2","probability":"0.6299497505038982"},{"target":"EPHB2","probability":"0.6261828967337048"},{"target":"AXL","probability":"0.6200482700519874"},{"target":"BMPR2","probability":"0.611"},{"target":"EPHA2","probability":"0.6014785629465792"},{"target":"AKT2","probability":"0.5955119464527026"},{"target":"PRKCE","probability":"0.5910829764311387"},{"target":"TGFBR2","probability":"0.5909967167072214"},{"target":"FYN","probability":"0.586754416363553"},{"target":"MUSK","probability":"0.5851811067737773"},{"target":"ZAP70","probability":"0.5700411875873459"},{"target":"PRKCB","probability":"0.5660735301736005"},{"target":"RPS6KB1","probability":"0.5614397898568544"},{"target":"STK32C","probability":"0.56"},{"target":"MAP2K7","probability":"0.5554661970397314"},{"target":"PTK2B","probability":"0.5514242720855097"},{"target":"PDK1","probability":"0.5456720590144926"},{"target":"GSK3B","probability":"0.5453274696529737"},{"target":"AKT1","probability":"0.5400068352699932"},{"target":"AVP","probability":"0.5359089167151022"},{"target":"LRRK2","probability":"0.5351301209811323"},{"target":"PRKCA","probability":"0.5198554409531188"},{"target":"CSNK1G1","probability":"0.515"},{"target":"STK11","probability":"0.5113218914561368"},{"target":"PAK1","probability":"0.5073934255474963"},{"target":"PRKCD","probability":"0.5029188087439004"},{"target":"SRPK3","probability":"0.5"},{"target":"AURKA","probability":"0.49603701250089943"},{"target":"MYO3A","probability":"0.495"},{"target":"CDK15","probability":"0.49"},{"target":"EIF2AK3","probability":"0.48990951587311365"},{"target":"CSK","probability":"0.4855605053833097"},{"target":"CDKN1A","probability":"0.4758332237211784"},{"target":"TTN","probability":"0.4715789909274388"},{"target":"PINK1","probability":"0.46784296251824065"},{"target":"TESK2","probability":"0.465"},{"target":"AURKB","probability":"0.4630700189852823"},{"target":"AKT3","probability":"0.4582497697258077"},{"target":"GRK2","probability":"0.4579256624097973"}],"source_name":"Carcinoma"}],["D009362",{"mesh_id":"D009362","trials":[{"ligand":"abemaciclib","mesh_id":"D009362","phase":"Phase 1","start_date":"2013","completion_date":"2017","nct_id":"NCT02688088;NCT02014129;NCT02919696;NCT02411591;NCT02117648"},{"ligand":"abemaciclib","mesh_id":"D009362","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02308020"},{"ligand":"abemaciclib","mesh_id":"D009362","phase":"Phase 4","start_date":"2021","completion_date":"2021","nct_id":"NCT04707196"},{"ligand":"acalabrutinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04462328"},{"ligand":"afatinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2012","completion_date":"2018","nct_id":"NCT03711422;NCT01679405"},{"ligand":"afatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT04148898;NCT02142036;NCT03785249;NCT01441596;NCT04158947"},{"ligand":"afatinib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"alectinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04634110;NCT04116541"},{"ligand":"alectinib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"apatinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03396211"},{"ligand":"apatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03356600;NCT03742193;NCT04682249;NCT03913182;NCT04202978"},{"ligand":"apatinib","mesh_id":"D009362","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02711007;NCT02702323"},{"ligand":"binimetinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03911869;NCT03898908"},{"ligand":"bosutinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00319254"},{"ligand":"brigatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04634110"},{"ligand":"cabozantinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT02132598;NCT03967522;NCT01599793;NCT01834651;NCT04116541;NCT02260531"},{"ligand":"ceritinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02605746"},{"ligand":"ceritinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04634110"},{"ligand":"ceritinib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"cetuximab","mesh_id":"D009362","phase":"Phase 1","start_date":"2005","completion_date":"2014","nct_id":"NCT02845999;NCT00835679;NCT02124148;NCT00207116"},{"ligand":"cetuximab","mesh_id":"D009362","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT03135652;NCT03493048;NCT00444678;NCT04189055;NCT01511146;NCT03164655;NCT00153998;NCT02142036;NCT01384994;NCT01289522;NCT00743678;NCT03323424;NCT01836653;NCT00852228;NCT00544349;NCT04464967;NCT01802645;NCT00125034;NCT00537823;NCT01322178;NCT00056030;NCT03009058;NCT03366155;NCT00438737;NCT00908024;NCT03785249;NCT00130689;NCT01442935;NCT01737450;NCT01703910;NCT00513266;NCT00044863;NCT01673607;NCT01923987"},{"ligand":"cetuximab","mesh_id":"D009362","phase":"Phase 3","start_date":"2007","completion_date":"2021","nct_id":"NCT04687631;NCT03031444;NCT04509635;NCT00433927;NCT04525326;NCT00482222"},{"ligand":"cetuximab","mesh_id":"D009362","phase":"Phase 4","start_date":"2006","completion_date":"2007","nct_id":"NCT00327093;NCT01564810;NCT00510627"},{"ligand":"cobimetinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03625141;NCT02537600;NCT03430947;NCT02230306"},{"ligand":"crizotinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02142036;NCT04634110;NCT04193007"},{"ligand":"crizotinib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"dabrafenib","mesh_id":"D009362","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03332589"},{"ligand":"dabrafenib","mesh_id":"D009362","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT01266967;NCT01978236;NCT02142036;NCT03972046;NCT02039947;NCT02974803"},{"ligand":"dacomitinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00728390"},{"ligand":"dacomitinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT04339829;NCT04675008;NCT02047747"},{"ligand":"dasatinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00835679"},{"ligand":"dasatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT00566618;NCT02142036;NCT01703910"},{"ligand":"encorafenib","mesh_id":"D009362","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03911869;NCT03898908"},{"ligand":"entrectinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02097810"},{"ligand":"erlotinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2006","completion_date":"2010","nct_id":"NCT01115803;NCT00536861"},{"ligand":"erlotinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2003","completion_date":"2019","nct_id":"NCT01578668;NCT01763385;NCT00312728;NCT02250846;NCT04148898;NCT02142036;NCT00123851;NCT00461708;NCT00125021;NCT04193007;NCT01703910;NCT00116506;NCT00663689"},{"ligand":"erlotinib","mesh_id":"D009362","phase":"Phase 3","start_date":"2005","completion_date":"2018","nct_id":"NCT01887795;NCT00268684;NCT02714010;NCT01456325;NCT03653546;NCT02882984"},{"ligand":"erlotinib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"everolimus","mesh_id":"D009362","phase":"Phase 1","start_date":"2007","completion_date":"2010","nct_id":"NCT00426530;NCT01115803;NCT01122199"},{"ligand":"everolimus","mesh_id":"D009362","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT00317720;NCT01298713;NCT02142036;NCT01678664;NCT01960829;NCT01499160;NCT00466102;NCT01783756;NCT01178151;NCT01305941"},{"ligand":"fedratinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04370301"},{"ligand":"gefitinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT04148898;NCT02142036;NCT00614809;NCT04193007;NCT00234442;NCT01951469"},{"ligand":"gefitinib","mesh_id":"D009362","phase":"Phase 3","start_date":"2000","completion_date":"2018","nct_id":"NCT02714010;NCT00034879;NCT02338011;NCT03653546;NCT02882984"},{"ligand":"ibrutinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03703167"},{"ligand":"ibrutinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2014","completion_date":"2019","nct_id":"NCT02315326;NCT03964090"},{"ligand":"icotinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2011","completion_date":"2018","nct_id":"NCT01516983;NCT03754530;NCT01688713;NCT02726568"},{"ligand":"icotinib","mesh_id":"D009362","phase":"Phase 3","start_date":"2012","completion_date":"2018","nct_id":"NCT01724801;NCT02714010;NCT04058704;NCT02882984"},{"ligand":"imatinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"imatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2003","completion_date":"2014","nct_id":"NCT02461849;NCT00769782;NCT02142036;NCT00080678;NCT01089595;NCT00084825;NCT00764595"},{"ligand":"lapatinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2007","completion_date":"2016","nct_id":"NCT02650752;NCT01427322;NCT00470847;NCT00614978"},{"ligand":"lapatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT01118975;NCT01218529;NCT02142036;NCT00263588;NCT01934894;NCT04334330;NCT02015169;NCT01499160;NCT00098605;NCT01783756;NCT01441596;NCT00437073"},{"ligand":"lapatinib","mesh_id":"D009362","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00820222"},{"ligand":"lenvatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2019","completion_date":"2021","nct_id":"NCT04170179;NCT04769908;NCT04729348"},{"ligand":"lorlatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04634110"},{"ligand":"necitumumab","mesh_id":"D009362","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02411591"},{"ligand":"neratinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431"},{"ligand":"nilotinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02142036;NCT01089595"},{"ligand":"nintedanib","mesh_id":"D009362","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02856867"},{"ligand":"olaratumab","mesh_id":"D009362","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02677116"},{"ligand":"osimertinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03257124;NCT04148898;NCT03769103;NCT04425681;NCT04233021"},{"ligand":"osimertinib","mesh_id":"D009362","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02972333"},{"ligand":"osimertinib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"palbociclib","mesh_id":"D009362","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT02896335;NCT04334330"},{"ligand":"panitumumab","mesh_id":"D009362","phase":"Phase 2","start_date":"2002","completion_date":"2019","nct_id":"NCT01508000;NCT00034346;NCT00101920;NCT03164655;NCT00083616;NCT02142036;NCT01384994;NCT01260415;NCT00346099;NCT03366155;NCT03142516;NCT03803436"},{"ligand":"panitumumab","mesh_id":"D009362","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02162563"},{"ligand":"panitumumab","mesh_id":"D009362","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT02015923"},{"ligand":"pazopanib","mesh_id":"D009362","phase":"Phase 1","start_date":"2010","completion_date":"2016","nct_id":"NCT01165385;NCT01642017;NCT02795819"},{"ligand":"pertuzumab","mesh_id":"D009362","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02598427"},{"ligand":"pertuzumab","mesh_id":"D009362","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT00781612;NCT04760431;NCT03323424;NCT03417544"},{"ligand":"pertuzumab","mesh_id":"D009362","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04337658"},{"ligand":"regorafenib","mesh_id":"D009362","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02168777"},{"ligand":"regorafenib","mesh_id":"D009362","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT04534218;NCT02195011;NCT02175654;NCT01875380;NCT02406170"},{"ligand":"regorafenib","mesh_id":"D009362","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01939223"},{"ligand":"ribociclib","mesh_id":"D009362","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04116541"},{"ligand":"ruxolitinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02528877"},{"ligand":"ruxolitinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT01644110;NCT04384692;NCT04370301;NCT02142036;NCT03558607;NCT02251821"},{"ligand":"sirolimus","mesh_id":"D009362","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT02528877;NCT02517918;NCT00667485;NCT01353625;NCT00375245;NCT03203525;NCT01122199"},{"ligand":"sirolimus","mesh_id":"D009362","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT01298713;NCT02142036;NCT01783756;NCT01020305;NCT00589563"},{"ligand":"sirolimus","mesh_id":"D009362","phase":"Phase 3","start_date":"2004","completion_date":"2004","nct_id":"NCT00083993"},{"ligand":"sorafenib","mesh_id":"D009362","phase":"Phase 1","start_date":"2005","completion_date":"2012","nct_id":"NCT00217646;NCT00639262;NCT01724606;NCT01276210"},{"ligand":"sorafenib","mesh_id":"D009362","phase":"Phase 2","start_date":"2002","completion_date":"2015","nct_id":"NCT00480389;NCT00657254;NCT02311205;NCT01953406;NCT00609401;NCT00892424;NCT01935700;NCT01703910"},{"ligand":"sorafenib","mesh_id":"D009362","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02711007"},{"ligand":"sorafenib","mesh_id":"D009362","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT03518502"},{"ligand":"sunitinib","mesh_id":"D009362","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00981890"},{"ligand":"sunitinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT01216371;NCT02142036;NCT00910039;NCT00806663;NCT00372775;NCT00556049;NCT01069770"},{"ligand":"trametinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2014","completion_date":"2019","nct_id":"NCT01978236;NCT03972046;NCT02039947;NCT02974803"},{"ligand":"trastuzumab","mesh_id":"D009362","phase":"Phase 1","start_date":"1999","completion_date":"2020","nct_id":"NCT02598427;NCT02571530;NCT04602117;NCT01921335;NCT00426530;NCT02735798;NCT00004074;NCT03219268;NCT00470847"},{"ligand":"trastuzumab","mesh_id":"D009362","phase":"Phase 2","start_date":"2005","completion_date":"2021","nct_id":"NCT00317720;NCT03203616;NCT02000882;NCT00781612;NCT00679341;NCT04760431;NCT02142036;NCT02308020;NCT00263588;NCT04334330;NCT01387295;NCT03323424;NCT01386580;NCT01783756;NCT04464967;NCT02048059;NCT01480583;NCT01441596;NCT01503983;NCT03190967;NCT04512261;NCT01387373;NCT03417544;NCT04158947;NCT00377780;NCT02004769;NCT02260531;NCT04420598;NCT01305941"},{"ligand":"trastuzumab","mesh_id":"D009362","phase":"Phase 3","start_date":"2009","completion_date":"2020","nct_id":"NCT04337658;NCT02158988;NCT02492711;NCT00820222"},{"ligand":"trastuzumab","mesh_id":"D009362","phase":"Phase 4","start_date":"2013","completion_date":"2021","nct_id":"NCT02380131;NCT04739761"},{"ligand":"tucatinib","mesh_id":"D009362","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431;NCT04512261"},{"ligand":"vandetanib","mesh_id":"D009362","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00807170"},{"ligand":"vandetanib","mesh_id":"D009362","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"vemurafenib","mesh_id":"D009362","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT03625141;NCT02537600;NCT02142036;NCT03430947;NCT02230306"},{"ligand":"vemurafenib","mesh_id":"D009362","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"}],"predictions":[{"target":"FLT3","probability":"1.0"},{"target":"ROS1","probability":"1.0"},{"target":"ERBB4","probability":"1.0"},{"target":"FGFR1","probability":"0.885"},{"target":"FGFR3","probability":"0.85"},{"target":"FGFR2","probability":"0.83"},{"target":"MOK","probability":"0.8"},{"target":"DCLK2","probability":"0.79"},{"target":"PKDCC","probability":"0.775"},{"target":"STK32B","probability":"0.77"},{"target":"SBK1","probability":"0.765"},{"target":"AMHR2","probability":"0.755"},{"target":"CSNK1G1","probability":"0.755"},{"target":"CDK15","probability":"0.755"},{"target":"DYRK4","probability":"0.745"},{"target":"JAK2","probability":"0.735"},{"target":"FRK","probability":"0.7300144927536232"},{"target":"STK32C","probability":"0.725"},{"target":"SRPK3","probability":"0.715"},{"target":"EPHB2","probability":"0.7052152383527078"},{"target":"ADCK1","probability":"0.705"},{"target":"FASTKD1","probability":"0.705"},{"target":"CILK1","probability":"0.705"},{"target":"NEK5","probability":"0.705"},{"target":"MYO3A","probability":"0.7"},{"target":"PHKG2","probability":"0.7"},{"target":"TESK2","probability":"0.695"},{"target":"LTK","probability":"0.6850115919629057"},{"target":"STK35","probability":"0.685"},{"target":"BCR","probability":"0.6801236263736263"},{"target":"CCL8","probability":"0.6800777202072539"},{"target":"NPR1","probability":"0.6759999999999999"},{"target":"FER","probability":"0.6750352609308885"},{"target":"CLK2","probability":"0.675"},{"target":"TRIM24","probability":"0.675"},{"target":"TNNI3K","probability":"0.675"},{"target":"CIT","probability":"0.675"},{"target":"CAMKV","probability":"0.675"},{"target":"EPHA5","probability":"0.6700144927536232"},{"target":"CDK16","probability":"0.67"},{"target":"TAF1","probability":"0.67"},{"target":"MARK3","probability":"0.67"},{"target":"PRKG2","probability":"0.665"},{"target":"CDK11B","probability":"0.665"},{"target":"PTK2","probability":"0.6603704764811897"},{"target":"AXL","probability":"0.6565771073204075"},{"target":"PIK3CD","probability":"0.6556000000000001"},{"target":"RPS6KA6","probability":"0.6550777202072539"},{"target":"BTK","probability":"0.6550379403794038"},{"target":"PAK5","probability":"0.655"},{"target":"MAP3K9","probability":"0.655"},{"target":"FGFR4","probability":"0.655"},{"target":"ZAP70","probability":"0.655"},{"target":"OBSCN","probability":"0.6501802212610687"},{"target":"PDK1","probability":"0.65"},{"target":"TGFBR2","probability":"0.65"},{"target":"MATK","probability":"0.65"},{"target":"LMTK3","probability":"0.65"},{"target":"CASK","probability":"0.65"},{"target":"NEK9","probability":"0.645"},{"target":"STK17B","probability":"0.645"},{"target":"SRMS","probability":"0.64"},{"target":"EPHA7","probability":"0.64"},{"target":"NEK1","probability":"0.635"},{"target":"FYN","probability":"0.6302355072463768"},{"target":"NUAK1","probability":"0.6300906344410876"},{"target":"PTK2B","probability":"0.6300201342281879"},{"target":"CAMK2A","probability":"0.63"},{"target":"LYN","probability":"0.63"},{"target":"ACVR1C","probability":"0.63"},{"target":"AKT2","probability":"0.63"},{"target":"CAMK1G","probability":"0.63"},{"target":"NPRL2","probability":"0.63"},{"target":"LMTK2","probability":"0.63"},{"target":"MAPK6","probability":"0.63"},{"target":"PRKCE","probability":"0.62768779342723"},{"target":"MAPKAPK3","probability":"0.6250115919629057"},{"target":"PRKCI","probability":"0.625"},{"target":"WNK2","probability":"0.625"},{"target":"PRKCH","probability":"0.6200115919629057"},{"target":"CCNK","probability":"0.62"},{"target":"MAPK4","probability":"0.62"},{"target":"CAMKK1","probability":"0.615"},{"target":"CDC42BPA","probability":"0.615"},{"target":"CSNK1A1L","probability":"0.615"},{"target":"NEK7","probability":"0.615"},{"target":"TAF1L","probability":"0.615"},{"target":"MAPK15","probability":"0.615"},{"target":"PDIK1L","probability":"0.615"},{"target":"SRPK2","probability":"0.61"},{"target":"RPS6KB2","probability":"0.61"},{"target":"SGK2","probability":"0.61"},{"target":"TGFBR1","probability":"0.6051604938271605"},{"target":"PEAK1","probability":"0.6050144927536232"},{"target":"CAMK2B","probability":"0.605"},{"target":"IRAK2","probability":"0.605"},{"target":"CDC42BPG","probability":"0.605"},{"target":"STK38","probability":"0.6000352609308885"},{"target":"TAOK1","probability":"0.6"},{"target":"STK25","probability":"0.6"},{"target":"MARK4","probability":"0.5950777202072539"},{"target":"CDK14","probability":"0.595"},{"target":"DYRK2","probability":"0.5901282051282051"},{"target":"SIK2","probability":"0.5900480769230769"},{"target":"GSK3B","probability":"0.5900294106660358"},{"target":"MAP3K10","probability":"0.59"},{"target":"CSNK1E","probability":"0.59"},{"target":"PRKACB","probability":"0.59"},{"target":"DCLK3","probability":"0.59"},{"target":"CDK10","probability":"0.59"},{"target":"DAPK2","probability":"0.5850777202072539"},{"target":"GRK4","probability":"0.5850115919629058"},{"target":"EPHA10","probability":"0.585"},{"target":"EPHA6","probability":"0.585"},{"target":"HIPK3","probability":"0.585"},{"target":"FASTKD3","probability":"0.585"},{"target":"EPHA2","probability":"0.5813758079289987"},{"target":"CDK19","probability":"0.5801282051282051"},{"target":"EPHB3","probability":"0.5800906344410877"},{"target":"ACVR2B","probability":"0.58"},{"target":"CSNK1A1","probability":"0.58"},{"target":"STK33","probability":"0.58"},{"target":"MAPKAPK5","probability":"0.58"},{"target":"BRSK2","probability":"0.58"},{"target":"EPHB4","probability":"0.5751802431980632"},{"target":"SYK","probability":"0.5750892857142857"},{"target":"GRK7","probability":"0.5750352609308886"},{"target":"MAP3K2","probability":"0.5750352609308886"},{"target":"DYRK1B","probability":"0.575"},{"target":"WNK3","probability":"0.575"},{"target":"MUSK","probability":"0.575"},{"target":"TTBK2","probability":"0.575"},{"target":"PKMYT1","probability":"0.575"},{"target":"VRK2","probability":"0.5725"},{"target":"EPHB1","probability":"0.5710352609308886"},{"target":"HIPK1","probability":"0.57"},{"target":"TIE1","probability":"0.57"},{"target":"MAP4K3","probability":"0.57"},{"target":"RPS6KA4","probability":"0.57"},{"target":"STK4","probability":"0.57"},{"target":"NEK4","probability":"0.565"},{"target":"TNIK","probability":"0.565"},{"target":"PRKCA","probability":"0.5605696472780157"},{"target":"RPS6KB1","probability":"0.5602402383527079"},{"target":"MAP4K1","probability":"0.5600144927536231"},{"target":"PDK3","probability":"0.56"},{"target":"STK38L","probability":"0.56"},{"target":"SIK3","probability":"0.56"},{"target":"ALPK3","probability":"0.56"},{"target":"MAK","probability":"0.56"},{"target":"NEK6","probability":"0.56"},{"target":"EIF2AK3","probability":"0.5596070364082667"},{"target":"RIPK4","probability":"0.5550144927536231"},{"target":"NUAK2","probability":"0.555"},{"target":"TBRG4","probability":"0.555"},{"target":"MYLK2","probability":"0.555"},{"target":"LRRK1","probability":"0.555"},{"target":"CDK11A","probability":"0.555"},{"target":"STYK1","probability":"0.5500144927536232"},{"target":"RYK","probability":"0.55"},{"target":"ATP23","probability":"0.55"},{"target":"MST1R","probability":"0.5452769344320924"},{"target":"AKT1","probability":"0.5451287543908306"},{"target":"BMPR2","probability":"0.545"},{"target":"CSNK1D","probability":"0.545"},{"target":"DCAF1","probability":"0.545"},{"target":"NRBP2","probability":"0.545"},{"target":"PKN2","probability":"0.5400352609308886"},{"target":"HASPIN","probability":"0.5400352609308886"},{"target":"CDKL1","probability":"0.54"},{"target":"TLK2","probability":"0.54"},{"target":"PTK7","probability":"0.54"},{"target":"TSSK4","probability":"0.535"},{"target":"PAK6","probability":"0.535"},{"target":"ITK","probability":"0.5346963151068665"},{"target":"CCL3","probability":"0.5311877934272301"},{"target":"NEK8","probability":"0.531"},{"target":"TTN","probability":"0.53"},{"target":"TLK1","probability":"0.53"},{"target":"STK40","probability":"0.53"},{"target":"ACVR2A","probability":"0.53"},{"target":"CCL5","probability":"0.5272601413292589"},{"target":"MAPK1","probability":"0.525145378966635"},{"target":"MKNK2","probability":"0.5250896087569755"},{"target":"MASTL","probability":"0.525048076923077"},{"target":"BCKDK","probability":"0.525"},{"target":"BRSK1","probability":"0.525"},{"target":"PRKD2","probability":"0.525"},{"target":"MAST3","probability":"0.525"},{"target":"PRKCD","probability":"0.5241353536509482"},{"target":"AVP","probability":"0.5206808254834177"},{"target":"MAP2K7","probability":"0.5204728753413792"},{"target":"MAP3K4","probability":"0.5201129811381425"},{"target":"TRPM6","probability":"0.52"},{"target":"STK26","probability":"0.52"},{"target":"AURKC","probability":"0.5150898718047725"},{"target":"MAP3K12","probability":"0.5150115919629057"},{"target":"CDK3","probability":"0.515"},{"target":"ALPK2","probability":"0.515"},{"target":"UHMK1","probability":"0.515"},{"target":"PDK2","probability":"0.5123115343923819"},{"target":"GRK3","probability":"0.5102918949378288"},{"target":"TRIO","probability":"0.5101120243000568"},{"target":"RIOK2","probability":"0.51"},{"target":"PAK3","probability":"0.505168629298163"},{"target":"DCLK1","probability":"0.5050777202072539"},{"target":"SGK3","probability":"0.5050352609308886"},{"target":"PRKCB","probability":"0.502794185721129"},{"target":"BMPR1B","probability":"0.5000777202072539"},{"target":"LRRK2","probability":"0.5"},{"target":"ULK2","probability":"0.5"},{"target":"TYRO3","probability":"0.4951787497618378"},{"target":"SRPK1","probability":"0.49516346605909367"},{"target":"KALRN","probability":"0.495"},{"target":"CAMK1D","probability":"0.495"},{"target":"PIK3R4","probability":"0.495"},{"target":"CLK4","probability":"0.495"},{"target":"SIK1","probability":"0.49016346605909367"},{"target":"EIF2AK1","probability":"0.49007772020725393"},{"target":"CDK17","probability":"0.49"},{"target":"CDK13","probability":"0.49"},{"target":"PAN3","probability":"0.49"},{"target":"MYLK","probability":"0.485312596749226"},{"target":"YES1","probability":"0.485054347826087"},{"target":"CLK3","probability":"0.485"},{"target":"PIM3","probability":"0.485"},{"target":"MARK2","probability":"0.485"},{"target":"CAMK2G","probability":"0.48151049382716044"},{"target":"ACVR1B","probability":"0.4800476678787794"},{"target":"CDK18","probability":"0.48"},{"target":"PRKD3","probability":"0.48"},{"target":"ALPK1","probability":"0.4753405226175957"},{"target":"ROCK2","probability":"0.4752152383527079"},{"target":"CDK12","probability":"0.47521503637683843"},{"target":"CSK","probability":"0.47518779342723005"},{"target":"CLK1","probability":"0.47518022126106874"},{"target":"KSR1","probability":"0.47510019599582365"},{"target":"OXSR1","probability":"0.475"},{"target":"PASK","probability":"0.475"},{"target":"NPR2","probability":"0.4735820567206971"},{"target":"PAK1","probability":"0.4702152383527079"},{"target":"CAMK1","probability":"0.4700352609308886"},{"target":"LIMK2","probability":"0.4700352609308886"},{"target":"PRKX","probability":"0.47"},{"target":"GRK1","probability":"0.47"},{"target":"ILK","probability":"0.46572872795907677"},{"target":"PKN1","probability":"0.4650352609308886"},{"target":"ANKK1","probability":"0.465"},{"target":"SPEG","probability":"0.465"},{"target":"MAP3K13","probability":"0.465"},{"target":"PIM1","probability":"0.46287158510193394"},{"target":"MAPK9","probability":"0.4624619057376592"},{"target":"TRPM7","probability":"0.46207905648515984"},{"target":"EPHA1","probability":"0.4609294932564216"},{"target":"CDK20","probability":"0.46034983082784636"},{"target":"ROR2","probability":"0.46014537896663504"},{"target":"PIM2","probability":"0.4601129811381425"},{"target":"MYLK3","probability":"0.4601025010538148"},{"target":"NLK","probability":"0.46005434782608695"},{"target":"MAP3K3","probability":"0.4600352609308886"},{"target":"MAPK3","probability":"0.4555025218237779"},{"target":"PRKD1","probability":"0.455403031779938"},{"target":"PRKACG","probability":"0.455"},{"target":"TTBK1","probability":"0.455"}],"source_name":"Neoplasm Metastasis"}],["D006258",{"mesh_id":"D006258","trials":[{"ligand":"abemaciclib","mesh_id":"D006258","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03292250;NCT03938337;NCT04169074;NCT03356223;NCT03356587"},{"ligand":"afatinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2007","completion_date":"2019","nct_id":"NCT02979977;NCT00514943;NCT03695510"},{"ligand":"afatinib","mesh_id":"D006258","phase":"Phase 3","start_date":"2011","completion_date":"2014","nct_id":"NCT01856478;NCT02131155;NCT01345682;NCT01345669"},{"ligand":"alpelisib","mesh_id":"D006258","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02051751"},{"ligand":"alpelisib","mesh_id":"D006258","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03292250"},{"ligand":"amlexanox","mesh_id":"D006258","phase":"Phase 2","start_date":"2000","completion_date":"2000","nct_id":"NCT01083875"},{"ligand":"apatinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02943252;NCT02989259;NCT03654612"},{"ligand":"axitinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02762513;NCT01469546"},{"ligand":"cetuximab","mesh_id":"D006258","phase":"Phase 1","start_date":"2004","completion_date":"2021","nct_id":"NCT00820417;NCT01540682;NCT00906360;NCT01334177;NCT02555644;NCT01184482;NCT02817113;NCT01445405;NCT00397384;NCT01871311;NCT01637194;NCT00757549;NCT00291707;NCT00882583;NCT00622674;NCT01255800;NCT01451632;NCT02110082;NCT02391727;NCT00402545;NCT04722523;NCT01987375;NCT01935921;NCT02229656;NCT00629226;NCT04065555;NCT02627274"},{"ligand":"cetuximab","mesh_id":"D006258","phase":"Phase 2","start_date":"1999","completion_date":"2020","nct_id":"NCT03844763;NCT03494322;NCT00462735;NCT01283334;NCT02573493;NCT03422536;NCT00927147;NCT00868491;NCT00665392;NCT02124707;NCT01620242;NCT00721513;NCT04474470;NCT01581970;NCT02633800;NCT03532737;NCT00468169;NCT00004865;NCT01262859;NCT01237483;NCT00939627;NCT03067610;NCT00646659;NCT00623558;NCT01816984;NCT01472653;NCT01040832;NCT01467115;NCT01979211;NCT00226239;NCT01256385;NCT01566435;NCT04282109;NCT01435252;NCT02979977;NCT00514943;NCT03134846;NCT01020864;NCT03769311;NCT02281955;NCT00319839;NCT01874860;NCT01412229;NCT00101348;NCT02630004;NCT03082534;NCT01081041;NCT01696955;NCT01437449;NCT02270814;NCT01316757;NCT01087970;NCT01057589;NCT00591149;NCT03727061;NCT00089297;NCT01744340;NCT00875849;NCT03691714;NCT01216020;NCT00881114;NCT00343083;NCT00714649;NCT02643550;NCT01009346;NCT00851877;NCT00570674;NCT01794845;NCT02422979;NCT03887442;NCT00005814;NCT00904345;NCT00409565;NCT00791141;NCT00301028;NCT01737450;NCT00660218;NCT01301248;NCT03356223;NCT00713219;NCT01588431;NCT00833261;NCT03051906;NCT00704639;NCT00703976;NCT01054625;NCT03713372;NCT00765011;NCT00738868;NCT00934518;NCT03077243"},{"ligand":"cetuximab","mesh_id":"D006258","phase":"Phase 3","start_date":"1999","completion_date":"2019","nct_id":"NCT00716391;NCT00265941;NCT03769506;NCT00003809;NCT00004227;NCT02236936;NCT02252042;NCT02358031;NCT01884623;NCT00122460;NCT01969877;NCT00956007;NCT03258554;NCT02551159"},{"ligand":"cetuximab","mesh_id":"D006258","phase":"Phase 4","start_date":"2011","completion_date":"2014","nct_id":"NCT02015650;NCT01553032"},{"ligand":"crizotinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"dacomitinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2008","completion_date":"2011","nct_id":"NCT00768664;NCT01449201"},{"ligand":"dasatinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00882583;NCT00779389"},{"ligand":"dasatinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT02558387;NCT00507767"},{"ligand":"entrectinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erlotinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2001","completion_date":"2011","nct_id":"NCT00400374;NCT00954226;NCT00049283;NCT01116336;NCT00397384;NCT00738751;NCT00113347;NCT00601913;NCT00405405;NCT01332279;NCT00140556;NCT00030498;NCT00779389"},{"ligand":"erlotinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2001","completion_date":"2013","nct_id":"NCT00392704;NCT00570232;NCT00281866;NCT00076310;NCT01192815;NCT01927744;NCT00101348;NCT00030576;NCT00720304;NCT00750555;NCT00304278;NCT01316757;NCT00970502;NCT00573989"},{"ligand":"erlotinib","mesh_id":"D006258","phase":"Phase 3","start_date":"2006","completion_date":"2007","nct_id":"NCT00448240;NCT00412217"},{"ligand":"everolimus","mesh_id":"D006258","phase":"Phase 1","start_date":"2008","completion_date":"2018","nct_id":"NCT00935961;NCT01637194;NCT00858663;NCT03578432;NCT01332279;NCT01057277;NCT01058408"},{"ligand":"everolimus","mesh_id":"D006258","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01283334;NCT01333085;NCT01313390;NCT01111058;NCT01118065;NCT01009346"},{"ligand":"fostamatinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00923481"},{"ligand":"gefitinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2002","completion_date":"2004","nct_id":"NCT00820417;NCT00185835;NCT00681967"},{"ligand":"gefitinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2001","completion_date":"2011","nct_id":"NCT00255476;NCT01449201;NCT01185171;NCT00169221;NCT00242762;NCT00242749;NCT00239304;NCT00519077;NCT00024089;NCT00195078;NCT00015964;NCT01405846;NCT00352105;NCT00193284"},{"ligand":"gefitinib","mesh_id":"D006258","phase":"Phase 3","start_date":"2004","completion_date":"2004","nct_id":"NCT00088907"},{"ligand":"imatinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2004","completion_date":"2007","nct_id":"NCT00485485;NCT00180921"},{"ligand":"lapatinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01184482"},{"ligand":"lapatinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2004","completion_date":"2013","nct_id":"NCT00387127;NCT01711658;NCT01612351;NCT00098631;NCT00490061;NCT00498953;NCT01044433"},{"ligand":"lapatinib","mesh_id":"D006258","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00424255"},{"ligand":"nilotinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01871311"},{"ligand":"nintedanib","mesh_id":"D006258","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT03292250;NCT02558387"},{"ligand":"palbociclib","mesh_id":"D006258","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03065062"},{"ligand":"panitumumab","mesh_id":"D006258","phase":"Phase 1","start_date":"2006","completion_date":"2019","nct_id":"NCT02415881;NCT00513383;NCT03733210"},{"ligand":"panitumumab","mesh_id":"D006258","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT00500760;NCT00446446;NCT00798655;NCT00454779;NCT01264328;NCT04511078;NCT01312493;NCT00547157"},{"ligand":"panitumumab","mesh_id":"D006258","phase":"Phase 3","start_date":"2007","completion_date":"2008","nct_id":"NCT00820248;NCT00460265"},{"ligand":"pazopanib","mesh_id":"D006258","phase":"Phase 1","start_date":"2009","completion_date":"2013","nct_id":"NCT01012362;NCT01639911"},{"ligand":"ponatinib","mesh_id":"D006258","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01761747"},{"ligand":"ruxolitinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02593929"},{"ligand":"ruxolitinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03153982"},{"ligand":"sirolimus","mesh_id":"D006258","phase":"Phase 1","start_date":"2008","completion_date":"2018","nct_id":"NCT03065062;NCT01637194;NCT03578432;NCT01332279"},{"ligand":"sirolimus","mesh_id":"D006258","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01195922;NCT01256385"},{"ligand":"sorafenib","mesh_id":"D006258","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D006258","phase":"Phase 2","start_date":"2004","completion_date":"2014","nct_id":"NCT00199160;NCT00939627;NCT02558387;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D006258","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D006258","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT00387335;NCT02558387"},{"ligand":"trastuzumab","mesh_id":"D006258","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02627274"},{"ligand":"vandetanib","mesh_id":"D006258","phase":"Phase 1","start_date":"2006","completion_date":"2008","nct_id":"NCT00450138;NCT00937417"},{"ligand":"vandetanib","mesh_id":"D006258","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00720083"}],"predictions":[{"target":"BCR","probability":"0.645"},{"target":"ERBB3","probability":"0.6401098901098902"},{"target":"BRAF","probability":"0.5658727030740168"},{"target":"INSR","probability":"0.54"},{"target":"IGF1R","probability":"0.54"},{"target":"FGFR1","probability":"0.535"},{"target":"FGFR3","probability":"0.5177759995985416"},{"target":"MAP2K7","probability":"0.47"}],"source_name":"Head and Neck Neoplasms"}],["D011471",{"mesh_id":"D011471","trials":[{"ligand":"abemaciclib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D011471","phase":"Phase 2","start_date":"2018","completion_date":"2021","nct_id":"NCT03706365;NCT04408924;NCT04298983;NCT04751929;NCT04272645"},{"ligand":"afatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT02465060;NCT00706628;NCT01320280"},{"ligand":"alpelisib","mesh_id":"D011471","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02913131"},{"ligand":"axitinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01409200;NCT01385059"},{"ligand":"binimetinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2011","completion_date":"2021","nct_id":"NCT01347788;NCT04514484;NCT04477512;NCT01574937;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT01703065;NCT01588821;NCT04631744;NCT01683994;NCT01630590;NCT01599793;NCT01428219;NCT01995058;NCT01834651;NCT03866382;NCT03964337"},{"ligand":"cabozantinib","mesh_id":"D011471","phase":"Phase 3","start_date":"2012","completion_date":"2020","nct_id":"NCT04446117;NCT01522443;NCT01605227"},{"ligand":"cetuximab","mesh_id":"D011471","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00448097;NCT00661492;NCT00728663"},{"ligand":"cobimetinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02465060;NCT04253262"},{"ligand":"crizotinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02207504"},{"ligand":"crizotinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01826838;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT01254864;NCT00385580;NCT00936975;NCT01685125;NCT02465060;NCT01260688;NCT00570700;NCT00860158;NCT01990196;NCT00918385;NCT00439270"},{"ligand":"dasatinib","mesh_id":"D011471","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00744497"},{"ligand":"erdafitinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT03999515;NCT04754425;NCT02465060"},{"ligand":"erlotinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00030498;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00203424;NCT00148772;NCT00996502;NCT00272038;NCT00087035"},{"ligand":"everolimus","mesh_id":"D011471","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT01548807;NCT00943956;NCT02125084;NCT02106507;NCT01642732;NCT03878524"},{"ligand":"everolimus","mesh_id":"D011471","phase":"Phase 2","start_date":"2004","completion_date":"2016","nct_id":"NCT00630344;NCT00085566;NCT00814788;NCT00574769;NCT00976755;NCT00629525;NCT01313559;NCT00657982;NCT00526591;NCT01051570;NCT00459186;NCT02913131"},{"ligand":"everolimus","mesh_id":"D011471","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03580239"},{"ligand":"gefitinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2001","completion_date":"2004","nct_id":"NCT00025116;NCT00085566;NCT00239291;NCT00319787;NCT00241475;NCT00635856;NCT00265070;NCT00483561;NCT00242918;NCT00418080"},{"ligand":"ibrutinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02643667"},{"ligand":"imatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00038194;NCT00424385;NCT03878524"},{"ligand":"imatinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2003","completion_date":"2007","nct_id":"NCT01316458;NCT00861471;NCT00500110;NCT00080678;NCT00427999;NCT00084825;NCT00251225"},{"ligand":"lapatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00313599"},{"ligand":"lapatinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00246753;NCT00953576;NCT00095667;NCT00103194"},{"ligand":"larotrectinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02861573;NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04781374"},{"ligand":"nintedanib","mesh_id":"D011471","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT02182219"},{"ligand":"nintedanib","mesh_id":"D011471","phase":"Phase 2","start_date":"2005","completion_date":"2006","nct_id":"NCT02182063;NCT00706628"},{"ligand":"olaratumab","mesh_id":"D011471","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01204710"},{"ligand":"osimertinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D011471","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02059213;NCT02905318;NCT02465060"},{"ligand":"panitumumab","mesh_id":"D011471","phase":"Phase 1","start_date":"2000","completion_date":"2000","nct_id":"NCT00004879"},{"ligand":"panitumumab","mesh_id":"D011471","phase":"Phase 2","start_date":"2002","completion_date":"2003","nct_id":"NCT00054574;NCT00061126"},{"ligand":"pazopanib","mesh_id":"D011471","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01385228"},{"ligand":"pazopanib","mesh_id":"D011471","phase":"Phase 2","start_date":"2006","completion_date":"2009","nct_id":"NCT00945477;NCT00454571;NCT00486642"},{"ligand":"pazopanib","mesh_id":"D011471","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02044354"},{"ligand":"pertuzumab","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D011471","phase":"Phase 2","start_date":"2003","completion_date":"2015","nct_id":"NCT00058539;NCT02465060;NCT02480010"},{"ligand":"ponatinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D011471","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00683475"},{"ligand":"regorafenib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ribociclib","mesh_id":"D011471","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02494921;NCT02555189"},{"ligand":"ruxolitinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00638378"},{"ligand":"sirolimus","mesh_id":"D011471","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01548807;NCT01522820;NCT02646319;NCT02064608;NCT01174199;NCT01353625;NCT00512668;NCT01155258;NCT03618355;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D011471","phase":"Phase 2","start_date":"2000","completion_date":"2016","nct_id":"NCT00887640;NCT00311623;NCT00012142;NCT00777959;NCT00919035;NCT02565901;NCT02091531;NCT01026623;NCT01206036;NCT01313559;NCT00657982;NCT01020305;NCT00110188;NCT02796898;NCT01083368;NCT00071968;NCT02407054"},{"ligand":"sirolimus","mesh_id":"D011471","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00922129"},{"ligand":"sorafenib","mesh_id":"D011471","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00424385;NCT00405210;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D011471","phase":"Phase 2","start_date":"2004","completion_date":"2008","nct_id":"NCT00452387;NCT00589420;NCT00466752;NCT00090545;NCT00694291;NCT00619996;NCT00414388;NCT00924807;NCT00093457"},{"ligand":"sunitinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00790595;NCT00631527;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2005","completion_date":"2015","nct_id":"NCT00748358;NCT00550810;NCT01254864;NCT00299741;NCT00795171;NCT00329043;NCT00137436;NCT00599313;NCT02465060;NCT00734851;NCT00672594;NCT00879619"},{"ligand":"sunitinib","mesh_id":"D011471","phase":"Phase 3","start_date":"2008","completion_date":"2014","nct_id":"NCT02044354;NCT00676650"},{"ligand":"tivozanib","mesh_id":"D011471","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01885949"},{"ligand":"trametinib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trametinib","mesh_id":"D011471","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT02465060;NCT01990196;NCT02881242"},{"ligand":"trastuzumab","mesh_id":"D011471","phase":"Phase 1","start_date":"1999","completion_date":"2020","nct_id":"NCT00004074;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D011471","phase":"Phase 2","start_date":"1998","completion_date":"2015","nct_id":"NCT00005857;NCT02465060;NCT00003740"},{"ligand":"vandetanib","mesh_id":"D011471","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00937417"},{"ligand":"vandetanib","mesh_id":"D011471","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT00757692;NCT00686036;NCT00659438;NCT00498797"},{"ligand":"vemurafenib","mesh_id":"D011471","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"IGF1R","probability":"0.5950811795271109"},{"target":"BCR","probability":"0.5750374732334047"},{"target":"INSR","probability":"0.5515701501153463"},{"target":"MAP2K7","probability":"0.5409465641424956"},{"target":"SRC","probability":"0.5002479046385926"},{"target":"ZAP70","probability":"0.4650890196251573"}],"source_name":"Prostatic Neoplasms"}],["D000230",{"mesh_id":"D000230","trials":[{"ligand":"abemaciclib","mesh_id":"D000230","phase":"Phase 1","start_date":"2019","completion_date":"2021","nct_id":"NCT04481113;NCT04049227;NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D000230","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03997448;NCT03643510;NCT04616183;NCT02981342"},{"ligand":"afatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT04201756;NCT02876081;NCT01003899;NCT01466660"},{"ligand":"afatinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2009","completion_date":"2010","nct_id":"NCT01121393;NCT00949650"},{"ligand":"alpelisib","mesh_id":"D000230","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02276027"},{"ligand":"apatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2015","completion_date":"2018","nct_id":"NCT03244774;NCT02691871;NCT03071042"},{"ligand":"apatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT04006821;NCT04781686;NCT03349866;NCT03788174;NCT04459078;NCT03030937;NCT02704767;NCT03707639;NCT04121039;NCT03707028;NCT04190745;NCT04446091;NCT03116555;NCT04572542;NCT04609176;NCT03599778;NCT02493582;NCT03376737"},{"ligand":"apatinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2017","completion_date":"2019","nct_id":"NCT03986385;NCT04208347;NCT03042611"},{"ligand":"avapritinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01409200"},{"ligand":"binimetinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT04044430;NCT01562899;NCT02276027"},{"ligand":"cabozantinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02496208;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT03539822;NCT04164979;NCT03866382;NCT02315430;NCT03213626;NCT01935934"},{"ligand":"ceritinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02513667;NCT02638909;NCT02276027"},{"ligand":"cetuximab","mesh_id":"D000230","phase":"Phase 1","start_date":"2005","completion_date":"2011","nct_id":"NCT00104910;NCT01294826;NCT00397384;NCT01198535;NCT00835679"},{"ligand":"cetuximab","mesh_id":"D000230","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT01360086;NCT00395252;NCT00162110;NCT04554836;NCT00517829;NCT04017650;NCT00165490;NCT00716456;NCT00580073;NCT01123811;NCT03365882;NCT04117945;NCT04616183;NCT00100841;NCT00353457;NCT00551421;NCT00827671;NCT01703910;NCT02599324"},{"ligand":"cetuximab","mesh_id":"D000230","phase":"Phase 3","start_date":"2003","completion_date":"2010","nct_id":"NCT00077233;NCT01107639;NCT00946712"},{"ligand":"cobimetinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT04005690;NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT03193190;NCT01506973;NCT03281369;NCT03108131"},{"ligand":"cobimetinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02788279"},{"ligand":"copanlisib","mesh_id":"D000230","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03586661;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D000230","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02728258"},{"ligand":"crizotinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2014","completion_date":"2016","nct_id":"NCT02183870;NCT02946359;NCT02664935;NCT02435108"},{"ligand":"dabrafenib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00818441"},{"ligand":"dasatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01440998;NCT00835679;NCT00598091;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT00474812;NCT01234935;NCT01652976;NCT01703910"},{"ligand":"encorafenib","mesh_id":"D000230","phase":"Phase 2","start_date":"2019","completion_date":"2020","nct_id":"NCT04017650;NCT04044430"},{"ligand":"erlotinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00266097;NCT00735306;NCT00060411;NCT01561014;NCT00397384;NCT00987766;NCT01851096;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT02155465;NCT01578668;NCT00059787;NCT00591123;NCT00126581;NCT00384826;NCT01222689;NCT02788058;NCT01131429;NCT02146118;NCT00045526;NCT00198380;NCT00716456;NCT01259089;NCT01204372;NCT01565538;NCT00769483;NCT00816868;NCT02704767;NCT01389440;NCT02787447;NCT04201756;NCT01108458;NCT00728000;NCT00873353;NCT02876081;NCT00137839;NCT00284141;NCT00832637;NCT01093222;NCT03076164;NCT03213626;NCT01703910;NCT00032110"},{"ligand":"erlotinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2009","completion_date":"2016","nct_id":"NCT01013649;NCT02889692;NCT02893332"},{"ligand":"erlotinib","mesh_id":"D000230","phase":"Phase 4","start_date":"2012","completion_date":"2015","nct_id":"NCT02399566;NCT01609543"},{"ligand":"everolimus","mesh_id":"D000230","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT02138929;NCT03878524;NCT00981162"},{"ligand":"everolimus","mesh_id":"D000230","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT02283658;NCT00560963;NCT02397083;NCT02985125;NCT03008408;NCT00597506;NCT02599324;NCT01231399"},{"ligand":"gefitinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT03486496;NCT02788058;NCT00198380;NCT02951637;NCT00716456;NCT01502202;NCT02787447;NCT02876081;NCT01871480;NCT00052585;NCT00344773;NCT01466660"},{"ligand":"gefitinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2005","completion_date":"2016","nct_id":"NCT02518802;NCT01243398;NCT00455936;NCT02889692;NCT01066195;NCT02929693;NCT02893332"},{"ligand":"ibrutinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02562898;NCT02599324"},{"ligand":"ibrutinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02436668"},{"ligand":"icotinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2014","completion_date":"2016","nct_id":"NCT02788058;NCT02787447;NCT02044328"},{"ligand":"icotinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2012","completion_date":"2014","nct_id":"NCT02125240;NCT02889692;NCT01719536"},{"ligand":"icotinib","mesh_id":"D000230","phase":"Phase 4","start_date":"2012","completion_date":"2014","nct_id":"NCT02103257;NCT02283424;NCT01665417"},{"ligand":"imatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT00598091;NCT03878524"},{"ligand":"imatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00209079"},{"ligand":"lapatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT01123473;NCT01395537;NCT00259987;NCT00574171;NCT00103324"},{"ligand":"lapatinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00450203"},{"ligand":"lenvatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02935309;NCT03878524"},{"ligand":"lenvatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04699071;NCT01877083"},{"ligand":"lenvatinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04662710"},{"ligand":"lorlatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04781374"},{"ligand":"nintedanib","mesh_id":"D000230","phase":"Phase 1","start_date":"2014","completion_date":"2016","nct_id":"NCT02668393;NCT02300298"},{"ligand":"nintedanib","mesh_id":"D000230","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT03361319;NCT02234596;NCT02393755;NCT02856867;NCT04046614;NCT01225887"},{"ligand":"osimertinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02664935"},{"ligand":"palbociclib","mesh_id":"D000230","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02501902;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D000230","phase":"Phase 2","start_date":"2009","completion_date":"2015","nct_id":"NCT02664935;NCT01037790"},{"ligand":"panitumumab","mesh_id":"D000230","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT00667420;NCT01077999;NCT03992456;NCT01814501;NCT01262183;NCT03069950;NCT01443065;NCT00613730;NCT00757172;NCT01379807;NCT04117945;NCT00948935;NCT01182610;NCT03087071;NCT01202409;NCT01307956;NCT01389414;NCT03584711;NCT03384238"},{"ligand":"pazopanib","mesh_id":"D000230","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01832259;NCT01035658"},{"ligand":"pertuzumab","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D000230","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT01108458;NCT03365882;NCT00551421"},{"ligand":"pertuzumab","mesh_id":"D000230","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03199885"},{"ligand":"ponatinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D000230","phase":"Phase 1","start_date":"2010","completion_date":"2017","nct_id":"NCT02443324;NCT02572687;NCT01253525;NCT03193918"},{"ligand":"ramucirumab","mesh_id":"D000230","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02213289;NCT04205968;NCT02678182;NCT02628951;NCT02514551;NCT03739801;NCT02082210;NCT03686488;NCT04069273;NCT03995017;NCT03704077;NCT04656002;NCT02443883;NCT04739202;NCT03745430;NCT03141034;NCT04660760;NCT03966118;NCT02539225;NCT03008278;NCT03281369;NCT04604132"},{"ligand":"ramucirumab","mesh_id":"D000230","phase":"Phase 3","start_date":"2009","completion_date":"2021","nct_id":"NCT04499924;NCT04704934;NCT01170663;NCT00917384;NCT04675983;NCT02314117;NCT02898077"},{"ligand":"regorafenib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04362839;NCT03878524"},{"ligand":"regorafenib","mesh_id":"D000230","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT03992456;NCT02023333;NCT02234180;NCT02368886;NCT02788006;NCT02425683;NCT04117945;NCT03722108;NCT04446091;NCT01929616;NCT04483219"},{"ligand":"regorafenib","mesh_id":"D000230","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02788279"},{"ligand":"ribociclib","mesh_id":"D000230","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02985125;NCT03008408"},{"ligand":"ruxolitinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT04303403;NCT03120624;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2014","completion_date":"2016","nct_id":"NCT02155465;NCT02713386"},{"ligand":"selumetinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01134601"},{"ligand":"selumetinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT00551070;NCT01222689;NCT01011933;NCT02664935;NCT02448290;NCT01859182;NCT04348045"},{"ligand":"sirolimus","mesh_id":"D000230","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT02048384;NCT02142803;NCT01537107;NCT03878524;NCT00981162"},{"ligand":"sirolimus","mesh_id":"D000230","phase":"Phase 2","start_date":"2005","completion_date":"2017","nct_id":"NCT02283658;NCT01010126;NCT00977574;NCT00560963;NCT01026792;NCT00106353;NCT02397083;NCT03008408;NCT01231399"},{"ligand":"sorafenib","mesh_id":"D000230","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00375310;NCT03878524;NCT00981162"},{"ligand":"sorafenib","mesh_id":"D000230","phase":"Phase 2","start_date":"2005","completion_date":"2012","nct_id":"NCT01262482;NCT00253370;NCT00238212;NCT00661830;NCT00430235;NCT01093222;NCT01703910;NCT00456716"},{"ligand":"sunitinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sunitinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2006","completion_date":"2013","nct_id":"NCT01020630;NCT00478426;NCT00430261;NCT00397787;NCT00389974;NCT00411151;NCT01829217;NCT00891878"},{"ligand":"tofacitinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04034238"},{"ligand":"trametinib","mesh_id":"D000230","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01935973;NCT04303403;NCT02900664;NCT03878524"},{"ligand":"trametinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03087071;NCT03076164"},{"ligand":"trametinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02101788"},{"ligand":"trastuzumab","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2021","nct_id":"NCT04704661;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D000230","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT02213289;NCT00478140;NCT03950271;NCT04150640;NCT02678182;NCT01204372;NCT04014075;NCT03329690;NCT03409848;NCT03365882;NCT04430738;NCT03783936;NCT03966118;NCT01472029;NCT04309578;NCT01359397;NCT00515411;NCT03368131;NCT04661150"},{"ligand":"trastuzumab","mesh_id":"D000230","phase":"Phase 3","start_date":"2010","completion_date":"2021","nct_id":"NCT04499924;NCT01196390;NCT04704934;NCT03615326;NCT03691454;NCT02578368;NCT03199885"},{"ligand":"tucatinib","mesh_id":"D000230","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04430738"},{"ligand":"tucatinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04499924"},{"ligand":"vandetanib","mesh_id":"D000230","phase":"Phase 1","start_date":"2005","completion_date":"2008","nct_id":"NCT00732745;NCT00507091"},{"ligand":"vemurafenib","mesh_id":"D000230","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"zanubrutinib","mesh_id":"D000230","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03777657"}],"predictions":[{"target":"PDGFRA","probability":"0.94"},{"target":"KIT","probability":"0.93"},{"target":"EPHB2","probability":"0.765"},{"target":"BCR","probability":"0.7450746268656716"},{"target":"FGFR1","probability":"0.7211527009222661"},{"target":"FGFR2","probability":"0.6665369695627987"},{"target":"MAP2K7","probability":"0.66"},{"target":"ZAP70","probability":"0.66"},{"target":"AXL","probability":"0.6380432054763316"},{"target":"NTRK1","probability":"0.6352168466996956"},{"target":"PRKACB","probability":"0.625"},{"target":"MUSK","probability":"0.625"},{"target":"FGFR3","probability":"0.6223432210342484"},{"target":"ACVRL1","probability":"0.6059628544958123"},{"target":"SRC","probability":"0.6018300931904729"},{"target":"NTRK2","probability":"0.6014436625860451"},{"target":"FAM20C","probability":"0.5766666666666667"},{"target":"ITK","probability":"0.5722823906329957"},{"target":"PTK2","probability":"0.5673128073287598"},{"target":"EPHA5","probability":"0.5650995024875622"},{"target":"MAP3K10","probability":"0.55"},{"target":"PDIK1L","probability":"0.55"},{"target":"EIF2AK1","probability":"0.5467256347290421"},{"target":"AURKA","probability":"0.545600572912986"},{"target":"MOK","probability":"0.5454618088836416"},{"target":"RPS6KB1","probability":"0.5427651966445144"},{"target":"CAMK1D","probability":"0.54"},{"target":"NTRK3","probability":"0.531819752552748"},{"target":"CDK2","probability":"0.530999639355897"},{"target":"BMPR2","probability":"0.5307105058905226"},{"target":"EPHA2","probability":"0.5293300339118922"},{"target":"HASPIN","probability":"0.5217790926669815"},{"target":"EIF2AK3","probability":"0.520930892266146"},{"target":"PRKG2","probability":"0.5185681220149548"},{"target":"MAPK4","probability":"0.5184313131313132"},{"target":"LRRK1","probability":"0.5166666666666666"},{"target":"PLK1","probability":"0.515363463241049"},{"target":"CDK14","probability":"0.5116199922971022"},{"target":"BMPR1A","probability":"0.5115871493336059"},{"target":"OBSCN","probability":"0.5106279023683499"},{"target":"FGFR4","probability":"0.5105034447112512"},{"target":"RPS6KA4","probability":"0.5082091796960045"},{"target":"AMHR2","probability":"0.5066739288307915"},{"target":"TTN","probability":"0.5057540934409661"},{"target":"SYK","probability":"0.50220157167099"},{"target":"PRKCA","probability":"0.5017969058533273"},{"target":"CDK1","probability":"0.4973736326932211"},{"target":"NEK1","probability":"0.4960943123070696"},{"target":"STK11","probability":"0.49593280146622926"},{"target":"GRK7","probability":"0.49166666666666664"},{"target":"CILK1","probability":"0.49135849284484173"},{"target":"WNK2","probability":"0.49133349284484173"},{"target":"HIPK3","probability":"0.49124435183997955"},{"target":"PKN1","probability":"0.4902036637242452"},{"target":"AKT1","probability":"0.48507630712914107"},{"target":"TGFBR2","probability":"0.4823349701037843"},{"target":"PRKCB","probability":"0.4819003378367247"},{"target":"CCL3","probability":"0.4780621601668493"},{"target":"PRKCE","probability":"0.4773928318734746"},{"target":"CCNK","probability":"0.4763334928448418"},{"target":"PAK1","probability":"0.47262582460430186"},{"target":"CSNK1D","probability":"0.47205109847864457"},{"target":"KALRN","probability":"0.4717210144927536"},{"target":"NPR1","probability":"0.47025588885345904"},{"target":"RIPK1","probability":"0.4698779883593501"},{"target":"PTK2B","probability":"0.46763470276748814"},{"target":"TGFBR1","probability":"0.4674838892204519"},{"target":"MST1R","probability":"0.46735286011452537"},{"target":"AKT2","probability":"0.4667199024309136"},{"target":"MAP3K1","probability":"0.4657700204498603"},{"target":"CLK3","probability":"0.465"},{"target":"MARK3","probability":"0.465"},{"target":"PRKCD","probability":"0.46158952759672267"},{"target":"AURKB","probability":"0.4612639054017674"},{"target":"MAP4K3","probability":"0.46090909090909093"},{"target":"PINK1","probability":"0.4609047189755991"},{"target":"TRPM6","probability":"0.4594789810100926"},{"target":"CAMK2B","probability":"0.45697436442167316"},{"target":"CIT","probability":"0.4563657550089666"},{"target":"CDK10","probability":"0.45613891619832503"},{"target":"NEK9","probability":"0.45592669654289375"},{"target":"MAPK14","probability":"0.455649938718269"}],"source_name":"Adenocarcinoma"}],["D016889",{"mesh_id":"D016889","trials":[{"ligand":"abemaciclib","mesh_id":"D016889","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04188548"},{"ligand":"abemaciclib","mesh_id":"D016889","phase":"Phase 2","start_date":"2018","completion_date":"2020","nct_id":"NCT03675893;NCT03339843;NCT04469764;NCT04393285"},{"ligand":"afatinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alpelisib","mesh_id":"D016889","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04188548"},{"ligand":"axitinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2016","completion_date":"2021","nct_id":"NCT04197219;NCT02912572"},{"ligand":"binimetinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT03367741;NCT03170960;NCT01935934"},{"ligand":"cetuximab","mesh_id":"D016889","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT00392769;NCT04464967"},{"ligand":"copanlisib","mesh_id":"D016889","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03586661"},{"ligand":"copanlisib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02465060;NCT04750941"},{"ligand":"crizotinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT04030429;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D016889","phase":"Phase 1","start_date":"2011","completion_date":"2012","nct_id":"NCT01482728;NCT01440998"},{"ligand":"dasatinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00030485"},{"ligand":"everolimus","mesh_id":"D016889","phase":"Phase 1","start_date":"2008","completion_date":"2019","nct_id":"NCT04188548;NCT00703807"},{"ligand":"everolimus","mesh_id":"D016889","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT01068249;NCT00870337;NCT02228681;NCT00087685;NCT02397083;NCT03008408;NCT01797523;NCT02188550"},{"ligand":"imatinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2000","completion_date":"2000","nct_id":"NCT00006357"},{"ligand":"lapatinib","mesh_id":"D016889","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01454479"},{"ligand":"lapatinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00096447"},{"ligand":"larotrectinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D016889","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02788708"},{"ligand":"lenvatinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01111461;NCT04781088;NCT03005015"},{"ligand":"lenvatinib","mesh_id":"D016889","phase":"Phase 3","start_date":"2018","completion_date":"2019","nct_id":"NCT03517449;NCT03884101"},{"ligand":"nintedanib","mesh_id":"D016889","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02730416"},{"ligand":"osimertinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02730429;NCT02465060"},{"ligand":"pemigatinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02393248;NCT04463771"},{"ligand":"pertuzumab","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ribociclib","mesh_id":"D016889","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT03008408;NCT02657928"},{"ligand":"ruxolitinib","mesh_id":"D016889","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03120624"},{"ligand":"sirolimus","mesh_id":"D016889","phase":"Phase 1","start_date":"2007","completion_date":"2016","nct_id":"NCT01198184;NCT02646319;NCT00659568;NCT01065662;NCT00982631;NCT01205672;NCT01364844;NCT01155258;NCT00703807;NCT00408655"},{"ligand":"sirolimus","mesh_id":"D016889","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT02730923;NCT00739830;NCT00977574;NCT00072176;NCT00122343;NCT02755844;NCT00087685;NCT01420081;NCT02397083;NCT03099499;NCT03008408;NCT00729586;NCT00723255;NCT02093598;NCT01460979"},{"ligand":"sunitinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT02465060;NCT00474994"},{"ligand":"trametinib","mesh_id":"D016889","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01935973"},{"ligand":"trametinib","mesh_id":"D016889","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D016889","phase":"Phase 1","start_date":"1999","completion_date":"2019","nct_id":"NCT04188548;NCT00028535;NCT01454479;NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D016889","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT04482309;NCT02393248;NCT01367002;NCT04464967;NCT02465060;NCT04205630"}],"predictions":[],"source_name":"Endometrial Neoplasms"}],["D006528",{"mesh_id":"D006528","trials":[{"ligand":"abemaciclib","mesh_id":"D006528","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03781960"},{"ligand":"afatinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"apatinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04665362"},{"ligand":"apatinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03520257;NCT03511703;NCT04523662;NCT02727309;NCT04297202;NCT03732105;NCT04191889;NCT04014101;NCT03793725;NCT03463876;NCT01192971;NCT02942329;NCT04479527;NCT04411706;NCT04035876;NCT03261791;NCT03046979;NCT04204577;NCT02772029;NCT04724226;NCT03114085;NCT03510416;NCT04701060;NCT03839550"},{"ligand":"apatinib","mesh_id":"D006528","phase":"Phase 3","start_date":"2014","completion_date":"2020","nct_id":"NCT04639180;NCT03274427;NCT02702323;NCT02329860;NCT03278444"},{"ligand":"axitinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2011","completion_date":"2017","nct_id":"NCT01441388;NCT03289533;NCT02814461"},{"ligand":"axitinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01334112;NCT01273662;NCT01210495;NCT01352728"},{"ligand":"binimetinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03299946;NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04454762;NCT04472767;NCT01658878;NCT04316182;NCT03899428;NCT03539822;NCT04497038;NCT03170960;NCT04588051;NCT03586973;NCT02867592;NCT04522908;NCT04511455;NCT04442581;NCT04767906;NCT04204850;NCT04435977"},{"ligand":"cabozantinib","mesh_id":"D006528","phase":"Phase 3","start_date":"2013","completion_date":"2018","nct_id":"NCT03755791;NCT01908426"},{"ligand":"cabozantinib","mesh_id":"D006528","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03963206"},{"ligand":"cetuximab","mesh_id":"D006528","phase":"Phase 2","start_date":"2005","completion_date":"2018","nct_id":"NCT00142428;NCT03563170"},{"ligand":"copanlisib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT02465060;NCT03735628"},{"ligand":"crizotinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441388"},{"ligand":"crizotinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"dasatinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT02465060;NCT00459108"},{"ligand":"erdafitinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060;NCT02421185"},{"ligand":"erlotinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2002","completion_date":"2009","nct_id":"NCT00047346;NCT00823290"},{"ligand":"erlotinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT04172779;NCT00047333;NCT00287222;NCT01180959;NCT00832637;NCT00242502;NCT00791544;NCT00365391;NCT00532441;NCT02273362"},{"ligand":"erlotinib","mesh_id":"D006528","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00901901"},{"ligand":"everolimus","mesh_id":"D006528","phase":"Phase 1","start_date":"2008","completion_date":"2012","nct_id":"NCT01733004;NCT00828594"},{"ligand":"everolimus","mesh_id":"D006528","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00516165;NCT00775073;NCT00390195;NCT01488487;NCT01379521;NCT01642186"},{"ligand":"everolimus","mesh_id":"D006528","phase":"Phase 3","start_date":"2010","completion_date":"2011","nct_id":"NCT01035229;NCT01265810"},{"ligand":"everolimus","mesh_id":"D006528","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02081755"},{"ligand":"gefitinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2004","completion_date":"2005","nct_id":"NCT00282100;NCT00071994"},{"ligand":"lapatinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00101036"},{"ligand":"larotrectinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2016","completion_date":"2019","nct_id":"NCT03006926;NCT02953743;NCT04008797;NCT03418922"},{"ligand":"lenvatinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT04444167;NCT04241523;NCT04605796;NCT00946153;NCT04490694;NCT04327700;NCT04170179;NCT04227808;NCT03899428;NCT04317248;NCT04193696;NCT04042805;NCT04741165;NCT04443309;NCT03775707;NCT04542837;NCT03433703;NCT03746249;NCT03919383;NCT04273100;NCT04368078;NCT04511455;NCT04627363;NCT04740307;NCT04044313;NCT04599790;NCT04080154;NCT04728321;NCT03803254;NCT03499626;NCT04401800;NCT03841201"},{"ligand":"lenvatinib","mesh_id":"D006528","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT03713593;NCT04194775;NCT04053985;NCT03744247;NCT04246177;NCT04044651;NCT01761266;NCT03905967;NCT04237740;NCT04229355;NCT04319484;NCT04168944;NCT03791918;NCT04687163;NCT04523493;NCT04053972;NCT04039607;NCT03775395;NCT04770896"},{"ligand":"lenvatinib","mesh_id":"D006528","phase":"Phase 4","start_date":"2019","completion_date":"2021","nct_id":"NCT04127396;NCT04297254"},{"ligand":"nintedanib","mesh_id":"D006528","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01594125"},{"ligand":"nintedanib","mesh_id":"D006528","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01004003;NCT00987935"},{"ligand":"osimertinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D006528","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01356628;NCT02465060"},{"ligand":"pazopanib","mesh_id":"D006528","phase":"Phase 1","start_date":"2006","completion_date":"2009","nct_id":"NCT00370513;NCT01012362"},{"ligand":"pazopanib","mesh_id":"D006528","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01265810"},{"ligand":"pertuzumab","mesh_id":"D006528","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04246671;NCT02465060"},{"ligand":"ramucirumab","mesh_id":"D006528","phase":"Phase 1","start_date":"2014","completion_date":"2018","nct_id":"NCT02572687;NCT02069041;NCT03652467"},{"ligand":"ramucirumab","mesh_id":"D006528","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT04316182;NCT02082210;NCT01246986;NCT00627042"},{"ligand":"ramucirumab","mesh_id":"D006528","phase":"Phase 3","start_date":"2010","completion_date":"2015","nct_id":"NCT01140347;NCT02435433"},{"ligand":"regorafenib","mesh_id":"D006528","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03347292"},{"ligand":"regorafenib","mesh_id":"D006528","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT04476329;NCT01003015;NCT04170556;NCT04718909;NCT04327700;NCT04316182;NCT03899428;NCT04310709;NCT04183088;NCT03475953;NCT04696055;NCT03732547"},{"ligand":"regorafenib","mesh_id":"D006528","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04777851;NCT01774344"},{"ligand":"ribociclib","mesh_id":"D006528","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02524119"},{"ligand":"selumetinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT00604721;NCT01029418"},{"ligand":"sirolimus","mesh_id":"D006528","phase":"Phase 1","start_date":"2009","completion_date":"2012","nct_id":"NCT01522820;NCT01008917;NCT02724332;NCT00999882"},{"ligand":"sirolimus","mesh_id":"D006528","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01374750;NCT01010126;NCT01251458;NCT01687673;NCT01567930;NCT00390195;NCT01281943;NCT01335074"},{"ligand":"sirolimus","mesh_id":"D006528","phase":"Phase 3","start_date":"1996","completion_date":"2019","nct_id":"NCT00554125;NCT00328770;NCT01265810;NCT04168944;NCT00355862"},{"ligand":"sorafenib","mesh_id":"D006528","phase":"Phase 1","start_date":"2007","completion_date":"2019","nct_id":"NCT01337492;NCT00956436;NCT03965546;NCT01131689;NCT02101593;NCT02143401;NCT01618253;NCT01441388;NCT00892658;NCT00844168;NCT02988440;NCT01498952;NCT00823290;NCT02423239;NCT01008917;NCT02642913;NCT02716012;NCT00997022;NCT00846131;NCT01628640;NCT01801163;NCT02358395;NCT00976170;NCT02989870;NCT00828594;NCT02323906;NCT03966209;NCT00478374;NCT02288507;NCT01308723;NCT00712855;NCT02292173;NCT01008566;NCT02069145;NCT01042041;NCT02240433;NCT01348503;NCT00960167;NCT01666756;NCT02354898;NCT01897038"},{"ligand":"sorafenib","mesh_id":"D006528","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT01900002;NCT01556815;NCT02290977;NCT01964235;NCT02426450;NCT03211416;NCT03163992;NCT01126645;NCT04476329;NCT00752063;NCT01387555;NCT03520257;NCT01171482;NCT00768937;NCT00044512;NCT03008512;NCT01840592;NCT00703365;NCT02702414;NCT00882869;NCT02452853;NCT02425605;NCT03582618;NCT02279719;NCT02981498;NCT03511703;NCT01658878;NCT04170556;NCT00906373;NCT01217034;NCT01171651;NCT01205828;NCT04327700;NCT00618384;NCT01306058;NCT01539018;NCT03439891;NCT03535259;NCT01272557;NCT04316182;NCT02311205;NCT03037437;NCT03722498;NCT03899428;NCT01170104;NCT01418729;NCT04317248;NCT01953406;NCT04193696;NCT00862082;NCT01502410;NCT00943449;NCT00919009;NCT04599777;NCT00712790;NCT01271504;NCT02406508;NCT03316872;NCT01687673;NCT01777594;NCT01752933;NCT01567930;NCT04135690;NCT00576056;NCT02942329;NCT04479527;NCT01180959;NCT04588051;NCT03586973;NCT03645980;NCT01624285;NCT01265576;NCT01204177;NCT01258608;NCT00813293;NCT00933816;NCT02129322;NCT03812783;NCT01334710;NCT02716766;NCT01754987;NCT03971201;NCT03578874;NCT00464919;NCT02115373;NCT00687596;NCT01264705;NCT03812770;NCT03648073;NCT02908165;NCT01605734;NCT02089763;NCT01101906;NCT02400788;NCT01381211;NCT00844688;NCT01480817;NCT03780634;NCT02939807;NCT00717756;NCT01375569;NCT00619541;NCT00490685;NCT04611165;NCT01357486;NCT03009461;NCT00844883;NCT02178358;NCT01246986;NCT04518852;NCT01545804;NCT02772029;NCT01911000;NCT02575339;NCT00108953;NCT04710641;NCT00855218;NCT03630640;NCT01032850;NCT01033240;NCT01004003;NCT01507064;NCT02672488;NCT01988493;NCT00808145;NCT01935700;NCT04069949;NCT03499626;NCT01897610;NCT01775501;NCT01911273;NCT03606590;NCT02560779;NCT00990860;NCT03563170;NCT02024087;NCT00791544;NCT01915602;NCT01232296;NCT00971126;NCT01029418;NCT03516071;NCT00987935;NCT01934829;NCT03732547;NCT03389126;NCT03275376;NCT00872014;NCT04000737;NCT02227914;NCT01259193;NCT00999843;NCT01335074;NCT03318562;NCT04162158"},{"ligand":"sorafenib","mesh_id":"D006528","phase":"Phase 3","start_date":"2005","completion_date":"2021","nct_id":"NCT04709380;NCT01035229;NCT01901692;NCT02774187;NCT01903694;NCT02436902;NCT02460991;NCT03164382;NCT02867280;NCT04720716;NCT02029157;NCT02645981;NCT00494299;NCT03434379;NCT01906216;NCT01829035;NCT01655693;NCT01015833;NCT00901901;NCT00699374;NCT02971696;NCT03017326;NCT03298451;NCT04465734;NCT04560894;NCT00858871;NCT04344158;NCT01747642;NCT01761266;NCT01009593;NCT01140347;NCT01833299;NCT01932385;NCT04167293;NCT01405573;NCT03794440;NCT01108705;NCT02738697;NCT03755791;NCT01214343;NCT01387503;NCT01135056;NCT01887717;NCT01908426;NCT04229355;NCT00692770;NCT01265810;NCT04387695;NCT04667351;NCT00105443;NCT01774344;NCT01482442;NCT01730937;NCT00492752;NCT03468231;NCT04103398;NCT01245582;NCT02856126;NCT04723004;NCT04687163;NCT02576509;NCT04143191;NCT02435433;NCT02562755;NCT02220088;NCT01004978;NCT03533582;NCT03412773;NCT04039607;NCT03775395;NCT03236649;NCT04770896;NCT02794337"},{"ligand":"sorafenib","mesh_id":"D006528","phase":"Phase 4","start_date":"2010","completion_date":"2019","nct_id":"NCT01849588;NCT02961998;NCT04127396;NCT03212625;NCT01203787;NCT03963206;NCT01806740;NCT02504983;NCT03518502;NCT01409499;NCT01098760;NCT02733809"},{"ligand":"sunitinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441388"},{"ligand":"sunitinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00495625;NCT00247676;NCT00787787;NCT02465060;NCT01215565;NCT00361309"},{"ligand":"sunitinib","mesh_id":"D006528","phase":"Phase 3","start_date":"2008","completion_date":"2011","nct_id":"NCT00699374;NCT01265810"},{"ligand":"tivozanib","mesh_id":"D006528","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT01807156;NCT03970616;NCT01835223"},{"ligand":"trametinib","mesh_id":"D006528","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02292173"},{"ligand":"trametinib","mesh_id":"D006528","phase":"Phase 2","start_date":"2014","completion_date":"2015","nct_id":"NCT02042443;NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D006528","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01556815;NCT04246671;NCT02465060"},{"ligand":"vandetanib","mesh_id":"D006528","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03291379"},{"ligand":"vandetanib","mesh_id":"D006528","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00508001"}],"predictions":[{"target":"KDR","probability":"1.0"},{"target":"RET","probability":"1.0"},{"target":"PDGFRB","probability":"0.97"},{"target":"IGF1R","probability":"0.9"},{"target":"ERBB3","probability":"0.88"},{"target":"JAK2","probability":"0.825"},{"target":"INSR","probability":"0.815"},{"target":"BCR","probability":"0.81"},{"target":"EPHB2","probability":"0.805"},{"target":"MAP2K7","probability":"0.7851369863013699"},{"target":"TGFBR2","probability":"0.765"},{"target":"JAK1","probability":"0.76"},{"target":"PTK2B","probability":"0.7500431034482758"},{"target":"AKT1","probability":"0.735"},{"target":"TGFBR1","probability":"0.72"},{"target":"AKT2","probability":"0.7154545454545455"},{"target":"PTK2","probability":"0.7050374732334046"},{"target":"SRC","probability":"0.7"},{"target":"BTK","probability":"0.7"},{"target":"PRKCA","probability":"0.7"},{"target":"AXL","probability":"0.695"},{"target":"EPHA2","probability":"0.6901478322883547"},{"target":"SYK","probability":"0.69"},{"target":"ACVRL1","probability":"0.685"},{"target":"RPS6KB1","probability":"0.6791228070175438"},{"target":"AURKA","probability":"0.6751851851851852"},{"target":"TXK","probability":"0.665026845637584"},{"target":"CDKN1A","probability":"0.645"},{"target":"AURKB","probability":"0.64"},{"target":"ZAP70","probability":"0.64"},{"target":"JAK3","probability":"0.6351211852602254"},{"target":"AVP","probability":"0.625"},{"target":"CCL5","probability":"0.6153458867844"},{"target":"GSK3B","probability":"0.6141228070175438"},{"target":"LYN","probability":"0.6100376916245688"},{"target":"PDK1","probability":"0.6100268456375839"},{"target":"PIM1","probability":"0.5890376916245686"},{"target":"MAPK3","probability":"0.5801369863013699"},{"target":"PRKCB","probability":"0.575"},{"target":"MUSK","probability":"0.575"},{"target":"FYN","probability":"0.5702777777777778"},{"target":"PAK1","probability":"0.5690108459869848"},{"target":"MAPK1","probability":"0.5654227005870842"},{"target":"CCL2","probability":"0.5650943396226416"},{"target":"ILK","probability":"0.5595028646749349"},{"target":"PLK1","probability":"0.5552282886334611"},{"target":"CDK2","probability":"0.545"},{"target":"AKT3","probability":"0.545"},{"target":"BMPR2","probability":"0.54025"},{"target":"ROCK2","probability":"0.5393158660327471"},{"target":"ITK","probability":"0.5352146085219884"},{"target":"PRKCE","probability":"0.5350432138284251"},{"target":"CDK5","probability":"0.5350374732334047"},{"target":"STK11","probability":"0.535"},{"target":"SMG1","probability":"0.5251783607890991"},{"target":"CDK1","probability":"0.5052805064609576"},{"target":"PRKCZ","probability":"0.505070059466009"},{"target":"TTN","probability":"0.5050374732334046"},{"target":"EPHB4","probability":"0.5050191791331031"},{"target":"EIF2AK3","probability":"0.5006874579476029"},{"target":"CCL3","probability":"0.5005475542191313"},{"target":"LRRK2","probability":"0.5003002825381943"},{"target":"GRK2","probability":"0.5001183786863985"},{"target":"BRD4","probability":"0.4900374732334047"},{"target":"MAP2K4","probability":"0.48917445953477456"},{"target":"CAMK2G","probability":"0.480066494792277"},{"target":"MYLK","probability":"0.4800374732334047"},{"target":"ROCK1","probability":"0.4792890203951631"},{"target":"CHEK2","probability":"0.4718908609023574"},{"target":"SBK1","probability":"0.47"},{"target":"CDK20","probability":"0.4656529517676746"},{"target":"ALPK1","probability":"0.4650507765830346"},{"target":"PRKG1","probability":"0.46"},{"target":"PRKD1","probability":"0.4590806870618298"},{"target":"MAPK8","probability":"0.4575094383697634"},{"target":"IKBKB","probability":"0.4553990198431914"}],"source_name":"Carcinoma, Hepatocellular"}],["D008654",{"mesh_id":"D008654","trials":[{"ligand":"abemaciclib","mesh_id":"D008654","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01655225"},{"ligand":"abemaciclib","mesh_id":"D008654","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03654833"},{"ligand":"axitinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01211275"},{"ligand":"bosutinib","mesh_id":"D008654","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03023319"},{"ligand":"cabozantinib","mesh_id":"D008654","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT04173338;NCT02071862"},{"ligand":"cetuximab","mesh_id":"D008654","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00996567"},{"ligand":"dasatinib","mesh_id":"D008654","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00652574"},{"ligand":"dasatinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00509041"},{"ligand":"erlotinib","mesh_id":"D008654","phase":"Phase 1","start_date":"2001","completion_date":"2014","nct_id":"NCT00030498;NCT02071862"},{"ligand":"erlotinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2002","completion_date":"2012","nct_id":"NCT00137826;NCT01592383;NCT00039182"},{"ligand":"everolimus","mesh_id":"D008654","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02071862"},{"ligand":"everolimus","mesh_id":"D008654","phase":"Phase 2","start_date":"2008","completion_date":"2009","nct_id":"NCT00770120;NCT01024946"},{"ligand":"gefitinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2001","completion_date":"2003","nct_id":"NCT00025207;NCT00787410"},{"ligand":"imatinib","mesh_id":"D008654","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00402766"},{"ligand":"imatinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2008","completion_date":"2014","nct_id":"NCT02303899;NCT00551252"},{"ligand":"lenvatinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04287829"},{"ligand":"nintedanib","mesh_id":"D008654","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT02568449;NCT02863055"},{"ligand":"nintedanib","mesh_id":"D008654","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01907100"},{"ligand":"pazopanib","mesh_id":"D008654","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00459862"},{"ligand":"ramucirumab","mesh_id":"D008654","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT03502746;NCT03560973"},{"ligand":"sirolimus","mesh_id":"D008654","phase":"Phase 1","start_date":"2015","completion_date":"2018","nct_id":"NCT03436732;NCT02372227"},{"ligand":"sirolimus","mesh_id":"D008654","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00770120"},{"ligand":"sorafenib","mesh_id":"D008654","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00703638"},{"ligand":"sorafenib","mesh_id":"D008654","phase":"Phase 2","start_date":"2004","completion_date":"2008","nct_id":"NCT00794859;NCT00107432"},{"ligand":"sunitinib","mesh_id":"D008654","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00392444"},{"ligand":"tofacitinib","mesh_id":"D008654","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04034238"},{"ligand":"vandetanib","mesh_id":"D008654","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00597116"}],"predictions":[{"target":"ERBB2","probability":"0.668367816091954"},{"target":"FLT1","probability":"0.6464285714285714"},{"target":"ERBB4","probability":"0.6152193854995579"},{"target":"BCR","probability":"0.5951177279874214"},{"target":"FGFR1","probability":"0.5900444444444445"},{"target":"PIK3CA","probability":"0.5850783197831979"},{"target":"FGFR2","probability":"0.5787686125913395"},{"target":"ALK","probability":"0.5718768266680125"},{"target":"BRAF","probability":"0.5507290003023053"},{"target":"ROS1","probability":"0.5193534848015566"},{"target":"IGF1R","probability":"0.5183333333333333"},{"target":"FGFR3","probability":"0.5169098493129247"},{"target":"ACVRL1","probability":"0.4655422523965214"},{"target":"NTRK1","probability":"0.45679260981692293"}],"source_name":"Mesothelioma"}],["D054219",{"mesh_id":"D054219","trials":[{"ligand":"abemaciclib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D054219","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03732703"},{"ligand":"acalabrutinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02211014"},{"ligand":"afatinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439136;NCT02465060"},{"ligand":"alpelisib","mesh_id":"D054219","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02144038"},{"ligand":"binimetinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02465060;NCT04439344;NCT02834364"},{"ligand":"cabozantinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01582295;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01866293;NCT03201250"},{"ligand":"cetuximab","mesh_id":"D054219","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00368121"},{"ligand":"cobimetinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03312530;NCT03732703"},{"ligand":"copanlisib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439266;NCT04439253;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D054219","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03091257;NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439292;NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04603872;NCT00560352;NCT00560391;NCT01609816;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2007","completion_date":"2016","nct_id":"NCT04439305;NCT00429949;NCT01116128;NCT02465060"},{"ligand":"encorafenib","mesh_id":"D054219","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02834364"},{"ligand":"erdafitinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02952573;NCT03732703;NCT02465060"},{"ligand":"erlotinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00725634;NCT03878524"},{"ligand":"everolimus","mesh_id":"D054219","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00729638;NCT01889420;NCT00962507;NCT02407509;NCT03878524"},{"ligand":"everolimus","mesh_id":"D054219","phase":"Phase 2","start_date":"2005","completion_date":"2010","nct_id":"NCT00618345;NCT00474929;NCT00918333;NCT01234974"},{"ligand":"ibrutinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03702725"},{"ligand":"ibrutinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT02902965;NCT03015792;NCT01962792;NCT01478581;NCT02548962;NCT02943473"},{"ligand":"imatinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"larotrectinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nintedanib","mesh_id":"D054219","phase":"Phase 1","start_date":"2003","completion_date":"2003","nct_id":"NCT02182141"},{"ligand":"osimertinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D054219","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT02030483;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D054219","phase":"Phase 2","start_date":"2008","completion_date":"2015","nct_id":"NCT00555906;NCT02465060"},{"ligand":"pertuzumab","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ponatinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03110822;NCT03017820;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT03773107;NCT00639002"},{"ligand":"selumetinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01085214"},{"ligand":"sirolimus","mesh_id":"D054219","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00602693;NCT01689987;NCT00398515;NCT01396200;NCT01163357;NCT00962507;NCT03657420;NCT00317798;NCT00513474;NCT03878524;NCT00693433"},{"ligand":"sirolimus","mesh_id":"D054219","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT00691015;NCT01116232;NCT00079456;NCT01460420;NCT01177397;NCT00474929;NCT01303965;NCT04176380;NCT01239368;NCT01534143;NCT00918333;NCT00544115;NCT00589563;NCT00089037;NCT00483262;NCT02722668"},{"ligand":"sorafenib","mesh_id":"D054219","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00303797;NCT00687674;NCT00118170;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D054219","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00536575;NCT00474929;NCT00253578"},{"ligand":"sunitinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT02465060;NCT00514137"},{"ligand":"trametinib","mesh_id":"D054219","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01476137;NCT03091257;NCT03878524"},{"ligand":"trametinib","mesh_id":"D054219","phase":"Phase 2","start_date":"2013","completion_date":"2016","nct_id":"NCT04439318;NCT04439279;NCT04439292;NCT02465060;NCT01989598;NCT02140840;NCT04439357"},{"ligand":"trastuzumab","mesh_id":"D054219","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00991562;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D054219","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439110;NCT02465060"},{"ligand":"vemurafenib","mesh_id":"D054219","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D054219","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115035"}],"predictions":[],"source_name":"Neoplasms, Plasma Cell"}],["D017253",{"mesh_id":"D017253","trials":[{"ligand":"abemaciclib","mesh_id":"D017253","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04750928"},{"ligand":"axitinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02129647"},{"ligand":"binimetinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03231306"},{"ligand":"brigatinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"cabozantinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02101736"},{"ligand":"cetuximab","mesh_id":"D017253","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"crizotinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04283669"},{"ligand":"dabrafenib","mesh_id":"D017253","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02124772;NCT04201457"},{"ligand":"dabrafenib","mesh_id":"D017253","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"erlotinib","mesh_id":"D017253","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00901849"},{"ligand":"everolimus","mesh_id":"D017253","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01880749"},{"ligand":"everolimus","mesh_id":"D017253","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01412892;NCT01490476;NCT02332902;NCT01345136;NCT01419639;NCT01365468"},{"ligand":"icotinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02934256"},{"ligand":"imatinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2006","completion_date":"2018","nct_id":"NCT02177825;NCT01673009;NCT01140360;NCT03688568"},{"ligand":"lapatinib","mesh_id":"D017253","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00863122"},{"ligand":"lapatinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00973739"},{"ligand":"nilotinib","mesh_id":"D017253","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01275586"},{"ligand":"selumetinib","mesh_id":"D017253","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT04590235;NCT03649165;NCT04495127"},{"ligand":"selumetinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01089101;NCT01362803;NCT02407405;NCT03109301;NCT03095248;NCT03326388;NCT02839720;NCT03433183"},{"ligand":"selumetinib","mesh_id":"D017253","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03871257"},{"ligand":"sirolimus","mesh_id":"D017253","phase":"Phase 1","start_date":"2007","completion_date":"2012","nct_id":"NCT01552434;NCT00901849;NCT01031901"},{"ligand":"sirolimus","mesh_id":"D017253","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT01412892;NCT01490476;NCT02332902;NCT03433183;NCT00634270"},{"ligand":"sirolimus","mesh_id":"D017253","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04461886"},{"ligand":"sorafenib","mesh_id":"D017253","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00727233"},{"ligand":"sorafenib","mesh_id":"D017253","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01338857"},{"ligand":"sunitinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT00589784;NCT01402817"},{"ligand":"trametinib","mesh_id":"D017253","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03741101;NCT02124772;NCT03363217;NCT03190915;NCT04201457"},{"ligand":"trametinib","mesh_id":"D017253","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"}],"predictions":[{"target":"JAK2","probability":"0.5400653594771242"},{"target":"MAP2K7","probability":"0.49"}],"source_name":"Neurofibromatoses"}],["D009456",{"mesh_id":"D009456","trials":[{"ligand":"abemaciclib","mesh_id":"D009456","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04750928"},{"ligand":"axitinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02129647"},{"ligand":"binimetinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03231306"},{"ligand":"brigatinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"cabozantinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02101736"},{"ligand":"crizotinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04283669"},{"ligand":"dabrafenib","mesh_id":"D009456","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04201457"},{"ligand":"dabrafenib","mesh_id":"D009456","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"erlotinib","mesh_id":"D009456","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00901849"},{"ligand":"everolimus","mesh_id":"D009456","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01412892;NCT01490476;NCT02332902;NCT01345136;NCT01419639;NCT01365468"},{"ligand":"icotinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02934256"},{"ligand":"imatinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2006","completion_date":"2018","nct_id":"NCT02177825;NCT01673009;NCT01140360;NCT03688568"},{"ligand":"lapatinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00973739"},{"ligand":"nilotinib","mesh_id":"D009456","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01275586"},{"ligand":"selumetinib","mesh_id":"D009456","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT04590235;NCT03649165;NCT04495127"},{"ligand":"selumetinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01089101;NCT01362803;NCT02407405;NCT03109301;NCT03095248;NCT03326388;NCT02839720;NCT03433183"},{"ligand":"selumetinib","mesh_id":"D009456","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03871257"},{"ligand":"sirolimus","mesh_id":"D009456","phase":"Phase 1","start_date":"2007","completion_date":"2009","nct_id":"NCT00901849;NCT01031901"},{"ligand":"sirolimus","mesh_id":"D009456","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT01412892;NCT01490476;NCT02332902;NCT03433183;NCT00634270"},{"ligand":"sirolimus","mesh_id":"D009456","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04461886"},{"ligand":"sorafenib","mesh_id":"D009456","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00727233"},{"ligand":"sorafenib","mesh_id":"D009456","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01338857"},{"ligand":"sunitinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT00589784;NCT01402817"},{"ligand":"trametinib","mesh_id":"D009456","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03741101;NCT03190915;NCT04201457"},{"ligand":"trametinib","mesh_id":"D009456","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"}],"predictions":[{"target":"JAK2","probability":"0.6100653594771243"},{"target":"BCR","probability":"0.5600653594771242"}],"source_name":"Neurofibromatosis 1"}],["D009455",{"mesh_id":"D009455","trials":[{"ligand":"abemaciclib","mesh_id":"D009455","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04750928"},{"ligand":"axitinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02129647"},{"ligand":"binimetinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03231306"},{"ligand":"brigatinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"cabozantinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02101736"},{"ligand":"crizotinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04283669"},{"ligand":"dabrafenib","mesh_id":"D009455","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02124772;NCT04201457"},{"ligand":"erlotinib","mesh_id":"D009455","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00901849"},{"ligand":"everolimus","mesh_id":"D009455","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01412892;NCT01490476;NCT02332902;NCT01345136;NCT01419639;NCT01365468"},{"ligand":"icotinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02934256"},{"ligand":"imatinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2006","completion_date":"2018","nct_id":"NCT02177825;NCT01673009;NCT01140360;NCT03688568"},{"ligand":"lapatinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00973739"},{"ligand":"nilotinib","mesh_id":"D009455","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01275586"},{"ligand":"selumetinib","mesh_id":"D009455","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT04590235;NCT03649165;NCT04495127"},{"ligand":"selumetinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01089101;NCT01362803;NCT02407405;NCT03109301;NCT03095248;NCT03326388;NCT02839720"},{"ligand":"selumetinib","mesh_id":"D009455","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03871257"},{"ligand":"sirolimus","mesh_id":"D009455","phase":"Phase 1","start_date":"2007","completion_date":"2009","nct_id":"NCT00901849;NCT01031901"},{"ligand":"sirolimus","mesh_id":"D009455","phase":"Phase 2","start_date":"2008","completion_date":"2015","nct_id":"NCT01412892;NCT01490476;NCT02332902;NCT00634270"},{"ligand":"sirolimus","mesh_id":"D009455","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04461886"},{"ligand":"sorafenib","mesh_id":"D009455","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00727233"},{"ligand":"sorafenib","mesh_id":"D009455","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01338857"},{"ligand":"sunitinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT00589784;NCT01402817"},{"ligand":"trametinib","mesh_id":"D009455","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03741101;NCT02124772;NCT03363217;NCT04201457"}],"predictions":[],"source_name":"Neurofibroma"}],["D064726",{"mesh_id":"D064726","trials":[{"ligand":"abemaciclib","mesh_id":"D064726","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"afatinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02511847"},{"ligand":"alpelisib","mesh_id":"D064726","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01623349"},{"ligand":"alpelisib","mesh_id":"D064726","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04216472"},{"ligand":"alpelisib","mesh_id":"D064726","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04251533"},{"ligand":"apatinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2017","completion_date":"2019","nct_id":"NCT03075462;NCT03945604"},{"ligand":"apatinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT03243838;NCT03805399;NCT03348098;NCT03735082;NCT03932526;NCT03775928;NCT03254654;NCT01176669;NCT03650738"},{"ligand":"apatinib","mesh_id":"D064726","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04335006"},{"ligand":"binimetinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04494958;NCT03106415;NCT03971409"},{"ligand":"cabozantinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02071862"},{"ligand":"cabozantinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03316586;NCT03170960"},{"ligand":"cetuximab","mesh_id":"D064726","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01451632"},{"ligand":"cetuximab","mesh_id":"D064726","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT03692689;NCT04464967;NCT01097642;NCT03761914"},{"ligand":"cobimetinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02322814"},{"ligand":"copanlisib","mesh_id":"D064726","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04345913"},{"ligand":"dacomitinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01920061"},{"ligand":"dasatinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT00817531;NCT02720185;NCT00371254"},{"ligand":"erlotinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2009","completion_date":"2014","nct_id":"NCT01650506;NCT00998036;NCT02071862"},{"ligand":"erlotinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00733408"},{"ligand":"everolimus","mesh_id":"D064726","phase":"Phase 1","start_date":"2014","completion_date":"2016","nct_id":"NCT02890069;NCT02616848;NCT02071862"},{"ligand":"everolimus","mesh_id":"D064726","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT02531932;NCT03805399;NCT01931163;NCT04395989"},{"ligand":"lenvatinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04427293"},{"ligand":"lenvatinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03797326"},{"ligand":"neratinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01111825;NCT03812393"},{"ligand":"palbociclib","mesh_id":"D064726","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04360941"},{"ligand":"palbociclib","mesh_id":"D064726","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04494958;NCT04553133"},{"ligand":"panitumumab","mesh_id":"D064726","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"regorafenib","mesh_id":"D064726","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03251378"},{"ligand":"regorafenib","mesh_id":"D064726","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"ribociclib","mesh_id":"D064726","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03090165"},{"ligand":"ruxolitinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03012230"},{"ligand":"selumetinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02685657;NCT02583542"},{"ligand":"sirolimus","mesh_id":"D064726","phase":"Phase 1","start_date":"2009","completion_date":"2015","nct_id":"NCT01920061;NCT02616848;NCT00998036"},{"ligand":"sirolimus","mesh_id":"D064726","phase":"Phase 2","start_date":"2010","completion_date":"2018","nct_id":"NCT01111825;NCT02723877;NCT03805399;NCT02583542"},{"ligand":"sorafenib","mesh_id":"D064726","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02624700;NCT03318562"},{"ligand":"sunitinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00887575"},{"ligand":"tivozanib","mesh_id":"D064726","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01745367"},{"ligand":"trametinib","mesh_id":"D064726","phase":"Phase 1","start_date":"2012","completion_date":"2016","nct_id":"NCT01467310;NCT02900664"},{"ligand":"trametinib","mesh_id":"D064726","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01964924"},{"ligand":"trastuzumab","mesh_id":"D064726","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04296942"},{"ligand":"trastuzumab","mesh_id":"D064726","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01111825;NCT03907800;NCT04464967;NCT03742102"},{"ligand":"trastuzumab","mesh_id":"D064726","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT03168880"}],"predictions":[],"source_name":"Triple Negative Breast Neoplasms"}],["D002278",{"mesh_id":"D002278","trials":[{"ligand":"abemaciclib","mesh_id":"D002278","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"everolimus","mesh_id":"D002278","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01259063"},{"ligand":"gefitinib","mesh_id":"D002278","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00082667"},{"ligand":"ruxolitinib","mesh_id":"D002278","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02928978"},{"ligand":"sirolimus","mesh_id":"D002278","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03333694"},{"ligand":"sirolimus","mesh_id":"D002278","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01259063"},{"ligand":"trastuzumab","mesh_id":"D002278","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01641406"},{"ligand":"trastuzumab","mesh_id":"D002278","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00769379"}],"predictions":[],"source_name":"Carcinoma in Situ"}],["D044584",{"mesh_id":"D044584","trials":[{"ligand":"abemaciclib","mesh_id":"D044584","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"afatinib","mesh_id":"D044584","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02451553"},{"ligand":"cabozantinib","mesh_id":"D044584","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03354884"},{"ligand":"erlotinib","mesh_id":"D044584","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01093222"},{"ligand":"gefitinib","mesh_id":"D044584","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00082667"},{"ligand":"lapatinib","mesh_id":"D044584","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01891357"},{"ligand":"palbociclib","mesh_id":"D044584","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03455270"},{"ligand":"ramucirumab","mesh_id":"D044584","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02520141"},{"ligand":"ruxolitinib","mesh_id":"D044584","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02928978"},{"ligand":"sorafenib","mesh_id":"D044584","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01762150;NCT01093222"},{"ligand":"trametinib","mesh_id":"D044584","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02042443"},{"ligand":"trastuzumab","mesh_id":"D044584","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01891357"},{"ligand":"trastuzumab","mesh_id":"D044584","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00769379"}],"predictions":[],"source_name":"Carcinoma, Ductal"}],["D002285",{"mesh_id":"D002285","trials":[{"ligand":"abemaciclib","mesh_id":"D002285","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"gefitinib","mesh_id":"D002285","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00082667"},{"ligand":"palbociclib","mesh_id":"D002285","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03535506"},{"ligand":"ruxolitinib","mesh_id":"D002285","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02928978"},{"ligand":"trastuzumab","mesh_id":"D002285","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00769379"}],"predictions":[],"source_name":"Carcinoma, Intraductal, Noninfiltrating"}],["D018275",{"mesh_id":"D018275","trials":[{"ligand":"abemaciclib","mesh_id":"D018275","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"crizotinib","mesh_id":"D018275","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03620643"},{"ligand":"entrectinib","mesh_id":"D018275","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04551495"},{"ligand":"ruxolitinib","mesh_id":"D018275","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02928978"},{"ligand":"trastuzumab","mesh_id":"D018275","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01641406"}],"predictions":[],"source_name":"Carcinoma, Lobular"}],["D000071960",{"mesh_id":"D000071960","trials":[{"ligand":"abemaciclib","mesh_id":"D000071960","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"gefitinib","mesh_id":"D000071960","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00082667"},{"ligand":"ruxolitinib","mesh_id":"D000071960","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02928978"},{"ligand":"trastuzumab","mesh_id":"D000071960","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01641406"}],"predictions":[],"source_name":"Breast Carcinoma In Situ"}],["D018270",{"mesh_id":"D018270","trials":[{"ligand":"abemaciclib","mesh_id":"D018270","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03979508"},{"ligand":"alpelisib","mesh_id":"D018270","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01791478"},{"ligand":"lapatinib","mesh_id":"D018270","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01891357"},{"ligand":"lapatinib","mesh_id":"D018270","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01426880"},{"ligand":"palbociclib","mesh_id":"D018270","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03455270"},{"ligand":"pertuzumab","mesh_id":"D018270","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02682693"},{"ligand":"pertuzumab","mesh_id":"D018270","phase":"Phase 3","start_date":"2012","completion_date":"2014","nct_id":"NCT02125344;NCT01583426"},{"ligand":"trastuzumab","mesh_id":"D018270","phase":"Phase 2","start_date":"2013","completion_date":"2017","nct_id":"NCT01891357;NCT02199418;NCT02682693"},{"ligand":"trastuzumab","mesh_id":"D018270","phase":"Phase 3","start_date":"2008","completion_date":"2014","nct_id":"NCT02125344;NCT01426880;NCT00769379;NCT01583426"}],"predictions":[],"source_name":"Carcinoma, Ductal, Breast"}],["D008545",{"mesh_id":"D008545","trials":[{"ligand":"abemaciclib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02308020"},{"ligand":"afatinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alpelisib","mesh_id":"D008545","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02273219"},{"ligand":"apatinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03422445;NCT04397770;NCT03955354;NCT04331093;NCT03986515;NCT03383237"},{"ligand":"avapritinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03086174"},{"ligand":"axitinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT01321437;NCT03941795;NCT04688658;NCT04493203;NCT01533948;NCT04180995;NCT01174238;NCT00094107"},{"ligand":"binimetinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2017","completion_date":"2021","nct_id":"NCT04759846;NCT04741997;NCT03026517;NCT03864042;NCT03878719;NCT04543188"},{"ligand":"binimetinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT04375527;NCT04511013;NCT02159066;NCT04221438;NCT04598009;NCT04074096;NCT01562899;NCT02631447;NCT01820364;NCT02902042;NCT03947385;NCT03911869;NCT01781572;NCT02263898;NCT03235245;NCT03563729;NCT01801358;NCT02465060;NCT04720768;NCT03898908;NCT02094872;NCT01320085;NCT04655157"},{"ligand":"binimetinib","mesh_id":"D008545","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04657991;NCT01909453;NCT01763164"},{"ligand":"cabozantinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT04514484;NCT01835184"},{"ligand":"cabozantinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT04091750;NCT01835145;NCT03957551"},{"ligand":"ceritinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03501368"},{"ligand":"ceritinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02645149;NCT02587650"},{"ligand":"cobimetinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT04109456;NCT01843738;NCT02818023;NCT01876641;NCT03026517;NCT03543969;NCT03178851;NCT02721459;NCT01271803;NCT01656642"},{"ligand":"cobimetinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT03625141;NCT02537600;NCT03514901;NCT02414750;NCT03101254;NCT02968303;NCT02303951;NCT01495988;NCT03224208;NCT04722575;NCT02583516;NCT03175432;NCT03430947;NCT01813214;NCT01959633;NCT03005639;NCT02036086;NCT02768207;NCT03554083;NCT02902029;NCT02230306"},{"ligand":"cobimetinib","mesh_id":"D008545","phase":"Phase 3","start_date":"2013","completion_date":"2017","nct_id":"NCT03273153;NCT02427893;NCT01689519;NCT02908672"},{"ligand":"copanlisib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02568267;NCT02223819;NCT03947385;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D008545","phase":"Phase 1","start_date":"2013","completion_date":"2019","nct_id":"NCT02447939;NCT01767454;NCT02027961;NCT02915666;NCT02097225;NCT02357732;NCT03088176;NCT03026517;NCT03272464;NCT03332589;NCT01940809;NCT02382549;NCT02200562"},{"ligand":"dabrafenib","mesh_id":"D008545","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01902173;NCT03149029;NCT02872259;NCT04310397;NCT02858921;NCT02625337;NCT02410863;NCT01266967;NCT01721603;NCT04527549;NCT01989585;NCT01928940;NCT02645149;NCT01978236;NCT02231775;NCT02083354;NCT02977052;NCT02257424;NCT01619774;NCT03754179;NCT02392871;NCT02314143;NCT03949153;NCT02968303;NCT02052193;NCT01972347;NCT03808441;NCT02130466;NCT03352947;NCT01519427;NCT03972046;NCT02296996;NCT02910700;NCT02110355;NCT01701037;NCT03563729;NCT04557956;NCT01726738;NCT03391050;NCT02465060;NCT02143050;NCT04059224;NCT01512251;NCT01153763;NCT02196181;NCT02039947;NCT03455764;NCT02974803;NCT01682213"},{"ligand":"dabrafenib","mesh_id":"D008545","phase":"Phase 3","start_date":"2010","completion_date":"2018","nct_id":"NCT01227889;NCT02967692;NCT02224781;NCT03551626;NCT01682083;NCT01584648;NCT01597908"},{"ligand":"dabrafenib","mesh_id":"D008545","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03340506"},{"ligand":"dasatinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01916135"},{"ligand":"dasatinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00436605;NCT02465060;NCT00597038;NCT00700882;NCT01876212;NCT01092728"},{"ligand":"duvelisib","mesh_id":"D008545","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04688658"},{"ligand":"encorafenib","mesh_id":"D008545","phase":"Phase 1","start_date":"2011","completion_date":"2021","nct_id":"NCT04759846;NCT04741997;NCT03026517;NCT01436656;NCT03864042;NCT03878719"},{"ligand":"encorafenib","mesh_id":"D008545","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04511013;NCT02159066;NCT04221438;NCT01894672;NCT04074096;NCT02631447;NCT01820364;NCT02902042;NCT03911869;NCT01519427;NCT02263898;NCT03235245;NCT03563729;NCT04720768;NCT03898908;NCT01777776;NCT04655157"},{"ligand":"encorafenib","mesh_id":"D008545","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04657991;NCT01909453"},{"ligand":"entrectinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02568267;NCT04589832;NCT02587650"},{"ligand":"erdafitinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2006","completion_date":"2007","nct_id":"NCT00600496;NCT00405405"},{"ligand":"erlotinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00466687"},{"ligand":"everolimus","mesh_id":"D008545","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00655655"},{"ligand":"everolimus","mesh_id":"D008545","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT01014351;NCT00591734;NCT00098553;NCT00402662;NCT01252251;NCT01960829;NCT00976573;NCT00521001"},{"ligand":"ibrutinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03021460"},{"ligand":"ibrutinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02581930"},{"ligand":"imatinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01738139"},{"ligand":"imatinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01099514;NCT04598009;NCT00424515;NCT04546074;NCT02812693;NCT01782508;NCT00402662;NCT00074308;NCT00421317;NCT00027586;NCT00881049;NCT00667953;NCT00470470;NCT00788775"},{"ligand":"lapatinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01264081"},{"ligand":"larotrectinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00121680"},{"ligand":"lenvatinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03776136;NCT04700072;NCT01136967;NCT04622566;NCT04207086;NCT04305054;NCT04305041;NCT01133977"},{"ligand":"lenvatinib","mesh_id":"D008545","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03820986"},{"ligand":"nilotinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2009","completion_date":"2010","nct_id":"NCT01099514;NCT01028222;NCT01395121;NCT01168050;NCT00788775"},{"ligand":"nintedanib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02308553"},{"ligand":"osimertinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D008545","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT03454919;NCT02465060;NCT04720768;NCT02202200;NCT01037790"},{"ligand":"pazopanib","mesh_id":"D008545","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT02645149;NCT01107665;NCT00861913;NCT01666418"},{"ligand":"pertuzumab","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"pexidartinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452424"},{"ligand":"ramucirumab","mesh_id":"D008545","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00533702"},{"ligand":"regorafenib","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02587650;NCT02501551"},{"ligand":"ribociclib","mesh_id":"D008545","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02974725"},{"ligand":"ribociclib","mesh_id":"D008545","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT02159066;NCT02645149;NCT01820364;NCT01781572;NCT04417621;NCT01777776;NCT03484923"},{"ligand":"selumetinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2007","completion_date":"2017","nct_id":"NCT00600496;NCT01364051;NCT00710515;NCT02768766"},{"ligand":"selumetinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01519427;NCT01256359;NCT00936221;NCT00866177;NCT00338130;NCT01166126;NCT01143402"},{"ligand":"selumetinib","mesh_id":"D008545","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT01974752"},{"ligand":"sirolimus","mesh_id":"D008545","phase":"Phase 1","start_date":"2004","completion_date":"2012","nct_id":"NCT00655655;NCT01522820;NCT00600496;NCT00349206;NCT00112476"},{"ligand":"sirolimus","mesh_id":"D008545","phase":"Phase 2","start_date":"2001","completion_date":"2012","nct_id":"NCT01014351;NCT01851408;NCT00397982;NCT01614301;NCT00281957;NCT01166126;NCT00022464"},{"ligand":"sorafenib","mesh_id":"D008545","phase":"Phase 1","start_date":"2006","completion_date":"2013","nct_id":"NCT00349206;NCT00565968;NCT01303341;NCT01078961;NCT01893099;NCT00418496"},{"ligand":"sorafenib","mesh_id":"D008545","phase":"Phase 2","start_date":"2005","completion_date":"2012","nct_id":"NCT00538005;NCT00794235;NCT00498836;NCT00492505;NCT00329641;NCT00623402;NCT00387751;NCT00119249;NCT01851408;NCT00602576;NCT00492297;NCT01377025;NCT00673361;NCT00110994;NCT00483301;NCT00811759;NCT00281957;NCT02517736"},{"ligand":"sorafenib","mesh_id":"D008545","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00110019;NCT00111007"},{"ligand":"sunitinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01005472"},{"ligand":"sunitinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00304200;NCT02400385;NCT01551459;NCT02068586;NCT00631618;NCT00482911;NCT00496223;NCT00577382;NCT02465060;NCT00462982;NCT01216657;NCT00489944"},{"ligand":"trametinib","mesh_id":"D008545","phase":"Phase 1","start_date":"2013","completion_date":"2019","nct_id":"NCT02447939;NCT01767454;NCT02027961;NCT02915666;NCT02097225;NCT03932253;NCT02357732;NCT03088176;NCT03026517;NCT03272464;NCT02300935;NCT02974725;NCT03501368;NCT01940809;NCT02382549;NCT02138292"},{"ligand":"trametinib","mesh_id":"D008545","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT01902173;NCT03149029;NCT02872259;NCT04310397;NCT02858921;NCT02625337;NCT02410863;NCT01721603;NCT04527549;NCT01989585;NCT03580382;NCT01928940;NCT02645149;NCT01978236;NCT02231775;NCT02083354;NCT02977052;NCT02257424;NCT01619774;NCT01941927;NCT03754179;NCT02392871;NCT02314143;NCT03949153;NCT02968303;NCT01972347;NCT03808441;NCT02130466;NCT03352947;NCT01328106;NCT03972046;NCT02296996;NCT02910700;NCT01037127;NCT04417621;NCT02110355;NCT01701037;NCT03563729;NCT04557956;NCT01726738;NCT03391050;NCT02465060;NCT02143050;NCT04059224;NCT01979523;NCT02196181;NCT02039947;NCT03455764;NCT02974803;NCT02296112"},{"ligand":"trametinib","mesh_id":"D008545","phase":"Phase 3","start_date":"2010","completion_date":"2018","nct_id":"NCT02967692;NCT02224781;NCT03551626;NCT01682083;NCT01584648;NCT01245062;NCT01597908"},{"ligand":"trametinib","mesh_id":"D008545","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03340506"},{"ligand":"trastuzumab","mesh_id":"D008545","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02308020;NCT02465060"},{"ligand":"vemurafenib","mesh_id":"D008545","phase":"Phase 1","start_date":"2006","completion_date":"2018","nct_id":"NCT01164891;NCT01611675;NCT01264380;NCT00405587;NCT02068079;NCT01657591;NCT01841463;NCT01843738;NCT01519323;NCT01826448;NCT01851824;NCT01603212;NCT01001299;NCT02818023;NCT01835184;NCT01765543;NCT01876641;NCT01765556;NCT01849666;NCT03026517;NCT01765569;NCT02077114;NCT01897116;NCT03543969;NCT01585415;NCT01943422;NCT02441465;NCT01107418;NCT02608034;NCT02721459;NCT01844674;NCT01271803;NCT01656642;NCT01910181;NCT01400451"},{"ligand":"vemurafenib","mesh_id":"D008545","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT02050321;NCT03625141;NCT00949702;NCT02537600;NCT03514901;NCT02414750;NCT03101254;NCT01659151;NCT01378975;NCT01983124;NCT01754376;NCT02968303;NCT02052193;NCT02038348;NCT02303951;NCT01495988;NCT01474551;NCT03224208;NCT04722575;NCT02583516;NCT01519427;NCT01781026;NCT02296996;NCT01638676;NCT01616199;NCT03430947;NCT01813214;NCT01673854;NCT01973322;NCT01586195;NCT02354690;NCT01959633;NCT03005639;NCT01942993;NCT02036086;NCT01512251;NCT02768207;NCT03554083;NCT01248936;NCT02902029;NCT02202200;NCT02230306"},{"ligand":"vemurafenib","mesh_id":"D008545","phase":"Phase 3","start_date":"2010","completion_date":"2017","nct_id":"NCT01307397;NCT02427893;NCT01909453;NCT01667419;NCT01689519;NCT01597908;NCT02908672;NCT01006980"},{"ligand":"vemurafenib","mesh_id":"D008545","phase":"Phase 4","start_date":"2012","completion_date":"2013","nct_id":"NCT01683188;NCT01898585"}],"predictions":[{"target":"MAP2K7","probability":"0.6755138757854483"},{"target":"PDGFRA","probability":"0.6401821336450852"},{"target":"ERBB3","probability":"0.5925326909841706"},{"target":"KIT","probability":"0.580041881443299"},{"target":"AKT1","probability":"0.5007485312479956"},{"target":"EPHB2","probability":"0.5002419265974861"},{"target":"BCR","probability":"0.480015666965085"},{"target":"JAK1","probability":"0.462279151376481"},{"target":"JAK2","probability":"0.4557482853215857"}],"source_name":"Melanoma"}],["D005909",{"mesh_id":"D005909","trials":[{"ligand":"abemaciclib","mesh_id":"D005909","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT04074785;NCT04391595"},{"ligand":"abemaciclib","mesh_id":"D005909","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT02981940;NCT02977780;NCT04118036"},{"ligand":"acalabrutinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02586857"},{"ligand":"afatinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00977431"},{"ligand":"alectinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03158389"},{"ligand":"axitinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2011","completion_date":"2018","nct_id":"NCT01441388;NCT03275558"},{"ligand":"axitinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT01562197;NCT03291314;NCT01508117"},{"ligand":"binimetinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03973918"},{"ligand":"bosutinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01331291;NCT00959946"},{"ligand":"cabozantinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00960492"},{"ligand":"cabozantinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT01068782;NCT00704288;NCT02885324"},{"ligand":"ceritinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02605746"},{"ligand":"ceritinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02465528"},{"ligand":"cetuximab","mesh_id":"D005909","phase":"Phase 1","start_date":"2009","completion_date":"2018","nct_id":"NCT03603379;NCT01238237"},{"ligand":"cetuximab","mesh_id":"D005909","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT02800486;NCT00463073;NCT02861898;NCT00311857;NCT01884740;NCT01044225"},{"ligand":"crizotinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2011","completion_date":"2014","nct_id":"NCT01441388;NCT02270034"},{"ligand":"dabrafenib","mesh_id":"D005909","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02684058;NCT03919071"},{"ligand":"dabrafenib","mesh_id":"D005909","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"dacomitinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2010","completion_date":"2012","nct_id":"NCT01112527;NCT01520870"},{"ligand":"dasatinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2008","completion_date":"2009","nct_id":"NCT00734864;NCT00895960;NCT00609999"},{"ligand":"dasatinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT00869401;NCT00423735;NCT00892177;NCT00948389"},{"ligand":"encorafenib","mesh_id":"D005909","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03973918"},{"ligand":"erlotinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2001","completion_date":"2010","nct_id":"NCT01103375;NCT00227032;NCT00609999;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT01110876;NCT00301418;NCT00525525;NCT00720356;NCT00445588;NCT00112736;NCT00671970;NCT00337883;NCT00187486;NCT00274833;NCT00672243;NCT00045110;NCT00054496;NCT00387894;NCT00086879;NCT00039494;NCT00335764"},{"ligand":"everolimus","mesh_id":"D005909","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT04135807;NCT03834740;NCT03355794;NCT00387400;NCT00613132"},{"ligand":"everolimus","mesh_id":"D005909","phase":"Phase 2","start_date":"2003","completion_date":"2016","nct_id":"NCT01062399;NCT00085566;NCT00515086;NCT00805961;NCT01434602;NCT00553150;NCT00107237"},{"ligand":"gefitinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00132158"},{"ligand":"gefitinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2001","completion_date":"2011","nct_id":"NCT00025675;NCT00042991;NCT00085566;NCT01310855;NCT00014170;NCT00238797;NCT00016991;NCT00250887;NCT00052208"},{"ligand":"ibrutinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03535350"},{"ligand":"imatinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2005","completion_date":"2007","nct_id":"NCT00613054;NCT00613132"},{"ligand":"imatinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2004","completion_date":"2007","nct_id":"NCT00606008;NCT00615927;NCT00290771;NCT00171938;NCT00354913"},{"ligand":"imatinib","mesh_id":"D005909","phase":"Phase 3","start_date":"2004","completion_date":"2018","nct_id":"NCT00154375;NCT03632135"},{"ligand":"lapatinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT04135807;NCT02101905"},{"ligand":"lapatinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT00095940;NCT00107003;NCT01591577"},{"ligand":"lenvatinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT03797326;NCT01433991"},{"ligand":"neratinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02977780"},{"ligand":"nintedanib","mesh_id":"D005909","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01666600;NCT01380782;NCT01251484"},{"ligand":"olaratumab","mesh_id":"D005909","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT00895180"},{"ligand":"osimertinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04135807"},{"ligand":"osimertinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03732352"},{"ligand":"palbociclib","mesh_id":"D005909","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D005909","phase":"Phase 2","start_date":"2010","completion_date":"2018","nct_id":"NCT01227434;NCT03158389"},{"ligand":"panitumumab","mesh_id":"D005909","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02766699"},{"ligand":"pazopanib","mesh_id":"D005909","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03275558"},{"ligand":"pazopanib","mesh_id":"D005909","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT02331498;NCT01931098;NCT01392352;NCT00459381"},{"ligand":"pexidartinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2011","completion_date":"2013","nct_id":"NCT01790503;NCT01349036"},{"ligand":"ponatinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02478164"},{"ligand":"ramucirumab","mesh_id":"D005909","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT00895180"},{"ligand":"regorafenib","mesh_id":"D005909","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02926222;NCT04051606"},{"ligand":"regorafenib","mesh_id":"D005909","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03970447"},{"ligand":"ribociclib","mesh_id":"D005909","phase":"Phase 1","start_date":"2016","completion_date":"2018","nct_id":"NCT03834740;NCT03355794;NCT02933736;NCT03434262;NCT02345824"},{"ligand":"ruxolitinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03514069"},{"ligand":"sirolimus","mesh_id":"D005909","phase":"Phase 1","start_date":"2004","completion_date":"2014","nct_id":"NCT00821080;NCT01522820;NCT02238496;NCT02142803;NCT01316809;NCT01353625;NCT00087451;NCT01240460;NCT00316849"},{"ligand":"sirolimus","mesh_id":"D005909","phase":"Phase 2","start_date":"2001","completion_date":"2018","nct_id":"NCT01177397;NCT01051557;NCT00515086;NCT00329719;NCT00112736;NCT00047073;NCT01019434;NCT03463265;NCT00672243;NCT03158389;NCT03522298;NCT00800917;NCT00016328;NCT00335764;NCT02850744;NCT02430363"},{"ligand":"sirolimus","mesh_id":"D005909","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03008148"},{"ligand":"sorafenib","mesh_id":"D005909","phase":"Phase 1","start_date":"2004","completion_date":"2011","nct_id":"NCT00734526;NCT01441388;NCT00884416;NCT00093613"},{"ligand":"sorafenib","mesh_id":"D005909","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT01817751;NCT00445588;NCT00329719;NCT00544817;NCT00597493;NCT01434602;NCT00621686;NCT02599090;NCT00335764"},{"ligand":"sunitinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2007","completion_date":"2018","nct_id":"NCT01441388;NCT00864864;NCT00611728;NCT01122888;NCT03275558"},{"ligand":"sunitinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT00606008;NCT00535379;NCT00499473;NCT01100177;NCT00923117;NCT02928575"},{"ligand":"sunitinib","mesh_id":"D005909","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03025893"},{"ligand":"tivozanib","mesh_id":"D005909","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01846871"},{"ligand":"trametinib","mesh_id":"D005909","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D005909","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02684058;NCT03919071"},{"ligand":"trametinib","mesh_id":"D005909","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"vandetanib","mesh_id":"D005909","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00821080;NCT00613054;NCT00613223"},{"ligand":"vandetanib","mesh_id":"D005909","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT00995007;NCT00441142"}],"predictions":[{"target":"MAP2K7","probability":"0.7207871794871795"},{"target":"FGFR2","probability":"0.48448439305855606"},{"target":"FGFR3","probability":"0.4750164187163034"},{"target":"NTRK1","probability":"0.4652458547741567"},{"target":"AKT1","probability":"0.4615911220802294"}],"source_name":"Glioblastoma"}],["D001932",{"mesh_id":"D001932","trials":[{"ligand":"abemaciclib","mesh_id":"D001932","phase":"Phase 1","start_date":"2016","completion_date":"2019","nct_id":"NCT04074785;NCT02644460"},{"ligand":"abemaciclib","mesh_id":"D001932","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220646"},{"ligand":"afatinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02423525"},{"ligand":"afatinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02768337;NCT04158947"},{"ligand":"apatinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03356600"},{"ligand":"binimetinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04543188"},{"ligand":"binimetinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2016","completion_date":"2019","nct_id":"NCT02285439;NCT03911869"},{"ligand":"cabozantinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02885324"},{"ligand":"cetuximab","mesh_id":"D001932","phase":"Phase 2","start_date":"2009","completion_date":"2016","nct_id":"NCT02800486;NCT01012609;NCT02861898;NCT02855086"},{"ligand":"cobimetinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03430947;NCT02230306"},{"ligand":"crizotinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02568267;NCT04193007"},{"ligand":"dabrafenib","mesh_id":"D001932","phase":"Phase 2","start_date":"2013","completion_date":"2016","nct_id":"NCT01677741;NCT02974803"},{"ligand":"dacomitinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT04339829;NCT01520870;NCT02047747"},{"ligand":"dasatinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02389309"},{"ligand":"dasatinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00423735"},{"ligand":"encorafenib","mesh_id":"D001932","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03911869"},{"ligand":"entrectinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erlotinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2004","completion_date":"2011","nct_id":"NCT00077454;NCT00360854;NCT00536861;NCT01257594;NCT00418327"},{"ligand":"erlotinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2006","completion_date":"2019","nct_id":"NCT01110876;NCT00871923;NCT01578668;NCT01763385;NCT00312728;NCT02250846;NCT02655536;NCT04193007;NCT00387894;NCT00663689"},{"ligand":"everolimus","mesh_id":"D001932","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT04135807;NCT00187174;NCT03387020"},{"ligand":"everolimus","mesh_id":"D001932","phase":"Phase 2","start_date":"2009","completion_date":"2016","nct_id":"NCT01434602;NCT00823459"},{"ligand":"gefitinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT00614809;NCT04193007;NCT00234442;NCT01951469"},{"ligand":"gefitinib","mesh_id":"D001932","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02338011"},{"ligand":"icotinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2011","completion_date":"2018","nct_id":"NCT01516983;NCT03754530;NCT02726568"},{"ligand":"icotinib","mesh_id":"D001932","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT04058704"},{"ligand":"imatinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00049127"},{"ligand":"lapatinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT04135807;NCT02101905;NCT00470847"},{"ligand":"lapatinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT00107003;NCT01218529;NCT04334330;NCT00883688;NCT00826241"},{"ligand":"neratinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431"},{"ligand":"osimertinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04135807"},{"ligand":"osimertinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03769103"},{"ligand":"palbociclib","mesh_id":"D001932","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04334330"},{"ligand":"panitumumab","mesh_id":"D001932","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03510208"},{"ligand":"pazopanib","mesh_id":"D001932","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01130623"},{"ligand":"pazopanib","mesh_id":"D001932","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT01931098"},{"ligand":"pertuzumab","mesh_id":"D001932","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02598427"},{"ligand":"pertuzumab","mesh_id":"D001932","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431"},{"ligand":"ribociclib","mesh_id":"D001932","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262;NCT03387020"},{"ligand":"sirolimus","mesh_id":"D001932","phase":"Phase 1","start_date":"2008","completion_date":"2018","nct_id":"NCT01522820;NCT00784914;NCT02238496;NCT00949026;NCT02389309;NCT03387020"},{"ligand":"sirolimus","mesh_id":"D001932","phase":"Phase 2","start_date":"2006","completion_date":"2010","nct_id":"NCT01051557;NCT00329719;NCT00823459"},{"ligand":"sorafenib","mesh_id":"D001932","phase":"Phase 1","start_date":"2008","completion_date":"2012","nct_id":"NCT00639262;NCT01724606"},{"ligand":"sorafenib","mesh_id":"D001932","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT01817751;NCT00329719;NCT01434602"},{"ligand":"sunitinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT01122888;NCT00981890"},{"ligand":"sunitinib","mesh_id":"D001932","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03025893"},{"ligand":"trametinib","mesh_id":"D001932","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02974803"},{"ligand":"trastuzumab","mesh_id":"D001932","phase":"Phase 1","start_date":"2007","completion_date":"2017","nct_id":"NCT02598427;NCT00470847"},{"ligand":"trastuzumab","mesh_id":"D001932","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT03203616;NCT02000882;NCT04760431;NCT04334330;NCT01386580;NCT02048059;NCT01480583;NCT03190967;NCT04512261;NCT04158947;NCT04420598"},{"ligand":"tucatinib","mesh_id":"D001932","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431;NCT04512261"},{"ligand":"vemurafenib","mesh_id":"D001932","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03430947;NCT02230306"}],"predictions":[{"target":"ERBB3","probability":"0.5658002562042237"},{"target":"IGF1R","probability":"0.5133452451856263"},{"target":"MAP2K7","probability":"0.5100632911392405"},{"target":"FGFR1","probability":"0.4709424866320031"},{"target":"JAK2","probability":"0.4600660792951542"},{"target":"BCR","probability":"0.45529974454240246"}],"source_name":"Brain Neoplasms"}],["D014594",{"mesh_id":"D014594","trials":[{"ligand":"abemaciclib","mesh_id":"D014594","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03643510"},{"ligand":"afatinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"apatinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04239443"},{"ligand":"binimetinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"copanlisib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01130519"},{"ligand":"everolimus","mesh_id":"D014594","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03285802"},{"ligand":"imatinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00506779"},{"ligand":"lapatinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00430781"},{"ligand":"larotrectinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"osimertinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"pazopanib","mesh_id":"D014594","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00430781"},{"ligand":"pertuzumab","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"sirolimus","mesh_id":"D014594","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02646319"},{"ligand":"sunitinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trametinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D014594","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT04579380;NCT02465060"},{"ligand":"tucatinib","mesh_id":"D014594","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04579380"}],"predictions":[],"source_name":"Uterine Neoplasms"}],["D012175",{"mesh_id":"D012175","trials":[{"ligand":"abemaciclib","mesh_id":"D012175","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03130439"},{"ligand":"cetuximab","mesh_id":"D012175","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"sirolimus","mesh_id":"D012175","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01331135"},{"ligand":"trastuzumab","mesh_id":"D012175","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"}],"predictions":[],"source_name":"Retinoblastoma"}],["D018281",{"mesh_id":"D018281","trials":[{"ligand":"abemaciclib","mesh_id":"D018281","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02784795"},{"ligand":"abemaciclib","mesh_id":"D018281","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03339843"},{"ligand":"apatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03251443;NCT04642664;NCT04454905;NCT03521219"},{"ligand":"bosutinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00959946"},{"ligand":"cabozantinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01954745"},{"ligand":"ceritinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02374489;NCT02638909"},{"ligand":"cetuximab","mesh_id":"D018281","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"cetuximab","mesh_id":"D018281","phase":"Phase 2","start_date":"2010","completion_date":"2020","nct_id":"NCT03693807;NCT04668976;NCT03768375;NCT01267344;NCT01247337;NCT02836847"},{"ligand":"cobimetinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03201458"},{"ligand":"copanlisib","mesh_id":"D018281","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02631590"},{"ligand":"crizotinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02568267;NCT03768375;NCT02836847"},{"ligand":"dasatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02428855"},{"ligand":"entrectinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erdafitinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02699606"},{"ligand":"erlotinib","mesh_id":"D018281","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00266097;NCT00955149;NCT00397384;NCT00987766"},{"ligand":"erlotinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2002","completion_date":"2010","nct_id":"NCT00356889;NCT00033462;NCT00350753;NCT00832637;NCT01093222"},{"ligand":"everolimus","mesh_id":"D018281","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00949949"},{"ligand":"everolimus","mesh_id":"D018281","phase":"Phase 2","start_date":"2009","completion_date":"2016","nct_id":"NCT00973713;NCT01525719;NCT03768375;NCT02836847"},{"ligand":"gefitinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT03768375;NCT02836847"},{"ligand":"imatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT01153750"},{"ligand":"lapatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2004","completion_date":"2016","nct_id":"NCT00107536;NCT03768375;NCT02836847;NCT00101036"},{"ligand":"lenvatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2018","completion_date":"2021","nct_id":"NCT03951597;NCT03801499;NCT04506281;NCT03779100;NCT04361331;NCT03895970;NCT04527679;NCT04550624;NCT04656249"},{"ligand":"lenvatinib","mesh_id":"D018281","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04669496"},{"ligand":"nintedanib","mesh_id":"D018281","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00363584"},{"ligand":"panitumumab","mesh_id":"D018281","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT03693807;NCT01206049;NCT04668976;NCT00779454;NCT00948935;NCT01320254"},{"ligand":"pazopanib","mesh_id":"D018281","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01438554"},{"ligand":"pazopanib","mesh_id":"D018281","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01855724"},{"ligand":"pemigatinib","mesh_id":"D018281","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04088188"},{"ligand":"pemigatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02393248;NCT04256980;NCT02924376"},{"ligand":"pemigatinib","mesh_id":"D018281","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03656536"},{"ligand":"ramucirumab","mesh_id":"D018281","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03872947"},{"ligand":"ramucirumab","mesh_id":"D018281","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02520141"},{"ligand":"regorafenib","mesh_id":"D018281","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02053376;NCT02162914"},{"ligand":"selumetinib","mesh_id":"D018281","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01242605"},{"ligand":"selumetinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT01859182;NCT00553332"},{"ligand":"sirolimus","mesh_id":"D018281","phase":"Phase 1","start_date":"2009","completion_date":"2013","nct_id":"NCT01888302;NCT00949949"},{"ligand":"sorafenib","mesh_id":"D018281","phase":"Phase 2","start_date":"2005","completion_date":"2016","nct_id":"NCT00238212;NCT03768375;NCT02836847;NCT00919061;NCT01093222;NCT00955721"},{"ligand":"sunitinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01718327"},{"ligand":"tivozanib","mesh_id":"D018281","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04645160"},{"ligand":"tofacitinib","mesh_id":"D018281","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04034238"},{"ligand":"trametinib","mesh_id":"D018281","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01438554"},{"ligand":"trametinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02042443;NCT04566133"},{"ligand":"trastuzumab","mesh_id":"D018281","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D018281","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT03613168;NCT00478140;NCT02393248;NCT02999672;NCT03768375;NCT04430738;NCT02836847"},{"ligand":"tucatinib","mesh_id":"D018281","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04430738"},{"ligand":"vandetanib","mesh_id":"D018281","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00753675"}],"predictions":[{"target":"ERBB4","probability":"0.6"},{"target":"BCR","probability":"0.5750563371880052"},{"target":"AXL","probability":"0.5213590033021093"},{"target":"CCL2","probability":"0.49631578947368427"},{"target":"EPHB2","probability":"0.495"},{"target":"ZAP70","probability":"0.49"},{"target":"TGFBR1","probability":"0.48"}],"source_name":"Cholangiocarcinoma"}],["D008080",{"mesh_id":"D008080","trials":[{"ligand":"abemaciclib","mesh_id":"D008080","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02846987"},{"ligand":"everolimus","mesh_id":"D008080","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03114527"},{"ligand":"imatinib","mesh_id":"D008080","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT00400569;NCT02048371"},{"ligand":"lenvatinib","mesh_id":"D008080","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03526679"},{"ligand":"nilotinib","mesh_id":"D008080","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT02587169"},{"ligand":"olaratumab","mesh_id":"D008080","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"palbociclib","mesh_id":"D008080","phase":"Phase 2","start_date":"2010","completion_date":"2020","nct_id":"NCT04438824;NCT01209598"},{"ligand":"pazopanib","mesh_id":"D008080","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT02357810;NCT01692496;NCT01532687;NCT01506596;NCT02048371"},{"ligand":"pazopanib","mesh_id":"D008080","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"regorafenib","mesh_id":"D008080","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"ribociclib","mesh_id":"D008080","phase":"Phase 1","start_date":"2015","completion_date":"2017","nct_id":"NCT02343172;NCT03009201"},{"ligand":"ribociclib","mesh_id":"D008080","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02571829;NCT03096912;NCT03114527"},{"ligand":"sirolimus","mesh_id":"D008080","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT02821507;NCT01614795;NCT00093080;NCT03114527"},{"ligand":"sorafenib","mesh_id":"D008080","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"sunitinib","mesh_id":"D008080","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT00400569;NCT02048371"}],"predictions":[],"source_name":"Liposarcoma"}],["D009837",{"mesh_id":"D009837","trials":[{"ligand":"abemaciclib","mesh_id":"D009837","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03969706"},{"ligand":"cetuximab","mesh_id":"D009837","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01884740"},{"ligand":"dabrafenib","mesh_id":"D009837","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02684058"},{"ligand":"dabrafenib","mesh_id":"D009837","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"dasatinib","mesh_id":"D009837","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00734864"},{"ligand":"erlotinib","mesh_id":"D009837","phase":"Phase 1","start_date":"2001","completion_date":"2010","nct_id":"NCT01103375;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D009837","phase":"Phase 2","start_date":"2002","completion_date":"2005","nct_id":"NCT00112736;NCT00045110"},{"ligand":"everolimus","mesh_id":"D009837","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04135807"},{"ligand":"everolimus","mesh_id":"D009837","phase":"Phase 2","start_date":"2009","completion_date":"2018","nct_id":"NCT02023905;NCT00823459"},{"ligand":"gefitinib","mesh_id":"D009837","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042991"},{"ligand":"imatinib","mesh_id":"D009837","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00049127"},{"ligand":"lapatinib","mesh_id":"D009837","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT04135807;NCT02101905"},{"ligand":"lapatinib","mesh_id":"D009837","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095940"},{"ligand":"nintedanib","mesh_id":"D009837","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01380782"},{"ligand":"osimertinib","mesh_id":"D009837","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04135807"},{"ligand":"palbociclib","mesh_id":"D009837","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D009837","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02530320"},{"ligand":"ribociclib","mesh_id":"D009837","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"sirolimus","mesh_id":"D009837","phase":"Phase 1","start_date":"2011","completion_date":"2014","nct_id":"NCT01522820;NCT02238496;NCT01316809"},{"ligand":"sirolimus","mesh_id":"D009837","phase":"Phase 2","start_date":"2005","completion_date":"2010","nct_id":"NCT01051557;NCT00112736;NCT00823459"},{"ligand":"sorafenib","mesh_id":"D009837","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00884416;NCT00093613"},{"ligand":"sunitinib","mesh_id":"D009837","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT01462695;NCT00499473"},{"ligand":"trametinib","mesh_id":"D009837","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D009837","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02684058"},{"ligand":"trametinib","mesh_id":"D009837","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"vandetanib","mesh_id":"D009837","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00995007"}],"predictions":[{"target":"MAP2K7","probability":"0.5019412243675033"}],"source_name":"Oligodendroglioma"}],["D018269",{"mesh_id":"D018269","trials":[{"ligand":"abemaciclib","mesh_id":"D018269","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04049227"},{"ligand":"cabozantinib","mesh_id":"D018269","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01935934"},{"ligand":"copanlisib","mesh_id":"D018269","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02728258"},{"ligand":"dasatinib","mesh_id":"D018269","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01440998"},{"ligand":"erlotinib","mesh_id":"D018269","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00059787"},{"ligand":"everolimus","mesh_id":"D018269","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02283658;NCT02397083;NCT03008408"},{"ligand":"palbociclib","mesh_id":"D018269","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04498520"},{"ligand":"ribociclib","mesh_id":"D018269","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03008408"},{"ligand":"ruxolitinib","mesh_id":"D018269","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03120624"},{"ligand":"ruxolitinib","mesh_id":"D018269","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"sirolimus","mesh_id":"D018269","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02142803"},{"ligand":"sirolimus","mesh_id":"D018269","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT02283658;NCT01010126;NCT02397083;NCT03008408;NCT02093598"},{"ligand":"sunitinib","mesh_id":"D018269","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00478426"}],"predictions":[],"source_name":"Carcinoma, Endometrioid"}],["D015179",{"mesh_id":"D015179","trials":[{"ligand":"abemaciclib","mesh_id":"D015179","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02857270"},{"ligand":"abemaciclib","mesh_id":"D015179","phase":"Phase 2","start_date":"2019","completion_date":"2020","nct_id":"NCT04616183;NCT04165031"},{"ligand":"afatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00801294;NCT01152437;NCT02465060;NCT01919879;NCT02450656"},{"ligand":"alpelisib","mesh_id":"D015179","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04753203;NCT01719380"},{"ligand":"apatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT03344614;NCT03271255;NCT04067986;NCT03190616;NCT04715633;NCT04073615;NCT03193814;NCT03397199;NCT01531777;NCT03377842;NCT03132025;NCT02829385;NCT03403452;NCT03912857;NCT03210064;NCT04202978;NCT03412994"},{"ligand":"apatinib","mesh_id":"D015179","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03365765"},{"ligand":"avapritinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT04355156;NCT00460603;NCT01490866;NCT00615056;NCT01483638"},{"ligand":"binimetinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2014","completion_date":"2018","nct_id":"NCT02613650;NCT02510001;NCT03374254"},{"ligand":"binimetinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT03981614;NCT04044430;NCT03271047;NCT01927341;NCT02465060;NCT03475004;NCT03693170"},{"ligand":"binimetinib","mesh_id":"D015179","phase":"Phase 3","start_date":"2016","completion_date":"2020","nct_id":"NCT02928224;NCT03803553"},{"ligand":"cabozantinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2014","completion_date":"2019","nct_id":"NCT02008383;NCT03798626"},{"ligand":"cabozantinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03542877"},{"ligand":"cetuximab","mesh_id":"D015179","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT02205398;NCT01380600;NCT03428958;NCT03319459;NCT03356158;NCT04449874;NCT03017807;NCT00478634;NCT00403052;NCT02573220;NCT00207155;NCT01787500;NCT00436072;NCT01184482;NCT00497497;NCT02124148;NCT00719199;NCT01420874;NCT02857270;NCT00671372;NCT00501410;NCT02630420;NCT01451632;NCT00925015;NCT00593060;NCT02110082;NCT02211443;NCT03290937;NCT03491709;NCT01791309;NCT00540943"},{"ligand":"cetuximab","mesh_id":"D015179","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT00910676;NCT04787341;NCT03693807;NCT02316496;NCT03135652;NCT00541112;NCT00862342;NCT00444678;NCT02063529;NCT00020917;NCT02291289;NCT00503685;NCT04561336;NCT04031872;NCT04668976;NCT01450319;NCT00215722;NCT03751176;NCT01801904;NCT04017650;NCT00614393;NCT01276379;NCT01079780;NCT04513951;NCT04241731;NCT00755534;NCT00842257;NCT00755118;NCT00055419;NCT01326000;NCT02216487;NCT00725400;NCT02164916;NCT03563157;NCT01832467;NCT00437268;NCT00522665;NCT04587128;NCT01522612;NCT04034459;NCT00005076;NCT00309179;NCT03164655;NCT02295930;NCT00954876;NCT01540344;NCT01225744;NCT00254137;NCT00227734;NCT01668498;NCT01384994;NCT00557102;NCT03169777;NCT00778830;NCT00803647;NCT01927341;NCT02953782;NCT02083653;NCT01413295;NCT01960023;NCT00290615;NCT00422773;NCT00594984;NCT01776307;NCT03405272;NCT00271011;NCT01032291;NCT01504477;NCT00551213;NCT00743678;NCT01075048;NCT02278133;NCT01836653;NCT03608046;NCT00466505;NCT02296203;NCT03874026;NCT04495621;NCT00852228;NCT01718808;NCT01640444;NCT01703390;NCT04515394;NCT03457896;NCT02508077;NCT00784667;NCT00479752;NCT04117945;NCT01152437;NCT03470350;NCT00286130;NCT00556413;NCT01281761;NCT02404935;NCT00544349;NCT04616183;NCT00362102;NCT00689624;NCT00598975;NCT04464967;NCT02965417;NCT00125034;NCT00537823;NCT00677924;NCT03567629;NCT03206073;NCT01086267;NCT04745130;NCT01387880;NCT02717923;NCT01409005;NCT00681876;NCT00251485;NCT00202787;NCT01322178;NCT00056030;NCT01892527;NCT00538291;NCT03366155;NCT01523639;NCT01919879;NCT01008475;NCT00637091;NCT01345526;NCT00766220;NCT00531115;NCT00766142;NCT00438737;NCT02713373;NCT01652482;NCT01925274;NCT01579357;NCT00361244;NCT01068132;NCT01442935;NCT03727763;NCT00559741;NCT00326495;NCT01867697;NCT00083720;NCT03174405;NCT00660582;NCT02117466;NCT00931840;NCT01394939;NCT00545545;NCT03693170;NCT04224415;NCT04160416;NCT00640081;NCT00251186;NCT01251536;NCT01703910;NCT01161316;NCT01190462;NCT00513266;NCT00044863;NCT01719380;NCT02515734;NCT04775862;NCT01252628;NCT01004159;NCT01673607;NCT02071069;NCT01858662;NCT00321100;NCT00577109;NCT03251612;NCT03186326;NCT01442649;NCT01051167;NCT03688230;NCT01060423;NCT02826837;NCT00439517;NCT03311750;NCT02292758;NCT00020930;NCT04165031;NCT04466254"},{"ligand":"cetuximab","mesh_id":"D015179","phase":"Phase 3","start_date":"2003","completion_date":"2021","nct_id":"NCT00061815;NCT04687631;NCT01878422;NCT04607421;NCT00640471;NCT00154102;NCT03206151;NCT01001377;NCT02928224;NCT00389870;NCT01910610;NCT01338558;NCT00063141;NCT01309126;NCT02978313;NCT04776655;NCT03391934;NCT01167725;NCT00975897;NCT01030042;NCT01895257;NCT00265850;NCT02942706;NCT00252564;NCT02934529;NCT00145314;NCT03362684;NCT04262635;NCT00182715;NCT04509635;NCT03717038;NCT00433927;NCT01741038;NCT01228734;NCT04525326;NCT02563002;NCT04008030;NCT02484833;NCT00079066;NCT03803553;NCT03231722;NCT00482222;NCT00208546;NCT03426371"},{"ligand":"cetuximab","mesh_id":"D015179","phase":"Phase 4","start_date":"2006","completion_date":"2011","nct_id":"NCT00327093;NCT01564810;NCT01315990"},{"ligand":"cobimetinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02876224"},{"ligand":"cobimetinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT02291289;NCT03340558;NCT02060188"},{"ligand":"copanlisib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02510001"},{"ligand":"crizotinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D015179","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04294160"},{"ligand":"dabrafenib","mesh_id":"D015179","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT01750918;NCT03668431;NCT03428126;NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02039336"},{"ligand":"dasatinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2007","completion_date":"2019","nct_id":"NCT04164069;NCT00920868;NCT00501410"},{"ligand":"dasatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT02465060;NCT01703910"},{"ligand":"encorafenib","mesh_id":"D015179","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02857270"},{"ligand":"encorafenib","mesh_id":"D015179","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT04017650;NCT04044430;NCT02278133;NCT03693170;NCT01719380"},{"ligand":"encorafenib","mesh_id":"D015179","phase":"Phase 3","start_date":"2016","completion_date":"2020","nct_id":"NCT04607421;NCT02928224;NCT03803553"},{"ligand":"entrectinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erdafitinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2002","completion_date":"2020","nct_id":"NCT04449874;NCT00047762;NCT00118261"},{"ligand":"erlotinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2002","completion_date":"2019","nct_id":"NCT00910676;NCT02723578;NCT03086538;NCT01135498;NCT00123851;NCT00784667;NCT00049101;NCT00642746;NCT00459901;NCT01187901;NCT00940316;NCT01703910;NCT00116506;NCT01243047;NCT04165031;NCT02961374"},{"ligand":"erlotinib","mesh_id":"D015179","phase":"Phase 3","start_date":"2005","completion_date":"2010","nct_id":"NCT00265824;NCT01229813;NCT00598156"},{"ligand":"everolimus","mesh_id":"D015179","phase":"Phase 1","start_date":"2007","completion_date":"2010","nct_id":"NCT00478634;NCT01154335"},{"ligand":"everolimus","mesh_id":"D015179","phase":"Phase 2","start_date":"2006","completion_date":"2010","nct_id":"NCT01047293;NCT00337545;NCT00522665;NCT01139138;NCT00390364;NCT01058655;NCT01387880;NCT00419159"},{"ligand":"fostamatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00923481"},{"ligand":"gefitinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2001","completion_date":"2018","nct_id":"NCT03491709;NCT00026364"},{"ligand":"gefitinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2001","completion_date":"2015","nct_id":"NCT02723578;NCT00030524;NCT00233623;NCT00242788;NCT00025350;NCT00087334;NCT00026299;NCT00025142"},{"ligand":"gefitinib","mesh_id":"D015179","phase":"Phase 3","start_date":"2003","completion_date":"2003","nct_id":"NCT00234429"},{"ligand":"ibrutinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03332498"},{"ligand":"imatinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2002","completion_date":"2009","nct_id":"NCT01271166;NCT00183833;NCT00920868"},{"ligand":"imatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2008","completion_date":"2009","nct_id":"NCT00784446;NCT00867334"},{"ligand":"lapatinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2007","completion_date":"2010","nct_id":"NCT00536809;NCT01184482"},{"ligand":"lapatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2002","completion_date":"2015","nct_id":"NCT02230553;NCT03225937;NCT00044343;NCT03418558"},{"ligand":"larotrectinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D015179","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04776148"},{"ligand":"necitumumab","mesh_id":"D015179","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00835185"},{"ligand":"neratinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01960023;NCT03457896"},{"ligand":"nintedanib","mesh_id":"D015179","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT02780700;NCT00801294;NCT01362361;NCT00904839"},{"ligand":"nintedanib","mesh_id":"D015179","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02149108"},{"ligand":"osimertinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D015179","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03981614;NCT02465060"},{"ligand":"panitumumab","mesh_id":"D015179","phase":"Phase 1","start_date":"2004","completion_date":"2018","nct_id":"NCT02205398;NCT03428958;NCT00101894;NCT02199223;NCT00563316;NCT02630420;NCT00879385;NCT02008383;NCT01791309"},{"ligand":"panitumumab","mesh_id":"D015179","phase":"Phase 2","start_date":"2002","completion_date":"2021","nct_id":"NCT01508000;NCT04787341;NCT03693807;NCT03992456;NCT00630786;NCT03764137;NCT00411450;NCT01591421;NCT04031872;NCT04668976;NCT01991873;NCT03751176;NCT01801904;NCT00958386;NCT03983993;NCT01328171;NCT04425239;NCT00842257;NCT00039273;NCT00332163;NCT04587128;NCT01288339;NCT02399943;NCT02904031;NCT00327119;NCT00508404;NCT01750918;NCT01312857;NCT03164655;NCT01110785;NCT00083616;NCT02613221;NCT03227926;NCT01668498;NCT01384994;NCT03069950;NCT01927341;NCT00819780;NCT01413295;NCT01139138;NCT01776307;NCT00111761;NCT02337946;NCT01504477;NCT01358812;NCT04515394;NCT02508077;NCT01057017;NCT01215539;NCT01260415;NCT04117945;NCT01152437;NCT03470350;NCT02980510;NCT00950820;NCT01892527;NCT00867334;NCT03366155;NCT00891930;NCT00792363;NCT03263429;NCT03087071;NCT01226719;NCT03142516;NCT01418742;NCT00940316;NCT00326495;NCT01144195;NCT00788957;NCT00089635;NCT02476045;NCT03803436;NCT01704703;NCT00418938;NCT00655499;NCT03167268;NCT04775862;NCT03251612;NCT03186326;NCT01126112;NCT00885885;NCT03940131;NCT03311750;NCT00475293;NCT04169347;NCT02448810"},{"ligand":"panitumumab","mesh_id":"D015179","phase":"Phase 3","start_date":"2004","completion_date":"2018","nct_id":"NCT00339183;NCT01001377;NCT00115765;NCT00389870;NCT03635021;NCT01910610;NCT02394795;NCT00113763;NCT03300609;NCT01895257;NCT01412957;NCT02934529;NCT00364013;NCT02394834;NCT02162563;NCT02885753;NCT03231722"},{"ligand":"panitumumab","mesh_id":"D015179","phase":"Phase 4","start_date":"2015","completion_date":"2015","nct_id":"NCT02301962"},{"ligand":"pazopanib","mesh_id":"D015179","phase":"Phase 1","start_date":"2006","completion_date":"2013","nct_id":"NCT00387387;NCT02009449;NCT00540943"},{"ligand":"pemigatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04096417"},{"ligand":"pertuzumab","mesh_id":"D015179","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT02291289;NCT03225937;NCT02465060"},{"ligand":"pexidartinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02777710"},{"ligand":"ramucirumab","mesh_id":"D015179","phase":"Phase 1","start_date":"2011","completion_date":"2019","nct_id":"NCT03428958;NCT01286818;NCT03798626"},{"ligand":"ramucirumab","mesh_id":"D015179","phase":"Phase 2","start_date":"2009","completion_date":"2018","nct_id":"NCT00862784;NCT01111604;NCT03271255;NCT01079780;NCT03251612"},{"ligand":"ramucirumab","mesh_id":"D015179","phase":"Phase 3","start_date":"2010","completion_date":"2019","nct_id":"NCT03520946;NCT01183780"},{"ligand":"regorafenib","mesh_id":"D015179","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00934882;NCT03081494;NCT03712943;NCT02199223;NCT02116894;NCT04362839;NCT03305913"},{"ligand":"regorafenib","mesh_id":"D015179","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT04787341;NCT03992456;NCT02835924;NCT01896856;NCT03190616;NCT02619435;NCT03880877;NCT03215264;NCT03563157;NCT02651415;NCT03099486;NCT02402036;NCT04030260;NCT04683965;NCT04534218;NCT04450836;NCT04008511;NCT02368886;NCT01298570;NCT04660812;NCT02316340;NCT02581059;NCT03946917;NCT03843853;NCT02425683;NCT02465502;NCT02699073;NCT04117945;NCT02466009;NCT03828799;NCT03898102;NCT02195011;NCT04745130;NCT02175654;NCT03475953;NCT01875380;NCT03377361;NCT04110093;NCT03844620;NCT01289821;NCT03657641;NCT04775862;NCT02119676;NCT03555149;NCT03251612;NCT02096354;NCT04126733;NCT01949194"},{"ligand":"regorafenib","mesh_id":"D015179","phase":"Phase 3","start_date":"2010","completion_date":"2021","nct_id":"NCT01584830;NCT03829462;NCT01939223;NCT01103323;NCT02934529;NCT01189903;NCT01786538;NCT04776148;NCT01853319"},{"ligand":"regorafenib","mesh_id":"D015179","phase":"Phase 4","start_date":"2014","completion_date":"2018","nct_id":"NCT02800330;NCT03564938;NCT02287025"},{"ligand":"ribociclib","mesh_id":"D015179","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02703571"},{"ligand":"ruxolitinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT04303403"},{"ligand":"ruxolitinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02119676"},{"ligand":"selumetinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02188264"},{"ligand":"selumetinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00514761;NCT01333475;NCT01116271;NCT02450656"},{"ligand":"sirolimus","mesh_id":"D015179","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01522820;NCT01154335;NCT03203525;NCT00593060"},{"ligand":"sirolimus","mesh_id":"D015179","phase":"Phase 2","start_date":"2007","completion_date":"2021","nct_id":"NCT01047293;NCT03439462;NCT00522665;NCT04094675;NCT02423954;NCT00827684;NCT03095703;NCT01925274;NCT04230499"},{"ligand":"sorafenib","mesh_id":"D015179","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00780169;NCT00779311"},{"ligand":"sorafenib","mesh_id":"D015179","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT00989469;NCT00889343;NCT01290926;NCT01471353;NCT00839111;NCT00865709;NCT01715441;NCT00326495;NCT01703910;NCT03251612;NCT01949194"},{"ligand":"sunitinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2005","completion_date":"2008","nct_id":"NCT00631410;NCT00777478;NCT00599924"},{"ligand":"sunitinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2003","completion_date":"2015","nct_id":"NCT00961571;NCT00806663;NCT00077987;NCT00609622;NCT02465060;NCT00361244;NCT00668863"},{"ligand":"sunitinib","mesh_id":"D015179","phase":"Phase 3","start_date":"2007","completion_date":"2019","nct_id":"NCT00457691;NCT03909724"},{"ligand":"tivozanib","mesh_id":"D015179","phase":"Phase 1","start_date":"2008","completion_date":"2010","nct_id":"NCT01306630;NCT00660153"},{"ligand":"tivozanib","mesh_id":"D015179","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01478594;NCT01058655"},{"ligand":"trametinib","mesh_id":"D015179","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT04303403;NCT04294160;NCT02703571;NCT03317119;NCT03714958"},{"ligand":"trametinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT02399943;NCT01750918;NCT02230553;NCT03668431;NCT03428126;NCT02465060;NCT03087071;NCT03377361"},{"ligand":"trastuzumab","mesh_id":"D015179","phase":"Phase 1","start_date":"2018","completion_date":"2021","nct_id":"NCT03319459;NCT04704661"},{"ligand":"trastuzumab","mesh_id":"D015179","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT02291289;NCT03185988;NCT03043313;NCT00003995;NCT03225937;NCT03457896;NCT04430738;NCT04464967;NCT04744831;NCT00006015;NCT02465060;NCT03418558;NCT03384940;NCT04380012"},{"ligand":"trastuzumab","mesh_id":"D015179","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT03288987"},{"ligand":"tucatinib","mesh_id":"D015179","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03043313;NCT04430738"},{"ligand":"vandetanib","mesh_id":"D015179","phase":"Phase 1","start_date":"2005","completion_date":"2006","nct_id":"NCT00532909;NCT00499850;NCT00496509"},{"ligand":"vandetanib","mesh_id":"D015179","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00500292;NCT00454116"},{"ligand":"vemurafenib","mesh_id":"D015179","phase":"Phase 1","start_date":"2006","completion_date":"2013","nct_id":"NCT00405587;NCT01787500;NCT01791309"},{"ligand":"vemurafenib","mesh_id":"D015179","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT02291289;NCT02164916;NCT03727763"}],"predictions":[{"target":"KIT","probability":"0.865"},{"target":"IGF1R","probability":"0.865"},{"target":"PDGFRA","probability":"0.820176282051282"},{"target":"FLT4","probability":"0.74"},{"target":"SRC","probability":"0.7307025862068965"},{"target":"INSR","probability":"0.7242997635276116"},{"target":"FLT1","probability":"0.7002400491595308"},{"target":"PTK2","probability":"0.6750775862068966"},{"target":"MAP2K7","probability":"0.645708029653155"},{"target":"PTK2B","probability":"0.6400431034482759"},{"target":"BCR","probability":"0.6152676094803838"},{"target":"AKT1","probability":"0.5969341166096767"},{"target":"CCL2","probability":"0.5950412867894759"},{"target":"EPHB2","probability":"0.595"},{"target":"MAPK3","probability":"0.575"},{"target":"LYN","probability":"0.5602438867246192"},{"target":"MAPK1","probability":"0.5526263157894737"},{"target":"CDK2","probability":"0.5503271909688374"},{"target":"PRKCA","probability":"0.5451118290487527"},{"target":"CCL5","probability":"0.5351744850078284"},{"target":"RPS6KB1","probability":"0.5321689284988514"},{"target":"PLK1","probability":"0.5242935457163748"},{"target":"AXL","probability":"0.516497582870771"},{"target":"TGFBR2","probability":"0.5059538097191597"},{"target":"CDK1","probability":"0.5053947956421746"},{"target":"ACVRL1","probability":"0.5052317196757093"},{"target":"ITK","probability":"0.4957993924912199"},{"target":"CCL3","probability":"0.4952788542836277"},{"target":"STK11","probability":"0.49234550750423495"},{"target":"AVP","probability":"0.4807611465742883"},{"target":"ZAP70","probability":"0.48021963947914587"},{"target":"FYN","probability":"0.47600000000000003"},{"target":"CDKN1A","probability":"0.4703389107631733"},{"target":"PIM1","probability":"0.4661217219403965"},{"target":"EPHA2","probability":"0.46000847457627114"},{"target":"TGFBR1","probability":"0.455414259759178"}],"source_name":"Colorectal Neoplasms"}],["D012004",{"mesh_id":"D012004","trials":[{"ligand":"abemaciclib","mesh_id":"D012004","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04616183"},{"ligand":"afatinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alpelisib","mesh_id":"D012004","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02550743"},{"ligand":"binimetinib","mesh_id":"D012004","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02041481"},{"ligand":"binimetinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04044430;NCT02465060"},{"ligand":"cetuximab","mesh_id":"D012004","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT01126450;NCT00392470;NCT00134069;NCT01294826;NCT01217450;NCT00397384;NCT01198535;NCT00835679;NCT01254617;NCT04638036"},{"ligand":"cetuximab","mesh_id":"D012004","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT00336856;NCT00541112;NCT00506844;NCT00689702;NCT04017650;NCT00964457;NCT00795301;NCT03391843;NCT00845039;NCT00383695;NCT00226941;NCT00101348;NCT03365882;NCT04616183;NCT00611858;NCT00100841;NCT00353457;NCT00551421;NCT00972881;NCT00077298;NCT00686166;NCT01609231;NCT00297128;NCT03022734;NCT01923987;NCT00527111"},{"ligand":"cetuximab","mesh_id":"D012004","phase":"Phase 3","start_date":"2007","completion_date":"2020","nct_id":"NCT00499369;NCT04215731"},{"ligand":"copanlisib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D012004","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00835679"},{"ligand":"dasatinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00504153;NCT02465060"},{"ligand":"encorafenib","mesh_id":"D012004","phase":"Phase 2","start_date":"2019","completion_date":"2020","nct_id":"NCT04017650;NCT04044430"},{"ligand":"erdafitinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D012004","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00543842;NCT00060411;NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2002","completion_date":"2008","nct_id":"NCT00307736;NCT00101348;NCT00754494;NCT00032110"},{"ligand":"gefitinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00052585"},{"ligand":"imatinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00041340"},{"ligand":"larotrectinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D012004","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02935309"},{"ligand":"midostaurin","mesh_id":"D012004","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01282502"},{"ligand":"nintedanib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02393755"},{"ligand":"osimertinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D012004","phase":"Phase 2","start_date":"2009","completion_date":"2015","nct_id":"NCT02465060;NCT01037790"},{"ligand":"panitumumab","mesh_id":"D012004","phase":"Phase 2","start_date":"2006","completion_date":"2020","nct_id":"NCT01443377;NCT03992456;NCT01814501;NCT01257360;NCT03000374;NCT00819780;NCT00967655;NCT00973193;NCT00346099;NCT00788957;NCT00814619"},{"ligand":"pertuzumab","mesh_id":"D012004","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT03365882;NCT02465060;NCT00551421"},{"ligand":"regorafenib","mesh_id":"D012004","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT04362839;NCT02910843"},{"ligand":"regorafenib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT03992456;NCT04503694;NCT02287727"},{"ligand":"selumetinib","mesh_id":"D012004","phase":"Phase 1","start_date":"2010","completion_date":"2012","nct_id":"NCT01217450;NCT01160926;NCT01134601"},{"ligand":"sirolimus","mesh_id":"D012004","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00409994"},{"ligand":"sorafenib","mesh_id":"D012004","phase":"Phase 1","start_date":"2005","completion_date":"2017","nct_id":"NCT01376453;NCT01383343;NCT00134069;NCT02910843"},{"ligand":"sorafenib","mesh_id":"D012004","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00869570;NCT00826540"},{"ligand":"sunitinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2009","completion_date":"2015","nct_id":"NCT00936832;NCT02465060"},{"ligand":"trametinib","mesh_id":"D012004","phase":"Phase 1","start_date":"2012","completion_date":"2018","nct_id":"NCT01740648;NCT03317119"},{"ligand":"trametinib","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D012004","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D012004","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT03365882;NCT02465060"},{"ligand":"vandetanib","mesh_id":"D012004","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00532909"}],"predictions":[{"target":"ERBB3","probability":"0.5603258334732562"},{"target":"JAK2","probability":"0.5451358824928639"},{"target":"INSR","probability":"0.5252140567765567"},{"target":"IGF1R","probability":"0.5001098901098902"},{"target":"BCR","probability":"0.49024669542340665"}],"source_name":"Rectal Neoplasms"}],["D003110",{"mesh_id":"D003110","trials":[{"ligand":"abemaciclib","mesh_id":"D003110","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04616183"},{"ligand":"afatinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"apatinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04625803"},{"ligand":"binimetinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02041481"},{"ligand":"binimetinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04044430;NCT02465060"},{"ligand":"cetuximab","mesh_id":"D003110","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT03774680;NCT01126450;NCT00494611;NCT01287130;NCT00134069;NCT01294826;NCT01217450;NCT00397384;NCT01198535;NCT00835679;NCT01637194;NCT01420874;NCT01254617"},{"ligand":"cetuximab","mesh_id":"D003110","phase":"Phase 2","start_date":"2003","completion_date":"2021","nct_id":"NCT00336856;NCT01675999;NCT00845039;NCT00101348;NCT03365882;NCT04616183;NCT00193219;NCT01744340;NCT03446157;NCT00100841;NCT00551421;NCT00766220;NCT00077298;NCT03641976;NCT04775862;NCT01292356;NCT03524820"},{"ligand":"cetuximab","mesh_id":"D003110","phase":"Phase 3","start_date":"2004","completion_date":"2010","nct_id":"NCT00647530;NCT00499369;NCT01167725;NCT00079274;NCT00265811"},{"ligand":"copanlisib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03711058;NCT02465060"},{"ligand":"crizotinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03428126;NCT02465060"},{"ligand":"dasatinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00835679"},{"ligand":"dasatinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00504153;NCT02465060"},{"ligand":"encorafenib","mesh_id":"D003110","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04044430"},{"ligand":"erdafitinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00600496;NCT00060411;NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2002","completion_date":"2008","nct_id":"NCT00101348;NCT00754494;NCT00032110"},{"ligand":"everolimus","mesh_id":"D003110","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"everolimus","mesh_id":"D003110","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01149434"},{"ligand":"gefitinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00052585"},{"ligand":"imatinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00183833"},{"ligand":"imatinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2002","completion_date":"2016","nct_id":"NCT00041340;NCT02685046"},{"ligand":"larotrectinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"nilotinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02774512"},{"ligand":"nintedanib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02393755"},{"ligand":"osimertinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D003110","phase":"Phase 2","start_date":"2009","completion_date":"2018","nct_id":"NCT03446157;NCT02465060;NCT01037790"},{"ligand":"panitumumab","mesh_id":"D003110","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT03992456;NCT01814501;NCT00332163;NCT00819780;NCT01108107;NCT00788957;NCT04775862;NCT03442569"},{"ligand":"panitumumab","mesh_id":"D003110","phase":"Phase 3","start_date":"2008","completion_date":"2017","nct_id":"NCT00647530;NCT04342676"},{"ligand":"panitumumab","mesh_id":"D003110","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT02015923"},{"ligand":"pazopanib","mesh_id":"D003110","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT01012362"},{"ligand":"pertuzumab","mesh_id":"D003110","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT03365882;NCT02465060;NCT00551421"},{"ligand":"regorafenib","mesh_id":"D003110","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03712943;NCT04362839"},{"ligand":"regorafenib","mesh_id":"D003110","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT03992456;NCT04775862"},{"ligand":"regorafenib","mesh_id":"D003110","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02664077"},{"ligand":"selumetinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2007","completion_date":"2012","nct_id":"NCT00600496;NCT01287130;NCT01217450"},{"ligand":"sirolimus","mesh_id":"D003110","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00600496;NCT01637194"},{"ligand":"sirolimus","mesh_id":"D003110","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01149434"},{"ligand":"sorafenib","mesh_id":"D003110","phase":"Phase 1","start_date":"2005","completion_date":"2011","nct_id":"NCT01383343;NCT00134069"},{"ligand":"sorafenib","mesh_id":"D003110","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00826540"},{"ligand":"sunitinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trametinib","mesh_id":"D003110","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03317119"},{"ligand":"trametinib","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03428126;NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D003110","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D003110","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT03365882;NCT02465060"}],"predictions":[{"target":"PDGFRB","probability":"0.81"},{"target":"KDR","probability":"0.6657425213675213"},{"target":"ERBB3","probability":"0.6601367942664647"},{"target":"IGF1R","probability":"0.6065692040573174"},{"target":"RET","probability":"0.5960529387351048"},{"target":"BCR","probability":"0.5766666666666667"},{"target":"INSR","probability":"0.5610162556791106"},{"target":"JAK2","probability":"0.5408201172569655"},{"target":"ZAP70","probability":"0.5205772448410485"},{"target":"EPHB2","probability":"0.4935904452597652"},{"target":"SRC","probability":"0.4707562962816344"}],"source_name":"Colonic Neoplasms"}],["D013964",{"mesh_id":"D013964","trials":[{"ligand":"abemaciclib","mesh_id":"D013964","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04552769"},{"ligand":"afatinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alectinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03131206"},{"ligand":"apatinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT02731352;NCT04180007;NCT04612894;NCT03300765;NCT04560127;NCT03167385;NCT03199677"},{"ligand":"apatinib","mesh_id":"D013964","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT03048877"},{"ligand":"axitinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00094055;NCT00176748;NCT00389441"},{"ligand":"binimetinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04061980;NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT04514484;NCT01100619;NCT00215605;NCT01709435"},{"ligand":"cabozantinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03838692;NCT02041260;NCT03170960;NCT02867592;NCT03914300;NCT01838642;NCT01811212;NCT03630120;NCT03866382"},{"ligand":"cabozantinib","mesh_id":"D013964","phase":"Phase 3","start_date":"2008","completion_date":"2021","nct_id":"NCT03690388;NCT00704730;NCT04760288;NCT04211337"},{"ligand":"cabozantinib","mesh_id":"D013964","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT01896479"},{"ligand":"ceritinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02289144"},{"ligand":"cetuximab","mesh_id":"D013964","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"cobimetinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03181100"},{"ligand":"copanlisib","mesh_id":"D013964","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04462471"},{"ligand":"copanlisib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D013964","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT03975231;NCT01947023"},{"ligand":"dabrafenib","mesh_id":"D013964","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04238624;NCT01723202;NCT04675710;NCT03244956;NCT04544111;NCT04739566;NCT04619316;NCT02465060;NCT04554680"},{"ligand":"dasatinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"encorafenib","mesh_id":"D013964","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04061980"},{"ligand":"entrectinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erdafitinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00405405"},{"ligand":"everolimus","mesh_id":"D013964","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT01270321;NCT01263951;NCT03139747;NCT01141309;NCT01164176;NCT01118065;NCT02143726;NCT01625520;NCT00936858"},{"ligand":"gefitinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00095836"},{"ligand":"imatinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03469011"},{"ligand":"imatinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00354523;NCT00115739"},{"ligand":"lapatinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01947023"},{"ligand":"larotrectinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"},{"ligand":"lenvatinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT04321954;NCT04731740;NCT02702388;NCT01728623;NCT02726503;NCT03139747;NCT03914300;NCT03732495;NCT02432274;NCT00784303;NCT03630120;NCT04171622;NCT03506048;NCT02973997;NCT02657369"},{"ligand":"lenvatinib","mesh_id":"D013964","phase":"Phase 3","start_date":"2011","completion_date":"2017","nct_id":"NCT01321554;NCT03048877;NCT02966093"},{"ligand":"lenvatinib","mesh_id":"D013964","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03573960"},{"ligand":"nintedanib","mesh_id":"D013964","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01788982"},{"ligand":"osimertinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"pazopanib","mesh_id":"D013964","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01413113;NCT01438554"},{"ligand":"pazopanib","mesh_id":"D013964","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT01813136;NCT00625846;NCT01236547"},{"ligand":"pertuzumab","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ponatinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03838692;NCT01838642"},{"ligand":"regorafenib","mesh_id":"D013964","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT03475953;NCT02657551"},{"ligand":"selumetinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03162627"},{"ligand":"selumetinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00559949;NCT02393690"},{"ligand":"selumetinib","mesh_id":"D013964","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01843062"},{"ligand":"sirolimus","mesh_id":"D013964","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"sirolimus","mesh_id":"D013964","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT03099356;NCT03139747;NCT01141309;NCT01025453"},{"ligand":"sorafenib","mesh_id":"D013964","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT03565536;NCT00654238;NCT00126568;NCT01263951;NCT01502410;NCT01141309;NCT02114658;NCT03914300;NCT02143726;NCT00095693;NCT03630120;NCT02084732;NCT01025453;NCT01736878;NCT00887107;NCT00390325;NCT00936858"},{"ligand":"sorafenib","mesh_id":"D013964","phase":"Phase 3","start_date":"2009","completion_date":"2016","nct_id":"NCT03048877;NCT00984282"},{"ligand":"sunitinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00381641;NCT00510640;NCT00668811;NCT02465060;NCT00519896"},{"ligand":"trametinib","mesh_id":"D013964","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT03975231;NCT03085056;NCT01438554"},{"ligand":"trametinib","mesh_id":"D013964","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04238624;NCT01723202;NCT04675710;NCT03244956;NCT04544111;NCT04739566;NCT04619316;NCT02152995;NCT02465060;NCT04554680"},{"ligand":"trastuzumab","mesh_id":"D013964","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D013964","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"vandetanib","mesh_id":"D013964","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01539655"},{"ligand":"vandetanib","mesh_id":"D013964","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT01661179;NCT03838692;NCT00537095;NCT00923247;NCT00098345;NCT01838642;NCT03630120;NCT00514046;NCT00358956"},{"ligand":"vandetanib","mesh_id":"D013964","phase":"Phase 3","start_date":"2006","completion_date":"2021","nct_id":"NCT01876784;NCT00410761;NCT04760288;NCT04211337;NCT01298323"},{"ligand":"vandetanib","mesh_id":"D013964","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT01496313"},{"ligand":"vemurafenib","mesh_id":"D013964","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT04462471;NCT02456701"},{"ligand":"vemurafenib","mesh_id":"D013964","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT01709292;NCT01286753;NCT03181100"}],"predictions":[{"target":"JAK2","probability":"0.782"},{"target":"ERBB3","probability":"0.75"},{"target":"BCR","probability":"0.7250047915668424"},{"target":"MAP2K7","probability":"0.6151228070175438"},{"target":"JAK1","probability":"0.557195045102958"},{"target":"PTK2","probability":"0.5452222605091274"},{"target":"SRC","probability":"0.5451583309962295"},{"target":"BTK","probability":"0.5300806396246626"},{"target":"AKT1","probability":"0.4705861581920904"},{"target":"ZAP70","probability":"0.4701878947671514"},{"target":"MAPK1","probability":"0.4676347188698369"},{"target":"CCL2","probability":"0.4600520176606049"},{"target":"SYK","probability":"0.4571939897167045"},{"target":"TGFBR2","probability":"0.4557761682803334"},{"target":"CDKN1A","probability":"0.4552976151621398"}],"source_name":"Thyroid Neoplasms"}],["D065646",{"mesh_id":"D065646","trials":[{"ligand":"abemaciclib","mesh_id":"D065646","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04552769"},{"ligand":"cabozantinib","mesh_id":"D065646","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04400474"},{"ligand":"ceritinib","mesh_id":"D065646","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02289144"},{"ligand":"cobimetinib","mesh_id":"D065646","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03181100"},{"ligand":"dabrafenib","mesh_id":"D065646","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03975231"},{"ligand":"dabrafenib","mesh_id":"D065646","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04238624;NCT04675710;NCT04739566"},{"ligand":"lenvatinib","mesh_id":"D065646","phase":"Phase 2","start_date":"2016","completion_date":"2021","nct_id":"NCT04731740;NCT02726503;NCT04171622;NCT02657369"},{"ligand":"pazopanib","mesh_id":"D065646","phase":"Phase 2","start_date":"2008","completion_date":"2010","nct_id":"NCT00625846;NCT01236547"},{"ligand":"sorafenib","mesh_id":"D065646","phase":"Phase 2","start_date":"2004","completion_date":"2018","nct_id":"NCT03565536;NCT00654238;NCT00126568;NCT00095693"},{"ligand":"trametinib","mesh_id":"D065646","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03975231;NCT03085056"},{"ligand":"trametinib","mesh_id":"D065646","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04238624;NCT04675710;NCT04739566"},{"ligand":"trastuzumab","mesh_id":"D065646","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vemurafenib","mesh_id":"D065646","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03181100"}],"predictions":[{"target":"EGFR","probability":"0.4804836127701881"}],"source_name":"Thyroid Carcinoma, Anaplastic"}],["D018284",{"mesh_id":"D018284","trials":[{"ligand":"abemaciclib","mesh_id":"D018284","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04633239"},{"ligand":"abemaciclib","mesh_id":"D018284","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03531645"},{"ligand":"afatinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02491099"},{"ligand":"cabozantinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01935934"},{"ligand":"copanlisib","mesh_id":"D018284","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03586661"},{"ligand":"copanlisib","mesh_id":"D018284","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02728258"},{"ligand":"dasatinib","mesh_id":"D018284","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01440998"},{"ligand":"erlotinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00059787"},{"ligand":"everolimus","mesh_id":"D018284","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02283658"},{"ligand":"everolimus","mesh_id":"D018284","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03285802"},{"ligand":"imatinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00506779"},{"ligand":"nintedanib","mesh_id":"D018284","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01225887"},{"ligand":"palbociclib","mesh_id":"D018284","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03531645"},{"ligand":"ribociclib","mesh_id":"D018284","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03673124"},{"ligand":"ruxolitinib","mesh_id":"D018284","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03120624"},{"ligand":"ruxolitinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"selumetinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00551070"},{"ligand":"sirolimus","mesh_id":"D018284","phase":"Phase 1","start_date":"2010","completion_date":"2014","nct_id":"NCT01198184;NCT02142803"},{"ligand":"sirolimus","mesh_id":"D018284","phase":"Phase 2","start_date":"2004","completion_date":"2014","nct_id":"NCT02283658;NCT01010126;NCT00977574;NCT00072176"},{"ligand":"sunitinib","mesh_id":"D018284","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00478426"},{"ligand":"trametinib","mesh_id":"D018284","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01935973"},{"ligand":"trametinib","mesh_id":"D018284","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02101788"},{"ligand":"trastuzumab","mesh_id":"D018284","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04585958"}],"predictions":[],"source_name":"Cystadenocarcinoma, Serous"}],["D005833",{"mesh_id":"D005833","trials":[{"ligand":"abemaciclib","mesh_id":"D005833","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03531645"},{"ligand":"cetuximab","mesh_id":"D005833","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"lenvatinib","mesh_id":"D005833","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"},{"ligand":"lenvatinib","mesh_id":"D005833","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04519151"},{"ligand":"nintedanib","mesh_id":"D005833","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT02182245"},{"ligand":"palbociclib","mesh_id":"D005833","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03531645"},{"ligand":"pazopanib","mesh_id":"D005833","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00800345"},{"ligand":"selumetinib","mesh_id":"D005833","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03162627"},{"ligand":"sirolimus","mesh_id":"D005833","phase":"Phase 1","start_date":"2007","completion_date":"2012","nct_id":"NCT00523432;NCT01552434"}],"predictions":[{"target":"ABL1","probability":"0.6952325581395349"}],"source_name":"Genital Neoplasms, Female"}],["D016609",{"mesh_id":"D016609","trials":[{"ligand":"abemaciclib","mesh_id":"D016609","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02919696"},{"ligand":"afatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT04148898;NCT02142036;NCT04158947"},{"ligand":"afatinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"alectinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"apatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03356600;NCT03913182"},{"ligand":"apatinib","mesh_id":"D016609","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02702323"},{"ligand":"binimetinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03911869"},{"ligand":"brigatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03868423"},{"ligand":"cabozantinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02132598"},{"ligand":"cabozantinib","mesh_id":"D016609","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03793166"},{"ligand":"ceritinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"cetuximab","mesh_id":"D016609","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT03135652;NCT01511146;NCT02142036;NCT00743678;NCT01836653;NCT00852228;NCT01923987"},{"ligand":"cetuximab","mesh_id":"D016609","phase":"Phase 3","start_date":"2016","completion_date":"2021","nct_id":"NCT04687631;NCT03031444;NCT04509635;NCT04525326"},{"ligand":"cetuximab","mesh_id":"D016609","phase":"Phase 4","start_date":"2006","completion_date":"2006","nct_id":"NCT00327093"},{"ligand":"crizotinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2019","nct_id":"NCT02142036;NCT04193007"},{"ligand":"crizotinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"dabrafenib","mesh_id":"D016609","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03332589"},{"ligand":"dabrafenib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"dasatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT00566618;NCT02142036"},{"ligand":"encorafenib","mesh_id":"D016609","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03911869"},{"ligand":"erlotinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01578668;NCT01763385;NCT02250846;NCT04148898;NCT02142036;NCT04193007"},{"ligand":"erlotinib","mesh_id":"D016609","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03653546"},{"ligand":"erlotinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"everolimus","mesh_id":"D016609","phase":"Phase 2","start_date":"2012","completion_date":"2014","nct_id":"NCT02142036;NCT01678664"},{"ligand":"gefitinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2007","completion_date":"2019","nct_id":"NCT04148898;NCT02142036;NCT00614809;NCT04193007"},{"ligand":"gefitinib","mesh_id":"D016609","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03653546"},{"ligand":"icotinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03754530"},{"ligand":"icotinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02283424"},{"ligand":"imatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"lapatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2010","completion_date":"2014","nct_id":"NCT01218529;NCT02142036;NCT01934894"},{"ligand":"lenvatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04729348"},{"ligand":"neratinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431"},{"ligand":"nilotinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"osimertinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04148898;NCT04425681;NCT04233021"},{"ligand":"osimertinib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"panitumumab","mesh_id":"D016609","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01508000;NCT04034173;NCT02142036;NCT01260415;NCT03803436"},{"ligand":"panitumumab","mesh_id":"D016609","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02162563"},{"ligand":"panitumumab","mesh_id":"D016609","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT02015923"},{"ligand":"pertuzumab","mesh_id":"D016609","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02598427"},{"ligand":"pertuzumab","mesh_id":"D016609","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431"},{"ligand":"ruxolitinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"sirolimus","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"sorafenib","mesh_id":"D016609","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00639262"},{"ligand":"sorafenib","mesh_id":"D016609","phase":"Phase 2","start_date":"2008","completion_date":"2015","nct_id":"NCT02311205;NCT01953406;NCT00892424"},{"ligand":"sunitinib","mesh_id":"D016609","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00981890"},{"ligand":"sunitinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"trastuzumab","mesh_id":"D016609","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02598427"},{"ligand":"trastuzumab","mesh_id":"D016609","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT04760431;NCT02142036;NCT01387295;NCT01386580;NCT02048059;NCT01480583;NCT03190967;NCT01387373;NCT04158947;NCT04420598"},{"ligand":"trastuzumab","mesh_id":"D016609","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02158988"},{"ligand":"tucatinib","mesh_id":"D016609","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04760431"},{"ligand":"vandetanib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"vemurafenib","mesh_id":"D016609","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02142036"},{"ligand":"vemurafenib","mesh_id":"D016609","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"}],"predictions":[{"target":"ERBB3","probability":"0.8261629892573262"},{"target":"PDGFRA","probability":"0.730702597912015"},{"target":"FGFR1","probability":"0.7155050604608306"},{"target":"FLT1","probability":"0.6462153802303018"},{"target":"OBSCN","probability":"0.6316751412429378"},{"target":"AMHR2","probability":"0.6264302325581395"},{"target":"NTRK1","probability":"0.6014539824282507"},{"target":"CDK18","probability":"0.585"},{"target":"DYRK4","probability":"0.5715555555555556"},{"target":"PRKG2","probability":"0.5618927769619014"},{"target":"STK33","probability":"0.5605"},{"target":"TEK","probability":"0.5561315806615847"},{"target":"CASK","probability":"0.5556551353802802"},{"target":"MAPKAPK5","probability":"0.5452588147861352"},{"target":"CCNK","probability":"0.5440030450669915"},{"target":"FGFR2","probability":"0.5361277412049398"},{"target":"FRK","probability":"0.5356328440575752"},{"target":"TRIM24","probability":"0.5310852661535058"},{"target":"MAPK15","probability":"0.529"},{"target":"EPHA5","probability":"0.5289346501986368"},{"target":"EPHA6","probability":"0.5187907361455748"},{"target":"TRPM6","probability":"0.5167216117216117"},{"target":"PIK3CA","probability":"0.5154912283385377"},{"target":"FER","probability":"0.5119978057120685"},{"target":"NEK9","probability":"0.5117021906453523"},{"target":"CILK1","probability":"0.5105168947971145"},{"target":"LMTK2","probability":"0.51"},{"target":"MOK","probability":"0.5045938265214472"},{"target":"CLK2","probability":"0.5002003802175959"},{"target":"NEK1","probability":"0.49823893092052335"},{"target":"STK25","probability":"0.49722222222222223"},{"target":"PKDCC","probability":"0.4955700483091788"},{"target":"NEK4","probability":"0.495"},{"target":"MAPK4","probability":"0.495"},{"target":"FLT4","probability":"0.4940498501912806"},{"target":"ACVR2B","probability":"0.49355035542884323"},{"target":"KSR2","probability":"0.490558600622547"},{"target":"PRKD2","probability":"0.485"},{"target":"CSNK1E","probability":"0.48111174782074473"},{"target":"TNIK","probability":"0.48070367291832583"},{"target":"MAPKAPK3","probability":"0.4798991546491176"},{"target":"NTRK3","probability":"0.4773169098997523"},{"target":"LTK","probability":"0.47679166666666667"},{"target":"PRKACG","probability":"0.47600000000000003"},{"target":"LIMK2","probability":"0.4756729218605711"},{"target":"PKN2","probability":"0.47505856146378117"},{"target":"CAMK1G","probability":"0.4750144927536232"},{"target":"MARK3","probability":"0.47108757824780817"},{"target":"SRMS","probability":"0.47057004830917876"},{"target":"WNK3","probability":"0.4700355239786856"},{"target":"NTRK2","probability":"0.4680132077145294"},{"target":"CDK16","probability":"0.465625"},{"target":"RYK","probability":"0.4655196253345227"},{"target":"MAP3K10","probability":"0.46512406947890816"},{"target":"CAMK1D","probability":"0.46505494505494505"},{"target":"TP53RK","probability":"0.465"},{"target":"STK26","probability":"0.46170219064535223"},{"target":"CAMKV","probability":"0.46057004830917875"},{"target":"SGK2","probability":"0.4605268456375839"},{"target":"EPHA10","probability":"0.46049999999999996"},{"target":"MAP4K1","probability":"0.4603552060491932"},{"target":"TXK","probability":"0.4588285185539551"},{"target":"EPHB2","probability":"0.4580365778640957"},{"target":"PAN3","probability":"0.4565555555555556"},{"target":"ATP23","probability":"0.45557004830917874"},{"target":"CAMK2A","probability":"0.45538827838827833"}],"source_name":"Neoplasms, Second Primary"}],["D055752",{"mesh_id":"D055752","trials":[{"ligand":"abemaciclib","mesh_id":"D055752","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04010357"},{"ligand":"afatinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02876081"},{"ligand":"apatinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2016","completion_date":"2021","nct_id":"NCT03547804;NCT03135977;NCT03417895;NCT02945852;NCT04128800;NCT04683198;NCT04453930;NCT02995187;NCT02980809;NCT03389087;NCT04659785;NCT03129698"},{"ligand":"apatinib","mesh_id":"D055752","phase":"Phase 3","start_date":"2016","completion_date":"2020","nct_id":"NCT02875457;NCT03100955;NCT04490421;NCT03651219"},{"ligand":"cabozantinib","mesh_id":"D055752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484"},{"ligand":"cetuximab","mesh_id":"D055752","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00104910"},{"ligand":"cetuximab","mesh_id":"D055752","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"dasatinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00470054"},{"ligand":"erlotinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT02876081;NCT02352948;NCT01306045"},{"ligand":"erlotinib","mesh_id":"D055752","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03890055"},{"ligand":"everolimus","mesh_id":"D055752","phase":"Phase 1","start_date":"2007","completion_date":"2009","nct_id":"NCT01079481;NCT00807755;NCT00466466"},{"ligand":"everolimus","mesh_id":"D055752","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00374140"},{"ligand":"gefitinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00298688;NCT02876081"},{"ligand":"gefitinib","mesh_id":"D055752","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT01720901"},{"ligand":"icotinib","mesh_id":"D055752","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT01720901"},{"ligand":"imatinib","mesh_id":"D055752","phase":"Phase 1","start_date":"2002","completion_date":"2003","nct_id":"NCT00052494;NCT00045604"},{"ligand":"imatinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2002","completion_date":"2003","nct_id":"NCT00248482;NCT00156286;NCT00052949"},{"ligand":"lapatinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306045"},{"ligand":"nintedanib","mesh_id":"D055752","phase":"Phase 2","start_date":"2011","completion_date":"2014","nct_id":"NCT01441297;NCT02152059"},{"ligand":"palbociclib","mesh_id":"D055752","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04553133"},{"ligand":"panitumumab","mesh_id":"D055752","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"pazopanib","mesh_id":"D055752","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01253369;NCT01797874;NCT01713296;NCT01392352;NCT01313663"},{"ligand":"pertuzumab","mesh_id":"D055752","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"},{"ligand":"ponatinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01935336"},{"ligand":"regorafenib","mesh_id":"D055752","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01187615"},{"ligand":"regorafenib","mesh_id":"D055752","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"selumetinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306045"},{"ligand":"sirolimus","mesh_id":"D055752","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155258"},{"ligand":"sirolimus","mesh_id":"D055752","phase":"Phase 2","start_date":"2002","completion_date":"2012","nct_id":"NCT01737502;NCT00028028"},{"ligand":"sorafenib","mesh_id":"D055752","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00466232"},{"ligand":"sorafenib","mesh_id":"D055752","phase":"Phase 2","start_date":"2005","completion_date":"2010","nct_id":"NCT01159327;NCT00182689;NCT00726986"},{"ligand":"sunitinib","mesh_id":"D055752","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT00620347;NCT00953459;NCT00616109;NCT00453154;NCT00695292;NCT01306045"},{"ligand":"trastuzumab","mesh_id":"D055752","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00028535"},{"ligand":"trastuzumab","mesh_id":"D055752","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"},{"ligand":"vandetanib","mesh_id":"D055752","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00066313"}],"predictions":[{"target":"INSR","probability":"0.6332911906241965"},{"target":"IGF1R","probability":"0.5954736600833065"},{"target":"JAK2","probability":"0.5952725981575793"},{"target":"LRRK1","probability":"0.5891783041470291"},{"target":"BCR","probability":"0.5863066211040596"},{"target":"ERBB3","probability":"0.5769485834314358"},{"target":"PIK3CA","probability":"0.5706635801009079"},{"target":"PDIK1L","probability":"0.5572353768158901"},{"target":"FGFR3","probability":"0.5515482233939815"},{"target":"FGFR1","probability":"0.5323688169840997"},{"target":"AMHR2","probability":"0.5253097937365235"},{"target":"CCNK","probability":"0.5142220917917355"},{"target":"PRKACB","probability":"0.5119422315092944"},{"target":"OBSCN","probability":"0.5107875365499244"},{"target":"CASK","probability":"0.4711037795721394"},{"target":"FAM20C","probability":"0.469178304147029"},{"target":"FGFR2","probability":"0.4620227089015507"},{"target":"MAP4K3","probability":"0.46194223150929437"},{"target":"CLK3","probability":"0.4602631578947369"},{"target":"PRKD2","probability":"0.4569706810114281"}],"source_name":"Small Cell Lung Carcinoma"}],["D012509",{"mesh_id":"D012509","trials":[{"ligand":"abemaciclib","mesh_id":"D012509","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02784795"},{"ligand":"abemaciclib","mesh_id":"D012509","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04040205"},{"ligand":"apatinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04074564"},{"ligand":"apatinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03711279;NCT04126993;NCT03064243;NCT03539172;NCT04072042;NCT04012827;NCT04126811;NCT03121846;NCT04447274;NCT03104335;NCT03163381;NCT04239443"},{"ligand":"avapritinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT03056599"},{"ligand":"avapritinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2010","completion_date":"2016","nct_id":"NCT02636725;NCT01140737"},{"ligand":"cabozantinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484;NCT04661852"},{"ligand":"cabozantinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT01755195;NCT04551430;NCT04200443;NCT02867592;NCT04220229;NCT01979393;NCT02243605"},{"ligand":"ceritinib","mesh_id":"D012509","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03784014"},{"ligand":"cetuximab","mesh_id":"D012509","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT01552434;NCT00622674;NCT03618381;NCT04483778"},{"ligand":"cetuximab","mesh_id":"D012509","phase":"Phase 2","start_date":"2005","completion_date":"2021","nct_id":"NCT04464967;NCT00148109"},{"ligand":"cobimetinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04216953"},{"ligand":"crizotinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT02568267;NCT01524926"},{"ligand":"dabrafenib","mesh_id":"D012509","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03784014"},{"ligand":"dasatinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2012","completion_date":"2013","nct_id":"NCT01643278;NCT01916135"},{"ligand":"dasatinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00464620;NCT00788125"},{"ligand":"entrectinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT03056599"},{"ligand":"entrectinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erdafitinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"erlotinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00068367"},{"ligand":"everolimus","mesh_id":"D012509","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00187174;NCT00927966;NCT04199026"},{"ligand":"everolimus","mesh_id":"D012509","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT01412515;NCT01281865;NCT01661283;NCT01216839;NCT01830153;NCT01048723;NCT00767819;NCT03114527"},{"ligand":"gefitinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00052754"},{"ligand":"imatinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2000","completion_date":"2019","nct_id":"NCT01281865;NCT00062205;NCT00085475;NCT00084630;NCT00006357;NCT00117299;NCT00385203;NCT04138381;NCT00031915;NCT00767819;NCT00400569;NCT00090987;NCT00359333;NCT00030667;NCT02048371"},{"ligand":"imatinib","mesh_id":"D012509","phase":"Phase 3","start_date":"2004","completion_date":"2015","nct_id":"NCT02413736;NCT00116935"},{"ligand":"lapatinib","mesh_id":"D012509","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03784014"},{"ligand":"larotrectinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT03056599"},{"ligand":"larotrectinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"lenvatinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2018","completion_date":"2021","nct_id":"NCT03526679;NCT04784247"},{"ligand":"nilotinib","mesh_id":"D012509","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03784014"},{"ligand":"nintedanib","mesh_id":"D012509","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02808247"},{"ligand":"olaratumab","mesh_id":"D012509","phase":"Phase 1","start_date":"2015","completion_date":"2018","nct_id":"NCT02326025;NCT02783599;NCT03056599;NCT03283696;NCT03126591;NCT03985722"},{"ligand":"olaratumab","mesh_id":"D012509","phase":"Phase 2","start_date":"2010","completion_date":"2018","nct_id":"NCT02584309;NCT01185964;NCT03698227;NCT02659020"},{"ligand":"olaratumab","mesh_id":"D012509","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02451943"},{"ligand":"palbociclib","mesh_id":"D012509","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT04129151;NCT03526250;NCT03242382;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D012509","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03784014"},{"ligand":"panitumumab","mesh_id":"D012509","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02192541"},{"ligand":"pazopanib","mesh_id":"D012509","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT01130623;NCT03139331;NCT00929903;NCT01985295;NCT04199026;NCT01438554;NCT01012362;NCT02795819;NCT01468922"},{"ligand":"pazopanib","mesh_id":"D012509","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT01755195;NCT02357810;NCT02300545;NCT01861951;NCT02367651;NCT01462630;NCT01418001;NCT01719302;NCT02601209;NCT01391962;NCT03798106;NCT01532687;NCT02207309;NCT03149120;NCT03660930;NCT02575066;NCT02113826;NCT01543802;NCT04605770;NCT01392352;NCT01900743;NCT01975519;NCT00297258;NCT01593748;NCT02048371"},{"ligand":"pazopanib","mesh_id":"D012509","phase":"Phase 3","start_date":"2008","completion_date":"2021","nct_id":"NCT04741438;NCT00753688;NCT02180867;NCT02049905"},{"ligand":"pazopanib","mesh_id":"D012509","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03735758"},{"ligand":"ramucirumab","mesh_id":"D012509","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00428272"},{"ligand":"ramucirumab","mesh_id":"D012509","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04145700"},{"ligand":"regorafenib","mesh_id":"D012509","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT02048722;NCT04698785;NCT03475953;NCT02389244;NCT01900743;NCT03793361;NCT02048371"},{"ligand":"ribociclib","mesh_id":"D012509","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"ribociclib","mesh_id":"D012509","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT02571829;NCT03096912;NCT03114527"},{"ligand":"selumetinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT01206140;NCT03155620;NCT01752569"},{"ligand":"sirolimus","mesh_id":"D012509","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT01552434;NCT01331135;NCT00450320;NCT04199026;NCT01548482;NCT01155258;NCT00288431;NCT04185883;NCT00996346;NCT01204450"},{"ligand":"sirolimus","mesh_id":"D012509","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT01842594;NCT01412515;NCT01281865;NCT03190174;NCT01222715;NCT00087074;NCT00743509;NCT01661283;NCT01614795;NCT02584647;NCT03213678;NCT02008877;NCT01206140;NCT03660930;NCT00043979;NCT03778996;NCT00357396;NCT02987959;NCT00093080;NCT00949325;NCT03155620;NCT01010672;NCT01016015;NCT03114527;NCT01946529;NCT01684449"},{"ligand":"sirolimus","mesh_id":"D012509","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00538239"},{"ligand":"sorafenib","mesh_id":"D012509","phase":"Phase 1","start_date":"2006","completion_date":"2011","nct_id":"NCT00287495;NCT01518413;NCT00822848;NCT01005797"},{"ligand":"sorafenib","mesh_id":"D012509","phase":"Phase 2","start_date":"2005","completion_date":"2014","nct_id":"NCT00541840;NCT00245102;NCT00874874;NCT00217620;NCT01391962;NCT00406601;NCT00864032;NCT00880542;NCT00837148;NCT00330421;NCT02050919;NCT00238121;NCT01946529;NCT02048371"},{"ligand":"sunitinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2011","completion_date":"2012","nct_id":"NCT01498835;NCT01308034"},{"ligand":"sunitinib","mesh_id":"D012509","phase":"Phase 2","start_date":"2006","completion_date":"2019","nct_id":"NCT01391962;NCT00753727;NCT00521092;NCT03641326;NCT03277924;NCT00474994;NCT02113826;NCT00767819;NCT00400569;NCT00859456;NCT02048371"},{"ligand":"tivozanib","mesh_id":"D012509","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01782313"},{"ligand":"trametinib","mesh_id":"D012509","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01438554"},{"ligand":"trametinib","mesh_id":"D012509","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03784014"},{"ligand":"trastuzumab","mesh_id":"D012509","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D012509","phase":"Phase 2","start_date":"2005","completion_date":"2021","nct_id":"NCT00104949;NCT02452554;NCT04464967"},{"ligand":"vemurafenib","mesh_id":"D012509","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"ERBB3","probability":"0.758421679197995"},{"target":"ERBB4","probability":"0.6202899515738499"},{"target":"JAK2","probability":"0.5841666666666667"},{"target":"MAP2K7","probability":"0.5744209039548023"},{"target":"PTK2","probability":"0.5736232849071833"},{"target":"BCR","probability":"0.5621877192982456"},{"target":"JAK1","probability":"0.5336752899197146"},{"target":"EPHB2","probability":"0.5067542372881355"},{"target":"PIK3CD","probability":"0.4888816882685278"},{"target":"SRC","probability":"0.48767559255752374"},{"target":"AXL","probability":"0.4738084700923684"},{"target":"TGFBR1","probability":"0.46333333333333326"}],"source_name":"Sarcoma"}],["D012516",{"mesh_id":"D012516","trials":[{"ligand":"abemaciclib","mesh_id":"D012516","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02644460"},{"ligand":"abemaciclib","mesh_id":"D012516","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04040205"},{"ligand":"apatinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04351308;NCT04044378;NCT03742193;NCT03539172;NCT03359018;NCT03163381"},{"ligand":"apatinib","mesh_id":"D012516","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02711007"},{"ligand":"cabozantinib","mesh_id":"D012516","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04661852"},{"ligand":"cabozantinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02867592;NCT02243605"},{"ligand":"cetuximab","mesh_id":"D012516","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"erdafitinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D012516","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"erlotinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"everolimus","mesh_id":"D012516","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01216826;NCT01804374;NCT01830153"},{"ligand":"gefitinib","mesh_id":"D012516","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00132158"},{"ligand":"imatinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2002","completion_date":"2014","nct_id":"NCT00031915;NCT00030667;NCT02048371"},{"ligand":"larotrectinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"lenvatinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT02432274;NCT04154189"},{"ligand":"palbociclib","mesh_id":"D012516","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"pazopanib","mesh_id":"D012516","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01130623"},{"ligand":"pazopanib","mesh_id":"D012516","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT02357810;NCT03359018;NCT01759303;NCT01532687;NCT02048371"},{"ligand":"pazopanib","mesh_id":"D012516","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ramucirumab","mesh_id":"D012516","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00428272"},{"ligand":"regorafenib","mesh_id":"D012516","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT04698785;NCT02389244;NCT02048371"},{"ligand":"selumetinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D012516","phase":"Phase 1","start_date":"2011","completion_date":"2015","nct_id":"NCT02517918;NCT01331135;NCT01353625"},{"ligand":"sirolimus","mesh_id":"D012516","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00743509;NCT01614795;NCT03213678;NCT00093080;NCT03155620;NCT02429973;NCT01016015"},{"ligand":"sirolimus","mesh_id":"D012516","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00538239"},{"ligand":"sorafenib","mesh_id":"D012516","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01518413"},{"ligand":"sorafenib","mesh_id":"D012516","phase":"Phase 2","start_date":"2006","completion_date":"2018","nct_id":"NCT00889057;NCT01804374;NCT03359018;NCT00330421;NCT02048371"},{"ligand":"sorafenib","mesh_id":"D012516","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02711007"},{"ligand":"sunitinib","mesh_id":"D012516","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03900793"},{"ligand":"sunitinib","mesh_id":"D012516","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT03277924;NCT02048371"},{"ligand":"trastuzumab","mesh_id":"D012516","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D012516","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT04616560;NCT00023998;NCT00005033"},{"ligand":"vemurafenib","mesh_id":"D012516","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"ALK","probability":"0.540171248835042"},{"target":"IGF1R","probability":"0.49044562859568047"},{"target":"ERBB3","probability":"0.46399999999999997"},{"target":"BCR","probability":"0.455"}],"source_name":"Osteosarcoma"}],["D002813",{"mesh_id":"D002813","trials":[{"ligand":"abemaciclib","mesh_id":"D002813","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04040205"},{"ligand":"dasatinib","mesh_id":"D002813","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"everolimus","mesh_id":"D002813","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02008019"},{"ligand":"imatinib","mesh_id":"D002813","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT00928525;NCT02048371"},{"ligand":"nilotinib","mesh_id":"D002813","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT02587169"},{"ligand":"pazopanib","mesh_id":"D002813","phase":"Phase 2","start_date":"2011","completion_date":"2014","nct_id":"NCT02066285;NCT01532687;NCT01330966;NCT02048371"},{"ligand":"pazopanib","mesh_id":"D002813","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"regorafenib","mesh_id":"D002813","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02389244;NCT02048371"},{"ligand":"sirolimus","mesh_id":"D002813","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02821507"},{"ligand":"sorafenib","mesh_id":"D002813","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"sunitinib","mesh_id":"D002813","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"}],"predictions":[{"target":"EGFR","probability":"0.47"},{"target":"PIK3CA","probability":"0.46056133200678145"}],"source_name":"Chondrosarcoma"}],["D002294",{"mesh_id":"D002294","trials":[{"ligand":"abemaciclib","mesh_id":"D002294","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03655444;NCT03356587"},{"ligand":"acalabrutinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02454179"},{"ligand":"afatinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2012","completion_date":"2018","nct_id":"NCT03652233;NCT01721525"},{"ligand":"afatinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT01732640;NCT01824823;NCT03088059;NCT03486509;NCT03157089;NCT01608022;NCT02979977;NCT00514943;NCT02541903;NCT03940976;NCT01538381;NCT02353936;NCT01415674;NCT03695510;NCT04533321"},{"ligand":"afatinib","mesh_id":"D002294","phase":"Phase 3","start_date":"2011","completion_date":"2012","nct_id":"NCT01427478;NCT01345682"},{"ligand":"afatinib","mesh_id":"D002294","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT04132102"},{"ligand":"alpelisib","mesh_id":"D002294","phase":"Phase 1","start_date":"2013","completion_date":"2015","nct_id":"NCT01822613;NCT02537223;NCT02282371"},{"ligand":"alpelisib","mesh_id":"D002294","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT02145312;NCT02298595;NCT03601507;NCT01602315"},{"ligand":"apatinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT04393506;NCT02645864"},{"ligand":"apatinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT03603756;NCT03274011;NCT03193424;NCT02976896;NCT03424291;NCT03224221;NCT04666090;NCT03267121;NCT03096184;NCT03857763;NCT04440917;NCT03251417;NCT03320629;NCT03913182"},{"ligand":"apatinib","mesh_id":"D002294","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03725423"},{"ligand":"axitinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01469546"},{"ligand":"cabozantinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2015","completion_date":"2018","nct_id":"NCT02496208;NCT03667482"},{"ligand":"cabozantinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03866382;NCT03943602;NCT03468218"},{"ligand":"cetuximab","mesh_id":"D002294","phase":"Phase 1","start_date":"2007","completion_date":"2021","nct_id":"NCT02205398;NCT03319459;NCT02764593;NCT00906360;NCT04361409;NCT01334177;NCT01046266;NCT00736619;NCT03524326;NCT02277197;NCT01445405;NCT00397384;NCT04091867;NCT02350712;NCT03498378;NCT02429089;NCT01360827;NCT02438995;NCT02938273;NCT00903461;NCT01637194;NCT01716416;NCT03667482;NCT01254617;NCT01758731;NCT00402545;NCT04722523;NCT01935921;NCT02229656;NCT02282371"},{"ligand":"cetuximab","mesh_id":"D002294","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT03387111;NCT04106362;NCT01218048;NCT00815295;NCT01332266;NCT01133665;NCT02573493;NCT00084318;NCT03422536;NCT02014831;NCT00957853;NCT01245985;NCT00815308;NCT01836029;NCT03953976;NCT03088059;NCT01577173;NCT02101034;NCT04229459;NCT00971932;NCT02124707;NCT03744208;NCT01884259;NCT02633800;NCT02822482;NCT03389477;NCT00165490;NCT00240682;NCT01181401;NCT03944941;NCT02057107;NCT01015664;NCT01221753;NCT00939627;NCT01009203;NCT03067610;NCT02624128;NCT00933387;NCT03024489;NCT03370276;NCT02255097;NCT00623558;NCT02298595;NCT01816984;NCT01040832;NCT02054442;NCT01979211;NCT01256385;NCT02812641;NCT03254927;NCT00968435;NCT04282109;NCT02979977;NCT00514943;NCT00661427;NCT03169764;NCT01154920;NCT03817567;NCT00705016;NCT02123381;NCT03769311;NCT01326923;NCT02281955;NCT02052960;NCT04428151;NCT01412229;NCT00671437;NCT00101348;NCT04375384;NCT03082534;NCT01760811;NCT03874741;NCT02753140;NCT01104922;NCT01488318;NCT02270814;NCT01316757;NCT04464967;NCT01830556;NCT03646461;NCT00591149;NCT01602315;NCT03691714;NCT02507154;NCT03126708;NCT00096174;NCT00343083;NCT02643550;NCT00570674;NCT01133678;NCT01794845;NCT02128906;NCT02369458;NCT00617734;NCT00409565;NCT01417936;NCT02499120;NCT00660218;NCT01864772;NCT01301248;NCT01252628;NCT01427205;NCT01588431;NCT02143622;NCT00251381;NCT03713372;NCT01592721;NCT01468896;NCT03109158;NCT02707588;NCT00934518;NCT03077243"},{"ligand":"cetuximab","mesh_id":"D002294","phase":"Phase 3","start_date":"2004","completion_date":"2020","nct_id":"NCT03386838;NCT02741570;NCT04590963;NCT03358472;NCT02105636;NCT01855451;NCT03342352;NCT02236936;NCT02252042;NCT01950689;NCT01810913;NCT02383966;NCT02409186;NCT00122460;NCT01012258;NCT01874171;NCT03258554;NCT01086826;NCT01177956;NCT03349710"},{"ligand":"cetuximab","mesh_id":"D002294","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02015650"},{"ligand":"cobimetinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03108131"},{"ligand":"copanlisib","mesh_id":"D002294","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02822482"},{"ligand":"crizotinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441128"},{"ligand":"crizotinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02664935"},{"ligand":"dacomitinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2011","completion_date":"2013","nct_id":"NCT01441128;NCT01737008"},{"ligand":"dacomitinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT03770988;NCT01728233;NCT01449201;NCT01608022;NCT02268747;NCT02353936"},{"ligand":"dasatinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT00563290;NCT01488318;NCT00507767"},{"ligand":"duvelisib","mesh_id":"D002294","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04193293"},{"ligand":"erlotinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2001","completion_date":"2011","nct_id":"NCT00079053;NCT01515137;NCT00049283;NCT00397384;NCT00113347;NCT01332279;NCT00049166;NCT00966472;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT00031993;NCT00942734;NCT00392665;NCT03486509;NCT00410826;NCT01009203;NCT00055913;NCT00076310;NCT01192815;NCT00369512;NCT01608022;NCT01927744;NCT00101348;NCT00720304;NCT00304278;NCT00476476;NCT01316757;NCT00063895;NCT01198028;NCT01059305;NCT02353936;NCT02748707;NCT00055770;NCT01064479;NCT01465815"},{"ligand":"erlotinib","mesh_id":"D002294","phase":"Phase 3","start_date":"2006","completion_date":"2012","nct_id":"NCT00448240;NCT01752205;NCT00442455;NCT00673049"},{"ligand":"everolimus","mesh_id":"D002294","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04339062;NCT01637194;NCT01332279"},{"ligand":"everolimus","mesh_id":"D002294","phase":"Phase 2","start_date":"2009","completion_date":"2010","nct_id":"NCT01051791;NCT00942734;NCT01133678"},{"ligand":"gefitinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2002","completion_date":"2004","nct_id":"NCT00185835;NCT00033449;NCT00083057"},{"ligand":"gefitinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT03486509;NCT00255476;NCT00126555;NCT00233636;NCT01449201;NCT01185158;NCT01608022;NCT00229723;NCT00519077;NCT02353936;NCT00054691"},{"ligand":"gefitinib","mesh_id":"D002294","phase":"Phase 3","start_date":"2003","completion_date":"2003","nct_id":"NCT00206219"},{"ligand":"ibrutinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03646461"},{"ligand":"imatinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00485485"},{"ligand":"lapatinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT00114283;NCT01612351;NCT00371566;NCT00098631;NCT00490061;NCT01044433;NCT01666431;NCT00239200"},{"ligand":"lenvatinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03524326"},{"ligand":"lenvatinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04428151"},{"ligand":"lenvatinib","mesh_id":"D002294","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04199104"},{"ligand":"necitumumab","mesh_id":"D002294","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03387111"},{"ligand":"osimertinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02664935"},{"ligand":"palbociclib","mesh_id":"D002294","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03498378"},{"ligand":"palbociclib","mesh_id":"D002294","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT03088059;NCT02101034;NCT03389477;NCT03024489;NCT03194373;NCT02664935;NCT02499120"},{"ligand":"panitumumab","mesh_id":"D002294","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT02205398;NCT00513383;NCT04163952"},{"ligand":"panitumumab","mesh_id":"D002294","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT01077999;NCT01285778;NCT00500760;NCT01221753;NCT00446446;NCT01262183;NCT01581840;NCT00756444;NCT01129154;NCT00547157;NCT01843452"},{"ligand":"panitumumab","mesh_id":"D002294","phase":"Phase 3","start_date":"2012","completion_date":"2012","nct_id":"NCT01627379"},{"ligand":"pazopanib","mesh_id":"D002294","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01716416"},{"ligand":"pazopanib","mesh_id":"D002294","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT01377298;NCT00454142;NCT02279576"},{"ligand":"ramucirumab","mesh_id":"D002294","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03650764;NCT03762564"},{"ligand":"ribociclib","mesh_id":"D002294","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT03179956;NCT04213404;NCT02429089"},{"ligand":"ruxolitinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02593929"},{"ligand":"selumetinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02664935"},{"ligand":"sirolimus","mesh_id":"D002294","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04339062;NCT01637194;NCT03333694;NCT01332279"},{"ligand":"sirolimus","mesh_id":"D002294","phase":"Phase 2","start_date":"2009","completion_date":"2010","nct_id":"NCT01195922;NCT01016769;NCT01015664;NCT01009203;NCT01256385"},{"ligand":"sorafenib","mesh_id":"D002294","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D002294","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00815295;NCT00939627;NCT00494182;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D002294","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2006","completion_date":"2011","nct_id":"NCT00387335;NCT01377298"},{"ligand":"trametinib","mesh_id":"D002294","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01553851"},{"ligand":"trastuzumab","mesh_id":"D002294","phase":"Phase 1","start_date":"1999","completion_date":"2018","nct_id":"NCT03319459;NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D002294","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03185988;NCT04464967"}],"predictions":[{"target":"ERBB3","probability":"0.8250284495021337"},{"target":"FGFR1","probability":"0.7652337585322168"},{"target":"IGF1R","probability":"0.7501101321585903"},{"target":"BRAF","probability":"0.7307171935768635"},{"target":"FGFR3","probability":"0.7256104155220542"},{"target":"FGFR2","probability":"0.7053357819455479"},{"target":"NTRK1","probability":"0.6852121498912854"},{"target":"BCR","probability":"0.685"},{"target":"INSR","probability":"0.675"},{"target":"NTRK2","probability":"0.6603252976801659"},{"target":"TEK","probability":"0.635064163787848"},{"target":"AURKA","probability":"0.6060443149280703"},{"target":"SRC","probability":"0.5758010778880203"},{"target":"MAP2K7","probability":"0.5550437062937063"},{"target":"CDKN1A","probability":"0.5350431034482759"},{"target":"EPHB2","probability":"0.535030276816609"},{"target":"ZAP70","probability":"0.515"},{"target":"EPHA2","probability":"0.5124252626933177"},{"target":"PRKCA","probability":"0.5104297482640141"},{"target":"NTRK3","probability":"0.5061162170131809"},{"target":"AXL","probability":"0.5005081902515471"},{"target":"AURKB","probability":"0.47521344870506693"},{"target":"FGFR4","probability":"0.4723832715227729"},{"target":"ATM","probability":"0.47133836753080616"},{"target":"SMG1","probability":"0.4704135956186669"},{"target":"CHEK1","probability":"0.46653613805497207"},{"target":"PTK2","probability":"0.46402076164112727"},{"target":"CDK2","probability":"0.4618067552602437"},{"target":"PTK2B","probability":"0.4613389779473828"},{"target":"SYK","probability":"0.4572961967940175"}],"source_name":"Carcinoma, Squamous Cell"}],["D000077195",{"mesh_id":"D000077195","trials":[{"ligand":"abemaciclib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03655444;NCT03356587"},{"ligand":"acalabrutinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02454179"},{"ligand":"afatinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT03652233;NCT01783587"},{"ligand":"afatinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01732640;NCT01824823;NCT03088059;NCT01538381;NCT01415674;NCT03695510"},{"ligand":"afatinib","mesh_id":"D000077195","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01427478"},{"ligand":"alpelisib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02537223"},{"ligand":"alpelisib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02145312;NCT01602315"},{"ligand":"apatinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT03424291;NCT03267121;NCT03096184;NCT04440917"},{"ligand":"axitinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02762513;NCT01469546"},{"ligand":"cabozantinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03468218"},{"ligand":"cetuximab","mesh_id":"D000077195","phase":"Phase 1","start_date":"2007","completion_date":"2021","nct_id":"NCT02205398;NCT03319459;NCT02764593;NCT02124850;NCT04361409;NCT01046266;NCT00736619;NCT03524326;NCT02277197;NCT04091867;NCT02350712;NCT03498378;NCT02429089;NCT01360827;NCT02438995;NCT02938273;NCT00903461;NCT01716416;NCT01758731;NCT00402545;NCT04722523"},{"ligand":"cetuximab","mesh_id":"D000077195","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT01218048;NCT01332266;NCT01283334;NCT02573493;NCT03422536;NCT00957853;NCT01245985;NCT01836029;NCT03953976;NCT03088059;NCT01577173;NCT02101034;NCT02216916;NCT00971932;NCT02124707;NCT03744208;NCT04474470;NCT01581970;NCT02822482;NCT03389477;NCT02057107;NCT01015664;NCT01221753;NCT02624128;NCT03370276;NCT02255097;NCT00623558;NCT01040832;NCT02054442;NCT01979211;NCT03254927;NCT00968435;NCT04282109;NCT03169764;NCT03134846;NCT01154920;NCT02052960;NCT04428151;NCT01412229;NCT00671437;NCT00865098;NCT04375384;NCT03082534;NCT03874741;NCT02753140;NCT04616196;NCT01104922;NCT01280318;NCT01696955;NCT03070366;NCT01488318;NCT02270814;NCT04464967;NCT00736944;NCT01830556;NCT03646461;NCT02268695;NCT01602315;NCT03691714;NCT02507154;NCT00096174;NCT00343083;NCT04278092;NCT02643550;NCT00570674;NCT01133678;NCT02369458;NCT01417936;NCT02499120;NCT01252628;NCT01427205;NCT01588431;NCT02143622;NCT01054625;NCT03713372;NCT01592721;NCT01468896;NCT03109158;NCT02707588"},{"ligand":"cetuximab","mesh_id":"D000077195","phase":"Phase 3","start_date":"2004","completion_date":"2020","nct_id":"NCT03386838;NCT01931150;NCT02741570;NCT04590963;NCT03358472;NCT02347332;NCT02105636;NCT03342352;NCT01950689;NCT02383966;NCT00609284;NCT00122460;NCT00999700;NCT01012258;NCT03258554;NCT01086826;NCT02551159;NCT01177956;NCT03349710"},{"ligand":"cetuximab","mesh_id":"D000077195","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02015650"},{"ligand":"copanlisib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02822482;NCT03735628"},{"ligand":"dacomitinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01737008"},{"ligand":"dacomitinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01449201"},{"ligand":"dasatinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01488318"},{"ligand":"duvelisib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04193293"},{"ligand":"erlotinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2003","completion_date":"2005","nct_id":"NCT00079053;NCT01515137"},{"ligand":"erlotinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2006","completion_date":"2013","nct_id":"NCT00392665;NCT01927744;NCT00304278;NCT01064479"},{"ligand":"erlotinib","mesh_id":"D000077195","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00442455"},{"ligand":"everolimus","mesh_id":"D000077195","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01283334;NCT01051791;NCT01133678"},{"ligand":"gefitinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00083057"},{"ligand":"gefitinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2004","completion_date":"2014","nct_id":"NCT02216916;NCT01449201;NCT00229723;NCT00519077"},{"ligand":"gefitinib","mesh_id":"D000077195","phase":"Phase 3","start_date":"2003","completion_date":"2003","nct_id":"NCT00206219"},{"ligand":"ibrutinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03646461"},{"ligand":"lapatinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01612351;NCT00371566"},{"ligand":"lenvatinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03524326"},{"ligand":"lenvatinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04428151"},{"ligand":"lenvatinib","mesh_id":"D000077195","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04199104"},{"ligand":"palbociclib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03498378"},{"ligand":"palbociclib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT03088059;NCT02101034;NCT03389477;NCT03194373;NCT02499120"},{"ligand":"panitumumab","mesh_id":"D000077195","phase":"Phase 1","start_date":"2006","completion_date":"2019","nct_id":"NCT02205398;NCT00513383;NCT03733210"},{"ligand":"panitumumab","mesh_id":"D000077195","phase":"Phase 2","start_date":"2007","completion_date":"2019","nct_id":"NCT01221753;NCT00446446;NCT00454779;NCT00756444;NCT03405142;NCT00547157;NCT01305772"},{"ligand":"pazopanib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01716416"},{"ligand":"pazopanib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01377298"},{"ligand":"pexidartinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452424"},{"ligand":"ramucirumab","mesh_id":"D000077195","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03650764"},{"ligand":"ribociclib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT04000529;NCT03179956;NCT04213404;NCT02429089"},{"ligand":"ruxolitinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02593929"},{"ligand":"ruxolitinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03153982"},{"ligand":"sirolimus","mesh_id":"D000077195","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01353625"},{"ligand":"sirolimus","mesh_id":"D000077195","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01195922;NCT01015664;NCT03740100;NCT01172769"},{"ligand":"sorafenib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00494182"},{"ligand":"sunitinib","mesh_id":"D000077195","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01377298"},{"ligand":"trametinib","mesh_id":"D000077195","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02538627"},{"ligand":"trastuzumab","mesh_id":"D000077195","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03319459"},{"ligand":"trastuzumab","mesh_id":"D000077195","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04464967"}],"predictions":[{"target":"ERBB3","probability":"0.6201572327044026"},{"target":"BCR","probability":"0.52"},{"target":"IGF1R","probability":"0.5177878787878788"},{"target":"FGFR3","probability":"0.5155194947056883"},{"target":"FGFR1","probability":"0.5151234567901235"},{"target":"INSR","probability":"0.504"},{"target":"ALK","probability":"0.5019406431814113"},{"target":"NTRK1","probability":"0.48189664876571325"},{"target":"FGFR2","probability":"0.48"},{"target":"BRAF","probability":"0.47526159196290574"}],"source_name":"Squamous Cell Carcinoma of Head and Neck"}],["D020522",{"mesh_id":"D020522","trials":[{"ligand":"abemaciclib","mesh_id":"D020522","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02745769"},{"ligand":"abemaciclib","mesh_id":"D020522","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01739309"},{"ligand":"acalabrutinib","mesh_id":"D020522","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02717624;NCT04564040;NCT03219047"},{"ligand":"acalabrutinib","mesh_id":"D020522","phase":"Phase 2","start_date":"2015","completion_date":"2022","nct_id":"NCT04765111;NCT04716075;NCT03162536;NCT04566887;NCT02213926;NCT03932331;NCT04115631;NCT03946878;NCT03863184;NCT04189757;NCT04783415;NCT03623373;NCT04626791;NCT04402138;NCT04116437;NCT04484012;NCT03740529"},{"ligand":"acalabrutinib","mesh_id":"D020522","phase":"Phase 3","start_date":"2016","completion_date":"2021","nct_id":"NCT02972840;NCT04662255;NCT02735876"},{"ligand":"cetuximab","mesh_id":"D020522","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"copanlisib","mesh_id":"D020522","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02455297;NCT03877055"},{"ligand":"dasatinib","mesh_id":"D020522","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"everolimus","mesh_id":"D020522","phase":"Phase 1","start_date":"2010","completion_date":"2014","nct_id":"NCT02240719;NCT01088048"},{"ligand":"everolimus","mesh_id":"D020522","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT00727207;NCT00702052;NCT01075321;NCT00516412;NCT01665768;NCT00918333;NCT00081874"},{"ligand":"ibrutinib","mesh_id":"D020522","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT03479268;NCT02756247;NCT02269085;NCT03440567;NCT01479842;NCT04043845;NCT02419560;NCT01955499;NCT02268851;NCT02109224;NCT02303392;NCT02159755;NCT02743546;NCT03295240;NCT03219047;NCT02950220;NCT02446236"},{"ligand":"ibrutinib","mesh_id":"D020522","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03162536;NCT03088878;NCT03617484;NCT01880567;NCT02455297;NCT02736617;NCT02356458;NCT04665115;NCT01599949;NCT04477486;NCT04419389;NCT02869633;NCT03282396;NCT02471391;NCT03877055;NCT02460276;NCT03710772;NCT03153202;NCT04189757;NCT03478514;NCT03232307;NCT02927964;NCT04234061;NCT04659044;NCT02242097;NCT02682641;NCT03323151;NCT03684694;NCT02013128;NCT04116437;NCT01109069;NCT02427620;NCT03235544;NCT02558816;NCT01236391;NCT02169180;NCT03939182;NCT03740529"},{"ligand":"ibrutinib","mesh_id":"D020522","phase":"Phase 3","start_date":"2012","completion_date":"2021","nct_id":"NCT04662255;NCT03112174;NCT02858258;NCT02735876;NCT02991638;NCT01776840;NCT01646021;NCT01804686"},{"ligand":"ibrutinib","mesh_id":"D020522","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03190330"},{"ligand":"imatinib","mesh_id":"D020522","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"palbociclib","mesh_id":"D020522","phase":"Phase 1","start_date":"2007","completion_date":"2014","nct_id":"NCT01111188;NCT02159755;NCT00420056"},{"ligand":"palbociclib","mesh_id":"D020522","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03478514"},{"ligand":"ramucirumab","mesh_id":"D020522","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02745769"},{"ligand":"sirolimus","mesh_id":"D020522","phase":"Phase 1","start_date":"2009","completion_date":"2014","nct_id":"NCT00787969;NCT02240719;NCT01184885;NCT01088048"},{"ligand":"sirolimus","mesh_id":"D020522","phase":"Phase 2","start_date":"2002","completion_date":"2017","nct_id":"NCT00105001;NCT01389427;NCT00727207;NCT01381692;NCT01251575;NCT01075321;NCT00033267;NCT01181271;NCT01078142;NCT01170052;NCT03246906;NCT00918333;NCT00109967;NCT02991898;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D020522","phase":"Phase 3","start_date":"2005","completion_date":"2012","nct_id":"NCT00117598;NCT01646021;NCT01231412"},{"ligand":"sirolimus","mesh_id":"D020522","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01180049"},{"ligand":"sorafenib","mesh_id":"D020522","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sorafenib","mesh_id":"D020522","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00278382"},{"ligand":"sunitinib","mesh_id":"D020522","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"zanubrutinib","mesh_id":"D020522","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02914938"},{"ligand":"zanubrutinib","mesh_id":"D020522","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT04282018;NCT03162536;NCT03206970;NCT04736914;NCT04624958;NCT04116437;NCT03740529"},{"ligand":"zanubrutinib","mesh_id":"D020522","phase":"Phase 3","start_date":"2019","completion_date":"2021","nct_id":"NCT04662255;NCT04002297"}],"predictions":[{"target":"YES1","probability":"0.5825047915668423"},{"target":"BMPR1B","probability":"0.58"},{"target":"FLT1","probability":"0.530533033295913"},{"target":"RET","probability":"0.5156539433231826"},{"target":"TIE1","probability":"0.5150732718106468"},{"target":"ERBB3","probability":"0.514212975378715"},{"target":"FGFR1","probability":"0.5123607244956732"},{"target":"ACVR2B","probability":"0.510023166023166"},{"target":"MET","probability":"0.5040647654378265"},{"target":"GRK4","probability":"0.500523166023166"},{"target":"NTRK1","probability":"0.4889642883777601"},{"target":"ACVR1B","probability":"0.4750100738750839"},{"target":"ROR2","probability":"0.4668000227194911"},{"target":"IGF1R","probability":"0.4653480842090345"}],"source_name":"Lymphoma, Mantle-Cell"}],["D018358",{"mesh_id":"D018358","trials":[{"ligand":"abemaciclib","mesh_id":"D018358","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03891784"},{"ligand":"alpelisib","mesh_id":"D018358","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02077933"},{"ligand":"axitinib","mesh_id":"D018358","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01744249"},{"ligand":"binimetinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03981614"},{"ligand":"cabozantinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01466036;NCT04524208;NCT04079712;NCT04412629;NCT04400474;NCT04427787;NCT04197310"},{"ligand":"cabozantinib","mesh_id":"D018358","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03375320"},{"ligand":"crizotinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"entrectinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erlotinib","mesh_id":"D018358","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01115803"},{"ligand":"erlotinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167;NCT00843531"},{"ligand":"everolimus","mesh_id":"D018358","phase":"Phase 1","start_date":"2008","completion_date":"2017","nct_id":"NCT01204476;NCT00942682;NCT01469572;NCT02077933;NCT01590199;NCT02063958;NCT01324492;NCT01115803;NCT01218555;NCT00804336;NCT01864070;NCT03014297;NCT01263353"},{"ligand":"everolimus","mesh_id":"D018358","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT02031536;NCT01784861;NCT01648465;NCT04665739;NCT00688623;NCT02113800;NCT02273752;NCT03670030;NCT00576680;NCT01175096;NCT01678664;NCT01628913;NCT01374451;NCT01229943;NCT03950609;NCT00843531;NCT03629847;NCT02713763;NCT02305810;NCT02315625;NCT00363051;NCT03070301"},{"ligand":"everolimus","mesh_id":"D018358","phase":"Phase 3","start_date":"2007","completion_date":"2017","nct_id":"NCT03049189;NCT00510068;NCT01524783;NCT02246127"},{"ligand":"everolimus","mesh_id":"D018358","phase":"Phase 4","start_date":"2011","completion_date":"2016","nct_id":"NCT02842749;NCT01595009;NCT01317615"},{"ligand":"gefitinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"ibrutinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02575300"},{"ligand":"lenvatinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02678780;NCT03290079;NCT03950609"},{"ligand":"nintedanib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02399215"},{"ligand":"palbociclib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03981614;NCT02806648"},{"ligand":"pazopanib","mesh_id":"D018358","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT01280201;NCT01465659;NCT01099540;NCT00454363;NCT01841736"},{"ligand":"pertuzumab","mesh_id":"D018358","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"regorafenib","mesh_id":"D018358","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02259725;NCT03475953"},{"ligand":"ribociclib","mesh_id":"D018358","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02420691;NCT03070301"},{"ligand":"sirolimus","mesh_id":"D018358","phase":"Phase 1","start_date":"2010","completion_date":"2012","nct_id":"NCT01204476;NCT01548482;NCT01218555"},{"ligand":"sirolimus","mesh_id":"D018358","phase":"Phase 2","start_date":"2009","completion_date":"2021","nct_id":"NCT02031536;NCT04665739;NCT01177397;NCT01010126;NCT02273752;NCT03670030;NCT01229943;NCT03950609;NCT01658436;NCT02279758;NCT02305810"},{"ligand":"sirolimus","mesh_id":"D018358","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02246127"},{"ligand":"sorafenib","mesh_id":"D018358","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00942682"},{"ligand":"sorafenib","mesh_id":"D018358","phase":"Phase 2","start_date":"2005","completion_date":"2008","nct_id":"NCT00605566;NCT00131911"},{"ligand":"sunitinib","mesh_id":"D018358","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01381822"},{"ligand":"sunitinib","mesh_id":"D018358","phase":"Phase 2","start_date":"2003","completion_date":"2017","nct_id":"NCT01215578;NCT01121562;NCT00434109;NCT02713763;NCT02315625;NCT00056693;NCT02402062"},{"ligand":"sunitinib","mesh_id":"D018358","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT01525550"},{"ligand":"vandetanib","mesh_id":"D018358","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01941849"}],"predictions":[{"target":"BCR","probability":"0.6905203697363916"},{"target":"JAK2","probability":"0.625"},{"target":"FGFR1","probability":"0.5735229980643541"},{"target":"INSR","probability":"0.5474587031078403"},{"target":"IGF1R","probability":"0.48837717967097105"},{"target":"FGFR3","probability":"0.4682959704027275"},{"target":"ERBB3","probability":"0.46464757591605116"}],"source_name":"Neuroendocrine Tumors"}],["D002276",{"mesh_id":"D002276","trials":[{"ligand":"abemaciclib","mesh_id":"D002276","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03891784"},{"ligand":"axitinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01435122"},{"ligand":"cabozantinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01466036;NCT04197310"},{"ligand":"cabozantinib","mesh_id":"D002276","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03375320"},{"ligand":"cetuximab","mesh_id":"D002276","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D002276","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"everolimus","mesh_id":"D002276","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00942682;NCT00655655;NCT00804336"},{"ligand":"everolimus","mesh_id":"D002276","phase":"Phase 2","start_date":"2008","completion_date":"2021","nct_id":"NCT04665739;NCT00688623;NCT01175096;NCT01152827;NCT03950609"},{"ligand":"everolimus","mesh_id":"D002276","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00412061"},{"ligand":"gefitinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"ibrutinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02575300"},{"ligand":"lenvatinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"nintedanib","mesh_id":"D002276","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02399215"},{"ligand":"panitumumab","mesh_id":"D002276","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01172717"},{"ligand":"pazopanib","mesh_id":"D002276","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00454363;NCT01841736"},{"ligand":"pertuzumab","mesh_id":"D002276","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"ramucirumab","mesh_id":"D002276","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02795858"},{"ligand":"regorafenib","mesh_id":"D002276","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D002276","phase":"Phase 1","start_date":"2004","completion_date":"2012","nct_id":"NCT01204476;NCT00655655;NCT01548482;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D002276","phase":"Phase 2","start_date":"2003","completion_date":"2021","nct_id":"NCT04665739;NCT01010126;NCT03950609;NCT00093782"},{"ligand":"sorafenib","mesh_id":"D002276","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00942682"},{"ligand":"sorafenib","mesh_id":"D002276","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"sunitinib","mesh_id":"D002276","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01731925"},{"ligand":"trastuzumab","mesh_id":"D002276","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"JAK2","probability":"0.5600818651501637"},{"target":"BCR","probability":"0.541157259634235"},{"target":"INSR","probability":"0.5072439365979402"}],"source_name":"Carcinoid Tumor"}],["D007414",{"mesh_id":"D007414","trials":[{"ligand":"abemaciclib","mesh_id":"D007414","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03891784"},{"ligand":"apatinib","mesh_id":"D007414","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03271255"},{"ligand":"cabozantinib","mesh_id":"D007414","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03375320"},{"ligand":"cetuximab","mesh_id":"D007414","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D007414","phase":"Phase 1","start_date":"2007","completion_date":"2009","nct_id":"NCT00397384;NCT00987766"},{"ligand":"everolimus","mesh_id":"D007414","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01204476;NCT01263353"},{"ligand":"everolimus","mesh_id":"D007414","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01648465"},{"ligand":"imatinib","mesh_id":"D007414","phase":"Phase 2","start_date":"2000","completion_date":"2000","nct_id":"NCT00006357"},{"ligand":"pazopanib","mesh_id":"D007414","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00454363;NCT01841736"},{"ligand":"ramucirumab","mesh_id":"D007414","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03271255"},{"ligand":"sirolimus","mesh_id":"D007414","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01204476"},{"ligand":"sirolimus","mesh_id":"D007414","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT01010126;NCT00589563"},{"ligand":"sunitinib","mesh_id":"D007414","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00474994"},{"ligand":"trastuzumab","mesh_id":"D007414","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vandetanib","mesh_id":"D007414","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00734890"}],"predictions":[],"source_name":"Intestinal Neoplasms"}],["D010190",{"mesh_id":"D010190","trials":[{"ligand":"abemaciclib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D010190","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03891784"},{"ligand":"acalabrutinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02362048;NCT02570711"},{"ligand":"afatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02451553;NCT02975141;NCT03878524"},{"ligand":"afatinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060;NCT02450656"},{"ligand":"alpelisib","mesh_id":"D010190","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02155088"},{"ligand":"apatinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2016","completion_date":"2021","nct_id":"NCT04723030;NCT03662035;NCT04101929;NCT02726854;NCT04415385;NCT02863367"},{"ligand":"axitinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00219557"},{"ligand":"axitinib","mesh_id":"D010190","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00471146"},{"ligand":"binimetinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04132505"},{"ligand":"binimetinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT03637491;NCT04390243;NCT02465060"},{"ligand":"bosutinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01025570"},{"ligand":"cabozantinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01663272;NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D010190","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03375320"},{"ligand":"ceritinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02227940"},{"ligand":"cetuximab","mesh_id":"D010190","phase":"Phase 1","start_date":"2005","completion_date":"2011","nct_id":"NCT00467116;NCT00397384;NCT01420874;NCT00622674"},{"ligand":"cetuximab","mesh_id":"D010190","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT00424827;NCT00536614;NCT00395252;NCT00225784;NCT00305877;NCT00338039;NCT01042028;NCT00408564;NCT00276744;NCT00101348;NCT01050426;NCT00871169;NCT00305760;NCT00091026;NCT04464967;NCT00042939;NCT00383149;NCT00326911;NCT00005591;NCT01077986;NCT00599833;NCT00923299"},{"ligand":"cetuximab","mesh_id":"D010190","phase":"Phase 3","start_date":"2004","completion_date":"2004","nct_id":"NCT00075686"},{"ligand":"cobimetinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT04005690;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01660971;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00474812;NCT01234935;NCT02465060;NCT01652976;NCT00544908;NCT01395017"},{"ligand":"encorafenib","mesh_id":"D010190","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04390243"},{"ligand":"entrectinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erdafitinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT03403049;NCT00266097;NCT00925769;NCT00761345;NCT02154737;NCT00614653;NCT00954525;NCT00397384;NCT00243854;NCT01660971;NCT00033241;NCT00047307;NCT01010945;NCT01181245;NCT00878163;NCT00987766;NCT00480584;NCT00063947;NCT00565487;NCT00030498;NCT00885066;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2003","completion_date":"2016","nct_id":"NCT01505530;NCT00366457;NCT01555489;NCT00497224;NCT00470535;NCT01454180;NCT00336700;NCT01222689;NCT00536770;NCT00837876;NCT00709826;NCT00376948;NCT02004262;NCT00564720;NCT00276744;NCT00922896;NCT00769483;NCT00640978;NCT00696696;NCT00652366;NCT00101348;NCT00674973;NCT01505413;NCT01210911;NCT00766636;NCT02737228;NCT00091026;NCT00461708;NCT01693419;NCT00733746;NCT01303029;NCT00125021;NCT01683422;NCT00550836;NCT00260364;NCT00636883;NCT00841035;NCT00617708;NCT00365144;NCT00810719;NCT01608841;NCT00482625;NCT00313560;NCT01531712"},{"ligand":"erlotinib","mesh_id":"D010190","phase":"Phase 3","start_date":"2001","completion_date":"2009","nct_id":"NCT00634725;NCT01013649;NCT00026338;NCT00440167;NCT02694536;NCT01214720;NCT00040183"},{"ligand":"erlotinib","mesh_id":"D010190","phase":"Phase 4","start_date":"2007","completion_date":"2007","nct_id":"NCT00642733"},{"ligand":"everolimus","mesh_id":"D010190","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT01204476;NCT01263353;NCT03878524;NCT00981162"},{"ligand":"everolimus","mesh_id":"D010190","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT01784861;NCT01648465;NCT02273752;NCT01042028;NCT00640978;NCT00409292;NCT01077986;NCT00363051"},{"ligand":"gefitinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2002","completion_date":"2004","nct_id":"NCT00177242;NCT00137761;NCT00234416"},{"ligand":"ibrutinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02403271"},{"ligand":"icotinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2013","completion_date":"2014","nct_id":"NCT02278458;NCT02024633"},{"ligand":"imatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT01048320;NCT00281996;NCT03878524"},{"ligand":"imatinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00161213"},{"ligand":"lapatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00439179"},{"ligand":"lapatinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT00881621;NCT00447122;NCT00962312"},{"ligand":"larotrectinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nintedanib","mesh_id":"D010190","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02902484"},{"ligand":"olaratumab","mesh_id":"D010190","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03086369"},{"ligand":"osimertinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D010190","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02897375;NCT03454035;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"panitumumab","mesh_id":"D010190","phase":"Phase 1","start_date":"2000","completion_date":"2000","nct_id":"NCT00004879"},{"ligand":"panitumumab","mesh_id":"D010190","phase":"Phase 2","start_date":"2007","completion_date":"2010","nct_id":"NCT01175733;NCT00613730;NCT01130701;NCT00550836;NCT00601627"},{"ligand":"pazopanib","mesh_id":"D010190","phase":"Phase 1","start_date":"2009","completion_date":"2013","nct_id":"NCT01012362;NCT02009449"},{"ligand":"pazopanib","mesh_id":"D010190","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00454363;NCT01080248;NCT01841736"},{"ligand":"pertuzumab","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ponatinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D010190","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02581215"},{"ligand":"regorafenib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D010190","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02080260;NCT02307500"},{"ligand":"ribociclib","mesh_id":"D010190","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02703571"},{"ligand":"ruxolitinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01423604"},{"ligand":"ruxolitinib","mesh_id":"D010190","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02117479;NCT02119663"},{"ligand":"selumetinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT01222689;NCT01658943;NCT03040986;NCT00372944;NCT02450656"},{"ligand":"sirolimus","mesh_id":"D010190","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01204476;NCT00593008;NCT01537107;NCT03878524;NCT00981162"},{"ligand":"sirolimus","mesh_id":"D010190","phase":"Phase 2","start_date":"2003","completion_date":"2018","nct_id":"NCT00075647;NCT01010126;NCT02273752;NCT00276744;NCT00499486;NCT01210911;NCT03662412"},{"ligand":"sirolimus","mesh_id":"D010190","phase":"Phase 3","start_date":"2018","completion_date":"2020","nct_id":"NCT03512756;NCT04229004"},{"ligand":"sorafenib","mesh_id":"D010190","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT02349867;NCT00375310;NCT00789763;NCT03878524;NCT00981162"},{"ligand":"sorafenib","mesh_id":"D010190","phase":"Phase 2","start_date":"2004","completion_date":"2008","nct_id":"NCT00114244;NCT00837876;NCT00696696;NCT00634751;NCT00758381;NCT00095966"},{"ligand":"sorafenib","mesh_id":"D010190","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00541021"},{"ligand":"sunitinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT00462553;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT01215578;NCT00967603;NCT00397787;NCT02230176;NCT02465060;NCT02402062;NCT00673504"},{"ligand":"trametinib","mesh_id":"D010190","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT03825289;NCT02703571;NCT03878524"},{"ligand":"trametinib","mesh_id":"D010190","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02704156;NCT02465060;NCT02428270"},{"ligand":"trastuzumab","mesh_id":"D010190","phase":"Phase 1","start_date":"1999","completion_date":"2020","nct_id":"NCT00004074;NCT01384253;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D010190","phase":"Phase 2","start_date":"1999","completion_date":"2021","nct_id":"NCT04482309;NCT02999672;NCT00005926;NCT04464967;NCT02465060;NCT00003797;NCT00923299"},{"ligand":"vandetanib","mesh_id":"D010190","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00681798"},{"ligand":"vandetanib","mesh_id":"D010190","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01601808"},{"ligand":"vemurafenib","mesh_id":"D010190","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"BCR","probability":"0.620573428759012"},{"target":"AKT1","probability":"0.5002564102564103"},{"target":"PRKG2","probability":"0.49501385041551244"},{"target":"CDK11B","probability":"0.48805132081250036"},{"target":"SGK3","probability":"0.481228541547509"},{"target":"ZAP70","probability":"0.4750649350649351"},{"target":"LRRK1","probability":"0.4711745458359764"},{"target":"TLK1","probability":"0.465"},{"target":"FAM20C","probability":"0.4558359526424664"}],"source_name":"Pancreatic Neoplasms"}],["D013274",{"mesh_id":"D013274","trials":[{"ligand":"abemaciclib","mesh_id":"D013274","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03891784"},{"ligand":"afatinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01649271"},{"ligand":"afatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2013","completion_date":"2016","nct_id":"NCT02501603;NCT01743365;NCT02465060"},{"ligand":"alpelisib","mesh_id":"D013274","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01613950"},{"ligand":"alpelisib","mesh_id":"D013274","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04526470"},{"ligand":"apatinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2016","completion_date":"2017","nct_id":"NCT03026881;NCT03276156;NCT02711969"},{"ligand":"apatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04089657;NCT03030937;NCT03428425;NCT03878472;NCT02697838;NCT04345783;NCT02529878;NCT03472365;NCT03334591;NCT02942329;NCT03007446;NCT02596256;NCT02485015;NCT04195828;NCT02662959;NCT03229096;NCT03219593;NCT03192735;NCT03950141;NCT03154983;NCT04267549;NCT04572542;NCT04182724;NCT04286711;NCT04609176;NCT04338438;NCT03599778;NCT03258034;NCT03718624;NCT03144843;NCT03104283;NCT03954756;NCT02525237;NCT03271073;NCT04258644"},{"ligand":"apatinib","mesh_id":"D013274","phase":"Phase 3","start_date":"2009","completion_date":"2020","nct_id":"NCT02537171;NCT02510469;NCT02409199;NCT03598348;NCT03355612;NCT03889626;NCT00970138;NCT02509806;NCT01512745;NCT04342910;NCT03813784;NCT03042611"},{"ligand":"apatinib","mesh_id":"D013274","phase":"Phase 4","start_date":"2015","completion_date":"2016","nct_id":"NCT02426034;NCT02776527;NCT03384511"},{"ligand":"axitinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00842244"},{"ligand":"binimetinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D013274","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03375320"},{"ligand":"cetuximab","mesh_id":"D013274","phase":"Phase 1","start_date":"2001","completion_date":"2018","nct_id":"NCT03319459;NCT00477880;NCT00397384"},{"ligand":"cetuximab","mesh_id":"D013274","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT00398398;NCT01360086;NCT00275951;NCT00477711;NCT00397904;NCT00699881;NCT01611506;NCT00439608;NCT00384878;NCT04136600;NCT01388790;NCT01123811;NCT04464967;NCT00857246;NCT00130689"},{"ligand":"cetuximab","mesh_id":"D013274","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00678535"},{"ligand":"copanlisib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03620643;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01152853"},{"ligand":"dasatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT01561014;NCT00397384"},{"ligand":"erlotinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00032123"},{"ligand":"everolimus","mesh_id":"D013274","phase":"Phase 1","start_date":"2008","completion_date":"2010","nct_id":"NCT01204476;NCT01049620;NCT01042782;NCT01263353"},{"ligand":"everolimus","mesh_id":"D013274","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT01482299;NCT01648465;NCT00519324;NCT01514110;NCT00985192;NCT00632268;NCT00729482;NCT01099527;NCT01231399"},{"ligand":"everolimus","mesh_id":"D013274","phase":"Phase 3","start_date":"2009","completion_date":"2011","nct_id":"NCT01248403;NCT00879333"},{"ligand":"gefitinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2003","completion_date":"2017","nct_id":"NCT00237900;NCT03170180;NCT00215995"},{"ligand":"imatinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00601510"},{"ligand":"imatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT03170180;NCT00068380"},{"ligand":"lapatinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2006","completion_date":"2012","nct_id":"NCT00313599;NCT01705340"},{"ligand":"lapatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT01152853;NCT01123473;NCT02015169;NCT00526669;NCT00103324"},{"ligand":"lapatinib","mesh_id":"D013274","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00486954"},{"ligand":"larotrectinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03609359;NCT03321630;NCT04519151;NCT04745988"},{"ligand":"osimertinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"panitumumab","mesh_id":"D013274","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01716546;NCT01443065;NCT01234324"},{"ligand":"panitumumab","mesh_id":"D013274","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00824785"},{"ligand":"pazopanib","mesh_id":"D013274","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01468922"},{"ligand":"pazopanib","mesh_id":"D013274","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT01130805;NCT01716546;NCT00454363;NCT01841736;NCT01503372"},{"ligand":"pemigatinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02393248"},{"ligand":"pertuzumab","mesh_id":"D013274","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT02205047;NCT02465060;NCT01461057"},{"ligand":"pertuzumab","mesh_id":"D013274","phase":"Phase 3","start_date":"2013","completion_date":"2016","nct_id":"NCT02581462;NCT01774786"},{"ligand":"ramucirumab","mesh_id":"D013274","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02359058"},{"ligand":"ramucirumab","mesh_id":"D013274","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT04632459;NCT02726399;NCT01246960;NCT03995017;NCT03704077;NCT04592211;NCT04739202;NCT02999295;NCT03766607;NCT04660760;NCT03008278;NCT03760822;NCT01983878;NCT03694977"},{"ligand":"ramucirumab","mesh_id":"D013274","phase":"Phase 3","start_date":"2009","completion_date":"2021","nct_id":"NCT04704934;NCT00917384;NCT02934464;NCT02661971"},{"ligand":"regorafenib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03627728;NCT03475953;NCT02406170"},{"ligand":"sirolimus","mesh_id":"D013274","phase":"Phase 1","start_date":"2010","completion_date":"2012","nct_id":"NCT01204476;NCT01522820"},{"ligand":"sirolimus","mesh_id":"D013274","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT03082833;NCT01010126;NCT00985192;NCT00632268;NCT03061708;NCT01231399"},{"ligand":"sorafenib","mesh_id":"D013274","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00663741"},{"ligand":"sorafenib","mesh_id":"D013274","phase":"Phase 2","start_date":"2005","completion_date":"2016","nct_id":"NCT00253370;NCT00565370;NCT01187212;NCT02942329;NCT01158287;NCT00595985"},{"ligand":"sunitinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00555672;NCT00555620;NCT00553696;NCT00524186"},{"ligand":"sunitinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT03170180;NCT00226811;NCT01238055;NCT02465060;NCT01803503"},{"ligand":"trametinib","mesh_id":"D013274","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04454476"},{"ligand":"trametinib","mesh_id":"D013274","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D013274","phase":"Phase 1","start_date":"1999","completion_date":"2018","nct_id":"NCT03319459;NCT02205463;NCT01148849;NCT01649271;NCT00004074;NCT03219268;NCT01384253;NCT01602406;NCT01705340"},{"ligand":"trastuzumab","mesh_id":"D013274","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT01152853;NCT02005484;NCT02901301;NCT02030561;NCT02726399;NCT01396707;NCT04510285;NCT03588533;NCT02393248;NCT01774851;NCT02725424;NCT01364493;NCT01746771;NCT01402401;NCT02689284;NCT01748773;NCT01130337;NCT04379596;NCT02205047;NCT03409848;NCT04464967;NCT03556345;NCT01228045;NCT03766607;NCT02465060;NCT01928290;NCT01503983;NCT01461057;NCT01736410;NCT01359397;NCT00515411;NCT02250209;NCT02805829;NCT04278144;NCT01702558;NCT04168931;NCT02004769;NCT03694977;NCT03701373;NCT04661150"},{"ligand":"trastuzumab","mesh_id":"D013274","phase":"Phase 3","start_date":"2005","completion_date":"2021","nct_id":"NCT04704934;NCT01450696;NCT01641939;NCT03615326;NCT02158988;NCT04082364;NCT02581462;NCT04714190;NCT02578368;NCT01041404;NCT01774786"},{"ligand":"trastuzumab","mesh_id":"D013274","phase":"Phase 4","start_date":"2011","completion_date":"2013","nct_id":"NCT02380131;NCT01260194"},{"ligand":"vandetanib","mesh_id":"D013274","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01183559"},{"ligand":"vandetanib","mesh_id":"D013274","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00683787"}],"predictions":[{"target":"ERBB3","probability":"0.82"},{"target":"IGF1R","probability":"0.795"},{"target":"INSR","probability":"0.76"},{"target":"JAK2","probability":"0.7302941176470589"},{"target":"BCR","probability":"0.7250097847358121"},{"target":"TGFBR2","probability":"0.6500239675516224"},{"target":"SRC","probability":"0.6350344827586207"},{"target":"STK11","probability":"0.6052158763677732"},{"target":"AKT1","probability":"0.6000666666666666"},{"target":"CCL2","probability":"0.5900431034482758"},{"target":"TGFBR1","probability":"0.585"},{"target":"EPHB2","probability":"0.585"},{"target":"JAK1","probability":"0.5754054763143742"},{"target":"MAP2K7","probability":"0.55625"},{"target":"CDKN1A","probability":"0.55"},{"target":"BTK","probability":"0.5400563868788288"},{"target":"PTK2","probability":"0.535"},{"target":"PTK2B","probability":"0.5302846875742456"},{"target":"SYK","probability":"0.53"},{"target":"TXK","probability":"0.525"},{"target":"ACVRL1","probability":"0.5202941176470588"},{"target":"AXL","probability":"0.5151131085564846"},{"target":"PRKCA","probability":"0.5050543478260869"},{"target":"AKT2","probability":"0.5000239675516224"},{"target":"MAPK3","probability":"0.5"},{"target":"BMPR2","probability":"0.4852941176470588"},{"target":"JAK3","probability":"0.4852941176470588"},{"target":"MAPK1","probability":"0.485"},{"target":"EPHA2","probability":"0.4800891410048622"},{"target":"PRKCE","probability":"0.4753724330247682"},{"target":"ZAP70","probability":"0.46667041490728844"},{"target":"CHEK2","probability":"0.4650569538637883"},{"target":"FYN","probability":"0.4602355072463768"},{"target":"LYN","probability":"0.4558605072463768"},{"target":"RPS6KB1","probability":"0.455"}],"source_name":"Stomach Neoplasms"}],["D005910",{"mesh_id":"D005910","trials":[{"ligand":"abemaciclib","mesh_id":"D005910","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02644460;NCT04220892"},{"ligand":"afatinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2008","completion_date":"2015","nct_id":"NCT00727506;NCT02465060"},{"ligand":"apatinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT04253873;NCT02848794;NCT03741244;NCT03390062;NCT04588987"},{"ligand":"axitinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03275558"},{"ligand":"binimetinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02285439;NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02885324"},{"ligand":"cetuximab","mesh_id":"D005910","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT00463073;NCT02855086;NCT01884740"},{"ligand":"copanlisib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01644773"},{"ligand":"crizotinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02684058;NCT03919071;NCT02465060;NCT04201457"},{"ligand":"dabrafenib","mesh_id":"D005910","phase":"Phase 4","start_date":"2017","completion_date":"2019","nct_id":"NCT03340506;NCT03975829"},{"ligand":"dasatinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2009","completion_date":"2012","nct_id":"NCT00734864;NCT01644773;NCT00996723"},{"ligand":"dasatinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02233049;NCT03352427;NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02465060;NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2001","completion_date":"2011","nct_id":"NCT01103375;NCT00509431;NCT00901849;NCT00360854;NCT01257594;NCT00418327;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2002","completion_date":"2014","nct_id":"NCT01182350;NCT00112736;NCT00124657;NCT02233049;NCT00671970;NCT00337883;NCT00672243;NCT00045110;NCT00602667"},{"ligand":"everolimus","mesh_id":"D005910","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT04135807;NCT03834740;NCT04485559;NCT03355794;NCT03387020"},{"ligand":"everolimus","mesh_id":"D005910","phase":"Phase 2","start_date":"2009","completion_date":"2019","nct_id":"NCT02023905;NCT00782626;NCT02233049;NCT03632317;NCT01434602;NCT03352427;NCT01158651;NCT01734512;NCT00823459"},{"ligand":"gefitinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00027625"},{"ligand":"gefitinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042991"},{"ligand":"imatinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2004","completion_date":"2007","nct_id":"NCT00401024;NCT00354068;NCT00613054"},{"ligand":"imatinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2001","completion_date":"2003","nct_id":"NCT00021229;NCT00049127;NCT00039364;NCT00010049"},{"ligand":"lapatinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT04135807;NCT02101905"},{"ligand":"lapatinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00095940;NCT00350727;NCT00107003"},{"ligand":"larotrectinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04655404"},{"ligand":"larotrectinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT03213704;NCT02465060;NCT03155620"},{"ligand":"lenvatinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01137604"},{"ligand":"nilotinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01884922"},{"ligand":"nilotinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01887522;NCT01140568"},{"ligand":"osimertinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04135807"},{"ligand":"osimertinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT03526250;NCT02465060;NCT03155620"},{"ligand":"panitumumab","mesh_id":"D005910","phase":"Phase 2","start_date":"2010","completion_date":"2018","nct_id":"NCT03510208;NCT01017653"},{"ligand":"pazopanib","mesh_id":"D005910","phase":"Phase 1","start_date":"2009","completion_date":"2018","nct_id":"NCT00929903;NCT03275558"},{"ligand":"pazopanib","mesh_id":"D005910","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00350727"},{"ligand":"pertuzumab","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ribociclib","mesh_id":"D005910","phase":"Phase 1","start_date":"2016","completion_date":"2018","nct_id":"NCT03834740;NCT03355794;NCT03434262;NCT03387020;NCT02345824"},{"ligand":"ribociclib","mesh_id":"D005910","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02607124"},{"ligand":"ruxolitinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03514069"},{"ligand":"selumetinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01089101;NCT03326388;NCT03155620"},{"ligand":"selumetinib","mesh_id":"D005910","phase":"Phase 3","start_date":"2019","completion_date":"2021","nct_id":"NCT03871257;NCT04576117;NCT04166409"},{"ligand":"sirolimus","mesh_id":"D005910","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00509431;NCT04485559;NCT02238496;NCT00901849;NCT01316809;NCT00087451;NCT03387020;NCT03696355;NCT02420613"},{"ligand":"sirolimus","mesh_id":"D005910","phase":"Phase 2","start_date":"2001","completion_date":"2018","nct_id":"NCT00022724;NCT01051557;NCT00112736;NCT03213678;NCT03463265;NCT00672243;NCT00823459;NCT03155620"},{"ligand":"sorafenib","mesh_id":"D005910","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00884416;NCT00093613"},{"ligand":"sorafenib","mesh_id":"D005910","phase":"Phase 2","start_date":"2011","completion_date":"2016","nct_id":"NCT01817751;NCT01434602;NCT01338857"},{"ligand":"sunitinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03275558"},{"ligand":"sunitinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT01462695;NCT00499473;NCT01200134;NCT02465060;NCT00923117"},{"ligand":"trametinib","mesh_id":"D005910","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT04485559;NCT03434262"},{"ligand":"trametinib","mesh_id":"D005910","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT02684058;NCT03919071;NCT03363217;NCT02465060;NCT04201457"},{"ligand":"trametinib","mesh_id":"D005910","phase":"Phase 4","start_date":"2017","completion_date":"2019","nct_id":"NCT03340506;NCT03975829"},{"ligand":"trastuzumab","mesh_id":"D005910","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01386580;NCT02465060"},{"ligand":"vandetanib","mesh_id":"D005910","phase":"Phase 1","start_date":"2007","completion_date":"2009","nct_id":"NCT00822887;NCT00472017;NCT00613054;NCT00996723;NCT00613223"},{"ligand":"vandetanib","mesh_id":"D005910","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00995007"},{"ligand":"vemurafenib","mesh_id":"D005910","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01748149"},{"ligand":"vemurafenib","mesh_id":"D005910","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"MAP2K7","probability":"0.715"},{"target":"AKT1","probability":"0.568548139624089"},{"target":"NTRK1","probability":"0.5653023714533616"},{"target":"CDKN1A","probability":"0.5452958073148975"},{"target":"IGF1R","probability":"0.52"},{"target":"ERBB3","probability":"0.509"},{"target":"MAPK1","probability":"0.5001022016450771"},{"target":"INSR","probability":"0.485"},{"target":"BCR","probability":"0.485"},{"target":"CDK2","probability":"0.46018960692871425"}],"source_name":"Glioma"}],["D009447",{"mesh_id":"D009447","trials":[{"ligand":"abemaciclib","mesh_id":"D009447","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02644460"},{"ligand":"ceritinib","mesh_id":"D009447","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02780128"},{"ligand":"ceritinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02559778"},{"ligand":"cetuximab","mesh_id":"D009447","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"crizotinib","mesh_id":"D009447","phase":"Phase 1","start_date":"2013","completion_date":"2017","nct_id":"NCT03107988;NCT01606878"},{"ligand":"crizotinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00939770"},{"ligand":"crizotinib","mesh_id":"D009447","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03126916"},{"ligand":"dasatinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2008","completion_date":"2015","nct_id":"NCT01467986;NCT00788125;NCT02559778"},{"ligand":"erdafitinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D009447","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"erlotinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"gefitinib","mesh_id":"D009447","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00132158"},{"ligand":"gefitinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00135135"},{"ligand":"imatinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00030667"},{"ligand":"larotrectinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"lorlatinib","mesh_id":"D009447","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03107988"},{"ligand":"palbociclib","mesh_id":"D009447","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03709680"},{"ligand":"palbociclib","mesh_id":"D009447","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"pazopanib","mesh_id":"D009447","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01130623"},{"ligand":"pertuzumab","mesh_id":"D009447","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"ramucirumab","mesh_id":"D009447","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00428272"},{"ligand":"ribociclib","mesh_id":"D009447","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT01747876;NCT02780128;NCT03434262"},{"ligand":"selumetinib","mesh_id":"D009447","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213691;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D009447","phase":"Phase 1","start_date":"2009","completion_date":"2012","nct_id":"NCT01331135;NCT01625351;NCT01204450"},{"ligand":"sirolimus","mesh_id":"D009447","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT01467986;NCT01767194;NCT00808899;NCT03213678;NCT03155620"},{"ligand":"sorafenib","mesh_id":"D009447","phase":"Phase 1","start_date":"2011","completion_date":"2015","nct_id":"NCT01518413;NCT02298348"},{"ligand":"sorafenib","mesh_id":"D009447","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02559778"},{"ligand":"trametinib","mesh_id":"D009447","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trastuzumab","mesh_id":"D009447","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D009447","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452554"},{"ligand":"vandetanib","mesh_id":"D009447","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00533169"},{"ligand":"vemurafenib","mesh_id":"D009447","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"ERBB3","probability":"0.635"},{"target":"MAP2K7","probability":"0.545"},{"target":"JAK1","probability":"0.5300167855644147"},{"target":"ERBB4","probability":"0.5250724637681159"},{"target":"PTK2","probability":"0.4897500390686044"}],"source_name":"Neuroblastoma"}],["D012208",{"mesh_id":"D012208","trials":[{"ligand":"abemaciclib","mesh_id":"D012208","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02644460"},{"ligand":"afatinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02372006"},{"ligand":"apatinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03868852"},{"ligand":"cabozantinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"cetuximab","mesh_id":"D012208","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"crizotinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01524926"},{"ligand":"dasatinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT00464620;NCT03041701"},{"ligand":"erdafitinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D012208","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"erlotinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"everolimus","mesh_id":"D012208","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00187174"},{"ligand":"everolimus","mesh_id":"D012208","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01216839"},{"ligand":"gefitinib","mesh_id":"D012208","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00132158"},{"ligand":"imatinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"larotrectinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D012208","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03709680"},{"ligand":"palbociclib","mesh_id":"D012208","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"pazopanib","mesh_id":"D012208","phase":"Phase 2","start_date":"2012","completion_date":"2014","nct_id":"NCT01532687;NCT02048371"},{"ligand":"ramucirumab","mesh_id":"D012208","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00428272"},{"ligand":"regorafenib","mesh_id":"D012208","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"ribociclib","mesh_id":"D012208","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"selumetinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D012208","phase":"Phase 1","start_date":"2011","completion_date":"2012","nct_id":"NCT01331135;NCT01625351"},{"ligand":"sirolimus","mesh_id":"D012208","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT01222715;NCT01614795;NCT03213678;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D012208","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02567435"},{"ligand":"sorafenib","mesh_id":"D012208","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01518413"},{"ligand":"sorafenib","mesh_id":"D012208","phase":"Phase 2","start_date":"2012","completion_date":"2014","nct_id":"NCT01871766;NCT01502410;NCT02050919;NCT02048371"},{"ligand":"sunitinib","mesh_id":"D012208","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"trastuzumab","mesh_id":"D012208","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D012208","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452554"},{"ligand":"vemurafenib","mesh_id":"D012208","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"PIK3CA","probability":"0.47000927643784784"},{"target":"IGF1R","probability":"0.4651622965641953"}],"source_name":"Rhabdomyosarcoma"}],["D012512",{"mesh_id":"D012512","trials":[{"ligand":"abemaciclib","mesh_id":"D012512","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02644460"},{"ligand":"cabozantinib","mesh_id":"D012512","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04661852"},{"ligand":"cabozantinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02867592;NCT02243605"},{"ligand":"cetuximab","mesh_id":"D012512","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"dasatinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"erdafitinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"imatinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00062205;NCT00030667"},{"ligand":"larotrectinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D012512","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03709680"},{"ligand":"palbociclib","mesh_id":"D012512","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT04129151;NCT03526250;NCT03155620"},{"ligand":"ramucirumab","mesh_id":"D012512","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00428272"},{"ligand":"regorafenib","mesh_id":"D012512","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02389244"},{"ligand":"selumetinib","mesh_id":"D012512","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D012512","phase":"Phase 1","start_date":"2011","completion_date":"2012","nct_id":"NCT01331135;NCT01625351"},{"ligand":"sirolimus","mesh_id":"D012512","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT03190174;NCT01614795;NCT03213678;NCT03778996;NCT03155620;NCT01946529"},{"ligand":"sorafenib","mesh_id":"D012512","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01518413"},{"ligand":"sorafenib","mesh_id":"D012512","phase":"Phase 2","start_date":"2006","completion_date":"2013","nct_id":"NCT00330421;NCT01946529"},{"ligand":"trastuzumab","mesh_id":"D012512","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"vemurafenib","mesh_id":"D012512","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[],"source_name":"Sarcoma, Ewing"}],["D018335",{"mesh_id":"D018335","trials":[{"ligand":"abemaciclib","mesh_id":"D018335","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02644460"},{"ligand":"cetuximab","mesh_id":"D018335","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"erdafitinib","mesh_id":"D018335","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"everolimus","mesh_id":"D018335","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03387020"},{"ligand":"larotrectinib","mesh_id":"D018335","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D018335","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03709680"},{"ligand":"palbociclib","mesh_id":"D018335","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"ribociclib","mesh_id":"D018335","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT01747876;NCT03434262;NCT03387020"},{"ligand":"selumetinib","mesh_id":"D018335","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D018335","phase":"Phase 1","start_date":"2011","completion_date":"2018","nct_id":"NCT01331135;NCT03387020;NCT01625351"},{"ligand":"sirolimus","mesh_id":"D018335","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213678;NCT03155620"},{"ligand":"trametinib","mesh_id":"D018335","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trastuzumab","mesh_id":"D018335","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"vemurafenib","mesh_id":"D018335","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"RET","probability":"0.4572493121489999"}],"source_name":"Rhabdoid Tumor"}],["D002292",{"mesh_id":"D002292","trials":[{"ligand":"abemaciclib","mesh_id":"D002292","phase":"Phase 1","start_date":"2019","completion_date":"2021","nct_id":"NCT03905889;NCT04627064"},{"ligand":"afatinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alectinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"alpelisib","mesh_id":"D002292","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02077933"},{"ligand":"apatinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT04535687;NCT02774200"},{"ligand":"axitinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01441388;NCT04522323;NCT03086174;NCT01334073;NCT02133742;NCT02493751"},{"ligand":"axitinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT01441414;NCT04540705;NCT03387514;NCT00282048;NCT02667886;NCT01798446;NCT02560012;NCT01806064;NCT01649180;NCT02579811;NCT03494816;NCT04118855;NCT03092856;NCT00569946;NCT03438708;NCT04387500;NCT04698213;NCT03172754;NCT01693822;NCT02639182;NCT04385654;NCT04337970;NCT02535533;NCT03595124;NCT03341845;NCT02187302;NCT00835978;NCT02489695;NCT04714697;NCT04370509;NCT02700568;NCT01727336;NCT03592199;NCT01263769"},{"ligand":"axitinib","mesh_id":"D002292","phase":"Phase 3","start_date":"2008","completion_date":"2021","nct_id":"NCT02853331;NCT04510597;NCT04394975;NCT01599754;NCT04764487;NCT02684006;NCT00678392;NCT00920816"},{"ligand":"binimetinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT02496208;NCT03200587;NCT04514484;NCT03138538;NCT01100619;NCT02293980;NCT03798626;NCT02071862"},{"ligand":"cabozantinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04540705;NCT03387514;NCT03149822;NCT04300140;NCT03541902;NCT03967522;NCT03463681;NCT04644432;NCT03354884;NCT03170960;NCT02867592;NCT01835158;NCT03635892;NCT03634540;NCT04413123;NCT04071223;NCT04134390;NCT03945773;NCT02761057;NCT03866382;NCT04322955;NCT03339219;NCT04022343;NCT02960906;NCT04714697;NCT03428217;NCT03685448"},{"ligand":"cabozantinib","mesh_id":"D002292","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04586231;NCT04338269;NCT03729245;NCT03141177;NCT01865747;NCT03793166;NCT03937219"},{"ligand":"cetuximab","mesh_id":"D002292","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00622674"},{"ligand":"cetuximab","mesh_id":"D002292","phase":"Phase 2","start_date":"2005","completion_date":"2015","nct_id":"NCT00101348;NCT02599324"},{"ligand":"copanlisib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441388"},{"ligand":"crizotinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01524926;NCT04644432;NCT02761057;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"dasatinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2007","completion_date":"2014","nct_id":"NCT00600496;NCT01115803;NCT02071862"},{"ligand":"erlotinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT00193258;NCT00060307;NCT00522249;NCT04644432;NCT00425386;NCT00045487;NCT00353301;NCT00081614;NCT01688973;NCT01130519;NCT00101348;NCT00193154"},{"ligand":"erlotinib","mesh_id":"D002292","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT01402089"},{"ligand":"everolimus","mesh_id":"D002292","phase":"Phase 1","start_date":"2004","completion_date":"2019","nct_id":"NCT00384969;NCT00655655;NCT01334073;NCT02890069;NCT02077933;NCT01677390;NCT02133742;NCT00788060;NCT01714765;NCT00422344;NCT02454478;NCT01115803;NCT01482156;NCT02577458;NCT03324373;NCT01152801;NCT02071862"},{"ligand":"everolimus","mesh_id":"D002292","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT00688753;NCT00831480;NCT01136733;NCT02089334;NCT01442090;NCT02560012;NCT01731158;NCT00719264;NCT02273752;NCT03173560;NCT01408004;NCT02479490;NCT01108445;NCT01616186;NCT00830895;NCT01715935;NCT01185366;NCT00651482;NCT01034631;NCT01566747;NCT00529802;NCT01239342;NCT00392821;NCT03163667;NCT00446368;NCT00331409;NCT01545817;NCT00448149;NCT01399918;NCT01217931;NCT01793636;NCT04134390;NCT01784978;NCT02504892;NCT01491672;NCT01582009;NCT00323739;NCT02187302;NCT02724020;NCT01453595;NCT01888042;NCT00827359;NCT04203901;NCT01462214;NCT01510119;NCT02915783;NCT02599324;NCT00903175"},{"ligand":"everolimus","mesh_id":"D002292","phase":"Phase 3","start_date":"2006","completion_date":"2020","nct_id":"NCT03095040;NCT01224288;NCT04195750;NCT01865747;NCT01120249;NCT01265810;NCT00410124;NCT01668784;NCT02811861;NCT01198158"},{"ligand":"everolimus","mesh_id":"D002292","phase":"Phase 4","start_date":"2009","completion_date":"2015","nct_id":"NCT02056587;NCT01206764;NCT01514448;NCT01266837;NCT02338570"},{"ligand":"fostamatinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00923481"},{"ligand":"gefitinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2001","completion_date":"2004","nct_id":"NCT00113529;NCT00467077;NCT00014183;NCT00012337"},{"ligand":"ibrutinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02899078;NCT02599324"},{"ligand":"imatinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT00193258;NCT00323791;NCT04644432;NCT00331409;NCT03165721"},{"ligand":"lapatinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2004","completion_date":"2007","nct_id":"NCT00516672;NCT00387205;NCT00158782;NCT00363194"},{"ligand":"larotrectinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2015","completion_date":"2019","nct_id":"NCT02454478;NCT03324373"},{"ligand":"lenvatinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT04267120;NCT01136733;NCT03173560;NCT04626479;NCT04626518;NCT04704219;NCT04393350;NCT04714697;NCT04203901;NCT02915783"},{"ligand":"lenvatinib","mesh_id":"D002292","phase":"Phase 3","start_date":"2016","completion_date":"2021","nct_id":"NCT04586231;NCT04736706;NCT02811861"},{"ligand":"nintedanib","mesh_id":"D002292","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02835833"},{"ligand":"nintedanib","mesh_id":"D002292","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01024920"},{"ligand":"osimertinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"palbociclib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"panitumumab","mesh_id":"D002292","phase":"Phase 2","start_date":"2003","completion_date":"2004","nct_id":"NCT00425035;NCT00425204"},{"ligand":"pazopanib","mesh_id":"D002292","phase":"Phase 1","start_date":"2004","completion_date":"2016","nct_id":"NCT00516672;NCT01472081;NCT00401583;NCT02406521;NCT00478725;NCT02729194;NCT00861029;NCT00387205;NCT00158782;NCT00363194;NCT01012362;NCT01221506;NCT02795819;NCT01202032;NCT02014636;NCT02009449;NCT00992121"},{"ligand":"pazopanib","mesh_id":"D002292","phase":"Phase 2","start_date":"2005","completion_date":"2018","nct_id":"NCT01513187;NCT03387514;NCT02324803;NCT02959554;NCT02560012;NCT01731158;NCT02122003;NCT01649180;NCT01408004;NCT01157091;NCT03334409;NCT01767636;NCT01361113;NCT01684397;NCT01566747;NCT01538238;NCT02089802;NCT00731211;NCT02956798;NCT01545817;NCT04462445;NCT01158521;NCT01217931;NCT01793636;NCT02599779;NCT01147822;NCT00256880;NCT02187302;NCT03379012;NCT00782275;NCT02960906;NCT01664182;NCT03200717;NCT01392183;NCT02700568;NCT00244764;NCT01577784"},{"ligand":"pazopanib","mesh_id":"D002292","phase":"Phase 3","start_date":"2006","completion_date":"2018","nct_id":"NCT01064310;NCT01613846;NCT01575548;NCT01224288;NCT03260894;NCT01235962;NCT03592472;NCT01265810;NCT00387764;NCT02535351;NCT00334282;NCT00720941"},{"ligand":"pazopanib","mesh_id":"D002292","phase":"Phase 4","start_date":"2012","completion_date":"2015","nct_id":"NCT02570789;NCT01514448;NCT02555748;NCT01521715;NCT02338570"},{"ligand":"pertuzumab","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ramucirumab","mesh_id":"D002292","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03872947;NCT03798626"},{"ligand":"ramucirumab","mesh_id":"D002292","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT02082210;NCT00515697"},{"ligand":"regorafenib","mesh_id":"D002292","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00664326"},{"ligand":"selumetinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00600496"},{"ligand":"sirolimus","mesh_id":"D002292","phase":"Phase 1","start_date":"2002","completion_date":"2019","nct_id":"NCT01198184;NCT00655655;NCT01522820;NCT02646319;NCT00600496;NCT02145559;NCT01548482;NCT01079286;NCT02133742;NCT00112476;NCT03324373;NCT01122615;NCT01155258;NCT00563147;NCT00045370"},{"ligand":"sirolimus","mesh_id":"D002292","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT01517243;NCT01798446;NCT02560012;NCT02019693;NCT02273752;NCT01372813;NCT01246817;NCT00353301;NCT01566747;NCT02423954;NCT01239342;NCT00331409;NCT02330783;NCT00112840;NCT01762033;NCT01582009;NCT00417677;NCT00782275;NCT01453595;NCT00979966;NCT00378703;NCT04203901;NCT00619268;NCT01392183;NCT00494091;NCT03685448;NCT01510119;NCT00923845"},{"ligand":"sirolimus","mesh_id":"D002292","phase":"Phase 3","start_date":"2003","completion_date":"2011","nct_id":"NCT00474786;NCT00065468;NCT01223027;NCT00631371;NCT01265810;NCT01198158"},{"ligand":"sirolimus","mesh_id":"D002292","phase":"Phase 4","start_date":"2009","completion_date":"2012","nct_id":"NCT01206764;NCT01521715"},{"ligand":"sorafenib","mesh_id":"D002292","phase":"Phase 1","start_date":"2006","completion_date":"2015","nct_id":"NCT00384969;NCT01497444;NCT01441388;NCT00589550;NCT02406521;NCT00622479;NCT00715182;NCT01005797;NCT00418496;NCT00405366;NCT00635791;NCT00398814"},{"ligand":"sorafenib","mesh_id":"D002292","phase":"Phase 2","start_date":"2002","completion_date":"2016","nct_id":"NCT00282048;NCT00480389;NCT01798446;NCT00126594;NCT00557830;NCT01100242;NCT00110344;NCT01444807;NCT00496301;NCT00854620;NCT02560012;NCT00866320;NCT01731158;NCT00101114;NCT00609934;NCT01342627;NCT00678288;NCT00923130;NCT02122003;NCT01649180;NCT00389285;NCT00448721;NCT00848640;NCT01041482;NCT01372813;NCT01616186;NCT01189370;NCT01246817;NCT00098618;NCT00609401;NCT00392821;NCT01538238;NCT02330783;NCT00126659;NCT00448149;NCT00496756;NCT00445042;NCT00079612;NCT00301847;NCT00121251;NCT01762150;NCT01582009;NCT00661375;NCT00126503;NCT00467025;NCT00672178;NCT02187302;NCT00618982;NCT00782275;NCT00378703;NCT01664182;NCT00586495;NCT00117637"},{"ligand":"sorafenib","mesh_id":"D002292","phase":"Phase 3","start_date":"2003","completion_date":"2016","nct_id":"NCT01030783;NCT00474786;NCT01223027;NCT00492986;NCT00586105;NCT01613846;NCT01076010;NCT02627963;NCT00732914;NCT00606866;NCT00492258;NCT01481870;NCT00678392;NCT00478114;NCT00111020;NCT01265810;NCT00073307;NCT00410124;NCT00326898;NCT00920816"},{"ligand":"sorafenib","mesh_id":"D002292","phase":"Phase 4","start_date":"2006","completion_date":"2015","nct_id":"NCT02056587;NCT00352859;NCT02338570"},{"ligand":"sunitinib","mesh_id":"D002292","phase":"Phase 1","start_date":"2006","completion_date":"2019","nct_id":"NCT01441388;NCT01472081;NCT00399152;NCT01243359;NCT00499135;NCT00694096;NCT01258348;NCT00788060;NCT01061411;NCT00890747;NCT00372853;NCT01714765;NCT00422344;NCT00715182;NCT00421512;NCT01381822;NCT01122615;NCT02386111;NCT03905889;NCT00747305"},{"ligand":"sunitinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT00113529;NCT00486538;NCT00267748;NCT03323710;NCT00338884;NCT03387514;NCT01517243;NCT00626509;NCT01673386;NCT01219751;NCT01499121;NCT00330564;NCT00459979;NCT02324803;NCT03066427;NCT01798446;NCT02072031;NCT01391130;NCT00890110;NCT02959554;NCT02560012;NCT00254540;NCT00866320;NCT01731158;NCT01342627;NCT00678288;NCT00853372;NCT00923130;NCT01649180;NCT02919371;NCT03541902;NCT00448721;NCT00522249;NCT03598816;NCT01108445;NCT03035630;NCT01372813;NCT01216371;NCT01616186;NCT04644432;NCT01246817;NCT01185366;NCT00425386;NCT00480935;NCT00089648;NCT01566747;NCT00077974;NCT01164228;NCT02398552;NCT01538238;NCT00731211;NCT00709995;NCT01835158;NCT00137423;NCT00465179;NCT00663559;NCT01793636;NCT02019576;NCT01024205;NCT02599779;NCT01784978;NCT00556205;NCT00717587;NCT01147822;NCT00853125;NCT02761057;NCT02465060;NCT00891475;NCT00541008;NCT01491672;NCT01482949;NCT00462982;NCT01582009;NCT00417677;NCT02432846;NCT03075423;NCT00459875;NCT00617253;NCT00678119;NCT00444314;NCT00814021;NCT02071641;NCT02187302;NCT02446795;NCT02626754;NCT01984242;NCT03379012;NCT00782275;NCT02960906;NCT03109015;NCT00556049;NCT00979966;NCT00975806;NCT03024437;NCT01829841;NCT01070186;NCT01664182;NCT00619268;NCT00715442;NCT00982657;NCT01034878;NCT02700568;NCT00570882;NCT03592199;NCT01158222;NCT02689167;NCT00491738;NCT01024920;NCT01069770;NCT02060370;NCT00903175"},{"ligand":"sunitinib","mesh_id":"D002292","phase":"Phase 3","start_date":"2004","completion_date":"2020","nct_id":"NCT00474786;NCT01064310;NCT02231749;NCT04523272;NCT01582672;NCT02853331;NCT00869011;NCT03091192;NCT04394975;NCT03260894;NCT00732914;NCT03729245;NCT03141177;NCT00397345;NCT02684006;NCT01481870;NCT03013946;NCT01265810;NCT01099423;NCT00410124;NCT02420821;NCT00326898;NCT01265901;NCT02535351;NCT02811861;NCT00930033;NCT00720941;NCT00083889"},{"ligand":"sunitinib","mesh_id":"D002292","phase":"Phase 4","start_date":"2008","completion_date":"2015","nct_id":"NCT02570789;NCT01402089;NCT02056587;NCT01514448;NCT02555748;NCT00706706;NCT00930345;NCT02338570"},{"ligand":"tivozanib","mesh_id":"D002292","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00563147"},{"ligand":"tivozanib","mesh_id":"D002292","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT01673386;NCT01297244;NCT00502307;NCT01834183;NCT03136627"},{"ligand":"tivozanib","mesh_id":"D002292","phase":"Phase 3","start_date":"2009","completion_date":"2016","nct_id":"NCT01030783;NCT01076010;NCT02627963"},{"ligand":"trametinib","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D002292","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D002292","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"vandetanib","mesh_id":"D002292","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT02495103;NCT01372813;NCT00566995"}],"predictions":[{"target":"LMTK2","probability":"0.5724105649649168"},{"target":"MAPK15","probability":"0.5377472871064151"},{"target":"PRKD2","probability":"0.5057026035065004"},{"target":"STK33","probability":"0.5048160160042875"},{"target":"EPHA10","probability":"0.4930909752953612"},{"target":"ERBB3","probability":"0.49081616446715715"},{"target":"IGF1R","probability":"0.4802757817592187"},{"target":"SGK2","probability":"0.47692953018717077"},{"target":"LTK","probability":"0.4650907946315686"},{"target":"CDK16","probability":"0.46095008558230155"},{"target":"OBSCN","probability":"0.45544602741041784"}],"source_name":"Carcinoma, Renal Cell"}],["D008223",{"mesh_id":"D008223","trials":[{"ligand":"abemaciclib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"abemaciclib","mesh_id":"D008223","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01739309"},{"ligand":"acalabrutinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT02717624;NCT04462328;NCT04688151;NCT03527147;NCT02112526;NCT03219047"},{"ligand":"acalabrutinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2022","nct_id":"NCT04765111;NCT02180711;NCT03162536;NCT04257578;NCT04566887;NCT04155710;NCT02213926;NCT04604067;NCT03932331;NCT04115631;NCT04002947;NCT04548648;NCT03571308;NCT03946878;NCT04646395;NCT03863184;NCT04189757;NCT04502394;NCT04783415;NCT02337829;NCT02362035;NCT04404088;NCT04189952;NCT03623373;NCT04169737;NCT03516617;NCT03788291;NCT04626791;NCT04402138;NCT04116437;NCT04484012;NCT04094142;NCT04546620;NCT03740529"},{"ligand":"acalabrutinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2016","completion_date":"2021","nct_id":"NCT04529772;NCT02972840;NCT04662255;NCT02735876;NCT04666038"},{"ligand":"afatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439136;NCT02465060"},{"ligand":"alectinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01634763"},{"ligand":"alectinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2016","completion_date":"2017","nct_id":"NCT02838420;NCT03194893"},{"ligand":"alectinib","mesh_id":"D008223","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04362072"},{"ligand":"apatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2018","completion_date":"2020","nct_id":"NCT04476459;NCT03701022"},{"ligand":"apatinib","mesh_id":"D008223","phase":"Phase 4","start_date":"2017","completion_date":"2018","nct_id":"NCT03631862;NCT03376958"},{"ligand":"binimetinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04292119;NCT02465060;NCT04439344"},{"ligand":"brigatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT03719898;NCT01449461;NCT04260009"},{"ligand":"cabozantinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ceritinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2012","completion_date":"2013","nct_id":"NCT01742286;NCT01634763"},{"ligand":"ceritinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02729961;NCT02465528"},{"ligand":"ceritinib","mesh_id":"D008223","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04362072"},{"ligand":"cetuximab","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"cetuximab","mesh_id":"D008223","phase":"Phase 3","start_date":"2000","completion_date":"2000","nct_id":"NCT00115700"},{"ligand":"cobimetinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D008223","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT03884998;NCT04156828;NCT03502733;NCT03498430;NCT02253420;NCT02155582;NCT03886649;NCT04431635;NCT04233697;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D008223","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT02391116;NCT03789240;NCT04155840;NCT04572763;NCT02455297;NCT04263584;NCT03581942;NCT03877055;NCT02342665;NCT03484819;NCT02535247;NCT02465060;NCT04433182;NCT03474744;NCT04750941;NCT01660451"},{"ligand":"copanlisib","mesh_id":"D008223","phase":"Phase 3","start_date":"2015","completion_date":"2016","nct_id":"NCT02367040;NCT02626455;NCT02369016"},{"ligand":"crizotinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2011","completion_date":"2013","nct_id":"NCT01121588;NCT01606878"},{"ligand":"crizotinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT01449461;NCT04439266;NCT04292119;NCT04439253;NCT02465060;NCT01979536;NCT02419287;NCT00939770"},{"ligand":"crizotinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2016","completion_date":"2017","nct_id":"NCT02838420;NCT03194893"},{"ligand":"crizotinib","mesh_id":"D008223","phase":"Phase 4","start_date":"2015","completion_date":"2018","nct_id":"NCT02487316;NCT03707847"},{"ligand":"dabrafenib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439292;NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04603872;NCT01643603;NCT00608361;NCT01609816;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT01173679;NCT00364286;NCT03023046;NCT04439305;NCT00918463;NCT00788125;NCT02465060;NCT02043587;NCT00550615"},{"ligand":"dasatinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03117751"},{"ligand":"duvelisib","mesh_id":"D008223","phase":"Phase 1","start_date":"2013","completion_date":"2021","nct_id":"NCT03892044;NCT02783625;NCT01871675;NCT04639843;NCT02598570;NCT02640833"},{"ligand":"duvelisib","mesh_id":"D008223","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT02605694;NCT04038359;NCT04707079;NCT02391545;NCT04331119;NCT03372057;NCT04379167;NCT01882803;NCT03370185;NCT03961672"},{"ligand":"duvelisib","mesh_id":"D008223","phase":"Phase 3","start_date":"2013","completion_date":"2015","nct_id":"NCT02576275;NCT02049515;NCT02004522;NCT02204982"},{"ligand":"erdafitinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02465060;NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00725634;NCT03878524;NCT00705874"},{"ligand":"erlotinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04004572"},{"ligand":"everolimus","mesh_id":"D008223","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00352443;NCT01334502;NCT01341834;NCT01567475;NCT02254239;NCT02240719;NCT00962507;NCT01854606;NCT01088048;NCT02900716;NCT00622258;NCT03328104;NCT00671112;NCT03878524"},{"ligand":"everolimus","mesh_id":"D008223","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT00727207;NCT00702052;NCT01164267;NCT00474929;NCT01075321;NCT00516412;NCT01665768;NCT01453504;NCT03697408;NCT00978432;NCT01198665;NCT04305444;NCT00967044;NCT00918333;NCT00081874;NCT00869999;NCT01022996;NCT00436618;NCT01637090"},{"ligand":"everolimus","mesh_id":"D008223","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00790036"},{"ligand":"fostamatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT00446095;NCT00798096;NCT01499303"},{"ligand":"ibrutinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2009","completion_date":"2021","nct_id":"NCT02640209;NCT02780830;NCT03479268;NCT02756247;NCT02055924;NCT02269085;NCT03220022;NCT03440567;NCT01479842;NCT04043845;NCT03223610;NCT03876028;NCT02419560;NCT01955499;NCT02954406;NCT02268851;NCT02109224;NCT03424122;NCT04739813;NCT01829568;NCT02303392;NCT03136497;NCT02159755;NCT02743546;NCT02966730;NCT02219737;NCT01292135;NCT01886859;NCT01644253;NCT02160015;NCT03703167;NCT02309580;NCT04781855;NCT00849654;NCT03295240;NCT01569750;NCT02203526;NCT02614508;NCT03219047;NCT02950220;NCT02446236"},{"ligand":"ibrutinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02662296;NCT02518555;NCT02406742;NCT02077166;NCT02910583;NCT03162536;NCT03088878;NCT04155710;NCT01980628;NCT03399513;NCT02874404;NCT03617484;NCT01880567;NCT02455297;NCT02736617;NCT02356458;NCT02542514;NCT04514393;NCT02760485;NCT04665115;NCT01599949;NCT04477486;NCT03045328;NCT02207062;NCT04419389;NCT02869633;NCT03282396;NCT04421560;NCT03581942;NCT02532257;NCT02471391;NCT03128879;NCT03877055;NCT02460276;NCT04548648;NCT04450173;NCT02940301;NCT02626884;NCT03710772;NCT03129828;NCT03331198;NCT02514083;NCT03153202;NCT03310619;NCT02733042;NCT02401048;NCT02420912;NCT04189757;NCT01779791;NCT01849263;NCT03478514;NCT02692248;NCT01980654;NCT02636322;NCT02747732;NCT04129710;NCT03232307;NCT02927964;NCT04234061;NCT02677948;NCT04659044;NCT02689869;NCT01520519;NCT03198026;NCT02451111;NCT02315326;NCT02242097;NCT02956382;NCT02682641;NCT03323151;NCT03684694;NCT03093831;NCT02670616;NCT02744612;NCT02332980;NCT04446962;NCT03697512;NCT04230304;NCT02670317;NCT02005289;NCT04116437;NCT01217749;NCT02824029;NCT02142049;NCT01109069;NCT03144674;NCT02623010;NCT03949062;NCT03964090;NCT01325701;NCT01744691;NCT02272686;NCT01589302;NCT03770416;NCT02427620;NCT03235544;NCT02558816;NCT02756897;NCT01236391;NCT02169180;NCT02436707;NCT03370185;NCT04066920;NCT03939182;NCT01500733;NCT03740529;NCT02955628;NCT04607772"},{"ligand":"ibrutinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2012","completion_date":"2021","nct_id":"NCT01722487;NCT03570892;NCT02947347;NCT01724346;NCT04662255;NCT03112174;NCT02858258;NCT02264574;NCT02048813;NCT02735876;NCT02991638;NCT01776840;NCT01974440;NCT03734016;NCT02443077;NCT01646021;NCT01855750;NCT01578707;NCT01611090;NCT01973387;NCT04212013;NCT02703272;NCT04666038;NCT01804686"},{"ligand":"ibrutinib","mesh_id":"D008223","phase":"Phase 4","start_date":"2017","completion_date":"2019","nct_id":"NCT03229200;NCT03190330"},{"ligand":"imatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2008","completion_date":"2018","nct_id":"NCT00990249;NCT02431403;NCT03023046;NCT02462538;NCT00882206;NCT01665001;NCT00684411;NCT02538926"},{"ligand":"imatinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02881086"},{"ligand":"lapatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00352443"},{"ligand":"larotrectinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT03213704;NCT02465060;NCT03155620"},{"ligand":"lenvatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT02578316;NCT01525394;NCT00121719;NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04292119;NCT03505554"},{"ligand":"lorlatinib","mesh_id":"D008223","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04362072"},{"ligand":"neratinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155817"},{"ligand":"osimertinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D008223","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01111188;NCT02159755;NCT00420056;NCT03792256;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D008223","phase":"Phase 2","start_date":"2014","completion_date":"2018","nct_id":"NCT02264613;NCT04439201;NCT03526250;NCT03478514;NCT02465060;NCT03155620"},{"ligand":"pazopanib","mesh_id":"D008223","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00674024"},{"ligand":"pertuzumab","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"ponatinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ramucirumab","mesh_id":"D008223","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03013218"},{"ligand":"regorafenib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ribociclib","mesh_id":"D008223","phase":"Phase 1","start_date":"2010","completion_date":"2015","nct_id":"NCT01237236;NCT02414724"},{"ligand":"ruxolitinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02613598;NCT03017820;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT03922724;NCT01877005;NCT01431209;NCT03041636;NCT02974647;NCT02164500;NCT03681561;NCT01965119"},{"ligand":"ruxolitinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03117751"},{"ligand":"selumetinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT03213691;NCT03155620;NCT01278615"},{"ligand":"sirolimus","mesh_id":"D008223","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT01535989;NCT04473911;NCT02343718;NCT00602693;NCT01902160;NCT01991938;NCT01614197;NCT01341834;NCT00659568;NCT01658007;NCT02728700;NCT00068302;NCT00787969;NCT02254239;NCT02240719;NCT00962507;NCT00275093;NCT01184885;NCT01854606;NCT00973804;NCT01588678;NCT01088048;NCT03018223;NCT01625351;NCT00622258;NCT03730142;NCT00513474;NCT01473095;NCT01634217;NCT01403415;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D008223","phase":"Phase 2","start_date":"2001","completion_date":"2019","nct_id":"NCT00105001;NCT01389427;NCT00727207;NCT00290472;NCT02669511;NCT01027000;NCT00691015;NCT01116232;NCT01177397;NCT01281917;NCT01381692;NCT00474929;NCT03922724;NCT02356159;NCT03120000;NCT01251575;NCT01075321;NCT02793544;NCT00033267;NCT00942747;NCT00838955;NCT00776373;NCT00317785;NCT03697408;NCT01181271;NCT01198665;NCT00074490;NCT02061800;NCT01843998;NCT03213678;NCT01078142;NCT01170052;NCT01076543;NCT03246906;NCT00918333;NCT03192397;NCT00577278;NCT00544115;NCT00589563;NCT03155620;NCT00086840;NCT00109967;NCT01162551;NCT02991898;NCT00869999;NCT00520130;NCT01220297;NCT01653067;NCT00089037;NCT02722668;NCT01637090"},{"ligand":"sirolimus","mesh_id":"D008223","phase":"Phase 3","start_date":"2005","completion_date":"2012","nct_id":"NCT00117598;NCT01646021;NCT00928018;NCT01231412"},{"ligand":"sirolimus","mesh_id":"D008223","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01180049"},{"ligand":"sorafenib","mesh_id":"D008223","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT01561833;NCT00118170;NCT00788099;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D008223","phase":"Phase 2","start_date":"2005","completion_date":"2007","nct_id":"NCT00474929;NCT00278382;NCT00131937"},{"ligand":"sunitinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00890747;NCT03878524;NCT00705874"},{"ligand":"sunitinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00398112;NCT02465060;NCT00392496"},{"ligand":"tofacitinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03598959"},{"ligand":"trametinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trametinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT04439318;NCT04439279;NCT04439292;NCT02465060;NCT04439357"},{"ligand":"trastuzumab","mesh_id":"D008223","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03013218;NCT03432741;NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D008223","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT04439110;NCT02465060"},{"ligand":"vandetanib","mesh_id":"D008223","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00734890"},{"ligand":"vemurafenib","mesh_id":"D008223","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D008223","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03013491;NCT03155620"},{"ligand":"zanubrutinib","mesh_id":"D008223","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02914938;NCT03189524;NCT04436107"},{"ligand":"zanubrutinib","mesh_id":"D008223","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT04458610;NCT04282018;NCT03162536;NCT03206970;NCT03145064;NCT04460248;NCT04705129;NCT04736914;NCT03206918;NCT04624958;NCT04668365;NCT04116437;NCT03520920;NCT03846427;NCT03332017;NCT03740529"},{"ligand":"zanubrutinib","mesh_id":"D008223","phase":"Phase 3","start_date":"2017","completion_date":"2021","nct_id":"NCT03336333;NCT04662255;NCT03734016;NCT04002297;NCT04666038"}],"predictions":[{"target":"PKDCC","probability":"0.81"},{"target":"DSTYK","probability":"0.8"},{"target":"SRMS","probability":"0.7903448275862069"},{"target":"PAN3","probability":"0.7803448275862069"},{"target":"ATP23","probability":"0.7803448275862069"},{"target":"BCR","probability":"0.775"},{"target":"CAMK1G","probability":"0.765"},{"target":"CDC42BPG","probability":"0.760344827586207"},{"target":"TSSK6","probability":"0.745344827586207"},{"target":"FASTKD1","probability":"0.745"},{"target":"STK32B","probability":"0.74"},{"target":"PHKG1","probability":"0.730344827586207"},{"target":"PRKACG","probability":"0.720344827586207"},{"target":"CAMKV","probability":"0.72"},{"target":"DCLK2","probability":"0.715344827586207"},{"target":"STK40","probability":"0.715344827586207"},{"target":"TSSK3","probability":"0.710344827586207"},{"target":"PTK2","probability":"0.6950357142857143"},{"target":"NEK5","probability":"0.69"},{"target":"MAST3","probability":"0.69"},{"target":"SRC","probability":"0.6891666666666667"},{"target":"ZAP70","probability":"0.68"},{"target":"BMPR1B","probability":"0.675"},{"target":"PRKCB","probability":"0.6704834600225087"},{"target":"DYRK4","probability":"0.665"},{"target":"CSNK1G1","probability":"0.665"},{"target":"TYRO3","probability":"0.6594"},{"target":"AXL","probability":"0.6550357142857144"},{"target":"SBK1","probability":"0.655"},{"target":"TAF1L","probability":"0.655"},{"target":"PIM1","probability":"0.6528699923605414"},{"target":"TEC","probability":"0.6494176056338028"},{"target":"POMK","probability":"0.6453448275862069"},{"target":"YES1","probability":"0.6419021739130435"},{"target":"MAP2K7","probability":"0.6391666666666667"},{"target":"TGFBR2","probability":"0.635044776119403"},{"target":"AVP","probability":"0.635"},{"target":"EPHB2","probability":"0.6191666666666668"},{"target":"TSSK4","probability":"0.6153448275862069"},{"target":"STK35","probability":"0.6103448275862069"},{"target":"PSKH1","probability":"0.6053448275862069"},{"target":"ACVRL1","probability":"0.60525"},{"target":"MAP3K4","probability":"0.605"},{"target":"CDK17","probability":"0.6003448275862069"},{"target":"CSNK1G2","probability":"0.6003448275862069"},{"target":"CSNK1A1L","probability":"0.5953448275862069"},{"target":"ACVR2B","probability":"0.5943999999999999"},{"target":"RPS6KB1","probability":"0.5902232142857143"},{"target":"BMPR2","probability":"0.59"},{"target":"AKT2","probability":"0.5878264877240464"},{"target":"AKT1","probability":"0.5851822143601768"},{"target":"GSK3B","probability":"0.5813100100881773"},{"target":"EPHB1","probability":"0.5800176056338028"},{"target":"MAST4","probability":"0.5753448275862069"},{"target":"ROR2","probability":"0.5752829386763814"},{"target":"TGFBR1","probability":"0.57525"},{"target":"EPHA4","probability":"0.575193413729128"},{"target":"SRPK3","probability":"0.575"},{"target":"ADCK1","probability":"0.57"},{"target":"MAPK13","probability":"0.5686666666666667"},{"target":"STK32C","probability":"0.565"},{"target":"VRK3","probability":"0.565"},{"target":"PRKCQ","probability":"0.5646304507661651"},{"target":"TBRG4","probability":"0.5603448275862069"},{"target":"BMP2K","probability":"0.5603448275862069"},{"target":"PAK1","probability":"0.5602552064592925"},{"target":"ALPK3","probability":"0.56"},{"target":"TESK2","probability":"0.555"},{"target":"RPS6KB2","probability":"0.5536666666666666"},{"target":"MAP2K5","probability":"0.5466666666666666"},{"target":"ACVR1","probability":"0.5450320512820512"},{"target":"TAOK3","probability":"0.5450144927536232"},{"target":"MAP3K3","probability":"0.545"},{"target":"MOS","probability":"0.545"},{"target":"PTK7","probability":"0.5444"},{"target":"PTK2B","probability":"0.540276405775076"},{"target":"IRAK3","probability":"0.5395547370051902"},{"target":"STK11","probability":"0.5367187359820634"},{"target":"MYO3A","probability":"0.535"},{"target":"EPHB4","probability":"0.530230450766165"},{"target":"MST1R","probability":"0.5301576994434137"},{"target":"DMPK","probability":"0.53"},{"target":"CDKL5","probability":"0.53"},{"target":"ACVR1B","probability":"0.5294111507582515"},{"target":"FYN","probability":"0.525088905775076"},{"target":"STK36","probability":"0.5203448275862069"},{"target":"MUSK","probability":"0.5201198216885057"},{"target":"CDK15","probability":"0.52"},{"target":"PIM2","probability":"0.5198138004642536"},{"target":"EPHA8","probability":"0.5194"},{"target":"PRKCI","probability":"0.5186666666666667"},{"target":"NME2","probability":"0.5159302325581395"},{"target":"MKNK2","probability":"0.515"},{"target":"LIMK2","probability":"0.5144"},{"target":"MYLK3","probability":"0.5130666666666667"},{"target":"CPNE3","probability":"0.5109698275862069"},{"target":"RPS6KA5","probability":"0.5104937634158714"},{"target":"SIK1","probability":"0.51"},{"target":"ATM","probability":"0.5063282654876604"},{"target":"AURKA","probability":"0.5056434490833199"},{"target":"FASTKD2","probability":"0.5053448275862069"},{"target":"LRRK2","probability":"0.5051965154404031"},{"target":"EPHA2","probability":"0.5051382605790949"},{"target":"NPR2","probability":"0.505"},{"target":"GRK2","probability":"0.5003329970595457"},{"target":"FASTKD3","probability":"0.5"},{"target":"STK39","probability":"0.49941115075825154"},{"target":"PRKCE","probability":"0.4963415771960329"},{"target":"CDK5","probability":"0.49616893357390046"},{"target":"BRD4","probability":"0.4903270996491077"},{"target":"RPS6KA1","probability":"0.4900264350453172"},{"target":"ACVR2A","probability":"0.4859478381919423"},{"target":"MAP3K15","probability":"0.4853448275862069"},{"target":"PRKCD","probability":"0.48378588659320726"},{"target":"IKBKE","probability":"0.4826140123363965"},{"target":"BMPR1A","probability":"0.4806387330528284"},{"target":"MAP2K3","probability":"0.4805718019111979"},{"target":"MAP3K2","probability":"0.4802355072463768"},{"target":"MAP3K8","probability":"0.48011538461538467"},{"target":"ILK","probability":"0.4752552064592925"},{"target":"CAMK1","probability":"0.475"},{"target":"CAMK2G","probability":"0.472226641841802"},{"target":"TTN","probability":"0.4711236462872676"},{"target":"MAP4K4","probability":"0.47"},{"target":"PBK","probability":"0.46979007268182654"},{"target":"ITK","probability":"0.46530967818872726"},{"target":"IRAK4","probability":"0.4653"},{"target":"CDK2","probability":"0.4650357142857143"},{"target":"PAK3","probability":"0.4650355239786856"},{"target":"ANKK1","probability":"0.46366666666666667"},{"target":"MAPK11","probability":"0.46166666666666667"},{"target":"PRKCA","probability":"0.46045459535539757"},{"target":"CDK8","probability":"0.46020664833274383"},{"target":"CDKN1A","probability":"0.46019341372912803"},{"target":"GRK4","probability":"0.46001115075825155"},{"target":"PTK6","probability":"0.45991198620642804"},{"target":"PDK1","probability":"0.4568704146311759"},{"target":"SGK1","probability":"0.45624005015191327"},{"target":"MAPK12","probability":"0.455"},{"target":"ULK3","probability":"0.455"}],"source_name":"Lymphoma"}],["D007938",{"mesh_id":"D007938","trials":[{"ligand":"abemaciclib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"acalabrutinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02296918;NCT02157324"},{"ligand":"acalabrutinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT03162536;NCT04155710;NCT03013998;NCT03932331;NCT03580928;NCT02029443;NCT04477291;NCT04502394;NCT04657094;NCT02337829;NCT02362035;NCT04189952;NCT04169737;NCT03516617;NCT03788291;NCT04016805;NCT03328273;NCT04624633;NCT04505254;NCT03740529"},{"ligand":"acalabrutinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2015","completion_date":"2021","nct_id":"NCT02477696;NCT04008706;NCT04075292;NCT04178798;NCT03836261;NCT02970318;NCT04666038"},{"ligand":"afatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"axitinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00071006"},{"ligand":"binimetinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2014","completion_date":"2015","nct_id":"NCT02225574;NCT02049801"},{"ligand":"binimetinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02089230;NCT04322383"},{"ligand":"bosutinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2017","completion_date":"2021","nct_id":"NCT02782403;NCT04655391"},{"ligand":"bosutinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT00261846;NCT04578847;NCT03654768;NCT03128411;NCT02767063;NCT02906696;NCT04709731;NCT04258943;NCT03831776;NCT02445742;NCT02638467;NCT04006847;NCT02311998;NCT03610971;NCT00811070;NCT02810990;NCT04626024"},{"ligand":"bosutinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2008","completion_date":"2019","nct_id":"NCT03746054;NCT00574873;NCT03106779;NCT02130557"},{"ligand":"bosutinib","mesh_id":"D007938","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02228382"},{"ligand":"cabozantinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01961765;NCT03878524"},{"ligand":"cetuximab","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"cetuximab","mesh_id":"D007938","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT03263208;NCT02028455"},{"ligand":"cobimetinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02670044;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D007938","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03884998;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D007938","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04155840;NCT04685915"},{"ligand":"dabrafenib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00316953;NCT00324077;NCT00732186;NCT00940524;NCT02680951;NCT00500006;NCT03560908;NCT00306202;NCT02081378;NCT00978731;NCT04603872;NCT03414450;NCT01077544;NCT00872976;NCT00103701;NCT03515200;NCT04580121;NCT00860535;NCT00345826;NCT01397734;NCT02047149;NCT02815059;NCT01751425;NCT03595917;NCT01460498;NCT02494882;NCT01643603;NCT00827138;NCT00892190;NCT00816283;NCT00064233;NCT01426334;NCT00608361;NCT02011945;NCT02819804;NCT02779283;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2001","completion_date":"2021","nct_id":"NCT01173679;NCT01667133;NCT00298987;NCT01310010;NCT04578847;NCT00866736;NCT01872442;NCT00101660;NCT01392170;NCT00777036;NCT01238211;NCT00391989;NCT02923986;NCT02143414;NCT03654768;NCT01218477;NCT00070499;NCT00982488;NCT00103844;NCT02767063;NCT03516279;NCT00895297;NCT00254423;NCT00364286;NCT00493181;NCT01606579;NCT03023046;NCT00438854;NCT01593254;NCT00829647;NCT01746836;NCT01804985;NCT00482703;NCT02113319;NCT02744768;NCT02689440;NCT01725204;NCT01207440;NCT01441882;NCT01030718;NCT01004497;NCT04006847;NCT01883219;NCT02709083;NCT00850382;NCT01342679;NCT00792948;NCT00337454;NCT01498445;NCT00563290;NCT01051115;NCT04747912;NCT01357655;NCT00852566;NCT00390793;NCT00101595;NCT00529763;NCT03610971;NCT01256398;NCT02420717;NCT01844765;NCT04216563;NCT01690065;NCT00949988;NCT02523976;NCT01802450;NCT00255346;NCT01916785;NCT01724879;NCT01620216;NCT00101816;NCT00036738;NCT02888990;NCT01460160;NCT01602952;NCT04126681;NCT01627132;NCT01887561;NCT03625388;NCT04329325;NCT00320190;NCT00112775;NCT04147533;NCT01850004;NCT01319981;NCT02043587;NCT04233346;NCT00101647;NCT04626024;NCT01876953"},{"ligand":"dasatinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2005","completion_date":"2020","nct_id":"NCT03079505;NCT02883049;NCT02890784;NCT03117751;NCT02108951;NCT04375683;NCT00481247;NCT01460693;NCT03746054;NCT00123474;NCT00720109;NCT03564470;NCT02326311;NCT00549848;NCT02013648;NCT00362466;NCT03020030;NCT00123487;NCT03624530;NCT04530565;NCT00349518"},{"ligand":"dasatinib","mesh_id":"D007938","phase":"Phase 4","start_date":"2012","completion_date":"2019","nct_id":"NCT02690922;NCT02389920;NCT04155411;NCT03216070;NCT01660906;NCT01901666"},{"ligand":"duvelisib","mesh_id":"D007938","phase":"Phase 1","start_date":"2013","completion_date":"2019","nct_id":"NCT03892044;NCT01871675;NCT02640833"},{"ligand":"duvelisib","mesh_id":"D007938","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT02028039;NCT03534323;NCT02158091;NCT03370185;NCT03961672;NCT04209621"},{"ligand":"duvelisib","mesh_id":"D007938","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT02049515;NCT02004522"},{"ligand":"erlotinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01664897;NCT01174043"},{"ligand":"everolimus","mesh_id":"D007938","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT03740334;NCT01154439;NCT00544999;NCT01523977;NCT01088048;NCT02900716;NCT00636922;NCT03328104;NCT00671112;NCT03878524"},{"ligand":"everolimus","mesh_id":"D007938","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT00935792;NCT00968253;NCT00093639;NCT01188889;NCT04305444;NCT00918333;NCT00762632;NCT00081874;NCT00436618"},{"ligand":"gefitinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00130702"},{"ligand":"gilteritinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT03625505;NCT02181660;NCT04655391;NCT02236013"},{"ligand":"gilteritinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT04140487;NCT03730012;NCT02927262;NCT02014558;NCT02115295;NCT04240002;NCT03013998;NCT03836209;NCT04477291;NCT02310321;NCT04336982"},{"ligand":"gilteritinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2015","completion_date":"2019","nct_id":"NCT02997202;NCT02752035;NCT04027309;NCT03182244;NCT02421939"},{"ligand":"ibrutinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2009","completion_date":"2021","nct_id":"NCT02759016;NCT02640209;NCT03479268;NCT02787369;NCT02537613;NCT02200848;NCT03422393;NCT02109224;NCT02556892;NCT02815059;NCT02303392;NCT01292135;NCT01886859;NCT01644253;NCT02160015;NCT04781855;NCT00849654;NCT03447808;NCT02611908;NCT02635074;NCT02614508;NCT02381080;NCT03400176"},{"ligand":"ibrutinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02662296;NCT02518555;NCT02689141;NCT02406742;NCT02910583;NCT02007044;NCT03162536;NCT03267186;NCT04155710;NCT02639910;NCT03708003;NCT02997761;NCT02912754;NCT03943342;NCT03873493;NCT04665115;NCT03734198;NCT02232386;NCT03045328;NCT04419389;NCT02869633;NCT03128879;NCT02666898;NCT02742090;NCT03513562;NCT04758975;NCT04010968;NCT03331198;NCT02514083;NCT03153202;NCT04754035;NCT02733042;NCT04685915;NCT04477291;NCT02420912;NCT02351037;NCT04771507;NCT03755947;NCT02629809;NCT02677948;NCT02427451;NCT02251548;NCT01520519;NCT03572634;NCT03280160;NCT02141282;NCT03514017;NCT02129062;NCT03980002;NCT03265717;NCT02332980;NCT03207555;NCT01752426;NCT04016805;NCT02758665;NCT02649387;NCT04230304;NCT02005289;NCT01217749;NCT02388048;NCT01109069;NCT01841723;NCT01105247;NCT01744691;NCT01589302;NCT02557516;NCT02756897;NCT02315768;NCT03370185;NCT04209621;NCT01500733;NCT03740529;NCT03226301"},{"ligand":"ibrutinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2012","completion_date":"2021","nct_id":"NCT01722487;NCT01724346;NCT02264574;NCT02048813;NCT02991638;NCT03701282;NCT02477696;NCT02863718;NCT03642236;NCT03734016;NCT02950051;NCT02801578;NCT02301156;NCT01578707;NCT01611090;NCT01973387;NCT03737981;NCT01886872;NCT04608318;NCT03462719;NCT04666038"},{"ligand":"ibrutinib","mesh_id":"D007938","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03190330"},{"ligand":"imatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT00324077;NCT00686218;NCT00306202;NCT00346632;NCT02081378;NCT00852709;NCT00101088;NCT01077544;NCT00103701;NCT00040105;NCT01933906;NCT01795716;NCT00860535;NCT00025415;NCT01397734;NCT00428909;NCT00301093;NCT00233961;NCT01751425;NCT01460498;NCT00047502;NCT01130688;NCT00827138;NCT00268229;NCT00064285;NCT00258271;NCT00066326;NCT00064233;NCT01426334;NCT03228303;NCT01214655;NCT00352677;NCT01066468;NCT00004932;NCT00100997;NCT03878524"},{"ligand":"imatinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT00261846;NCT00298987;NCT01698905;NCT01383447;NCT00136409;NCT00048672;NCT00990249;NCT04578847;NCT00866736;NCT01872442;NCT00042003;NCT00101660;NCT00219726;NCT00511121;NCT01392170;NCT00777036;NCT00815321;NCT00006053;NCT00511069;NCT00006052;NCT00384228;NCT00042016;NCT03578367;NCT00750659;NCT01279473;NCT00244829;NCT00022490;NCT00045422;NCT00070499;NCT00458848;NCT00858806;NCT00416884;NCT00015834;NCT00982488;NCT02687425;NCT00363649;NCT00103844;NCT02767063;NCT00171223;NCT03516279;NCT00895297;NCT01312818;NCT01227135;NCT00049192;NCT01126814;NCT00149136;NCT00493181;NCT00219752;NCT00451997;NCT00499889;NCT04709731;NCT00466726;NCT00427791;NCT03023046;NCT00388895;NCT00167180;NCT00171912;NCT00015847;NCT01005758;NCT01593254;NCT00039377;NCT04043676;NCT00093639;NCT00109707;NCT00088231;NCT00114959;NCT01746836;NCT01804985;NCT00482703;NCT00510926;NCT01227356;NCT00769327;NCT01725204;NCT01030718;NCT00030394;NCT00469014;NCT00514969;NCT01004497;NCT04006847;NCT00661180;NCT00558961;NCT00882206;NCT04070443;NCT01883219;NCT02709083;NCT01092741;NCT00130195;NCT01188889;NCT00154349;NCT04688983;NCT00337454;NCT00509093;NCT02398825;NCT00702403;NCT00028847;NCT02852486;NCT00852566;NCT00101595;NCT00529763;NCT01003054;NCT00041990;NCT01616238;NCT03610971;NCT00905398;NCT00267085;NCT00811070;NCT00219765;NCT00110058;NCT00415857;NCT00618501;NCT00973752;NCT01844765;NCT00594555;NCT00763763;NCT00054431;NCT00015860;NCT01690065;NCT00058747;NCT01802450;NCT01503502;NCT00335868;NCT01916785;NCT00038649;NCT00171249;NCT01724879;NCT00415909;NCT00101816;NCT00036738;NCT02888990;NCT00006475;NCT01602952;NCT00375219;NCT04126681;NCT01914484;NCT00287105;NCT00320190;NCT00376467;NCT00112775;NCT00210119;NCT04147533;NCT00038610;NCT02001818;NCT00955916;NCT01319981;NCT02896842;NCT00511303;NCT01005914;NCT00199186;NCT00053248;NCT02538926;NCT01429610;NCT02115672;NCT00101647;NCT04626024;NCT01641107;NCT01221376;NCT00573378;NCT00276926;NCT00079313;NCT03241199;NCT00081133;NCT00061945;NCT01011998"},{"ligand":"imatinib","mesh_id":"D007938","phase":"Phase 3","start_date":"1993","completion_date":"2021","nct_id":"NCT00022737;NCT00514488;NCT00137111;NCT04307576;NCT02174445;NCT03007147;NCT02108951;NCT00802841;NCT04375683;NCT00481247;NCT02103322;NCT00237120;NCT01460693;NCT03459534;NCT02115386;NCT03746054;NCT00519090;NCT00123474;NCT02272777;NCT01085617;NCT01755325;NCT00006343;NCT00055874;NCT00574873;NCT00327678;NCT02326311;NCT00264160;NCT01254188;NCT00471497;NCT00795756;NCT01511289;NCT03589326;NCT00050531;NCT00362466;NCT01275196;NCT00002514;NCT00123487;NCT00760877;NCT00327262;NCT02881086;NCT02130557;NCT03624530;NCT00219739;NCT02627677;NCT00124748;NCT01650805;NCT03515018;NCT01819389;NCT00349518;NCT01126892;NCT00333840;NCT03722420;NCT04722848"},{"ligand":"imatinib","mesh_id":"D007938","phase":"Phase 4","start_date":"2003","completion_date":"2016","nct_id":"NCT02317159;NCT00390897;NCT00786812;NCT02204722;NCT01243489;NCT02894645;NCT00081926;NCT01043874;NCT00171899;NCT00644878;NCT02602314;NCT01368523;NCT00461929;NCT00980018;NCT00845221;NCT01131325;NCT01660906;NCT01901666;NCT01491763"},{"ligand":"larotrectinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03834961"},{"ligand":"lenvatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D007938","phase":"Phase 1","start_date":"2004","completion_date":"2019","nct_id":"NCT03900949;NCT00093600;NCT02078609;NCT01130662;NCT01174888;NCT04075747"},{"ligand":"midostaurin","mesh_id":"D007938","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT02634827;NCT01093573;NCT00233454;NCT02115295;NCT01477606;NCT00866281;NCT03951961;NCT03836209;NCT03280030;NCT01846624;NCT03760445;NCT04477291;NCT03226418;NCT01883362;NCT04385290;NCT01202877;NCT03207334;NCT03686345;NCT00045942;NCT00782067;NCT03609060"},{"ligand":"midostaurin","mesh_id":"D007938","phase":"Phase 3","start_date":"2008","completion_date":"2019","nct_id":"NCT02665065;NCT03512197;NCT03092674;NCT04027309;NCT03379727;NCT00651261"},{"ligand":"neratinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2009","completion_date":"2017","nct_id":"NCT01220648;NCT02081378;NCT01077544;NCT00860535;NCT01397734;NCT02225574;NCT01751425;NCT01460498;NCT01702064;NCT00827138;NCT01456676;NCT03228303"},{"ligand":"nilotinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01667133;NCT01698905;NCT04578847;NCT01784068;NCT01392170;NCT00384228;NCT01274351;NCT03578367;NCT00750659;NCT01279473;NCT03654768;NCT01218477;NCT02767063;NCT03516279;NCT01806571;NCT00109707;NCT01746836;NCT01804985;NCT00769327;NCT01207440;NCT04006847;NCT01883219;NCT02709083;NCT01222143;NCT00702403;NCT00809211;NCT00129740;NCT03610971;NCT00905398;NCT00844298;NCT02917720;NCT01294618;NCT01844765;NCT04216563;NCT01690065;NCT00036738;NCT01602952;NCT04126681;NCT01914484;NCT00762632;NCT03874858;NCT04147533;NCT02001818;NCT01528085;NCT04233346;NCT02353728;NCT04626024;NCT00573378;NCT01670084"},{"ligand":"nilotinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2007","completion_date":"2020","nct_id":"NCT03079505;NCT02201459;NCT02174445;NCT02108951;NCT00802841;NCT04375683;NCT01535391;NCT02115386;NCT03746054;NCT00519090;NCT02272777;NCT02326311;NCT01254188;NCT00471497;NCT01275196;NCT00760877;NCT02627677;NCT01819389;NCT03942094;NCT01126892;NCT01657604"},{"ligand":"nilotinib","mesh_id":"D007938","phase":"Phase 4","start_date":"2008","completion_date":"2016","nct_id":"NCT00786812;NCT01043874;NCT02389920;NCT00644878;NCT02602314;NCT01368523;NCT01227577;NCT00980018;NCT03332511;NCT01131325;NCT01901666"},{"ligand":"nintedanib","mesh_id":"D007938","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03513484"},{"ligand":"nintedanib","mesh_id":"D007938","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02665143;NCT01488344"},{"ligand":"palbociclib","mesh_id":"D007938","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT03515200;NCT01701375;NCT03472573;NCT03792256;NCT03132454;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D007938","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03844997;NCT02310243"},{"ligand":"pazopanib","mesh_id":"D007938","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01361334"},{"ligand":"pemigatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04659616"},{"ligand":"pertuzumab","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00660920;NCT02779283;NCT03878524"},{"ligand":"ponatinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01667133;NCT02629692;NCT04188405;NCT02829840;NCT04501614;NCT03895671;NCT02767063;NCT03147612;NCT04554459;NCT04709731;NCT04043676;NCT01746836;NCT01424982;NCT04475731;NCT01207440;NCT04070443;NCT01883219;NCT04688983;NCT02398825;NCT04747912;NCT03934372;NCT03263572;NCT01570868;NCT02467270;NCT01620216;NCT03807479;NCT04233346;NCT01641107;NCT03576547"},{"ligand":"ponatinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2012","completion_date":"2021","nct_id":"NCT03746054;NCT03589326;NCT03624530;NCT02627677;NCT01650805;NCT04530565;NCT04722848"},{"ligand":"quizartinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2007","completion_date":"2018","nct_id":"NCT02834390;NCT03552029;NCT03723681;NCT01390337;NCT00462761;NCT01411267;NCT01468467"},{"ligand":"quizartinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT03661307;NCT04107727;NCT01892371;NCT02829840;NCT04493138;NCT03735875;NCT03793478;NCT04128748;NCT04477291;NCT04112589;NCT02984995;NCT01565668;NCT04209725;NCT00989261;NCT04047641;NCT04687761"},{"ligand":"quizartinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2014","completion_date":"2016","nct_id":"NCT02668653;NCT02039726"},{"ligand":"regorafenib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ribociclib","mesh_id":"D007938","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03740334"},{"ligand":"ruxolitinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT02528877;NCT03515200;NCT01164163;NCT03571321;NCT01751425;NCT01702064;NCT02494882;NCT03017820;NCT03874052;NCT02779283;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT03722407;NCT03654768;NCT04055844;NCT02912754;NCT04669210;NCT03286530;NCT02015208;NCT02131584;NCT03558607;NCT03610971;NCT02257138;NCT03041636;NCT01712659;NCT01251965;NCT02420717;NCT01776723;NCT01620216;NCT02723994;NCT01914484;NCT01319981;NCT02092324;NCT03613428;NCT00674479"},{"ligand":"ruxolitinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03117751"},{"ligand":"selumetinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2007","completion_date":"2018","nct_id":"NCT00588809;NCT03705507"},{"ligand":"sirolimus","mesh_id":"D007938","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT04473911;NCT00101088;NCT02528877;NCT00602693;NCT01822015;NCT01614197;NCT02226861;NCT01658007;NCT02728700;NCT00068302;NCT01523977;NCT02861040;NCT00874562;NCT01184885;NCT00973804;NCT01088048;NCT03018223;NCT00780104;NCT00513474;NCT00473551;NCT01756118;NCT00957320;NCT01634217;NCT01403415;NCT00861874;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D007938","phase":"Phase 2","start_date":"1996","completion_date":"2020","nct_id":"NCT00105001;NCT00002790;NCT04339101;NCT00290472;NCT00795886;NCT01869114;NCT00634244;NCT01027000;NCT00691015;NCT01116232;NCT00935792;NCT03670966;NCT00133367;NCT00084916;NCT00775593;NCT00144703;NCT01611116;NCT00144677;NCT02583893;NCT01251575;NCT02790515;NCT02793544;NCT00776373;NCT00317785;NCT00792948;NCT01188889;NCT00074490;NCT02061800;NCT01363297;NCT01488253;NCT03434704;NCT03970096;NCT03246906;NCT01885689;NCT02756572;NCT00918333;NCT00544466;NCT03192397;NCT00577278;NCT00235560;NCT00544115;NCT00589563;NCT00086840;NCT01162551;NCT02991898;NCT00520130;NCT03128034;NCT00089037;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D007938","phase":"Phase 3","start_date":"2006","completion_date":"2012","nct_id":"NCT01539291;NCT00406393;NCT00382109;NCT01231412;NCT01188798"},{"ligand":"sorafenib","mesh_id":"D007938","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00303797;NCT00908167;NCT00943943;NCT00217646;NCT01861314;NCT00665990;NCT00875745;NCT00131989;NCT01159301;NCT03132454;NCT02779283;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D007938","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT00303966;NCT01534260;NCT02829840;NCT00542971;NCT01253070;NCT02135874;NCT00661180;NCT02196857;NCT03164057;NCT04752527;NCT00516828;NCT02530476;NCT01510756;NCT02728050;NCT01620216;NCT03247088;NCT00893373;NCT01445080;NCT04326439;NCT01254890"},{"ligand":"sorafenib","mesh_id":"D007938","phase":"Phase 3","start_date":"2011","completion_date":"2020","nct_id":"NCT01371981;NCT04674345;NCT02665065;NCT03642236;NCT02474290"},{"ligand":"sunitinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT02779283;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00451048;NCT00398112;NCT00387426;NCT01620216"},{"ligand":"trametinib","mesh_id":"D007938","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT02016729;NCT03878524"},{"ligand":"trametinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT01907815;NCT04487106;NCT03190915;NCT00920140"},{"ligand":"trastuzumab","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D007938","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00724360"},{"ligand":"vemurafenib","mesh_id":"D007938","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D007938","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT03410875;NCT01711632"},{"ligand":"zanubrutinib","mesh_id":"D007938","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04458610;NCT03162536;NCT03824483;NCT04477291;NCT03206918;NCT03740529"},{"ligand":"zanubrutinib","mesh_id":"D007938","phase":"Phase 3","start_date":"2017","completion_date":"2021","nct_id":"NCT03336333;NCT03734016;NCT04666038"}],"predictions":[{"target":"FGFR1","probability":"0.91"},{"target":"FGFR2","probability":"0.8650864779874214"},{"target":"PTK7","probability":"0.85"},{"target":"AXL","probability":"0.845"},{"target":"ROR2","probability":"0.8250891410048622"},{"target":"IGF1R","probability":"0.815"},{"target":"PTK2","probability":"0.81"},{"target":"FGFR3","probability":"0.8050891410048622"},{"target":"EPHA2","probability":"0.8016666666666665"},{"target":"BMPR1B","probability":"0.8"},{"target":"EPHA4","probability":"0.795"},{"target":"EPHB2","probability":"0.79"},{"target":"YES1","probability":"0.78"},{"target":"ACVR2B","probability":"0.7600891410048622"},{"target":"TIE1","probability":"0.7600370370370371"},{"target":"ACVR1B","probability":"0.755"},{"target":"EPHB4","probability":"0.75"},{"target":"FYN","probability":"0.7450877192982456"},{"target":"CCL5","probability":"0.7400864779874214"},{"target":"NLK","probability":"0.74"},{"target":"INSR","probability":"0.73"},{"target":"MERTK","probability":"0.7250891410048622"},{"target":"PIM2","probability":"0.7202411435615411"},{"target":"TNK2","probability":"0.72"},{"target":"TYRO3","probability":"0.715"},{"target":"MAP4K4","probability":"0.7000891410048622"},{"target":"GRK4","probability":"0.7000287356321838"},{"target":"TGFBR2","probability":"0.695"},{"target":"BCR","probability":"0.6902238903290778"},{"target":"PTK6","probability":"0.6802496348320227"},{"target":"EPHA8","probability":"0.6801323548332874"},{"target":"TEC","probability":"0.6800891410048622"},{"target":"MST1R","probability":"0.675"},{"target":"EPHA1","probability":"0.6702152383527078"},{"target":"MAPK13","probability":"0.6651604938271605"},{"target":"IKBKE","probability":"0.6650716633305589"},{"target":"GRK3","probability":"0.665"},{"target":"ACVR1","probability":"0.665"},{"target":"TGFBR1","probability":"0.6600891410048623"},{"target":"CSK","probability":"0.660043213828425"},{"target":"PAK1","probability":"0.6552653815977627"},{"target":"ILK","probability":"0.6552004465328277"},{"target":"PRKCQ","probability":"0.655"},{"target":"CDKL2","probability":"0.650043213828425"},{"target":"FGFR4","probability":"0.6457142857142857"},{"target":"PRKCD","probability":"0.6450864779874215"},{"target":"IKBKB","probability":"0.6400432138284251"},{"target":"PRKCZ","probability":"0.6352004465328277"},{"target":"CAMK4","probability":"0.6350891410048622"},{"target":"ACVR2A","probability":"0.635"},{"target":"PRKD1","probability":"0.63"},{"target":"PRKCB","probability":"0.6272628240034263"},{"target":"GRK2","probability":"0.6255748997098338"},{"target":"CCL3","probability":"0.6252822124498529"},{"target":"TAOK2","probability":"0.6251572327044026"},{"target":"MAP3K3","probability":"0.6250891410048622"},{"target":"PAK2","probability":"0.6250432138284251"},{"target":"MAP2K7","probability":"0.625"},{"target":"MAP3K8","probability":"0.6200432138284251"},{"target":"CHUK","probability":"0.6150432138284251"},{"target":"GRK5","probability":"0.6102974743381956"},{"target":"BMPR1A","probability":"0.61"},{"target":"ACVRL1","probability":"0.61"},{"target":"TRIM28","probability":"0.6050577065820483"},{"target":"SYK","probability":"0.600834282780816"},{"target":"CCL2","probability":"0.6001630434782609"},{"target":"AKT1","probability":"0.6"},{"target":"RPS6KB2","probability":"0.6"},{"target":"NME2","probability":"0.5973714316536555"},{"target":"PTK2B","probability":"0.5950432138284252"},{"target":"ITK","probability":"0.5907142857142857"},{"target":"NPR2","probability":"0.585"},{"target":"HCK","probability":"0.5806410399153816"},{"target":"CDK20","probability":"0.5801081488933602"},{"target":"RPS6KB1","probability":"0.5800432138284252"},{"target":"CDK8","probability":"0.5800432138284252"},{"target":"BMPR2","probability":"0.580037037037037"},{"target":"ALPK1","probability":"0.5767174432497013"},{"target":"DCLK1","probability":"0.5751350264662478"},{"target":"AKT3","probability":"0.5706164383561644"},{"target":"MAP3K4","probability":"0.5700891410048622"},{"target":"WNK1","probability":"0.5668903940886699"},{"target":"MAP3K1","probability":"0.5651572327044025"},{"target":"PBK","probability":"0.5600891410048622"},{"target":"MAP3K11","probability":"0.5600891410048622"},{"target":"SIK1","probability":"0.5600891410048622"},{"target":"IRAK4","probability":"0.5554979208710232"},{"target":"CAMK2G","probability":"0.5553253043899151"},{"target":"MAP2K3","probability":"0.5551524351545725"},{"target":"STK39","probability":"0.5550716633305588"},{"target":"PRKCG","probability":"0.555"},{"target":"EIF2AK1","probability":"0.5501610904654712"},{"target":"PDPK1","probability":"0.5500891410048623"},{"target":"RPS6KA5","probability":"0.5450891410048623"},{"target":"GRK6","probability":"0.5450891410048623"},{"target":"PIM1","probability":"0.5413584407488155"},{"target":"PIM3","probability":"0.5402496348320227"},{"target":"TRPM7","probability":"0.5402463737092648"},{"target":"IRAK3","probability":"0.5401610904654712"},{"target":"CSNK1G2","probability":"0.5353448275862069"},{"target":"MAP3K14","probability":"0.5352493398383321"},{"target":"MAP2K6","probability":"0.5351323548332874"},{"target":"MAP3K2","probability":"0.5350891410048623"},{"target":"TRIM24","probability":"0.535"},{"target":"EIF2AK2","probability":"0.5303355547934486"},{"target":"PRKCA","probability":"0.5302004465328277"},{"target":"PRKCE","probability":"0.5301898734177215"},{"target":"RPS6KA1","probability":"0.5301323548332874"},{"target":"RPS6KA3","probability":"0.5301323548332874"},{"target":"AKT2","probability":"0.5300432138284251"},{"target":"MAPK7","probability":"0.5259137495324573"},{"target":"RIPK3","probability":"0.5252567351919647"},{"target":"PAK4","probability":"0.5252538783942292"},{"target":"LIMK1","probability":"0.525043213828425"},{"target":"GSK3B","probability":"0.5204058973986262"},{"target":"EPHB3","probability":"0.52"},{"target":"MUSK","probability":"0.52"},{"target":"KSR1","probability":"0.5150891410048622"},{"target":"ANKK1","probability":"0.515"},{"target":"PLK4","probability":"0.5119641410048622"},{"target":"LATS1","probability":"0.5101974608415347"},{"target":"EPHB1","probability":"0.51"},{"target":"PDK1","probability":"0.5071097361182813"},{"target":"MKNK2","probability":"0.5052496348320227"},{"target":"AVP","probability":"0.505"},{"target":"CDK14","probability":"0.505"},{"target":"PLK2","probability":"0.502309906390895"},{"target":"RIPK2","probability":"0.5004547070425981"},{"target":"VRK3","probability":"0.5000175378206146"},{"target":"MAP3K21","probability":"0.5"},{"target":"IRAK1","probability":"0.4953358178257535"},{"target":"CAMK1","probability":"0.49508914100486223"},{"target":"MAPK11","probability":"0.49508914100486223"},{"target":"MYLK3","probability":"0.495"},{"target":"WNK4","probability":"0.495"},{"target":"CSNK2B","probability":"0.495"},{"target":"PDK4","probability":"0.4906451739883483"},{"target":"MAP2K4","probability":"0.49054558803014026"},{"target":"EIF2AK3","probability":"0.4904428684332231"},{"target":"MAPK12","probability":"0.4901604938271605"},{"target":"TTK","probability":"0.48645370765558554"},{"target":"SMG1","probability":"0.48584321382842505"},{"target":"BRD4","probability":"0.4855860557054067"},{"target":"RPS6KA2","probability":"0.48514350559153885"},{"target":"CDK2","probability":"0.485"},{"target":"LATS2","probability":"0.48032957719055636"},{"target":"DMPK","probability":"0.4802235124237233"},{"target":"MAPK9","probability":"0.4801840396419334"},{"target":"MAPK3","probability":"0.48"},{"target":"MAPKAPK2","probability":"0.4760645582231178"},{"target":"RIPK1","probability":"0.4752674712177041"},{"target":"AURKA","probability":"0.47046666666666664"},{"target":"BUB1","probability":"0.47004321382842507"},{"target":"PLK1","probability":"0.47"},{"target":"CDK7","probability":"0.4652004465328276"},{"target":"PLK3","probability":"0.4650891410048622"},{"target":"ERN1","probability":"0.4607868670519343"},{"target":"ZAP70","probability":"0.46074764244182675"},{"target":"MKNK1","probability":"0.4601435055915388"},{"target":"SRPK1","probability":"0.4600891410048622"},{"target":"PRKACA","probability":"0.46"},{"target":"CDKN1A","probability":"0.46"},{"target":"MAPK1","probability":"0.46"},{"target":"STK11","probability":"0.457578617930454"},{"target":"CDK9","probability":"0.4557011313495006"}],"source_name":"Leukemia"}],["D007951",{"mesh_id":"D007951","trials":[{"ligand":"abemaciclib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"acalabrutinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT03013998;NCT04477291"},{"ligand":"afatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"axitinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2003","completion_date":"2015","nct_id":"NCT02638428;NCT00071006"},{"ligand":"binimetinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2014","completion_date":"2015","nct_id":"NCT02225574;NCT02049801"},{"ligand":"binimetinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02089230"},{"ligand":"bosutinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2008","completion_date":"2021","nct_id":"NCT02782403;NCT00759837;NCT04655391"},{"ligand":"bosutinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2007","completion_date":"2021","nct_id":"NCT04578847;NCT03205267;NCT03654768;NCT03128411;NCT02767063;NCT02906696;NCT04709731;NCT04258943;NCT03831776;NCT02445742;NCT04006847;NCT02311998;NCT03610971;NCT00811070;NCT02810990;NCT04626024"},{"ligand":"bosutinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2014","completion_date":"2019","nct_id":"NCT03746054;NCT03106779;NCT02130557"},{"ligand":"bosutinib","mesh_id":"D007951","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02228382"},{"ligand":"cabozantinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01961765;NCT03878524"},{"ligand":"cetuximab","mesh_id":"D007951","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"cobimetinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02670044;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"crizotinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02638428"},{"ligand":"dabrafenib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00316953;NCT00324077;NCT00732186;NCT02680951;NCT00500006;NCT02081378;NCT00978731;NCT03414450;NCT01077544;NCT00103701;NCT04580121;NCT00860535;NCT00345826;NCT01397734;NCT02047149;NCT01751425;NCT03595917;NCT01460498;NCT01643603;NCT00892190;NCT00816283;NCT00064233;NCT01426334;NCT02011945;NCT02779283;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01667133;NCT00298987;NCT04578847;NCT00866736;NCT01872442;NCT00101660;NCT02638428;NCT01392170;NCT03205267;NCT01238211;NCT02923986;NCT03654768;NCT00070499;NCT00982488;NCT00103844;NCT02767063;NCT03516279;NCT00895297;NCT00254423;NCT00493181;NCT01606579;NCT01593254;NCT01746836;NCT01804985;NCT00482703;NCT02113319;NCT02689440;NCT01725204;NCT01207440;NCT01030718;NCT04006847;NCT02709083;NCT00850382;NCT01342679;NCT00337454;NCT01498445;NCT00852566;NCT00101595;NCT03610971;NCT01844765;NCT04216563;NCT01690065;NCT01802450;NCT00255346;NCT01916785;NCT01620216;NCT00101816;NCT00036738;NCT01602952;NCT04126681;NCT01627132;NCT01887561;NCT03625388;NCT00320190;NCT00112775;NCT04147533;NCT01850004;NCT04233346;NCT00101647;NCT04626024;NCT01876953"},{"ligand":"dasatinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2005","completion_date":"2019","nct_id":"NCT03079505;NCT02890784;NCT02108951;NCT00481247;NCT01460693;NCT03746054;NCT00123474;NCT02013648;NCT00362466;NCT00123487"},{"ligand":"dasatinib","mesh_id":"D007951","phase":"Phase 4","start_date":"2012","completion_date":"2019","nct_id":"NCT04155411;NCT03216070;NCT01660906;NCT01901666"},{"ligand":"erlotinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2013","completion_date":"2015","nct_id":"NCT02638428;NCT01664897"},{"ligand":"everolimus","mesh_id":"D007951","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01154439;NCT00544999;NCT00636922;NCT03878524"},{"ligand":"everolimus","mesh_id":"D007951","phase":"Phase 2","start_date":"2004","completion_date":"2015","nct_id":"NCT02638428;NCT00093639;NCT01188889;NCT00762632"},{"ligand":"gefitinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00130702"},{"ligand":"gilteritinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT03625505;NCT02181660;NCT04655391;NCT02236013"},{"ligand":"gilteritinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT04140487;NCT03730012;NCT02927262;NCT02014558;NCT02115295;NCT02561455;NCT04240002;NCT03013998;NCT03836209;NCT04477291;NCT02310321;NCT04336982"},{"ligand":"gilteritinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2015","completion_date":"2019","nct_id":"NCT02997202;NCT02752035;NCT04027309;NCT03182244;NCT02421939"},{"ligand":"ibrutinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02635074"},{"ligand":"ibrutinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04477291;NCT02351037"},{"ligand":"ibrutinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03642236"},{"ligand":"imatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT00324077;NCT00346632;NCT02081378;NCT00852709;NCT00101088;NCT01077544;NCT00103701;NCT00040105;NCT01933906;NCT01795716;NCT00860535;NCT00025415;NCT01397734;NCT00428909;NCT01751425;NCT01460498;NCT00047502;NCT01130688;NCT00066326;NCT00064233;NCT01426334;NCT03228303;NCT00352677;NCT01066468;NCT00100997;NCT03878524;NCT00455221"},{"ligand":"imatinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT00298987;NCT01698905;NCT00048672;NCT04578847;NCT00866736;NCT01872442;NCT00042003;NCT00101660;NCT02638428;NCT00511121;NCT01392170;NCT00815321;NCT03205267;NCT00006053;NCT00006052;NCT00384228;NCT00042016;NCT03578367;NCT00750659;NCT01279473;NCT00022490;NCT00045422;NCT00070499;NCT00481052;NCT00858806;NCT00015834;NCT00982488;NCT02687425;NCT00103844;NCT02767063;NCT00171223;NCT03516279;NCT00895297;NCT00049192;NCT00493181;NCT00451997;NCT04709731;NCT00466726;NCT00167180;NCT00015847;NCT01593254;NCT04043676;NCT00093639;NCT00109707;NCT00088231;NCT00114959;NCT01746836;NCT01804985;NCT00482703;NCT02888964;NCT00510926;NCT01227356;NCT02480608;NCT01725204;NCT01030718;NCT00030394;NCT00469014;NCT00514969;NCT04006847;NCT00661180;NCT04070443;NCT02709083;NCT01092741;NCT01188889;NCT00337454;NCT00509093;NCT02398825;NCT00702403;NCT00852566;NCT00101595;NCT01003054;NCT00041990;NCT03610971;NCT00267085;NCT00811070;NCT00110058;NCT01844765;NCT00594555;NCT00763763;NCT00054431;NCT01690065;NCT00058747;NCT01802450;NCT01503502;NCT00335868;NCT01916785;NCT00038649;NCT00171249;NCT00415909;NCT00101816;NCT00036738;NCT00006475;NCT01602952;NCT00375219;NCT04126681;NCT01914484;NCT00320190;NCT00146913;NCT00112775;NCT00210119;NCT04147533;NCT02001818;NCT02896842;NCT00511303;NCT00053248;NCT02115672;NCT00101647;NCT04626024;NCT01221376;NCT00573378;NCT00079313;NCT03241199;NCT00081133;NCT01774630;NCT01011998"},{"ligand":"imatinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2000","completion_date":"2019","nct_id":"NCT00514488;NCT02174445;NCT02108951;NCT00802841;NCT00481247;NCT02103322;NCT00237120;NCT01460693;NCT03459534;NCT02115386;NCT03746054;NCT00519090;NCT00123474;NCT02272777;NCT01755325;NCT01743989;NCT00006343;NCT00055874;NCT00264160;NCT01254188;NCT00471497;NCT01511289;NCT00050531;NCT00297570;NCT00362466;NCT01275196;NCT00123487;NCT00760877;NCT00327262;NCT02130557;NCT02627677;NCT00124748;NCT01650805;NCT01819389;NCT01827930;NCT01126892;NCT00333840;NCT03722420"},{"ligand":"imatinib","mesh_id":"D007951","phase":"Phase 4","start_date":"2003","completion_date":"2016","nct_id":"NCT02317159;NCT00390897;NCT00786812;NCT02204722;NCT01243489;NCT00081926;NCT01043874;NCT00171899;NCT00644878;NCT02602314;NCT01368523;NCT00461929;NCT00980018;NCT00845221;NCT01131325;NCT01660906;NCT01901666"},{"ligand":"lenvatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D007951","phase":"Phase 1","start_date":"2004","completion_date":"2019","nct_id":"NCT01161550;NCT03900949;NCT00093600;NCT01130662;NCT01174888;NCT04075747"},{"ligand":"midostaurin","mesh_id":"D007951","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT02634827;NCT01093573;NCT02115295;NCT01477606;NCT00866281;NCT03951961;NCT03591510;NCT03836209;NCT03280030;NCT01846624;NCT01830361;NCT03760445;NCT04477291;NCT03226418;NCT01883362;NCT04385290;NCT03207334;NCT00045942;NCT03609060"},{"ligand":"midostaurin","mesh_id":"D007951","phase":"Phase 3","start_date":"2008","completion_date":"2019","nct_id":"NCT02665065;NCT03512197;NCT03092674;NCT04027309;NCT03379727;NCT00651261"},{"ligand":"neratinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2009","completion_date":"2017","nct_id":"NCT01220648;NCT02081378;NCT01077544;NCT00860535;NCT01397734;NCT02225574;NCT01751425;NCT01460498;NCT01702064;NCT01456676;NCT03228303"},{"ligand":"nilotinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01667133;NCT01698905;NCT04578847;NCT01784068;NCT01392170;NCT03205267;NCT00384228;NCT01274351;NCT03578367;NCT00750659;NCT01279473;NCT03654768;NCT00481052;NCT02767063;NCT03516279;NCT01856283;NCT01806571;NCT00109707;NCT01746836;NCT01804985;NCT01207440;NCT04006847;NCT02709083;NCT01222143;NCT00702403;NCT00809211;NCT00129740;NCT03610971;NCT02917720;NCT01294618;NCT01844765;NCT04216563;NCT01690065;NCT00036738;NCT01602952;NCT04126681;NCT01914484;NCT00762632;NCT03874858;NCT04147533;NCT02001818;NCT04233346;NCT02353728;NCT04626024;NCT00573378;NCT01670084;NCT01774630"},{"ligand":"nilotinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2007","completion_date":"2019","nct_id":"NCT03079505;NCT02174445;NCT02108951;NCT00802841;NCT01535391;NCT02115386;NCT03746054;NCT00519090;NCT02272777;NCT01743989;NCT01254188;NCT00471497;NCT01275196;NCT00760877;NCT02627677;NCT01819389;NCT03942094;NCT01126892;NCT01657604"},{"ligand":"nilotinib","mesh_id":"D007951","phase":"Phase 4","start_date":"2008","completion_date":"2016","nct_id":"NCT00786812;NCT02546674;NCT01043874;NCT00644878;NCT02602314;NCT01368523;NCT01227577;NCT00980018;NCT03332511;NCT01131325;NCT01901666"},{"ligand":"nintedanib","mesh_id":"D007951","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03513484"},{"ligand":"nintedanib","mesh_id":"D007951","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02665143;NCT01488344"},{"ligand":"palbociclib","mesh_id":"D007951","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03132454;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D007951","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03844997"},{"ligand":"panitumumab","mesh_id":"D007951","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"pazopanib","mesh_id":"D007951","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT02638428;NCT01361334"},{"ligand":"pemigatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04659616"},{"ligand":"pertuzumab","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00660920;NCT02779283;NCT03878524"},{"ligand":"ponatinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01667133;NCT02629692;NCT04188405;NCT03690115;NCT02829840;NCT04160546;NCT03895671;NCT02767063;NCT03147612;NCT04709731;NCT04043676;NCT01746836;NCT01424982;NCT01207440;NCT04070443;NCT02398825;NCT03934372;NCT03263572;NCT01570868;NCT02467270;NCT01620216;NCT03807479;NCT04233346;NCT03576547"},{"ligand":"ponatinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2012","completion_date":"2019","nct_id":"NCT03746054;NCT02627677;NCT01650805"},{"ligand":"quizartinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2007","completion_date":"2018","nct_id":"NCT02834390;NCT03552029;NCT03723681;NCT01390337;NCT00462761;NCT01468467"},{"ligand":"quizartinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT03661307;NCT04107727;NCT01892371;NCT02829840;NCT03735875;NCT03793478;NCT04128748;NCT04477291;NCT04112589;NCT02984995;NCT01565668;NCT04209725;NCT00989261;NCT04047641;NCT04687761"},{"ligand":"quizartinib","mesh_id":"D007951","phase":"Phase 3","start_date":"2014","completion_date":"2016","nct_id":"NCT02668653;NCT02039726"},{"ligand":"regorafenib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D007951","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"ruxolitinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT02528877;NCT01751425;NCT01702064;NCT03017820;NCT03874052;NCT02779283;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT02638428;NCT03654768;NCT02158858;NCT03286530;NCT03558607;NCT03610971;NCT02257138;NCT01620216;NCT01914484;NCT02092324;NCT00674479"},{"ligand":"selumetinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03326310"},{"ligand":"selumetinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00588809"},{"ligand":"sirolimus","mesh_id":"D007951","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00101088;NCT02528877;NCT01822015;NCT02226861;NCT02728700;NCT00780104;NCT01756118;NCT01634217;NCT00861874;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D007951","phase":"Phase 2","start_date":"2003","completion_date":"2019","nct_id":"NCT00105001;NCT01869114;NCT00634244;NCT03670966;NCT00133367;NCT00084916;NCT00775593;NCT01611116;NCT00144677;NCT02583893;NCT02109744;NCT01251575;NCT02790515;NCT01188889;NCT01488253;NCT01885689;NCT02756572;NCT00235560;NCT02991898;NCT03128034"},{"ligand":"sirolimus","mesh_id":"D007951","phase":"Phase 3","start_date":"2006","completion_date":"2010","nct_id":"NCT00406393;NCT01188798"},{"ligand":"sorafenib","mesh_id":"D007951","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00943943;NCT00217646;NCT01861314;NCT00875745;NCT00131989;NCT01159301;NCT03132454;NCT02779283;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D007951","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT02638428;NCT01534260;NCT02829840;NCT00542971;NCT01253070;NCT00373373;NCT00661180;NCT02196857;NCT03164057;NCT04752527;NCT02530476;NCT02728050;NCT01620216;NCT03247088;NCT00893373;NCT01445080;NCT04326439"},{"ligand":"sorafenib","mesh_id":"D007951","phase":"Phase 3","start_date":"2011","completion_date":"2018","nct_id":"NCT01371981;NCT02665065;NCT03642236;NCT02474290"},{"ligand":"sunitinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT02779283;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00387426;NCT00783653;NCT01620216"},{"ligand":"trametinib","mesh_id":"D007951","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT02016729;NCT01428427;NCT03878524"},{"ligand":"trametinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT01907815;NCT04487106"},{"ligand":"trastuzumab","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D007951","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02638428"},{"ligand":"vandetanib","mesh_id":"D007951","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02638428"},{"ligand":"vemurafenib","mesh_id":"D007951","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D007951","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02638428"},{"ligand":"zanubrutinib","mesh_id":"D007951","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04477291"}],"predictions":[{"target":"FGFR1","probability":"0.87"},{"target":"IGF1R","probability":"0.75"},{"target":"PTK2","probability":"0.735"},{"target":"TIE1","probability":"0.725"},{"target":"EPHB2","probability":"0.725"},{"target":"FGFR2","probability":"0.7151228070175438"},{"target":"FYN","probability":"0.715"},{"target":"EPHB4","probability":"0.6951632611786752"},{"target":"EPHA2","probability":"0.69"},{"target":"PTK7","probability":"0.69"},{"target":"NTRK1","probability":"0.68"},{"target":"ROR2","probability":"0.6750891410048623"},{"target":"AXL","probability":"0.67"},{"target":"SYK","probability":"0.6450585124624564"},{"target":"EPHA4","probability":"0.645"},{"target":"NTRK2","probability":"0.64"},{"target":"EPHA1","probability":"0.6251228070175439"},{"target":"BMPR1B","probability":"0.6150891410048622"},{"target":"INSR","probability":"0.615"},{"target":"TNK2","probability":"0.6100891410048622"},{"target":"TGFBR2","probability":"0.61"},{"target":"ITK","probability":"0.6000335345405768"},{"target":"PAK1","probability":"0.6000200803212852"},{"target":"PTK2B","probability":"0.5851572327044026"},{"target":"TEC","probability":"0.5800891410048622"},{"target":"CCL5","probability":"0.5750055617352614"},{"target":"ACVR2B","probability":"0.5650891410048622"},{"target":"FGFR3","probability":"0.5553310955203943"},{"target":"YES1","probability":"0.5551178766370461"},{"target":"NTRK3","probability":"0.555"},{"target":"BCR","probability":"0.5544209947704348"},{"target":"GRK4","probability":"0.5500287356321839"},{"target":"ILK","probability":"0.5400200803212851"},{"target":"PRKCQ","probability":"0.5300284495021337"},{"target":"AVP","probability":"0.53"},{"target":"MAP4K4","probability":"0.5259982319139531"},{"target":"CSK","probability":"0.5202320575512351"},{"target":"RPS6KB2","probability":"0.52"},{"target":"ACVR1B","probability":"0.5107142857142857"},{"target":"CCL3","probability":"0.5101576994434137"},{"target":"MAP2K7","probability":"0.510048076923077"},{"target":"IKBKE","probability":"0.5050200803212852"},{"target":"CCL2","probability":"0.48516304347826084"},{"target":"CDKL2","probability":"0.4850831940276812"},{"target":"TAOK2","probability":"0.4850827973282207"},{"target":"MAP3K8","probability":"0.4850827973282207"},{"target":"CDK14","probability":"0.4850144927536232"},{"target":"CDK20","probability":"0.485"},{"target":"MAPK13","probability":"0.4800891410048622"},{"target":"IKBKB","probability":"0.4750200803212852"},{"target":"PRKCA","probability":"0.47058251043469407"},{"target":"NLK","probability":"0.47002844950213374"},{"target":"RPS6KB1","probability":"0.46512345679012346"},{"target":"MAP3K3","probability":"0.4650891410048622"},{"target":"FGFR4","probability":"0.4607142857142857"},{"target":"TGFBR1","probability":"0.46018864349242444"},{"target":"PRKCZ","probability":"0.46015151515151514"},{"target":"GRK3","probability":"0.4600891410048622"},{"target":"ANKK1","probability":"0.46002873563218394"},{"target":"ACVR1","probability":"0.45654146353036074"},{"target":"CASK","probability":"0.4550144927536232"},{"target":"PRKACA","probability":"0.455"},{"target":"EPHA8","probability":"0.455"}],"source_name":"Leukemia, Myeloid"}],["D015470",{"mesh_id":"D015470","trials":[{"ligand":"abemaciclib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"acalabrutinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT03013998;NCT04477291"},{"ligand":"afatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00071006"},{"ligand":"binimetinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02049801"},{"ligand":"binimetinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02089230"},{"ligand":"bosutinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04655391"},{"ligand":"cabozantinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01961765;NCT03878524"},{"ligand":"cetuximab","mesh_id":"D015470","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"cobimetinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02670044;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT02680951;NCT03560908;NCT04580121;NCT00892190;NCT02779283;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2005","completion_date":"2017","nct_id":"NCT01238211;NCT02923986;NCT01606579;NCT02113319;NCT00850382;NCT01690065;NCT00255346;NCT01620216;NCT01876953"},{"ligand":"dasatinib","mesh_id":"D015470","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02013648"},{"ligand":"erlotinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01664897;NCT01174043"},{"ligand":"everolimus","mesh_id":"D015470","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT01154439;NCT00544999;NCT00636922;NCT03878524"},{"ligand":"everolimus","mesh_id":"D015470","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00762632"},{"ligand":"gefitinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00130702"},{"ligand":"gilteritinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT03625505;NCT02181660;NCT04655391;NCT02236013"},{"ligand":"gilteritinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT04140487;NCT03730012;NCT02927262;NCT02014558;NCT02115295;NCT02561455;NCT04240002;NCT03013998;NCT03836209;NCT04477291;NCT02310321;NCT04336982"},{"ligand":"gilteritinib","mesh_id":"D015470","phase":"Phase 3","start_date":"2015","completion_date":"2019","nct_id":"NCT02997202;NCT02752035;NCT04027309;NCT03182244;NCT02421939"},{"ligand":"ibrutinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02635074"},{"ligand":"ibrutinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04477291;NCT02351037"},{"ligand":"ibrutinib","mesh_id":"D015470","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03642236"},{"ligand":"imatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00346632;NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT00171223;NCT01126814;NCT00088231;NCT00469014;NCT00509093;NCT00594555;NCT01690065;NCT00171249;NCT00744081;NCT00955916"},{"ligand":"lenvatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D015470","phase":"Phase 1","start_date":"2004","completion_date":"2019","nct_id":"NCT01161550;NCT03900949;NCT00093600;NCT02078609;NCT01130662;NCT01174888;NCT04075747"},{"ligand":"midostaurin","mesh_id":"D015470","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT02634827;NCT01093573;NCT02115295;NCT01477606;NCT00866281;NCT03951961;NCT03591510;NCT03836209;NCT03280030;NCT01846624;NCT01830361;NCT03760445;NCT04477291;NCT03226418;NCT01883362;NCT04385290;NCT03207334;NCT00045942;NCT03609060"},{"ligand":"midostaurin","mesh_id":"D015470","phase":"Phase 3","start_date":"2008","completion_date":"2019","nct_id":"NCT02665065;NCT03512197;NCT03092674;NCT04027309;NCT03379727;NCT00651261"},{"ligand":"neratinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT01806571;NCT01222143;NCT01690065;NCT00762632"},{"ligand":"nintedanib","mesh_id":"D015470","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03513484"},{"ligand":"nintedanib","mesh_id":"D015470","phase":"Phase 2","start_date":"2012","completion_date":"2016","nct_id":"NCT02665143;NCT01488344"},{"ligand":"palbociclib","mesh_id":"D015470","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03132454;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D015470","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03844997;NCT02310243"},{"ligand":"panitumumab","mesh_id":"D015470","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"pazopanib","mesh_id":"D015470","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01361334"},{"ligand":"pemigatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04659616"},{"ligand":"pertuzumab","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02779283;NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT04188405;NCT03690115;NCT02829840;NCT01620216"},{"ligand":"quizartinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2007","completion_date":"2018","nct_id":"NCT02834390;NCT03552029;NCT03723681;NCT01390337;NCT00462761;NCT01411267;NCT01468467"},{"ligand":"quizartinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT03661307;NCT04107727;NCT01892371;NCT02829840;NCT03735875;NCT03793478;NCT04128748;NCT04477291;NCT04112589;NCT02984995;NCT01565668;NCT04209725;NCT00989261;NCT04047641;NCT04687761"},{"ligand":"quizartinib","mesh_id":"D015470","phase":"Phase 3","start_date":"2014","completion_date":"2016","nct_id":"NCT02668653;NCT02039726"},{"ligand":"regorafenib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D015470","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03761914"},{"ligand":"ruxolitinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02528877;NCT03017820;NCT03874052;NCT02779283;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2008","completion_date":"2018","nct_id":"NCT02158858;NCT03286530;NCT03558607;NCT02257138;NCT01620216;NCT00674479"},{"ligand":"selumetinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00588809"},{"ligand":"sirolimus","mesh_id":"D015470","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT04473911;NCT02528877;NCT01822015;NCT02226861;NCT02728700;NCT01756118;NCT01634217;NCT00861874;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D015470","phase":"Phase 2","start_date":"2003","completion_date":"2019","nct_id":"NCT00105001;NCT01869114;NCT00634244;NCT03670966;NCT00084916;NCT00775593;NCT01611116;NCT00144677;NCT02583893;NCT02109744;NCT01251575;NCT02790515;NCT02793544;NCT02061800;NCT01885689;NCT02756572;NCT00235560;NCT02991898;NCT03128034"},{"ligand":"sirolimus","mesh_id":"D015470","phase":"Phase 3","start_date":"2006","completion_date":"2010","nct_id":"NCT00406393;NCT01188798"},{"ligand":"sorafenib","mesh_id":"D015470","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00908167;NCT00943943;NCT00217646;NCT01861314;NCT02412475;NCT00875745;NCT00131989;NCT01159301;NCT03132454;NCT02779283;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D015470","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT01534260;NCT02829840;NCT00542971;NCT01253070;NCT00373373;NCT02196857;NCT03164057;NCT04752527;NCT02530476;NCT02728050;NCT01620216;NCT03247088;NCT00893373;NCT04326439;NCT03622541"},{"ligand":"sorafenib","mesh_id":"D015470","phase":"Phase 3","start_date":"2011","completion_date":"2018","nct_id":"NCT01371981;NCT02665065;NCT03642236;NCT02474290"},{"ligand":"sunitinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT02779283;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00387426;NCT00783653;NCT01620216"},{"ligand":"trametinib","mesh_id":"D015470","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT02016729;NCT01428427;NCT03878524"},{"ligand":"trametinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT01907815;NCT04487106"},{"ligand":"trastuzumab","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D015470","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"zanubrutinib","mesh_id":"D015470","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04477291"}],"predictions":[{"target":"ERBB3","probability":"0.82"},{"target":"FGFR1","probability":"0.72"},{"target":"LCK","probability":"0.69"},{"target":"IGF1R","probability":"0.68"},{"target":"NTRK1","probability":"0.6350115919629057"},{"target":"BCR","probability":"0.5721964582664861"},{"target":"NTRK2","probability":"0.5700666666666667"},{"target":"INSR","probability":"0.57"},{"target":"FGFR2","probability":"0.565"},{"target":"EPHB2","probability":"0.56"},{"target":"SRC","probability":"0.555"},{"target":"FGFR3","probability":"0.5401756189922836"},{"target":"PTK7","probability":"0.5257769321833249"},{"target":"SYK","probability":"0.5252340796216306"},{"target":"EPHB4","probability":"0.515"},{"target":"AXL","probability":"0.51"},{"target":"MAP2K7","probability":"0.5004666666666666"},{"target":"AKT1","probability":"0.495"},{"target":"PTK2B","probability":"0.49200000000000005"},{"target":"FYN","probability":"0.49015723270440253"},{"target":"PTK2","probability":"0.485"},{"target":"NTRK3","probability":"0.48"},{"target":"CCL5","probability":"0.479"},{"target":"CCL3","probability":"0.47215769944341374"},{"target":"ZAP70","probability":"0.46553693070562424"},{"target":"EPHA2","probability":"0.465"}],"source_name":"Leukemia, Myeloid, Acute"}],["D011289",{"mesh_id":"D011289","trials":[{"ligand":"abemaciclib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00071006"},{"ligand":"cabozantinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01643603;NCT00892190;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2005","completion_date":"2017","nct_id":"NCT02923986;NCT00255346"},{"ligand":"erlotinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00977548;NCT01664897;NCT01085838;NCT00570375"},{"ligand":"everolimus","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D011289","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00809185"},{"ligand":"gilteritinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2014","completion_date":"2019","nct_id":"NCT04140487;NCT02115295"},{"ligand":"gilteritinib","mesh_id":"D011289","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT04027309"},{"ligand":"ibrutinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2016","completion_date":"2017","nct_id":"NCT03359460;NCT02553941"},{"ligand":"imatinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00346632;NCT00852709;NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00451997;NCT00469014"},{"ligand":"lenvatinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D011289","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02078609"},{"ligand":"midostaurin","mesh_id":"D011289","phase":"Phase 2","start_date":"2002","completion_date":"2014","nct_id":"NCT02115295;NCT00045942"},{"ligand":"midostaurin","mesh_id":"D011289","phase":"Phase 3","start_date":"2017","completion_date":"2019","nct_id":"NCT03092674;NCT04027309"},{"ligand":"neratinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D011289","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01701375;NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02829840"},{"ligand":"quizartinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT03661307;NCT01892371;NCT02829840;NCT04493138;NCT04128748;NCT04047641"},{"ligand":"regorafenib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT01164163;NCT01895842;NCT03017820;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2008","completion_date":"2014","nct_id":"NCT02158858;NCT00674479"},{"ligand":"sirolimus","mesh_id":"D011289","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT04473911;NCT02728700;NCT00513474;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D011289","phase":"Phase 2","start_date":"1996","completion_date":"2020","nct_id":"NCT00105001;NCT00002790;NCT04339101;NCT01869114;NCT00691015;NCT01116232;NCT03670966;NCT00084916;NCT01251575;NCT02790515;NCT02793544;NCT00317785;NCT01111448;NCT00074490;NCT02061800;NCT03434704;NCT01885689;NCT02756572;NCT00506948;NCT00544466;NCT00544115;NCT00589563;NCT00520130;NCT03128034;NCT00089037"},{"ligand":"sorafenib","mesh_id":"D011289","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00217646;NCT00875745;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D011289","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT02829840;NCT00510289;NCT02196857;NCT00516828;NCT02728050;NCT01254890"},{"ligand":"sunitinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00451048"},{"ligand":"trametinib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trametinib","mesh_id":"D011289","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04487106"},{"ligand":"trastuzumab","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D011289","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[],"source_name":"Preleukemia"}],["D007945",{"mesh_id":"D007945","trials":[{"ligand":"abemaciclib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"acalabrutinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02296918;NCT02157324"},{"ligand":"acalabrutinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT04716075;NCT03162536;NCT04155710;NCT03685708;NCT03932331;NCT03580928;NCT02029443;NCT04502394;NCT03702231;NCT04657094;NCT02337829;NCT04189952;NCT04169737;NCT03516617;NCT03788291;NCT04016805;NCT03787264;NCT03328273;NCT04624633;NCT02717611;NCT04505254;NCT03740529"},{"ligand":"acalabrutinib","mesh_id":"D007945","phase":"Phase 3","start_date":"2015","completion_date":"2021","nct_id":"NCT02477696;NCT04008706;NCT04075292;NCT04178798;NCT03836261;NCT02970318;NCT04666038"},{"ligand":"afatinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"bosutinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02311998"},{"ligand":"cabozantinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cetuximab","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"cobimetinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D007945","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03884998;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D007945","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04155840;NCT04685915"},{"ligand":"dabrafenib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00316953;NCT00940524;NCT02081378;NCT04603872;NCT03414450;NCT01077544;NCT00872976;NCT03515200;NCT00860535;NCT02815059;NCT03595917;NCT02494882;NCT01643603;NCT00816283;NCT00608361;NCT02819804;NCT02779283;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2001","completion_date":"2021","nct_id":"NCT01173679;NCT01667133;NCT00298987;NCT01310010;NCT00391989;NCT02143414;NCT01361438;NCT00364286;NCT03023046;NCT00438854;NCT00829647;NCT02744768;NCT01207440;NCT01441882;NCT01030718;NCT01004497;NCT01883219;NCT00792948;NCT00563290;NCT01051115;NCT04747912;NCT00390793;NCT00101595;NCT01256398;NCT02420717;NCT00949988;NCT02523976;NCT01724879;NCT01620216;NCT00036738;NCT02888990;NCT01460160;NCT04329325;NCT01319981;NCT02043587"},{"ligand":"dasatinib","mesh_id":"D007945","phase":"Phase 3","start_date":"2006","completion_date":"2020","nct_id":"NCT02883049;NCT03117751;NCT00720109;NCT00549848;NCT03020030;NCT04530565;NCT00349518"},{"ligand":"dasatinib","mesh_id":"D007945","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT02690922"},{"ligand":"duvelisib","mesh_id":"D007945","phase":"Phase 1","start_date":"2013","completion_date":"2019","nct_id":"NCT03892044;NCT01871675;NCT02640833"},{"ligand":"duvelisib","mesh_id":"D007945","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT02028039;NCT03534323;NCT02158091;NCT03370185;NCT03961672;NCT04209621"},{"ligand":"duvelisib","mesh_id":"D007945","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT02049515;NCT02004522"},{"ligand":"erlotinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D007945","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT03740334;NCT01523977;NCT01088048;NCT02900716;NCT03328104;NCT03878524"},{"ligand":"everolimus","mesh_id":"D007945","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT00935792;NCT00968253;NCT04305444;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2011","completion_date":"2021","nct_id":"NCT02759016;NCT02640209;NCT03479268;NCT03301207;NCT02787369;NCT02537613;NCT04043845;NCT02200848;NCT03422393;NCT02268851;NCT02109224;NCT02556892;NCT02815059;NCT02303392;NCT02743546;NCT01292135;NCT01886859;NCT01644253;NCT02160015;NCT04781855;NCT03447808;NCT02611908;NCT02614508;NCT02381080;NCT03400176"},{"ligand":"ibrutinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02662296;NCT02518555;NCT02689141;NCT02406742;NCT02910583;NCT02007044;NCT03162536;NCT03088878;NCT04155710;NCT02639910;NCT03708003;NCT02997761;NCT02912754;NCT03943342;NCT04665115;NCT03685708;NCT03734198;NCT02232386;NCT03045328;NCT04419389;NCT02869633;NCT03128879;NCT02666898;NCT02742090;NCT03513562;NCT04758975;NCT04010968;NCT03331198;NCT02514083;NCT03153202;NCT04754035;NCT02733042;NCT04685915;NCT02420912;NCT04771507;NCT03755947;NCT02629809;NCT03702231;NCT04494503;NCT02677948;NCT02427451;NCT02251548;NCT01520519;NCT03572634;NCT03280160;NCT02141282;NCT03514017;NCT02129062;NCT03980002;NCT04560322;NCT03265717;NCT02332980;NCT03207555;NCT04016805;NCT02758665;NCT02649387;NCT04230304;NCT02005289;NCT01217749;NCT02388048;NCT01109069;NCT01105247;NCT01744691;NCT01589302;NCT02557516;NCT02756897;NCT02315768;NCT02717611;NCT03370185;NCT04209621;NCT01500733;NCT03204188;NCT03740529;NCT03226301"},{"ligand":"ibrutinib","mesh_id":"D007945","phase":"Phase 3","start_date":"2012","completion_date":"2021","nct_id":"NCT01722487;NCT01724346;NCT02264574;NCT02048813;NCT02991638;NCT03701282;NCT02477696;NCT02863718;NCT03734016;NCT02950051;NCT02801578;NCT02301156;NCT02757040;NCT01578707;NCT01611090;NCT01973387;NCT03737981;NCT01886872;NCT04608318;NCT03462719;NCT04666038;NCT01804686"},{"ligand":"ibrutinib","mesh_id":"D007945","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03190330"},{"ligand":"imatinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT02081378;NCT00852709;NCT01077544;NCT00860535;NCT00025415;NCT00352677;NCT01066468;NCT03878524"},{"ligand":"imatinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2001","completion_date":"2021","nct_id":"NCT00298987;NCT01383447;NCT00990249;NCT00384228;NCT00750659;NCT01279473;NCT00458848;NCT00171223;NCT01312818;NCT00149136;NCT00427791;NCT03023046;NCT00388895;NCT00167180;NCT00039377;NCT00109707;NCT01030718;NCT01004497;NCT00558961;NCT00882206;NCT01883219;NCT00130195;NCT00154349;NCT04688983;NCT00702403;NCT00101595;NCT01616238;NCT00905398;NCT00618501;NCT00973752;NCT00763763;NCT00171249;NCT01724879;NCT00036738;NCT02888990;NCT01914484;NCT00287105;NCT00376467;NCT00038610;NCT01319981;NCT01005914;NCT00199186;NCT02538926;NCT01429610;NCT01641107;NCT00081133;NCT00061945"},{"ligand":"imatinib","mesh_id":"D007945","phase":"Phase 3","start_date":"1993","completion_date":"2021","nct_id":"NCT00022737;NCT00137111;NCT04307576;NCT03007147;NCT01085617;NCT00327678;NCT00795756;NCT03589326;NCT00002514;NCT02881086;NCT00349518;NCT04722848"},{"ligand":"imatinib","mesh_id":"D007945","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT02894645;NCT01491763"},{"ligand":"lenvatinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D007945","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00866281"},{"ligand":"neratinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2009","completion_date":"2014","nct_id":"NCT02081378;NCT01077544;NCT00860535"},{"ligand":"nilotinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2001","completion_date":"2013","nct_id":"NCT01667133;NCT00384228;NCT00750659;NCT01279473;NCT00109707;NCT01207440;NCT01883219;NCT00702403;NCT00905398;NCT00844298;NCT00036738;NCT01914484;NCT01528085;NCT01670084"},{"ligand":"palbociclib","mesh_id":"D007945","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03515200;NCT03472573;NCT03792256;NCT03132454;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D007945","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02310243"},{"ligand":"pertuzumab","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02779283;NCT03878524"},{"ligand":"ponatinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01667133;NCT04501614;NCT03147612;NCT04554459;NCT01424982;NCT04475731;NCT01207440;NCT01883219;NCT04688983;NCT04747912;NCT03263572;NCT01620216;NCT02776605;NCT01641107;NCT03576547"},{"ligand":"ponatinib","mesh_id":"D007945","phase":"Phase 3","start_date":"2018","completion_date":"2021","nct_id":"NCT03589326;NCT04530565;NCT04722848"},{"ligand":"regorafenib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ribociclib","mesh_id":"D007945","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03740334"},{"ligand":"ruxolitinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT03515200;NCT03571321;NCT02494882;NCT02779283;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT02912754;NCT04669210;NCT02015208;NCT02131584;NCT03041636;NCT02420717;NCT01620216;NCT02723994;NCT01914484;NCT01319981;NCT00674479"},{"ligand":"ruxolitinib","mesh_id":"D007945","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03117751"},{"ligand":"selumetinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03705507"},{"ligand":"sirolimus","mesh_id":"D007945","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT04473911;NCT01614197;NCT02226861;NCT01658007;NCT02728700;NCT01523977;NCT02861040;NCT00874562;NCT01184885;NCT01088048;NCT00957320;NCT01634217;NCT01403415;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D007945","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT00105001;NCT00290472;NCT00795886;NCT01027000;NCT00935792;NCT03670966;NCT00084916;NCT01251575;NCT00776373;NCT00792948;NCT01363297;NCT03246906;NCT00918333;NCT00086840;NCT01162551;NCT03128034"},{"ligand":"sirolimus","mesh_id":"D007945","phase":"Phase 3","start_date":"2006","completion_date":"2012","nct_id":"NCT01539291;NCT00406393;NCT00382109;NCT01231412"},{"ligand":"sorafenib","mesh_id":"D007945","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00303797;NCT00131989;NCT03132454;NCT02779283;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D007945","phase":"Phase 2","start_date":"2005","completion_date":"2012","nct_id":"NCT00303966;NCT01510756;NCT01620216"},{"ligand":"sunitinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT02779283;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00398112;NCT00387426;NCT01620216"},{"ligand":"trametinib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D007945","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00724360"},{"ligand":"vemurafenib","mesh_id":"D007945","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"zanubrutinib","mesh_id":"D007945","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04458610;NCT03162536;NCT03824483;NCT04515238;NCT03206918;NCT03740529"},{"ligand":"zanubrutinib","mesh_id":"D007945","phase":"Phase 3","start_date":"2017","completion_date":"2021","nct_id":"NCT03336333;NCT03734016;NCT04666038"}],"predictions":[{"target":"FGFR1","probability":"0.755"},{"target":"AXL","probability":"0.6858534402165034"},{"target":"IGF1R","probability":"0.685"},{"target":"FGFR3","probability":"0.6512059799256597"},{"target":"TEC","probability":"0.6150231660231661"},{"target":"BCR","probability":"0.6004571809276865"},{"target":"EPHA1","probability":"0.5957369701531191"},{"target":"EPHB2","probability":"0.595087260034904"},{"target":"NTRK1","probability":"0.5940949786181985"},{"target":"PTK7","probability":"0.578623454345542"},{"target":"TIE1","probability":"0.575"},{"target":"PRKCQ","probability":"0.575"},{"target":"NTRK2","probability":"0.5651098901098901"},{"target":"YES1","probability":"0.555023166023166"},{"target":"EPHA2","probability":"0.5507762379143853"},{"target":"SYK","probability":"0.5503450078538523"},{"target":"MST1R","probability":"0.55"},{"target":"ROR2","probability":"0.5451045350935322"},{"target":"TYRO3","probability":"0.5361927672016266"},{"target":"INSR","probability":"0.5300326909841706"},{"target":"FGFR2","probability":"0.5274041400686216"},{"target":"TNK2","probability":"0.525185952970297"},{"target":"ALPK1","probability":"0.525139586823222"},{"target":"CDKL2","probability":"0.5201413327307814"},{"target":"PTK2","probability":"0.5153483914672418"},{"target":"EPHB4","probability":"0.5131922183345669"},{"target":"EPHA4","probability":"0.5101864483818095"},{"target":"FGFR4","probability":"0.5004487259616615"},{"target":"BMPR1B","probability":"0.49875"},{"target":"RPS6KB2","probability":"0.49"},{"target":"PTK6","probability":"0.4852496348320227"},{"target":"EPHA8","probability":"0.48505219172591924"},{"target":"GRK4","probability":"0.48000972762645916"},{"target":"NLK","probability":"0.4706318324448343"},{"target":"CCL5","probability":"0.47002392158838263"},{"target":"TAOK2","probability":"0.46839061244596514"},{"target":"MERTK","probability":"0.46671395998569287"},{"target":"FYN","probability":"0.4667072152552057"},{"target":"ACVR2B","probability":"0.46595910256984086"},{"target":"PAK6","probability":"0.46099823191395317"},{"target":"ITK","probability":"0.4598554828408711"},{"target":"PAK1","probability":"0.45786638147410513"},{"target":"MAP4K4","probability":"0.4560750685355501"}],"source_name":"Leukemia, Lymphoid"}],["D054198",{"mesh_id":"D054198","trials":[{"ligand":"abemaciclib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"bosutinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02311998"},{"ligand":"cabozantinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cetuximab","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"cetuximab","mesh_id":"D054198","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03263208"},{"ligand":"cobimetinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00316953;NCT00940524;NCT00500006;NCT02081378;NCT04603872;NCT03414450;NCT01077544;NCT00103701;NCT03515200;NCT00860535;NCT02815059;NCT03595917;NCT02494882;NCT00816283;NCT00608361;NCT02819804;NCT02779283;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2001","completion_date":"2021","nct_id":"NCT01667133;NCT00298987;NCT01310010;NCT00391989;NCT02143414;NCT01361438;NCT03023046;NCT02744768;NCT01207440;NCT01030718;NCT01004497;NCT01883219;NCT00792948;NCT04747912;NCT00390793;NCT00101595;NCT01256398;NCT02420717;NCT02523976;NCT01724879;NCT01620216;NCT00036738;NCT02888990;NCT01460160;NCT04329325;NCT01319981;NCT02043587;NCT04233346"},{"ligand":"dasatinib","mesh_id":"D054198","phase":"Phase 3","start_date":"2005","completion_date":"2020","nct_id":"NCT02883049;NCT03117751;NCT04375683;NCT00720109;NCT03564470;NCT00549848;NCT03020030;NCT00123487;NCT03624530;NCT04530565;NCT00349518"},{"ligand":"dasatinib","mesh_id":"D054198","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT02690922"},{"ligand":"duvelisib","mesh_id":"D054198","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT02028039"},{"ligand":"erlotinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D054198","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT03740334;NCT01523977;NCT03328104;NCT03878524"},{"ligand":"everolimus","mesh_id":"D054198","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00968253;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2014","completion_date":"2019","nct_id":"NCT03960840;NCT02109224;NCT02815059"},{"ligand":"ibrutinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT03267186;NCT02997761;NCT02129062;NCT02388048"},{"ligand":"imatinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT00346632;NCT02081378;NCT00852709;NCT01077544;NCT00103701;NCT00860535;NCT00025415;NCT00352677;NCT01066468;NCT03878524"},{"ligand":"imatinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2001","completion_date":"2021","nct_id":"NCT00298987;NCT01383447;NCT00990249;NCT00476190;NCT00384228;NCT00750659;NCT01279473;NCT00458848;NCT00171223;NCT01312818;NCT00149136;NCT00427791;NCT03023046;NCT00388895;NCT00167180;NCT01005758;NCT00039377;NCT00109707;NCT01030718;NCT01004497;NCT00882206;NCT01883219;NCT00130195;NCT00154349;NCT04688983;NCT00702403;NCT00101595;NCT01616238;NCT00905398;NCT00618501;NCT00973752;NCT00763763;NCT00171249;NCT01724879;NCT00036738;NCT02888990;NCT01914484;NCT00287105;NCT00376467;NCT00038610;NCT01319981;NCT01005914;NCT00199186;NCT02538926;NCT01429610;NCT01641107;NCT00081133;NCT00061945"},{"ligand":"imatinib","mesh_id":"D054198","phase":"Phase 3","start_date":"1993","completion_date":"2021","nct_id":"NCT00022737;NCT00137111;NCT04307576;NCT03007147;NCT02611492;NCT04375683;NCT01085617;NCT00327678;NCT00795756;NCT03589326;NCT00002514;NCT00123487;NCT02881086;NCT03624530;NCT00349518;NCT04722848"},{"ligand":"imatinib","mesh_id":"D054198","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT02894645;NCT01491763"},{"ligand":"lenvatinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D054198","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00866281"},{"ligand":"neratinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2009","completion_date":"2014","nct_id":"NCT02081378;NCT01077544;NCT00860535"},{"ligand":"nilotinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01667133;NCT00384228;NCT00750659;NCT01279473;NCT00109707;NCT01207440;NCT01883219;NCT00702403;NCT00905398;NCT00844298;NCT00036738;NCT01914484;NCT01528085;NCT04233346;NCT01670084"},{"ligand":"nilotinib","mesh_id":"D054198","phase":"Phase 3","start_date":"2016","completion_date":"2020","nct_id":"NCT02611492;NCT04375683"},{"ligand":"palbociclib","mesh_id":"D054198","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT03515200;NCT03472573;NCT03792256;NCT03132454;NCT03878524"},{"ligand":"palbociclib","mesh_id":"D054198","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02310243"},{"ligand":"pertuzumab","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02779283;NCT03878524"},{"ligand":"ponatinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01667133;NCT04501614;NCT03147612;NCT04554459;NCT01424982;NCT04475731;NCT01207440;NCT01883219;NCT04688983;NCT04747912;NCT03934372;NCT03263572;NCT01620216;NCT02776605;NCT04233346;NCT01641107;NCT03576547"},{"ligand":"ponatinib","mesh_id":"D054198","phase":"Phase 3","start_date":"2018","completion_date":"2021","nct_id":"NCT03589326;NCT03624530;NCT04530565;NCT04722848"},{"ligand":"quizartinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01411267"},{"ligand":"regorafenib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ribociclib","mesh_id":"D054198","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03740334"},{"ligand":"ruxolitinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT03515200;NCT03571321;NCT02494882;NCT02779283;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT04669210;NCT02420717;NCT01620216;NCT02723994;NCT01914484;NCT01319981;NCT00674479"},{"ligand":"ruxolitinib","mesh_id":"D054198","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03117751"},{"ligand":"selumetinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03705507"},{"ligand":"sirolimus","mesh_id":"D054198","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT04473911;NCT01614197;NCT02226861;NCT01658007;NCT02728700;NCT01523977;NCT02861040;NCT00874562;NCT01184885;NCT01756118;NCT00957320;NCT01634217;NCT01403415;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D054198","phase":"Phase 2","start_date":"2002","completion_date":"2019","nct_id":"NCT00105001;NCT00290472;NCT00795886;NCT03670966;NCT00084916;NCT00144703;NCT00144677;NCT01251575;NCT02790515;NCT02793544;NCT00776373;NCT00792948;NCT02061800;NCT01363297;NCT03970096;NCT03246906;NCT01885689;NCT00918333;NCT03192397;NCT01162551;NCT02991898;NCT03128034;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D054198","phase":"Phase 3","start_date":"2006","completion_date":"2010","nct_id":"NCT00406393;NCT00382109;NCT01231412;NCT01188798"},{"ligand":"sorafenib","mesh_id":"D054198","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00217646;NCT00118170;NCT00131989;NCT03132454;NCT02779283;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D054198","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01620216;NCT01445080"},{"ligand":"sunitinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT02779283;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D054198","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00387426;NCT01620216"},{"ligand":"trametinib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D054198","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00724360"},{"ligand":"vemurafenib","mesh_id":"D054198","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"FGFR1","probability":"0.815"},{"target":"NTRK1","probability":"0.81"},{"target":"BMPR1B","probability":"0.8"},{"target":"FGFR3","probability":"0.7550864779874215"},{"target":"ROR2","probability":"0.755"},{"target":"PTK7","probability":"0.7450030450669913"},{"target":"IGF1R","probability":"0.74"},{"target":"EPHA4","probability":"0.725"},{"target":"EPHB4","probability":"0.725"},{"target":"TIE1","probability":"0.72"},{"target":"EPHA1","probability":"0.715"},{"target":"NTRK2","probability":"0.7"},{"target":"AXL","probability":"0.695"},{"target":"MERTK","probability":"0.69"},{"target":"TNK2","probability":"0.68"},{"target":"FGFR2","probability":"0.675"},{"target":"NTRK3","probability":"0.67"},{"target":"ACVR2B","probability":"0.67"},{"target":"MST1R","probability":"0.665"},{"target":"YES1","probability":"0.6606164383561643"},{"target":"EPHB2","probability":"0.655"},{"target":"DCLK1","probability":"0.655"},{"target":"BMPR1A","probability":"0.65"},{"target":"EPHA2","probability":"0.645"},{"target":"INSR","probability":"0.645"},{"target":"FGFR4","probability":"0.645"},{"target":"ITK","probability":"0.64"},{"target":"TEC","probability":"0.635"},{"target":"NLK","probability":"0.63"},{"target":"TAOK2","probability":"0.6200933845670688"},{"target":"ACVR1B","probability":"0.62"},{"target":"MAPK13","probability":"0.62"},{"target":"IRAK1","probability":"0.6102553026547297"},{"target":"ACVR2A","probability":"0.6100030450669915"},{"target":"PIM2","probability":"0.5950284495021337"},{"target":"PIM3","probability":"0.585"},{"target":"BCR","probability":"0.5769461993486403"},{"target":"TGFBR2","probability":"0.575"},{"target":"MAP3K8","probability":"0.57"},{"target":"PRKCQ","probability":"0.57"},{"target":"TYRO3","probability":"0.565064935064935"},{"target":"MELK","probability":"0.5650030450669914"},{"target":"EPHB1","probability":"0.565"},{"target":"ACVR1","probability":"0.5602127659574468"},{"target":"PBK","probability":"0.56"},{"target":"MAP3K4","probability":"0.56"},{"target":"FYN","probability":"0.5551572327044025"},{"target":"GRK4","probability":"0.5550030450669915"},{"target":"PTK2","probability":"0.555"},{"target":"GRK3","probability":"0.545"},{"target":"MAP3K7","probability":"0.545"},{"target":"RIPK3","probability":"0.540054347826087"},{"target":"ALPK1","probability":"0.5400340112373951"},{"target":"CCL5","probability":"0.54"},{"target":"PTK6","probability":"0.5350284495021337"},{"target":"AKT2","probability":"0.535"},{"target":"PRKCB","probability":"0.530243710691824"},{"target":"GRK5","probability":"0.5301572327044025"},{"target":"PAK4","probability":"0.530064935064935"},{"target":"RIPK1","probability":"0.5300200803212851"},{"target":"MAP2K5","probability":"0.5300030450669915"},{"target":"EPHB3","probability":"0.53"},{"target":"EPHA8","probability":"0.53"},{"target":"IKBKE","probability":"0.5250485298234189"},{"target":"IRAK4","probability":"0.5250284495021337"},{"target":"NME2","probability":"0.525"},{"target":"WNK1","probability":"0.5200284495021337"},{"target":"MAP3K2","probability":"0.5200030450669915"},{"target":"LATS1","probability":"0.52"},{"target":"PAK1","probability":"0.52"},{"target":"KSR1","probability":"0.52"},{"target":"CAMKK2","probability":"0.52"},{"target":"CSK","probability":"0.5150200803212851"},{"target":"MAPK12","probability":"0.515"},{"target":"CCL3","probability":"0.515"},{"target":"SRPK1","probability":"0.515"},{"target":"PDPK1","probability":"0.5100284495021338"},{"target":"PIK3C3","probability":"0.51"},{"target":"LATS2","probability":"0.51"},{"target":"SYK","probability":"0.5058882909916194"},{"target":"RPS6KB2","probability":"0.505"},{"target":"AVP","probability":"0.5"},{"target":"MAP4K4","probability":"0.4950030450669915"},{"target":"TRIM24","probability":"0.495"},{"target":"DYRK1B","probability":"0.49000304506699144"},{"target":"MAP2K7","probability":"0.49"},{"target":"WNK4","probability":"0.49"},{"target":"ILK","probability":"0.49"},{"target":"NPR2","probability":"0.49"},{"target":"GRK2","probability":"0.4851773130256877"},{"target":"STK39","probability":"0.48501463702989717"},{"target":"TGFBR1","probability":"0.485"},{"target":"MKNK1","probability":"0.485"},{"target":"AURKC","probability":"0.485"},{"target":"ANKK1","probability":"0.485"},{"target":"MAP2K4","probability":"0.485"},{"target":"OBSCN","probability":"0.48000304506699143"},{"target":"RPS6KA3","probability":"0.47500304506699154"},{"target":"CAMK4","probability":"0.475"},{"target":"MAP3K14","probability":"0.4701773130256877"},{"target":"MAP3K1","probability":"0.4701572327044026"},{"target":"TRPM7","probability":"0.47002844950213374"},{"target":"MAP3K3","probability":"0.47000304506699153"},{"target":"MAP3K11","probability":"0.47000304506699153"},{"target":"PLK4","probability":"0.47"},{"target":"HCK","probability":"0.47"},{"target":"TRIM28","probability":"0.46502844950213373"},{"target":"ACVRL1","probability":"0.465"},{"target":"RIPK2","probability":"0.4601688246673083"},{"target":"ROCK2","probability":"0.4600765270278408"},{"target":"SGK1","probability":"0.4600316722841909"},{"target":"MAPK7","probability":"0.46002008032128516"},{"target":"CDK14","probability":"0.4600030450669915"},{"target":"MKNK2","probability":"0.46000304506699147"},{"target":"RPS6KA1","probability":"0.46"},{"target":"SIK1","probability":"0.46"},{"target":"CDK8","probability":"0.4572222222222222"},{"target":"AKT3","probability":"0.45627008032128513"},{"target":"MAPK10","probability":"0.45515723270440256"},{"target":"RPS6KB1","probability":"0.4551234567901235"},{"target":"LIMK1","probability":"0.45506493506493506"},{"target":"MAPK11","probability":"0.455"}],"source_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma"}],["D015451",{"mesh_id":"D015451","trials":[{"ligand":"abemaciclib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"acalabrutinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02296918;NCT02157324"},{"ligand":"acalabrutinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT04716075;NCT03162536;NCT04155710;NCT04660045;NCT03685708;NCT03932331;NCT04722172;NCT03580928;NCT02029443;NCT04502394;NCT03702231;NCT04657094;NCT02337829;NCT02362035;NCT04189952;NCT04169737;NCT03516617;NCT03788291;NCT04016805;NCT03787264;NCT04116437;NCT03328273;NCT04624633;NCT02717611;NCT04505254;NCT03740529"},{"ligand":"acalabrutinib","mesh_id":"D015451","phase":"Phase 3","start_date":"2015","completion_date":"2021","nct_id":"NCT02477696;NCT04008706;NCT02475681;NCT04075292;NCT04178798;NCT03836261;NCT02970318;NCT04666038"},{"ligand":"afatinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cetuximab","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"cobimetinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D015451","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03884998;NCT03878524"},{"ligand":"copanlisib","mesh_id":"D015451","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04155840;NCT04685915"},{"ligand":"dabrafenib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00872976;NCT00608361;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2006","completion_date":"2011","nct_id":"NCT01173679;NCT00364286;NCT00438854;NCT00829647;NCT01441882;NCT00563290;NCT01051115;NCT00949988"},{"ligand":"duvelisib","mesh_id":"D015451","phase":"Phase 1","start_date":"2013","completion_date":"2019","nct_id":"NCT02292225;NCT03892044;NCT01871675;NCT03757000;NCT02640833"},{"ligand":"duvelisib","mesh_id":"D015451","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT03534323;NCT02158091;NCT03370185;NCT03961672;NCT04209621"},{"ligand":"duvelisib","mesh_id":"D015451","phase":"Phase 3","start_date":"2013","completion_date":"2015","nct_id":"NCT02576275;NCT02049515;NCT02004522"},{"ligand":"erlotinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D015451","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT02240719;NCT01088048;NCT02900716;NCT03878524"},{"ligand":"everolimus","mesh_id":"D015451","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT00935792;NCT04305444;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2009","completion_date":"2021","nct_id":"NCT02759016;NCT02640209;NCT03479268;NCT03301207;NCT02787369;NCT02537613;NCT03454165;NCT04043845;NCT02200848;NCT03422393;NCT03960840;NCT02268851;NCT02109224;NCT02556892;NCT04688385;NCT02303392;NCT02743546;NCT02006485;NCT01292135;NCT01886859;NCT01644253;NCT02160015;NCT04781855;NCT00849654;NCT03447808;NCT02611908;NCT02614508;NCT02381080;NCT03400176"},{"ligand":"ibrutinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02662296;NCT02518555;NCT02689141;NCT02406742;NCT02910583;NCT02007044;NCT03162536;NCT03088878;NCT04155710;NCT02639910;NCT03708003;NCT02912754;NCT03943342;NCT04665115;NCT03685708;NCT03734198;NCT02232386;NCT03045328;NCT04419389;NCT02869633;NCT03128879;NCT02666898;NCT02742090;NCT03513562;NCT04758975;NCT04010968;NCT03331198;NCT02514083;NCT03153202;NCT04754035;NCT02733042;NCT04685915;NCT02420912;NCT04771507;NCT03755947;NCT02629809;NCT03702231;NCT04494503;NCT02677948;NCT04659044;NCT02427451;NCT02251548;NCT01520519;NCT03572634;NCT03280160;NCT02141282;NCT03514017;NCT03980002;NCT04560322;NCT03265717;NCT02332980;NCT03207555;NCT02013128;NCT04016805;NCT02758665;NCT02649387;NCT04230304;NCT02005289;NCT04116437;NCT01217749;NCT02388048;NCT01109069;NCT01105247;NCT01744691;NCT01589302;NCT02557516;NCT02756897;NCT02315768;NCT02717611;NCT03370185;NCT04209621;NCT01500733;NCT03204188;NCT03740529;NCT03226301"},{"ligand":"ibrutinib","mesh_id":"D015451","phase":"Phase 3","start_date":"2012","completion_date":"2021","nct_id":"NCT01722487;NCT01724346;NCT02264574;NCT02048813;NCT02991638;NCT03701282;NCT02477696;NCT02863718;NCT03734016;NCT02950051;NCT02801578;NCT02301156;NCT02757040;NCT01578707;NCT01611090;NCT01973387;NCT03737981;NCT01886872;NCT04608318;NCT03462719;NCT04666038;NCT01804686"},{"ligand":"ibrutinib","mesh_id":"D015451","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03190330"},{"ligand":"imatinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2004","completion_date":"2005","nct_id":"NCT00167180;NCT00558961"},{"ligand":"lenvatinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02912754;NCT02015208;NCT02131584;NCT03041636"},{"ligand":"sirolimus","mesh_id":"D015451","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT02226861;NCT02240719;NCT01353625;NCT01088048;NCT01634217;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D015451","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00105001;NCT00290472;NCT01027000;NCT00935792;NCT01381692;NCT01251575;NCT02793544;NCT01181271;NCT03246906;NCT00918333;NCT00086840;NCT02991898;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D015451","phase":"Phase 3","start_date":"2010","completion_date":"2012","nct_id":"NCT01539291;NCT01231412"},{"ligand":"sorafenib","mesh_id":"D015451","phase":"Phase 1","start_date":"2004","completion_date":"2020","nct_id":"NCT00303797;NCT00118170;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D015451","phase":"Phase 2","start_date":"2005","completion_date":"2011","nct_id":"NCT00303966;NCT01510756"},{"ligand":"sunitinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00398112;NCT00387426"},{"ligand":"trametinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D015451","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"zanubrutinib","mesh_id":"D015451","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02914938"},{"ligand":"zanubrutinib","mesh_id":"D015451","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04458610;NCT04282018;NCT03162536;NCT03824483;NCT04515238;NCT03206918;NCT04116437;NCT03740529"},{"ligand":"zanubrutinib","mesh_id":"D015451","phase":"Phase 3","start_date":"2017","completion_date":"2021","nct_id":"NCT03336333;NCT03734016;NCT04666038"}],"predictions":[{"target":"FGFR1","probability":"0.77"},{"target":"IGF1R","probability":"0.66"},{"target":"FGFR3","probability":"0.6055756001694035"},{"target":"EPHA2","probability":"0.6006840152328874"},{"target":"ROR2","probability":"0.5951970695221539"},{"target":"NTRK1","probability":"0.5811226177426448"},{"target":"NTRK2","probability":"0.5763076605831824"},{"target":"SRC","probability":"0.5601479580151847"},{"target":"EPHB2","probability":"0.56"},{"target":"AXL","probability":"0.551663336057579"},{"target":"TEC","probability":"0.5509505343617473"},{"target":"BCR","probability":"0.5495955862596819"},{"target":"TIE1","probability":"0.5410524061978466"},{"target":"ACVR1B","probability":"0.53875"},{"target":"FGFR2","probability":"0.5286293999966815"},{"target":"BMPR1B","probability":"0.5214459158200652"},{"target":"TYRO3","probability":"0.5200710859049374"},{"target":"EPHA4","probability":"0.5153700491595307"},{"target":"DCLK1","probability":"0.5115530679059966"},{"target":"MST1R","probability":"0.5103538636827152"},{"target":"PTK2","probability":"0.5101234567901235"},{"target":"IRAK3","probability":"0.505909090909091"},{"target":"GRK4","probability":"0.500909090909091"},{"target":"YES1","probability":"0.4973325163628066"},{"target":"PTK7","probability":"0.4913253196892244"},{"target":"FGFR4","probability":"0.48625"},{"target":"PRKCQ","probability":"0.4822914528207214"},{"target":"CDKL2","probability":"0.4818041595020391"},{"target":"SYK","probability":"0.4804353676284653"},{"target":"ALPK1","probability":"0.47009203972268276"},{"target":"EPHA8","probability":"0.4700317158261973"},{"target":"NTRK3","probability":"0.46621391785454797"},{"target":"INSR","probability":"0.4613771352956558"},{"target":"NPR2","probability":"0.4608694691090349"},{"target":"FYN","probability":"0.45883343438268925"},{"target":"EPHB4","probability":"0.4586977704732923"},{"target":"EPHA1","probability":"0.45578432119018186"}],"source_name":"Leukemia, Lymphocytic, Chronic, B-Cell"}],["D006689",{"mesh_id":"D006689","trials":[{"ligand":"abemaciclib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT01643603;NCT00608361;NCT01609816;NCT03878524"},{"ligand":"erlotinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D006689","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT02254239;NCT02240719;NCT03878524"},{"ligand":"everolimus","mesh_id":"D006689","phase":"Phase 2","start_date":"2009","completion_date":"2019","nct_id":"NCT01075321;NCT01665768;NCT01453504;NCT03697408;NCT00918333;NCT01022996"},{"ligand":"ibrutinib","mesh_id":"D006689","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02869633;NCT02940301;NCT02626884;NCT02744612;NCT02824029"},{"ligand":"imatinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00025415;NCT03878524"},{"ligand":"lenvatinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D006689","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01877005;NCT02164500;NCT03681561;NCT01965119"},{"ligand":"sirolimus","mesh_id":"D006689","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT04473911;NCT01902160;NCT02728700;NCT02254239;NCT02240719;NCT00973804;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D006689","phase":"Phase 2","start_date":"2002","completion_date":"2019","nct_id":"NCT00105001;NCT00133367;NCT00144703;NCT00144677;NCT01075321;NCT00838955;NCT03697408;NCT01181271;NCT01076543;NCT00918333;NCT00086840"},{"ligand":"sirolimus","mesh_id":"D006689","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01188798"},{"ligand":"sorafenib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sunitinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"trametinib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D006689","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT03432741;NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D006689","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"IGF1R","probability":"0.7352943485086343"},{"target":"FGFR1","probability":"0.65"},{"target":"FGFR3","probability":"0.630044776119403"},{"target":"INSR","probability":"0.605"},{"target":"BCR","probability":"0.5800579387377989"},{"target":"AXL","probability":"0.5455363586109855"},{"target":"NTRK1","probability":"0.5234353741496599"},{"target":"NTRK2","probability":"0.5211253311751133"},{"target":"FGFR2","probability":"0.505"},{"target":"EPHB2","probability":"0.48003703703703704"},{"target":"MUSK","probability":"0.47533138554567134"},{"target":"PTK2","probability":"0.4675"},{"target":"MAP2K7","probability":"0.4675"},{"target":"EPHA2","probability":"0.46508181315644004"},{"target":"SRC","probability":"0.4565335662902932"}],"source_name":"Hodgkin Disease"}],["D015464",{"mesh_id":"D015464","trials":[{"ligand":"abemaciclib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"binimetinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02225574"},{"ligand":"bosutinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2008","completion_date":"2017","nct_id":"NCT02782403;NCT00759837;NCT01374139"},{"ligand":"bosutinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT00261846;NCT04578847;NCT03205267;NCT03654768;NCT03128411;NCT02767063;NCT02906696;NCT04709731;NCT04258943;NCT03831776;NCT02638467;NCT04006847;NCT02311998;NCT03610971;NCT00811070;NCT02810990;NCT04626024"},{"ligand":"bosutinib","mesh_id":"D015464","phase":"Phase 3","start_date":"2008","completion_date":"2019","nct_id":"NCT03746054;NCT00574873;NCT03106779;NCT02130557"},{"ligand":"bosutinib","mesh_id":"D015464","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT02228382"},{"ligand":"cabozantinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00316953;NCT00324077;NCT00732186;NCT00500006;NCT02081378;NCT00978731;NCT03414450;NCT01077544;NCT00103701;NCT00860535;NCT00345826;NCT01397734;NCT02047149;NCT01751425;NCT03595917;NCT01460498;NCT00827138;NCT00816283;NCT00064233;NCT01426334;NCT02011945;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01667133;NCT00298987;NCT04578847;NCT00866736;NCT01872442;NCT00101660;NCT01392170;NCT03205267;NCT03193281;NCT02268370;NCT02923986;NCT03654768;NCT00070499;NCT03573596;NCT00982488;NCT00103844;NCT02767063;NCT03516279;NCT00895297;NCT00254423;NCT00493181;NCT01606579;NCT01593254;NCT01746836;NCT01804985;NCT00482703;NCT02689440;NCT01725204;NCT01207440;NCT01030718;NCT04006847;NCT02709083;NCT01342679;NCT03906292;NCT00337454;NCT01498445;NCT00852566;NCT00390793;NCT00101595;NCT03610971;NCT01844765;NCT04216563;NCT01690065;NCT01802450;NCT01916785;NCT00101816;NCT00036738;NCT01602952;NCT04126681;NCT01627132;NCT01887561;NCT03625388;NCT00320190;NCT00112775;NCT04147533;NCT01850004;NCT04233346;NCT00101647;NCT04626024"},{"ligand":"dasatinib","mesh_id":"D015464","phase":"Phase 3","start_date":"2005","completion_date":"2019","nct_id":"NCT03079505;NCT02890784;NCT02108951;NCT00481247;NCT01460693;NCT03746054;NCT00123474;NCT02326311;NCT00362466;NCT00123487;NCT00349518"},{"ligand":"dasatinib","mesh_id":"D015464","phase":"Phase 4","start_date":"2012","completion_date":"2019","nct_id":"NCT02389920;NCT04155411;NCT03216070;NCT01660906;NCT01901666"},{"ligand":"erlotinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D015464","phase":"Phase 2","start_date":"2004","completion_date":"2013","nct_id":"NCT00093639;NCT01188889"},{"ligand":"gilteritinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115295"},{"ligand":"ibrutinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03267186"},{"ligand":"imatinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT00324077;NCT00346632;NCT02081378;NCT00852709;NCT00101088;NCT01077544;NCT00103701;NCT00040105;NCT01933906;NCT01795716;NCT00860535;NCT00025415;NCT01397734;NCT00428909;NCT00301093;NCT00233961;NCT01751425;NCT01460498;NCT00047502;NCT01130688;NCT00827138;NCT00258271;NCT00066326;NCT01270984;NCT00064233;NCT01426334;NCT03228303;NCT01751919;NCT00352677;NCT01066468;NCT00100997;NCT03878524;NCT00455221"},{"ligand":"imatinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT00261846;NCT00298987;NCT01698905;NCT00048672;NCT04578847;NCT00866736;NCT01872442;NCT00042003;NCT00101660;NCT00219726;NCT00511121;NCT01392170;NCT00815321;NCT03205267;NCT03193281;NCT00006053;NCT00006052;NCT00384228;NCT00042016;NCT03578367;NCT00750659;NCT01279473;NCT02268370;NCT00022490;NCT00045422;NCT00070499;NCT00481052;NCT00858806;NCT00015834;NCT00982488;NCT02687425;NCT00103844;NCT01866553;NCT02767063;NCT00171223;NCT03516279;NCT00895297;NCT01227135;NCT00049192;NCT00493181;NCT00219752;NCT04709731;NCT00466726;NCT00167180;NCT00015847;NCT01593254;NCT04043676;NCT00093639;NCT00109707;NCT00088231;NCT00114959;NCT01746836;NCT01804985;NCT00482703;NCT02888964;NCT00510926;NCT01227356;NCT02480608;NCT00769327;NCT01725204;NCT01030718;NCT00030394;NCT00469014;NCT00514969;NCT04006847;NCT00661180;NCT04070443;NCT02709083;NCT01092741;NCT01188889;NCT03906292;NCT00337454;NCT02398825;NCT00702403;NCT00028847;NCT02852486;NCT00852566;NCT00101595;NCT01003054;NCT00041990;NCT03610971;NCT00267085;NCT00811070;NCT00219765;NCT00110058;NCT01844765;NCT00594555;NCT00763763;NCT00054431;NCT00015860;NCT01690065;NCT00058747;NCT01802450;NCT01503502;NCT00335868;NCT01916785;NCT00038649;NCT00171249;NCT00415909;NCT00101816;NCT00036738;NCT00006475;NCT00171158;NCT01602952;NCT00375219;NCT04126681;NCT01914484;NCT00320190;NCT00146913;NCT00112775;NCT00210119;NCT04147533;NCT02001818;NCT02896842;NCT00511303;NCT00199186;NCT00053248;NCT02115672;NCT02949570;NCT00101647;NCT04626024;NCT01221376;NCT00573378;NCT00079313;NCT03241199;NCT00081133;NCT01774630;NCT01011998"},{"ligand":"imatinib","mesh_id":"D015464","phase":"Phase 3","start_date":"2000","completion_date":"2019","nct_id":"NCT00514488;NCT02174445;NCT02108951;NCT00802841;NCT01400074;NCT00481247;NCT02103322;NCT00237120;NCT01460693;NCT03459534;NCT02115386;NCT03746054;NCT00519090;NCT00123474;NCT02272777;NCT01755325;NCT01743989;NCT00006343;NCT00055874;NCT00574873;NCT02326311;NCT00264160;NCT01254188;NCT00471497;NCT01511289;NCT00050531;NCT00297570;NCT00362466;NCT01275196;NCT00123487;NCT00760877;NCT00327262;NCT02130557;NCT00219739;NCT02627677;NCT00124748;NCT01650805;NCT03515018;NCT01819389;NCT01827930;NCT00349518;NCT01126892;NCT00333840;NCT03722420"},{"ligand":"imatinib","mesh_id":"D015464","phase":"Phase 4","start_date":"2003","completion_date":"2021","nct_id":"NCT02317159;NCT00390897;NCT00786812;NCT02204722;NCT01243489;NCT00081926;NCT01043874;NCT00171899;NCT00644878;NCT02602314;NCT04677439;NCT01368523;NCT00461929;NCT00980018;NCT02086487;NCT01578213;NCT00845221;NCT01131325;NCT01660906;NCT01901666"},{"ligand":"lenvatinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D015464","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115295"},{"ligand":"neratinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2009","completion_date":"2017","nct_id":"NCT01220648;NCT02081378;NCT01077544;NCT00860535;NCT01397734;NCT02225574;NCT01223898;NCT01751425;NCT01460498;NCT01702064;NCT00827138;NCT01456676;NCT02253277;NCT03228303"},{"ligand":"nilotinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2001","completion_date":"2020","nct_id":"NCT01667133;NCT01698905;NCT04578847;NCT01784068;NCT01392170;NCT03205267;NCT00384228;NCT01274351;NCT03578367;NCT00750659;NCT01279473;NCT03654768;NCT00481052;NCT01866553;NCT02767063;NCT03516279;NCT01856283;NCT00109707;NCT01746836;NCT01804985;NCT00769327;NCT01207440;NCT04006847;NCT02709083;NCT03906292;NCT00702403;NCT00809211;NCT00129740;NCT03610971;NCT02917720;NCT02973711;NCT01294618;NCT01844765;NCT04216563;NCT01690065;NCT00036738;NCT01602952;NCT04126681;NCT01914484;NCT03874858;NCT04147533;NCT02001818;NCT04233346;NCT02353728;NCT04626024;NCT00573378;NCT01670084;NCT01774630"},{"ligand":"nilotinib","mesh_id":"D015464","phase":"Phase 3","start_date":"2007","completion_date":"2019","nct_id":"NCT03079505;NCT02201459;NCT02174445;NCT02108951;NCT00802841;NCT01400074;NCT01535391;NCT02115386;NCT03746054;NCT00519090;NCT02272777;NCT01743989;NCT02326311;NCT01254188;NCT00471497;NCT01275196;NCT00760877;NCT02627677;NCT01819389;NCT03942094;NCT01126892;NCT01657604"},{"ligand":"nilotinib","mesh_id":"D015464","phase":"Phase 4","start_date":"2008","completion_date":"2016","nct_id":"NCT00786812;NCT01605981;NCT02546674;NCT01043874;NCT02389920;NCT00644878;NCT02602314;NCT01368523;NCT01227577;NCT00980018;NCT02086487;NCT03332511;NCT01131325;NCT01901666"},{"ligand":"palbociclib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00660920;NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01667133;NCT02629692;NCT04188405;NCT04160546;NCT03895671;NCT02767063;NCT03147612;NCT04709731;NCT04043676;NCT01746836;NCT01424982;NCT01207440;NCT04070443;NCT02398825;NCT03934372;NCT03263572;NCT01570868;NCT02467270;NCT03807479;NCT04233346;NCT03576547"},{"ligand":"ponatinib","mesh_id":"D015464","phase":"Phase 3","start_date":"2012","completion_date":"2019","nct_id":"NCT03746054;NCT02627677;NCT01650805"},{"ligand":"regorafenib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01751425;NCT01702064;NCT02253277;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT03654768;NCT03610971;NCT02973711;NCT01914484;NCT02092324;NCT00674479"},{"ligand":"selumetinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03326310"},{"ligand":"sirolimus","mesh_id":"D015464","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00101088;NCT02226861;NCT02728700;NCT03018223;NCT01756118;NCT01634217;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D015464","phase":"Phase 2","start_date":"2003","completion_date":"2017","nct_id":"NCT00105001;NCT00084916;NCT00144677;NCT01251575;NCT02790515;NCT01188889;NCT02061800;NCT01488253;NCT03246906;NCT03192397;NCT02991898;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D015464","phase":"Phase 3","start_date":"2006","completion_date":"2010","nct_id":"NCT00406393;NCT01231412;NCT01188798"},{"ligand":"sorafenib","mesh_id":"D015464","phase":"Phase 1","start_date":"2010","completion_date":"2020","nct_id":"NCT01159301;NCT03878524"},{"ligand":"sorafenib","mesh_id":"D015464","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00661180;NCT01445080"},{"ligand":"sunitinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015464","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"},{"ligand":"trametinib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D015464","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"FGFR1","probability":"0.795"},{"target":"AXL","probability":"0.78"},{"target":"IGF1R","probability":"0.765"},{"target":"SYK","probability":"0.735"},{"target":"BMPR1B","probability":"0.705"},{"target":"PTK7","probability":"0.68"},{"target":"TIE1","probability":"0.675"},{"target":"ROR2","probability":"0.66"},{"target":"TYRO3","probability":"0.6551522885114216"},{"target":"EPHA2","probability":"0.65"},{"target":"EPHA1","probability":"0.645"},{"target":"EPHB4","probability":"0.645"},{"target":"MST1R","probability":"0.64"},{"target":"EPHB2","probability":"0.64"},{"target":"PTK2","probability":"0.64"},{"target":"EPHA4","probability":"0.62"},{"target":"TNK2","probability":"0.62"},{"target":"NTRK2","probability":"0.615"},{"target":"NTRK1","probability":"0.61"},{"target":"ITK","probability":"0.6001228070175438"},{"target":"FGFR2","probability":"0.6000864779874214"},{"target":"ACVR1","probability":"0.585010073875084"},{"target":"ACVR1B","probability":"0.585"},{"target":"MERTK","probability":"0.585"},{"target":"YES1","probability":"0.565"},{"target":"INSR","probability":"0.565"},{"target":"TEC","probability":"0.5601238390092879"},{"target":"ACVR2B","probability":"0.56"},{"target":"FGFR4","probability":"0.555"},{"target":"CCL5","probability":"0.545"},{"target":"BCR","probability":"0.5430081761754998"},{"target":"FGFR3","probability":"0.5408594398037269"},{"target":"GRK4","probability":"0.54"},{"target":"TAOK2","probability":"0.5351515151515152"},{"target":"NTRK3","probability":"0.530054347826087"},{"target":"MUSK","probability":"0.53"},{"target":"ALPK1","probability":"0.525"},{"target":"ACVR2A","probability":"0.52"},{"target":"NPR2","probability":"0.52"},{"target":"CCL3","probability":"0.515"},{"target":"PTK2B","probability":"0.515"},{"target":"EPHA8","probability":"0.505"},{"target":"VRK3","probability":"0.5000144927536232"},{"target":"GRK3","probability":"0.5"},{"target":"FYN","probability":"0.5"},{"target":"DCLK1","probability":"0.5"},{"target":"PIM2","probability":"0.5"},{"target":"MAP2K7","probability":"0.4965"},{"target":"MAPK13","probability":"0.495"},{"target":"ANKK1","probability":"0.495"},{"target":"BMPR1A","probability":"0.49"},{"target":"TGFBR2","probability":"0.49"},{"target":"PRKCQ","probability":"0.49"},{"target":"HCK","probability":"0.47545454545454546"},{"target":"NLK","probability":"0.47502844950213374"},{"target":"PAK1","probability":"0.475"},{"target":"CCL2","probability":"0.47"},{"target":"FASTKD2","probability":"0.46501449275362317"},{"target":"CDKL2","probability":"0.465"},{"target":"NME2","probability":"0.460186888001499"},{"target":"TGFBR1","probability":"0.455"}],"source_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive"}],["D019337",{"mesh_id":"D019337","trials":[{"ligand":"abemaciclib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"acalabrutinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT03162536;NCT04630756;NCT02362035"},{"ligand":"afatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"avapritinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03580655"},{"ligand":"binimetinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01885195"},{"ligand":"cabozantinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ceritinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02343679"},{"ligand":"cetuximab","mesh_id":"D019337","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03783403"},{"ligand":"cobimetinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"crizotinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT02034981"},{"ligand":"dabrafenib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT01643603;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D019337","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT03844360"},{"ligand":"duvelisib","mesh_id":"D019337","phase":"Phase 1","start_date":"2011","completion_date":"2017","nct_id":"NCT01476657;NCT03757000"},{"ligand":"duvelisib","mesh_id":"D019337","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02711852"},{"ligand":"encorafenib","mesh_id":"D019337","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01981187"},{"ligand":"erlotinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02355431"},{"ligand":"everolimus","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"fostamatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02611063"},{"ligand":"ibrutinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2015","completion_date":"2017","nct_id":"NCT02352558;NCT03328078"},{"ligand":"ibrutinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT03162536;NCT02329847"},{"ligand":"imatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02352558;NCT03878524"},{"ligand":"imatinib","mesh_id":"D019337","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT03844360"},{"ligand":"lenvatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pazopanib","mesh_id":"D019337","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00666081"},{"ligand":"pertuzumab","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2008","completion_date":"2020","nct_id":"NCT00660920;NCT03878524"},{"ligand":"regorafenib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT04016116;NCT04582604;NCT01523171;NCT01594723;NCT00674479"},{"ligand":"sirolimus","mesh_id":"D019337","phase":"Phase 1","start_date":"2011","completion_date":"2021","nct_id":"NCT00890500;NCT04177004;NCT03963024;NCT02728700;NCT01353625;NCT03531281;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D019337","phase":"Phase 2","start_date":"2002","completion_date":"2019","nct_id":"NCT01203722;NCT01244906;NCT00086125;NCT01460420;NCT00144703;NCT00146614;NCT02790515;NCT03983850;NCT01428973;NCT03434704;NCT00506948"},{"ligand":"sirolimus","mesh_id":"D019337","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01231412;NCT01188798"},{"ligand":"sorafenib","mesh_id":"D019337","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00908167;NCT02270788;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trametinib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D019337","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT01351350;NCT03219268;NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D019337","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D019337","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02304809"},{"ligand":"zanubrutinib","mesh_id":"D019337","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03162536"}],"predictions":[{"target":"FGFR1","probability":"0.745"},{"target":"DDR2","probability":"0.6256466863900422"},{"target":"NTRK1","probability":"0.615168781598197"},{"target":"NTRK2","probability":"0.602659070437759"},{"target":"FGFR3","probability":"0.5955892880816651"},{"target":"AXL","probability":"0.5856213803716034"},{"target":"TIE1","probability":"0.585"},{"target":"ACVR2B","probability":"0.58"},{"target":"EPHA2","probability":"0.5750200803212852"},{"target":"PTK7","probability":"0.5651576994434138"},{"target":"EPHB3","probability":"0.565"},{"target":"FGFR2","probability":"0.5633333333333332"},{"target":"TYRO3","probability":"0.5507573681673142"},{"target":"SRC","probability":"0.550313877176045"},{"target":"EPHB4","probability":"0.53"},{"target":"EPHB2","probability":"0.5251463961107589"},{"target":"ROR2","probability":"0.5250910966680024"},{"target":"FYN","probability":"0.525054347826087"},{"target":"BMPR1B","probability":"0.52000627090301"},{"target":"MAP3K20","probability":"0.515"},{"target":"EPHB1","probability":"0.51"},{"target":"BCR","probability":"0.4971840059172554"},{"target":"MST1R","probability":"0.49581798544295735"},{"target":"EPHA4","probability":"0.49006493506493504"},{"target":"EPHA1","probability":"0.485"},{"target":"GRK4","probability":"0.46523643741316156"},{"target":"ACVRL1","probability":"0.4635132532952383"},{"target":"MUSK","probability":"0.46012206287957325"},{"target":"PTK2B","probability":"0.4600744281473721"},{"target":"NTRK3","probability":"0.46002855489755634"}],"source_name":"Hematologic Neoplasms"}],["D015477",{"mesh_id":"D015477","trials":[{"ligand":"abemaciclib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04409639"},{"ligand":"copanlisib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2005","completion_date":"2012","nct_id":"NCT00255346;NCT01620216"},{"ligand":"erlotinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01664897"},{"ligand":"everolimus","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ibrutinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02553941"},{"ligand":"imatinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00852709;NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2002","completion_date":"2004","nct_id":"NCT00136409;NCT00171912;NCT00039416;NCT00079313"},{"ligand":"lenvatinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01620216"},{"ligand":"quizartinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT01892371;NCT04493138"},{"ligand":"regorafenib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT03722407;NCT01776723;NCT01620216"},{"ligand":"sirolimus","mesh_id":"D015477","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT04473911;NCT03018223;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D015477","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT03670966;NCT00084916;NCT01885689;NCT02756572;NCT03192397;NCT03128034"},{"ligand":"sorafenib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sorafenib","mesh_id":"D015477","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00510289;NCT01620216"},{"ligand":"sunitinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00451048;NCT00387426;NCT01620216"},{"ligand":"trametinib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trametinib","mesh_id":"D015477","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04487106;NCT03190915"},{"ligand":"trastuzumab","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D015477","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[],"source_name":"Leukemia, Myelomonocytic, Chronic"}],["D054429",{"mesh_id":"D054429","trials":[{"ligand":"abemaciclib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04409639"},{"ligand":"copanlisib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01620216"},{"ligand":"erlotinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01664897"},{"ligand":"everolimus","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ibrutinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02553941"},{"ligand":"imatinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00852709;NCT00025415;NCT03878524"},{"ligand":"imatinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2002","completion_date":"2004","nct_id":"NCT00136409;NCT00171912;NCT00039416;NCT00079313"},{"ligand":"lenvatinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01620216"},{"ligand":"quizartinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT01892371;NCT04493138"},{"ligand":"regorafenib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT03722407;NCT01776723;NCT01620216"},{"ligand":"sirolimus","mesh_id":"D054429","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT04473911;NCT03018223;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D054429","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT03670966;NCT00084916;NCT02790515;NCT02061800;NCT01885689;NCT02756572;NCT03192397;NCT03128034"},{"ligand":"sorafenib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sorafenib","mesh_id":"D054429","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01620216;NCT01445080"},{"ligand":"sunitinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT00451048;NCT00387426;NCT01620216"},{"ligand":"trametinib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trametinib","mesh_id":"D054429","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04487106;NCT03190915"},{"ligand":"trastuzumab","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D054429","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[],"source_name":"Leukemia, Myelomonocytic, Juvenile"}],["D015466",{"mesh_id":"D015466","trials":[{"ligand":"abemaciclib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"bosutinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2016","completion_date":"2021","nct_id":"NCT03205267;NCT03654768;NCT03128411;NCT02767063;NCT02906696;NCT04709731;NCT04258943;NCT03610971"},{"ligand":"bosutinib","mesh_id":"D015466","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02130557"},{"ligand":"cabozantinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00324077;NCT00103701;NCT00064233;NCT01426334;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2005","completion_date":"2019","nct_id":"NCT00777036;NCT03205267;NCT03654768;NCT02767063;NCT03516279;NCT00254423;NCT01593254;NCT01746836;NCT02689440;NCT01725204;NCT02709083;NCT03906292;NCT03610971;NCT01887561;NCT03625388;NCT00320190;NCT00112775;NCT01850004"},{"ligand":"dasatinib","mesh_id":"D015466","phase":"Phase 3","start_date":"2005","completion_date":"2017","nct_id":"NCT03079505;NCT01460693;NCT00123474"},{"ligand":"dasatinib","mesh_id":"D015466","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT01660906"},{"ligand":"erlotinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D015466","phase":"Phase 2","start_date":"2004","completion_date":"2013","nct_id":"NCT00093639;NCT01188889"},{"ligand":"imatinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00324077;NCT00686218;NCT00101088;NCT00103701;NCT00040105;NCT01933906;NCT00025415;NCT00301093;NCT00064233;NCT01426334;NCT00100997;NCT03878524"},{"ligand":"imatinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2001","completion_date":"2021","nct_id":"NCT00048672;NCT00777036;NCT03205267;NCT00045422;NCT02767063;NCT03516279;NCT00049192;NCT04709731;NCT01593254;NCT00093639;NCT00114959;NCT01746836;NCT02888964;NCT00510926;NCT00769327;NCT01725204;NCT00030394;NCT02709083;NCT01092741;NCT01188889;NCT03906292;NCT00702403;NCT03610971;NCT00038649;NCT01914484;NCT00320190;NCT00146913;NCT00112775;NCT02949570"},{"ligand":"imatinib","mesh_id":"D015466","phase":"Phase 3","start_date":"2002","completion_date":"2018","nct_id":"NCT01460693;NCT03459534;NCT00123474;NCT00055874;NCT02130557;NCT02627677;NCT00124748;NCT01827930"},{"ligand":"imatinib","mesh_id":"D015466","phase":"Phase 4","start_date":"2003","completion_date":"2012","nct_id":"NCT00390897;NCT00644878;NCT01660906"},{"ligand":"lenvatinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01702064"},{"ligand":"nilotinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2005","completion_date":"2019","nct_id":"NCT03205267;NCT03654768;NCT02767063;NCT03516279;NCT01856283;NCT01746836;NCT00769327;NCT02709083;NCT03906292;NCT00702403;NCT00809211;NCT00129740;NCT03610971;NCT02973711;NCT01294618;NCT01914484"},{"ligand":"nilotinib","mesh_id":"D015466","phase":"Phase 3","start_date":"2015","completion_date":"2017","nct_id":"NCT03079505;NCT02627677"},{"ligand":"nilotinib","mesh_id":"D015466","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00644878"},{"ligand":"palbociclib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT02767063;NCT04709731;NCT01746836;NCT03934372;NCT02467270;NCT03807479"},{"ligand":"ponatinib","mesh_id":"D015466","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02627677"},{"ligand":"regorafenib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2013","completion_date":"2020","nct_id":"NCT01702064;NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03654768;NCT03610971;NCT02973711;NCT01914484"},{"ligand":"sirolimus","mesh_id":"D015466","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00101088;NCT02728700;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D015466","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01251575;NCT01188889;NCT01488253"},{"ligand":"sorafenib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015466","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"},{"ligand":"trametinib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D015466","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[{"target":"BMPR1B","probability":"0.4903543754229476"},{"target":"ACVR2B","probability":"0.4785767563648429"},{"target":"ACVR2A","probability":"0.46509915210999425"}],"source_name":"Leukemia, Myeloid, Chronic-Phase"}],["D015465",{"mesh_id":"D015465","trials":[{"ligand":"abemaciclib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"bosutinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"bosutinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04258943"},{"ligand":"cabozantinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2006","completion_date":"2020","nct_id":"NCT00316953;NCT01426334;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00101647"},{"ligand":"dasatinib","mesh_id":"D015465","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00123487"},{"ligand":"erlotinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"imatinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT00101088;NCT00025415;NCT01426334;NCT03878524"},{"ligand":"imatinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2000","completion_date":"2013","nct_id":"NCT00006052;NCT00114959;NCT00702403;NCT00110058;NCT00054431;NCT01914484;NCT00101647"},{"ligand":"imatinib","mesh_id":"D015465","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00123487"},{"ligand":"lenvatinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT00702403;NCT01914484"},{"ligand":"palbociclib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT03147612;NCT01424982;NCT03934372;NCT03263572"},{"ligand":"regorafenib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01914484"},{"ligand":"sirolimus","mesh_id":"D015465","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00101088;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D015465","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT00105001;NCT01488253"},{"ligand":"sorafenib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D015465","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"},{"ligand":"trametinib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D015465","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[],"source_name":"Leukemia, Myeloid, Accelerated Phase"}],["D054438",{"mesh_id":"D054438","trials":[{"ligand":"abemaciclib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cabozantinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"erlotinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"imatinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00025415;NCT03878524"},{"ligand":"lenvatinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"neratinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"palbociclib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"regorafenib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D054438","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02092324"},{"ligand":"sirolimus","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sirolimus","mesh_id":"D054438","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00105001"},{"ligand":"sorafenib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sunitinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2009","completion_date":"2020","nct_id":"NCT00890747;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D054438","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"},{"ligand":"trametinib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D054438","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[],"source_name":"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"}],["D001752",{"mesh_id":"D001752","trials":[{"ligand":"abemaciclib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"afatinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"axitinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"bosutinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02782403"},{"ligand":"bosutinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04258943;NCT02311998"},{"ligand":"cabozantinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"cobimetinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"copanlisib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dabrafenib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dacomitinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"dasatinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2003","completion_date":"2020","nct_id":"NCT00316953;NCT03414450;NCT00103701;NCT00860535;NCT03595917;NCT00816283;NCT03878524"},{"ligand":"dasatinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT01498445;NCT00390793;NCT00101595;NCT01690065;NCT00101816"},{"ligand":"erlotinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"everolimus","mesh_id":"D001752","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00081874"},{"ligand":"fedratinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04282187"},{"ligand":"gilteritinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115295"},{"ligand":"imatinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00316953;NCT00101088;NCT00103701;NCT00860535;NCT00025415;NCT00258271;NCT03878524"},{"ligand":"imatinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2000","completion_date":"2013","nct_id":"NCT00042003;NCT00015834;NCT00114959;NCT00514969;NCT00702403;NCT00101595;NCT00594555;NCT00763763;NCT00054431;NCT01690065;NCT00101816;NCT00006475;NCT00171158;NCT01914484;NCT00199186;NCT00081133"},{"ligand":"imatinib","mesh_id":"D001752","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01126892"},{"ligand":"imatinib","mesh_id":"D001752","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00786812;NCT01368523"},{"ligand":"lenvatinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"lorlatinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"midostaurin","mesh_id":"D001752","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115295"},{"ligand":"neratinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"nilotinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00860535"},{"ligand":"nilotinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT00702403;NCT01690065;NCT01914484;NCT01670084"},{"ligand":"nilotinib","mesh_id":"D001752","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01126892"},{"ligand":"nilotinib","mesh_id":"D001752","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00786812;NCT01368523"},{"ligand":"palbociclib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"pertuzumab","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ponatinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT04188405;NCT03895671;NCT03147612;NCT01424982;NCT03934372;NCT03263572;NCT03576547"},{"ligand":"regorafenib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"ruxolitinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04282187;NCT04281498;NCT01914484"},{"ligand":"sirolimus","mesh_id":"D001752","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00101088;NCT02728700;NCT03878524"},{"ligand":"sirolimus","mesh_id":"D001752","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00105001;NCT00084916"},{"ligand":"sorafenib","mesh_id":"D001752","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00217646;NCT01159301;NCT03878524"},{"ligand":"sunitinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"sunitinib","mesh_id":"D001752","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"},{"ligand":"trametinib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"trastuzumab","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"},{"ligand":"vemurafenib","mesh_id":"D001752","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03878524"}],"predictions":[],"source_name":"Blast Crisis"}],["D016393",{"mesh_id":"D016393","trials":[{"ligand":"acalabrutinib","mesh_id":"D016393","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02112526"},{"ligand":"acalabrutinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02180711;NCT03162536;NCT04257578;NCT04604067;NCT04002947;NCT03571308;NCT04502394;NCT04189952;NCT04094142;NCT04546620;NCT03740529"},{"ligand":"acalabrutinib","mesh_id":"D016393","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04529772"},{"ligand":"apatinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04476459"},{"ligand":"apatinib","mesh_id":"D016393","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03376958"},{"ligand":"cetuximab","mesh_id":"D016393","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"copanlisib","mesh_id":"D016393","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT04156828;NCT03886649"},{"ligand":"copanlisib","mesh_id":"D016393","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02391116;NCT04572763;NCT04263584;NCT03484819;NCT04433182"},{"ligand":"copanlisib","mesh_id":"D016393","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02367040"},{"ligand":"dasatinib","mesh_id":"D016393","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"dasatinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00918463"},{"ligand":"duvelisib","mesh_id":"D016393","phase":"Phase 1","start_date":"2017","completion_date":"2019","nct_id":"NCT03892044;NCT03757000"},{"ligand":"duvelisib","mesh_id":"D016393","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04331119"},{"ligand":"everolimus","mesh_id":"D016393","phase":"Phase 1","start_date":"2010","completion_date":"2016","nct_id":"NCT01334502;NCT01854606;NCT01088048;NCT02900716"},{"ligand":"everolimus","mesh_id":"D016393","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT01164267;NCT01075321;NCT01665768;NCT00978432;NCT04305444;NCT00918333;NCT00869999"},{"ligand":"everolimus","mesh_id":"D016393","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00790036"},{"ligand":"fostamatinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT00446095;NCT01499303"},{"ligand":"ibrutinib","mesh_id":"D016393","phase":"Phase 1","start_date":"2009","completion_date":"2021","nct_id":"NCT02780830;NCT03479268;NCT02756247;NCT02055924;NCT03220022;NCT03440567;NCT01479842;NCT03223610;NCT03876028;NCT01955499;NCT01704963;NCT02109224;NCT03424122;NCT04739813;NCT03136497;NCT02219737;NCT00849654;NCT01569750;NCT02950220"},{"ligand":"ibrutinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT02077166;NCT03162536;NCT03399513;NCT02874404;NCT02760485;NCT02207062;NCT03129828;NCT03478514;NCT02692248;NCT01980654;NCT02636322;NCT02747732;NCT04659044;NCT03684694;NCT03093831;NCT02670616;NCT02332980;NCT02670317;NCT02142049;NCT01109069;NCT03949062;NCT03964090;NCT01325701;NCT02272686;NCT03770416;NCT02436707;NCT03939182;NCT03740529;NCT02955628;NCT04607772"},{"ligand":"ibrutinib","mesh_id":"D016393","phase":"Phase 3","start_date":"2013","completion_date":"2019","nct_id":"NCT03570892;NCT02991638;NCT02443077;NCT01855750;NCT02703272;NCT01804686"},{"ligand":"ibrutinib","mesh_id":"D016393","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03229200"},{"ligand":"imatinib","mesh_id":"D016393","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"palbociclib","mesh_id":"D016393","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03478514"},{"ligand":"ruxolitinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2011","completion_date":"2013","nct_id":"NCT01431209;NCT01965119"},{"ligand":"selumetinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01278615"},{"ligand":"sirolimus","mesh_id":"D016393","phase":"Phase 1","start_date":"2010","completion_date":"2013","nct_id":"NCT01854606;NCT01088048"},{"ligand":"sirolimus","mesh_id":"D016393","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT00290472;NCT01251575;NCT01075321;NCT00918333;NCT00577278;NCT00869999;NCT01653067"},{"ligand":"sorafenib","mesh_id":"D016393","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sunitinib","mesh_id":"D016393","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"sunitinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00392496"},{"ligand":"zanubrutinib","mesh_id":"D016393","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02914938;NCT03189524;NCT04436107"},{"ligand":"zanubrutinib","mesh_id":"D016393","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03162536;NCT03145064;NCT04460248;NCT04705129;NCT04668365;NCT03520920;NCT03740529"}],"predictions":[{"target":"PDGFRA","probability":"0.7701162790697674"},{"target":"IGF1R","probability":"0.77"},{"target":"FGFR1","probability":"0.76"},{"target":"ERBB3","probability":"0.75"},{"target":"MET","probability":"0.69"},{"target":"FGFR3","probability":"0.6852379782660936"},{"target":"INSR","probability":"0.675"},{"target":"ERBB2","probability":"0.6619090909090909"},{"target":"FGFR2","probability":"0.65"},{"target":"BRAF","probability":"0.614092274544371"},{"target":"FLT1","probability":"0.6001101321585903"},{"target":"ROR2","probability":"0.5901995863776355"},{"target":"TYRO3","probability":"0.5814974190986698"},{"target":"PTK7","probability":"0.5659249075087314"},{"target":"NTRK2","probability":"0.5544258571793881"},{"target":"ROS1","probability":"0.5508447366589523"},{"target":"NTRK1","probability":"0.5505039200191577"},{"target":"DCLK1","probability":"0.5456082408420646"},{"target":"BMPR1B","probability":"0.545"},{"target":"NPR2","probability":"0.5300681198910082"},{"target":"YES1","probability":"0.5236158736134967"},{"target":"SRC","probability":"0.522539101721781"},{"target":"ACVR2B","probability":"0.5201604938271605"},{"target":"BCR","probability":"0.5155268725025561"},{"target":"ARAF","probability":"0.515"},{"target":"NTRK3","probability":"0.5106194786676082"},{"target":"ALK","probability":"0.5068031606890149"},{"target":"PTK2","probability":"0.4915673284202373"},{"target":"EPHB2","probability":"0.485"},{"target":"EPHA4","probability":"0.48109077542113715"},{"target":"TEC","probability":"0.4762855239786856"},{"target":"TGFBR2","probability":"0.47405619648995606"},{"target":"FGFR4","probability":"0.4700555555555556"},{"target":"TGFBR1","probability":"0.46059152750916915"},{"target":"MAP2K7","probability":"0.46"}],"source_name":"Lymphoma, B-Cell"}],["D008224",{"mesh_id":"D008224","trials":[{"ligand":"acalabrutinib","mesh_id":"D008224","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03162536;NCT04404088"},{"ligand":"cetuximab","mesh_id":"D008224","phase":"Phase 3","start_date":"2000","completion_date":"2000","nct_id":"NCT00115700"},{"ligand":"copanlisib","mesh_id":"D008224","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04156828"},{"ligand":"copanlisib","mesh_id":"D008224","phase":"Phase 2","start_date":"2019","completion_date":"2021","nct_id":"NCT03789240;NCT04750941"},{"ligand":"dasatinib","mesh_id":"D008224","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D008224","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03892044"},{"ligand":"duvelisib","mesh_id":"D008224","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT02605694;NCT04707079;NCT02391545;NCT04379167"},{"ligand":"duvelisib","mesh_id":"D008224","phase":"Phase 3","start_date":"2014","completion_date":"2015","nct_id":"NCT02576275;NCT02204982"},{"ligand":"everolimus","mesh_id":"D008224","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02240719"},{"ligand":"everolimus","mesh_id":"D008224","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT01075321;NCT04305444;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D008224","phase":"Phase 1","start_date":"2011","completion_date":"2018","nct_id":"NCT03479268;NCT02756247;NCT01479842;NCT01955499;NCT02109224;NCT01829568;NCT02743546;NCT02966730;NCT02950220"},{"ligand":"ibrutinib","mesh_id":"D008224","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03162536;NCT02869633;NCT02532257;NCT04450173;NCT03310619;NCT01779791;NCT01849263;NCT01980654;NCT02927964;NCT04659044;NCT02689869;NCT02451111;NCT02956382;NCT02332980"},{"ligand":"ibrutinib","mesh_id":"D008224","phase":"Phase 3","start_date":"2013","completion_date":"2017","nct_id":"NCT02947347;NCT01804686"},{"ligand":"imatinib","mesh_id":"D008224","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D008224","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02240719"},{"ligand":"sirolimus","mesh_id":"D008224","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00105001;NCT00290472;NCT01381692;NCT01075321;NCT01078142;NCT00918333"},{"ligand":"sorafenib","mesh_id":"D008224","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sunitinib","mesh_id":"D008224","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"zanubrutinib","mesh_id":"D008224","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03162536;NCT03332017"}],"predictions":[{"target":"RET","probability":"0.6256561778838556"},{"target":"MET","probability":"0.5407515994567029"},{"target":"IGF1R","probability":"0.5306775847827969"},{"target":"ERBB3","probability":"0.5162545971868782"},{"target":"JAK2","probability":"0.500625360957899"},{"target":"FGFR1","probability":"0.5001418439716312"},{"target":"ERBB2","probability":"0.4955094504168288"},{"target":"BRAF","probability":"0.4878413445606175"},{"target":"PDGFRA","probability":"0.48246375049633256"},{"target":"INSR","probability":"0.47511397058823523"},{"target":"FGFR3","probability":"0.4607195658274683"}],"source_name":"Lymphoma, Follicular"}],["D018442",{"mesh_id":"D018442","trials":[{"ligand":"acalabrutinib","mesh_id":"D018442","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03162536;NCT04646395;NCT04189952;NCT03740529"},{"ligand":"copanlisib","mesh_id":"D018442","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03474744"},{"ligand":"dasatinib","mesh_id":"D018442","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D018442","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02576275"},{"ligand":"everolimus","mesh_id":"D018442","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01164267;NCT01075321;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D018442","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT03479268;NCT01479842;NCT04043845;NCT02109224"},{"ligand":"ibrutinib","mesh_id":"D018442","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT03162536;NCT01980628;NCT02532257;NCT02927964;NCT04659044;NCT03093831;NCT02332980;NCT03697512;NCT03144674;NCT03740529"},{"ligand":"ibrutinib","mesh_id":"D018442","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT04212013"},{"ligand":"imatinib","mesh_id":"D018442","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D018442","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00105001;NCT00290472;NCT01381692;NCT01075321;NCT00918333;NCT02991898;NCT02722668"},{"ligand":"sorafenib","mesh_id":"D018442","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sunitinib","mesh_id":"D018442","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"trastuzumab","mesh_id":"D018442","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03432741"},{"ligand":"zanubrutinib","mesh_id":"D018442","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02914938"},{"ligand":"zanubrutinib","mesh_id":"D018442","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03162536;NCT03520920;NCT03846427;NCT03740529"}],"predictions":[{"target":"PDGFRA","probability":"0.5103207508509993"},{"target":"ERBB3","probability":"0.4567492849987069"}],"source_name":"Lymphoma, B-Cell, Marginal Zone"}],["D016403",{"mesh_id":"D016403","trials":[{"ligand":"acalabrutinib","mesh_id":"D016403","phase":"Phase 1","start_date":"2014","completion_date":"2018","nct_id":"NCT03527147;NCT02112526"},{"ligand":"acalabrutinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03162536;NCT04257578;NCT04604067;NCT04002947;NCT03571308;NCT03736616;NCT04502394;NCT04189952;NCT04546620"},{"ligand":"acalabrutinib","mesh_id":"D016403","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04529772"},{"ligand":"apatinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04476459"},{"ligand":"apatinib","mesh_id":"D016403","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03376958"},{"ligand":"cetuximab","mesh_id":"D016403","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT03579888"},{"ligand":"copanlisib","mesh_id":"D016403","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03884998;NCT04156828"},{"ligand":"copanlisib","mesh_id":"D016403","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02391116;NCT04572763;NCT04263584;NCT03484819;NCT04433182"},{"ligand":"dasatinib","mesh_id":"D016403","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"dasatinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00918463"},{"ligand":"duvelisib","mesh_id":"D016403","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03892044"},{"ligand":"everolimus","mesh_id":"D016403","phase":"Phase 1","start_date":"2012","completion_date":"2014","nct_id":"NCT01334502;NCT02240719;NCT01854606"},{"ligand":"everolimus","mesh_id":"D016403","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT01075321;NCT00978432;NCT04305444;NCT00918333;NCT00869999"},{"ligand":"everolimus","mesh_id":"D016403","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00790036"},{"ligand":"fostamatinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01499303"},{"ligand":"ibrutinib","mesh_id":"D016403","phase":"Phase 1","start_date":"2011","completion_date":"2021","nct_id":"NCT02780830;NCT03479268;NCT02756247;NCT03220022;NCT03440567;NCT01479842;NCT03223610;NCT03876028;NCT01955499;NCT03960840;NCT02109224;NCT04739813;NCT02303392;NCT03136497;NCT02743546;NCT02219737;NCT02950220"},{"ligand":"ibrutinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT04025593;NCT02077166;NCT03162536;NCT03399513;NCT02874404;NCT02760485;NCT03731234;NCT03129828;NCT03310619;NCT02401048;NCT02692248;NCT02636322;NCT02747732;NCT03684694;NCT02670616;NCT04446962;NCT02142049;NCT03949062;NCT01325701;NCT03939182;NCT02955628;NCT04607772"},{"ligand":"ibrutinib","mesh_id":"D016403","phase":"Phase 3","start_date":"2013","completion_date":"2016","nct_id":"NCT02443077;NCT01855750;NCT01804686"},{"ligand":"imatinib","mesh_id":"D016403","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"ruxolitinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01431209"},{"ligand":"selumetinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01278615"},{"ligand":"sirolimus","mesh_id":"D016403","phase":"Phase 1","start_date":"2013","completion_date":"2014","nct_id":"NCT02240719;NCT01854606"},{"ligand":"sirolimus","mesh_id":"D016403","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00105001;NCT00290472;NCT01177397;NCT01251575;NCT01075321;NCT01181271;NCT03246906;NCT00918333;NCT00086840;NCT00869999;NCT01653067"},{"ligand":"sirolimus","mesh_id":"D016403","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01231412"},{"ligand":"sorafenib","mesh_id":"D016403","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sorafenib","mesh_id":"D016403","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00278382;NCT00131937"},{"ligand":"sunitinib","mesh_id":"D016403","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"sunitinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00392496"},{"ligand":"zanubrutinib","mesh_id":"D016403","phase":"Phase 1","start_date":"2016","completion_date":"2020","nct_id":"NCT02914938;NCT04436107"},{"ligand":"zanubrutinib","mesh_id":"D016403","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04282018;NCT03162536;NCT03145064;NCT04460248;NCT04668365;NCT03520920"}],"predictions":[],"source_name":"Lymphoma, Large B-Cell, Diffuse"}],["D008258",{"mesh_id":"D008258","trials":[{"ligand":"acalabrutinib","mesh_id":"D008258","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT03162536;NCT04624906;NCT02362035;NCT02180724;NCT04116437;NCT03740529"},{"ligand":"copanlisib","mesh_id":"D008258","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03884998"},{"ligand":"dasatinib","mesh_id":"D008258","phase":"Phase 1","start_date":"2008","completion_date":"2019","nct_id":"NCT00608361;NCT04115059"},{"ligand":"everolimus","mesh_id":"D008258","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT01125293;NCT00918333;NCT00976248"},{"ligand":"ibrutinib","mesh_id":"D008258","phase":"Phase 1","start_date":"2011","completion_date":"2020","nct_id":"NCT03479268;NCT01479842;NCT04260217;NCT04043845;NCT04274738;NCT01955499;NCT02109224;NCT02950220;NCT04115059"},{"ligand":"ibrutinib","mesh_id":"D008258","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT03162536;NCT02604511;NCT04665115;NCT03225716;NCT01614821;NCT03506373;NCT04062448;NCT03620903;NCT04273139;NCT02332980;NCT04116437;NCT01109069;NCT03679624;NCT03740529"},{"ligand":"ibrutinib","mesh_id":"D008258","phase":"Phase 3","start_date":"2013","completion_date":"2021","nct_id":"NCT04061512;NCT02991638;NCT04263480;NCT03053440;NCT02165397;NCT01804686"},{"ligand":"ibrutinib","mesh_id":"D008258","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT04042376"},{"ligand":"imatinib","mesh_id":"D008258","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D008258","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00105001;NCT00290472;NCT01381692;NCT01251575;NCT01075321;NCT01076543;NCT03246906;NCT00918333;NCT03192397;NCT02991898;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D008258","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01231412"},{"ligand":"sorafenib","mesh_id":"D008258","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sunitinib","mesh_id":"D008258","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"zanubrutinib","mesh_id":"D008258","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03162536;NCT04463953;NCT03332173;NCT04116437;NCT03740529"},{"ligand":"zanubrutinib","mesh_id":"D008258","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03053440"}],"predictions":[],"source_name":"Waldenstrom Macroglobulinemia"}],["D015463",{"mesh_id":"D015463","trials":[{"ligand":"acalabrutinib","mesh_id":"D015463","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02296918"},{"ligand":"acalabrutinib","mesh_id":"D015463","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02029443"},{"ligand":"ibrutinib","mesh_id":"D015463","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT03479268;NCT02303392;NCT01886859"},{"ligand":"ibrutinib","mesh_id":"D015463","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT02662296;NCT02007044;NCT03873493;NCT02005289;NCT01589302"},{"ligand":"imatinib","mesh_id":"D015463","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D015463","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT01251575;NCT03246906;NCT02991898;NCT02722668"},{"ligand":"sirolimus","mesh_id":"D015463","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01231412"},{"ligand":"sunitinib","mesh_id":"D015463","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"sunitinib","mesh_id":"D015463","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"}],"predictions":[],"source_name":"Leukemia, Prolymphocytic"}],["D010051",{"mesh_id":"D010051","trials":[{"ligand":"acalabrutinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02537444"},{"ligand":"afatinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alpelisib","mesh_id":"D010051","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01623349"},{"ligand":"alpelisib","mesh_id":"D010051","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04729387"},{"ligand":"apatinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03075462"},{"ligand":"apatinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT04590625;NCT04068974;NCT03587129;NCT03393507;NCT04348032;NCT02867956;NCT03298074;NCT04383977;NCT04517357;NCT03262545;NCT03942068;NCT03547375"},{"ligand":"apatinib","mesh_id":"D010051","phase":"Phase 3","start_date":"2019","completion_date":"2020","nct_id":"NCT04229615;NCT04000295"},{"ligand":"apatinib","mesh_id":"D010051","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT03384511"},{"ligand":"binimetinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"binimetinib","mesh_id":"D010051","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01849874"},{"ligand":"cabozantinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484"},{"ligand":"cetuximab","mesh_id":"D010051","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT04464967;NCT00082212"},{"ligand":"cobimetinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03695380"},{"ligand":"cobimetinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03363867"},{"ligand":"copanlisib","mesh_id":"D010051","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03586661"},{"ligand":"copanlisib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00672295"},{"ligand":"dasatinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"entrectinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erdafitinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00130520;NCT00030446;NCT01003938;NCT00217529"},{"ligand":"erlotinib","mesh_id":"D010051","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00263822"},{"ligand":"everolimus","mesh_id":"D010051","phase":"Phase 2","start_date":"2010","completion_date":"2014","nct_id":"NCT02283658;NCT01149434;NCT02188550"},{"ligand":"fostamatinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03246074"},{"ligand":"gefitinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2002","completion_date":"2004","nct_id":"NCT00181688;NCT00049556;NCT00317772"},{"ligand":"imatinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00840450;NCT00042952;NCT00216112;NCT00039585;NCT00510653;NCT00928642"},{"ligand":"lapatinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00317434;NCT04608409"},{"ligand":"larotrectinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02788708"},{"ligand":"lenvatinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01133756;NCT04519151;NCT04781088"},{"ligand":"neratinib","mesh_id":"D010051","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04502602"},{"ligand":"nintedanib","mesh_id":"D010051","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01485874;NCT01314105;NCT01329549"},{"ligand":"nintedanib","mesh_id":"D010051","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT01583322;NCT01669798;NCT00710762;NCT01610869"},{"ligand":"nintedanib","mesh_id":"D010051","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01015118"},{"ligand":"olaratumab","mesh_id":"D010051","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00913835"},{"ligand":"osimertinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D010051","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04498520"},{"ligand":"palbociclib","mesh_id":"D010051","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT04553133;NCT02465060;NCT03936270;NCT01037790"},{"ligand":"panitumumab","mesh_id":"D010051","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01296035;NCT01388621;NCT00861120"},{"ligand":"pazopanib","mesh_id":"D010051","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01608009"},{"ligand":"pazopanib","mesh_id":"D010051","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT01238770;NCT00281632;NCT01227928;NCT01644825;NCT01262014;NCT01600573;NCT01610206;NCT00561795;NCT02055690;NCT02383251"},{"ligand":"pazopanib","mesh_id":"D010051","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00866697"},{"ligand":"pertuzumab","mesh_id":"D010051","phase":"Phase 2","start_date":"2003","completion_date":"2015","nct_id":"NCT02465060;NCT02004093;NCT00058552"},{"ligand":"pertuzumab","mesh_id":"D010051","phase":"Phase 3","start_date":"2012","completion_date":"2012","nct_id":"NCT01684878"},{"ligand":"ramucirumab","mesh_id":"D010051","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00721162"},{"ligand":"regorafenib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02736305;NCT02584465"},{"ligand":"ribociclib","mesh_id":"D010051","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03294694;NCT03056833"},{"ligand":"ruxolitinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"sirolimus","mesh_id":"D010051","phase":"Phase 1","start_date":"2007","completion_date":"2017","nct_id":"NCT01522820;NCT02646319;NCT02142803;NCT02833506;NCT00982631;NCT02312661;NCT01155258;NCT00408655"},{"ligand":"sirolimus","mesh_id":"D010051","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02283658;NCT00926107;NCT01010126;NCT01149434;NCT01196429;NCT01460979"},{"ligand":"sorafenib","mesh_id":"D010051","phase":"Phase 2","start_date":"2006","completion_date":"2010","nct_id":"NCT00526799;NCT00436215;NCT00390611;NCT00791778;NCT01047891"},{"ligand":"sunitinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00979992;NCT00543049;NCT01824615;NCT02465060"},{"ligand":"tivozanib","mesh_id":"D010051","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01972516"},{"ligand":"trametinib","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D010051","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01384253"},{"ligand":"trastuzumab","mesh_id":"D010051","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT04482309;NCT04464967;NCT02465060;NCT00194714"},{"ligand":"vandetanib","mesh_id":"D010051","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT00445549;NCT00862836"}],"predictions":[{"target":"IGF1R","probability":"0.5207956357175013"}],"source_name":"Ovarian Neoplasms"}],["D000077216",{"mesh_id":"D000077216","trials":[{"ligand":"acalabrutinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02537444"},{"ligand":"afatinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alpelisib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01623349"},{"ligand":"alpelisib","mesh_id":"D000077216","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04729387"},{"ligand":"apatinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03075462"},{"ligand":"apatinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT04590625;NCT04068974;NCT03587129;NCT03393507;NCT04348032;NCT02867956;NCT03298074;NCT04383977;NCT04517357;NCT03942068;NCT03547375"},{"ligand":"apatinib","mesh_id":"D000077216","phase":"Phase 3","start_date":"2019","completion_date":"2020","nct_id":"NCT04229615;NCT04000295"},{"ligand":"binimetinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01649336"},{"ligand":"binimetinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"binimetinib","mesh_id":"D000077216","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01849874"},{"ligand":"cabozantinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484"},{"ligand":"cobimetinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03695380"},{"ligand":"cobimetinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03363867"},{"ligand":"copanlisib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03586661"},{"ligand":"copanlisib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dasatinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00030498"},{"ligand":"erlotinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00130520;NCT00059787;NCT00126542;NCT00030446;NCT00063895;NCT01003938;NCT00217529"},{"ligand":"erlotinib","mesh_id":"D000077216","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00263822"},{"ligand":"everolimus","mesh_id":"D000077216","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01281514"},{"ligand":"everolimus","mesh_id":"D000077216","phase":"Phase 2","start_date":"2010","completion_date":"2014","nct_id":"NCT02283658;NCT01149434;NCT02188550"},{"ligand":"fostamatinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03246074"},{"ligand":"gefitinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2002","completion_date":"2003","nct_id":"NCT00181688;NCT00049556"},{"ligand":"imatinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00036751;NCT00041041;NCT00216112;NCT00039585;NCT00510653;NCT00928642"},{"ligand":"lapatinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2005","completion_date":"2020","nct_id":"NCT00317434;NCT04608409"},{"ligand":"lapatinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00316407;NCT00113373"},{"ligand":"larotrectinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02788708"},{"ligand":"lenvatinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2010","completion_date":"2021","nct_id":"NCT01133756;NCT04519151;NCT04781088"},{"ligand":"neratinib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04502602"},{"ligand":"nintedanib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01485874"},{"ligand":"nintedanib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT02866370;NCT01583322;NCT01669798;NCT01610869"},{"ligand":"osimertinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04498520"},{"ligand":"palbociclib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT01536743;NCT02465060;NCT03936270"},{"ligand":"panitumumab","mesh_id":"D000077216","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01296035;NCT01388621;NCT00861120"},{"ligand":"pazopanib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01608009"},{"ligand":"pazopanib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT01238770;NCT00281632;NCT01644825;NCT01262014;NCT01600573;NCT01610206;NCT00561795;NCT02055690;NCT02383251"},{"ligand":"pertuzumab","mesh_id":"D000077216","phase":"Phase 2","start_date":"2003","completion_date":"2015","nct_id":"NCT02465060;NCT02004093;NCT00058552"},{"ligand":"pertuzumab","mesh_id":"D000077216","phase":"Phase 3","start_date":"2012","completion_date":"2012","nct_id":"NCT01684878"},{"ligand":"ramucirumab","mesh_id":"D000077216","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00721162"},{"ligand":"regorafenib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02736305;NCT02584465"},{"ligand":"ribociclib","mesh_id":"D000077216","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03294694;NCT03056833"},{"ligand":"ruxolitinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"sirolimus","mesh_id":"D000077216","phase":"Phase 1","start_date":"2007","completion_date":"2017","nct_id":"NCT01522820;NCT02646319;NCT02142803;NCT02833506;NCT00982631;NCT02312661;NCT01155258;NCT01281514;NCT00408655;NCT01536054"},{"ligand":"sirolimus","mesh_id":"D000077216","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT02283658;NCT00926107;NCT01010126;NCT00429793;NCT01149434;NCT01196429"},{"ligand":"sorafenib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2004","completion_date":"2010","nct_id":"NCT00526799;NCT00522301;NCT00390611;NCT00096395;NCT01047891"},{"ligand":"sunitinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00979992;NCT00543049;NCT02465060;NCT00388037"},{"ligand":"tivozanib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01853644"},{"ligand":"trametinib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D000077216","phase":"Phase 1","start_date":"1999","completion_date":"2001","nct_id":"NCT00028535;NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D000077216","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02465060;NCT00194714"},{"ligand":"vandetanib","mesh_id":"D000077216","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00862836"}],"predictions":[],"source_name":"Carcinoma, Ovarian Epithelial"}],["D002295",{"mesh_id":"D002295","trials":[{"ligand":"acalabrutinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02351739"},{"ligand":"axitinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"cabozantinib","mesh_id":"D002295","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02496208;NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT03534804;NCT01688999;NCT03866382"},{"ligand":"crizotinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"dasatinib","mesh_id":"D002295","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01440998"},{"ligand":"dasatinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"erdafitinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03473743"},{"ligand":"erlotinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT02788201;NCT00749892"},{"ligand":"everolimus","mesh_id":"D002295","phase":"Phase 2","start_date":"2008","completion_date":"2011","nct_id":"NCT01801137;NCT00714025;NCT01215136;NCT00933374;NCT00805129"},{"ligand":"gefitinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2001","completion_date":"2017","nct_id":"NCT02788201;NCT00014144;NCT00041106"},{"ligand":"imatinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"lapatinib","mesh_id":"D002295","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00623064"},{"ligand":"lapatinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT01382706;NCT02788201"},{"ligand":"lenvatinib","mesh_id":"D002295","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03898180"},{"ligand":"nilotinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"nintedanib","mesh_id":"D002295","phase":"Phase 2","start_date":"2011","completion_date":"2014","nct_id":"NCT02278978;NCT01225887"},{"ligand":"palbociclib","mesh_id":"D002295","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02334527"},{"ligand":"panitumumab","mesh_id":"D002295","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02192541"},{"ligand":"panitumumab","mesh_id":"D002295","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT02818725"},{"ligand":"pazopanib","mesh_id":"D002295","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT01620970;NCT02788201;NCT00471536;NCT01031875;NCT01622660"},{"ligand":"pemigatinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT02872714;NCT03914794;NCT04586244;NCT04003610"},{"ligand":"ramucirumab","mesh_id":"D002295","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02443324"},{"ligand":"ramucirumab","mesh_id":"D002295","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04179110"},{"ligand":"ramucirumab","mesh_id":"D002295","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02426125"},{"ligand":"ruxolitinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"},{"ligand":"sirolimus","mesh_id":"D002295","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT03047213;NCT02788201;NCT01856101;NCT01090466;NCT00805129"},{"ligand":"sorafenib","mesh_id":"D002295","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01844947"},{"ligand":"sorafenib","mesh_id":"D002295","phase":"Phase 2","start_date":"2005","completion_date":"2017","nct_id":"NCT00714948;NCT02788201;NCT00112905;NCT00112671"},{"ligand":"sunitinib","mesh_id":"D002295","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT01118351;NCT00393796;NCT00859339;NCT01089088;NCT00792025;NCT02788201;NCT01042795;NCT01118039;NCT00794950;NCT00397488"},{"ligand":"trastuzumab","mesh_id":"D002295","phase":"Phase 1","start_date":"1999","completion_date":"2018","nct_id":"NCT03523572;NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D002295","phase":"Phase 2","start_date":"2000","completion_date":"2019","nct_id":"NCT03507166;NCT00005831;NCT03809013;NCT04073602;NCT01828736;NCT00004856"},{"ligand":"vandetanib","mesh_id":"D002295","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT02788201;NCT01191892;NCT00880334"},{"ligand":"vemurafenib","mesh_id":"D002295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02788201"}],"predictions":[],"source_name":"Carcinoma, Transitional Cell"}],["D014523",{"mesh_id":"D014523","trials":[{"ligand":"afatinib","mesh_id":"D014523","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT02122172"},{"ligand":"cabozantinib","mesh_id":"D014523","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02496208"},{"ligand":"cabozantinib","mesh_id":"D014523","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01688999;NCT03866382"},{"ligand":"crizotinib","mesh_id":"D014523","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02612194"},{"ligand":"erlotinib","mesh_id":"D014523","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00749892"},{"ligand":"gefitinib","mesh_id":"D014523","phase":"Phase 2","start_date":"2001","completion_date":"2001","nct_id":"NCT00014144"},{"ligand":"pazopanib","mesh_id":"D014523","phase":"Phase 2","start_date":"2008","completion_date":"2009","nct_id":"NCT00471536;NCT01031875"},{"ligand":"sirolimus","mesh_id":"D014523","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01090466"},{"ligand":"sorafenib","mesh_id":"D014523","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01844947"},{"ligand":"sorafenib","mesh_id":"D014523","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00112905"},{"ligand":"sunitinib","mesh_id":"D014523","phase":"Phase 2","start_date":"2006","completion_date":"2009","nct_id":"NCT01089088;NCT01118039;NCT00397488"},{"ligand":"trastuzumab","mesh_id":"D014523","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D014523","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00004856"},{"ligand":"vandetanib","mesh_id":"D014523","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01191892"}],"predictions":[{"target":"ERBB3","probability":"0.4922602168619653"},{"target":"FGFR1","probability":"0.48796302162749533"},{"target":"NTRK1","probability":"0.4844233976894587"}],"source_name":"Urethral Neoplasms"}],["D014516",{"mesh_id":"D014516","trials":[{"ligand":"afatinib","mesh_id":"D014516","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT02122172"},{"ligand":"cabozantinib","mesh_id":"D014516","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02496208"},{"ligand":"crizotinib","mesh_id":"D014516","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02612194"},{"ligand":"erlotinib","mesh_id":"D014516","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00749892"},{"ligand":"everolimus","mesh_id":"D014516","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01182168"},{"ligand":"gefitinib","mesh_id":"D014516","phase":"Phase 2","start_date":"2001","completion_date":"2002","nct_id":"NCT00014144;NCT00041106"},{"ligand":"lapatinib","mesh_id":"D014516","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00623064"},{"ligand":"pazopanib","mesh_id":"D014516","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01031875"},{"ligand":"sirolimus","mesh_id":"D014516","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01090466"},{"ligand":"sorafenib","mesh_id":"D014516","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01844947"},{"ligand":"sorafenib","mesh_id":"D014516","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00112905;NCT00112671"},{"ligand":"sunitinib","mesh_id":"D014516","phase":"Phase 2","start_date":"2006","completion_date":"2009","nct_id":"NCT01089088;NCT00792025;NCT01118039;NCT00397488"},{"ligand":"trastuzumab","mesh_id":"D014516","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D014516","phase":"Phase 2","start_date":"2000","completion_date":"2002","nct_id":"NCT00005831;NCT00004856"},{"ligand":"vandetanib","mesh_id":"D014516","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01191892"}],"predictions":[],"source_name":"Ureteral Neoplasms"}],["D008577",{"mesh_id":"D008577","trials":[{"ligand":"afatinib","mesh_id":"D008577","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03711422"},{"ligand":"pertuzumab","mesh_id":"D008577","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04588545"},{"ligand":"trastuzumab","mesh_id":"D008577","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04588545"}],"predictions":[{"target":"BRAF","probability":"0.4553561830987451"}],"source_name":"Meningeal Neoplasms"}],["D004938",{"mesh_id":"D004938","trials":[{"ligand":"afatinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2014","completion_date":"2015","nct_id":"NCT02274012;NCT02465060;NCT02353936"},{"ligand":"alpelisib","mesh_id":"D004938","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01613950"},{"ligand":"apatinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03787251;NCT02683655;NCT03274011;NCT03649945;NCT02544737;NCT03170310;NCT03542422"},{"ligand":"apatinib","mesh_id":"D004938","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03285906"},{"ligand":"avapritinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"binimetinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cetuximab","mesh_id":"D004938","phase":"Phase 1","start_date":"2007","completion_date":"2019","nct_id":"NCT04161560;NCT00397384"},{"ligand":"cetuximab","mesh_id":"D004938","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT01360086;NCT01787006;NCT00165490;NCT00397904;NCT00096031;NCT02636088;NCT00551759;NCT00439608;NCT00109850;NCT00425425;NCT00445861;NCT00544362;NCT01034189;NCT04464967;NCT00381706;NCT00130689;NCT00578201;NCT00735345;NCT00733889;NCT00636298"},{"ligand":"cetuximab","mesh_id":"D004938","phase":"Phase 3","start_date":"2008","completion_date":"2010","nct_id":"NCT00655876;NCT01107639;NCT00509561"},{"ligand":"cobimetinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03281369"},{"ligand":"copanlisib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dacomitinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03770988;NCT02353936"},{"ligand":"dasatinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2016","nct_id":"NCT02465060;NCT02699606"},{"ligand":"erlotinib","mesh_id":"D004938","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00566800;NCT01561014;NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2002","completion_date":"2015","nct_id":"NCT00032123;NCT00591123;NCT00045526;NCT00393068;NCT00442507;NCT00524121;NCT00539617;NCT02353936"},{"ligand":"erlotinib","mesh_id":"D004938","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00686114"},{"ligand":"everolimus","mesh_id":"D004938","phase":"Phase 1","start_date":"2012","completion_date":"2014","nct_id":"NCT01490749;NCT02138929"},{"ligand":"everolimus","mesh_id":"D004938","phase":"Phase 2","start_date":"2009","completion_date":"2012","nct_id":"NCT00985192;NCT01231399"},{"ligand":"gefitinib","mesh_id":"D004938","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00290719"},{"ligand":"gefitinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2003","completion_date":"2015","nct_id":"NCT00258323;NCT00258297;NCT00493025;NCT00268346;NCT00215995;NCT01291823;NCT00100945;NCT02353936;NCT00093652"},{"ligand":"gefitinib","mesh_id":"D004938","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01243398"},{"ligand":"icotinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2013","completion_date":"2015","nct_id":"NCT02375581;NCT01855854"},{"ligand":"lapatinib","mesh_id":"D004938","phase":"Phase 1","start_date":"2006","completion_date":"2012","nct_id":"NCT00313599;NCT01705340"},{"ligand":"lapatinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2005","completion_date":"2011","nct_id":"NCT01123473;NCT01395537;NCT01145404;NCT00239200"},{"ligand":"larotrectinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"osimertinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"panitumumab","mesh_id":"D004938","phase":"Phase 1","start_date":"2000","completion_date":"2000","nct_id":"NCT00004879"},{"ligand":"panitumumab","mesh_id":"D004938","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT01077999;NCT01262183;NCT01128387;NCT01443065;NCT00757172;NCT01379807;NCT00578071;NCT01307956"},{"ligand":"pertuzumab","mesh_id":"D004938","phase":"Phase 2","start_date":"2014","completion_date":"2015","nct_id":"NCT02465060;NCT02120911"},{"ligand":"ramucirumab","mesh_id":"D004938","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02970539"},{"ligand":"ramucirumab","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2021","nct_id":"NCT02628951;NCT02514551;NCT03739801;NCT03995017;NCT02443883;NCT03141034;NCT04660760;NCT03762564;NCT02539225;NCT03008278;NCT03281369"},{"ligand":"ramucirumab","mesh_id":"D004938","phase":"Phase 3","start_date":"2015","completion_date":"2021","nct_id":"NCT04499924;NCT04704934;NCT02314117;NCT02898077"},{"ligand":"regorafenib","mesh_id":"D004938","phase":"Phase 2","start_date":"2014","completion_date":"2015","nct_id":"NCT02234180;NCT02406170"},{"ligand":"regorafenib","mesh_id":"D004938","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02773524"},{"ligand":"sirolimus","mesh_id":"D004938","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01522820"},{"ligand":"sirolimus","mesh_id":"D004938","phase":"Phase 2","start_date":"2009","completion_date":"2012","nct_id":"NCT00985192;NCT01231399"},{"ligand":"sorafenib","mesh_id":"D004938","phase":"Phase 2","start_date":"2008","completion_date":"2015","nct_id":"NCT01262482;NCT01158287;NCT02544737"},{"ligand":"sunitinib","mesh_id":"D004938","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00524186"},{"ligand":"sunitinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00730353;NCT00400114;NCT02465060;NCT00891878;NCT00702884"},{"ligand":"trametinib","mesh_id":"D004938","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D004938","phase":"Phase 1","start_date":"1999","completion_date":"2021","nct_id":"NCT04704661;NCT00004074;NCT01705340"},{"ligand":"trastuzumab","mesh_id":"D004938","phase":"Phase 2","start_date":"2006","completion_date":"2021","nct_id":"NCT04510285;NCT01774851;NCT03783936;NCT04464967;NCT02465060;NCT02120911;NCT01928290;NCT01472029;NCT01359397;NCT00515411;NCT03368131"},{"ligand":"trastuzumab","mesh_id":"D004938","phase":"Phase 3","start_date":"2010","completion_date":"2021","nct_id":"NCT04499924;NCT01196390;NCT04704934;NCT03615326"},{"ligand":"tucatinib","mesh_id":"D004938","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04499924"},{"ligand":"vandetanib","mesh_id":"D004938","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00732745;NCT01183559"},{"ligand":"zanubrutinib","mesh_id":"D004938","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03777657"}],"predictions":[{"target":"ERBB3","probability":"0.7651572327044025"},{"target":"KIT","probability":"0.765"},{"target":"PDGFRA","probability":"0.755"},{"target":"IGF1R","probability":"0.7151572327044025"},{"target":"FLT1","probability":"0.7103125"},{"target":"CSF1R","probability":"0.7"},{"target":"JAK2","probability":"0.65"},{"target":"INSR","probability":"0.63"},{"target":"BCR","probability":"0.6151056338028169"},{"target":"FLT4","probability":"0.6150284495021338"},{"target":"JAK1","probability":"0.5700862068965518"},{"target":"ZAP70","probability":"0.57"},{"target":"ACVRL1","probability":"0.5451683278480551"},{"target":"SRC","probability":"0.5451503759398496"},{"target":"CDKN1A","probability":"0.5350431034482759"},{"target":"TGFBR2","probability":"0.49052850688730987"},{"target":"SYK","probability":"0.4900431034482759"},{"target":"AKT2","probability":"0.475060165328331"},{"target":"PTK2","probability":"0.4750431034482759"},{"target":"CHEK2","probability":"0.4743507357018008"},{"target":"MAP2K7","probability":"0.46125"},{"target":"JAK3","probability":"0.46019633905514196"},{"target":"PTK2B","probability":"0.4552422175959774"},{"target":"EPHA2","probability":"0.4550206611570248"},{"target":"TGFBR1","probability":"0.455"}],"source_name":"Esophageal Neoplasms"}],["D002817",{"mesh_id":"D002817","trials":[{"ligand":"afatinib","mesh_id":"D002817","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03083678"},{"ligand":"cetuximab","mesh_id":"D002817","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03647423"},{"ligand":"dasatinib","mesh_id":"D002817","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"imatinib","mesh_id":"D002817","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01175109"},{"ligand":"imatinib","mesh_id":"D002817","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT04042597;NCT00150072"},{"ligand":"nilotinib","mesh_id":"D002817","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01407198"},{"ligand":"palbociclib","mesh_id":"D002817","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03110744"},{"ligand":"pertuzumab","mesh_id":"D002817","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"},{"ligand":"sirolimus","mesh_id":"D002817","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03190174"},{"ligand":"trastuzumab","mesh_id":"D002817","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"}],"predictions":[],"source_name":"Chordoma"}],["D055756",{"mesh_id":"D055756","trials":[{"ligand":"afatinib","mesh_id":"D055756","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04148898"},{"ligand":"afatinib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"alectinib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"ceritinib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"crizotinib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"erlotinib","mesh_id":"D055756","phase":"Phase 2","start_date":"2009","completion_date":"2019","nct_id":"NCT04148898;NCT00830245"},{"ligand":"erlotinib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"gefitinib","mesh_id":"D055756","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00372515"},{"ligand":"gefitinib","mesh_id":"D055756","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04148898"},{"ligand":"lenvatinib","mesh_id":"D055756","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04729348"},{"ligand":"osimertinib","mesh_id":"D055756","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03257124;NCT04148898;NCT04425681;NCT04233021"},{"ligand":"osimertinib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"},{"ligand":"trastuzumab","mesh_id":"D055756","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01373710"},{"ligand":"vemurafenib","mesh_id":"D055756","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04356118"}],"predictions":[{"target":"PIK3CA","probability":"0.6459951507164027"},{"target":"PRKACB","probability":"0.5364970765114437"},{"target":"CCNK","probability":"0.5250789735724356"},{"target":"NEK9","probability":"0.512300342685405"},{"target":"CSNK1A1","probability":"0.5031956909014581"},{"target":"PRKG2","probability":"0.49493091021167507"},{"target":"SRPK2","probability":"0.4751181024284216"},{"target":"WNK3","probability":"0.4745489529421673"},{"target":"KDR","probability":"0.4722592213772827"},{"target":"LRRK1","probability":"0.47109438567439427"},{"target":"MAPK4","probability":"0.4678332763092953"},{"target":"CDK13","probability":"0.4657738408373258"},{"target":"PRKD2","probability":"0.46501629678713735"},{"target":"MOK","probability":"0.462995225468875"}],"source_name":"Meningeal Carcinomatosis"}],["D017599",{"mesh_id":"D017599","trials":[{"ligand":"afatinib","mesh_id":"D017599","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02372006"},{"ligand":"erdafitinib","mesh_id":"D017599","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D017599","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"erlotinib","mesh_id":"D017599","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"imatinib","mesh_id":"D017599","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00030667"},{"ligand":"larotrectinib","mesh_id":"D017599","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D017599","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D017599","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"ribociclib","mesh_id":"D017599","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"selumetinib","mesh_id":"D017599","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D017599","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT01614795;NCT03213678;NCT03155620;NCT01946529"},{"ligand":"sorafenib","mesh_id":"D017599","phase":"Phase 2","start_date":"2006","completion_date":"2013","nct_id":"NCT00330421;NCT01946529"},{"ligand":"trametinib","mesh_id":"D017599","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"vemurafenib","mesh_id":"D017599","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[],"source_name":"Neuroectodermal Tumors"}],["D018242",{"mesh_id":"D018242","trials":[{"ligand":"afatinib","mesh_id":"D018242","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02372006"},{"ligand":"erdafitinib","mesh_id":"D018242","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D018242","phase":"Phase 1","start_date":"2001","completion_date":"2004","nct_id":"NCT00077454;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D018242","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"imatinib","mesh_id":"D018242","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00030667"},{"ligand":"larotrectinib","mesh_id":"D018242","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D018242","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D018242","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"ribociclib","mesh_id":"D018242","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"selumetinib","mesh_id":"D018242","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D018242","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT01614795;NCT03213678;NCT03155620;NCT01946529"},{"ligand":"sorafenib","mesh_id":"D018242","phase":"Phase 2","start_date":"2006","completion_date":"2013","nct_id":"NCT00330421;NCT01946529"},{"ligand":"trametinib","mesh_id":"D018242","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"vemurafenib","mesh_id":"D018242","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"JAK2","probability":"0.655"},{"target":"PDGFRA","probability":"0.65"},{"target":"BCR","probability":"0.635"},{"target":"PDGFRB","probability":"0.62"},{"target":"ALK","probability":"0.58"},{"target":"MAP2K7","probability":"0.57"},{"target":"AKT1","probability":"0.52"},{"target":"PIK3CD","probability":"0.485"},{"target":"RET","probability":"0.475"}],"source_name":"Neuroectodermal Tumors, Primitive"}],["D000077277",{"mesh_id":"D000077277","trials":[{"ligand":"afatinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01608022;NCT03940976;NCT02353936"},{"ligand":"alpelisib","mesh_id":"D000077277","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01822613"},{"ligand":"apatinib","mesh_id":"D000077277","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02645864"},{"ligand":"apatinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT03603756;NCT03274011;NCT03193424;NCT02976896;NCT03224221;NCT04666090;NCT03857763;NCT03251417;NCT03320629;NCT03913182"},{"ligand":"cetuximab","mesh_id":"D000077277","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT00815308;NCT04229459;NCT00165490;NCT02812641;NCT03817567;NCT02123381;NCT03126708"},{"ligand":"cetuximab","mesh_id":"D000077277","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02409186"},{"ligand":"dacomitinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT01608022;NCT02353936"},{"ligand":"erlotinib","mesh_id":"D000077277","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT01561014"},{"ligand":"erlotinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2002","completion_date":"2015","nct_id":"NCT00045526;NCT01608022;NCT02353936"},{"ligand":"gefitinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT01608022;NCT02353936"},{"ligand":"icotinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01973725"},{"ligand":"lapatinib","mesh_id":"D000077277","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00239200"},{"ligand":"panitumumab","mesh_id":"D000077277","phase":"Phase 3","start_date":"2012","completion_date":"2012","nct_id":"NCT01627379"},{"ligand":"ramucirumab","mesh_id":"D000077277","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03762564"},{"ligand":"ribociclib","mesh_id":"D000077277","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04000529"},{"ligand":"trastuzumab","mesh_id":"D000077277","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03185988"}],"predictions":[{"target":"FLT3","probability":"0.72"},{"target":"ERBB3","probability":"0.6901236263736262"},{"target":"PDGFRA","probability":"0.6202337585322166"},{"target":"MET","probability":"0.6202229185073515"},{"target":"FGFR2","probability":"0.62"},{"target":"IGF1R","probability":"0.615"},{"target":"FGFR3","probability":"0.6101470588235294"},{"target":"FGFR1","probability":"0.61"},{"target":"FLT1","probability":"0.605072463768116"},{"target":"FLT4","probability":"0.605"},{"target":"KIT","probability":"0.6"},{"target":"NTRK1","probability":"0.5901480725379941"},{"target":"CSF1R","probability":"0.59"},{"target":"ABL1","probability":"0.575"},{"target":"INSR","probability":"0.569"},{"target":"BCR","probability":"0.5502337585322167"},{"target":"JAK2","probability":"0.53"},{"target":"MTOR","probability":"0.5202337585322167"},{"target":"CDK6","probability":"0.5103267367905175"},{"target":"CHEK2","probability":"0.4952048694828296"},{"target":"NTRK2","probability":"0.4901480725379941"},{"target":"JAK1","probability":"0.4901101321585903"},{"target":"CDKN1A","probability":"0.485"},{"target":"RAF1","probability":"0.48014807253799413"},{"target":"CCL2","probability":"0.475"},{"target":"TEK","probability":"0.475"},{"target":"ATM","probability":"0.47278061849357017"},{"target":"ALK","probability":"0.4711602021881627"},{"target":"AKT1","probability":"0.4555084498834499"},{"target":"PIK3CD","probability":"0.45546697104338973"},{"target":"PTK2","probability":"0.45515037593984964"}],"source_name":"Esophageal Squamous Cell Carcinoma"}],["D018307",{"mesh_id":"D018307","trials":[{"ligand":"afatinib","mesh_id":"D018307","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01721525"},{"ligand":"afatinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02979977"},{"ligand":"alpelisib","mesh_id":"D018307","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02282371"},{"ligand":"apatinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03603756;NCT03224221"},{"ligand":"cabozantinib","mesh_id":"D018307","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03667482"},{"ligand":"cetuximab","mesh_id":"D018307","phase":"Phase 1","start_date":"2014","completion_date":"2018","nct_id":"NCT03667482;NCT02282371"},{"ligand":"cetuximab","mesh_id":"D018307","phase":"Phase 2","start_date":"2007","completion_date":"2018","nct_id":"NCT00815295;NCT03666325;NCT03370276;NCT02979977;NCT00661427;NCT00705016;NCT01326923;NCT03126708;NCT01864772;NCT00934518"},{"ligand":"cetuximab","mesh_id":"D018307","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02252042"},{"ligand":"dacomitinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2008","completion_date":"2014","nct_id":"NCT00768664;NCT01449201;NCT02268747"},{"ligand":"erlotinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00076310;NCT01192815;NCT01059305"},{"ligand":"gefitinib","mesh_id":"D018307","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00185835"},{"ligand":"gefitinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00255476;NCT01449201;NCT00229723"},{"ligand":"imatinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00485485"},{"ligand":"panitumumab","mesh_id":"D018307","phase":"Phase 3","start_date":"2012","completion_date":"2012","nct_id":"NCT01627379"},{"ligand":"ribociclib","mesh_id":"D018307","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03179956"},{"ligand":"sirolimus","mesh_id":"D018307","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01016769"},{"ligand":"sorafenib","mesh_id":"D018307","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00815295;NCT00494182"},{"ligand":"trametinib","mesh_id":"D018307","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01553851"}],"predictions":[],"source_name":"Neoplasms, Squamous Cell"}],["D000077192",{"mesh_id":"D000077192","trials":[{"ligand":"afatinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT04201756;NCT01003899;NCT01466660"},{"ligand":"alpelisib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02276027"},{"ligand":"apatinib","mesh_id":"D000077192","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02691871"},{"ligand":"apatinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04459078;NCT02704767;NCT02493582;NCT03376737"},{"ligand":"binimetinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02276027"},{"ligand":"ceritinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02513667;NCT02276027"},{"ligand":"cetuximab","mesh_id":"D000077192","phase":"Phase 2","start_date":"2005","completion_date":"2008","nct_id":"NCT00716456;NCT00118183;NCT00368992"},{"ligand":"cetuximab","mesh_id":"D000077192","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00946712"},{"ligand":"crizotinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2014","completion_date":"2016","nct_id":"NCT02946359;NCT02134912"},{"ligand":"dacomitinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00818441"},{"ligand":"erlotinib","mesh_id":"D000077192","phase":"Phase 1","start_date":"2002","completion_date":"2013","nct_id":"NCT00042835;NCT01851096"},{"ligand":"erlotinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2004","completion_date":"2020","nct_id":"NCT00087412;NCT02759835;NCT01294306;NCT02155465;NCT01578668;NCT00126581;NCT02788058;NCT01131429;NCT02146118;NCT00198380;NCT00716456;NCT01259089;NCT01565538;NCT02704767;NCT02787447;NCT04201756;NCT00950365;NCT00137839;NCT01557959;NCT00284141;NCT03076164"},{"ligand":"erlotinib","mesh_id":"D000077192","phase":"Phase 3","start_date":"2013","completion_date":"2016","nct_id":"NCT02889692;NCT02893332"},{"ligand":"erlotinib","mesh_id":"D000077192","phase":"Phase 4","start_date":"2012","completion_date":"2015","nct_id":"NCT02399566;NCT01609543"},{"ligand":"gefitinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT02759835;NCT03486496;NCT02788058;NCT00198380;NCT02951637;NCT00716456;NCT01502202;NCT02787447;NCT00040794;NCT01466660"},{"ligand":"gefitinib","mesh_id":"D000077192","phase":"Phase 3","start_date":"2001","completion_date":"2016","nct_id":"NCT00049543;NCT02518802;NCT00020709;NCT02889692;NCT02929693;NCT02893332"},{"ligand":"icotinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2015","completion_date":"2018","nct_id":"NCT02264210;NCT02788058;NCT02787447;NCT03402464;NCT03544814;NCT02737774"},{"ligand":"icotinib","mesh_id":"D000077192","phase":"Phase 3","start_date":"2012","completion_date":"2013","nct_id":"NCT02889692;NCT01719536"},{"ligand":"icotinib","mesh_id":"D000077192","phase":"Phase 4","start_date":"2012","completion_date":"2014","nct_id":"NCT02103257;NCT02283424;NCT01665417"},{"ligand":"lenvatinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01877083"},{"ligand":"nintedanib","mesh_id":"D000077192","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02668393"},{"ligand":"nintedanib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2018","completion_date":"2020","nct_id":"NCT03361319;NCT04046614"},{"ligand":"osimertinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT02759835;NCT04770688"},{"ligand":"ponatinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01935336"},{"ligand":"ruxolitinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02155465"},{"ligand":"sirolimus","mesh_id":"D000077192","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01737502"},{"ligand":"sorafenib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00456716"},{"ligand":"sunitinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00430261;NCT01829217"},{"ligand":"trametinib","mesh_id":"D000077192","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03076164"}],"predictions":[{"target":"ERBB3","probability":"0.82"},{"target":"FGFR2","probability":"0.8153213997642241"},{"target":"FGFR3","probability":"0.7633590828643716"},{"target":"CSF1R","probability":"0.71"},{"target":"NTRK1","probability":"0.6952076776364351"},{"target":"FGFR1","probability":"0.695"},{"target":"BRAF","probability":"0.6469657748715508"},{"target":"BCR","probability":"0.645"},{"target":"TEK","probability":"0.6301056338028169"},{"target":"MOK","probability":"0.6202864884867207"},{"target":"AMHR2","probability":"0.6100602813735089"},{"target":"CASK","probability":"0.5954770088360075"},{"target":"ACVRL1","probability":"0.5901369307373839"},{"target":"SGK3","probability":"0.589255807671529"},{"target":"CDK4","probability":"0.585"},{"target":"NTRK3","probability":"0.5804715277712854"},{"target":"LRRK1","probability":"0.5705700483091788"},{"target":"OBSCN","probability":"0.56025"},{"target":"TGFBR2","probability":"0.5554479820427052"},{"target":"NTRK2","probability":"0.55519117598627"},{"target":"CDK14","probability":"0.5550725773746061"},{"target":"EPHA5","probability":"0.5502415015896307"},{"target":"LTK","probability":"0.5502127659574468"},{"target":"FGFR4","probability":"0.547283288715696"},{"target":"PDIK1L","probability":"0.5402624069478908"},{"target":"BRSK2","probability":"0.5400283431691356"},{"target":"CDK6","probability":"0.54"},{"target":"HIPK3","probability":"0.53525"},{"target":"BMPR2","probability":"0.5351612903225806"},{"target":"NEK9","probability":"0.5350283431691356"},{"target":"TRPM6","probability":"0.5302355072463768"},{"target":"NEK6","probability":"0.5300111507582516"},{"target":"TXK","probability":"0.5257096667408926"},{"target":"FRK","probability":"0.5250398863904355"},{"target":"CAMK2B","probability":"0.5250283431691356"},{"target":"PRKG2","probability":"0.52025"},{"target":"CAMK2A","probability":"0.5200283431691356"},{"target":"PKN2","probability":"0.5152611507582515"},{"target":"CSNK1A1","probability":"0.5152415015896308"},{"target":"LMTK2","probability":"0.5150570788013196"},{"target":"CCNK","probability":"0.5150283431691356"},{"target":"PAK6","probability":"0.5145248223192888"},{"target":"AXL","probability":"0.5124961810394989"},{"target":"ACVR1C","probability":"0.5104627659574468"},{"target":"ZAP70","probability":"0.5100720914219555"},{"target":"CCL8","probability":"0.5062322042344829"},{"target":"MAPKAPK5","probability":"0.5055789458744258"},{"target":"CLK2","probability":"0.5052539085375216"},{"target":"PKMYT1","probability":"0.5050432283858072"},{"target":"CILK1","probability":"0.5005584375938813"},{"target":"DYRK1B","probability":"0.5003761296122196"},{"target":"MAPK4","probability":"0.5000144927536232"},{"target":"MAP3K10","probability":"0.5000138504155125"},{"target":"NEK1","probability":"0.4952698447587664"},{"target":"CDKN1A","probability":"0.49504310344827585"},{"target":"NPRL2","probability":"0.4950398863904355"},{"target":"FAM20C","probability":"0.49502834316913563"},{"target":"MAK","probability":"0.4950144927536232"},{"target":"LMTK3","probability":"0.49501115075825153"},{"target":"NPR1","probability":"0.4855446601022393"},{"target":"CDC42BPA","probability":"0.485080271973088"},{"target":"EPHA2","probability":"0.4816785785189597"},{"target":"PAK5","probability":"0.4805107658002668"},{"target":"MATK","probability":"0.48027934898879904"},{"target":"RPS6KA6","probability":"0.4800897823384937"},{"target":"STK33","probability":"0.480025001173764"},{"target":"MAPK15","probability":"0.48"},{"target":"TGFBR1","probability":"0.475553615845522"},{"target":"RPS6KA4","probability":"0.4752553520051432"},{"target":"STK25","probability":"0.4750570788013196"},{"target":"IRAK2","probability":"0.4705431617504264"},{"target":"HASPIN","probability":"0.4702355072463768"},{"target":"RYK","probability":"0.4702127659574468"},{"target":"DCLK3","probability":"0.47001449275362317"},{"target":"DAPK2","probability":"0.4652884518705553"},{"target":"PRKD2","probability":"0.46501449275362317"},{"target":"EPHB4","probability":"0.46253645225550544"},{"target":"MST1R","probability":"0.4609783358852606"},{"target":"INSRR","probability":"0.46027640722113466"},{"target":"NEK7","probability":"0.4600394939273872"},{"target":"TNIK","probability":"0.459218960004993"},{"target":"MAP3K13","probability":"0.4552415015896307"},{"target":"CDK11B","probability":"0.4550756859131085"},{"target":"AKT1","probability":"0.45504310344827587"},{"target":"STK26","probability":"0.45502834316913565"}],"source_name":"Adenocarcinoma of Lung"}],["D005706",{"mesh_id":"D005706","trials":[{"ligand":"afatinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04183712"},{"ligand":"apatinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03702491"},{"ligand":"cetuximab","mesh_id":"D005706","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"cetuximab","mesh_id":"D005706","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT03768375;NCT02836847"},{"ligand":"crizotinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT03768375;NCT02836847"},{"ligand":"erlotinib","mesh_id":"D005706","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00266097;NCT00397384;NCT00987766"},{"ligand":"erlotinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2002","completion_date":"2010","nct_id":"NCT00356889;NCT00033462;NCT00350753;NCT00832637;NCT01093222"},{"ligand":"everolimus","mesh_id":"D005706","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00949949"},{"ligand":"everolimus","mesh_id":"D005706","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT03768375;NCT02836847"},{"ligand":"gefitinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT03768375;NCT02836847"},{"ligand":"lapatinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2004","completion_date":"2016","nct_id":"NCT00107536;NCT03768375;NCT02836847;NCT00101036"},{"ligand":"nintedanib","mesh_id":"D005706","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00363584"},{"ligand":"panitumumab","mesh_id":"D005706","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01308840"},{"ligand":"pazopanib","mesh_id":"D005706","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01855724"},{"ligand":"ramucirumab","mesh_id":"D005706","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02520141"},{"ligand":"selumetinib","mesh_id":"D005706","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01242605"},{"ligand":"selumetinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01859182"},{"ligand":"sirolimus","mesh_id":"D005706","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00949949"},{"ligand":"sorafenib","mesh_id":"D005706","phase":"Phase 2","start_date":"2005","completion_date":"2016","nct_id":"NCT00238212;NCT03768375;NCT02836847;NCT00919061;NCT01093222;NCT00955721"},{"ligand":"trametinib","mesh_id":"D005706","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02042443"},{"ligand":"trastuzumab","mesh_id":"D005706","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D005706","phase":"Phase 2","start_date":"2007","completion_date":"2016","nct_id":"NCT00478140;NCT03768375;NCT02836847"},{"ligand":"vandetanib","mesh_id":"D005706","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00753675"}],"predictions":[{"target":"ERBB3","probability":"0.6302925611210495"},{"target":"FGFR1","probability":"0.5958056306306306"},{"target":"FGFR2","probability":"0.5854076066607758"},{"target":"IGF1R","probability":"0.5852499999999999"},{"target":"FLT4","probability":"0.5546783100544357"},{"target":"NTRK1","probability":"0.5161886467474497"},{"target":"FGFR3","probability":"0.4856003000472133"},{"target":"INSR","probability":"0.48480512937688397"},{"target":"JAK1","probability":"0.4667880199095316"},{"target":"TEK","probability":"0.4618012563877225"},{"target":"CDK4","probability":"0.46025"},{"target":"BCR","probability":"0.4578096153846154"}],"source_name":"Gallbladder Neoplasms"}],["D058922",{"mesh_id":"D058922","trials":[{"ligand":"afatinib","mesh_id":"D058922","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01325428"},{"ligand":"cobimetinib","mesh_id":"D058922","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03202316"},{"ligand":"lapatinib","mesh_id":"D058922","phase":"Phase 2","start_date":"2005","completion_date":"2008","nct_id":"NCT00105950;NCT00756470;NCT00111787;NCT00558103"},{"ligand":"lapatinib","mesh_id":"D058922","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01426880"},{"ligand":"neratinib","mesh_id":"D058922","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03101748"},{"ligand":"nintedanib","mesh_id":"D058922","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02389764"},{"ligand":"panitumumab","mesh_id":"D058922","phase":"Phase 2","start_date":"2010","completion_date":"2016","nct_id":"NCT01036087;NCT02876107"},{"ligand":"pazopanib","mesh_id":"D058922","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00558103"},{"ligand":"pertuzumab","mesh_id":"D058922","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT02682693;NCT03101748;NCT03742986;NCT01730833"},{"ligand":"pertuzumab","mesh_id":"D058922","phase":"Phase 3","start_date":"2012","completion_date":"2014","nct_id":"NCT02125344;NCT01583426"},{"ligand":"ruxolitinib","mesh_id":"D058922","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02876302"},{"ligand":"sunitinib","mesh_id":"D058922","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00513695"},{"ligand":"trastuzumab","mesh_id":"D058922","phase":"Phase 1","start_date":"1999","completion_date":"2011","nct_id":"NCT00004074;NCT01880385"},{"ligand":"trastuzumab","mesh_id":"D058922","phase":"Phase 2","start_date":"2005","completion_date":"2019","nct_id":"NCT00118053;NCT02199418;NCT02682693;NCT03101748;NCT03742986;NCT01641406;NCT01325428;NCT01730833"},{"ligand":"trastuzumab","mesh_id":"D058922","phase":"Phase 3","start_date":"2001","completion_date":"2014","nct_id":"NCT02125344;NCT01426880;NCT01583426;NCT00016276"}],"predictions":[],"source_name":"Inflammatory Breast Neoplasms"}],["D012878",{"mesh_id":"D012878","trials":[{"ligand":"afatinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"axitinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00094107"},{"ligand":"binimetinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04375527;NCT04511013;NCT04221438;NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D012878","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02036476"},{"ligand":"ceritinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02587650"},{"ligand":"cetuximab","mesh_id":"D012878","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03666325;NCT03944941"},{"ligand":"cobimetinib","mesh_id":"D012878","phase":"Phase 1","start_date":"2016","completion_date":"2018","nct_id":"NCT03543969;NCT02721459"},{"ligand":"cobimetinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03175432;NCT03554083"},{"ligand":"copanlisib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D012878","phase":"Phase 1","start_date":"2013","completion_date":"2014","nct_id":"NCT02097225;NCT01940809"},{"ligand":"dabrafenib","mesh_id":"D012878","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT01902173;NCT04310397;NCT04527549;NCT01989585;NCT02231775;NCT02910700;NCT04557956;NCT02465060;NCT02196181"},{"ligand":"dabrafenib","mesh_id":"D012878","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02224781"},{"ligand":"dasatinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00563290;NCT02465060"},{"ligand":"encorafenib","mesh_id":"D012878","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04511013;NCT04221438"},{"ligand":"entrectinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02587650"},{"ligand":"erdafitinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01130519;NCT01059305;NCT01465815"},{"ligand":"everolimus","mesh_id":"D012878","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00655655"},{"ligand":"everolimus","mesh_id":"D012878","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00799188"},{"ligand":"gefitinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00423397;NCT00126555;NCT00054691"},{"ligand":"ibrutinib","mesh_id":"D012878","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03021460"},{"ligand":"ibrutinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02581930"},{"ligand":"imatinib","mesh_id":"D012878","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01738139"},{"ligand":"imatinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2001","completion_date":"2016","nct_id":"NCT02812693;NCT00027586;NCT00068783"},{"ligand":"larotrectinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"osimertinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"palbociclib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"pertuzumab","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"regorafenib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02587650"},{"ligand":"selumetinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00866177"},{"ligand":"sirolimus","mesh_id":"D012878","phase":"Phase 1","start_date":"2004","completion_date":"2012","nct_id":"NCT00655655;NCT01522820;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D012878","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT01764607;NCT00397982"},{"ligand":"sirolimus","mesh_id":"D012878","phase":"Phase 3","start_date":"2004","completion_date":"2008","nct_id":"NCT00133887;NCT00799188"},{"ligand":"sirolimus","mesh_id":"D012878","phase":"Phase 4","start_date":"2005","completion_date":"2018","nct_id":"NCT00866684;NCT03767660;NCT01797315;NCT00129961"},{"ligand":"sorafenib","mesh_id":"D012878","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01303341"},{"ligand":"sorafenib","mesh_id":"D012878","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387751"},{"ligand":"sorafenib","mesh_id":"D012878","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00110019"},{"ligand":"sunitinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"trametinib","mesh_id":"D012878","phase":"Phase 1","start_date":"2013","completion_date":"2014","nct_id":"NCT02097225;NCT01940809"},{"ligand":"trametinib","mesh_id":"D012878","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT01902173;NCT04310397;NCT04527549;NCT01989585;NCT02231775;NCT02910700;NCT04557956;NCT02465060;NCT02196181"},{"ligand":"trametinib","mesh_id":"D012878","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02224781"},{"ligand":"trastuzumab","mesh_id":"D012878","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"vemurafenib","mesh_id":"D012878","phase":"Phase 1","start_date":"2016","completion_date":"2018","nct_id":"NCT03543969;NCT02721459"},{"ligand":"vemurafenib","mesh_id":"D012878","phase":"Phase 2","start_date":"2013","completion_date":"2018","nct_id":"NCT01973322;NCT03554083"}],"predictions":[{"target":"ERBB3","probability":"0.5905978260869564"},{"target":"MAP2K7","probability":"0.5057259401873957"},{"target":"JAK2","probability":"0.485"}],"source_name":"Skin Neoplasms"}],["D007680",{"mesh_id":"D007680","trials":[{"ligand":"afatinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"alectinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"alpelisib","mesh_id":"D007680","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02077933"},{"ligand":"axitinib","mesh_id":"D007680","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03086174"},{"ligand":"axitinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT00076011;NCT00282048;NCT04698213;NCT03456401;NCT04385654;NCT04337970;NCT03736330;NCT02597322;NCT01263769"},{"ligand":"axitinib","mesh_id":"D007680","phase":"Phase 3","start_date":"2008","completion_date":"2012","nct_id":"NCT01599754;NCT00678392;NCT00920816"},{"ligand":"binimetinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"cabozantinib","mesh_id":"D007680","phase":"Phase 1","start_date":"2014","completion_date":"2015","nct_id":"NCT02496208;NCT02293980"},{"ligand":"cabozantinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT04644432;NCT01688999;NCT01835158;NCT03634540;NCT04134390;NCT04322955;NCT02960906"},{"ligand":"cetuximab","mesh_id":"D007680","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00622674"},{"ligand":"copanlisib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"crizotinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"dabrafenib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"dasatinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erdafitinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"erlotinib","mesh_id":"D007680","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00600496"},{"ligand":"erlotinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT04644432;NCT00425386;NCT00045487;NCT00193154;NCT00749892"},{"ligand":"everolimus","mesh_id":"D007680","phase":"Phase 1","start_date":"2004","completion_date":"2016","nct_id":"NCT02890069;NCT01184326;NCT02077933;NCT00303732;NCT01714765;NCT00422344"},{"ligand":"everolimus","mesh_id":"D007680","phase":"Phase 2","start_date":"2006","completion_date":"2020","nct_id":"NCT00688753;NCT00831480;NCT01408004;NCT02479490;NCT01715935;NCT01185366;NCT00651482;NCT01239342;NCT00392821;NCT00331409;NCT01217931;NCT01793636;NCT04134390;NCT01784978;NCT02504892;NCT00323739;NCT01453595;NCT01888042;NCT00827359"},{"ligand":"everolimus","mesh_id":"D007680","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01120249"},{"ligand":"gefitinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2001","completion_date":"2004","nct_id":"NCT00467077;NCT00014144;NCT00014183;NCT00012337;NCT00041106"},{"ligand":"imatinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2006","completion_date":"2020","nct_id":"NCT00323791;NCT04644432;NCT00331409;NCT03165721"},{"ligand":"lapatinib","mesh_id":"D007680","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00623064"},{"ligand":"larotrectinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"lenvatinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04393350"},{"ligand":"osimertinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"palbociclib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"panitumumab","mesh_id":"D007680","phase":"Phase 1","start_date":"2000","completion_date":"2000","nct_id":"NCT00004879"},{"ligand":"pazopanib","mesh_id":"D007680","phase":"Phase 1","start_date":"2009","completion_date":"2011","nct_id":"NCT01184326;NCT01012362"},{"ligand":"pazopanib","mesh_id":"D007680","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT01408004;NCT03456401;NCT01217931;NCT01793636;NCT00782275;NCT02960906;NCT01961583;NCT01392183;NCT01031875"},{"ligand":"pertuzumab","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02465060"},{"ligand":"selumetinib","mesh_id":"D007680","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00600496"},{"ligand":"sirolimus","mesh_id":"D007680","phase":"Phase 1","start_date":"2002","completion_date":"2014","nct_id":"NCT00600496;NCT02145559;NCT00659568;NCT01122615;NCT00045370"},{"ligand":"sirolimus","mesh_id":"D007680","phase":"Phase 2","start_date":"2006","completion_date":"2014","nct_id":"NCT01264341;NCT02019693;NCT01372813;NCT01239342;NCT00331409;NCT00498966;NCT00782275;NCT01453595;NCT00979966;NCT01392183;NCT01090466"},{"ligand":"sirolimus","mesh_id":"D007680","phase":"Phase 3","start_date":"2003","completion_date":"2003","nct_id":"NCT00065468"},{"ligand":"sorafenib","mesh_id":"D007680","phase":"Phase 1","start_date":"2006","completion_date":"2012","nct_id":"NCT01497444;NCT00589550;NCT01005797;NCT00418496;NCT00405366;NCT00398814"},{"ligand":"sorafenib","mesh_id":"D007680","phase":"Phase 2","start_date":"2005","completion_date":"2014","nct_id":"NCT00282048;NCT00854620;NCT00866320;NCT01372813;NCT00112905;NCT00392821;NCT03456401;NCT00496756;NCT00301847;NCT00498966;NCT00112671;NCT00782275"},{"ligand":"sorafenib","mesh_id":"D007680","phase":"Phase 3","start_date":"2007","completion_date":"2009","nct_id":"NCT00492258;NCT00678392;NCT00920816"},{"ligand":"sunitinib","mesh_id":"D007680","phase":"Phase 1","start_date":"2006","completion_date":"2015","nct_id":"NCT00399152;NCT01714765;NCT00422344;NCT00421512;NCT01122615;NCT02386111;NCT00747305"},{"ligand":"sunitinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT00054886;NCT00626509;NCT00459979;NCT03066427;NCT00866320;NCT01089088;NCT00792025;NCT03035630;NCT01372813;NCT04644432;NCT01185366;NCT00425386;NCT01164228;NCT03456401;NCT01835158;NCT00465179;NCT01793636;NCT01024205;NCT01784978;NCT00717587;NCT00853125;NCT02465060;NCT00498966;NCT00541008;NCT00462982;NCT00459875;NCT00814021;NCT02446795;NCT00782275;NCT02960906;NCT01118039;NCT00979966;NCT03024437;NCT00397488;NCT01034878;NCT02689167;NCT02060370"},{"ligand":"sunitinib","mesh_id":"D007680","phase":"Phase 3","start_date":"2006","completion_date":"2020","nct_id":"NCT04523272;NCT03091192;NCT00375674;NCT00397345;NCT01099423"},{"ligand":"trametinib","mesh_id":"D007680","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT04644432;NCT02465060"},{"ligand":"trastuzumab","mesh_id":"D007680","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D007680","phase":"Phase 2","start_date":"2000","completion_date":"2020","nct_id":"NCT00005831;NCT04644432;NCT02465060;NCT00004856"},{"ligand":"vandetanib","mesh_id":"D007680","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT02495103;NCT01372813;NCT01191892;NCT00566995"}],"predictions":[{"target":"JAK2","probability":"0.5161365427296334"},{"target":"BCR","probability":"0.5054179970374714"},{"target":"INSR","probability":"0.49056391862718596"},{"target":"ERBB3","probability":"0.47572290439032494"}],"source_name":"Kidney Neoplasms"}],["D014571",{"mesh_id":"D014571","trials":[{"ligand":"afatinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02780687"},{"ligand":"alectinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"cabozantinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2018","completion_date":"2020","nct_id":"NCT03541902;NCT04644432"},{"ligand":"cetuximab","mesh_id":"D014571","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"cetuximab","mesh_id":"D014571","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00350025"},{"ligand":"crizotinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"dabrafenib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"erlotinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"imatinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"lenvatinib","mesh_id":"D014571","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"},{"ligand":"osimertinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"palbociclib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"sirolimus","mesh_id":"D014571","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"sunitinib","mesh_id":"D014571","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02386111"},{"ligand":"sunitinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2018","completion_date":"2020","nct_id":"NCT03541902;NCT04644432"},{"ligand":"sunitinib","mesh_id":"D014571","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03091192"},{"ligand":"trametinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"trastuzumab","mesh_id":"D014571","phase":"Phase 2","start_date":"2000","completion_date":"2021","nct_id":"NCT04579380;NCT04644432;NCT00151034;NCT02006667;NCT02675829;NCT02013765"},{"ligand":"tucatinib","mesh_id":"D014571","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04579380"}],"predictions":[{"target":"ERBB3","probability":"0.5900191791331032"},{"target":"FGFR1","probability":"0.5800537634408601"},{"target":"NTRK1","probability":"0.5041762820512821"},{"target":"FGFR3","probability":"0.484786582132385"},{"target":"IGF1R","probability":"0.46905376344086025"},{"target":"FGFR2","probability":"0.4605942928039702"}],"source_name":"Urologic Neoplasms"}],["D005770",{"mesh_id":"D005770","trials":[{"ligand":"afatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02450656"},{"ligand":"alectinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"apatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03271255"},{"ligand":"apatinib","mesh_id":"D005770","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03889626"},{"ligand":"brigatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"cabozantinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04197310"},{"ligand":"cetuximab","mesh_id":"D005770","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"cobimetinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04214418;NCT04591431"},{"ligand":"copanlisib","mesh_id":"D005770","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02631590"},{"ligand":"entrectinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"erlotinib","mesh_id":"D005770","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2006","completion_date":"2020","nct_id":"NCT00356889;NCT04591431"},{"ligand":"everolimus","mesh_id":"D005770","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D005770","phase":"Phase 2","start_date":"2010","completion_date":"2020","nct_id":"NCT01648465;NCT01567488;NCT01058655;NCT04591431"},{"ligand":"gefitinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"imatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2004","completion_date":"2007","nct_id":"NCT00570635;NCT00089960"},{"ligand":"imatinib","mesh_id":"D005770","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00793871"},{"ligand":"lapatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT00526669;NCT04591431"},{"ligand":"lapatinib","mesh_id":"D005770","phase":"Phase 3","start_date":"2007","completion_date":"2008","nct_id":"NCT00680901;NCT00486954"},{"ligand":"nilotinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01270893"},{"ligand":"palbociclib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"panitumumab","mesh_id":"D005770","phase":"Phase 2","start_date":"2008","completion_date":"2010","nct_id":"NCT01202409;NCT00788957"},{"ligand":"pazopanib","mesh_id":"D005770","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01639911"},{"ligand":"pazopanib","mesh_id":"D005770","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00454363;NCT01392352;NCT01841736"},{"ligand":"pemigatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"pertuzumab","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"ponatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"},{"ligand":"ramucirumab","mesh_id":"D005770","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03271255"},{"ligand":"regorafenib","mesh_id":"D005770","phase":"Phase 2","start_date":"2014","completion_date":"2016","nct_id":"NCT02241720;NCT02259725;NCT02024607"},{"ligand":"selumetinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02450656"},{"ligand":"sirolimus","mesh_id":"D005770","phase":"Phase 1","start_date":"2004","completion_date":"2012","nct_id":"NCT01204476;NCT00655655;NCT01625351;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D005770","phase":"Phase 2","start_date":"2003","completion_date":"2011","nct_id":"NCT01010126;NCT01567488;NCT00093782"},{"ligand":"sirolimus","mesh_id":"D005770","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03767660"},{"ligand":"sorafenib","mesh_id":"D005770","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01640665"},{"ligand":"sorafenib","mesh_id":"D005770","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT01556815;NCT00131911;NCT04518852"},{"ligand":"sorafenib","mesh_id":"D005770","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01009593"},{"ligand":"sunitinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00570635"},{"ligand":"sunitinib","mesh_id":"D005770","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00793871"},{"ligand":"tivozanib","mesh_id":"D005770","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00660153"},{"ligand":"tivozanib","mesh_id":"D005770","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01058655"},{"ligand":"trastuzumab","mesh_id":"D005770","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D005770","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01556815;NCT03329690;NCT04430738;NCT04591431"},{"ligand":"tucatinib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04430738"},{"ligand":"vemurafenib","mesh_id":"D005770","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04591431"}],"predictions":[],"source_name":"Gastrointestinal Neoplasms"}],["D004067",{"mesh_id":"D004067","trials":[{"ligand":"afatinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02450656"},{"ligand":"apatinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03271255"},{"ligand":"apatinib","mesh_id":"D004067","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03889626"},{"ligand":"cabozantinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04197310"},{"ligand":"copanlisib","mesh_id":"D004067","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02631590"},{"ligand":"everolimus","mesh_id":"D004067","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01648465;NCT01567488"},{"ligand":"imatinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00570635"},{"ligand":"imatinib","mesh_id":"D004067","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00793871"},{"ligand":"lapatinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00526669"},{"ligand":"lapatinib","mesh_id":"D004067","phase":"Phase 3","start_date":"2007","completion_date":"2008","nct_id":"NCT00680901;NCT00486954"},{"ligand":"pazopanib","mesh_id":"D004067","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01639911"},{"ligand":"ramucirumab","mesh_id":"D004067","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03271255"},{"ligand":"selumetinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02450656"},{"ligand":"sirolimus","mesh_id":"D004067","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01625351"},{"ligand":"sirolimus","mesh_id":"D004067","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01567488"},{"ligand":"sorafenib","mesh_id":"D004067","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01640665"},{"ligand":"sorafenib","mesh_id":"D004067","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01556815;NCT04518852"},{"ligand":"sorafenib","mesh_id":"D004067","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01009593"},{"ligand":"sunitinib","mesh_id":"D004067","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00570635"},{"ligand":"sunitinib","mesh_id":"D004067","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00793871"},{"ligand":"trastuzumab","mesh_id":"D004067","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT01556815;NCT03329690"}],"predictions":[{"target":"BCR","probability":"0.69"},{"target":"FGFR1","probability":"0.6507745108833138"},{"target":"ERBB3","probability":"0.6169600410357297"},{"target":"IGF1R","probability":"0.6065913919187826"},{"target":"JAK2","probability":"0.6000229080953922"},{"target":"FLT4","probability":"0.546913376203979"},{"target":"BRAF","probability":"0.5456574712643678"},{"target":"ALK","probability":"0.542360833241079"},{"target":"INSR","probability":"0.525896347288422"},{"target":"NTRK1","probability":"0.4932942907514887"},{"target":"CDK6","probability":"0.4908373717822779"},{"target":"ROS1","probability":"0.4770274436490527"},{"target":"FGFR2","probability":"0.4632023296220234"}],"source_name":"Digestive System Neoplasms"}],["D009382",{"mesh_id":"D009382","trials":[{"ligand":"alectinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03498521"},{"ligand":"cetuximab","mesh_id":"D009382","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384"},{"ligand":"cetuximab","mesh_id":"D009382","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00939627;NCT01816984;NCT00101348;NCT01316757;NCT00894569"},{"ligand":"cobimetinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03498521"},{"ligand":"dasatinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"entrectinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03498521"},{"ligand":"erlotinib","mesh_id":"D009382","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00049283;NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2004","completion_date":"2018","nct_id":"NCT03498521;NCT00101348;NCT01316757;NCT00193622;NCT00360360"},{"ligand":"everolimus","mesh_id":"D009382","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00936702"},{"ligand":"gefitinib","mesh_id":"D009382","phase":"Phase 3","start_date":"2003","completion_date":"2003","nct_id":"NCT00193596"},{"ligand":"lapatinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00098631;NCT01044433"},{"ligand":"pertuzumab","mesh_id":"D009382","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03498521"},{"ligand":"sorafenib","mesh_id":"D009382","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D009382","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D009382","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D009382","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387335"},{"ligand":"trastuzumab","mesh_id":"D009382","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D009382","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03498521"},{"ligand":"vemurafenib","mesh_id":"D009382","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03498521"}],"predictions":[],"source_name":"Neoplasms, Unknown Primary"}],["D016543",{"mesh_id":"D016543","trials":[{"ligand":"alectinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04774718"},{"ligand":"avapritinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"axitinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02164838"},{"ligand":"cabozantinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01709435"},{"ligand":"cabozantinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"dasatinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2008","completion_date":"2009","nct_id":"NCT00869401;NCT00788125"},{"ligand":"entrectinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02650401"},{"ligand":"erdafitinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2005","completion_date":"2006","nct_id":"NCT00227032;NCT00509431;NCT00360854"},{"ligand":"erlotinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00720356;NCT00124657;NCT00274833;NCT00054496;NCT00086879;NCT00602667"},{"ligand":"everolimus","mesh_id":"D016543","phase":"Phase 1","start_date":"2006","completion_date":"2008","nct_id":"NCT00387400;NCT00756340"},{"ligand":"everolimus","mesh_id":"D016543","phase":"Phase 2","start_date":"2003","completion_date":"2017","nct_id":"NCT01062399;NCT00085566;NCT03245151;NCT00553150;NCT00107237"},{"ligand":"gefitinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00027625"},{"ligand":"gefitinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2001","completion_date":"2004","nct_id":"NCT00025675;NCT00085566;NCT00016991"},{"ligand":"ibrutinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04446962"},{"ligand":"imatinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2004","completion_date":"2006","nct_id":"NCT00401024;NCT00354068;NCT00387933"},{"ligand":"imatinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2001","completion_date":"2009","nct_id":"NCT00021229;NCT00039364;NCT00904735;NCT00010049"},{"ligand":"lapatinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00313599"},{"ligand":"lapatinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00099060"},{"ligand":"larotrectinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03213704;NCT03834961;NCT03155620"},{"ligand":"lenvatinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03245151"},{"ligand":"neratinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02932280"},{"ligand":"palbociclib","mesh_id":"D016543","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"pazopanib","mesh_id":"D016543","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT01931098"},{"ligand":"ribociclib","mesh_id":"D016543","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"selumetinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213691;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D016543","phase":"Phase 1","start_date":"2001","completion_date":"2018","nct_id":"NCT00003712;NCT00509431;NCT01135563;NCT00784914;NCT03696355;NCT02975882;NCT01204450"},{"ligand":"sirolimus","mesh_id":"D016543","phase":"Phase 2","start_date":"2001","completion_date":"2017","nct_id":"NCT02574728;NCT00022724;NCT00047073;NCT01019434;NCT03213678;NCT03155620"},{"ligand":"sorafenib","mesh_id":"D016543","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00621686"},{"ligand":"sunitinib","mesh_id":"D016543","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00589784"},{"ligand":"trametinib","mesh_id":"D016543","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trastuzumab","mesh_id":"D016543","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT00397501"},{"ligand":"vandetanib","mesh_id":"D016543","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00472017"},{"ligand":"vemurafenib","mesh_id":"D016543","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"KIT","probability":"0.625"},{"target":"PDGFRA","probability":"0.5753333333333334"},{"target":"RET","probability":"0.5556448243173204"},{"target":"ALK","probability":"0.5068642409205445"},{"target":"BCR","probability":"0.4806032871791517"},{"target":"JAK2","probability":"0.46058447230049426"}],"source_name":"Central Nervous System Neoplasms"}],["D014565",{"mesh_id":"D014565","trials":[{"ligand":"alectinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"cabozantinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"crizotinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"dabrafenib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"erlotinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"imatinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2003","completion_date":"2020","nct_id":"NCT01316458;NCT04644432"},{"ligand":"lenvatinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04519151"},{"ligand":"osimertinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"palbociclib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"pazopanib","mesh_id":"D014565","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01639911"},{"ligand":"sunitinib","mesh_id":"D014565","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02386111"},{"ligand":"sunitinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2014","completion_date":"2020","nct_id":"NCT04644432;NCT02060370"},{"ligand":"trametinib","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"},{"ligand":"trastuzumab","mesh_id":"D014565","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04644432"}],"predictions":[{"target":"FGFR1","probability":"0.5050537634408602"},{"target":"ERBB3","probability":"0.4784037558685446"}],"source_name":"Urogenital Neoplasms"}],["D014604",{"mesh_id":"D014604","trials":[{"ligand":"alpelisib","mesh_id":"D014604","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02273219"},{"ligand":"axitinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01533948"},{"ligand":"binimetinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01801358"},{"ligand":"cabozantinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01835145"},{"ligand":"crizotinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02223819"},{"ligand":"entrectinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04589832"},{"ligand":"everolimus","mesh_id":"D014604","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01252251"},{"ligand":"selumetinib","mesh_id":"D014604","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT02768766"},{"ligand":"selumetinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01143402"},{"ligand":"selumetinib","mesh_id":"D014604","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT01974752"},{"ligand":"sorafenib","mesh_id":"D014604","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00329641;NCT01377025"},{"ligand":"sunitinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2010","completion_date":"2014","nct_id":"NCT01551459;NCT02068586"},{"ligand":"trametinib","mesh_id":"D014604","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01328106;NCT01979523"}],"predictions":[],"source_name":"Uveal Neoplasms"}],["D009959",{"mesh_id":"D009959","trials":[{"ligand":"alpelisib","mesh_id":"D009959","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02298595"},{"ligand":"cetuximab","mesh_id":"D009959","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D009959","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT04106362;NCT03422536;NCT01884259;NCT04508829;NCT00939627;NCT02298595;NCT01816984;NCT01435252;NCT02281955;NCT00101348;NCT03082534;NCT01316757;NCT01440270;NCT00251381;NCT03077243"},{"ligand":"cetuximab","mesh_id":"D009959","phase":"Phase 3","start_date":"2011","completion_date":"2017","nct_id":"NCT01434394;NCT03258554"},{"ligand":"dasatinib","mesh_id":"D009959","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"erlotinib","mesh_id":"D009959","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00049283;NCT00397384;NCT00049166;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D009959","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00410826;NCT00055913;NCT01192815;NCT00101348;NCT01316757;NCT00063895;NCT00055770"},{"ligand":"everolimus","mesh_id":"D009959","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"gefitinib","mesh_id":"D009959","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00033449"},{"ligand":"lapatinib","mesh_id":"D009959","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00114283;NCT00098631;NCT01044433"},{"ligand":"sirolimus","mesh_id":"D009959","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"sorafenib","mesh_id":"D009959","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D009959","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D009959","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D009959","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387335"},{"ligand":"trastuzumab","mesh_id":"D009959","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"BCR","probability":"0.545"},{"target":"PDGFRA","probability":"0.52"},{"target":"ERBB3","probability":"0.515"},{"target":"ABL1","probability":"0.5103321678321678"},{"target":"CDK6","probability":"0.4953321678321679"},{"target":"FGFR2","probability":"0.4951786910315642"},{"target":"CDK4","probability":"0.4903321678321679"},{"target":"IGF1R","probability":"0.48532051282051286"},{"target":"NTRK1","probability":"0.4852673648629928"},{"target":"BRAF","probability":"0.4850115919629057"},{"target":"FGFR1","probability":"0.47"},{"target":"INSR","probability":"0.465"},{"target":"MAP2K7","probability":"0.455"}],"source_name":"Oropharyngeal Neoplasms"}],["D046152",{"mesh_id":"D046152","trials":[{"ligand":"alpelisib","mesh_id":"D046152","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01735968"},{"ligand":"avapritinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02508532"},{"ligand":"avapritinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04254939"},{"ligand":"avapritinib","mesh_id":"D046152","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03465722"},{"ligand":"axitinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04258956"},{"ligand":"binimetinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03158103"},{"ligand":"binimetinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01991379"},{"ligand":"cabozantinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02071862"},{"ligand":"cabozantinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02216578"},{"ligand":"cetuximab","mesh_id":"D046152","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"dasatinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01643278"},{"ligand":"dasatinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00464620;NCT00568750"},{"ligand":"dasatinib","mesh_id":"D046152","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00688766"},{"ligand":"erlotinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2007","completion_date":"2014","nct_id":"NCT00397384;NCT02071862"},{"ligand":"erlotinib","mesh_id":"D046152","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT01402089"},{"ligand":"everolimus","mesh_id":"D046152","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02071862"},{"ligand":"everolimus","mesh_id":"D046152","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT01275222"},{"ligand":"everolimus","mesh_id":"D046152","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01265810"},{"ligand":"everolimus","mesh_id":"D046152","phase":"Phase 4","start_date":"2006","completion_date":"2006","nct_id":"NCT00510354"},{"ligand":"imatinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2001","completion_date":"2020","nct_id":"NCT00573404;NCT04276415;NCT02164240;NCT02508532;NCT00025415;NCT00135005;NCT01735968;NCT01738139;NCT01270984;NCT00441155;NCT01468688;NCT01751919;NCT04006769;NCT02185937;NCT02268435"},{"ligand":"imatinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2000","completion_date":"2020","nct_id":"NCT02257541;NCT01091207;NCT00137449;NCT00265798;NCT02342600;NCT00769782;NCT00585221;NCT00455559;NCT01389583;NCT01172548;NCT00112632;NCT03171389;NCT01110668;NCT00278876;NCT00237185;NCT02365441;NCT00500188;NCT04193553;NCT04633122;NCT03944304;NCT02336724;NCT03440515;NCT00867113;NCT02889328;NCT01440959;NCT00570635;NCT02216578;NCT00006357;NCT00117299;NCT02712112;NCT03609424;NCT04258956;NCT00618319;NCT02607332;NCT01294202;NCT01991379;NCT00782834;NCT01541709;NCT01039519;NCT03291054;NCT00385203;NCT01391611;NCT01068769;NCT04138381;NCT01478373;NCT01506336;NCT01275222;NCT00764595;NCT00254267;NCT03556384;NCT00940563;NCT01267695;NCT00025246;NCT00091078;NCT01907607;NCT03165721;NCT00290485;NCT01483014;NCT00718562;NCT00457743;NCT00089960;NCT00028002;NCT00359333;NCT00030667;NCT02401815;NCT01524848;NCT04106024;NCT00633295;NCT01323400;NCT00237172"},{"ligand":"imatinib","mesh_id":"D046152","phase":"Phase 3","start_date":"2000","completion_date":"2020","nct_id":"NCT03673501;NCT03353753;NCT03465722;NCT00751036;NCT02260505;NCT02103322;NCT00293124;NCT01031628;NCT01271712;NCT00471328;NCT00041197;NCT00324987;NCT00075218;NCT03426722;NCT00785785;NCT00685828;NCT00956072;NCT00103168;NCT01151852;NCT00367861;NCT00009906;NCT04409223;NCT00116935;NCT00688766;NCT00812240;NCT01289028;NCT02576080;NCT00372567;NCT01694277"},{"ligand":"imatinib","mesh_id":"D046152","phase":"Phase 4","start_date":"2004","completion_date":"2008","nct_id":"NCT00171977;NCT00793871;NCT00510354"},{"ligand":"lenvatinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04193553"},{"ligand":"nilotinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00441155"},{"ligand":"nilotinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT01110668;NCT00782834;NCT01863745;NCT00718562;NCT01270893;NCT00633295"},{"ligand":"nilotinib","mesh_id":"D046152","phase":"Phase 3","start_date":"2007","completion_date":"2009","nct_id":"NCT00751036;NCT00471328;NCT00785785;NCT00688766;NCT01289028"},{"ligand":"nilotinib","mesh_id":"D046152","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT00756509"},{"ligand":"olaratumab","mesh_id":"D046152","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01316263"},{"ligand":"palbociclib","mesh_id":"D046152","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01907607"},{"ligand":"pazopanib","mesh_id":"D046152","phase":"Phase 2","start_date":"2011","completion_date":"2017","nct_id":"NCT02342600;NCT01391611;NCT01524848;NCT01323400"},{"ligand":"pazopanib","mesh_id":"D046152","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01265810"},{"ligand":"pexidartinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03158103"},{"ligand":"pexidartinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452424"},{"ligand":"ponatinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2013","completion_date":"2017","nct_id":"NCT03171389;NCT01874665"},{"ligand":"regorafenib","mesh_id":"D046152","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02164240"},{"ligand":"regorafenib","mesh_id":"D046152","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT02638766;NCT03171389;NCT02365441;NCT03944304;NCT02889328;NCT03609424;NCT01068769;NCT02606097"},{"ligand":"regorafenib","mesh_id":"D046152","phase":"Phase 3","start_date":"2011","completion_date":"2018","nct_id":"NCT03353753;NCT03465722;NCT01271712"},{"ligand":"regorafenib","mesh_id":"D046152","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT02800330"},{"ligand":"ribociclib","mesh_id":"D046152","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04000529"},{"ligand":"selumetinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03109301"},{"ligand":"sirolimus","mesh_id":"D046152","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00087074"},{"ligand":"sirolimus","mesh_id":"D046152","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01265810"},{"ligand":"sorafenib","mesh_id":"D046152","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT01091207;NCT00265798"},{"ligand":"sorafenib","mesh_id":"D046152","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01265810"},{"ligand":"sunitinib","mesh_id":"D046152","phase":"Phase 1","start_date":"2007","completion_date":"2019","nct_id":"NCT00573404;NCT02164240;NCT01735968;NCT01381822;NCT01468688;NCT04006769;NCT02268435"},{"ligand":"sunitinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT01091207;NCT00137449;NCT00265798;NCT02342600;NCT01389583;NCT03171389;NCT04193553;NCT04633122;NCT01396148;NCT03944304;NCT02889328;NCT01440959;NCT00570635;NCT02216578;NCT02712112;NCT03609424;NCT04258956;NCT00618319;NCT02607332;NCT00782834;NCT01039519;NCT01068769;NCT01506336;NCT03556384;NCT01907607;NCT00718562;NCT00457743;NCT02401815;NCT01524848;NCT04106024;NCT00633295;NCT01323400"},{"ligand":"sunitinib","mesh_id":"D046152","phase":"Phase 3","start_date":"2003","completion_date":"2020","nct_id":"NCT03673501;NCT03353753;NCT01271712;NCT00471328;NCT00075218;NCT01151852;NCT01265810;NCT04409223;NCT00688766;NCT01289028;NCT00372567;NCT01694277"},{"ligand":"sunitinib","mesh_id":"D046152","phase":"Phase 4","start_date":"2008","completion_date":"2012","nct_id":"NCT01402089;NCT00793871"},{"ligand":"trametinib","mesh_id":"D046152","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02342600"},{"ligand":"vandetanib","mesh_id":"D046152","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT02015065"}],"predictions":[{"target":"IGF1R","probability":"0.655706166580201"},{"target":"AMHR2","probability":"0.6306676171116068"},{"target":"FGFR1","probability":"0.6266439272915677"},{"target":"MOK","probability":"0.6054670663434173"},{"target":"LTK","probability":"0.6043999999999999"},{"target":"PRKG2","probability":"0.6014753699108538"},{"target":"CCNK","probability":"0.6"},{"target":"SRPK2","probability":"0.5996352330348473"},{"target":"CILK1","probability":"0.595"},{"target":"ERBB4","probability":"0.5791830641541076"},{"target":"CLK2","probability":"0.5755540736145575"},{"target":"ERBB2","probability":"0.5706367096018735"},{"target":"MAPK15","probability":"0.5700124069478908"},{"target":"STK25","probability":"0.5694124069478907"},{"target":"TRIM24","probability":"0.5685601502639269"},{"target":"CCL8","probability":"0.5609112113758288"},{"target":"NPRL2","probability":"0.5606071937321938"},{"target":"OBSCN","probability":"0.5601142954332851"},{"target":"PRPF4B","probability":"0.56"},{"target":"MAK","probability":"0.5544144927536232"},{"target":"CDK11B","probability":"0.5469167080685216"},{"target":"PRKCI","probability":"0.5464189016686775"},{"target":"CASK","probability":"0.5450378790959992"},{"target":"MAP3K9","probability":"0.5444124069478908"},{"target":"CDK11A","probability":"0.5444115919629057"},{"target":"PAK6","probability":"0.5406926042067158"},{"target":"STK33","probability":"0.5394124069478908"},{"target":"ERBB3","probability":"0.5370554711081662"},{"target":"TAF1","probability":"0.5357838600371357"},{"target":"FRK","probability":"0.5357658424908425"},{"target":"UHMK1","probability":"0.535"},{"target":"LMTK2","probability":"0.5344124069478908"},{"target":"TNIK","probability":"0.5307962962962963"},{"target":"NPR1","probability":"0.5306386655929947"},{"target":"MAPKAPK5","probability":"0.530023386342376"},{"target":"INSR","probability":"0.5274095664197564"},{"target":"MAP4K1","probability":"0.5252439024390244"},{"target":"SGK2","probability":"0.5250268997015141"},{"target":"CDK16","probability":"0.5246207402812242"},{"target":"NUAK2","probability":"0.5244"},{"target":"DAPK2","probability":"0.5159802610953035"},{"target":"CAMK2A","probability":"0.5144"},{"target":"CDK14","probability":"0.5104522357723578"},{"target":"TRPM6","probability":"0.5094287356321839"},{"target":"NEK9","probability":"0.5061996876496453"},{"target":"NEK7","probability":"0.5050124069478908"},{"target":"PRKD2","probability":"0.5046352330348474"},{"target":"BRSK2","probability":"0.5046352330348474"},{"target":"PDIK1L","probability":"0.500026899701514"},{"target":"PRKCH","probability":"0.4955996810207337"},{"target":"EPHB2","probability":"0.495559503237051"},{"target":"PIK3R4","probability":"0.495"},{"target":"HIPK3","probability":"0.49392076597687756"},{"target":"MARK2","probability":"0.49102502892758937"},{"target":"PEAK1","probability":"0.4905336622518584"},{"target":"SIK2","probability":"0.48964390243902445"},{"target":"MAP3K10","probability":"0.4894896087569755"},{"target":"PRKACB","probability":"0.4894625696767001"},{"target":"TAOK1","probability":"0.4894124069478908"},{"target":"TNNI3K","probability":"0.4894124069478908"},{"target":"TGFBR1","probability":"0.48654679632991515"},{"target":"CSNK1D","probability":"0.4852083333333333"},{"target":"PKMYT1","probability":"0.48309356636818074"},{"target":"CCL5","probability":"0.48157889096034956"},{"target":"MAPK6","probability":"0.4802155270655271"},{"target":"CDK13","probability":"0.480026899701514"},{"target":"VRK2","probability":"0.48"},{"target":"PAK5","probability":"0.4768987640499976"},{"target":"RPS6KA6","probability":"0.4760246593678902"},{"target":"NEK1","probability":"0.4758742111626493"},{"target":"KSR2","probability":"0.475"},{"target":"CLK3","probability":"0.4744"},{"target":"SRC","probability":"0.4740640144990403"},{"target":"DYRK1B","probability":"0.4709172833377659"},{"target":"RYK","probability":"0.47063866559299455"},{"target":"FAM20C","probability":"0.470026899701514"},{"target":"AAK1","probability":"0.4700124069478908"},{"target":"TLK1","probability":"0.46963523303484733"},{"target":"STK26","probability":"0.46960833333333335"},{"target":"DYRK2","probability":"0.4695469500853029"},{"target":"NEK6","probability":"0.4694294880003112"},{"target":"CAMK2B","probability":"0.4694"},{"target":"FGFR2","probability":"0.46761835624008236"},{"target":"JAK2","probability":"0.4652653978202255"},{"target":"CDC42BPA","probability":"0.4650294307089423"},{"target":"PRKX","probability":"0.46462074028122413"},{"target":"NUAK1","probability":"0.4638869200912783"},{"target":"EPHA5","probability":"0.46203336526181354"},{"target":"STK4","probability":"0.4603478260869565"},{"target":"CIT","probability":"0.45957818621729785"},{"target":"MARK3","probability":"0.4553687076111185"},{"target":"IRAK2","probability":"0.45533439233035655"},{"target":"CAMKK1","probability":"0.4550124069478908"},{"target":"PRKD3","probability":"0.455"}],"source_name":"Gastrointestinal Stromal Tumors"}],["D008579",{"mesh_id":"D008579","trials":[{"ligand":"alpelisib","mesh_id":"D008579","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03631953"},{"ligand":"brigatinib","mesh_id":"D008579","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"erlotinib","mesh_id":"D008579","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00045110"},{"ligand":"everolimus","mesh_id":"D008579","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01880749"},{"ligand":"everolimus","mesh_id":"D008579","phase":"Phase 2","start_date":"2010","completion_date":"2015","nct_id":"NCT02333565;NCT00972335"},{"ligand":"gefitinib","mesh_id":"D008579","phase":"Phase 2","start_date":"2001","completion_date":"2001","nct_id":"NCT00025675"},{"ligand":"imatinib","mesh_id":"D008579","phase":"Phase 2","start_date":"2001","completion_date":"2009","nct_id":"NCT00354913;NCT00045734;NCT00904735;NCT00010049"},{"ligand":"palbociclib","mesh_id":"D008579","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"ribociclib","mesh_id":"D008579","phase":"Phase 1","start_date":"2016","completion_date":"2018","nct_id":"NCT02933736;NCT03434262"},{"ligand":"selumetinib","mesh_id":"D008579","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03095248"},{"ligand":"sirolimus","mesh_id":"D008579","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03631953"},{"ligand":"sunitinib","mesh_id":"D008579","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00589784"},{"ligand":"trametinib","mesh_id":"D008579","phase":"Phase 1","start_date":"2018","completion_date":"2019","nct_id":"NCT03434262;NCT03631953"}],"predictions":[],"source_name":"Meningioma"}],["D017728",{"mesh_id":"D017728","trials":[{"ligand":"apatinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04476459"},{"ligand":"brigatinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2011","completion_date":"2020","nct_id":"NCT03719898;NCT01449461;NCT04260009"},{"ligand":"ceritinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT02729961;NCT02465528"},{"ligand":"crizotinib","mesh_id":"D017728","phase":"Phase 1","start_date":"2006","completion_date":"2013","nct_id":"NCT00585195;NCT01606878"},{"ligand":"crizotinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2009","completion_date":"2015","nct_id":"NCT02568267;NCT01524926;NCT01449461;NCT01979536;NCT02419287;NCT00939770"},{"ligand":"crizotinib","mesh_id":"D017728","phase":"Phase 4","start_date":"2015","completion_date":"2018","nct_id":"NCT02487316;NCT03707847"},{"ligand":"dasatinib","mesh_id":"D017728","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"entrectinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"everolimus","mesh_id":"D017728","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT01198665;NCT00918333"},{"ligand":"imatinib","mesh_id":"D017728","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"imatinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02462538"},{"ligand":"lorlatinib","mesh_id":"D017728","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03505554"},{"ligand":"ruxolitinib","mesh_id":"D017728","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03017820"},{"ligand":"sirolimus","mesh_id":"D017728","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT00105001;NCT01075321;NCT01198665;NCT00918333"},{"ligand":"sorafenib","mesh_id":"D017728","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00278382;NCT00131937"},{"ligand":"sunitinib","mesh_id":"D017728","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Lymphoma, Large-Cell, Anaplastic"}],["D000077274",{"mesh_id":"D000077274","trials":[{"ligand":"apatinib","mesh_id":"D000077274","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04073784"},{"ligand":"apatinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2016","completion_date":"2020","nct_id":"NCT03130270;NCT04548271;NCT03180476;NCT02874651;NCT04586088;NCT03612219;NCT04547088;NCT03213587;NCT04350190"},{"ligand":"axitinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01249547"},{"ligand":"cetuximab","mesh_id":"D000077274","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D000077274","phase":"Phase 2","start_date":"2005","completion_date":"2020","nct_id":"NCT01271439;NCT01614938;NCT01230476;NCT00939627;NCT01326559;NCT00700440;NCT04508816;NCT01816984;NCT00101348;NCT03082534;NCT01316757;NCT02507154;NCT01712919;NCT04534855"},{"ligand":"cetuximab","mesh_id":"D000077274","phase":"Phase 3","start_date":"2015","completion_date":"2018","nct_id":"NCT03529279;NCT02633176"},{"ligand":"dasatinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"erlotinib","mesh_id":"D000077274","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00049283;NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00410826;NCT00055913;NCT01192815;NCT00101348;NCT01316757;NCT00603915;NCT00063895;NCT00055770"},{"ligand":"everolimus","mesh_id":"D000077274","phase":"Phase 1","start_date":"2008","completion_date":"2010","nct_id":"NCT01341834;NCT01637194"},{"ligand":"gefitinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00212108"},{"ligand":"icotinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2012","completion_date":"2014","nct_id":"NCT01534585;NCT02328261"},{"ligand":"lapatinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2004","completion_date":"2005","nct_id":"NCT00114283;NCT00098631"},{"ligand":"palbociclib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04605562"},{"ligand":"pazopanib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2007","completion_date":"2020","nct_id":"NCT00454142;NCT04534855"},{"ligand":"sirolimus","mesh_id":"D000077274","phase":"Phase 1","start_date":"2008","completion_date":"2010","nct_id":"NCT01341834;NCT01637194"},{"ligand":"sorafenib","mesh_id":"D000077274","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00747799;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D000077274","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D000077274","phase":"Phase 2","start_date":"2006","completion_date":"2011","nct_id":"NCT00387335;NCT01309633"},{"ligand":"trastuzumab","mesh_id":"D000077274","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"ERBB3","probability":"0.65"},{"target":"BCR","probability":"0.635"},{"target":"CDK4","probability":"0.5900284495021337"},{"target":"MET","probability":"0.59"},{"target":"ERBB4","probability":"0.575"},{"target":"PIK3CA","probability":"0.5650284495021337"},{"target":"CDK6","probability":"0.5600284495021337"},{"target":"FGFR1","probability":"0.56"},{"target":"IGF1R","probability":"0.5550284495021337"},{"target":"ZAP70","probability":"0.5200284495021337"},{"target":"NTRK1","probability":"0.52"},{"target":"FGFR3","probability":"0.515"},{"target":"JAK2","probability":"0.515"},{"target":"FGFR2","probability":"0.51"},{"target":"INSR","probability":"0.505"},{"target":"NTRK2","probability":"0.48002844950213375"},{"target":"CDKN1A","probability":"0.46549764890282136"},{"target":"BRAF","probability":"0.4603520378992078"},{"target":"ALK","probability":"0.46012362637362636"},{"target":"TEK","probability":"0.4600491106591585"},{"target":"JAK1","probability":"0.46"},{"target":"BTK","probability":"0.4554113418087913"},{"target":"MAP2K7","probability":"0.45515723270440256"}],"source_name":"Nasopharyngeal Carcinoma"}],["D016399",{"mesh_id":"D016399","trials":[{"ligand":"apatinib","mesh_id":"D016399","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT03701022;NCT02844881"},{"ligand":"apatinib","mesh_id":"D016399","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03631862"},{"ligand":"copanlisib","mesh_id":"D016399","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04233697"},{"ligand":"copanlisib","mesh_id":"D016399","phase":"Phase 2","start_date":"2016","completion_date":"2018","nct_id":"NCT03052933;NCT02535247"},{"ligand":"dasatinib","mesh_id":"D016399","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D016399","phase":"Phase 1","start_date":"2013","completion_date":"2021","nct_id":"NCT02783625;NCT01871675;NCT04639843"},{"ligand":"duvelisib","mesh_id":"D016399","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03372057"},{"ligand":"erlotinib","mesh_id":"D016399","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04004572"},{"ligand":"everolimus","mesh_id":"D016399","phase":"Phase 2","start_date":"2009","completion_date":"2012","nct_id":"NCT01075321;NCT01198665;NCT00918333;NCT01637090"},{"ligand":"fostamatinib","mesh_id":"D016399","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00798096"},{"ligand":"ibrutinib","mesh_id":"D016399","phase":"Phase 1","start_date":"2012","completion_date":"2015","nct_id":"NCT01644253;NCT02309580"},{"ligand":"imatinib","mesh_id":"D016399","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"imatinib","mesh_id":"D016399","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00684411"},{"ligand":"nilotinib","mesh_id":"D016399","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155817"},{"ligand":"ruxolitinib","mesh_id":"D016399","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03017820"},{"ligand":"ruxolitinib","mesh_id":"D016399","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT03922724;NCT01431209"},{"ligand":"sirolimus","mesh_id":"D016399","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01403415"},{"ligand":"sirolimus","mesh_id":"D016399","phase":"Phase 2","start_date":"2009","completion_date":"2019","nct_id":"NCT03922724;NCT01075321;NCT01198665;NCT01843998;NCT01076543;NCT00918333;NCT01637090"},{"ligand":"sorafenib","mesh_id":"D016399","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT01561833"},{"ligand":"sorafenib","mesh_id":"D016399","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D016399","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"tofacitinib","mesh_id":"D016399","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03598959"},{"ligand":"trastuzumab","mesh_id":"D016399","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03432741"}],"predictions":[{"target":"IGF1R","probability":"0.785"},{"target":"PDGFRA","probability":"0.7751101321585904"},{"target":"FGFR1","probability":"0.7510416666666666"},{"target":"ERBB3","probability":"0.73"},{"target":"MET","probability":"0.7"},{"target":"FGFR3","probability":"0.6902394601318774"},{"target":"ERBB4","probability":"0.6483333333333334"},{"target":"INSR","probability":"0.625"},{"target":"BRAF","probability":"0.6051527942187073"},{"target":"BCR","probability":"0.595"},{"target":"ROS1","probability":"0.5914029254969698"},{"target":"FGFR2","probability":"0.565"},{"target":"FLT1","probability":"0.5601101321585903"},{"target":"NTRK1","probability":"0.5510045185182997"},{"target":"ALK","probability":"0.5509864526547119"},{"target":"NTRK2","probability":"0.5105919697523243"},{"target":"TEK","probability":"0.5000906344410876"},{"target":"PTK2","probability":"0.4950763386859446"},{"target":"EPHB2","probability":"0.49424906546634106"},{"target":"MAP2K1","probability":"0.4578442511345466"},{"target":"TGFBR1","probability":"0.45716136280555375"}],"source_name":"Lymphoma, T-Cell"}],["D016411",{"mesh_id":"D016411","trials":[{"ligand":"apatinib","mesh_id":"D016411","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03631862"},{"ligand":"copanlisib","mesh_id":"D016411","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04233697"},{"ligand":"copanlisib","mesh_id":"D016411","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02535247"},{"ligand":"dasatinib","mesh_id":"D016411","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D016411","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03372057"},{"ligand":"everolimus","mesh_id":"D016411","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01075321;NCT01198665"},{"ligand":"ibrutinib","mesh_id":"D016411","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01644253"},{"ligand":"nilotinib","mesh_id":"D016411","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155817"},{"ligand":"palbociclib","mesh_id":"D016411","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02264613"},{"ligand":"ruxolitinib","mesh_id":"D016411","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03017820"},{"ligand":"ruxolitinib","mesh_id":"D016411","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT03922724;NCT01431209"},{"ligand":"sirolimus","mesh_id":"D016411","phase":"Phase 1","start_date":"2011","completion_date":"2015","nct_id":"NCT01614197;NCT01403415"},{"ligand":"sirolimus","mesh_id":"D016411","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT03922724;NCT01075321;NCT01198665"},{"ligand":"sorafenib","mesh_id":"D016411","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D016411","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[{"target":"FGFR1","probability":"0.6144103225971622"},{"target":"IGF1R","probability":"0.5909418122122737"},{"target":"BRAF","probability":"0.558411787809698"},{"target":"INSR","probability":"0.5311176975647937"},{"target":"PDGFRA","probability":"0.5276322322250915"},{"target":"ERBB2","probability":"0.5114553430875006"},{"target":"FLT4","probability":"0.4974854331091683"},{"target":"FGFR2","probability":"0.49005887392743014"},{"target":"ERBB3","probability":"0.476694984105184"}],"source_name":"Lymphoma, T-Cell, Peripheral"}],["D009062",{"mesh_id":"D009062","trials":[{"ligand":"apatinib","mesh_id":"D009062","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04393506"},{"ligand":"cetuximab","mesh_id":"D009062","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01445405;NCT01254617"},{"ligand":"cetuximab","mesh_id":"D009062","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT03067610;NCT00933387;NCT03082534;NCT01216020;NCT01440270"},{"ligand":"cetuximab","mesh_id":"D009062","phase":"Phase 3","start_date":"2011","completion_date":"2017","nct_id":"NCT01434394;NCT03258554"},{"ligand":"dacomitinib","mesh_id":"D009062","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01116843"},{"ligand":"erlotinib","mesh_id":"D009062","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00402779"},{"ligand":"sirolimus","mesh_id":"D009062","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01195922"},{"ligand":"trametinib","mesh_id":"D009062","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01553851"}],"predictions":[{"target":"KIT","probability":"0.665041881443299"},{"target":"ERBB3","probability":"0.6551991141477015"},{"target":"ERBB2","probability":"0.605"},{"target":"CDK4","probability":"0.59"},{"target":"JAK2","probability":"0.56"},{"target":"ABL1","probability":"0.5452461561766265"},{"target":"FGFR2","probability":"0.5442402987512706"},{"target":"ALK","probability":"0.5410327172827173"},{"target":"CDK6","probability":"0.5400418814432989"},{"target":"BRAF","probability":"0.5357381876510149"},{"target":"FLT3","probability":"0.535"},{"target":"FGFR3","probability":"0.5254666675044948"},{"target":"ROS1","probability":"0.5154995507575107"},{"target":"PDGFRA","probability":"0.515"},{"target":"MET","probability":"0.5101991141477015"},{"target":"FLT1","probability":"0.505041881443299"},{"target":"MAP2K7","probability":"0.5002222777222777"},{"target":"ERBB4","probability":"0.49504188144329897"},{"target":"BCR","probability":"0.4901234567901235"},{"target":"FGFR1","probability":"0.4707318376068376"},{"target":"INSR","probability":"0.4601653382334224"}],"source_name":"Mouth Neoplasms"}],["D002583",{"mesh_id":"D002583","trials":[{"ligand":"apatinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03816553;NCT03546855;NCT04188847"},{"ligand":"bosutinib","mesh_id":"D002583","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03023319"},{"ligand":"cabozantinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04205799;NCT04230954"},{"ligand":"cetuximab","mesh_id":"D002583","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00104910"},{"ligand":"cetuximab","mesh_id":"D002583","phase":"Phase 2","start_date":"2004","completion_date":"2021","nct_id":"NCT00997009;NCT00957411;NCT00292955;NCT00518193;NCT00101192;NCT04464967"},{"ligand":"erlotinib","mesh_id":"D002583","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00030498;NCT00428194"},{"ligand":"everolimus","mesh_id":"D002583","phase":"Phase 1","start_date":"2009","completion_date":"2011","nct_id":"NCT00967928;NCT01217177"},{"ligand":"gefitinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00049556"},{"ligand":"lapatinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00430781"},{"ligand":"nintedanib","mesh_id":"D002583","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02009579"},{"ligand":"panitumumab","mesh_id":"D002583","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01158248"},{"ligand":"pazopanib","mesh_id":"D002583","phase":"Phase 2","start_date":"2006","completion_date":"2016","nct_id":"NCT02348398;NCT00430781"},{"ligand":"sirolimus","mesh_id":"D002583","phase":"Phase 1","start_date":"2010","completion_date":"2016","nct_id":"NCT02646319;NCT01155258;NCT01217177"},{"ligand":"sirolimus","mesh_id":"D002583","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01026792"},{"ligand":"sorafenib","mesh_id":"D002583","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00510250"},{"ligand":"sunitinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00389974"},{"ligand":"trametinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01958112"},{"ligand":"trastuzumab","mesh_id":"D002583","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D002583","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04579380;NCT04464967"},{"ligand":"tucatinib","mesh_id":"D002583","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04579380"}],"predictions":[{"target":"CDK4","probability":"0.5311655011655012"},{"target":"CDKN1A","probability":"0.49655011655011655"},{"target":"CDK6","probability":"0.4801056338028169"},{"target":"BCR","probability":"0.465"},{"target":"JAK2","probability":"0.460385931273028"}],"source_name":"Uterine Cervical Neoplasms"}],["D008113",{"mesh_id":"D008113","trials":[{"ligand":"apatinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04523662;NCT03092895;NCT04204577"},{"ligand":"apatinib","mesh_id":"D008113","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02702323"},{"ligand":"axitinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04010071"},{"ligand":"cetuximab","mesh_id":"D008113","phase":"Phase 1","start_date":"2007","completion_date":"2009","nct_id":"NCT00397384;NCT00835679"},{"ligand":"cetuximab","mesh_id":"D008113","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT03135652;NCT01511146;NCT00153998;NCT01384994;NCT00743678;NCT00852228;NCT00483405"},{"ligand":"cetuximab","mesh_id":"D008113","phase":"Phase 3","start_date":"2020","completion_date":"2021","nct_id":"NCT04687631;NCT04509635;NCT04525326"},{"ligand":"cetuximab","mesh_id":"D008113","phase":"Phase 4","start_date":"2006","completion_date":"2007","nct_id":"NCT01564810;NCT00510627"},{"ligand":"dasatinib","mesh_id":"D008113","phase":"Phase 1","start_date":"2008","completion_date":"2009","nct_id":"NCT00835679;NCT00608361"},{"ligand":"dasatinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00788125;NCT00459108"},{"ligand":"erlotinib","mesh_id":"D008113","phase":"Phase 1","start_date":"2001","completion_date":"2009","nct_id":"NCT00047346;NCT00397384;NCT00987766;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00293436;NCT00881751;NCT00047333;NCT01180959;NCT00033462;NCT00242502;NCT00605722;NCT00365391"},{"ligand":"everolimus","mesh_id":"D008113","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01864070"},{"ligand":"everolimus","mesh_id":"D008113","phase":"Phase 2","start_date":"2008","completion_date":"2010","nct_id":"NCT01423708;NCT01005199;NCT01009801;NCT00775073"},{"ligand":"gefitinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00071994"},{"ligand":"lapatinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2004","completion_date":"2012","nct_id":"NCT02015169;NCT00107536;NCT00101036"},{"ligand":"lenvatinib","mesh_id":"D008113","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04008797"},{"ligand":"lenvatinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2019","completion_date":"2021","nct_id":"NCT03895970;NCT04627363"},{"ligand":"nintedanib","mesh_id":"D008113","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00363584"},{"ligand":"palbociclib","mesh_id":"D008113","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01356628"},{"ligand":"panitumumab","mesh_id":"D008113","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01508000;NCT01384994;NCT01260415;NCT03803436"},{"ligand":"pazopanib","mesh_id":"D008113","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT01012362"},{"ligand":"pertuzumab","mesh_id":"D008113","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"},{"ligand":"ramucirumab","mesh_id":"D008113","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02082210"},{"ligand":"selumetinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00604721;NCT01859182"},{"ligand":"sirolimus","mesh_id":"D008113","phase":"Phase 1","start_date":"2006","completion_date":"2014","nct_id":"NCT02145559;NCT00467194"},{"ligand":"sirolimus","mesh_id":"D008113","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01010126;NCT01281943;NCT01079767"},{"ligand":"sorafenib","mesh_id":"D008113","phase":"Phase 1","start_date":"2008","completion_date":"2019","nct_id":"NCT03965546;NCT01497444;NCT01011010;NCT01618253;NCT00844168;NCT00767468;NCT02716012;NCT00997022;NCT00873002;NCT01075113;NCT02288507;NCT02292173;NCT01008566;NCT02069145;NCT01042041;NCT01666756"},{"ligand":"sorafenib","mesh_id":"D008113","phase":"Phase 2","start_date":"2008","completion_date":"2020","nct_id":"NCT01556815;NCT01387555;NCT00875615;NCT01217034;NCT00881751;NCT01306058;NCT03037437;NCT01502410;NCT01005199;NCT01180959;NCT01624285;NCT00813293;NCT01334710;NCT01754987;NCT01009801;NCT03971201;NCT01264705;NCT00717756;NCT01375569;NCT00949182;NCT04518852;NCT00892424;NCT00867321;NCT01033240;NCT01182272;NCT04069949;NCT01775501;NCT02632864;NCT00941967"},{"ligand":"sorafenib","mesh_id":"D008113","phase":"Phase 3","start_date":"2009","completion_date":"2019","nct_id":"NCT03164382;NCT01075555;NCT01324076;NCT01009593;NCT01214343;NCT04163237;NCT01730937;NCT00825955;NCT01245582;NCT03533582;NCT02794337"},{"ligand":"sorafenib","mesh_id":"D008113","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT01849588"},{"ligand":"sunitinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2006","completion_date":"2008","nct_id":"NCT00495625;NCT00247676;NCT00514228;NCT00524316;NCT00787787;NCT00361309"},{"ligand":"sunitinib","mesh_id":"D008113","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01164202"},{"ligand":"tivozanib","mesh_id":"D008113","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01807156"},{"ligand":"trametinib","mesh_id":"D008113","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02292173"},{"ligand":"trametinib","mesh_id":"D008113","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02042443"},{"ligand":"trastuzumab","mesh_id":"D008113","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D008113","phase":"Phase 2","start_date":"2010","completion_date":"2020","nct_id":"NCT01556815;NCT04246671;NCT01387295;NCT01387373"},{"ligand":"trastuzumab","mesh_id":"D008113","phase":"Phase 4","start_date":"2013","completion_date":"2013","nct_id":"NCT02380131"}],"predictions":[{"target":"ERBB3","probability":"0.76"},{"target":"FGFR1","probability":"0.7550432138284251"},{"target":"IGF1R","probability":"0.7151594928981925"},{"target":"ERBB4","probability":"0.6917894736842105"},{"target":"FGFR3","probability":"0.6500746823598936"},{"target":"MET","probability":"0.6353856795818498"},{"target":"JAK2","probability":"0.635328947368421"},{"target":"BCR","probability":"0.6251056338028169"},{"target":"FGFR2","probability":"0.6140432138284251"},{"target":"JAK1","probability":"0.6107844928981926"},{"target":"NTRK1","probability":"0.6056682138284252"},{"target":"TEK","probability":"0.5892098804950918"},{"target":"EPHB2","probability":"0.5625391292695263"},{"target":"MAP2K7","probability":"0.5602014315523003"},{"target":"BRAF","probability":"0.545029187247418"},{"target":"INSR","probability":"0.539416020845969"},{"target":"ZAP70","probability":"0.5250675268000529"},{"target":"CSNK1G1","probability":"0.5250400821040285"},{"target":"LYN","probability":"0.5220626215057957"},{"target":"MUSK","probability":"0.5143104955304388"},{"target":"ROS1","probability":"0.5060007081789286"},{"target":"ALK","probability":"0.4973403727497028"},{"target":"NTRK2","probability":"0.48970379276434656"},{"target":"BTK","probability":"0.4810265765181098"},{"target":"NTRK3","probability":"0.47399864018501425"},{"target":"FGFR4","probability":"0.4718390631724386"},{"target":"PIK3CD","probability":"0.47086275700953495"},{"target":"SRC","probability":"0.4577869990078966"},{"target":"AKT2","probability":"0.457624907224328"}],"source_name":"Liver Neoplasms"}],["D013899",{"mesh_id":"D013899","trials":[{"ligand":"apatinib","mesh_id":"D013899","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT04133337;NCT03389256"},{"ligand":"cetuximab","mesh_id":"D013899","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"erlotinib","mesh_id":"D013899","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03389256"},{"ligand":"erlotinib","mesh_id":"D013899","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01024413"},{"ligand":"gefitinib","mesh_id":"D013899","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03389256"},{"ligand":"gefitinib","mesh_id":"D013899","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01024413"},{"ligand":"imatinib","mesh_id":"D013899","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03389256"},{"ligand":"pazopanib","mesh_id":"D013899","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01639911"},{"ligand":"sirolimus","mesh_id":"D013899","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"sunitinib","mesh_id":"D013899","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00437372"}],"predictions":[],"source_name":"Thoracic Neoplasms"}],["D018268",{"mesh_id":"D018268","trials":[{"ligand":"apatinib","mesh_id":"D018268","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04318730"},{"ligand":"axitinib","mesh_id":"D018268","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01255137"},{"ligand":"cabozantinib","mesh_id":"D018268","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02867592;NCT03370718;NCT03612232"},{"ligand":"gefitinib","mesh_id":"D018268","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00215202"},{"ligand":"sorafenib","mesh_id":"D018268","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00786110"},{"ligand":"sunitinib","mesh_id":"D018268","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00453895"},{"ligand":"trastuzumab","mesh_id":"D018268","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Adrenocortical Carcinoma"}],["D031901",{"mesh_id":"D031901","trials":[{"ligand":"apatinib","mesh_id":"D031901","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04047017"}],"predictions":[{"target":"ABL1","probability":"0.6152325581395349"},{"target":"KIT","probability":"0.595"}],"source_name":"Gestational Trophoblastic Disease"}],["D005185",{"mesh_id":"D005185","trials":[{"ligand":"apatinib","mesh_id":"D005185","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04229615"},{"ligand":"binimetinib","mesh_id":"D005185","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01649336"},{"ligand":"binimetinib","mesh_id":"D005185","phase":"Phase 3","start_date":"2013","completion_date":"2013","nct_id":"NCT01849874"},{"ligand":"cetuximab","mesh_id":"D005185","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00063401"},{"ligand":"cobimetinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03363867"},{"ligand":"copanlisib","mesh_id":"D005185","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03586661"},{"ligand":"dasatinib","mesh_id":"D005185","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00672295"},{"ligand":"erlotinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2002","completion_date":"2007","nct_id":"NCT00059787;NCT00126542;NCT00030446;NCT00520013;NCT00217529"},{"ligand":"erlotinib","mesh_id":"D005185","phase":"Phase 3","start_date":"2005","completion_date":"2005","nct_id":"NCT00263822"},{"ligand":"everolimus","mesh_id":"D005185","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01281514"},{"ligand":"everolimus","mesh_id":"D005185","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01031381"},{"ligand":"gefitinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2002","completion_date":"2004","nct_id":"NCT00049556;NCT00317772"},{"ligand":"imatinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00039585"},{"ligand":"lenvatinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04781088"},{"ligand":"nintedanib","mesh_id":"D005185","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01314105"},{"ligand":"nintedanib","mesh_id":"D005185","phase":"Phase 2","start_date":"2013","completion_date":"2014","nct_id":"NCT01669798;NCT01610869"},{"ligand":"palbociclib","mesh_id":"D005185","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04498520"},{"ligand":"panitumumab","mesh_id":"D005185","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01296035"},{"ligand":"pazopanib","mesh_id":"D005185","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01402271;NCT00281632;NCT01035658;NCT01610206"},{"ligand":"pertuzumab","mesh_id":"D005185","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00096993"},{"ligand":"ramucirumab","mesh_id":"D005185","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00721162"},{"ligand":"regorafenib","mesh_id":"D005185","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02278783"},{"ligand":"ribociclib","mesh_id":"D005185","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03056833"},{"ligand":"ruxolitinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"sirolimus","mesh_id":"D005185","phase":"Phase 1","start_date":"2010","completion_date":"2017","nct_id":"NCT02142803;NCT02833506;NCT01065662;NCT01281514;NCT01536054"},{"ligand":"sirolimus","mesh_id":"D005185","phase":"Phase 2","start_date":"2007","completion_date":"2010","nct_id":"NCT01010126;NCT00429793;NCT01031381"},{"ligand":"sorafenib","mesh_id":"D005185","phase":"Phase 2","start_date":"2004","completion_date":"2007","nct_id":"NCT00436215;NCT00522301;NCT00096200"},{"ligand":"sunitinib","mesh_id":"D005185","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00543049;NCT00768144;NCT00388037"},{"ligand":"tivozanib","mesh_id":"D005185","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01972516;NCT01853644"},{"ligand":"trastuzumab","mesh_id":"D005185","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vandetanib","mesh_id":"D005185","phase":"Phase 2","start_date":"2007","completion_date":"2010","nct_id":"NCT00445549;NCT00872989"}],"predictions":[],"source_name":"Fallopian Tube Neoplasms"}],["D003528",{"mesh_id":"D003528","trials":[{"ligand":"apatinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02775370;NCT02942693"},{"ligand":"axitinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01558661;NCT03990571;NCT02859012"},{"ligand":"cetuximab","mesh_id":"D003528","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D003528","phase":"Phase 2","start_date":"2005","completion_date":"2012","nct_id":"NCT01192087;NCT00101348"},{"ligand":"dasatinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00859937"},{"ligand":"erlotinib","mesh_id":"D003528","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"everolimus","mesh_id":"D003528","phase":"Phase 1","start_date":"2008","completion_date":"2010","nct_id":"NCT01637194;NCT01218555"},{"ligand":"everolimus","mesh_id":"D003528","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01152840"},{"ligand":"imatinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00180921"},{"ligand":"lapatinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095563"},{"ligand":"lenvatinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02860936;NCT02780310;NCT04209660"},{"ligand":"regorafenib","mesh_id":"D003528","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02098538"},{"ligand":"sirolimus","mesh_id":"D003528","phase":"Phase 1","start_date":"2008","completion_date":"2010","nct_id":"NCT01637194;NCT01218555"},{"ligand":"sunitinib","mesh_id":"D003528","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00886132"},{"ligand":"trastuzumab","mesh_id":"D003528","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Carcinoma, Adenoid Cystic"}],["D018204",{"mesh_id":"D018204","trials":[{"ligand":"apatinib","mesh_id":"D018204","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03539172"}],"predictions":[],"source_name":"Neoplasms, Connective and Soft Tissue"}],["D009303",{"mesh_id":"D009303","trials":[{"ligand":"apatinib","mesh_id":"D009303","phase":"Phase 2","start_date":"2016","completion_date":"2017","nct_id":"NCT03180476;NCT02874651"},{"ligand":"cetuximab","mesh_id":"D009303","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT03082534;NCT02507154"},{"ligand":"erlotinib","mesh_id":"D009303","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT00603915;NCT01187901;NCT02961374"},{"ligand":"sirolimus","mesh_id":"D009303","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT04094675;NCT03095703;NCT04230499"},{"ligand":"sorafenib","mesh_id":"D009303","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00747799"}],"predictions":[{"target":"KIT","probability":"0.555"},{"target":"PDGFRA","probability":"0.50525"},{"target":"ERBB3","probability":"0.47023759398496245"}],"source_name":"Nasopharyngeal Neoplasms"}],["D001661",{"mesh_id":"D001661","trials":[{"ligand":"apatinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT04642664;NCT03144856;NCT03427242;NCT04720131"},{"ligand":"axitinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04010071"},{"ligand":"binimetinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02773459"},{"ligand":"cetuximab","mesh_id":"D001661","phase":"Phase 2","start_date":"2006","completion_date":"2008","nct_id":"NCT00747097;NCT01216345;NCT00552149"},{"ligand":"erlotinib","mesh_id":"D001661","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00987766"},{"ligand":"erlotinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT03110484"},{"ligand":"lenvatinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT03797326;NCT04211168;NCT04656249;NCT02579616"},{"ligand":"nintedanib","mesh_id":"D001661","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00363584"},{"ligand":"panitumumab","mesh_id":"D001661","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01308840"},{"ligand":"ramucirumab","mesh_id":"D001661","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02443324"},{"ligand":"ramucirumab","mesh_id":"D001661","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02711553"},{"ligand":"regorafenib","mesh_id":"D001661","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02386397;NCT04781192;NCT03475953"},{"ligand":"selumetinib","mesh_id":"D001661","phase":"Phase 1","start_date":"2012","completion_date":"2015","nct_id":"NCT01949870;NCT01242605;NCT02586987"},{"ligand":"selumetinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00553332"},{"ligand":"sorafenib","mesh_id":"D001661","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00955721"},{"ligand":"trametinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04566133;NCT01943864"},{"ligand":"trastuzumab","mesh_id":"D001661","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03613168;NCT04482309;NCT04579380;NCT03185988;NCT04329429;NCT04722133"},{"ligand":"tucatinib","mesh_id":"D001661","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04579380"},{"ligand":"vandetanib","mesh_id":"D001661","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00753675"}],"predictions":[{"target":"ERBB3","probability":"0.5525387293249703"},{"target":"FGFR1","probability":"0.5450862068965517"},{"target":"CSF1R","probability":"0.5421051725799911"},{"target":"INSR","probability":"0.5092760803142732"},{"target":"ERBB4","probability":"0.48564478062429983"},{"target":"IGF1R","probability":"0.4612931034482759"},{"target":"JAK2","probability":"0.45536368832297425"},{"target":"NTRK1","probability":"0.4550399540403084"}],"source_name":"Biliary Tract Neoplasms"}],["D018279",{"mesh_id":"D018279","trials":[{"ligand":"apatinib","mesh_id":"D018279","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03355612"},{"ligand":"cetuximab","mesh_id":"D018279","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01198535"}],"predictions":[],"source_name":"Carcinoma, Signet Ring Cell"}],["D008527",{"mesh_id":"D008527","trials":[{"ligand":"apatinib","mesh_id":"D008527","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04501718"},{"ligand":"erdafitinib","mesh_id":"D008527","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D008527","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"erlotinib","mesh_id":"D008527","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"everolimus","mesh_id":"D008527","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03387020"},{"ligand":"lapatinib","mesh_id":"D008527","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095940"},{"ligand":"larotrectinib","mesh_id":"D008527","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D008527","phase":"Phase 1","start_date":"2014","completion_date":"2019","nct_id":"NCT03709680;NCT02255461"},{"ligand":"palbociclib","mesh_id":"D008527","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"ribociclib","mesh_id":"D008527","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262;NCT03387020"},{"ligand":"selumetinib","mesh_id":"D008527","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D008527","phase":"Phase 1","start_date":"2011","completion_date":"2018","nct_id":"NCT01331135;NCT03387020"},{"ligand":"sirolimus","mesh_id":"D008527","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213678;NCT03155620"},{"ligand":"trametinib","mesh_id":"D008527","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"vemurafenib","mesh_id":"D008527","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"}],"predictions":[{"target":"KIT","probability":"0.5057292494760425"}],"source_name":"Medulloblastoma"}],["D002288",{"mesh_id":"D002288","trials":[{"ligand":"apatinib","mesh_id":"D002288","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04446091"},{"ligand":"cetuximab","mesh_id":"D002288","phase":"Phase 1","start_date":"2009","completion_date":"2010","nct_id":"NCT01198535;NCT00835679"},{"ligand":"cetuximab","mesh_id":"D002288","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00100841"},{"ligand":"dasatinib","mesh_id":"D002288","phase":"Phase 1","start_date":"2009","completion_date":"2011","nct_id":"NCT01440998;NCT00835679"},{"ligand":"erlotinib","mesh_id":"D002288","phase":"Phase 1","start_date":"2003","completion_date":"2003","nct_id":"NCT00060411"},{"ligand":"gefitinib","mesh_id":"D002288","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00052585"},{"ligand":"nintedanib","mesh_id":"D002288","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01225887"},{"ligand":"panitumumab","mesh_id":"D002288","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01814501"},{"ligand":"regorafenib","mesh_id":"D002288","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04446091"}],"predictions":[],"source_name":"Adenocarcinoma, Mucinous"}],["D003536",{"mesh_id":"D003536","trials":[{"ligand":"apatinib","mesh_id":"D003536","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04446091"},{"ligand":"cetuximab","mesh_id":"D003536","phase":"Phase 1","start_date":"2009","completion_date":"2010","nct_id":"NCT01198535;NCT00835679"},{"ligand":"cetuximab","mesh_id":"D003536","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00100841"},{"ligand":"dasatinib","mesh_id":"D003536","phase":"Phase 1","start_date":"2009","completion_date":"2011","nct_id":"NCT01440998;NCT00835679"},{"ligand":"dasatinib","mesh_id":"D003536","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02059265"},{"ligand":"erlotinib","mesh_id":"D003536","phase":"Phase 1","start_date":"2003","completion_date":"2003","nct_id":"NCT00060411"},{"ligand":"erlotinib","mesh_id":"D003536","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00059787"},{"ligand":"everolimus","mesh_id":"D003536","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02283658"},{"ligand":"gefitinib","mesh_id":"D003536","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00052585"},{"ligand":"nintedanib","mesh_id":"D003536","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01225887"},{"ligand":"panitumumab","mesh_id":"D003536","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01814501"},{"ligand":"regorafenib","mesh_id":"D003536","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04446091"},{"ligand":"sirolimus","mesh_id":"D003536","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02142803"},{"ligand":"sirolimus","mesh_id":"D003536","phase":"Phase 2","start_date":"2010","completion_date":"2014","nct_id":"NCT02283658;NCT01196429"}],"predictions":[],"source_name":"Cystadenocarcinoma"}],["D001650",{"mesh_id":"D001650","trials":[{"ligand":"apatinib","mesh_id":"D001650","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03609489"},{"ligand":"cabozantinib","mesh_id":"D001650","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01954745"},{"ligand":"cetuximab","mesh_id":"D001650","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D001650","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00266097;NCT00397384;NCT00987766"},{"ligand":"erlotinib","mesh_id":"D001650","phase":"Phase 2","start_date":"2002","completion_date":"2010","nct_id":"NCT00356889;NCT00033462;NCT00832637;NCT01093222"},{"ligand":"lapatinib","mesh_id":"D001650","phase":"Phase 2","start_date":"2004","completion_date":"2005","nct_id":"NCT00107536;NCT00101036"},{"ligand":"nintedanib","mesh_id":"D001650","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00363584"},{"ligand":"regorafenib","mesh_id":"D001650","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115542"},{"ligand":"selumetinib","mesh_id":"D001650","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT01859182;NCT00553332"},{"ligand":"sorafenib","mesh_id":"D001650","phase":"Phase 2","start_date":"2005","completion_date":"2010","nct_id":"NCT00238212;NCT00634751;NCT00919061;NCT01093222"},{"ligand":"tivozanib","mesh_id":"D001650","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04645160"},{"ligand":"trametinib","mesh_id":"D001650","phase":"Phase 2","start_date":"2014","completion_date":"2021","nct_id":"NCT02042443;NCT04566133"},{"ligand":"trastuzumab","mesh_id":"D001650","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D001650","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00478140"}],"predictions":[{"target":"FLT1","probability":"0.5221265420373713"},{"target":"ERBB3","probability":"0.5065657894736841"},{"target":"FGFR1","probability":"0.5025101760851761"},{"target":"CSF1R","probability":"0.45679788314143815"}],"source_name":"Bile Duct Neoplasms"}],["D008415",{"mesh_id":"D008415","trials":[{"ligand":"avapritinib","mesh_id":"D008415","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02561988"},{"ligand":"avapritinib","mesh_id":"D008415","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03580655;NCT03731260"},{"ligand":"dasatinib","mesh_id":"D008415","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT00979160;NCT00255346"},{"ligand":"everolimus","mesh_id":"D008415","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00449748"},{"ligand":"ibrutinib","mesh_id":"D008415","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02415608"},{"ligand":"imatinib","mesh_id":"D008415","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00171912;NCT00109707"},{"ligand":"imatinib","mesh_id":"D008415","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01297777"},{"ligand":"midostaurin","mesh_id":"D008415","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00233454;NCT01920204;NCT00782067"},{"ligand":"nilotinib","mesh_id":"D008415","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00109707"}],"predictions":[],"source_name":"Mastocytosis"}],["D034721",{"mesh_id":"D034721","trials":[{"ligand":"avapritinib","mesh_id":"D034721","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02561988"},{"ligand":"avapritinib","mesh_id":"D034721","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03580655;NCT03731260"},{"ligand":"dasatinib","mesh_id":"D034721","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00979160"},{"ligand":"everolimus","mesh_id":"D034721","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00449748"},{"ligand":"ibrutinib","mesh_id":"D034721","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02415608"},{"ligand":"imatinib","mesh_id":"D034721","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00171912;NCT00109707"},{"ligand":"imatinib","mesh_id":"D034721","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01297777"},{"ligand":"midostaurin","mesh_id":"D034721","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00233454;NCT01920204;NCT00782067"},{"ligand":"nilotinib","mesh_id":"D034721","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00109707"}],"predictions":[{"target":"ERBB3","probability":"0.5200313479623824"},{"target":"ERBB2","probability":"0.5076873100858743"},{"target":"PTK7","probability":"0.46853039438013155"},{"target":"IGF1R","probability":"0.4573809523809524"}],"source_name":"Mastocytosis, Systemic"}],["D007946",{"mesh_id":"D007946","trials":[{"ligand":"avapritinib","mesh_id":"D007946","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02561988"},{"ligand":"avapritinib","mesh_id":"D007946","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03580655"},{"ligand":"ibrutinib","mesh_id":"D007946","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02415608"},{"ligand":"midostaurin","mesh_id":"D007946","phase":"Phase 2","start_date":"2005","completion_date":"2008","nct_id":"NCT00233454;NCT00782067"},{"ligand":"sunitinib","mesh_id":"D007946","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"sunitinib","mesh_id":"D007946","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"}],"predictions":[],"source_name":"Leukemia, Mast-Cell"}],["D009423",{"mesh_id":"D009423","trials":[{"ligand":"avapritinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04771520"},{"ligand":"cabozantinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01709435"},{"ligand":"cabozantinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"dasatinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2008","completion_date":"2009","nct_id":"NCT00869401;NCT00788125"},{"ligand":"erdafitinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2005","completion_date":"2006","nct_id":"NCT00227032;NCT00509431;NCT00360854"},{"ligand":"erlotinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00720356;NCT00124657;NCT00054496;NCT00086879;NCT00602667"},{"ligand":"everolimus","mesh_id":"D009423","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00387400"},{"ligand":"everolimus","mesh_id":"D009423","phase":"Phase 2","start_date":"2003","completion_date":"2010","nct_id":"NCT01062399;NCT00085566;NCT00553150;NCT00107237"},{"ligand":"gefitinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00027625"},{"ligand":"gefitinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2001","completion_date":"2004","nct_id":"NCT00025675;NCT00085566;NCT00016991"},{"ligand":"ibrutinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04446962"},{"ligand":"imatinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2004","completion_date":"2006","nct_id":"NCT00401024;NCT00354068;NCT00387933"},{"ligand":"imatinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2001","completion_date":"2009","nct_id":"NCT00021229;NCT00039364;NCT00904735;NCT00010049"},{"ligand":"lapatinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00313599"},{"ligand":"lapatinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00099060"},{"ligand":"larotrectinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT03213704;NCT03834961;NCT03155620"},{"ligand":"neratinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02932280"},{"ligand":"palbociclib","mesh_id":"D009423","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D009423","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"pazopanib","mesh_id":"D009423","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT01931098"},{"ligand":"ribociclib","mesh_id":"D009423","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"selumetinib","mesh_id":"D009423","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213691;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D009423","phase":"Phase 1","start_date":"2001","completion_date":"2018","nct_id":"NCT00003712;NCT00509431;NCT01135563;NCT00784914;NCT03696355;NCT02975882;NCT01204450"},{"ligand":"sirolimus","mesh_id":"D009423","phase":"Phase 2","start_date":"2001","completion_date":"2017","nct_id":"NCT00022724;NCT00047073;NCT01019434;NCT03213678;NCT03155620"},{"ligand":"sorafenib","mesh_id":"D009423","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00621686"},{"ligand":"sunitinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00437372"},{"ligand":"trametinib","mesh_id":"D009423","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trastuzumab","mesh_id":"D009423","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT00397501"},{"ligand":"vandetanib","mesh_id":"D009423","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00472017"},{"ligand":"vemurafenib","mesh_id":"D009423","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[],"source_name":"Nervous System Neoplasms"}],["D010673",{"mesh_id":"D010673","trials":[{"ligand":"axitinib","mesh_id":"D010673","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT01967576;NCT03839498"},{"ligand":"cabozantinib","mesh_id":"D010673","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02302833;NCT04400474"},{"ligand":"everolimus","mesh_id":"D010673","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00655655"},{"ligand":"everolimus","mesh_id":"D010673","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01152827"},{"ligand":"fostamatinib","mesh_id":"D010673","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00923481"},{"ligand":"imatinib","mesh_id":"D010673","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03165721"},{"ligand":"lenvatinib","mesh_id":"D010673","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03008369"},{"ligand":"pazopanib","mesh_id":"D010673","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01340794"},{"ligand":"sirolimus","mesh_id":"D010673","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT00655655;NCT01155258"},{"ligand":"sunitinib","mesh_id":"D010673","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01371201;NCT00843037"},{"ligand":"vandetanib","mesh_id":"D010673","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01941849"}],"predictions":[{"target":"ERBB2","probability":"0.46"}],"source_name":"Pheochromocytoma"}],["D010235",{"mesh_id":"D010235","trials":[{"ligand":"axitinib","mesh_id":"D010235","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT01967576;NCT03839498"},{"ligand":"cabozantinib","mesh_id":"D010235","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02302833;NCT04400474"},{"ligand":"everolimus","mesh_id":"D010235","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01204476"},{"ligand":"everolimus","mesh_id":"D010235","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01152827"},{"ligand":"imatinib","mesh_id":"D010235","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03165721"},{"ligand":"lenvatinib","mesh_id":"D010235","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03008369"},{"ligand":"pazopanib","mesh_id":"D010235","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01340794"},{"ligand":"sirolimus","mesh_id":"D010235","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01204476;NCT01155258"},{"ligand":"sunitinib","mesh_id":"D010235","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01371201;NCT00843037"},{"ligand":"vandetanib","mesh_id":"D010235","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01941849"}],"predictions":[],"source_name":"Paraganglioma"}],["D002345",{"mesh_id":"D002345","trials":[{"ligand":"axitinib","mesh_id":"D002345","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT01967576;NCT03839498"},{"ligand":"cabozantinib","mesh_id":"D002345","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02302833"},{"ligand":"everolimus","mesh_id":"D002345","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01152827"},{"ligand":"imatinib","mesh_id":"D002345","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03165721"},{"ligand":"lenvatinib","mesh_id":"D002345","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03008369"},{"ligand":"pazopanib","mesh_id":"D002345","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01340794"},{"ligand":"sirolimus","mesh_id":"D002345","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155258"},{"ligand":"sunitinib","mesh_id":"D002345","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01371201;NCT00843037"},{"ligand":"vandetanib","mesh_id":"D002345","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT01941849"}],"predictions":[],"source_name":"Carotid Body Tumor"}],["D009442",{"mesh_id":"D009442","trials":[{"ligand":"axitinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02129647"},{"ligand":"brigatinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"crizotinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04283669"},{"ligand":"everolimus","mesh_id":"D009442","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01880749"},{"ligand":"everolimus","mesh_id":"D009442","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT01490476;NCT01345136"},{"ligand":"icotinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02934256"},{"ligand":"lapatinib","mesh_id":"D009442","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00863122"},{"ligand":"lapatinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00973739"},{"ligand":"nilotinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01201538"},{"ligand":"selumetinib","mesh_id":"D009442","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03095248"},{"ligand":"sirolimus","mesh_id":"D009442","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01490476"}],"predictions":[],"source_name":"Neurilemmoma"}],["D009464",{"mesh_id":"D009464","trials":[{"ligand":"axitinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02129647"},{"ligand":"brigatinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"crizotinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04283669"},{"ligand":"everolimus","mesh_id":"D009464","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01880749"},{"ligand":"everolimus","mesh_id":"D009464","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT01490476;NCT01345136"},{"ligand":"icotinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02934256"},{"ligand":"lapatinib","mesh_id":"D009464","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00863122"},{"ligand":"lapatinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00973739"},{"ligand":"nilotinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01201538"},{"ligand":"selumetinib","mesh_id":"D009464","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03095248"},{"ligand":"sirolimus","mesh_id":"D009464","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01490476"}],"predictions":[{"target":"BRAF","probability":"0.4907422951009261"}],"source_name":"Neuroma, Acoustic"}],["D016518",{"mesh_id":"D016518","trials":[{"ligand":"axitinib","mesh_id":"D016518","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02129647"},{"ligand":"brigatinib","mesh_id":"D016518","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"cetuximab","mesh_id":"D016518","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"crizotinib","mesh_id":"D016518","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04283669"},{"ligand":"everolimus","mesh_id":"D016518","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01880749"},{"ligand":"everolimus","mesh_id":"D016518","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01490476;NCT01345136;NCT01419639"},{"ligand":"icotinib","mesh_id":"D016518","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02934256"},{"ligand":"lapatinib","mesh_id":"D016518","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00863122"},{"ligand":"lapatinib","mesh_id":"D016518","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00973739"},{"ligand":"selumetinib","mesh_id":"D016518","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03095248"},{"ligand":"sirolimus","mesh_id":"D016518","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"sirolimus","mesh_id":"D016518","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01490476"}],"predictions":[],"source_name":"Neurofibromatosis 2"}],["D000306",{"mesh_id":"D000306","trials":[{"ligand":"axitinib","mesh_id":"D000306","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01255137"}],"predictions":[],"source_name":"Adrenal Cortex Neoplasms"}],["D018234",{"mesh_id":"D018234","trials":[{"ligand":"axitinib","mesh_id":"D018234","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02636725"},{"ligand":"cabozantinib","mesh_id":"D018234","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"crizotinib","mesh_id":"D018234","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01524926"},{"ligand":"dasatinib","mesh_id":"D018234","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"pazopanib","mesh_id":"D018234","phase":"Phase 2","start_date":"2011","completion_date":"2014","nct_id":"NCT01391962;NCT01532687;NCT02113826"},{"ligand":"pazopanib","mesh_id":"D018234","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"sirolimus","mesh_id":"D018234","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01614795"},{"ligand":"sorafenib","mesh_id":"D018234","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01391962"},{"ligand":"sunitinib","mesh_id":"D018234","phase":"Phase 2","start_date":"2011","completion_date":"2014","nct_id":"NCT01391962;NCT02113826"}],"predictions":[],"source_name":"Sarcoma, Alveolar Soft Part"}],["D012468",{"mesh_id":"D012468","trials":[{"ligand":"axitinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02857712"},{"ligand":"cabozantinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03729297"},{"ligand":"cetuximab","mesh_id":"D012468","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384;NCT01637194;NCT01254617"},{"ligand":"cetuximab","mesh_id":"D012468","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00984217;NCT00939627;NCT01816984;NCT01256385;NCT00101348;NCT01316757"},{"ligand":"crizotinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"dasatinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT00859937;NCT02558387;NCT00507767"},{"ligand":"entrectinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"erlotinib","mesh_id":"D012468","phase":"Phase 1","start_date":"2001","completion_date":"2011","nct_id":"NCT00397384;NCT01332279;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00101348;NCT01316757;NCT00055770"},{"ligand":"everolimus","mesh_id":"D012468","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"gefitinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00509002"},{"ligand":"imatinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00045669"},{"ligand":"lapatinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00114283;NCT00095563;NCT01044433"},{"ligand":"lenvatinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2015","completion_date":"2020","nct_id":"NCT02860936;NCT04209660"},{"ligand":"nintedanib","mesh_id":"D012468","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02558387"},{"ligand":"panitumumab","mesh_id":"D012468","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"},{"ligand":"pazopanib","mesh_id":"D012468","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT02393820"},{"ligand":"sirolimus","mesh_id":"D012468","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"sirolimus","mesh_id":"D012468","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01256385"},{"ligand":"sorafenib","mesh_id":"D012468","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D012468","phase":"Phase 2","start_date":"2004","completion_date":"2014","nct_id":"NCT00939627;NCT02857712;NCT01703455;NCT02558387;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D012468","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D012468","phase":"Phase 2","start_date":"2007","completion_date":"2014","nct_id":"NCT00886132;NCT02558387"},{"ligand":"trastuzumab","mesh_id":"D012468","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D012468","phase":"Phase 2","start_date":"1999","completion_date":"2020","nct_id":"NCT00004163;NCT04620187;NCT00126607"}],"predictions":[],"source_name":"Salivary Gland Neoplasms"}],["D021441",{"mesh_id":"D021441","trials":[{"ligand":"axitinib","mesh_id":"D021441","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00471146"},{"ligand":"erlotinib","mesh_id":"D021441","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01394120"}],"predictions":[{"target":"FLT3","probability":"0.6300431034482759"},{"target":"RET","probability":"0.5753428907395436"},{"target":"FGFR1","probability":"0.54"},{"target":"FLT1","probability":"0.52"},{"target":"KDR","probability":"0.5155635835648167"},{"target":"ERBB2","probability":"0.5151506768106466"},{"target":"FGFR3","probability":"0.4913882534902314"},{"target":"BRAF","probability":"0.4910956982393856"},{"target":"IGF1R","probability":"0.49025141161632363"},{"target":"INSR","probability":"0.46528321678321677"},{"target":"PIK3CA","probability":"0.4622413703334724"},{"target":"CSF1R","probability":"0.4551650943396226"}],"source_name":"Carcinoma, Pancreatic Ductal"}],["D054364",{"mesh_id":"D054364","trials":[{"ligand":"axitinib","mesh_id":"D054364","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02261207"},{"ligand":"pazopanib","mesh_id":"D054364","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02066285"}],"predictions":[],"source_name":"Solitary Fibrous Tumors"}],["D018218",{"mesh_id":"D018218","trials":[{"ligand":"axitinib","mesh_id":"D018218","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02261207"},{"ligand":"lenvatinib","mesh_id":"D018218","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"},{"ligand":"pazopanib","mesh_id":"D018218","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02066285"}],"predictions":[{"target":"FLT3","probability":"0.88"},{"target":"BRAF","probability":"0.84"},{"target":"MTOR","probability":"0.805"},{"target":"BTK","probability":"0.75"},{"target":"ALK","probability":"0.745"},{"target":"PIK3CA","probability":"0.72"},{"target":"JAK2","probability":"0.72"},{"target":"MAP2K7","probability":"0.695"},{"target":"BCR","probability":"0.69"},{"target":"FGFR1","probability":"0.67"},{"target":"AKT1","probability":"0.665"},{"target":"JAK1","probability":"0.615"},{"target":"FGFR3","probability":"0.59"},{"target":"ERBB2","probability":"0.585"},{"target":"PIK3CD","probability":"0.585"},{"target":"CDK4","probability":"0.58"},{"target":"EGFR","probability":"0.575"},{"target":"IGF1R","probability":"0.565"},{"target":"MET","probability":"0.56"},{"target":"SRC","probability":"0.555"},{"target":"ERBB4","probability":"0.545"},{"target":"CDK6","probability":"0.54"},{"target":"FGFR2","probability":"0.535"},{"target":"ERBB3","probability":"0.53"},{"target":"STK11","probability":"0.5201239322757779"},{"target":"MAPK1","probability":"0.52"},{"target":"JAK3","probability":"0.51"},{"target":"RPS6KB1","probability":"0.51"},{"target":"MAPK3","probability":"0.5"},{"target":"ZAP70","probability":"0.5"},{"target":"MAP2K2","probability":"0.495"},{"target":"MAP2K1","probability":"0.49"},{"target":"ROS1","probability":"0.47545454545454546"},{"target":"TGFBR1","probability":"0.475"},{"target":"NTRK3","probability":"0.475"},{"target":"NTRK2","probability":"0.45509278350515464"},{"target":"TEK","probability":"0.455"},{"target":"NTRK1","probability":"0.455"}],"source_name":"Neoplasms, Fibrous Tissue"}],["D006394",{"mesh_id":"D006394","trials":[{"ligand":"axitinib","mesh_id":"D006394","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01140737"},{"ligand":"cabozantinib","mesh_id":"D006394","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04339738"},{"ligand":"neratinib","mesh_id":"D006394","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01042379"},{"ligand":"olaratumab","mesh_id":"D006394","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D006394","phase":"Phase 2","start_date":"2011","completion_date":"2014","nct_id":"NCT01462630;NCT01532687;NCT02212015"},{"ligand":"pazopanib","mesh_id":"D006394","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT02979899"},{"ligand":"pertuzumab","mesh_id":"D006394","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01042379"},{"ligand":"regorafenib","mesh_id":"D006394","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048722"},{"ligand":"ribociclib","mesh_id":"D006394","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"sirolimus","mesh_id":"D006394","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01614795"},{"ligand":"sorafenib","mesh_id":"D006394","phase":"Phase 2","start_date":"2005","completion_date":"2008","nct_id":"NCT00245102;NCT00874874"},{"ligand":"trastuzumab","mesh_id":"D006394","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01042379"},{"ligand":"tucatinib","mesh_id":"D006394","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01042379"}],"predictions":[{"target":"EGFR","probability":"0.465"}],"source_name":"Hemangiosarcoma"}],["D018316",{"mesh_id":"D018316","trials":[{"ligand":"axitinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03275558"},{"ligand":"binimetinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03973918"},{"ligand":"cabozantinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00960492"},{"ligand":"dasatinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2008","completion_date":"2009","nct_id":"NCT00734864;NCT00609999"},{"ligand":"dasatinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00423735"},{"ligand":"encorafenib","mesh_id":"D018316","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03973918"},{"ligand":"erlotinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2001","completion_date":"2010","nct_id":"NCT01103375;NCT00609999;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2002","completion_date":"2009","nct_id":"NCT00525525;NCT00720356;NCT00445588;NCT00112736;NCT00671970;NCT00187486;NCT00672243;NCT00045110;NCT00387894;NCT00039494;NCT00335764"},{"ligand":"everolimus","mesh_id":"D018316","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00613132"},{"ligand":"gefitinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2001","completion_date":"2002","nct_id":"NCT00042991;NCT00014170;NCT00052208"},{"ligand":"imatinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2005","completion_date":"2007","nct_id":"NCT00613054;NCT00613132"},{"ligand":"imatinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2005","completion_date":"2006","nct_id":"NCT00615927;NCT00354913"},{"ligand":"lapatinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02101905"},{"ligand":"lapatinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2004","completion_date":"2005","nct_id":"NCT00095940;NCT00107003"},{"ligand":"nintedanib","mesh_id":"D018316","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01380782"},{"ligand":"palbociclib","mesh_id":"D018316","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D018316","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01227434"},{"ligand":"pazopanib","mesh_id":"D018316","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03275558"},{"ligand":"pazopanib","mesh_id":"D018316","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT01931098;NCT00459381"},{"ligand":"sirolimus","mesh_id":"D018316","phase":"Phase 1","start_date":"2004","completion_date":"2006","nct_id":"NCT00087451;NCT00316849"},{"ligand":"sirolimus","mesh_id":"D018316","phase":"Phase 2","start_date":"2001","completion_date":"2013","nct_id":"NCT01051557;NCT00329719;NCT00112736;NCT01614795;NCT00672243;NCT00016328;NCT00335764;NCT02430363"},{"ligand":"sorafenib","mesh_id":"D018316","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00734526;NCT00884416;NCT00093613"},{"ligand":"sorafenib","mesh_id":"D018316","phase":"Phase 2","start_date":"2006","completion_date":"2008","nct_id":"NCT00445588;NCT00329719;NCT02599090;NCT00335764"},{"ligand":"sunitinib","mesh_id":"D018316","phase":"Phase 1","start_date":"2009","completion_date":"2018","nct_id":"NCT01122888;NCT03275558"},{"ligand":"sunitinib","mesh_id":"D018316","phase":"Phase 2","start_date":"2007","completion_date":"2019","nct_id":"NCT00499473;NCT03641326"},{"ligand":"vandetanib","mesh_id":"D018316","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00613054;NCT00613223"},{"ligand":"vandetanib","mesh_id":"D018316","phase":"Phase 2","start_date":"2007","completion_date":"2009","nct_id":"NCT00995007;NCT00441142"}],"predictions":[],"source_name":"Gliosarcoma"}],["D012983",{"mesh_id":"D012983","trials":[{"ligand":"binimetinib","mesh_id":"D012983","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02285439"},{"ligand":"cetuximab","mesh_id":"D012983","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"lenvatinib","mesh_id":"D012983","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"},{"ligand":"sirolimus","mesh_id":"D012983","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"}],"predictions":[],"source_name":"Soft Tissue Neoplasms"}],["D018318",{"mesh_id":"D018318","trials":[{"ligand":"binimetinib","mesh_id":"D018318","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03231306"},{"ligand":"cabozantinib","mesh_id":"D018318","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02101736"},{"ligand":"dabrafenib","mesh_id":"D018318","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02124772"},{"ligand":"everolimus","mesh_id":"D018318","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01412892;NCT01365468"},{"ligand":"imatinib","mesh_id":"D018318","phase":"Phase 2","start_date":"2006","completion_date":"2018","nct_id":"NCT02177825;NCT01673009;NCT01140360;NCT03688568"},{"ligand":"nilotinib","mesh_id":"D018318","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01275586"},{"ligand":"selumetinib","mesh_id":"D018318","phase":"Phase 1","start_date":"2018","completion_date":"2020","nct_id":"NCT04590235;NCT03649165"},{"ligand":"selumetinib","mesh_id":"D018318","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT01362803;NCT02407405;NCT03326388"},{"ligand":"sirolimus","mesh_id":"D018318","phase":"Phase 2","start_date":"2008","completion_date":"2011","nct_id":"NCT01412892;NCT00634270"},{"ligand":"sorafenib","mesh_id":"D018318","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00727233"},{"ligand":"sunitinib","mesh_id":"D018318","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01402817"},{"ligand":"trametinib","mesh_id":"D018318","phase":"Phase 2","start_date":"2015","completion_date":"2019","nct_id":"NCT03741101;NCT02124772;NCT03363217"}],"predictions":[],"source_name":"Neurofibroma, Plexiform"}],["D007943",{"mesh_id":"D007943","trials":[{"ligand":"binimetinib","mesh_id":"D007943","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04322383;NCT04324112"},{"ligand":"dasatinib","mesh_id":"D007943","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"encorafenib","mesh_id":"D007943","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04324112"},{"ligand":"ibrutinib","mesh_id":"D007943","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02109224"},{"ligand":"ibrutinib","mesh_id":"D007943","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01841723"},{"ligand":"imatinib","mesh_id":"D007943","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sunitinib","mesh_id":"D007943","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"sunitinib","mesh_id":"D007943","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"},{"ligand":"vemurafenib","mesh_id":"D007943","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT03410875;NCT04324112;NCT01711632"}],"predictions":[],"source_name":"Leukemia, Hairy Cell"}],["D007948",{"mesh_id":"D007948","trials":[{"ligand":"binimetinib","mesh_id":"D007948","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02049801"},{"ligand":"sirolimus","mesh_id":"D007948","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01822015"},{"ligand":"sirolimus","mesh_id":"D007948","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00634244"},{"ligand":"sorafenib","mesh_id":"D007948","phase":"Phase 1","start_date":"2005","completion_date":"2010","nct_id":"NCT00217646;NCT00131989;NCT01159301"}],"predictions":[],"source_name":"Leukemia, Monocytic, Acute"}],["D015479",{"mesh_id":"D015479","trials":[{"ligand":"binimetinib","mesh_id":"D015479","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02049801"},{"ligand":"erlotinib","mesh_id":"D015479","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01174043"},{"ligand":"imatinib","mesh_id":"D015479","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00852709"},{"ligand":"imatinib","mesh_id":"D015479","phase":"Phase 2","start_date":"2002","completion_date":"2004","nct_id":"NCT00136409;NCT00079313"},{"ligand":"quizartinib","mesh_id":"D015479","phase":"Phase 2","start_date":"2013","completion_date":"2020","nct_id":"NCT01892371;NCT04493138"},{"ligand":"ruxolitinib","mesh_id":"D015479","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03722407;NCT01776723"},{"ligand":"sirolimus","mesh_id":"D015479","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01822015"},{"ligand":"sirolimus","mesh_id":"D015479","phase":"Phase 2","start_date":"2008","completion_date":"2014","nct_id":"NCT00634244;NCT01885689"},{"ligand":"sorafenib","mesh_id":"D015479","phase":"Phase 1","start_date":"2005","completion_date":"2010","nct_id":"NCT00217646;NCT00131989;NCT01159301"},{"ligand":"sunitinib","mesh_id":"D015479","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00451048"},{"ligand":"trametinib","mesh_id":"D015479","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT04487106;NCT03190915"}],"predictions":[],"source_name":"Leukemia, Myelomonocytic, Acute"}],["D004915",{"mesh_id":"D004915","trials":[{"ligand":"binimetinib","mesh_id":"D004915","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02049801"},{"ligand":"sirolimus","mesh_id":"D004915","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01822015"},{"ligand":"sirolimus","mesh_id":"D004915","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00634244"},{"ligand":"sorafenib","mesh_id":"D004915","phase":"Phase 1","start_date":"2005","completion_date":"2010","nct_id":"NCT00217646;NCT00131989;NCT01159301"}],"predictions":[{"target":"PDGFRA","probability":"0.5687891875685888"},{"target":"BRAF","probability":"0.5302070332517224"},{"target":"KIT","probability":"0.5098326201968678"},{"target":"IGF1R","probability":"0.5094741172839768"},{"target":"PDGFRB","probability":"0.5056610588887078"},{"target":"EGFR","probability":"0.5050417246175243"},{"target":"MET","probability":"0.4835337371913811"},{"target":"RET","probability":"0.46802298137163395"},{"target":"ERBB3","probability":"0.464752553384701"},{"target":"ALK","probability":"0.4556056918511874"}],"source_name":"Leukemia, Erythroblastic, Acute"}],["D001254",{"mesh_id":"D001254","trials":[{"ligand":"binimetinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03973918"},{"ligand":"cabozantinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT01068782;NCT02885324"},{"ligand":"cetuximab","mesh_id":"D001254","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT01238237"},{"ligand":"cetuximab","mesh_id":"D001254","phase":"Phase 2","start_date":"2009","completion_date":"2016","nct_id":"NCT02800486;NCT01012609;NCT01884740"},{"ligand":"dabrafenib","mesh_id":"D001254","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02684058;NCT03919071"},{"ligand":"dabrafenib","mesh_id":"D001254","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"dasatinib","mesh_id":"D001254","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00734864"},{"ligand":"encorafenib","mesh_id":"D001254","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03973918"},{"ligand":"erlotinib","mesh_id":"D001254","phase":"Phase 1","start_date":"2001","completion_date":"2010","nct_id":"NCT01103375;NCT00077454;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2002","completion_date":"2006","nct_id":"NCT00301418;NCT00112736;NCT00045110"},{"ligand":"everolimus","mesh_id":"D001254","phase":"Phase 1","start_date":"2017","completion_date":"2020","nct_id":"NCT04135807;NCT03355794"},{"ligand":"everolimus","mesh_id":"D001254","phase":"Phase 2","start_date":"2007","completion_date":"2018","nct_id":"NCT02023905;NCT00782626;NCT00411619;NCT00823459"},{"ligand":"everolimus","mesh_id":"D001254","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00789828"},{"ligand":"gefitinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2001","completion_date":"2002","nct_id":"NCT00025675;NCT00042991"},{"ligand":"imatinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00606008"},{"ligand":"imatinib","mesh_id":"D001254","phase":"Phase 3","start_date":"2004","completion_date":"2004","nct_id":"NCT00154375"},{"ligand":"lapatinib","mesh_id":"D001254","phase":"Phase 1","start_date":"2014","completion_date":"2020","nct_id":"NCT04135807;NCT02101905"},{"ligand":"lapatinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095940"},{"ligand":"nintedanib","mesh_id":"D001254","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01380782"},{"ligand":"osimertinib","mesh_id":"D001254","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04135807"},{"ligand":"palbociclib","mesh_id":"D001254","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"palbociclib","mesh_id":"D001254","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01227434"},{"ligand":"panitumumab","mesh_id":"D001254","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02766699"},{"ligand":"ribociclib","mesh_id":"D001254","phase":"Phase 1","start_date":"2017","completion_date":"2018","nct_id":"NCT03355794;NCT03434262"},{"ligand":"selumetinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01089101"},{"ligand":"selumetinib","mesh_id":"D001254","phase":"Phase 3","start_date":"2020","completion_date":"2021","nct_id":"NCT04576117;NCT04166409"},{"ligand":"sirolimus","mesh_id":"D001254","phase":"Phase 1","start_date":"2011","completion_date":"2014","nct_id":"NCT01522820;NCT01331135;NCT02238496;NCT01316809;NCT01240460"},{"ligand":"sirolimus","mesh_id":"D001254","phase":"Phase 2","start_date":"2005","completion_date":"2010","nct_id":"NCT01051557;NCT00112736;NCT00411619;NCT00823459"},{"ligand":"sirolimus","mesh_id":"D001254","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00789828"},{"ligand":"sorafenib","mesh_id":"D001254","phase":"Phase 1","start_date":"2004","completion_date":"2009","nct_id":"NCT00884416;NCT00093613"},{"ligand":"sorafenib","mesh_id":"D001254","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01338857"},{"ligand":"sunitinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2007","completion_date":"2012","nct_id":"NCT00606008;NCT01462695;NCT00499473"},{"ligand":"trametinib","mesh_id":"D001254","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D001254","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02684058;NCT03919071"},{"ligand":"trametinib","mesh_id":"D001254","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"vandetanib","mesh_id":"D001254","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00995007"}],"predictions":[{"target":"MAP2K7","probability":"0.639021052631579"},{"target":"MAPK3","probability":"0.5001630434782609"},{"target":"IGF1R","probability":"0.4606666666666666"},{"target":"MAPK1","probability":"0.46017625450774274"},{"target":"AKT1","probability":"0.45566829743114867"}],"source_name":"Astrocytoma"}],["D013945",{"mesh_id":"D013945","trials":[{"ligand":"bosutinib","mesh_id":"D013945","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03023319"},{"ligand":"cetuximab","mesh_id":"D013945","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01025089"},{"ligand":"erlotinib","mesh_id":"D013945","phase":"Phase 2","start_date":"2006","completion_date":"2011","nct_id":"NCT00369889;NCT01306045"},{"ligand":"everolimus","mesh_id":"D013945","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT02049047"},{"ligand":"imatinib","mesh_id":"D013945","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00314873"},{"ligand":"lapatinib","mesh_id":"D013945","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306045"},{"ligand":"lenvatinib","mesh_id":"D013945","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04710628"},{"ligand":"ramucirumab","mesh_id":"D013945","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03921671;NCT03694002"},{"ligand":"regorafenib","mesh_id":"D013945","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02307500"},{"ligand":"ribociclib","mesh_id":"D013945","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02420691"},{"ligand":"selumetinib","mesh_id":"D013945","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01610544;NCT01306045"},{"ligand":"sirolimus","mesh_id":"D013945","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT02049047"},{"ligand":"sunitinib","mesh_id":"D013945","phase":"Phase 2","start_date":"2011","completion_date":"2021","nct_id":"NCT04710628;NCT02623127;NCT03463460;NCT01621568;NCT03449173;NCT01306045"}],"predictions":[{"target":"KDR","probability":"0.5751311475409836"},{"target":"PDGFRA","probability":"0.535"},{"target":"JAK2","probability":"0.5203015848980416"},{"target":"RET","probability":"0.4908970567006643"},{"target":"IGF1R","probability":"0.4903234552332913"},{"target":"FLT1","probability":"0.49029333864529584"},{"target":"PIK3CA","probability":"0.46163048668169365"}],"source_name":"Thymoma"}],["D013953",{"mesh_id":"D013953","trials":[{"ligand":"bosutinib","mesh_id":"D013953","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03023319"},{"ligand":"cetuximab","mesh_id":"D013953","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01025089"},{"ligand":"erlotinib","mesh_id":"D013953","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00369889"},{"ligand":"everolimus","mesh_id":"D013953","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT02049047"},{"ligand":"palbociclib","mesh_id":"D013953","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03219554"},{"ligand":"ramucirumab","mesh_id":"D013953","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03921671"},{"ligand":"regorafenib","mesh_id":"D013953","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02307500"},{"ligand":"ribociclib","mesh_id":"D013953","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02420691"},{"ligand":"selumetinib","mesh_id":"D013953","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01610544"},{"ligand":"sirolimus","mesh_id":"D013953","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT02049047"},{"ligand":"sunitinib","mesh_id":"D013953","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT01621568;NCT03449173"}],"predictions":[{"target":"PDGFRA","probability":"0.48556128553428424"}],"source_name":"Thymus Neoplasms"}],["D004806",{"mesh_id":"D004806","trials":[{"ligand":"brigatinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04374305"},{"ligand":"erdafitinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D004806","phase":"Phase 1","start_date":"2001","completion_date":"2004","nct_id":"NCT00077454;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2007","completion_date":"2016","nct_id":"NCT01247922;NCT02689336;NCT01032070;NCT00602667"},{"ligand":"everolimus","mesh_id":"D004806","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03387020"},{"ligand":"everolimus","mesh_id":"D004806","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02155920"},{"ligand":"lapatinib","mesh_id":"D004806","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02101905"},{"ligand":"lapatinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00095940;NCT00883688;NCT00826241"},{"ligand":"larotrectinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D004806","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"ribociclib","mesh_id":"D004806","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262;NCT03387020"},{"ligand":"selumetinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03095248;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D004806","phase":"Phase 1","start_date":"2011","completion_date":"2018","nct_id":"NCT01331135;NCT03387020"},{"ligand":"sirolimus","mesh_id":"D004806","phase":"Phase 2","start_date":"2015","completion_date":"2017","nct_id":"NCT02155920;NCT03213678;NCT03155620"},{"ligand":"sunitinib","mesh_id":"D004806","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01462695"},{"ligand":"trametinib","mesh_id":"D004806","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trastuzumab","mesh_id":"D004806","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02774421"},{"ligand":"vemurafenib","mesh_id":"D004806","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[],"source_name":"Ependymoma"}],["D015266",{"mesh_id":"D015266","trials":[{"ligand":"cabozantinib","mesh_id":"D015266","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02036476"},{"ligand":"everolimus","mesh_id":"D015266","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"imatinib","mesh_id":"D015266","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00068783"},{"ligand":"pertuzumab","mesh_id":"D015266","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"},{"ligand":"sirolimus","mesh_id":"D015266","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D015266","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02514824"},{"ligand":"trastuzumab","mesh_id":"D015266","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04246671"}],"predictions":[],"source_name":"Carcinoma, Merkel Cell"}],["D018278",{"mesh_id":"D018278","trials":[{"ligand":"cabozantinib","mesh_id":"D018278","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02496208;NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D018278","phase":"Phase 2","start_date":"2017","completion_date":"2020","nct_id":"NCT03838692;NCT04524208;NCT04079712;NCT02867592;NCT03866382"},{"ligand":"cabozantinib","mesh_id":"D018278","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT04211337"},{"ligand":"cabozantinib","mesh_id":"D018278","phase":"Phase 4","start_date":"2014","completion_date":"2014","nct_id":"NCT01896479"},{"ligand":"erdafitinib","mesh_id":"D018278","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04754425"},{"ligand":"everolimus","mesh_id":"D018278","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D018278","phase":"Phase 2","start_date":"2005","completion_date":"2016","nct_id":"NCT02687958;NCT00607113;NCT02113800;NCT02248012;NCT02205515;NCT00113360;NCT02695459;NCT01563354;NCT02315625;NCT00363051;NCT01625520"},{"ligand":"imatinib","mesh_id":"D018278","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00068783"},{"ligand":"lenvatinib","mesh_id":"D018278","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03290079"},{"ligand":"nintedanib","mesh_id":"D018278","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01788982"},{"ligand":"palbociclib","mesh_id":"D018278","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02806648"},{"ligand":"pazopanib","mesh_id":"D018278","phase":"Phase 2","start_date":"2007","completion_date":"2008","nct_id":"NCT00625846;NCT00454363"},{"ligand":"pertuzumab","mesh_id":"D018278","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01121939"},{"ligand":"ponatinib","mesh_id":"D018278","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03838692"},{"ligand":"sirolimus","mesh_id":"D018278","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D018278","phase":"Phase 2","start_date":"2003","completion_date":"2016","nct_id":"NCT02687958;NCT01010126;NCT02205515;NCT00093782"},{"ligand":"sorafenib","mesh_id":"D018278","phase":"Phase 2","start_date":"2006","completion_date":"2012","nct_id":"NCT01736878;NCT00390325"},{"ligand":"sunitinib","mesh_id":"D018278","phase":"Phase 2","start_date":"2006","completion_date":"2015","nct_id":"NCT00381641;NCT02230176;NCT02315625"},{"ligand":"vandetanib","mesh_id":"D018278","phase":"Phase 2","start_date":"2006","completion_date":"2019","nct_id":"NCT01661179;NCT03838692;NCT00514046;NCT00358956"},{"ligand":"vandetanib","mesh_id":"D018278","phase":"Phase 3","start_date":"2006","completion_date":"2020","nct_id":"NCT00410761;NCT04211337;NCT01298323"}],"predictions":[{"target":"FGFR1","probability":"0.7059698202263911"},{"target":"INSR","probability":"0.6265415383750984"},{"target":"JAK2","probability":"0.615"},{"target":"BCR","probability":"0.6021497683747771"},{"target":"ERBB4","probability":"0.5945310160900635"},{"target":"IGF1R","probability":"0.5938555676364297"},{"target":"ERBB3","probability":"0.5927380109082808"},{"target":"FGFR3","probability":"0.587303165577506"},{"target":"PIK3CA","probability":"0.5706919022771243"},{"target":"FGFR2","probability":"0.5679196244551195"},{"target":"BRAF","probability":"0.5061212568762506"},{"target":"NTRK3","probability":"0.4913099840970753"}],"source_name":"Carcinoma, Neuroendocrine"}],["D002296",{"mesh_id":"D002296","trials":[{"ligand":"cabozantinib","mesh_id":"D002296","phase":"Phase 2","start_date":"2013","completion_date":"2021","nct_id":"NCT04149275;NCT01935934"},{"ligand":"imatinib","mesh_id":"D002296","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00075400"},{"ligand":"lapatinib","mesh_id":"D002296","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01454479"},{"ligand":"pazopanib","mesh_id":"D002296","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT01247571;NCT02203760"},{"ligand":"ruxolitinib","mesh_id":"D002296","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03120624"},{"ligand":"sirolimus","mesh_id":"D002296","phase":"Phase 2","start_date":"2009","completion_date":"2010","nct_id":"NCT01010126;NCT01061606"},{"ligand":"sorafenib","mesh_id":"D002296","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00245102;NCT00238121"},{"ligand":"sunitinib","mesh_id":"D002296","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00478426"},{"ligand":"trastuzumab","mesh_id":"D002296","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01454479"}],"predictions":[],"source_name":"Carcinosarcoma"}],["D018200",{"mesh_id":"D018200","trials":[{"ligand":"cabozantinib","mesh_id":"D018200","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04149275"},{"ligand":"erlotinib","mesh_id":"D018200","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00520013"},{"ligand":"imatinib","mesh_id":"D018200","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00075400"},{"ligand":"lapatinib","mesh_id":"D018200","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01454479"},{"ligand":"pazopanib","mesh_id":"D018200","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT01247571;NCT02203760"},{"ligand":"sirolimus","mesh_id":"D018200","phase":"Phase 2","start_date":"2009","completion_date":"2010","nct_id":"NCT01010126;NCT01061606"},{"ligand":"sorafenib","mesh_id":"D018200","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00238121"},{"ligand":"sunitinib","mesh_id":"D018200","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00478426"},{"ligand":"trastuzumab","mesh_id":"D018200","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01454479"}],"predictions":[],"source_name":"Mixed Tumor, Mullerian"}],["D018276",{"mesh_id":"D018276","trials":[{"ligand":"cabozantinib","mesh_id":"D018276","phase":"Phase 1","start_date":"2012","completion_date":"2020","nct_id":"NCT02496208;NCT04514484;NCT01709435"},{"ligand":"cabozantinib","mesh_id":"D018276","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02867592;NCT04071223;NCT03866382"},{"ligand":"everolimus","mesh_id":"D018276","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"pazopanib","mesh_id":"D018276","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT01767636;NCT00625846"},{"ligand":"sirolimus","mesh_id":"D018276","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655;NCT01155258"},{"ligand":"sorafenib","mesh_id":"D018276","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00390325"},{"ligand":"sunitinib","mesh_id":"D018276","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00381641;NCT00519896"},{"ligand":"trastuzumab","mesh_id":"D018276","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vandetanib","mesh_id":"D018276","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00358956"}],"predictions":[{"target":"BRAF","probability":"0.505"},{"target":"PIK3CA","probability":"0.46"}],"source_name":"Carcinoma, Medullary"}],["D010412",{"mesh_id":"D010412","trials":[{"ligand":"cabozantinib","mesh_id":"D010412","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02496208"},{"ligand":"cabozantinib","mesh_id":"D010412","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03866382"},{"ligand":"dacomitinib","mesh_id":"D010412","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01728233"}],"predictions":[],"source_name":"Penile Neoplasms"}],["D010386",{"mesh_id":"D010386","trials":[{"ligand":"cabozantinib","mesh_id":"D010386","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02496208"},{"ligand":"erlotinib","mesh_id":"D010386","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00749892"},{"ligand":"everolimus","mesh_id":"D010386","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01182168"},{"ligand":"regorafenib","mesh_id":"D010386","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02459119"},{"ligand":"sorafenib","mesh_id":"D010386","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01844947"},{"ligand":"sunitinib","mesh_id":"D010386","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00437372"}],"predictions":[],"source_name":"Pelvic Neoplasms"}],["D018288",{"mesh_id":"D018288","trials":[{"ligand":"cabozantinib","mesh_id":"D018288","phase":"Phase 1","start_date":"2015","completion_date":"2020","nct_id":"NCT02496208;NCT04514484"},{"ligand":"cabozantinib","mesh_id":"D018288","phase":"Phase 2","start_date":"2019","completion_date":"2020","nct_id":"NCT04079712;NCT03866382"},{"ligand":"cetuximab","mesh_id":"D018288","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00104910"},{"ligand":"erdafitinib","mesh_id":"D018288","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04754425"},{"ligand":"erlotinib","mesh_id":"D018288","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306045"},{"ligand":"lapatinib","mesh_id":"D018288","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306045"},{"ligand":"selumetinib","mesh_id":"D018288","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306045"},{"ligand":"sorafenib","mesh_id":"D018288","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00466232"},{"ligand":"sunitinib","mesh_id":"D018288","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT00453154;NCT01306045"}],"predictions":[{"target":"PDGFRA","probability":"0.7604233709659186"},{"target":"ABL1","probability":"0.6507759867267608"},{"target":"IGF1R","probability":"0.6012053996669181"},{"target":"INSR","probability":"0.5953419247370366"},{"target":"BRAF","probability":"0.5855077330274379"},{"target":"JAK2","probability":"0.5803906951775082"},{"target":"FLT1","probability":"0.5784062824999828"},{"target":"BCR","probability":"0.5564464511804833"},{"target":"PIK3CA","probability":"0.5283562018739073"},{"target":"FGFR1","probability":"0.5227713226181396"},{"target":"FGFR3","probability":"0.5220022406881627"},{"target":"ERBB3","probability":"0.5143900400215443"},{"target":"ERBB4","probability":"0.4585731869371296"}],"source_name":"Carcinoma, Small Cell"}],["D012514",{"mesh_id":"D012514","trials":[{"ligand":"cabozantinib","mesh_id":"D012514","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04514484"},{"ligand":"everolimus","mesh_id":"D012514","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01412515"},{"ligand":"imatinib","mesh_id":"D012514","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00090987"},{"ligand":"selumetinib","mesh_id":"D012514","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01752569"},{"ligand":"sirolimus","mesh_id":"D012514","phase":"Phase 1","start_date":"2007","completion_date":"2020","nct_id":"NCT00450320;NCT04409691"},{"ligand":"sirolimus","mesh_id":"D012514","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT01412515;NCT02110069;NCT03188068"},{"ligand":"sirolimus","mesh_id":"D012514","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04775173"},{"ligand":"sirolimus","mesh_id":"D012514","phase":"Phase 4","start_date":"2019","completion_date":"2020","nct_id":"NCT04077515;NCT04448873"},{"ligand":"sorafenib","mesh_id":"D012514","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00287495"},{"ligand":"sunitinib","mesh_id":"D012514","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00521092"}],"predictions":[{"target":"PDGFRA","probability":"0.5850306184935701"},{"target":"FGFR3","probability":"0.5651249581162117"},{"target":"IGF1R","probability":"0.5237747464178082"},{"target":"PIK3CA","probability":"0.5152547739146099"},{"target":"INSR","probability":"0.5076236263736263"},{"target":"EGFR","probability":"0.49"},{"target":"ERBB2","probability":"0.48"},{"target":"FLT1","probability":"0.4750836820083682"},{"target":"ERBB3","probability":"0.4703968878374581"},{"target":"BCR","probability":"0.460151401016939"},{"target":"JAK2","probability":"0.46013688794784846"}],"source_name":"Sarcoma, Kaposi"}],["D007890",{"mesh_id":"D007890","trials":[{"ligand":"cabozantinib","mesh_id":"D007890","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04200443"},{"ligand":"cetuximab","mesh_id":"D007890","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D007890","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"everolimus","mesh_id":"D007890","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03114527"},{"ligand":"imatinib","mesh_id":"D007890","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00400569"},{"ligand":"lenvatinib","mesh_id":"D007890","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03526679"},{"ligand":"nilotinib","mesh_id":"D007890","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT02587169"},{"ligand":"olaratumab","mesh_id":"D007890","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03437070"},{"ligand":"olaratumab","mesh_id":"D007890","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D007890","phase":"Phase 2","start_date":"2011","completion_date":"2019","nct_id":"NCT01418001;NCT02203760;NCT02601209;NCT01532687;NCT02378142;NCT01442662"},{"ligand":"pazopanib","mesh_id":"D007890","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ribociclib","mesh_id":"D007890","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"ribociclib","mesh_id":"D007890","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03114527"},{"ligand":"sirolimus","mesh_id":"D007890","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT01614795;NCT00093080;NCT03114527"},{"ligand":"sorafenib","mesh_id":"D007890","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT00245102;NCT00837148"},{"ligand":"sunitinib","mesh_id":"D007890","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00378911;NCT00400569"}],"predictions":[],"source_name":"Leiomyosarcoma"}],["D000077273",{"mesh_id":"D000077273","trials":[{"ligand":"cabozantinib","mesh_id":"D000077273","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01100619"},{"ligand":"cabozantinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03914300;NCT01811212;NCT03630120"},{"ligand":"copanlisib","mesh_id":"D000077273","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04462471"},{"ligand":"crizotinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"dabrafenib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01723202;NCT04544111"},{"ligand":"entrectinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02568267"},{"ligand":"imatinib","mesh_id":"D000077273","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03469011"},{"ligand":"lenvatinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03914300;NCT03630120;NCT03506048;NCT02973997"},{"ligand":"pazopanib","mesh_id":"D000077273","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01413113"},{"ligand":"selumetinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00559949;NCT02393690"},{"ligand":"sorafenib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT01502410;NCT03914300;NCT00095693;NCT03630120;NCT00887107"},{"ligand":"sunitinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2006","completion_date":"2008","nct_id":"NCT00381641;NCT00668811;NCT00519896"},{"ligand":"trametinib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01723202;NCT04544111;NCT02152995"},{"ligand":"trastuzumab","mesh_id":"D000077273","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vandetanib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03630120"},{"ligand":"vemurafenib","mesh_id":"D000077273","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04462471"},{"ligand":"vemurafenib","mesh_id":"D000077273","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01286753"}],"predictions":[{"target":"ERBB3","probability":"0.5803078567096358"},{"target":"FGFR1","probability":"0.5652361565388112"},{"target":"JAK2","probability":"0.5601228070175438"},{"target":"TEK","probability":"0.5451946720521582"},{"target":"BCR","probability":"0.5151745795836464"},{"target":"IGF1R","probability":"0.5006656202696053"},{"target":"ERBB4","probability":"0.47079905124059074"},{"target":"MAP2K7","probability":"0.4622277602874522"},{"target":"INSR","probability":"0.46024558181007746"}],"source_name":"Thyroid Cancer, Papillary"}],["D018263",{"mesh_id":"D018263","trials":[{"ligand":"cabozantinib","mesh_id":"D018263","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01100619"},{"ligand":"cabozantinib","mesh_id":"D018263","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03914300;NCT01811212;NCT03630120"},{"ligand":"dabrafenib","mesh_id":"D018263","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01723202;NCT04544111"},{"ligand":"lenvatinib","mesh_id":"D018263","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03914300;NCT03630120;NCT03506048;NCT02973997"},{"ligand":"pazopanib","mesh_id":"D018263","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01413113"},{"ligand":"selumetinib","mesh_id":"D018263","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02393690"},{"ligand":"sorafenib","mesh_id":"D018263","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT03914300;NCT00095693;NCT03630120"},{"ligand":"sunitinib","mesh_id":"D018263","phase":"Phase 2","start_date":"2006","completion_date":"2008","nct_id":"NCT00381641;NCT00668811;NCT00519896"},{"ligand":"trametinib","mesh_id":"D018263","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01723202;NCT04544111;NCT02152995"},{"ligand":"trastuzumab","mesh_id":"D018263","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vandetanib","mesh_id":"D018263","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03630120"}],"predictions":[],"source_name":"Adenocarcinoma, Follicular"}],["D007516",{"mesh_id":"D007516","trials":[{"ligand":"cabozantinib","mesh_id":"D007516","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03375320"},{"ligand":"everolimus","mesh_id":"D007516","phase":"Phase 2","start_date":"2008","completion_date":"2017","nct_id":"NCT00576680;NCT01628913;NCT01374451;NCT01229943;NCT02713763;NCT02305810"},{"ligand":"everolimus","mesh_id":"D007516","phase":"Phase 4","start_date":"2016","completion_date":"2016","nct_id":"NCT02842749"},{"ligand":"ribociclib","mesh_id":"D007516","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02420691"},{"ligand":"sirolimus","mesh_id":"D007516","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT01229943;NCT01658436;NCT02305810"},{"ligand":"sunitinib","mesh_id":"D007516","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01381822"},{"ligand":"sunitinib","mesh_id":"D007516","phase":"Phase 2","start_date":"2006","completion_date":"2017","nct_id":"NCT01121562;NCT00434109;NCT02713763"},{"ligand":"sunitinib","mesh_id":"D007516","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00428597"},{"ligand":"sunitinib","mesh_id":"D007516","phase":"Phase 4","start_date":"2012","completion_date":"2012","nct_id":"NCT01525550"}],"predictions":[{"target":"BRAF","probability":"0.825"},{"target":"PDGFRA","probability":"0.775"},{"target":"PIK3CA","probability":"0.75"},{"target":"JAK2","probability":"0.72"},{"target":"ALK","probability":"0.7"},{"target":"MAP2K7","probability":"0.7"},{"target":"AKT1","probability":"0.665"},{"target":"ABL1","probability":"0.645"},{"target":"BCR","probability":"0.63"},{"target":"ERBB2","probability":"0.545"},{"target":"FGFR1","probability":"0.53"},{"target":"PIK3CD","probability":"0.525"},{"target":"BTK","probability":"0.475024154589372"},{"target":"MAPK1","probability":"0.46"}],"source_name":"Adenoma, Islet Cell"}],["D009396",{"mesh_id":"D009396","trials":[{"ligand":"cabozantinib","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"cetuximab","mesh_id":"D009396","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"erdafitinib","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"erlotinib","mesh_id":"D009396","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02689336"},{"ligand":"larotrectinib","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"pazopanib","mesh_id":"D009396","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01130623"},{"ligand":"selumetinib","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D009396","phase":"Phase 1","start_date":"2011","completion_date":"2012","nct_id":"NCT01331135;NCT01625351"},{"ligand":"sirolimus","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213678;NCT03155620"},{"ligand":"sorafenib","mesh_id":"D009396","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01502410"},{"ligand":"trastuzumab","mesh_id":"D009396","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D009396","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452554"},{"ligand":"vemurafenib","mesh_id":"D009396","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[],"source_name":"Wilms Tumor"}],["D018197",{"mesh_id":"D018197","trials":[{"ligand":"cabozantinib","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"cetuximab","mesh_id":"D018197","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"erdafitinib","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"larotrectinib","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"selumetinib","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D018197","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01331135"},{"ligand":"sirolimus","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213678;NCT03155620"},{"ligand":"sirolimus","mesh_id":"D018197","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00980460"},{"ligand":"sorafenib","mesh_id":"D018197","phase":"Phase 3","start_date":"2017","completion_date":"2018","nct_id":"NCT03017326;NCT03533582"},{"ligand":"trastuzumab","mesh_id":"D018197","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"vemurafenib","mesh_id":"D018197","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"IGF1R","probability":"0.56"},{"target":"PDGFRB","probability":"0.5433333333333333"},{"target":"ERBB3","probability":"0.5185876582728696"},{"target":"FLT1","probability":"0.5164612624127422"},{"target":"PDGFRA","probability":"0.5127616858237548"},{"target":"PIK3CA","probability":"0.4735255639097744"}],"source_name":"Hepatoblastoma"}],["D018227",{"mesh_id":"D018227","trials":[{"ligand":"cabozantinib","mesh_id":"D018227","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02867592"},{"ligand":"cetuximab","mesh_id":"D018227","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"cobimetinib","mesh_id":"D018227","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02968303"},{"ligand":"crizotinib","mesh_id":"D018227","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01524926"},{"ligand":"dabrafenib","mesh_id":"D018227","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02968303"},{"ligand":"pazopanib","mesh_id":"D018227","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"sirolimus","mesh_id":"D018227","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01331135"},{"ligand":"sunitinib","mesh_id":"D018227","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01061411"},{"ligand":"trametinib","mesh_id":"D018227","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02968303"},{"ligand":"trastuzumab","mesh_id":"D018227","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"vemurafenib","mesh_id":"D018227","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02968303"}],"predictions":[],"source_name":"Sarcoma, Clear Cell"}],["D002291",{"mesh_id":"D002291","trials":[{"ligand":"cabozantinib","mesh_id":"D002291","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03914300;NCT01811212"},{"ligand":"lenvatinib","mesh_id":"D002291","phase":"Phase 2","start_date":"2018","completion_date":"2019","nct_id":"NCT03914300;NCT03506048;NCT02973997"},{"ligand":"selumetinib","mesh_id":"D002291","phase":"Phase 2","start_date":"2007","completion_date":"2015","nct_id":"NCT00559949;NCT02393690"},{"ligand":"sorafenib","mesh_id":"D002291","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03914300"},{"ligand":"sunitinib","mesh_id":"D002291","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00381641"},{"ligand":"trametinib","mesh_id":"D002291","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02152995"}],"predictions":[],"source_name":"Carcinoma, Papillary"}],["D018262",{"mesh_id":"D018262","trials":[{"ligand":"cabozantinib","mesh_id":"D018262","phase":"Phase 2","start_date":"2013","completion_date":"2019","nct_id":"NCT03866382;NCT02315430;NCT01935934"},{"ligand":"dasatinib","mesh_id":"D018262","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01440998"},{"ligand":"dasatinib","mesh_id":"D018262","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02059265"},{"ligand":"lenvatinib","mesh_id":"D018262","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04699071"},{"ligand":"nintedanib","mesh_id":"D018262","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT02866370;NCT01225887"},{"ligand":"ruxolitinib","mesh_id":"D018262","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03120624"},{"ligand":"ruxolitinib","mesh_id":"D018262","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"selumetinib","mesh_id":"D018262","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01011933"},{"ligand":"sirolimus","mesh_id":"D018262","phase":"Phase 1","start_date":"2012","completion_date":"2014","nct_id":"NCT02142803;NCT01625351"},{"ligand":"sirolimus","mesh_id":"D018262","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00977574;NCT00072176"},{"ligand":"sunitinib","mesh_id":"D018262","phase":"Phase 2","start_date":"2010","completion_date":"2013","nct_id":"NCT00979992;NCT01824615"},{"ligand":"trametinib","mesh_id":"D018262","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01935973"}],"predictions":[],"source_name":"Adenocarcinoma, Clear Cell"}],["D007984",{"mesh_id":"D007984","trials":[{"ligand":"cabozantinib","mesh_id":"D007984","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03866382"}],"predictions":[],"source_name":"Leydig Cell Tumor"}],["D012707",{"mesh_id":"D012707","trials":[{"ligand":"cabozantinib","mesh_id":"D012707","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03866382"}],"predictions":[],"source_name":"Sertoli Cell Tumor"}],["D018196",{"mesh_id":"D018196","trials":[{"ligand":"cabozantinib","mesh_id":"D018196","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01935934"},{"ligand":"cetuximab","mesh_id":"D018196","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00104910"},{"ligand":"cetuximab","mesh_id":"D018196","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00570674"},{"ligand":"erlotinib","mesh_id":"D018196","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00126581"},{"ligand":"erlotinib","mesh_id":"D018196","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00673049"},{"ligand":"selumetinib","mesh_id":"D018196","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01011933"},{"ligand":"sirolimus","mesh_id":"D018196","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00977574;NCT00072176;NCT01026792"},{"ligand":"sunitinib","mesh_id":"D018196","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00389974"}],"predictions":[],"source_name":"Carcinoma, Adenosquamous"}],["D004701",{"mesh_id":"D004701","trials":[{"ligand":"cabozantinib","mesh_id":"D004701","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04400474"},{"ligand":"cetuximab","mesh_id":"D004701","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"erlotinib","mesh_id":"D004701","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"everolimus","mesh_id":"D004701","phase":"Phase 2","start_date":"2009","completion_date":"2019","nct_id":"NCT00688623;NCT01678664;NCT01149434;NCT03950609;NCT02294006"},{"ligand":"lenvatinib","mesh_id":"D004701","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"pazopanib","mesh_id":"D004701","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"pertuzumab","mesh_id":"D004701","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"sirolimus","mesh_id":"D004701","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"sirolimus","mesh_id":"D004701","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01149434;NCT03950609;NCT02294006"},{"ligand":"sorafenib","mesh_id":"D004701","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00390325"},{"ligand":"sunitinib","mesh_id":"D004701","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01215578"},{"ligand":"vandetanib","mesh_id":"D004701","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00514046"}],"predictions":[],"source_name":"Endocrine Gland Neoplasms"}],["D018285",{"mesh_id":"D018285","trials":[{"ligand":"ceritinib","mesh_id":"D018285","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02374489"},{"ligand":"erlotinib","mesh_id":"D018285","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01093222"},{"ligand":"sorafenib","mesh_id":"D018285","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01093222"},{"ligand":"trametinib","mesh_id":"D018285","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02042443"}],"predictions":[{"target":"KIT","probability":"0.61525"},{"target":"ERBB2","probability":"0.48009278350515466"},{"target":"PDGFRB","probability":"0.4772497538209572"}],"source_name":"Klatskin Tumor"}],["D007822",{"mesh_id":"D007822","trials":[{"ligand":"cetuximab","mesh_id":"D007822","phase":"Phase 1","start_date":"2007","completion_date":"2014","nct_id":"NCT00906360;NCT01334177;NCT01445405;NCT00397384;NCT01637194;NCT02229656"},{"ligand":"cetuximab","mesh_id":"D007822","phase":"Phase 2","start_date":"2005","completion_date":"2017","nct_id":"NCT00462735;NCT00169247;NCT01245985;NCT01884259;NCT00939627;NCT01816984;NCT00599131;NCT01435252;NCT00101348;NCT03082534;NCT00941135;NCT01316757;NCT01216020;NCT00765011"},{"ligand":"cetuximab","mesh_id":"D007822","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03258554"},{"ligand":"dasatinib","mesh_id":"D007822","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"erlotinib","mesh_id":"D007822","phase":"Phase 1","start_date":"2001","completion_date":"2011","nct_id":"NCT00049283;NCT00397384;NCT01332279;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D007822","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00410826;NCT00055913;NCT01192815;NCT00101348;NCT01316757;NCT00970502;NCT00063895;NCT00055770"},{"ligand":"everolimus","mesh_id":"D007822","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"gefitinib","mesh_id":"D007822","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00033449"},{"ligand":"lapatinib","mesh_id":"D007822","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00114283;NCT00098631;NCT01044433"},{"ligand":"sirolimus","mesh_id":"D007822","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"sorafenib","mesh_id":"D007822","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D007822","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D007822","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D007822","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387335"},{"ligand":"trastuzumab","mesh_id":"D007822","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"ERBB3","probability":"0.745"},{"target":"MET","probability":"0.6655555555555556"},{"target":"FLT1","probability":"0.6365010351966874"},{"target":"FGFR3","probability":"0.6353734567901235"},{"target":"CDK6","probability":"0.61"},{"target":"PDGFRA","probability":"0.61"},{"target":"CDK4","probability":"0.6"},{"target":"FGFR2","probability":"0.5650927835051547"},{"target":"NTRK1","probability":"0.5641653382334224"},{"target":"IGF1R","probability":"0.5623333333333334"},{"target":"PIK3CA","probability":"0.5601234567901234"},{"target":"ERBB4","probability":"0.5451991141477015"},{"target":"JAK2","probability":"0.530122699386503"},{"target":"ALK","probability":"0.5261183360031547"},{"target":"FGFR1","probability":"0.5254484173079715"},{"target":"INSR","probability":"0.5251234567901235"},{"target":"FLT4","probability":"0.5150183598531212"},{"target":"ABL1","probability":"0.51"},{"target":"BRAF","probability":"0.505"},{"target":"AKT1","probability":"0.505"},{"target":"BCR","probability":"0.5001056338028169"},{"target":"RET","probability":"0.49102282690923665"},{"target":"TEK","probability":"0.4764285714285715"},{"target":"CDK2","probability":"0.46071120689655176"},{"target":"MAP2K7","probability":"0.46054184808901794"},{"target":"AXL","probability":"0.46022936209528764"},{"target":"CDKN1A","probability":"0.455"}],"source_name":"Laryngeal Neoplasms"}],["D010610",{"mesh_id":"D010610","trials":[{"ligand":"cetuximab","mesh_id":"D010610","phase":"Phase 1","start_date":"2008","completion_date":"2012","nct_id":"NCT01552434;NCT01445405"},{"ligand":"cetuximab","mesh_id":"D010610","phase":"Phase 2","start_date":"2007","completion_date":"2017","nct_id":"NCT00462735;NCT03067610;NCT01216020"},{"ligand":"erlotinib","mesh_id":"D010610","phase":"Phase 1","start_date":"2005","completion_date":"2005","nct_id":"NCT00140556"},{"ligand":"erlotinib","mesh_id":"D010610","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00970502"},{"ligand":"sirolimus","mesh_id":"D010610","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"}],"predictions":[{"target":"KIT","probability":"0.465"}],"source_name":"Pharyngeal Neoplasms"}],["D010255",{"mesh_id":"D010255","trials":[{"ligand":"cetuximab","mesh_id":"D010255","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D010255","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00462735;NCT00939627;NCT01816984;NCT00101348;NCT01316757"},{"ligand":"dasatinib","mesh_id":"D010255","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"erlotinib","mesh_id":"D010255","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D010255","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT00055913;NCT00101348;NCT01316757;NCT00970502;NCT00055770"},{"ligand":"everolimus","mesh_id":"D010255","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"lapatinib","mesh_id":"D010255","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00114283;NCT00098631;NCT01044433"},{"ligand":"sirolimus","mesh_id":"D010255","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"sorafenib","mesh_id":"D010255","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D010255","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D010255","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"sunitinib","mesh_id":"D010255","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387335"}],"predictions":[],"source_name":"Paranasal Sinus Neoplasms"}],["D009669",{"mesh_id":"D009669","trials":[{"ligand":"cetuximab","mesh_id":"D009669","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00462735"}],"predictions":[],"source_name":"Nose Neoplasms"}],["D018289",{"mesh_id":"D018289","trials":[{"ligand":"cetuximab","mesh_id":"D018289","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384;NCT01637194;NCT01254617"},{"ligand":"cetuximab","mesh_id":"D018289","phase":"Phase 2","start_date":"2005","completion_date":"2013","nct_id":"NCT00939627;NCT01816984;NCT01256385;NCT00101348;NCT01316757"},{"ligand":"dasatinib","mesh_id":"D018289","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"erlotinib","mesh_id":"D018289","phase":"Phase 1","start_date":"2001","completion_date":"2011","nct_id":"NCT00049283;NCT00397384;NCT01332279;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D018289","phase":"Phase 2","start_date":"2005","completion_date":"2011","nct_id":"NCT01192815;NCT00101348;NCT01316757"},{"ligand":"everolimus","mesh_id":"D018289","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"lapatinib","mesh_id":"D018289","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT00114283;NCT01044433"},{"ligand":"sirolimus","mesh_id":"D018289","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"sirolimus","mesh_id":"D018289","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01256385"},{"ligand":"sorafenib","mesh_id":"D018289","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D018289","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D018289","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"},{"ligand":"vandetanib","mesh_id":"D018289","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01414426"}],"predictions":[],"source_name":"Carcinoma, Verrucous"}],["D014062",{"mesh_id":"D014062","trials":[{"ligand":"cetuximab","mesh_id":"D014062","phase":"Phase 1","start_date":"2007","completion_date":"2011","nct_id":"NCT00906360;NCT01334177;NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D014062","phase":"Phase 2","start_date":"2009","completion_date":"2013","nct_id":"NCT00939627;NCT01816984;NCT01316757"},{"ligand":"dasatinib","mesh_id":"D014062","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00507767"},{"ligand":"erlotinib","mesh_id":"D014062","phase":"Phase 1","start_date":"2002","completion_date":"2011","nct_id":"NCT00049283;NCT00397384;NCT01332279"},{"ligand":"erlotinib","mesh_id":"D014062","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01316757;NCT02748707"},{"ligand":"everolimus","mesh_id":"D014062","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"lapatinib","mesh_id":"D014062","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00114283"},{"ligand":"sirolimus","mesh_id":"D014062","phase":"Phase 1","start_date":"2008","completion_date":"2011","nct_id":"NCT01637194;NCT01332279"},{"ligand":"sirolimus","mesh_id":"D014062","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01195922"},{"ligand":"sorafenib","mesh_id":"D014062","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02035527"},{"ligand":"sorafenib","mesh_id":"D014062","phase":"Phase 2","start_date":"2004","completion_date":"2009","nct_id":"NCT00939627;NCT00096512"},{"ligand":"sunitinib","mesh_id":"D014062","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00906360"}],"predictions":[{"target":"MET","probability":"0.48534246575342466"},{"target":"ERBB3","probability":"0.48103163787839326"},{"target":"NTRK1","probability":"0.4754779718394915"},{"target":"PDGFRA","probability":"0.4752819158540989"}],"source_name":"Tongue Neoplasms"}],["D000236",{"mesh_id":"D000236","trials":[{"ligand":"cetuximab","mesh_id":"D000236","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"},{"ligand":"gefitinib","mesh_id":"D000236","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02484755"},{"ligand":"lapatinib","mesh_id":"D000236","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00939523"},{"ligand":"panitumumab","mesh_id":"D000236","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"},{"ligand":"sirolimus","mesh_id":"D000236","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01010126"},{"ligand":"sorafenib","mesh_id":"D000236","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306058"}],"predictions":[{"target":"KIT","probability":"0.6400142993326977"},{"target":"PDGFRB","probability":"0.585"},{"target":"JAK2","probability":"0.5507689860210995"},{"target":"PIK3CA","probability":"0.5455339874247453"},{"target":"ABL1","probability":"0.5404314339100056"},{"target":"PDGFRA","probability":"0.5308313061189502"},{"target":"IGF1R","probability":"0.525800435453353"},{"target":"INSR","probability":"0.4653232266243367"},{"target":"BCR","probability":"0.46085110676961344"},{"target":"FGFR3","probability":"0.4553729125879855"}],"source_name":"Adenoma"}],["D008949",{"mesh_id":"D008949","trials":[{"ligand":"cetuximab","mesh_id":"D008949","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"},{"ligand":"panitumumab","mesh_id":"D008949","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"}],"predictions":[],"source_name":"Adenoma, Pleomorphic"}],["D018252",{"mesh_id":"D018252","trials":[{"ligand":"cetuximab","mesh_id":"D018252","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"},{"ligand":"panitumumab","mesh_id":"D018252","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT00984217"}],"predictions":[],"source_name":"Syringoma"}],["D001005",{"mesh_id":"D001005","trials":[{"ligand":"cetuximab","mesh_id":"D001005","phase":"Phase 1","start_date":"2007","completion_date":"2012","nct_id":"NCT01621217;NCT00397384"},{"ligand":"cetuximab","mesh_id":"D001005","phase":"Phase 2","start_date":"2006","completion_date":"2018","nct_id":"NCT00324415;NCT03944252;NCT00316888;NCT03381352;NCT00955240"},{"ligand":"erlotinib","mesh_id":"D001005","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"panitumumab","mesh_id":"D001005","phase":"Phase 2","start_date":"2010","completion_date":"2012","nct_id":"NCT01285778;NCT01581840"},{"ligand":"trastuzumab","mesh_id":"D001005","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"KIT","probability":"0.5101762820512821"}],"source_name":"Anus Neoplasms"}],["D010212",{"mesh_id":"D010212","trials":[{"ligand":"cetuximab","mesh_id":"D010212","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D010212","phase":"Phase 2","start_date":"2005","completion_date":"2011","nct_id":"NCT01221753;NCT00101348"},{"ligand":"erlotinib","mesh_id":"D010212","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D010212","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"everolimus","mesh_id":"D010212","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"lenvatinib","mesh_id":"D010212","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04645602"},{"ligand":"panitumumab","mesh_id":"D010212","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01221753"},{"ligand":"sirolimus","mesh_id":"D010212","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"}],"predictions":[{"target":"PIK3CA","probability":"0.475216228909907"},{"target":"PDGFRB","probability":"0.46836988218751885"}],"source_name":"Papilloma"}],["D011230",{"mesh_id":"D011230","trials":[{"ligand":"cetuximab","mesh_id":"D011230","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00477880"},{"ligand":"cetuximab","mesh_id":"D011230","phase":"Phase 2","start_date":"2007","completion_date":"2010","nct_id":"NCT00524017;NCT01084083"},{"ligand":"cetuximab","mesh_id":"D011230","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01302834"},{"ligand":"erlotinib","mesh_id":"D011230","phase":"Phase 1","start_date":"2007","completion_date":"2010","nct_id":"NCT00566800;NCT01013831;NCT01116336"},{"ligand":"erlotinib","mesh_id":"D011230","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00314262"},{"ligand":"ruxolitinib","mesh_id":"D011230","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02928978"},{"ligand":"sirolimus","mesh_id":"D011230","phase":"Phase 2","start_date":"2001","completion_date":"2007","nct_id":"NCT00544115;NCT00589563"},{"ligand":"vandetanib","mesh_id":"D011230","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01414426"}],"predictions":[{"target":"ERBB3","probability":"0.5086142322097378"},{"target":"ERBB2","probability":"0.49"},{"target":"PDGFRB","probability":"0.46"},{"target":"KDR","probability":"0.45515723270440256"}],"source_name":"Precancerous Conditions"}],["D010534",{"mesh_id":"D010534","trials":[{"ligand":"cetuximab","mesh_id":"D010534","phase":"Phase 2","start_date":"2003","completion_date":"2010","nct_id":"NCT01540344;NCT00766142;NCT00063401"},{"ligand":"erlotinib","mesh_id":"D010534","phase":"Phase 2","start_date":"2005","completion_date":"2007","nct_id":"NCT00126542;NCT00520013"},{"ligand":"gefitinib","mesh_id":"D010534","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00317772"},{"ligand":"nintedanib","mesh_id":"D010534","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01314105"},{"ligand":"nintedanib","mesh_id":"D010534","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01015118"},{"ligand":"palbociclib","mesh_id":"D010534","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04498520"},{"ligand":"ruxolitinib","mesh_id":"D010534","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02713386"},{"ligand":"sirolimus","mesh_id":"D010534","phase":"Phase 1","start_date":"2012","completion_date":"2017","nct_id":"NCT02142803;NCT02833506;NCT01536054"},{"ligand":"sirolimus","mesh_id":"D010534","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01010126"},{"ligand":"sorafenib","mesh_id":"D010534","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00436215"},{"ligand":"sunitinib","mesh_id":"D010534","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00388037"},{"ligand":"tivozanib","mesh_id":"D010534","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01853644"},{"ligand":"trastuzumab","mesh_id":"D010534","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01384253"},{"ligand":"trastuzumab","mesh_id":"D010534","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02158988"},{"ligand":"vandetanib","mesh_id":"D010534","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00445549"}],"predictions":[{"target":"PDGFRA","probability":"0.48606774692863625"},{"target":"PIK3CA","probability":"0.4720194116353025"},{"target":"BRAF","probability":"0.46747299352564836"}],"source_name":"Peritoneal Neoplasms"}],["D018192",{"mesh_id":"D018192","trials":[{"ligand":"cetuximab","mesh_id":"D018192","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"everolimus","mesh_id":"D018192","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT04388371"},{"ligand":"everolimus","mesh_id":"D018192","phase":"Phase 2","start_date":"2005","completion_date":"2018","nct_id":"NCT01059318;NCT03131999;NCT02061397;NCT02484664;NCT00792766;NCT00457964"},{"ligand":"everolimus","mesh_id":"D018192","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00790400"},{"ligand":"imatinib","mesh_id":"D018192","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03131999"},{"ligand":"nintedanib","mesh_id":"D018192","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT03062943"},{"ligand":"sirolimus","mesh_id":"D018192","phase":"Phase 1","start_date":"2012","completion_date":"2019","nct_id":"NCT01552434;NCT04388371;NCT01687179"},{"ligand":"sirolimus","mesh_id":"D018192","phase":"Phase 2","start_date":"2002","completion_date":"2018","nct_id":"NCT00490789;NCT01059318;NCT03131999;NCT00457808;NCT03253913;NCT02061397;NCT02484664;NCT00457964"},{"ligand":"sirolimus","mesh_id":"D018192","phase":"Phase 3","start_date":"2006","completion_date":"2018","nct_id":"NCT00414648;NCT03150914;NCT00790400"}],"predictions":[],"source_name":"Lymphangioleiomyomatosis"}],["D012142",{"mesh_id":"D012142","trials":[{"ligand":"cetuximab","mesh_id":"D012142","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"gefitinib","mesh_id":"D012142","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01039948"},{"ligand":"sirolimus","mesh_id":"D012142","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"}],"predictions":[{"target":"KIT","probability":"0.575"},{"target":"KDR","probability":"0.4862326243979707"}],"source_name":"Respiratory Tract Neoplasms"}],["D005834",{"mesh_id":"D005834","trials":[{"ligand":"cetuximab","mesh_id":"D005834","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"imatinib","mesh_id":"D005834","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT01316458"},{"ligand":"lenvatinib","mesh_id":"D005834","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"},{"ligand":"selumetinib","mesh_id":"D005834","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03162627"},{"ligand":"sirolimus","mesh_id":"D005834","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"}],"predictions":[],"source_name":"Genital Neoplasms, Male"}],["D018301",{"mesh_id":"D018301","trials":[{"ligand":"cetuximab","mesh_id":"D018301","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"},{"ligand":"sirolimus","mesh_id":"D018301","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01552434"}],"predictions":[],"source_name":"Neoplasms, Mesothelial"}],["D020295",{"mesh_id":"D020295","trials":[{"ligand":"cetuximab","mesh_id":"D020295","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01012609"},{"ligand":"dasatinib","mesh_id":"D020295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03352427"},{"ligand":"everolimus","mesh_id":"D020295","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03352427"},{"ligand":"sirolimus","mesh_id":"D020295","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01182883"}],"predictions":[{"target":"KIT","probability":"0.4658690943721466"}],"source_name":"Brain Stem Neoplasms"}],["D002280",{"mesh_id":"D002280","trials":[{"ligand":"cetuximab","mesh_id":"D002280","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D002280","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"erlotinib","mesh_id":"D002280","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D002280","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"everolimus","mesh_id":"D002280","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"sirolimus","mesh_id":"D002280","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"}],"predictions":[],"source_name":"Carcinoma, Basal Cell"}],["D018277",{"mesh_id":"D018277","trials":[{"ligand":"cetuximab","mesh_id":"D018277","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D018277","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"erlotinib","mesh_id":"D018277","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D018277","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"everolimus","mesh_id":"D018277","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"lapatinib","mesh_id":"D018277","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095563"},{"ligand":"sirolimus","mesh_id":"D018277","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"trastuzumab","mesh_id":"D018277","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"trastuzumab","mesh_id":"D018277","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00126607"}],"predictions":[],"source_name":"Carcinoma, Mucoepidermoid"}],["D018304",{"mesh_id":"D018304","trials":[{"ligand":"cetuximab","mesh_id":"D018304","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D018304","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"erlotinib","mesh_id":"D018304","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D018304","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"everolimus","mesh_id":"D018304","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"sirolimus","mesh_id":"D018304","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"}],"predictions":[],"source_name":"Esthesioneuroblastoma, Olfactory"}],["D018308",{"mesh_id":"D018308","trials":[{"ligand":"cetuximab","mesh_id":"D018308","phase":"Phase 1","start_date":"2007","completion_date":"2008","nct_id":"NCT00397384;NCT01637194"},{"ligand":"cetuximab","mesh_id":"D018308","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"erlotinib","mesh_id":"D018308","phase":"Phase 1","start_date":"2001","completion_date":"2007","nct_id":"NCT00397384;NCT00030498"},{"ligand":"erlotinib","mesh_id":"D018308","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00101348"},{"ligand":"everolimus","mesh_id":"D018308","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"},{"ligand":"sirolimus","mesh_id":"D018308","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT01637194"}],"predictions":[],"source_name":"Papilloma, Inverted"}],["D008303",{"mesh_id":"D008303","trials":[{"ligand":"cetuximab","mesh_id":"D008303","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"erlotinib","mesh_id":"D008303","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00397384"},{"ligand":"everolimus","mesh_id":"D008303","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D008303","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00412061"},{"ligand":"gefitinib","mesh_id":"D008303","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"panitumumab","mesh_id":"D008303","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01172717"},{"ligand":"pazopanib","mesh_id":"D008303","phase":"Phase 2","start_date":"2007","completion_date":"2013","nct_id":"NCT00454363;NCT01841736"},{"ligand":"regorafenib","mesh_id":"D008303","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D008303","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D008303","phase":"Phase 2","start_date":"2003","completion_date":"2009","nct_id":"NCT01010126;NCT00093782"},{"ligand":"sorafenib","mesh_id":"D008303","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"trastuzumab","mesh_id":"D008303","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Malignant Carcinoid Syndrome"}],["D007012",{"mesh_id":"D007012","trials":[{"ligand":"cetuximab","mesh_id":"D007012","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01435252"}],"predictions":[{"target":"KDR","probability":"0.605"},{"target":"ERBB2","probability":"0.5907177835051547"},{"target":"KIT","probability":"0.5654548672186709"},{"target":"PDGFRB","probability":"0.5651056338028169"},{"target":"ERBB3","probability":"0.5550862068965517"},{"target":"IGF1R","probability":"0.49545562462229137"},{"target":"FLT3","probability":"0.47031307895203184"},{"target":"CDK6","probability":"0.4606485552126714"}],"source_name":"Hypopharyngeal Neoplasms"}],["D016066",{"mesh_id":"D016066","trials":[{"ligand":"cetuximab","mesh_id":"D016066","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00118183"},{"ligand":"erlotinib","mesh_id":"D016066","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00126581"},{"ligand":"imatinib","mesh_id":"D016066","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00408460"},{"ligand":"trastuzumab","mesh_id":"D016066","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"FLT3","probability":"0.4858438892798499"},{"target":"MTOR","probability":"0.4554265099832994"}],"source_name":"Pleural Effusion, Malignant"}],["D009157",{"mesh_id":"D009157","trials":[{"ligand":"cetuximab","mesh_id":"D009157","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00294658"},{"ligand":"tofacitinib","mesh_id":"D009157","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04431895"}],"predictions":[{"target":"PIK3CA","probability":"0.46786708500469715"},{"target":"KIT","probability":"0.45569877578331386"}],"source_name":"Myasthenia Gravis"}],["D009360",{"mesh_id":"D009360","trials":[{"ligand":"cetuximab","mesh_id":"D009360","phase":"Phase 2","start_date":"2012","completion_date":"2021","nct_id":"NCT04648189;NCT01640444"},{"ligand":"everolimus","mesh_id":"D009360","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02035813"},{"ligand":"lapatinib","mesh_id":"D009360","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00820924"},{"ligand":"lapatinib","mesh_id":"D009360","phase":"Phase 3","start_date":"2012","completion_date":"2012","nct_id":"NCT01619111"},{"ligand":"ribociclib","mesh_id":"D009360","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02035813"},{"ligand":"sirolimus","mesh_id":"D009360","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00887640"},{"ligand":"trastuzumab","mesh_id":"D009360","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01975142;NCT01548677"}],"predictions":[],"source_name":"Neoplastic Cells, Circulating"}],["D002282",{"mesh_id":"D002282","trials":[{"ligand":"cetuximab","mesh_id":"D002282","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00368992"},{"ligand":"erlotinib","mesh_id":"D002282","phase":"Phase 1","start_date":"2002","completion_date":"2002","nct_id":"NCT00042835"},{"ligand":"erlotinib","mesh_id":"D002282","phase":"Phase 2","start_date":"2005","completion_date":"2011","nct_id":"NCT01294306;NCT00339586;NCT00126581;NCT00384826;NCT00436332;NCT00950365;NCT01557959"},{"ligand":"gefitinib","mesh_id":"D002282","phase":"Phase 2","start_date":"2001","completion_date":"2002","nct_id":"NCT00029003;NCT00040794"},{"ligand":"gefitinib","mesh_id":"D002282","phase":"Phase 3","start_date":"2001","completion_date":"2002","nct_id":"NCT00049543;NCT00020709"}],"predictions":[{"target":"KIT","probability":"0.5319294658829543"},{"target":"ERBB3","probability":"0.5060219037854328"},{"target":"PDGFRB","probability":"0.49064098136075485"},{"target":"KDR","probability":"0.4855968329423386"},{"target":"PDGFRA","probability":"0.4803435077093493"}],"source_name":"Adenocarcinoma, Bronchiolo-Alveolar"}],["D013584",{"mesh_id":"D013584","trials":[{"ligand":"cetuximab","mesh_id":"D013584","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"everolimus","mesh_id":"D013584","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01281865"},{"ligand":"gefitinib","mesh_id":"D013584","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00052754"},{"ligand":"imatinib","mesh_id":"D013584","phase":"Phase 2","start_date":"2002","completion_date":"2011","nct_id":"NCT01281865;NCT00030667"},{"ligand":"olaratumab","mesh_id":"D013584","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D013584","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT02601209;NCT01532687"},{"ligand":"pazopanib","mesh_id":"D013584","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ramucirumab","mesh_id":"D013584","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04145700"},{"ligand":"ribociclib","mesh_id":"D013584","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"sirolimus","mesh_id":"D013584","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01281865;NCT01614795"},{"ligand":"sorafenib","mesh_id":"D013584","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT00245102;NCT00837148"},{"ligand":"trastuzumab","mesh_id":"D013584","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D013584","phase":"Phase 2","start_date":"2005","completion_date":"2015","nct_id":"NCT00104949;NCT02452554"}],"predictions":[],"source_name":"Sarcoma, Synovial"}],["D018317",{"mesh_id":"D018317","trials":[{"ligand":"cetuximab","mesh_id":"D018317","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"dasatinib","mesh_id":"D018317","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"erlotinib","mesh_id":"D018317","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00068367"},{"ligand":"everolimus","mesh_id":"D018317","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01661283"},{"ligand":"imatinib","mesh_id":"D018317","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00427583"},{"ligand":"olaratumab","mesh_id":"D018317","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D018317","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01418001;NCT02601209;NCT01532687"},{"ligand":"pazopanib","mesh_id":"D018317","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ribociclib","mesh_id":"D018317","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"selumetinib","mesh_id":"D018317","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03433183"},{"ligand":"sirolimus","mesh_id":"D018317","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01661283;NCT01614795;NCT02584647;NCT02008877;NCT03433183"},{"ligand":"sorafenib","mesh_id":"D018317","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00837148"},{"ligand":"trastuzumab","mesh_id":"D018317","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D018317","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452554"}],"predictions":[{"target":"BRAF","probability":"0.48"}],"source_name":"Nerve Sheath Neoplasms"}],["D058405",{"mesh_id":"D058405","trials":[{"ligand":"cetuximab","mesh_id":"D058405","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"imatinib","mesh_id":"D058405","phase":"Phase 2","start_date":"2002","completion_date":"2005","nct_id":"NCT00417807;NCT00062205;NCT00030667"},{"ligand":"pazopanib","mesh_id":"D058405","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01532687"},{"ligand":"ramucirumab","mesh_id":"D058405","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04145349"},{"ligand":"sirolimus","mesh_id":"D058405","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01946529"},{"ligand":"sorafenib","mesh_id":"D058405","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01946529"},{"ligand":"trastuzumab","mesh_id":"D058405","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"}],"predictions":[],"source_name":"Desmoplastic Small Round Cell Tumor"}],["D018319",{"mesh_id":"D018319","trials":[{"ligand":"cetuximab","mesh_id":"D018319","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"dasatinib","mesh_id":"D018319","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"erlotinib","mesh_id":"D018319","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00068367"},{"ligand":"everolimus","mesh_id":"D018319","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01661283"},{"ligand":"imatinib","mesh_id":"D018319","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00427583"},{"ligand":"olaratumab","mesh_id":"D018319","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D018319","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01418001;NCT02601209;NCT01532687"},{"ligand":"pazopanib","mesh_id":"D018319","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ribociclib","mesh_id":"D018319","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"selumetinib","mesh_id":"D018319","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03433183"},{"ligand":"sirolimus","mesh_id":"D018319","phase":"Phase 2","start_date":"2012","completion_date":"2019","nct_id":"NCT01661283;NCT01614795;NCT02584647;NCT02008877;NCT03433183"},{"ligand":"sorafenib","mesh_id":"D018319","phase":"Phase 2","start_date":"2005","completion_date":"2009","nct_id":"NCT00245102;NCT00837148"},{"ligand":"trastuzumab","mesh_id":"D018319","phase":"Phase 1","start_date":"2019","completion_date":"2020","nct_id":"NCT03618381;NCT04483778"},{"ligand":"trastuzumab","mesh_id":"D018319","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452554"}],"predictions":[],"source_name":"Neurofibrosarcoma"}],["D008048",{"mesh_id":"D008048","trials":[{"ligand":"cetuximab","mesh_id":"D008048","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03258554"},{"ligand":"erlotinib","mesh_id":"D008048","phase":"Phase 3","start_date":"2006","completion_date":"2006","nct_id":"NCT00402779"},{"ligand":"lenvatinib","mesh_id":"D008048","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"}],"predictions":[],"source_name":"Lip Neoplasms"}],["D003397",{"mesh_id":"D003397","trials":[{"ligand":"cobimetinib","mesh_id":"D003397","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03224767"},{"ligand":"vemurafenib","mesh_id":"D003397","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03224767"}],"predictions":[],"source_name":"Craniopharyngioma"}],["D050398",{"mesh_id":"D050398","trials":[{"ligand":"cobimetinib","mesh_id":"D050398","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03224767"},{"ligand":"dabrafenib","mesh_id":"D050398","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02367859"},{"ligand":"trametinib","mesh_id":"D050398","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02367859"},{"ligand":"vemurafenib","mesh_id":"D050398","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03224767"}],"predictions":[],"source_name":"Adamantinoma"}],["D054747",{"mesh_id":"D054747","trials":[{"ligand":"cobimetinib","mesh_id":"D054747","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04079179"},{"ligand":"erdafitinib","mesh_id":"D054747","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"larotrectinib","mesh_id":"D054747","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"palbociclib","mesh_id":"D054747","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"selumetinib","mesh_id":"D054747","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D054747","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"vemurafenib","mesh_id":"D054747","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"}],"predictions":[],"source_name":"Histiocytic Sarcoma"}],["D015620",{"mesh_id":"D015620","trials":[{"ligand":"cobimetinib","mesh_id":"D015620","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04079179"}],"predictions":[],"source_name":"Histiocytic Disorders, Malignant"}],["D018198",{"mesh_id":"D018198","trials":[{"ligand":"copanlisib","mesh_id":"D018198","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03458728"}],"predictions":[{"target":"EGFR","probability":"0.76"},{"target":"PDGFRB","probability":"0.735"},{"target":"KDR","probability":"0.7100457326475665"},{"target":"FLT3","probability":"0.635"},{"target":"PDGFRA","probability":"0.6152806122448979"},{"target":"RET","probability":"0.6106"},{"target":"ERBB3","probability":"0.6015"},{"target":"ERBB2","probability":"0.5808804346720976"},{"target":"ABL1","probability":"0.575"},{"target":"FLT1","probability":"0.5704691486881805"},{"target":"IGF1R","probability":"0.55625"},{"target":"FGFR1","probability":"0.5401282351705816"},{"target":"ERBB4","probability":"0.5220853128893719"},{"target":"INSR","probability":"0.520066622775871"},{"target":"BCR","probability":"0.51"},{"target":"CSF1R","probability":"0.5067064166076904"},{"target":"BRAF","probability":"0.48104824936439156"},{"target":"MET","probability":"0.45520445135526283"}],"source_name":"Mixed Tumor, Malignant"}],["D018232",{"mesh_id":"D018232","trials":[{"ligand":"crizotinib","mesh_id":"D018232","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01524926"},{"ligand":"dasatinib","mesh_id":"D018232","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03041701"},{"ligand":"sirolimus","mesh_id":"D018232","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01222715"},{"ligand":"sirolimus","mesh_id":"D018232","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02567435"}],"predictions":[],"source_name":"Rhabdomyosarcoma, Alveolar"}],["D018287",{"mesh_id":"D018287","trials":[{"ligand":"crizotinib","mesh_id":"D018287","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441128"},{"ligand":"dacomitinib","mesh_id":"D018287","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01441128"},{"ligand":"erlotinib","mesh_id":"D018287","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00673049"},{"ligand":"everolimus","mesh_id":"D018287","phase":"Phase 4","start_date":"2011","completion_date":"2011","nct_id":"NCT01317615"}],"predictions":[],"source_name":"Carcinoma, Large Cell"}],["D018305",{"mesh_id":"D018305","trials":[{"ligand":"crizotinib","mesh_id":"D018305","phase":"Phase 3","start_date":"2018","completion_date":"2018","nct_id":"NCT03126916"},{"ligand":"ribociclib","mesh_id":"D018305","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"sirolimus","mesh_id":"D018305","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01767194"},{"ligand":"trametinib","mesh_id":"D018305","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"}],"predictions":[{"target":"BRAF","probability":"0.5207803559251902"}],"source_name":"Ganglioneuroblastoma"}],["D000564",{"mesh_id":"D000564","trials":[{"ligand":"dabrafenib","mesh_id":"D000564","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02367859"},{"ligand":"trametinib","mesh_id":"D000564","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02367859"}],"predictions":[],"source_name":"Ameloblastoma"}],["D018303",{"mesh_id":"D018303","trials":[{"ligand":"dabrafenib","mesh_id":"D018303","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02684058;NCT03919071"},{"ligand":"dabrafenib","mesh_id":"D018303","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"ribociclib","mesh_id":"D018303","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D018303","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D018303","phase":"Phase 2","start_date":"2017","completion_date":"2019","nct_id":"NCT02684058;NCT03919071"},{"ligand":"trametinib","mesh_id":"D018303","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"}],"predictions":[],"source_name":"Ganglioglioma"}],["D018306",{"mesh_id":"D018306","trials":[{"ligand":"dabrafenib","mesh_id":"D018306","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02684058"},{"ligand":"dabrafenib","mesh_id":"D018306","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"trametinib","mesh_id":"D018306","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02684058"},{"ligand":"trametinib","mesh_id":"D018306","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"}],"predictions":[],"source_name":"Neurocytoma"}],["D005729",{"mesh_id":"D005729","trials":[{"ligand":"dabrafenib","mesh_id":"D005729","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02684058"},{"ligand":"dabrafenib","mesh_id":"D005729","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"},{"ligand":"trametinib","mesh_id":"D005729","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02684058"},{"ligand":"trametinib","mesh_id":"D005729","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT03975829"}],"predictions":[],"source_name":"Ganglioneuroma"}],["D018249",{"mesh_id":"D018249","trials":[{"ligand":"dabrafenib","mesh_id":"D018249","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04544111"},{"ligand":"trametinib","mesh_id":"D018249","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04544111"}],"predictions":[],"source_name":"Adenoma, Oxyphilic"}],["D005870",{"mesh_id":"D005870","trials":[{"ligand":"dasatinib","mesh_id":"D005870","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"nilotinib","mesh_id":"D005870","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01261429;NCT01207492"},{"ligand":"pexidartinib","mesh_id":"D005870","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04703322"},{"ligand":"pexidartinib","mesh_id":"D005870","phase":"Phase 3","start_date":"2015","completion_date":"2020","nct_id":"NCT02371369;NCT04488822"},{"ligand":"pexidartinib","mesh_id":"D005870","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04526704"}],"predictions":[{"target":"KIT","probability":"0.9933982683982683"},{"target":"CSF1R","probability":"0.9422138925428554"}],"source_name":"Giant Cell Tumors"}],["D006393",{"mesh_id":"D006393","trials":[{"ligand":"dasatinib","mesh_id":"D006393","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"imatinib","mesh_id":"D006393","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00045734"},{"ligand":"pazopanib","mesh_id":"D006393","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01532687"},{"ligand":"sunitinib","mesh_id":"D006393","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00589784"}],"predictions":[],"source_name":"Hemangiopericytoma"}],["D001859",{"mesh_id":"D001859","trials":[{"ligand":"dasatinib","mesh_id":"D001859","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620;NCT00566618"},{"ligand":"lenvatinib","mesh_id":"D001859","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"}],"predictions":[{"target":"EGFR","probability":"0.5552884615384616"},{"target":"KIT","probability":"0.5450867489933766"},{"target":"FLT3","probability":"0.52"},{"target":"BRAF","probability":"0.49128743746108633"},{"target":"PDGFRB","probability":"0.47506811989100817"},{"target":"ERBB2","probability":"0.46511879045252935"}],"source_name":"Bone Neoplasms"}],["D018212",{"mesh_id":"D018212","trials":[{"ligand":"dasatinib","mesh_id":"D018212","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"}],"predictions":[],"source_name":"Giant Cell Tumor of Bone"}],["D018241",{"mesh_id":"D018241","trials":[{"ligand":"dasatinib","mesh_id":"D018241","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00464620"},{"ligand":"erdafitinib","mesh_id":"D018241","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03210714;NCT03155620"},{"ligand":"imatinib","mesh_id":"D018241","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00062205;NCT00030667"},{"ligand":"larotrectinib","mesh_id":"D018241","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D018241","phase":"Phase 2","start_date":"2017","completion_date":"2018","nct_id":"NCT03526250;NCT03155620"},{"ligand":"selumetinib","mesh_id":"D018241","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D018241","phase":"Phase 2","start_date":"2012","completion_date":"2020","nct_id":"NCT01614795;NCT03213678;NCT03778996;NCT03155620;NCT01946529"},{"ligand":"sorafenib","mesh_id":"D018241","phase":"Phase 2","start_date":"2006","completion_date":"2013","nct_id":"NCT00330421;NCT01946529"},{"ligand":"vemurafenib","mesh_id":"D018241","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03220035;NCT03155620"}],"predictions":[{"target":"PIK3CA","probability":"0.68"},{"target":"JAK2","probability":"0.5800653594771242"},{"target":"PDGFRB","probability":"0.525"},{"target":"BCR","probability":"0.5102325581395348"},{"target":"PDGFRA","probability":"0.51"},{"target":"AKT1","probability":"0.46"},{"target":"MAP2K7","probability":"0.46"}],"source_name":"Neuroectodermal Tumors, Primitive, Peripheral"}],["D011087",{"mesh_id":"D011087","trials":[{"ligand":"dasatinib","mesh_id":"D011087","phase":"Phase 2","start_date":"2005","completion_date":"2007","nct_id":"NCT00538980;NCT00255346"},{"ligand":"erlotinib","mesh_id":"D011087","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01038856"},{"ligand":"fedratinib","mesh_id":"D011087","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00631462"},{"ligand":"fedratinib","mesh_id":"D011087","phase":"Phase 2","start_date":"2020","completion_date":"2021","nct_id":"NCT04282187;NCT04629508;NCT04446650"},{"ligand":"fedratinib","mesh_id":"D011087","phase":"Phase 3","start_date":"2019","completion_date":"2019","nct_id":"NCT03952039;NCT03755518"},{"ligand":"imatinib","mesh_id":"D011087","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"imatinib","mesh_id":"D011087","phase":"Phase 2","start_date":"2002","completion_date":"2007","nct_id":"NCT00430066;NCT00039416;NCT01120821"},{"ligand":"ruxolitinib","mesh_id":"D011087","phase":"Phase 1","start_date":"2011","completion_date":"2019","nct_id":"NCT01433445;NCT03373877;NCT02436135;NCT02493530;NCT03935555"},{"ligand":"ruxolitinib","mesh_id":"D011087","phase":"Phase 2","start_date":"2007","completion_date":"2021","nct_id":"NCT04282187;NCT04629508;NCT04485260;NCT01369498;NCT01348490;NCT03878199;NCT01790295;NCT00726232;NCT00509899;NCT02577926;NCT01392443;NCT01787487;NCT04644211;NCT01445769;NCT01981850;NCT04455841;NCT03287245;NCT02966353;NCT03627403;NCT02226172;NCT01787552;NCT03669965"},{"ligand":"ruxolitinib","mesh_id":"D011087","phase":"Phase 3","start_date":"2009","completion_date":"2021","nct_id":"NCT01632904;NCT04603495;NCT04116502;NCT04551053;NCT01243944;NCT02292446;NCT03952039;NCT02101268;NCT02055781;NCT02038036;NCT04551066;NCT00934544;NCT01969838;NCT03755518;NCT00952289;NCT03165734;NCT02087059"},{"ligand":"ruxolitinib","mesh_id":"D011087","phase":"Phase 4","start_date":"2010","completion_date":"2010","nct_id":"NCT02386800"},{"ligand":"sunitinib","mesh_id":"D011087","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[{"target":"ERBB3","probability":"0.5354529300520681"},{"target":"PDGFRA","probability":"0.5325664660399901"},{"target":"MET","probability":"0.506858816711081"},{"target":"FLT1","probability":"0.4906043972907306"},{"target":"FGFR1","probability":"0.48724672723409485"},{"target":"FGFR2","probability":"0.4817840115125717"},{"target":"TBK1","probability":"0.47992226793438464"},{"target":"NTRK1","probability":"0.4793969147383782"},{"target":"INSR","probability":"0.4759412818464542"},{"target":"ERBB4","probability":"0.4745337212467674"},{"target":"EPHB2","probability":"0.46359035446389835"}],"source_name":"Polycythemia Vera"}],["D010871",{"mesh_id":"D010871","trials":[{"ligand":"dasatinib","mesh_id":"D010871","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02596828"},{"ligand":"palbociclib","mesh_id":"D010871","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"ribociclib","mesh_id":"D010871","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"sirolimus","mesh_id":"D010871","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01182883"},{"ligand":"sirolimus","mesh_id":"D010871","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02596828"},{"ligand":"trametinib","mesh_id":"D010871","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"}],"predictions":[{"target":"BRAF","probability":"0.5768315005732199"}],"source_name":"Pinealoma"}],["D018267",{"mesh_id":"D018267","trials":[{"ligand":"dasatinib","mesh_id":"D018267","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01234935"},{"ligand":"erlotinib","mesh_id":"D018267","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00878163"},{"ligand":"erlotinib","mesh_id":"D018267","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01013649"},{"ligand":"everolimus","mesh_id":"D018267","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00981162"},{"ligand":"lapatinib","mesh_id":"D018267","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095563"},{"ligand":"selumetinib","mesh_id":"D018267","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01658943"},{"ligand":"sirolimus","mesh_id":"D018267","phase":"Phase 1","start_date":"2009","completion_date":"2012","nct_id":"NCT01537107;NCT00981162"},{"ligand":"sorafenib","mesh_id":"D018267","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00981162"},{"ligand":"sunitinib","mesh_id":"D018267","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00397787"},{"ligand":"trastuzumab","mesh_id":"D018267","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00126607"}],"predictions":[],"source_name":"Carcinoma, Acinar Cell"}],["D015448",{"mesh_id":"D015448","trials":[{"ligand":"dasatinib","mesh_id":"D015448","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT03564470"},{"ligand":"ibrutinib","mesh_id":"D015448","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00849654"},{"ligand":"ibrutinib","mesh_id":"D015448","phase":"Phase 4","start_date":"2017","completion_date":"2017","nct_id":"NCT03229200"}],"predictions":[],"source_name":"Leukemia, B-Cell"}],["D009373",{"mesh_id":"D009373","trials":[{"ligand":"dasatinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00788125"},{"ligand":"erdafitinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"erlotinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01962896"},{"ligand":"everolimus","mesh_id":"D009373","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01242631;NCT01466231"},{"ligand":"gefitinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00198159"},{"ligand":"imatinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042952"},{"ligand":"lapatinib","mesh_id":"D009373","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00313599"},{"ligand":"larotrectinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03213704;NCT03155620"},{"ligand":"palbociclib","mesh_id":"D009373","phase":"Phase 2","start_date":"2009","completion_date":"2018","nct_id":"NCT03526250;NCT03155620;NCT01037790"},{"ligand":"pazopanib","mesh_id":"D009373","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00929903"},{"ligand":"pazopanib","mesh_id":"D009373","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01743482"},{"ligand":"ribociclib","mesh_id":"D009373","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"selumetinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"},{"ligand":"sirolimus","mesh_id":"D009373","phase":"Phase 1","start_date":"2007","completion_date":"2010","nct_id":"NCT01155258;NCT00408655"},{"ligand":"sirolimus","mesh_id":"D009373","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT03213678;NCT01962896;NCT03155620"},{"ligand":"sunitinib","mesh_id":"D009373","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00387920"},{"ligand":"sunitinib","mesh_id":"D009373","phase":"Phase 2","start_date":"2006","completion_date":"2009","nct_id":"NCT00453310;NCT00371553;NCT00912912"},{"ligand":"trametinib","mesh_id":"D009373","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trastuzumab","mesh_id":"D009373","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"},{"ligand":"vemurafenib","mesh_id":"D009373","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03155620"}],"predictions":[],"source_name":"Neoplasms, Germ Cell and Embryonal"}],["D054218",{"mesh_id":"D054218","trials":[{"ligand":"dasatinib","mesh_id":"D054218","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"dasatinib","mesh_id":"D054218","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00792948"},{"ligand":"imatinib","mesh_id":"D054218","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT02538926"},{"ligand":"imatinib","mesh_id":"D054218","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03007147"},{"ligand":"ruxolitinib","mesh_id":"D054218","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03613428"},{"ligand":"sirolimus","mesh_id":"D054218","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01403415"},{"ligand":"sirolimus","mesh_id":"D054218","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00792948"}],"predictions":[{"target":"PDGFRA","probability":"0.6358746883316472"},{"target":"ERBB3","probability":"0.5901403200189018"},{"target":"PDGFRB","probability":"0.5611761408572052"},{"target":"IGF1R","probability":"0.5448321678321678"},{"target":"KDR","probability":"0.5395"},{"target":"MET","probability":"0.5095698974836905"},{"target":"EGFR","probability":"0.49099999999999994"},{"target":"FGFR1","probability":"0.48515690052263266"},{"target":"BRAF","probability":"0.4738240852822074"},{"target":"FLT1","probability":"0.465274884132197"},{"target":"ERBB2","probability":"0.4629960655241554"},{"target":"NTRK1","probability":"0.461213519203972"},{"target":"ERBB4","probability":"0.45525143609910323"}],"source_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma"}],["D002051",{"mesh_id":"D002051","trials":[{"ligand":"dasatinib","mesh_id":"D002051","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"everolimus","mesh_id":"D002051","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"ibrutinib","mesh_id":"D002051","phase":"Phase 1","start_date":"2014","completion_date":"2021","nct_id":"NCT03223610;NCT02109224;NCT04739813;NCT02950220"},{"ligand":"ibrutinib","mesh_id":"D002051","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01109069"},{"ligand":"imatinib","mesh_id":"D002051","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D002051","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01184885"},{"ligand":"sirolimus","mesh_id":"D002051","phase":"Phase 2","start_date":"2004","completion_date":"2017","nct_id":"NCT00105001;NCT00290472;NCT01075321;NCT00776373;NCT00918333;NCT02991898;NCT02722668"},{"ligand":"sorafenib","mesh_id":"D002051","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sunitinib","mesh_id":"D002051","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[{"target":"ERBB3","probability":"0.685"},{"target":"PDGFRA","probability":"0.65"},{"target":"PIK3CA","probability":"0.6223645010903076"},{"target":"FGFR3","probability":"0.6054337764163817"},{"target":"FLT1","probability":"0.5984434654919236"},{"target":"MET","probability":"0.593519056158028"},{"target":"ERBB2","probability":"0.5933333333333334"},{"target":"FGFR1","probability":"0.59"},{"target":"IGF1R","probability":"0.585"},{"target":"BRAF","probability":"0.5822493965125392"},{"target":"RET","probability":"0.5703804551426369"},{"target":"NTRK1","probability":"0.5656299865262993"},{"target":"EGFR","probability":"0.535"},{"target":"ROS1","probability":"0.5213947339648627"},{"target":"ERBB4","probability":"0.5200943396226415"},{"target":"JAK2","probability":"0.515"},{"target":"INSR","probability":"0.4960253699788584"},{"target":"BCR","probability":"0.49508620689655175"},{"target":"ALK","probability":"0.48571723827904406"},{"target":"FGFR2","probability":"0.48507692307692307"},{"target":"PTK2","probability":"0.46500927643784784"}],"source_name":"Burkitt Lymphoma"}],["D009182",{"mesh_id":"D009182","trials":[{"ligand":"dasatinib","mesh_id":"D009182","phase":"Phase 1","start_date":"2008","completion_date":"2015","nct_id":"NCT00608361;NCT01609816"},{"ligand":"duvelisib","mesh_id":"D009182","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04652960"},{"ligand":"everolimus","mesh_id":"D009182","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"imatinib","mesh_id":"D009182","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"ruxolitinib","mesh_id":"D009182","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03017820"},{"ligand":"sirolimus","mesh_id":"D009182","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"sunitinib","mesh_id":"D009182","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"trastuzumab","mesh_id":"D009182","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03432741"}],"predictions":[],"source_name":"Mycosis Fungoides"}],["D012751",{"mesh_id":"D012751","trials":[{"ligand":"dasatinib","mesh_id":"D012751","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D012751","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04652960"},{"ligand":"everolimus","mesh_id":"D012751","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"imatinib","mesh_id":"D012751","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D012751","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"sunitinib","mesh_id":"D012751","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Sezary Syndrome"}],["D016410",{"mesh_id":"D016410","trials":[{"ligand":"dasatinib","mesh_id":"D016410","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"everolimus","mesh_id":"D016410","phase":"Phase 2","start_date":"2009","completion_date":"2012","nct_id":"NCT01198665;NCT00918333;NCT01637090"},{"ligand":"imatinib","mesh_id":"D016410","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"ruxolitinib","mesh_id":"D016410","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03017820"},{"ligand":"sirolimus","mesh_id":"D016410","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT01198665;NCT01843998;NCT00918333;NCT01637090"},{"ligand":"sorafenib","mesh_id":"D016410","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D016410","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"trastuzumab","mesh_id":"D016410","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03432741"}],"predictions":[{"target":"PDGFRA","probability":"0.5610057538325139"},{"target":"RET","probability":"0.5217642426234645"},{"target":"ERBB3","probability":"0.5052082840114573"},{"target":"EGFR","probability":"0.4812999375780274"},{"target":"MET","probability":"0.4812997475143851"},{"target":"FGFR1","probability":"0.45605720999953275"}],"source_name":"Lymphoma, T-Cell, Cutaneous"}],["D015458",{"mesh_id":"D015458","trials":[{"ligand":"dasatinib","mesh_id":"D015458","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D015458","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04639843"},{"ligand":"everolimus","mesh_id":"D015458","phase":"Phase 2","start_date":"2004","completion_date":"2011","nct_id":"NCT01075321;NCT00918333;NCT00081874"},{"ligand":"imatinib","mesh_id":"D015458","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"palbociclib","mesh_id":"D015458","phase":"Phase 1","start_date":"2019","completion_date":"2019","nct_id":"NCT03792256"},{"ligand":"ruxolitinib","mesh_id":"D015458","phase":"Phase 2","start_date":"2012","completion_date":"2018","nct_id":"NCT01712659;NCT03613428"},{"ligand":"sirolimus","mesh_id":"D015458","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01184885"},{"ligand":"sirolimus","mesh_id":"D015458","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"sorafenib","mesh_id":"D015458","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D015458","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[{"target":"ERBB3","probability":"0.6053703703703703"},{"target":"PDGFRA","probability":"0.5801966101460116"},{"target":"FLT1","probability":"0.5359277959762541"},{"target":"MET","probability":"0.535"},{"target":"IGF1R","probability":"0.5102092066022973"},{"target":"FGFR1","probability":"0.5"},{"target":"ERBB2","probability":"0.49255886970172696"},{"target":"FGFR3","probability":"0.47797356905298244"},{"target":"BRAF","probability":"0.4720277869594894"},{"target":"ERBB4","probability":"0.45546092851868536"},{"target":"INSR","probability":"0.45522912759781337"}],"source_name":"Leukemia, T-Cell"}],["D015459",{"mesh_id":"D015459","trials":[{"ligand":"dasatinib","mesh_id":"D015459","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D015459","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04639843"},{"ligand":"everolimus","mesh_id":"D015459","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"imatinib","mesh_id":"D015459","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"ruxolitinib","mesh_id":"D015459","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01712659"},{"ligand":"sirolimus","mesh_id":"D015459","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01184885"},{"ligand":"sirolimus","mesh_id":"D015459","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"sorafenib","mesh_id":"D015459","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D015459","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[{"target":"ERBB2","probability":"0.5302337585322167"},{"target":"MET","probability":"0.5251938141669585"},{"target":"PDGFRA","probability":"0.5201206881051068"},{"target":"FLT1","probability":"0.4803635550287555"},{"target":"ERBB3","probability":"0.47549882028986606"},{"target":"IGF1R","probability":"0.4704157393868657"},{"target":"ROS1","probability":"0.46547574440042566"},{"target":"PIK3CA","probability":"0.4625209072776015"},{"target":"BRAF","probability":"0.4620277869594894"}],"source_name":"Leukemia-Lymphoma, Adult T-Cell"}],["D008230",{"mesh_id":"D008230","trials":[{"ligand":"dasatinib","mesh_id":"D008230","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"ibrutinib","mesh_id":"D008230","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02109224"},{"ligand":"sorafenib","mesh_id":"D008230","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sunitinib","mesh_id":"D008230","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Lymphomatoid Granulomatosis"}],["D054391",{"mesh_id":"D054391","trials":[{"ligand":"dasatinib","mesh_id":"D054391","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"duvelisib","mesh_id":"D054391","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04639843"},{"ligand":"everolimus","mesh_id":"D054391","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"sirolimus","mesh_id":"D054391","phase":"Phase 2","start_date":"2009","completion_date":"2011","nct_id":"NCT01075321;NCT00918333"},{"ligand":"sunitinib","mesh_id":"D054391","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"tofacitinib","mesh_id":"D054391","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03598959"}],"predictions":[{"target":"PDGFRA","probability":"0.6"},{"target":"RET","probability":"0.5841033569056182"},{"target":"FLT1","probability":"0.5823560864927854"},{"target":"ERBB3","probability":"0.5818302616736577"},{"target":"FGFR3","probability":"0.5611041648424279"},{"target":"FGFR1","probability":"0.5563725120934658"},{"target":"IGF1R","probability":"0.5552810716683784"},{"target":"MET","probability":"0.5020610573949232"},{"target":"FLT4","probability":"0.4876154672058899"},{"target":"CSF1R","probability":"0.48577563560453174"},{"target":"PIK3CA","probability":"0.4827042434771016"},{"target":"BRAF","probability":"0.4803966665264431"},{"target":"NTRK1","probability":"0.4689954212054736"}],"source_name":"Lymphoma, Extranodal NK-T-Cell"}],["D064090",{"mesh_id":"D064090","trials":[{"ligand":"dasatinib","mesh_id":"D064090","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"ibrutinib","mesh_id":"D064090","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02109224"},{"ligand":"ibrutinib","mesh_id":"D064090","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02542514"},{"ligand":"imatinib","mesh_id":"D064090","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sunitinib","mesh_id":"D064090","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Intraocular Lymphoma"}],["D054066",{"mesh_id":"D054066","trials":[{"ligand":"dasatinib","mesh_id":"D054066","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"imatinib","mesh_id":"D054066","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sunitinib","mesh_id":"D054066","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"},{"ligand":"sunitinib","mesh_id":"D054066","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00387426"}],"predictions":[],"source_name":"Leukemia, Large Granular Lymphocytic"}],["D000069293",{"mesh_id":"D000069293","trials":[{"ligand":"dasatinib","mesh_id":"D000069293","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"ibrutinib","mesh_id":"D000069293","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02109224"},{"ligand":"imatinib","mesh_id":"D000069293","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D000069293","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00105001;NCT00290472"},{"ligand":"sorafenib","mesh_id":"D000069293","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sorafenib","mesh_id":"D000069293","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D000069293","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Plasmablastic Lymphoma"}],["D016400",{"mesh_id":"D016400","trials":[{"ligand":"dasatinib","mesh_id":"D016400","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00608361"},{"ligand":"ibrutinib","mesh_id":"D016400","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02109224"},{"ligand":"imatinib","mesh_id":"D016400","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D016400","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00105001;NCT00290472"},{"ligand":"sorafenib","mesh_id":"D016400","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00118170"},{"ligand":"sorafenib","mesh_id":"D016400","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131937"},{"ligand":"sunitinib","mesh_id":"D016400","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Lymphoma, Large-Cell, Immunoblastic"}],["D058527",{"mesh_id":"D058527","trials":[{"ligand":"duvelisib","mesh_id":"D058527","phase":"Phase 1","start_date":"2021","completion_date":"2021","nct_id":"NCT04639843"}],"predictions":[{"target":"KDR","probability":"0.48514821616027914"},{"target":"KIT","probability":"0.4714645755305868"}],"source_name":"Enteropathy-Associated T-Cell Lymphoma"}],["D018233",{"mesh_id":"D018233","trials":[{"ligand":"erlotinib","mesh_id":"D018233","phase":"Phase 1","start_date":"2004","completion_date":"2004","nct_id":"NCT00077454"},{"ligand":"sirolimus","mesh_id":"D018233","phase":"Phase 2","start_date":"2010","completion_date":"2012","nct_id":"NCT01222715;NCT01614795"},{"ligand":"sirolimus","mesh_id":"D018233","phase":"Phase 3","start_date":"2016","completion_date":"2016","nct_id":"NCT02567435"},{"ligand":"sorafenib","mesh_id":"D018233","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01502410"}],"predictions":[],"source_name":"Rhabdomyosarcoma, Embryonal"}],["D001471",{"mesh_id":"D001471","trials":[{"ligand":"erlotinib","mesh_id":"D001471","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00566800"},{"ligand":"sunitinib","mesh_id":"D001471","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00411151"}],"predictions":[{"target":"PDGFRA","probability":"0.46517628205128203"}],"source_name":"Barrett Esophagus"}],["D018282",{"mesh_id":"D018282","trials":[{"ligand":"erlotinib","mesh_id":"D018282","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00059787"},{"ligand":"sirolimus","mesh_id":"D018282","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02142803"}],"predictions":[],"source_name":"Cystadenocarcinoma, Mucinous"}],["D001948",{"mesh_id":"D001948","trials":[{"ligand":"erlotinib","mesh_id":"D001948","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00059787"},{"ligand":"selumetinib","mesh_id":"D001948","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00551070"}],"predictions":[],"source_name":"Brenner Tumor"}],["D015473",{"mesh_id":"D015473","trials":[{"ligand":"erlotinib","mesh_id":"D015473","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01664897"},{"ligand":"imatinib","mesh_id":"D015473","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00852709"},{"ligand":"quizartinib","mesh_id":"D015473","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03989713"},{"ligand":"ruxolitinib","mesh_id":"D015473","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT04446806"},{"ligand":"selumetinib","mesh_id":"D015473","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00588809"},{"ligand":"sirolimus","mesh_id":"D015473","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00105001"},{"ligand":"sorafenib","mesh_id":"D015473","phase":"Phase 1","start_date":"2005","completion_date":"2009","nct_id":"NCT00217646;NCT00875745"},{"ligand":"sorafenib","mesh_id":"D015473","phase":"Phase 2","start_date":"2006","completion_date":"2011","nct_id":"NCT01253070;NCT01445080"}],"predictions":[{"target":"ERBB3","probability":"0.71"},{"target":"FGFR1","probability":"0.68"},{"target":"FGFR2","probability":"0.66"},{"target":"ERBB4","probability":"0.6353846153846154"},{"target":"LCK","probability":"0.6350055617352615"},{"target":"PIK3CA","probability":"0.635"},{"target":"BRAF","probability":"0.6250864779874213"},{"target":"FLT1","probability":"0.62"},{"target":"IGF1R","probability":"0.61"},{"target":"FGFR3","probability":"0.6051556991774383"},{"target":"NTRK1","probability":"0.6"},{"target":"EPHB2","probability":"0.5950432138284252"},{"target":"ERBB2","probability":"0.585"},{"target":"INSR","probability":"0.585"},{"target":"TBK1","probability":"0.585"},{"target":"MET","probability":"0.575"},{"target":"ALK","probability":"0.5702657982109147"},{"target":"TXK","probability":"0.5700716633305588"},{"target":"NTRK2","probability":"0.57"},{"target":"SRC","probability":"0.5501234567901235"},{"target":"FYN","probability":"0.545"},{"target":"TEK","probability":"0.535"},{"target":"CDK6","probability":"0.5304666666666666"},{"target":"PTK2","probability":"0.53"},{"target":"FLT4","probability":"0.525"},{"target":"TGFBR2","probability":"0.52"},{"target":"MAP2K7","probability":"0.515"},{"target":"LYN","probability":"0.5112053273453548"},{"target":"ITK","probability":"0.506051282051282"},{"target":"CDK4","probability":"0.5"},{"target":"BTK","probability":"0.4908529040799563"},{"target":"AVP","probability":"0.4854130648867491"},{"target":"CCL3","probability":"0.4803207429216746"},{"target":"MST1R","probability":"0.48002844950213375"},{"target":"CCL2","probability":"0.48"},{"target":"MAP3K7","probability":"0.47537046540086053"},{"target":"CCL5","probability":"0.4751686052135223"},{"target":"FGFR4","probability":"0.47507590481259576"},{"target":"PIK3CD","probability":"0.4750526315789474"},{"target":"PTK2B","probability":"0.475"},{"target":"PAK1","probability":"0.47062583084419596"},{"target":"NTRK3","probability":"0.47002844950213374"},{"target":"ROS1","probability":"0.4654829445399805"},{"target":"IRAK1","probability":"0.46506407545254613"},{"target":"SYK","probability":"0.46041862662201055"},{"target":"AKT1","probability":"0.46"},{"target":"TGFBR1","probability":"0.4550030450669915"}],"source_name":"Leukemia, Promyelocytic, Acute"}],["D000077779",{"mesh_id":"D000077779","trials":[{"ligand":"erlotinib","mesh_id":"D000077779","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00482625"},{"ligand":"erlotinib","mesh_id":"D000077779","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT01013649"}],"predictions":[{"target":"KDR","probability":"0.49047713495848905"}],"source_name":"Pancreatic Intraductal Neoplasms"}],["D009377",{"mesh_id":"D009377","trials":[{"ligand":"erlotinib","mesh_id":"D009377","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"everolimus","mesh_id":"D009377","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"lenvatinib","mesh_id":"D009377","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"pazopanib","mesh_id":"D009377","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"pertuzumab","mesh_id":"D009377","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00947167"},{"ligand":"sirolimus","mesh_id":"D009377","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"sorafenib","mesh_id":"D009377","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00390325"},{"ligand":"vandetanib","mesh_id":"D009377","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00514046"}],"predictions":[],"source_name":"Multiple Endocrine Neoplasia"}],["D018231",{"mesh_id":"D018231","trials":[{"ligand":"erlotinib","mesh_id":"D018231","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01130519"},{"ligand":"sirolimus","mesh_id":"D018231","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03500367"},{"ligand":"vandetanib","mesh_id":"D018231","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02495103"}],"predictions":[],"source_name":"Leiomyomatosis"}],["D009386",{"mesh_id":"D009386","trials":[{"ligand":"erlotinib","mesh_id":"D009386","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01130519"}],"predictions":[{"target":"KIT","probability":"0.5770193517234001"},{"target":"PDGFRA","probability":"0.5602365488111649"},{"target":"PDGFRB","probability":"0.5601402006581501"},{"target":"FLT3","probability":"0.5336561743341405"},{"target":"ERBB3","probability":"0.5000445815463465"},{"target":"KDR","probability":"0.4900212314225053"},{"target":"ABL1","probability":"0.48004188144329896"},{"target":"ERBB2","probability":"0.475"},{"target":"NTRK1","probability":"0.46511608143400757"},{"target":"ALK","probability":"0.4613007853892966"}],"source_name":"Neoplastic Syndromes, Hereditary"}],["D018256",{"mesh_id":"D018256","trials":[{"ligand":"erlotinib","mesh_id":"D018256","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00754494"}],"predictions":[{"target":"ERBB2","probability":"0.49552796746875166"},{"target":"KIT","probability":"0.48529433962264157"},{"target":"PDGFRB","probability":"0.46552669355538207"},{"target":"ERBB3","probability":"0.45631040960273156"},{"target":"PDGFRA","probability":"0.4556019979776347"}],"source_name":"Adenomatous Polyps"}],["D011125",{"mesh_id":"D011125","trials":[{"ligand":"erlotinib","mesh_id":"D011125","phase":"Phase 2","start_date":"2010","completion_date":"2017","nct_id":"NCT01187901;NCT02961374"},{"ligand":"sirolimus","mesh_id":"D011125","phase":"Phase 2","start_date":"2017","completion_date":"2021","nct_id":"NCT03095703;NCT04230499"}],"predictions":[{"target":"KDR","probability":"0.48704318307994254"},{"target":"FLT3","probability":"0.4735951948885655"},{"target":"ERBB2","probability":"0.47142857142857136"}],"source_name":"Adenomatous Polyposis Coli"}],["D018567",{"mesh_id":"D018567","trials":[{"ligand":"erlotinib","mesh_id":"D018567","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00030498"},{"ligand":"everolimus","mesh_id":"D018567","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01783756"},{"ligand":"gefitinib","mesh_id":"D018567","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00024154"},{"ligand":"imatinib","mesh_id":"D018567","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00045188"},{"ligand":"lapatinib","mesh_id":"D018567","phase":"Phase 1","start_date":"2010","completion_date":"2012","nct_id":"NCT01245205;NCT01705340"},{"ligand":"lapatinib","mesh_id":"D018567","phase":"Phase 2","start_date":"2004","completion_date":"2013","nct_id":"NCT00118157;NCT00098605;NCT01783756;NCT01868503"},{"ligand":"lapatinib","mesh_id":"D018567","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00770809"},{"ligand":"palbociclib","mesh_id":"D018567","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01037790"},{"ligand":"pazopanib","mesh_id":"D018567","phase":"Phase 1","start_date":"2007","completion_date":"2007","nct_id":"NCT00450879"},{"ligand":"pazopanib","mesh_id":"D018567","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01394211"},{"ligand":"pertuzumab","mesh_id":"D018567","phase":"Phase 1","start_date":"2014","completion_date":"2018","nct_id":"NCT02060253;NCT03387553"},{"ligand":"pertuzumab","mesh_id":"D018567","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03112590"},{"ligand":"sirolimus","mesh_id":"D018567","phase":"Phase 1","start_date":"2010","completion_date":"2010","nct_id":"NCT01155258"},{"ligand":"sirolimus","mesh_id":"D018567","phase":"Phase 2","start_date":"2008","completion_date":"2013","nct_id":"NCT01783756;NCT00699491"},{"ligand":"sorafenib","mesh_id":"D018567","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00096434"},{"ligand":"sunitinib","mesh_id":"D018567","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00513695"},{"ligand":"trastuzumab","mesh_id":"D018567","phase":"Phase 1","start_date":"1999","completion_date":"2018","nct_id":"NCT01245205;NCT00028535;NCT02060253;NCT03387553;NCT00004074;NCT00039455;NCT01705340"},{"ligand":"trastuzumab","mesh_id":"D018567","phase":"Phase 2","start_date":"2000","completion_date":"2017","nct_id":"NCT00024154;NCT00331552;NCT01783756;NCT00077376;NCT00006228;NCT00343109;NCT00258349;NCT03112590"},{"ligand":"trastuzumab","mesh_id":"D018567","phase":"Phase 3","start_date":"2008","completion_date":"2008","nct_id":"NCT00770809"}],"predictions":[],"source_name":"Breast Neoplasms, Male"}],["D018315",{"mesh_id":"D018315","trials":[{"ligand":"erlotinib","mesh_id":"D018315","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00030498"}],"predictions":[{"target":"BRAF","probability":"0.6108028055356172"}],"source_name":"Glioma, Subependymal"}],["D009364",{"mesh_id":"D009364","trials":[{"ligand":"erlotinib","mesh_id":"D009364","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00095225"}],"predictions":[{"target":"KDR","probability":"0.46334016860332655"}],"source_name":"Neoplasm Recurrence, Local"}],["D007340",{"mesh_id":"D007340","trials":[{"ligand":"everolimus","mesh_id":"D007340","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D007340","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02031536;NCT02273752"},{"ligand":"gefitinib","mesh_id":"D007340","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"pazopanib","mesh_id":"D007340","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"regorafenib","mesh_id":"D007340","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D007340","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"sirolimus","mesh_id":"D007340","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02031536;NCT01010126;NCT02273752"},{"ligand":"sorafenib","mesh_id":"D007340","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"trastuzumab","mesh_id":"D007340","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"ABL1","probability":"0.4651646544385109"}],"source_name":"Insulinoma"}],["D018273",{"mesh_id":"D018273","trials":[{"ligand":"everolimus","mesh_id":"D018273","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D018273","phase":"Phase 2","start_date":"2005","completion_date":"2014","nct_id":"NCT02031536;NCT02273752;NCT00113360;NCT00363051"},{"ligand":"gefitinib","mesh_id":"D018273","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"palbociclib","mesh_id":"D018273","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02806648"},{"ligand":"pazopanib","mesh_id":"D018273","phase":"Phase 2","start_date":"2007","completion_date":"2011","nct_id":"NCT01465659;NCT00454363"},{"ligand":"regorafenib","mesh_id":"D018273","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D018273","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655;NCT01155258"},{"ligand":"sirolimus","mesh_id":"D018273","phase":"Phase 2","start_date":"2003","completion_date":"2014","nct_id":"NCT02031536;NCT01010126;NCT02273752;NCT00093782"},{"ligand":"sorafenib","mesh_id":"D018273","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"sunitinib","mesh_id":"D018273","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02230176"},{"ligand":"sunitinib","mesh_id":"D018273","phase":"Phase 3","start_date":"2007","completion_date":"2007","nct_id":"NCT00428597"},{"ligand":"trastuzumab","mesh_id":"D018273","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Carcinoma, Islet Cell"}],["D015408",{"mesh_id":"D015408","trials":[{"ligand":"everolimus","mesh_id":"D015408","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D015408","phase":"Phase 2","start_date":"2010","completion_date":"2014","nct_id":"NCT02031536;NCT02273752;NCT01229943"},{"ligand":"gefitinib","mesh_id":"D015408","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"pazopanib","mesh_id":"D015408","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"regorafenib","mesh_id":"D015408","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D015408","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"sirolimus","mesh_id":"D015408","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02031536;NCT01010126;NCT02273752;NCT01229943"},{"ligand":"sorafenib","mesh_id":"D015408","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"trastuzumab","mesh_id":"D015408","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Gastrinoma"}],["D005935",{"mesh_id":"D005935","trials":[{"ligand":"everolimus","mesh_id":"D005935","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D005935","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02031536;NCT02273752"},{"ligand":"gefitinib","mesh_id":"D005935","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"pazopanib","mesh_id":"D005935","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"regorafenib","mesh_id":"D005935","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D005935","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"sirolimus","mesh_id":"D005935","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02031536;NCT01010126;NCT02273752"},{"ligand":"sorafenib","mesh_id":"D005935","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"trastuzumab","mesh_id":"D005935","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Glucagonoma"}],["D013005",{"mesh_id":"D013005","trials":[{"ligand":"everolimus","mesh_id":"D013005","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"everolimus","mesh_id":"D013005","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02031536;NCT02273752"},{"ligand":"gefitinib","mesh_id":"D013005","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"pazopanib","mesh_id":"D013005","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"regorafenib","mesh_id":"D013005","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02259725"},{"ligand":"sirolimus","mesh_id":"D013005","phase":"Phase 1","start_date":"2004","completion_date":"2010","nct_id":"NCT01204476;NCT00655655"},{"ligand":"sirolimus","mesh_id":"D013005","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02031536;NCT01010126;NCT02273752"},{"ligand":"sorafenib","mesh_id":"D013005","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"trastuzumab","mesh_id":"D013005","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Somatostatinoma"}],["D000231",{"mesh_id":"D000231","trials":[{"ligand":"everolimus","mesh_id":"D000231","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02283658"},{"ligand":"sirolimus","mesh_id":"D000231","phase":"Phase 2","start_date":"2009","completion_date":"2014","nct_id":"NCT02283658;NCT01010126"}],"predictions":[],"source_name":"Adenocarcinoma, Papillary"}],["D014402",{"mesh_id":"D014402","trials":[{"ligand":"everolimus","mesh_id":"D014402","phase":"Phase 2","start_date":"2005","completion_date":"2014","nct_id":"NCT01954693;NCT01929642;NCT00411619;NCT02201212;NCT01289912;NCT01070316;NCT02451696;NCT02061397;NCT00792766;NCT00457964"},{"ligand":"everolimus","mesh_id":"D014402","phase":"Phase 3","start_date":"2009","completion_date":"2020","nct_id":"NCT01730209;NCT01713946;NCT02962414;NCT00789828;NCT00790400;NCT02860494"},{"ligand":"everolimus","mesh_id":"D014402","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03525834"},{"ligand":"sirolimus","mesh_id":"D014402","phase":"Phase 1","start_date":"2009","completion_date":"2013","nct_id":"NCT01853423;NCT01031901"},{"ligand":"sirolimus","mesh_id":"D014402","phase":"Phase 2","start_date":"2002","completion_date":"2020","nct_id":"NCT00490789;NCT00457808;NCT02104011;NCT01929642;NCT04595513;NCT00411619;NCT01070316;NCT02061397;NCT01526356;NCT03363763;NCT03356769;NCT00457964"},{"ligand":"sirolimus","mesh_id":"D014402","phase":"Phase 3","start_date":"2009","completion_date":"2019","nct_id":"NCT02634931;NCT01730209;NCT01713946;NCT02635789;NCT00789828;NCT03826628;NCT03140449;NCT00790400"},{"ligand":"sirolimus","mesh_id":"D014402","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT01217125"}],"predictions":[{"target":"EGFR","probability":"0.4551296097386323"}],"source_name":"Tuberous Sclerosis"}],["D010954",{"mesh_id":"D010954","trials":[{"ligand":"everolimus","mesh_id":"D010954","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00962507"},{"ligand":"everolimus","mesh_id":"D010954","phase":"Phase 2","start_date":"2005","completion_date":"2007","nct_id":"NCT00618345;NCT00474929"},{"ligand":"imatinib","mesh_id":"D010954","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sirolimus","mesh_id":"D010954","phase":"Phase 1","start_date":"2006","completion_date":"2009","nct_id":"NCT00602693;NCT00962507;NCT00317798"},{"ligand":"sirolimus","mesh_id":"D010954","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00474929"},{"ligand":"sorafenib","mesh_id":"D010954","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00687674"},{"ligand":"sorafenib","mesh_id":"D010954","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00474929"},{"ligand":"sunitinib","mesh_id":"D010954","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Plasmacytoma"}],["D013736",{"mesh_id":"D013736","trials":[{"ligand":"everolimus","mesh_id":"D013736","phase":"Phase 2","start_date":"2010","completion_date":"2011","nct_id":"NCT01242631;NCT01466231"},{"ligand":"imatinib","mesh_id":"D013736","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042952"},{"ligand":"palbociclib","mesh_id":"D013736","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01037790"},{"ligand":"sorafenib","mesh_id":"D013736","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00772694"},{"ligand":"sunitinib","mesh_id":"D013736","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00453310"},{"ligand":"trastuzumab","mesh_id":"D013736","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"ERBB3","probability":"0.72"},{"target":"IGF1R","probability":"0.6904350265197877"},{"target":"PDGFRA","probability":"0.675"},{"target":"TEK","probability":"0.64"},{"target":"ERBB4","probability":"0.624187898089172"},{"target":"EGFR","probability":"0.62"},{"target":"FLT1","probability":"0.610625"},{"target":"MET","probability":"0.5912530450669915"},{"target":"FGFR1","probability":"0.5733883218463998"},{"target":"NTRK1","probability":"0.5653160819208441"},{"target":"FLT4","probability":"0.5650183598531212"},{"target":"INSR","probability":"0.5354347826086956"},{"target":"FGFR3","probability":"0.5324818091088311"},{"target":"BRAF","probability":"0.5320666666666667"},{"target":"FGFR2","probability":"0.5055837178708764"},{"target":"ALK","probability":"0.49541982048776106"},{"target":"MAP2K7","probability":"0.4800212314225053"},{"target":"JAK1","probability":"0.4786138656740029"},{"target":"JAK2","probability":"0.47002123142250535"},{"target":"ROS1","probability":"0.46080977405537055"}],"source_name":"Testicular Neoplasms"}],["D010580",{"mesh_id":"D010580","trials":[{"ligand":"everolimus","mesh_id":"D010580","phase":"Phase 2","start_date":"2008","completion_date":"2010","nct_id":"NCT00811590;NCT01178151"},{"ligand":"sirolimus","mesh_id":"D010580","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00811590"},{"ligand":"sirolimus","mesh_id":"D010580","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03781050"}],"predictions":[{"target":"EGFR","probability":"0.4883333333333333"}],"source_name":"Peutz-Jeghers Syndrome"}],["D013341",{"mesh_id":"D013341","trials":[{"ligand":"everolimus","mesh_id":"D013341","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01997255"},{"ligand":"sirolimus","mesh_id":"D013341","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT02080624"},{"ligand":"sirolimus","mesh_id":"D013341","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03047980"}],"predictions":[],"source_name":"Sturge-Weber Syndrome"}],["D010236",{"mesh_id":"D010236","trials":[{"ligand":"everolimus","mesh_id":"D010236","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT01152827"},{"ligand":"pazopanib","mesh_id":"D010236","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01340794"}],"predictions":[],"source_name":"Paraganglioma, Extra-Adrenal"}],["D018207",{"mesh_id":"D018207","trials":[{"ligand":"everolimus","mesh_id":"D018207","phase":"Phase 2","start_date":"2005","completion_date":"2015","nct_id":"NCT02539459;NCT00792766;NCT00457964"},{"ligand":"everolimus","mesh_id":"D018207","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00790400"},{"ligand":"everolimus","mesh_id":"D018207","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03525834"},{"ligand":"sirolimus","mesh_id":"D018207","phase":"Phase 2","start_date":"2005","completion_date":"2015","nct_id":"NCT02104011;NCT00126672;NCT00457964"},{"ligand":"sirolimus","mesh_id":"D018207","phase":"Phase 3","start_date":"2009","completion_date":"2009","nct_id":"NCT00790400"},{"ligand":"sirolimus","mesh_id":"D018207","phase":"Phase 4","start_date":"2008","completion_date":"2008","nct_id":"NCT01217125"}],"predictions":[],"source_name":"Angiomyolipoma"}],["D003969",{"mesh_id":"D003969","trials":[{"ligand":"everolimus","mesh_id":"D003969","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01229943"},{"ligand":"gefitinib","mesh_id":"D003969","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT00075439"},{"ligand":"sirolimus","mesh_id":"D003969","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01229943"},{"ligand":"sorafenib","mesh_id":"D003969","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00131911"},{"ligand":"trastuzumab","mesh_id":"D003969","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Vipoma"}],["D018761",{"mesh_id":"D018761","trials":[{"ligand":"everolimus","mesh_id":"D018761","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"lenvatinib","mesh_id":"D018761","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"},{"ligand":"pazopanib","mesh_id":"D018761","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00454363"},{"ligand":"sirolimus","mesh_id":"D018761","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03950609"}],"predictions":[],"source_name":"Multiple Endocrine Neoplasia Type 1"}],["D058249",{"mesh_id":"D058249","trials":[{"ligand":"everolimus","mesh_id":"D058249","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02504892"},{"ligand":"sirolimus","mesh_id":"D058249","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT00928798"}],"predictions":[],"source_name":"Birt-Hogg-Dube Syndrome"}],["D009463",{"mesh_id":"D009463","trials":[{"ligand":"everolimus","mesh_id":"D009463","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT01345136"},{"ligand":"lapatinib","mesh_id":"D009463","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00863122"}],"predictions":[],"source_name":"Neuroma"}],["D006222",{"mesh_id":"D006222","trials":[{"ligand":"everolimus","mesh_id":"D006222","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02991807"},{"ligand":"sirolimus","mesh_id":"D006222","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT04094675;NCT00971789"}],"predictions":[],"source_name":"Hamartoma"}],["D006223",{"mesh_id":"D006223","trials":[{"ligand":"everolimus","mesh_id":"D006223","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02991807"},{"ligand":"sirolimus","mesh_id":"D006223","phase":"Phase 2","start_date":"2008","completion_date":"2019","nct_id":"NCT04094675;NCT00971789"},{"ligand":"trastuzumab","mesh_id":"D006223","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00620594"}],"predictions":[],"source_name":"Hamartoma Syndrome, Multiple"}],["D009385",{"mesh_id":"D009385","trials":[{"ligand":"everolimus","mesh_id":"D009385","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01178151"}],"predictions":[{"target":"PDGFRB","probability":"0.5208093814033339"},{"target":"KIT","probability":"0.465"}],"source_name":"Neoplastic Processes"}],["D018206",{"mesh_id":"D018206","trials":[{"ligand":"everolimus","mesh_id":"D018206","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00792766"}],"predictions":[],"source_name":"Angiolipoma"}],["D018322",{"mesh_id":"D018322","trials":[{"ligand":"everolimus","mesh_id":"D018322","phase":"Phase 3","start_date":"2020","completion_date":"2020","nct_id":"NCT02860494"},{"ligand":"sirolimus","mesh_id":"D018322","phase":"Phase 1","start_date":"2009","completion_date":"2013","nct_id":"NCT01853423;NCT01031901"},{"ligand":"sirolimus","mesh_id":"D018322","phase":"Phase 2","start_date":"2012","completion_date":"2017","nct_id":"NCT01526356;NCT03363763"},{"ligand":"sirolimus","mesh_id":"D018322","phase":"Phase 3","start_date":"2013","completion_date":"2019","nct_id":"NCT02634931;NCT02635789;NCT03826628;NCT03140449"}],"predictions":[],"source_name":"Angiofibroma"}],["D049913",{"mesh_id":"D049913","trials":[{"ligand":"gefitinib","mesh_id":"D049913","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02484755"}],"predictions":[],"source_name":"ACTH-Secreting Pituitary Adenoma"}],["D018302",{"mesh_id":"D018302","trials":[{"ligand":"gefitinib","mesh_id":"D018302","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042991"},{"ligand":"palbociclib","mesh_id":"D018302","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"},{"ligand":"ribociclib","mesh_id":"D018302","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"},{"ligand":"trametinib","mesh_id":"D018302","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03434262"}],"predictions":[{"target":"BRAF","probability":"0.7605140115627177"}],"source_name":"Neoplasms, Neuroepithelial"}],["D002283",{"mesh_id":"D002283","trials":[{"ligand":"gefitinib","mesh_id":"D002283","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01485809"}],"predictions":[{"target":"PDGFRB","probability":"0.755"},{"target":"PDGFRA","probability":"0.6901553421998236"},{"target":"PIK3CA","probability":"0.65085"},{"target":"FLT3","probability":"0.6400847457627118"},{"target":"KIT","probability":"0.6301056338028169"},{"target":"IGF1R","probability":"0.6258688505059554"},{"target":"ROS1","probability":"0.6201819828031977"},{"target":"ABL1","probability":"0.6201311475409836"},{"target":"ERBB2","probability":"0.62"},{"target":"CDK4","probability":"0.6051241472759555"},{"target":"FGFR3","probability":"0.5961499640232435"},{"target":"JAK2","probability":"0.5951373496290142"},{"target":"FLT1","probability":"0.5919030047670226"},{"target":"FGFR1","probability":"0.5906466218993975"},{"target":"ERBB4","probability":"0.5903974355187089"},{"target":"KDR","probability":"0.5751556943687782"},{"target":"NTRK1","probability":"0.5653589405812766"},{"target":"ALK","probability":"0.5606073046124864"},{"target":"ERBB3","probability":"0.5603702202826236"},{"target":"CDK6","probability":"0.5554326910071271"},{"target":"BCR","probability":"0.5552367813438005"},{"target":"TEK","probability":"0.5454105745294671"},{"target":"INSR","probability":"0.5405781718281718"},{"target":"ZAP70","probability":"0.5352380952380953"},{"target":"BRAF","probability":"0.5261553724053725"},{"target":"MET","probability":"0.5218382999988157"},{"target":"EPHB2","probability":"0.5208576196299443"},{"target":"FLT4","probability":"0.5154043825763364"},{"target":"FGFR2","probability":"0.5055510523715149"},{"target":"BTK","probability":"0.4815252897356574"},{"target":"RET","probability":"0.4716957868164559"}],"source_name":"Carcinoma, Bronchogenic"}],["D015456",{"mesh_id":"D015456","trials":[{"ligand":"gilteritinib","mesh_id":"D015456","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115295"},{"ligand":"ibrutinib","mesh_id":"D015456","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03267186"},{"ligand":"midostaurin","mesh_id":"D015456","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02115295"},{"ligand":"quizartinib","mesh_id":"D015456","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT04047641"},{"ligand":"sirolimus","mesh_id":"D015456","phase":"Phase 2","start_date":"2016","completion_date":"2019","nct_id":"NCT02793544;NCT03970096"},{"ligand":"sorafenib","mesh_id":"D015456","phase":"Phase 2","start_date":"2014","completion_date":"2016","nct_id":"NCT02135874;NCT02728050"}],"predictions":[],"source_name":"Leukemia, Biphenotypic, Acute"}],["D054403",{"mesh_id":"D054403","trials":[{"ligand":"ibrutinib","mesh_id":"D054403","phase":"Phase 1","start_date":"2013","completion_date":"2018","nct_id":"NCT03479268;NCT01886859"},{"ligand":"ibrutinib","mesh_id":"D054403","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01589302"}],"predictions":[],"source_name":"Leukemia, Prolymphocytic, B-Cell"}],["D016483",{"mesh_id":"D016483","trials":[{"ligand":"ibrutinib","mesh_id":"D016483","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03220022"}],"predictions":[],"source_name":"Lymphoma, AIDS-Related"}],["D015461",{"mesh_id":"D015461","trials":[{"ligand":"ibrutinib","mesh_id":"D015461","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT03873493"},{"ligand":"sirolimus","mesh_id":"D015461","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01251575"}],"predictions":[],"source_name":"Leukemia, Prolymphocytic, T-Cell"}],["D000075363",{"mesh_id":"D000075363","trials":[{"ligand":"ibrutinib","mesh_id":"D000075363","phase":"Phase 2","start_date":"2018","completion_date":"2018","nct_id":"NCT03130348"},{"ligand":"imatinib","mesh_id":"D000075363","phase":"Phase 1","start_date":"2001","completion_date":"2001","nct_id":"NCT00025415"},{"ligand":"sunitinib","mesh_id":"D000075363","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00890747"}],"predictions":[],"source_name":"Immunoglobulin Light-chain Amyloidosis"}],["D000075122",{"mesh_id":"D000075122","trials":[{"ligand":"ibrutinib","mesh_id":"D000075122","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02943473"}],"predictions":[],"source_name":"Smoldering Multiple Myeloma"}],["D001984",{"mesh_id":"D001984","trials":[{"ligand":"icotinib","mesh_id":"D001984","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02264210"},{"ligand":"osimertinib","mesh_id":"D001984","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03516214"},{"ligand":"trametinib","mesh_id":"D001984","phase":"Phase 1","start_date":"2018","completion_date":"2018","nct_id":"NCT03516214"}],"predictions":[],"source_name":"Bronchial Neoplasms"}],["D018222",{"mesh_id":"D018222","trials":[{"ligand":"imatinib","mesh_id":"D018222","phase":"Phase 2","start_date":"2004","completion_date":"2019","nct_id":"NCT03802084;NCT01137916;NCT00928525;NCT00287846;NCT02495519"},{"ligand":"pazopanib","mesh_id":"D018222","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01876082"},{"ligand":"sirolimus","mesh_id":"D018222","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01265030"},{"ligand":"sorafenib","mesh_id":"D018222","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02066181"},{"ligand":"sunitinib","mesh_id":"D018222","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00474994"}],"predictions":[{"target":"BRAF","probability":"0.505"}],"source_name":"Fibromatosis, Aggressive"}],["D018223",{"mesh_id":"D018223","trials":[{"ligand":"imatinib","mesh_id":"D018223","phase":"Phase 2","start_date":"2004","completion_date":"2010","nct_id":"NCT01059656;NCT00085475;NCT00171912;NCT00084630;NCT00243191;NCT00122473"},{"ligand":"pazopanib","mesh_id":"D018223","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01059656"}],"predictions":[{"target":"MTOR","probability":"0.4616513307918193"}],"source_name":"Dermatofibrosarcoma"}],["D018237",{"mesh_id":"D018237","trials":[{"ligand":"imatinib","mesh_id":"D018237","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042952"},{"ligand":"palbociclib","mesh_id":"D018237","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01037790"},{"ligand":"pazopanib","mesh_id":"D018237","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00929903"},{"ligand":"sirolimus","mesh_id":"D018237","phase":"Phase 1","start_date":"2007","completion_date":"2010","nct_id":"NCT01155258;NCT00408655"},{"ligand":"sunitinib","mesh_id":"D018237","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00387920"}],"predictions":[{"target":"BRAF","probability":"0.7405844989027698"},{"target":"PIK3CA","probability":"0.5526215166015784"}],"source_name":"Germinoma"}],["D018239",{"mesh_id":"D018239","trials":[{"ligand":"imatinib","mesh_id":"D018239","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042952"},{"ligand":"palbociclib","mesh_id":"D018239","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01037790"}],"predictions":[{"target":"PDGFRA","probability":"0.5483401686033266"},{"target":"BRAF","probability":"0.547"},{"target":"ERBB2","probability":"0.5414764468342345"},{"target":"PDGFRB","probability":"0.5265959005257251"},{"target":"ERBB3","probability":"0.525"},{"target":"KDR","probability":"0.4954761904761905"},{"target":"FLT3","probability":"0.475"},{"target":"EGFR","probability":"0.47125"}],"source_name":"Seminoma"}],["D004407",{"mesh_id":"D004407","trials":[{"ligand":"imatinib","mesh_id":"D004407","phase":"Phase 2","start_date":"2002","completion_date":"2002","nct_id":"NCT00042952"}],"predictions":[],"source_name":"Dysgerminoma"}],["D000008",{"mesh_id":"D000008","trials":[{"ligand":"imatinib","mesh_id":"D000008","phase":"Phase 2","start_date":"2003","completion_date":"2003","nct_id":"NCT01316458"}],"predictions":[],"source_name":"Abdominal Neoplasms"}],["D005354",{"mesh_id":"D005354","trials":[{"ligand":"imatinib","mesh_id":"D005354","phase":"Phase 2","start_date":"2004","completion_date":"2006","nct_id":"NCT00084630;NCT00400569"},{"ligand":"larotrectinib","mesh_id":"D005354","phase":"Phase 2","start_date":"2019","completion_date":"2019","nct_id":"NCT03834961"},{"ligand":"olaratumab","mesh_id":"D005354","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D005354","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01532687"},{"ligand":"pazopanib","mesh_id":"D005354","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ribociclib","mesh_id":"D005354","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"sirolimus","mesh_id":"D005354","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01614795"},{"ligand":"sunitinib","mesh_id":"D005354","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00400569"}],"predictions":[{"target":"PIK3CA","probability":"0.5354237060580399"},{"target":"FGFR3","probability":"0.5317840605816073"},{"target":"FGFR1","probability":"0.5303666802545627"},{"target":"ERBB2","probability":"0.5063644633883516"},{"target":"RET","probability":"0.5012688199305747"},{"target":"BRAF","probability":"0.4959898588163385"},{"target":"EGFR","probability":"0.495"},{"target":"ERBB4","probability":"0.49183734251984906"},{"target":"IGF1R","probability":"0.49045434054800696"},{"target":"ALK","probability":"0.48695026270681835"},{"target":"INSR","probability":"0.4758214908799291"},{"target":"FGFR2","probability":"0.4712574452252213"},{"target":"ERBB3","probability":"0.46404822290435915"}],"source_name":"Fibrosarcoma"}],["D015452",{"mesh_id":"D015452","trials":[{"ligand":"imatinib","mesh_id":"D015452","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00905398"},{"ligand":"nilotinib","mesh_id":"D015452","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00905398"}],"predictions":[],"source_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma"}],["D005350",{"mesh_id":"D005350","trials":[{"ligand":"imatinib","mesh_id":"D005350","phase":"Phase 2","start_date":"2004","completion_date":"2014","nct_id":"NCT01137916;NCT00287846;NCT02495519"},{"ligand":"sirolimus","mesh_id":"D005350","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT01265030"},{"ligand":"sorafenib","mesh_id":"D005350","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02066181"}],"predictions":[],"source_name":"Fibroma"}],["D051642",{"mesh_id":"D051642","trials":[{"ligand":"imatinib","mesh_id":"D051642","phase":"Phase 2","start_date":"2002","completion_date":"2006","nct_id":"NCT00031915;NCT00400569"},{"ligand":"pazopanib","mesh_id":"D051642","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01418001"},{"ligand":"pazopanib","mesh_id":"D051642","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"sorafenib","mesh_id":"D051642","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00245102"},{"ligand":"sunitinib","mesh_id":"D051642","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00474994;NCT00400569"}],"predictions":[{"target":"BRAF","probability":"0.685"},{"target":"JAK2","probability":"0.47006535947712424"},{"target":"MTOR","probability":"0.46"}],"source_name":"Histiocytoma"}],["D018219",{"mesh_id":"D018219","trials":[{"ligand":"imatinib","mesh_id":"D018219","phase":"Phase 2","start_date":"2002","completion_date":"2006","nct_id":"NCT00031915;NCT00400569"},{"ligand":"pazopanib","mesh_id":"D018219","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"sorafenib","mesh_id":"D018219","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00245102"},{"ligand":"sunitinib","mesh_id":"D018219","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00474994;NCT00400569"}],"predictions":[],"source_name":"Histiocytoma, Benign Fibrous"}],["D051677",{"mesh_id":"D051677","trials":[{"ligand":"imatinib","mesh_id":"D051677","phase":"Phase 2","start_date":"2002","completion_date":"2006","nct_id":"NCT00031915;NCT00400569"},{"ligand":"olaratumab","mesh_id":"D051677","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02584309"},{"ligand":"pazopanib","mesh_id":"D051677","phase":"Phase 2","start_date":"2011","completion_date":"2015","nct_id":"NCT01418001;NCT02601209;NCT01532687"},{"ligand":"pazopanib","mesh_id":"D051677","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"ribociclib","mesh_id":"D051677","phase":"Phase 1","start_date":"2017","completion_date":"2017","nct_id":"NCT03009201"},{"ligand":"sorafenib","mesh_id":"D051677","phase":"Phase 2","start_date":"2005","completion_date":"2005","nct_id":"NCT00245102"},{"ligand":"sunitinib","mesh_id":"D051677","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00474994;NCT00400569"}],"predictions":[],"source_name":"Histiocytoma, Malignant Fibrous"}],["D018211",{"mesh_id":"D018211","trials":[{"ligand":"imatinib","mesh_id":"D018211","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"pazopanib","mesh_id":"D018211","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"pazopanib","mesh_id":"D018211","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"},{"ligand":"regorafenib","mesh_id":"D018211","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"sirolimus","mesh_id":"D018211","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02821507"},{"ligand":"sorafenib","mesh_id":"D018211","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"},{"ligand":"sunitinib","mesh_id":"D018211","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02048371"}],"predictions":[],"source_name":"Chondrosarcoma, Mesenchymal"}],["D010911",{"mesh_id":"D010911","trials":[{"ligand":"lapatinib","mesh_id":"D010911","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00939523"}],"predictions":[{"target":"ABL1","probability":"0.47029842125529453"}],"source_name":"Pituitary Neoplasms"}],["D015175",{"mesh_id":"D015175","trials":[{"ligand":"lapatinib","mesh_id":"D015175","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00939523"}],"predictions":[],"source_name":"Prolactinoma"}],["D013120",{"mesh_id":"D013120","trials":[{"ligand":"lapatinib","mesh_id":"D013120","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT00826241"}],"predictions":[{"target":"BRAF","probability":"0.5038840761510986"},{"target":"KIT","probability":"0.48092754374529806"},{"target":"PIK3CA","probability":"0.47066017112787883"}],"source_name":"Spinal Cord Neoplasms"}],["D005134",{"mesh_id":"D005134","trials":[{"ligand":"lenvatinib","mesh_id":"D005134","phase":"Phase 1","start_date":"2016","completion_date":"2016","nct_id":"NCT02915172"}],"predictions":[],"source_name":"Eye Neoplasms"}],["D009375",{"mesh_id":"D009375","trials":[{"ligand":"lenvatinib","mesh_id":"D009375","phase":"Phase 2","start_date":"2020","completion_date":"2020","nct_id":"NCT04519151"},{"ligand":"sorafenib","mesh_id":"D009375","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01556815"},{"ligand":"sorafenib","mesh_id":"D009375","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01009593"},{"ligand":"trastuzumab","mesh_id":"D009375","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01556815"}],"predictions":[{"target":"KIT","probability":"0.71"},{"target":"ABL1","probability":"0.6402325581395348"},{"target":"PDGFRB","probability":"0.615"},{"target":"BRAF","probability":"0.5052233640939597"}],"source_name":"Neoplasms, Glandular and Epithelial"}],["D000070779",{"mesh_id":"D000070779","trials":[{"ligand":"nilotinib","mesh_id":"D000070779","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01261429;NCT01207492"},{"ligand":"pexidartinib","mesh_id":"D000070779","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04703322"},{"ligand":"pexidartinib","mesh_id":"D000070779","phase":"Phase 3","start_date":"2015","completion_date":"2020","nct_id":"NCT02371369;NCT04488822"},{"ligand":"pexidartinib","mesh_id":"D000070779","phase":"Phase 4","start_date":"2020","completion_date":"2020","nct_id":"NCT04526704"}],"predictions":[{"target":"KIT","probability":"0.9838988095238094"},{"target":"CSF1R","probability":"0.823805566016787"}],"source_name":"Giant Cell Tumor of Tendon Sheath"}],["D013586",{"mesh_id":"D013586","trials":[{"ligand":"nilotinib","mesh_id":"D013586","phase":"Phase 2","start_date":"2010","completion_date":"2010","nct_id":"NCT01261429;NCT01207492"},{"ligand":"pexidartinib","mesh_id":"D013586","phase":"Phase 3","start_date":"2015","completion_date":"2015","nct_id":"NCT02371369"}],"predictions":[],"source_name":"Synovitis, Pigmented Villonodular"}],["D055331",{"mesh_id":"D055331","trials":[{"ligand":"nintedanib","mesh_id":"D055331","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02866370"},{"ligand":"sirolimus","mesh_id":"D055331","phase":"Phase 1","start_date":"2012","completion_date":"2012","nct_id":"NCT01625351"},{"ligand":"sirolimus","mesh_id":"D055331","phase":"Phase 2","start_date":"2004","completion_date":"2004","nct_id":"NCT00072176"},{"ligand":"sunitinib","mesh_id":"D055331","phase":"Phase 2","start_date":"2013","completion_date":"2013","nct_id":"NCT01824615"}],"predictions":[],"source_name":"Adenomyoepithelioma"}],["D001063",{"mesh_id":"D001063","trials":[{"ligand":"nintedanib","mesh_id":"D001063","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03287947"}],"predictions":[],"source_name":"Appendiceal Neoplasms"}],["D016545",{"mesh_id":"D016545","trials":[{"ligand":"palbociclib","mesh_id":"D016545","phase":"Phase 1","start_date":"2014","completion_date":"2014","nct_id":"NCT02255461"}],"predictions":[],"source_name":"Choroid Plexus Neoplasms"}],["D013724",{"mesh_id":"D013724","trials":[{"ligand":"palbociclib","mesh_id":"D013724","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01037790"},{"ligand":"pazopanib","mesh_id":"D013724","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00929903"},{"ligand":"ribociclib","mesh_id":"D013724","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02300987"},{"ligand":"sunitinib","mesh_id":"D013724","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00387920"},{"ligand":"sunitinib","mesh_id":"D013724","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00453310"}],"predictions":[{"target":"BRAF","probability":"0.57691030143272"},{"target":"MTOR","probability":"0.476870273240404"}],"source_name":"Teratoma"}],["D003884",{"mesh_id":"D003884","trials":[{"ligand":"palbociclib","mesh_id":"D003884","phase":"Phase 2","start_date":"2009","completion_date":"2009","nct_id":"NCT01037790"}],"predictions":[],"source_name":"Dermoid Cyst"}],["D018240",{"mesh_id":"D018240","trials":[{"ligand":"pazopanib","mesh_id":"D018240","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00929903"},{"ligand":"sunitinib","mesh_id":"D018240","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00387920"}],"predictions":[],"source_name":"Endodermal Sinus Tumor"}],["D002822",{"mesh_id":"D002822","trials":[{"ligand":"pazopanib","mesh_id":"D002822","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00929903"},{"ligand":"sunitinib","mesh_id":"D002822","phase":"Phase 1","start_date":"2006","completion_date":"2006","nct_id":"NCT00387920"}],"predictions":[{"target":"EGFR","probability":"0.460625"}],"source_name":"Choriocarcinoma"}],["D006390",{"mesh_id":"D006390","trials":[{"ligand":"pazopanib","mesh_id":"D006390","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01532687"},{"ligand":"sirolimus","mesh_id":"D006390","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04409691"},{"ligand":"sirolimus","mesh_id":"D006390","phase":"Phase 2","start_date":"2009","completion_date":"2017","nct_id":"NCT00975819;NCT02110069;NCT03188068"},{"ligand":"sirolimus","mesh_id":"D006390","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04775173"},{"ligand":"sirolimus","mesh_id":"D006390","phase":"Phase 4","start_date":"2019","completion_date":"2020","nct_id":"NCT04077515;NCT04406870;NCT04448873"},{"ligand":"trametinib","mesh_id":"D006390","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03148275"}],"predictions":[],"source_name":"Hemangioendothelioma"}],["D018323",{"mesh_id":"D018323","trials":[{"ligand":"pazopanib","mesh_id":"D018323","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01532687"},{"ligand":"trametinib","mesh_id":"D018323","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03148275"}],"predictions":[],"source_name":"Hemangioendothelioma, Epithelioid"}],["D005918",{"mesh_id":"D005918","trials":[{"ligand":"pazopanib","mesh_id":"D005918","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"}],"predictions":[],"source_name":"Glomus Tumor"}],["D016586",{"mesh_id":"D016586","trials":[{"ligand":"pazopanib","mesh_id":"D016586","phase":"Phase 3","start_date":"2014","completion_date":"2014","nct_id":"NCT02180867"}],"predictions":[],"source_name":"Granular Cell Tumor"}],["D061206",{"mesh_id":"D061206","trials":[{"ligand":"pertuzumab","mesh_id":"D061206","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04569747"},{"ligand":"trastuzumab","mesh_id":"D061206","phase":"Phase 1","start_date":"2009","completion_date":"2009","nct_id":"NCT00949247"},{"ligand":"trastuzumab","mesh_id":"D061206","phase":"Phase 2","start_date":"2021","completion_date":"2021","nct_id":"NCT04569747"}],"predictions":[],"source_name":"Neoplasm Micrometastasis"}],["D002812",{"mesh_id":"D002812","trials":[{"ligand":"regorafenib","mesh_id":"D002812","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02389244"}],"predictions":[],"source_name":"Chondroma"}],["D020339",{"mesh_id":"D020339","trials":[{"ligand":"selumetinib","mesh_id":"D020339","phase":"Phase 2","start_date":"2010","completion_date":"2019","nct_id":"NCT01089101;NCT03326388;NCT02839720"}],"predictions":[{"target":"BRAF","probability":"0.5177388095087472"}],"source_name":"Optic Nerve Glioma"}],["D009380",{"mesh_id":"D009380","trials":[{"ligand":"selumetinib","mesh_id":"D009380","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT03109301"}],"predictions":[],"source_name":"Neoplasms, Nerve Tissue"}],["D008202",{"mesh_id":"D008202","trials":[{"ligand":"sirolimus","mesh_id":"D008202","phase":"Phase 2","start_date":"2009","completion_date":"2020","nct_id":"NCT00975819;NCT03243019;NCT04128722;NCT03972592"}],"predictions":[],"source_name":"Lymphangioma"}],["D007947",{"mesh_id":"D007947","trials":[{"ligand":"sirolimus","mesh_id":"D007947","phase":"Phase 1","start_date":"2013","completion_date":"2013","nct_id":"NCT01822015"},{"ligand":"sirolimus","mesh_id":"D007947","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00634244"},{"ligand":"sorafenib","mesh_id":"D007947","phase":"Phase 1","start_date":"2005","completion_date":"2010","nct_id":"NCT00217646;NCT00131989;NCT01159301"}],"predictions":[],"source_name":"Leukemia, Megakaryoblastic, Acute"}],["D006391",{"mesh_id":"D006391","trials":[{"ligand":"sirolimus","mesh_id":"D006391","phase":"Phase 2","start_date":"2014","completion_date":"2017","nct_id":"NCT02042326;NCT02110069"},{"ligand":"sirolimus","mesh_id":"D006391","phase":"Phase 4","start_date":"2019","completion_date":"2019","nct_id":"NCT04077515"}],"predictions":[],"source_name":"Hemangioma"}],["D018324",{"mesh_id":"D018324","trials":[{"ligand":"sirolimus","mesh_id":"D018324","phase":"Phase 1","start_date":"2008","completion_date":"2008","nct_id":"NCT00830466;NCT00800722"}],"predictions":[],"source_name":"Hemangioma, Capillary"}],["D018329",{"mesh_id":"D018329","trials":[{"ligand":"sirolimus","mesh_id":"D018329","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03767660"}],"predictions":[],"source_name":"Nevus, Blue"}],["D059885",{"mesh_id":"D059885","trials":[{"ligand":"sirolimus","mesh_id":"D059885","phase":"Phase 1","start_date":"2020","completion_date":"2020","nct_id":"NCT04409691"},{"ligand":"sirolimus","mesh_id":"D059885","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02110069;NCT03188068"},{"ligand":"sirolimus","mesh_id":"D059885","phase":"Phase 3","start_date":"2021","completion_date":"2021","nct_id":"NCT04775173"},{"ligand":"sirolimus","mesh_id":"D059885","phase":"Phase 4","start_date":"2019","completion_date":"2020","nct_id":"NCT04077515;NCT04448873"}],"predictions":[],"source_name":"Kasabach-Merritt Syndrome"}],["D023981",{"mesh_id":"D023981","trials":[{"ligand":"sirolimus","mesh_id":"D023981","phase":"Phase 2","start_date":"2016","completion_date":"2016","nct_id":"NCT02790515"},{"ligand":"sorafenib","mesh_id":"D023981","phase":"Phase 3","start_date":"2011","completion_date":"2011","nct_id":"NCT01371981"}],"predictions":[],"source_name":"Sarcoma, Myeloid"}],["D054973",{"mesh_id":"D054973","trials":[{"ligand":"sirolimus","mesh_id":"D054973","phase":"Phase 2","start_date":"2012","completion_date":"2015","nct_id":"NCT01690871;NCT02494570"}],"predictions":[],"source_name":"Perivascular Epithelioid Cell Neoplasms"}],["D018208",{"mesh_id":"D018208","trials":[{"ligand":"sirolimus","mesh_id":"D018208","phase":"Phase 2","start_date":"2014","completion_date":"2014","nct_id":"NCT02821507"}],"predictions":[],"source_name":"Liposarcoma, Myxoid"}],["D007952",{"mesh_id":"D007952","trials":[{"ligand":"sirolimus","mesh_id":"D007952","phase":"Phase 1","start_date":"2011","completion_date":"2011","nct_id":"NCT01163357"},{"ligand":"sirolimus","mesh_id":"D007952","phase":"Phase 2","start_date":"2017","completion_date":"2017","nct_id":"NCT02722668"}],"predictions":[{"target":"KIT","probability":"0.5100241545893719"}],"source_name":"Leukemia, Plasma Cell"}],["D007889",{"mesh_id":"D007889","trials":[{"ligand":"sirolimus","mesh_id":"D007889","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03500367"}],"predictions":[],"source_name":"Leiomyoma"}],["D047708",{"mesh_id":"D047708","trials":[{"ligand":"sirolimus","mesh_id":"D047708","phase":"Phase 4","start_date":"2018","completion_date":"2018","nct_id":"NCT03500367"}],"predictions":[],"source_name":"Myofibroma"}],["D009371",{"mesh_id":"D009371","trials":[{"ligand":"sorafenib","mesh_id":"D009371","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01556815"},{"ligand":"sorafenib","mesh_id":"D009371","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01009593"},{"ligand":"sunitinib","mesh_id":"D009371","phase":"Phase 3","start_date":"2017","completion_date":"2017","nct_id":"NCT03091192"},{"ligand":"trastuzumab","mesh_id":"D009371","phase":"Phase 2","start_date":"2011","completion_date":"2012","nct_id":"NCT01556815;NCT01472146"}],"predictions":[],"source_name":"Neoplasms by Site"}],["D009370",{"mesh_id":"D009370","trials":[{"ligand":"sorafenib","mesh_id":"D009370","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01556815"},{"ligand":"sorafenib","mesh_id":"D009370","phase":"Phase 3","start_date":"2010","completion_date":"2010","nct_id":"NCT01009593"},{"ligand":"sunitinib","mesh_id":"D009370","phase":"Phase 1","start_date":"2015","completion_date":"2015","nct_id":"NCT02386111"},{"ligand":"trastuzumab","mesh_id":"D009370","phase":"Phase 2","start_date":"2012","completion_date":"2012","nct_id":"NCT01556815"}],"predictions":[],"source_name":"Neoplasms by Histologic Type"}],["D015471",{"mesh_id":"D015471","trials":[{"ligand":"sorafenib","mesh_id":"D015471","phase":"Phase 1","start_date":"2005","completion_date":"2010","nct_id":"NCT00217646;NCT00131989;NCT01159301"}],"predictions":[],"source_name":"Leukemia, Basophilic, Acute"}],["D015472",{"mesh_id":"D015472","trials":[{"ligand":"sorafenib","mesh_id":"D015472","phase":"Phase 1","start_date":"2005","completion_date":"2010","nct_id":"NCT00217646;NCT00131989;NCT01159301"}],"predictions":[],"source_name":"Leukemia, Eosinophilic, Acute"}],["D009374",{"mesh_id":"D009374","trials":[{"ligand":"sorafenib","mesh_id":"D009374","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306058"}],"predictions":[],"source_name":"Neoplasms, Experimental"}],["D018248",{"mesh_id":"D018248","trials":[{"ligand":"sorafenib","mesh_id":"D018248","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306058"}],"predictions":[{"target":"EGFR","probability":"0.5458333333333333"},{"target":"KIT","probability":"0.4951923076923077"},{"target":"ERBB2","probability":"0.4858333333333333"}],"source_name":"Adenoma, Liver Cell"}],["D008114",{"mesh_id":"D008114","trials":[{"ligand":"sorafenib","mesh_id":"D008114","phase":"Phase 2","start_date":"2011","completion_date":"2011","nct_id":"NCT01306058"}],"predictions":[],"source_name":"Liver Neoplasms, Experimental"}],["D018813",{"mesh_id":"D018813","trials":[{"ligand":"sorafenib","mesh_id":"D018813","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00390325"},{"ligand":"vandetanib","mesh_id":"D018813","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00514046;NCT00358956"}],"predictions":[],"source_name":"Multiple Endocrine Neoplasia Type 2a"}],["D018814",{"mesh_id":"D018814","trials":[{"ligand":"sorafenib","mesh_id":"D018814","phase":"Phase 2","start_date":"2006","completion_date":"2006","nct_id":"NCT00390325"},{"ligand":"vandetanib","mesh_id":"D018814","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00514046"}],"predictions":[],"source_name":"Multiple Endocrine Neoplasia Type 2b"}],["D018325",{"mesh_id":"D018325","trials":[{"ligand":"sunitinib","mesh_id":"D018325","phase":"Phase 2","start_date":"2006","completion_date":"2007","nct_id":"NCT00330564;NCT00589784"}],"predictions":[{"target":"BRAF","probability":"0.48233981873370724"}],"source_name":"Hemangioblastoma"}],["D009376",{"mesh_id":"D009376","trials":[{"ligand":"sunitinib","mesh_id":"D009376","phase":"Phase 2","start_date":"2008","completion_date":"2008","nct_id":"NCT00748358"}],"predictions":[],"source_name":"Neoplasms, Hormone-Dependent"}],["D003230",{"mesh_id":"D003230","trials":[{"ligand":"sunitinib","mesh_id":"D003230","phase":"Phase 2","start_date":"2007","completion_date":"2007","nct_id":"NCT00482911"}],"predictions":[],"source_name":"Conjunctival Neoplasms"}],["D018202",{"mesh_id":"D018202","trials":[{"ligand":"trastuzumab","mesh_id":"D018202","phase":"Phase 2","start_date":"2015","completion_date":"2015","nct_id":"NCT02452554"}],"predictions":[],"source_name":"Pulmonary Blastoma"}],["D014846",{"mesh_id":"D014846","trials":[{"ligand":"trastuzumab","mesh_id":"D014846","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Vulvar Neoplasms"}],["D014625",{"mesh_id":"D014625","trials":[{"ligand":"trastuzumab","mesh_id":"D014625","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[],"source_name":"Vaginal Neoplasms"}],["D010282",{"mesh_id":"D010282","trials":[{"ligand":"trastuzumab","mesh_id":"D010282","phase":"Phase 1","start_date":"1999","completion_date":"1999","nct_id":"NCT00004074"}],"predictions":[{"target":"EGFR","probability":"0.4950068352699932"}],"source_name":"Parathyroid Neoplasms"}],["D018326",{"mesh_id":"D018326","trials":[],"predictions":[{"target":"BRAF","probability":"0.925"},{"target":"ABL1","probability":"0.73"},{"target":"PIK3CA","probability":"0.7150671140939597"},{"target":"JAK2","probability":"0.5750653594771242"},{"target":"BCR","probability":"0.5502325581395349"},{"target":"FLT3","probability":"0.5500653594771242"},{"target":"PDGFRA","probability":"0.54"},{"target":"KIT","probability":"0.52"},{"target":"MAP2K7","probability":"0.51"},{"target":"MTOR","probability":"0.505"},{"target":"PDGFRB","probability":"0.49"},{"target":"MAP2K2","probability":"0.4863546137032078"}],"source_name":"Nevi and Melanomas"}],["D008639",{"mesh_id":"D008639","trials":[],"predictions":[{"target":"KIT","probability":"0.915"},{"target":"KDR","probability":"0.88"},{"target":"FLT3","probability":"0.855"},{"target":"BRAF","probability":"0.85"},{"target":"PDGFRB","probability":"0.85"},{"target":"PDGFRA","probability":"0.825"},{"target":"MTOR","probability":"0.805"},{"target":"ALK","probability":"0.71"},{"target":"PIK3CA","probability":"0.695"},{"target":"JAK2","probability":"0.675"},{"target":"BCR","probability":"0.66"},{"target":"ABL1","probability":"0.655"},{"target":"AKT1","probability":"0.615"},{"target":"MAP2K7","probability":"0.61"},{"target":"FGFR1","probability":"0.58"},{"target":"RET","probability":"0.56"},{"target":"ERBB2","probability":"0.535"},{"target":"PIK3CD","probability":"0.515"},{"target":"FGFR3","probability":"0.5104545454545455"},{"target":"FGFR2","probability":"0.51"},{"target":"BTK","probability":"0.5"},{"target":"CDK4","probability":"0.49"},{"target":"NTRK1","probability":"0.48"},{"target":"JAK1","probability":"0.47"}],"source_name":"Mesenteric Cyst"}],["D060426",{"mesh_id":"D060426","trials":[],"predictions":[{"target":"BRAF","probability":"0.905"},{"target":"PIK3CA","probability":"0.8"},{"target":"ABL1","probability":"0.685"},{"target":"MTOR","probability":"0.605"},{"target":"MAP2K2","probability":"0.6000842696629214"},{"target":"MAP2K1","probability":"0.555"},{"target":"BCR","probability":"0.5503268977621765"},{"target":"FLT3","probability":"0.535122699386503"},{"target":"JAK2","probability":"0.535"},{"target":"ALK","probability":"0.525"},{"target":"PDGFRA","probability":"0.515"},{"target":"PDGFRB","probability":"0.5"},{"target":"RET","probability":"0.4550568181818182"}],"source_name":"Anti-N-Methyl-D-Aspartate Receptor Encephalitis"}],["D012511",{"mesh_id":"D012511","trials":[],"predictions":[{"target":"BRAF","probability":"0.88"},{"target":"PIK3CA","probability":"0.815"},{"target":"ABL1","probability":"0.695"},{"target":"JAK2","probability":"0.6650653594771242"},{"target":"MTOR","probability":"0.62"},{"target":"BCR","probability":"0.61"},{"target":"PDGFRA","probability":"0.59"},{"target":"FLT3","probability":"0.5850653594771242"},{"target":"PDGFRB","probability":"0.565"},{"target":"MAP2K2","probability":"0.5452255639097744"},{"target":"ALK","probability":"0.4950653594771242"},{"target":"RET","probability":"0.49"},{"target":"MAP2K1","probability":"0.48522556390977445"},{"target":"MAP2K7","probability":"0.46"}],"source_name":"Sarcoma 37"}],["D003803",{"mesh_id":"D003803","trials":[],"predictions":[{"target":"BRAF","probability":"0.875"},{"target":"FLT3","probability":"0.77"},{"target":"PIK3CA","probability":"0.76"},{"target":"MTOR","probability":"0.755"},{"target":"KIT","probability":"0.72"},{"target":"PDGFRA","probability":"0.715"},{"target":"JAK2","probability":"0.71"},{"target":"PDGFRB","probability":"0.645"},{"target":"ABL1","probability":"0.64"},{"target":"BCR","probability":"0.635"},{"target":"ALK","probability":"0.5850653594771242"},{"target":"MAP2K7","probability":"0.575"},{"target":"KDR","probability":"0.53"},{"target":"MAP2K2","probability":"0.48522556390977445"},{"target":"MAP2K1","probability":"0.485"},{"target":"PIK3CD","probability":"0.48"},{"target":"RET","probability":"0.47"}],"source_name":"Dentigerous Cyst"}],["D018245",{"mesh_id":"D018245","trials":[],"predictions":[{"target":"BRAF","probability":"0.875"},{"target":"ABL1","probability":"0.705"},{"target":"PIK3CA","probability":"0.6951598975991143"},{"target":"FLT3","probability":"0.5501851851851852"},{"target":"PDGFRB","probability":"0.55"},{"target":"JAK2","probability":"0.55"},{"target":"MTOR","probability":"0.53"},{"target":"MAP2K2","probability":"0.5251287141073658"},{"target":"PDGFRA","probability":"0.49"},{"target":"MAP2K1","probability":"0.475"}],"source_name":"Trophoblastic Tumor, Placental Site"}],["D000182",{"mesh_id":"D000182","trials":[],"predictions":[{"target":"BRAF","probability":"0.87"},{"target":"PIK3CA","probability":"0.7250927835051547"},{"target":"ABL1","probability":"0.72"},{"target":"JAK2","probability":"0.58"},{"target":"MAP2K2","probability":"0.57"},{"target":"BCR","probability":"0.565"},{"target":"MTOR","probability":"0.545"},{"target":"FLT3","probability":"0.540122699386503"},{"target":"ALK","probability":"0.53"},{"target":"MAP2K1","probability":"0.53"},{"target":"PDGFRB","probability":"0.48"},{"target":"PDGFRA","probability":"0.475"}],"source_name":"ACTH Syndrome, Ectopic"}],["D002430",{"mesh_id":"D002430","trials":[],"predictions":[{"target":"BRAF","probability":"0.87"},{"target":"MTOR","probability":"0.78"},{"target":"PIK3CA","probability":"0.78"},{"target":"FLT3","probability":"0.7"},{"target":"KIT","probability":"0.675"},{"target":"ABL1","probability":"0.66"},{"target":"JAK2","probability":"0.65"},{"target":"PDGFRA","probability":"0.635"},{"target":"BCR","probability":"0.61"},{"target":"ALK","probability":"0.5900653594771242"},{"target":"PDGFRB","probability":"0.575"},{"target":"KDR","probability":"0.5600946372239748"},{"target":"AKT1","probability":"0.515"},{"target":"MAP2K7","probability":"0.505"},{"target":"ERBB2","probability":"0.5"},{"target":"MAP2K2","probability":"0.495"},{"target":"RET","probability":"0.455"},{"target":"PIK3CD","probability":"0.455"}],"source_name":"Cecal Neoplasms"}],["D009631",{"mesh_id":"D009631","trials":[],"predictions":[{"target":"MTOR","probability":"0.87"},{"target":"PDGFRB","probability":"0.87"},{"target":"KIT","probability":"0.845"},{"target":"FLT3","probability":"0.84"},{"target":"BRAF","probability":"0.84"},{"target":"KDR","probability":"0.84"},{"target":"PDGFRA","probability":"0.805"},{"target":"PIK3CA","probability":"0.735"},{"target":"ALK","probability":"0.715"},{"target":"ABL1","probability":"0.71"},{"target":"JAK2","probability":"0.69"},{"target":"MAP2K7","probability":"0.625"},{"target":"AKT1","probability":"0.62"},{"target":"FGFR1","probability":"0.615"},{"target":"BCR","probability":"0.61"},{"target":"RET","probability":"0.595"},{"target":"BTK","probability":"0.55"},{"target":"FGFR3","probability":"0.5300671140939598"},{"target":"PIK3CD","probability":"0.495"},{"target":"ERBB2","probability":"0.49"},{"target":"MAP2K1","probability":"0.465"},{"target":"JAK1","probability":"0.4560526315789474"}],"source_name":"Nonodontogenic Cysts"}],["D005153",{"mesh_id":"D005153","trials":[],"predictions":[{"target":"BRAF","probability":"0.865"},{"target":"PIK3CA","probability":"0.76"},{"target":"ABL1","probability":"0.65"},{"target":"MTOR","probability":"0.635"},{"target":"BCR","probability":"0.59"},{"target":"FLT3","probability":"0.5750653594771242"},{"target":"JAK2","probability":"0.5700653594771242"},{"target":"PDGFRA","probability":"0.54"},{"target":"ALK","probability":"0.5254078252305489"},{"target":"PDGFRB","probability":"0.5"}],"source_name":"Facial Neoplasms"}],["D002284",{"mesh_id":"D002284","trials":[],"predictions":[{"target":"BRAF","probability":"0.86"},{"target":"PIK3CA","probability":"0.765"},{"target":"MTOR","probability":"0.73"},{"target":"FLT3","probability":"0.675"},{"target":"JAK2","probability":"0.66"},{"target":"ABL1","probability":"0.655"},{"target":"BCR","probability":"0.625"},{"target":"KIT","probability":"0.62"},{"target":"PDGFRA","probability":"0.61"},{"target":"PDGFRB","probability":"0.605"},{"target":"KDR","probability":"0.5850946372239748"},{"target":"ALK","probability":"0.54"},{"target":"MAP2K7","probability":"0.54"},{"target":"MAP2K2","probability":"0.52"},{"target":"AKT1","probability":"0.49"},{"target":"ERBB2","probability":"0.475"},{"target":"RET","probability":"0.46"},{"target":"MAP2K1","probability":"0.455"}],"source_name":"Carcinoma, Brown-Pearce"}],["D013125",{"mesh_id":"D013125","trials":[],"predictions":[{"target":"BRAF","probability":"0.855"},{"target":"MTOR","probability":"0.785"},{"target":"FLT3","probability":"0.77"},{"target":"KDR","probability":"0.735"},{"target":"PDGFRA","probability":"0.73"},{"target":"ABL1","probability":"0.715"},{"target":"PIK3CA","probability":"0.71"},{"target":"PDGFRB","probability":"0.705"},{"target":"JAK2","probability":"0.685"},{"target":"ALK","probability":"0.655"},{"target":"BCR","probability":"0.65"},{"target":"KIT","probability":"0.63"},{"target":"MAP2K7","probability":"0.575"},{"target":"AKT1","probability":"0.525"},{"target":"RET","probability":"0.52"},{"target":"PIK3CD","probability":"0.48"},{"target":"FGFR1","probability":"0.475"},{"target":"ERBB2","probability":"0.47"},{"target":"MAP2K2","probability":"0.46"},{"target":"MAP2K1","probability":"0.46"}],"source_name":"Spinal Neoplasms"}],["D008210",{"mesh_id":"D008210","trials":[],"predictions":[{"target":"BRAF","probability":"0.85"},{"target":"PIK3CA","probability":"0.745"},{"target":"ABL1","probability":"0.685"},{"target":"JAK2","probability":"0.66"},{"target":"MTOR","probability":"0.585"},{"target":"BCR","probability":"0.5700653594771242"},{"target":"FLT3","probability":"0.555"},{"target":"ALK","probability":"0.545"},{"target":"MAP2K2","probability":"0.5350842696629213"},{"target":"PDGFRA","probability":"0.53"},{"target":"PDGFRB","probability":"0.475"}],"source_name":"Lymphocele"}],["D010157",{"mesh_id":"D010157","trials":[],"predictions":[{"target":"BRAF","probability":"0.835"},{"target":"PIK3CA","probability":"0.675"},{"target":"MTOR","probability":"0.67"},{"target":"JAK2","probability":"0.665"},{"target":"FLT3","probability":"0.655"},{"target":"ABL1","probability":"0.65"},{"target":"BCR","probability":"0.63"},{"target":"PDGFRA","probability":"0.62"},{"target":"KDR","probability":"0.615"},{"target":"PDGFRB","probability":"0.55"},{"target":"KIT","probability":"0.51"},{"target":"MAP2K2","probability":"0.505"},{"target":"AKT1","probability":"0.495"},{"target":"ALK","probability":"0.49"},{"target":"ERBB2","probability":"0.46"},{"target":"RET","probability":"0.4550568181818182"}],"source_name":"Palatal Neoplasms"}],["D018193",{"mesh_id":"D018193","trials":[],"predictions":[{"target":"BRAF","probability":"0.835"},{"target":"PIK3CA","probability":"0.72"},{"target":"MTOR","probability":"0.715"},{"target":"FLT3","probability":"0.71"},{"target":"ABL1","probability":"0.685"},{"target":"KIT","probability":"0.655"},{"target":"PDGFRA","probability":"0.63"},{"target":"JAK2","probability":"0.605"},{"target":"BCR","probability":"0.605"},{"target":"PDGFRB","probability":"0.595"},{"target":"ALK","probability":"0.58"},{"target":"AKT1","probability":"0.575"},{"target":"KDR","probability":"0.53"},{"target":"MAP2K2","probability":"0.51"},{"target":"MAP2K7","probability":"0.505"},{"target":"ERBB2","probability":"0.48"},{"target":"RET","probability":"0.475"}],"source_name":"Neoplasms, Complex and Mixed"}],["D009379",{"mesh_id":"D009379","trials":[],"predictions":[{"target":"BRAF","probability":"0.83"},{"target":"FLT3","probability":"0.77"},{"target":"MTOR","probability":"0.77"},{"target":"PIK3CA","probability":"0.695"},{"target":"KDR","probability":"0.69"},{"target":"JAK2","probability":"0.69"},{"target":"BCR","probability":"0.645"},{"target":"ABL1","probability":"0.63"},{"target":"KIT","probability":"0.605"},{"target":"MAP2K7","probability":"0.6"},{"target":"ALK","probability":"0.5900653594771242"},{"target":"PDGFRB","probability":"0.585"},{"target":"PDGFRA","probability":"0.57"},{"target":"MAP2K1","probability":"0.51"},{"target":"PIK3CD","probability":"0.495"},{"target":"MAP2K2","probability":"0.48030983357269574"},{"target":"RET","probability":"0.465"}],"source_name":"Neoplasms, Muscle Tissue"}],["D006607",{"mesh_id":"D006607","trials":[],"predictions":[{"target":"KIT","probability":"0.825"},{"target":"BRAF","probability":"0.815"},{"target":"PDGFRA","probability":"0.81"},{"target":"FLT3","probability":"0.805"},{"target":"PDGFRB","probability":"0.785"},{"target":"ALK","probability":"0.78"},{"target":"BTK","probability":"0.78"},{"target":"ROS1","probability":"0.77"},{"target":"KDR","probability":"0.76"},{"target":"RET","probability":"0.74"},{"target":"PIK3CA","probability":"0.735"},{"target":"JAK2","probability":"0.73"},{"target":"MTOR","probability":"0.725"},{"target":"JAK1","probability":"0.725"},{"target":"ABL1","probability":"0.725"},{"target":"MAP2K7","probability":"0.72"},{"target":"NTRK1","probability":"0.71"},{"target":"FGFR2","probability":"0.71"},{"target":"FGFR3","probability":"0.705"},{"target":"TEK","probability":"0.7"},{"target":"AKT1","probability":"0.695"},{"target":"FGFR1","probability":"0.69"},{"target":"JAK3","probability":"0.685"},{"target":"BCR","probability":"0.685"},{"target":"EGFR","probability":"0.68"},{"target":"SRC","probability":"0.68"},{"target":"PIK3CD","probability":"0.68"},{"target":"ERBB2","probability":"0.675"},{"target":"RPS6KB1","probability":"0.675"},{"target":"MET","probability":"0.67"},{"target":"IGF1R","probability":"0.67"},{"target":"GSK3B","probability":"0.665"},{"target":"MAP2K2","probability":"0.66"},{"target":"PTK2","probability":"0.65"},{"target":"MAP2K1","probability":"0.65"},{"target":"FLT4","probability":"0.65"},{"target":"ACVRL1","probability":"0.65"},{"target":"ERBB4","probability":"0.65"},{"target":"ERBB3","probability":"0.64"},{"target":"RAF1","probability":"0.64"},{"target":"AXL","probability":"0.635"},{"target":"MAPK1","probability":"0.63"},{"target":"CSF1R","probability":"0.625"},{"target":"TGFBR1","probability":"0.62"},{"target":"TXK","probability":"0.62"},{"target":"FLT1","probability":"0.62"},{"target":"TGFBR2","probability":"0.615"},{"target":"PTK2B","probability":"0.615"},{"target":"ZAP70","probability":"0.615"},{"target":"MAPK3","probability":"0.61"},{"target":"PDK1","probability":"0.605"},{"target":"AURKA","probability":"0.605"},{"target":"CDK4","probability":"0.6"},{"target":"CDK6","probability":"0.6"},{"target":"AKT2","probability":"0.6"},{"target":"SYK","probability":"0.595"},{"target":"PIM1","probability":"0.595"},{"target":"EPHB2","probability":"0.585"},{"target":"CDKN1A","probability":"0.585"},{"target":"LRRK2","probability":"0.5802"},{"target":"STK11","probability":"0.575"},{"target":"NTRK3","probability":"0.57"},{"target":"NTRK2","probability":"0.57"},{"target":"MAPK8","probability":"0.565"},{"target":"INSR","probability":"0.565"},{"target":"CDK2","probability":"0.56"},{"target":"ITK","probability":"0.56"},{"target":"PLK1","probability":"0.555"},{"target":"MAPK14","probability":"0.555"},{"target":"PRKAA1","probability":"0.55"},{"target":"FGFR4","probability":"0.545"},{"target":"PRKAA2","probability":"0.54"},{"target":"LCK","probability":"0.535"},{"target":"PRKCA","probability":"0.535"},{"target":"CCL2","probability":"0.525"},{"target":"EPHA2","probability":"0.525"},{"target":"LYN","probability":"0.525"},{"target":"CAMK2G","probability":"0.525"},{"target":"ATM","probability":"0.52"},{"target":"AURKB","probability":"0.515"},{"target":"FYN","probability":"0.51"},{"target":"DAPK1","probability":"0.505"},{"target":"BMPR2","probability":"0.5"},{"target":"CCL5","probability":"0.5"},{"target":"ROCK1","probability":"0.5"},{"target":"MAP2K4","probability":"0.4950653594771242"},{"target":"TYK2","probability":"0.495"},{"target":"CDK1","probability":"0.495"},{"target":"BRD4","probability":"0.485"},{"target":"CDK20","probability":"0.4800653594771242"},{"target":"CHEK1","probability":"0.48"},{"target":"GSK3A","probability":"0.48"},{"target":"MAP3K7","probability":"0.47"},{"target":"PRKCD","probability":"0.465"},{"target":"EIF2AK3","probability":"0.46"},{"target":"PAK1","probability":"0.46"},{"target":"CCL3","probability":"0.46"},{"target":"PRKG1","probability":"0.455"},{"target":"ILK","probability":"0.455"}],"source_name":"Adenoma, Sweat Gland"}],["D000694",{"mesh_id":"D000694","trials":[],"predictions":[{"target":"BRAF","probability":"0.795"},{"target":"ABL1","probability":"0.74"},{"target":"PDGFRB","probability":"0.6"},{"target":"PIK3CA","probability":"0.595"},{"target":"PDGFRA","probability":"0.5100946372239747"},{"target":"FLT3","probability":"0.5054206170031621"},{"target":"JAK2","probability":"0.5050653594771242"},{"target":"KIT","probability":"0.47"},{"target":"MTOR","probability":"0.47"}],"source_name":"Anal Gland Neoplasms"}],["D002287",{"mesh_id":"D002287","trials":[],"predictions":[{"target":"ABL1","probability":"0.775"},{"target":"BRAF","probability":"0.665"},{"target":"KIT","probability":"0.62"},{"target":"PDGFRB","probability":"0.57"},{"target":"PIK3CA","probability":"0.49018405218848643"},{"target":"FLT3","probability":"0.4854206170031621"},{"target":"PDGFRA","probability":"0.48"},{"target":"MTOR","probability":"0.475"},{"target":"JAK2","probability":"0.46506535947712424"}],"source_name":"Carcinoma, Krebs 2"}],["D018205",{"mesh_id":"D018205","trials":[],"predictions":[{"target":"BRAF","probability":"0.77"},{"target":"ABL1","probability":"0.695"},{"target":"PIK3CA","probability":"0.6201598975991144"},{"target":"MTOR","probability":"0.505"},{"target":"JAK2","probability":"0.5"},{"target":"PDGFRB","probability":"0.495"},{"target":"KIT","probability":"0.48"},{"target":"FLT3","probability":"0.475"},{"target":"PDGFRA","probability":"0.455"}],"source_name":"Neoplasms, Adipose Tissue"}],["D009507",{"mesh_id":"D009507","trials":[],"predictions":[{"target":"ABL1","probability":"0.765"},{"target":"BRAF","probability":"0.655"},{"target":"KIT","probability":"0.57"},{"target":"PDGFRB","probability":"0.545"},{"target":"PIK3CA","probability":"0.4601598975991144"}],"source_name":"Nevus of Ota"}],["D013365",{"mesh_id":"D013365","trials":[],"predictions":[{"target":"BRAF","probability":"0.76"},{"target":"ABL1","probability":"0.74"},{"target":"KIT","probability":"0.625"},{"target":"PDGFRB","probability":"0.6"},{"target":"PIK3CA","probability":"0.5701169380945267"},{"target":"FLT3","probability":"0.49018805886362726"},{"target":"PDGFRA","probability":"0.49"},{"target":"JAK2","probability":"0.4750653594771242"},{"target":"MAP2K7","probability":"0.46"}],"source_name":"Submandibular Gland Neoplasms"}],["D054446",{"mesh_id":"D054446","trials":[],"predictions":[{"target":"ABL1","probability":"0.7502325581395348"},{"target":"KIT","probability":"0.585"},{"target":"PDGFRB","probability":"0.560024154589372"},{"target":"BRAF","probability":"0.53"}],"source_name":"Lymphoma, Primary Cutaneous Anaplastic Large Cell"}],["D002820",{"mesh_id":"D002820","trials":[],"predictions":[{"target":"BRAF","probability":"0.74"},{"target":"ABL1","probability":"0.705"},{"target":"KIT","probability":"0.57"},{"target":"PDGFRB","probability":"0.56"},{"target":"FLT3","probability":"0.5001880588636273"},{"target":"JAK2","probability":"0.4750653594771242"},{"target":"PDGFRA","probability":"0.475"},{"target":"PIK3CA","probability":"0.46009278350515465"}],"source_name":"Hydatidiform Mole, Invasive"}],["D008539",{"mesh_id":"D008539","trials":[],"predictions":[{"target":"ABL1","probability":"0.74"},{"target":"KIT","probability":"0.65"},{"target":"PDGFRB","probability":"0.62"},{"target":"BRAF","probability":"0.615"}],"source_name":"Meigs Syndrome"}],["D007942",{"mesh_id":"D007942","trials":[],"predictions":[{"target":"BRAF","probability":"0.735"},{"target":"ABL1","probability":"0.705"},{"target":"KIT","probability":"0.67"},{"target":"PDGFRB","probability":"0.535"},{"target":"FLT3","probability":"0.48012269938650304"},{"target":"JAK2","probability":"0.47574074074074074"}],"source_name":"Leukemia, Experimental"}],["D018190",{"mesh_id":"D018190","trials":[],"predictions":[{"target":"ABL1","probability":"0.73"},{"target":"BRAF","probability":"0.725"},{"target":"KIT","probability":"0.615"},{"target":"PDGFRB","probability":"0.58"},{"target":"FLT3","probability":"0.5051880588636273"},{"target":"PIK3CA","probability":"0.5051598975991144"},{"target":"PDGFRA","probability":"0.5000946372239747"},{"target":"MTOR","probability":"0.48"},{"target":"JAK2","probability":"0.4750653594771242"}],"source_name":"Lymphatic Vessel Tumors"}],["D010039",{"mesh_id":"D010039","trials":[],"predictions":[{"target":"ABL1","probability":"0.7102325581395348"},{"target":"KIT","probability":"0.685"},{"target":"PDGFRB","probability":"0.51"},{"target":"BRAF","probability":"0.4752987938596491"}],"source_name":"Otorhinolaryngologic Neoplasms"}],["D018213",{"mesh_id":"D018213","trials":[],"predictions":[{"target":"ABL1","probability":"0.71"},{"target":"BRAF","probability":"0.645"},{"target":"KIT","probability":"0.63"},{"target":"PDGFRB","probability":"0.575"}],"source_name":"Neoplasms, Bone Tissue"}],["D009369",{"mesh_id":"D009369","trials":[],"predictions":[{"target":"PDGFRA","probability":"0.6855952380952381"},{"target":"EGFR","probability":"0.68"},{"target":"KIT","probability":"0.66025"},{"target":"FLT3","probability":"0.6400141520112286"},{"target":"KDR","probability":"0.6107467426723057"},{"target":"RET","probability":"0.6101063891922791"},{"target":"BRAF","probability":"0.6059722312712397"},{"target":"IGF1R","probability":"0.5957925550668968"},{"target":"ABL1","probability":"0.5903099876367767"},{"target":"PDGFRB","probability":"0.5857274582988773"},{"target":"PIK3CA","probability":"0.5410519814542162"},{"target":"INSR","probability":"0.538409090909091"},{"target":"BCR","probability":"0.5329147183156165"},{"target":"JAK2","probability":"0.5104661716171617"},{"target":"MTOR","probability":"0.4906892379301548"},{"target":"NTRK1","probability":"0.4769770676964392"},{"target":"CDK4","probability":"0.4698334183995897"},{"target":"MET","probability":"0.46067896633222283"},{"target":"MAP2K7","probability":"0.4557002816113805"},{"target":"FLT1","probability":"0.4553647021170714"}],"source_name":"Neoplasms"}],["D010509",{"mesh_id":"D010509","trials":[],"predictions":[{"target":"KIT","probability":"0.68"},{"target":"ABL1","probability":"0.655"},{"target":"PDGFRB","probability":"0.51"}],"source_name":"Periodontal Cyst"}],["D018295",{"mesh_id":"D018295","trials":[],"predictions":[{"target":"KIT","probability":"0.67"},{"target":"ABL1","probability":"0.6352325581395349"},{"target":"BRAF","probability":"0.6"},{"target":"PDGFRB","probability":"0.55"}],"source_name":"Neoplasms, Basal Cell"}],["D063646",{"mesh_id":"D063646","trials":[],"predictions":[{"target":"PDGFRA","probability":"0.67"},{"target":"FGFR3","probability":"0.66"},{"target":"RET","probability":"0.6400543478260868"},{"target":"PIK3CA","probability":"0.6350084745762712"},{"target":"PDGFRB","probability":"0.625"},{"target":"JAK2","probability":"0.62"},{"target":"EGFR","probability":"0.61"},{"target":"KIT","probability":"0.605"},{"target":"INSR","probability":"0.6"},{"target":"ABL1","probability":"0.6"},{"target":"FGFR1","probability":"0.59"},{"target":"MTOR","probability":"0.58020336896973"},{"target":"IGF1R","probability":"0.575"},{"target":"NTRK1","probability":"0.57"},{"target":"ERBB2","probability":"0.5450142993326978"},{"target":"BRAF","probability":"0.5359090909090909"},{"target":"MAP2K7","probability":"0.5352577757654214"},{"target":"MAPK1","probability":"0.530108618074376"},{"target":"ERBB3","probability":"0.5250355239786856"},{"target":"FGFR2","probability":"0.5209302325581395"},{"target":"MET","probability":"0.505"},{"target":"FLT3","probability":"0.5"},{"target":"ALK","probability":"0.4950355239786856"},{"target":"AKT1","probability":"0.4902793294395661"},{"target":"ERBB4","probability":"0.47504399855495677"},{"target":"CDK4","probability":"0.47201428923855526"},{"target":"MAPK3","probability":"0.4651860234963606"},{"target":"KDR","probability":"0.46517251028005546"}],"source_name":"Carcinogenesis"}],["D002472",{"mesh_id":"D002472","trials":[],"predictions":[{"target":"KIT","probability":"0.665"},{"target":"ABL1","probability":"0.5753695444409047"},{"target":"PDGFRB","probability":"0.520024154589372"}],"source_name":"Cell Transformation, Viral"}],["D009366",{"mesh_id":"D009366","trials":[],"predictions":[{"target":"ABL1","probability":"0.6607881136950905"},{"target":"KIT","probability":"0.605"},{"target":"PDGFRB","probability":"0.530024154589372"},{"target":"BRAF","probability":"0.48506711409395975"}],"source_name":"Neoplasm Seeding"}],["D003043",{"mesh_id":"D003043","trials":[],"predictions":[{"target":"KIT","probability":"0.625"},{"target":"PDGFRB","probability":"0.51"},{"target":"FLT3","probability":"0.4702989814377851"}],"source_name":"Cocarcinogenesis"}],["D011252",{"mesh_id":"D011252","trials":[],"predictions":[{"target":"ABL1","probability":"0.6204325581395349"},{"target":"KIT","probability":"0.58"}],"source_name":"Pregnancy Complications, Neoplastic"}],["D018228",{"mesh_id":"D018228","trials":[],"predictions":[{"target":"KIT","probability":"0.61"},{"target":"ABL1","probability":"0.5806515362417247"}],"source_name":"Sarcoma, Small Cell"}],["D058288",{"mesh_id":"D058288","trials":[],"predictions":[{"target":"KIT","probability":"0.61"},{"target":"ABL1","probability":"0.6002325581395348"},{"target":"PDGFRB","probability":"0.495024154589372"}],"source_name":"Sister Mary Joseph's Nodule"}],["D000708",{"mesh_id":"D000708","trials":[],"predictions":[{"target":"BRAF","probability":"0.5851807028144698"},{"target":"PIK3CA","probability":"0.5404274378776683"}],"source_name":"Anaplasia"}],["D000237",{"mesh_id":"D000237","trials":[],"predictions":[{"target":"KIT","probability":"0.585"},{"target":"PDGFRB","probability":"0.470024154589372"}],"source_name":"Adenoma, Basophil"}],["D000074723",{"mesh_id":"D000074723","trials":[],"predictions":[{"target":"KIT","probability":"0.58"},{"target":"FLT3","probability":"0.47538167278266286"}],"source_name":"Oncogene Addiction"}],["D008339",{"mesh_id":"D008339","trials":[],"predictions":[{"target":"KIT","probability":"0.575"}],"source_name":"Mandibular Neoplasms"}],["D020288",{"mesh_id":"D020288","trials":[],"predictions":[{"target":"BRAF","probability":"0.550736168564196"},{"target":"PIK3CA","probability":"0.4975037522966144"}],"source_name":"Papilloma, Choroid Plexus"}],["D017254",{"mesh_id":"D017254","trials":[],"predictions":[{"target":"EGFR","probability":"0.55"},{"target":"ERBB2","probability":"0.5250980392156862"},{"target":"PIK3CA","probability":"0.4850381357481462"},{"target":"BRAF","probability":"0.4664285714285714"},{"target":"FLT3","probability":"0.45521108349927614"}],"source_name":"Leukemic Infiltration"}],["D018243",{"mesh_id":"D018243","trials":[],"predictions":[{"target":"KIT","probability":"0.5453571428571429"},{"target":"BRAF","probability":"0.5164344827586207"},{"target":"EGFR","probability":"0.5"},{"target":"ERBB3","probability":"0.48546806167534085"},{"target":"IGF1R","probability":"0.4697808988764045"}],"source_name":"Teratocarcinoma"}],["D002578",{"mesh_id":"D002578","trials":[],"predictions":[{"target":"KIT","probability":"0.545"},{"target":"ABL1","probability":"0.4753695444409047"},{"target":"PDGFRB","probability":"0.45502415458937195"}],"source_name":"Uterine Cervical Dysplasia"}],["D019042",{"mesh_id":"D019042","trials":[],"predictions":[{"target":"KIT","probability":"0.545"},{"target":"ABL1","probability":"0.4953695444409047"}],"source_name":"Muscle Neoplasms"}],["D065310",{"mesh_id":"D065310","trials":[],"predictions":[{"target":"KIT","probability":"0.545"}],"source_name":"Squamous Intraepithelial Lesions of the Cervix"}],["D018220",{"mesh_id":"D018220","trials":[],"predictions":[{"target":"MTOR","probability":"0.543189195368521"}],"source_name":"Fibroma, Desmoplastic"}],["D010145",{"mesh_id":"D010145","trials":[],"predictions":[{"target":"KIT","probability":"0.54"}],"source_name":"Paget Disease, Extramammary"}],["D019292",{"mesh_id":"D019292","trials":[],"predictions":[{"target":"ABL1","probability":"0.5352325581395349"},{"target":"PDGFRB","probability":"0.53"},{"target":"KIT","probability":"0.505"},{"target":"FLT3","probability":"0.4601226993865031"}],"source_name":"Skull Base Neoplasms"}],["D018299",{"mesh_id":"D018299","trials":[],"predictions":[{"target":"KIT","probability":"0.5300653594771242"}],"source_name":"Neoplasms, Ductal, Lobular, and Medullary"}],["D007029",{"mesh_id":"D007029","trials":[],"predictions":[{"target":"BRAF","probability":"0.5204387544603908"}],"source_name":"Hypothalamic Neoplasms"}],["D000310",{"mesh_id":"D000310","trials":[],"predictions":[{"target":"KIT","probability":"0.5152218305759869"},{"target":"PDGFRB","probability":"0.4801108208215599"},{"target":"ERBB2","probability":"0.477578125"},{"target":"EGFR","probability":"0.4550349690309202"}],"source_name":"Adrenal Gland Neoplasms"}],["D019043",{"mesh_id":"D019043","trials":[],"predictions":[{"target":"MTOR","probability":"0.5138745246052985"}],"source_name":"Vascular Neoplasms"}],["D010257",{"mesh_id":"D010257","trials":[],"predictions":[{"target":"KIT","probability":"0.5105749185466361"},{"target":"FLT3","probability":"0.49009800733693404"},{"target":"BRAF","probability":"0.4624323057815012"},{"target":"EGFR","probability":"0.4614120370370371"},{"target":"PDGFRB","probability":"0.45600326190823337"}],"source_name":"Paraneoplastic Syndromes"}],["D012186",{"mesh_id":"D012186","trials":[],"predictions":[{"target":"EGFR","probability":"0.5103916017928757"},{"target":"ERBB2","probability":"0.5000864779874213"},{"target":"KIT","probability":"0.49505177256610255"},{"target":"PIK3CA","probability":"0.4723021871114172"},{"target":"BRAF","probability":"0.4700423803060276"},{"target":"PDGFRB","probability":"0.46700911345674373"}],"source_name":"Retroperitoneal Neoplasms"}],["D010524",{"mesh_id":"D010524","trials":[],"predictions":[{"target":"BRAF","probability":"0.5087662182457274"}],"source_name":"Peripheral Nervous System Neoplasms"}],["D015192",{"mesh_id":"D015192","trials":[],"predictions":[{"target":"BRAF","probability":"0.5081038962864531"}],"source_name":"Infratentorial Neoplasms"}],["D010997",{"mesh_id":"D010997","trials":[],"predictions":[{"target":"KIT","probability":"0.5070350293472912"}],"source_name":"Pleural Neoplasms"}],["D019048",{"mesh_id":"D019048","trials":[],"predictions":[{"target":"ERBB2","probability":"0.5051392933387114"},{"target":"KIT","probability":"0.4551084745762711"}],"source_name":"Prostatic Intraepithelial Neoplasia"}],["D009378",{"mesh_id":"D009378","trials":[],"predictions":[{"target":"EGFR","probability":"0.5012037037037037"},{"target":"KIT","probability":"0.49328034399467396"},{"target":"ERBB2","probability":"0.49000683526999317"},{"target":"PDGFRA","probability":"0.48027214444228167"}],"source_name":"Neoplasms, Multiple Primary"}],["D043604",{"mesh_id":"D043604","trials":[],"predictions":[{"target":"KIT","probability":"0.5"}],"source_name":"Glomus Tympanicum Tumor"}],["D018827",{"mesh_id":"D018827","trials":[],"predictions":[{"target":"BRAF","probability":"0.4957352286304875"},{"target":"MET","probability":"0.4861403032430346"},{"target":"EGFR","probability":"0.4853125"},{"target":"KDR","probability":"0.45614730046948354"}],"source_name":"Carcinoma, Lewis Lung"}],["D016080",{"mesh_id":"D016080","trials":[],"predictions":[{"target":"BRAF","probability":"0.49518583796391236"}],"source_name":"Arachnoid Cysts"}],["D015174",{"mesh_id":"D015174","trials":[],"predictions":[{"target":"KIT","probability":"0.495"}],"source_name":"Epidural Neoplasms"}],["D002286",{"mesh_id":"D002286","trials":[],"predictions":[{"target":"EGFR","probability":"0.49"},{"target":"PIK3CA","probability":"0.4608521588350161"},{"target":"PDGFRB","probability":"0.4605083088954056"}],"source_name":"Carcinoma, Ehrlich Tumor"}],["D011648",{"mesh_id":"D011648","trials":[],"predictions":[{"target":"KIT","probability":"0.49"}],"source_name":"Pulmonary Adenomatosis, Ovine"}],["D004416",{"mesh_id":"D004416","trials":[],"predictions":[{"target":"ERBB2","probability":"0.48623811684383367"},{"target":"EGFR","probability":"0.4862037037037037"},{"target":"MTOR","probability":"0.47995893988536653"}],"source_name":"Dysplastic Nevus Syndrome"}],["D001353",{"mesh_id":"D001353","trials":[],"predictions":[{"target":"KIT","probability":"0.485"}],"source_name":"Avian Leukosis"}],["D018330",{"mesh_id":"D018330","trials":[],"predictions":[{"target":"MTOR","probability":"0.48004444444444444"}],"source_name":"Nevus, Intradermal"}],["D006338",{"mesh_id":"D006338","trials":[],"predictions":[{"target":"EGFR","probability":"0.48"}],"source_name":"Heart Neoplasms"}],["D010864",{"mesh_id":"D010864","trials":[],"predictions":[{"target":"KIT","probability":"0.48"}],"source_name":"Pilonidal Sinus"}],["D016582",{"mesh_id":"D016582","trials":[],"predictions":[{"target":"KIT","probability":"0.48"}],"source_name":"Leukemia, Feline"}],["D018236",{"mesh_id":"D018236","trials":[],"predictions":[{"target":"BRAF","probability":"0.4772551731049719"},{"target":"IGF1R","probability":"0.4759708013322048"},{"target":"PDGFRB","probability":"0.47544541812822394"},{"target":"EGFR","probability":"0.47"},{"target":"PDGFRA","probability":"0.4660642176609936"}],"source_name":"Carcinoma, Embryonal"}],["D012811",{"mesh_id":"D012811","trials":[],"predictions":[{"target":"FLT3","probability":"0.475095330799419"}],"source_name":"Sigmoid Neoplasms"}],["D000239",{"mesh_id":"D000239","trials":[],"predictions":[{"target":"KIT","probability":"0.475024154589372"}],"source_name":"Adenoma, Acidophil"}],["D000069584",{"mesh_id":"D000069584","trials":[],"predictions":[{"target":"KIT","probability":"0.47025"}],"source_name":"Unilateral Breast Neoplasms"}],["D000080443",{"mesh_id":"D000080443","trials":[],"predictions":[{"target":"KIT","probability":"0.47"}],"source_name":"Diffuse Intrinsic Pontine Glioma"}],["D020863",{"mesh_id":"D020863","trials":[],"predictions":[{"target":"BRAF","probability":"0.4673686796043311"}],"source_name":"Central Nervous System Cysts"}],["D003123",{"mesh_id":"D003123","trials":[],"predictions":[{"target":"ERBB2","probability":"0.4652564102564103"}],"source_name":"Colorectal Neoplasms, Hereditary Nonpolyposis"}],["D016583",{"mesh_id":"D016583","trials":[],"predictions":[{"target":"PDGFRA","probability":"0.465"}],"source_name":"Enzootic Bovine Leukosis"}],["D005497",{"mesh_id":"D005497","trials":[],"predictions":[{"target":"KIT","probability":"0.46"}],"source_name":"Follicular Cyst"}],["D010192",{"mesh_id":"D010192","trials":[],"predictions":[{"target":"KIT","probability":"0.4554164120307647"}],"source_name":"Pancreatic Pseudocyst"}],["D010181",{"mesh_id":"D010181","trials":[],"predictions":[{"target":"EGFR","probability":"0.4552704326923077"}],"source_name":"Pancreatic Cyst"}],["D054975",{"mesh_id":"D054975","trials":[],"predictions":[{"target":"KIT","probability":"0.455"}],"source_name":"Pallister-Hall Syndrome"}]]}